data_2prf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2prf _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.57 ' CE2' HD11 ' A' ' 96' ' ' LEU . 1.7 m-90 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.49 -67.31 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.072 -1.018 . . . . 0.0 109.568 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.503 ' O ' HG23 ' A' ' 8' ' ' THR . 1.8 m -65.81 -30.85 71.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.532 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.534 ' CB ' HD13 ' A' ' 10' ' ' LEU . 6.6 m-30 -81.73 -3.08 52.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.12 -0.987 . . . . 0.0 109.456 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.531 ' HA ' ' CG2' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -83.19 -41.05 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.983 -1.073 . . . . 0.0 108.794 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -90.46 48.29 1.53 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.378 -0.827 . . . . 0.0 111.117 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -165.85 -96.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.708 -1.245 . . . . 0.0 110.792 179.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -101.46 -68.97 0.8 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.982 -1.073 . . . . 0.0 110.925 -178.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.534 HD13 ' CB ' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -23.05 -43.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.561 ' N ' ' O ' ' A' ' 9' ' ' ASN . 48.9 t -91.94 -55.5 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.725 -1.235 . . . . 0.0 110.815 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.491 ' C ' ' CG2' ' A' ' 13' ' ' THR . . . -40.03 -47.78 3.39 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.525 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER 163.62 41.28 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.709 -0.877 . . . . 0.0 108.792 178.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -87.19 22.2 16.57 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 153.97 -34.1 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -134.46 137.94 50.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.509 ' C ' ' CG ' ' A' ' 18' ' ' GLN . 69.2 p -78.21 2.39 18.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.955 -1.091 . . . . 0.0 108.869 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.509 ' CG ' ' C ' ' A' ' 17' ' ' THR . 6.4 mt-30 -161.83 151.11 15.99 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.488 ' CB ' HG23 ' A' ' 11' ' ' VAL . . . -163.47 147.97 10.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.967 -1.083 . . . . 0.0 109.973 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -141.81 152.03 43.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.429 -0.795 . . . . 0.0 108.974 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.484 HD13 ' C ' ' A' ' 2' ' ' TRP . 7.0 mt -120.88 103.22 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.949 . . . . 0.0 109.669 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.48 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -136.55 164.23 28.67 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.578 ' O ' ' CH2' ' A' ' 29' ' ' TRP . . . 132.64 172.79 13.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.504 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.4 mp 60.78 121.0 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.148 0 O-C-N 121.159 -1.2 . . . . 0.0 108.377 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -78.03 39.3 0.3 Allowed 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.806 -0.559 . . . . 0.0 111.448 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -105.98 -32.62 3.74 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER 162.79 -172.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.621 -0.929 . . . . 0.0 109.167 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.45 ' O ' ' CD1' ' A' ' 29' ' ' TRP . 1.3 m -98.56 -174.49 2.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.091 -1.006 . . . . 0.0 108.536 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.625 ' CH2' ' HA ' ' A' ' 94' ' ' SER . 3.8 m-90 -142.8 -54.67 0.41 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.013 -1.055 . . . . 0.0 109.993 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' A' ' 29' ' ' TRP . . . -177.0 134.87 0.2 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.536 -1.266 . . . . 0.0 110.464 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 1.4 t -135.1 157.41 46.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.573 -0.705 . . . . 0.0 109.113 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.474 ' CB ' HG12 ' A' ' 11' ' ' VAL . 13.9 m -159.88 100.59 1.43 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.608 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.523 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . . . -169.81 -164.4 0.43 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 109.161 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -118.13 35.34 4.07 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.523 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 10.7 p90 -141.59 124.3 16.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 109.48 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 63' ' ' ALA . . . -94.0 116.03 28.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.438 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.484 ' CG2' ' CE2' ' A' ' 35' ' ' PHE . 3.5 t -81.78 143.77 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.778 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.535 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 11.2 p -51.05 160.61 0.82 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 0.0 109.444 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 3.9 Cg_exo -59.54 -18.84 49.15 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.128 1.885 . . . . 0.0 110.425 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.4 ' O ' ' OG1' ' A' ' 44' ' ' THR . . . -89.17 50.14 1.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.0 109.536 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.535 ' CG ' ' O ' ' A' ' 38' ' ' THR . 36.5 mt-30 -78.36 -55.15 5.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.103 -0.998 . . . . 0.0 109.805 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.94 -17.39 78.49 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -89.66 -18.21 26.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -1.191 . . . . 0.0 109.478 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 40' ' ' ALA . 53.4 m -89.68 -26.01 20.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.883 . . . . 0.0 109.576 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.9 mt -81.65 -46.53 14.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.81 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.42 87.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.129 -0.982 . . . . 0.0 109.459 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 m -77.56 -39.3 46.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.93 . . . . 0.0 109.421 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.75 -29.86 63.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.322 -0.861 . . . . 0.0 109.25 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -87.31 64.55 8.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 109.446 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.1 -69.51 0.77 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 109.227 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.428 ' CG ' ' O ' ' A' ' 51' ' ' ASN . 19.1 t-20 -138.98 33.35 2.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.0 109.069 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 56' ' ' ARG . . . 49.06 22.42 0.6 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.573 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.571 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -88.51 -57.41 0.28 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.636 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.571 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 1.1 Cg_endo -65.62 -41.35 15.08 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.886 1.724 . . . . 0.0 111.005 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.449 ' O ' ' HA2' ' A' ' 59' ' ' GLY . 0.2 OUTLIER -75.56 -37.2 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.168 -0.957 . . . . 0.0 109.797 -179.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -69.01 -66.94 0.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.0 109.899 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.546 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -77.03 126.03 30.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.107 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 3.5 t 82.52 -42.72 0.13 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.741 -0.599 . . . . 0.0 110.17 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 55' ' ' ILE . . . 95.48 -171.59 29.43 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -126.08 164.02 21.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -1.193 . . . . 0.0 109.55 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 66' ' ' HIS . 54.0 m-20 -128.55 162.51 27.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.881 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.4 mt -137.0 -147.2 0.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.137 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 36' ' ' ALA . . . -53.78 -54.51 37.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.103 -0.998 . . . . 0.0 109.633 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.75 20.23 0.69 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.491 HG13 ' CE1' ' A' ' 67' ' ' TYR . 71.9 t -135.88 149.0 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -1.188 . . . . 0.0 109.36 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.445 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 13.6 p-80 -153.55 160.18 42.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.1 -1.0 . . . . 0.0 109.837 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.567 ' CE1' HG13 ' A' ' 86' ' ' VAL . 52.1 m-85 -139.83 178.47 7.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.355 -0.84 . . . . 0.0 109.481 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.482 ' O ' ' HB ' ' A' ' 69' ' ' THR . 6.0 p -92.03 -29.3 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.212 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 68' ' ' VAL . 98.8 m 63.85 109.08 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.554 -0.716 . . . . 0.0 109.484 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.6 mt -89.91 -67.65 0.83 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.871 . . . . 0.0 109.503 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.37 137.2 50.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.839 . . . . 0.0 109.298 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 73' ' ' ASP . . . -159.07 91.6 1.04 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 109.527 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 46.7 t0 178.08 -31.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 109.624 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.471 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -66.25 -93.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.145 -0.972 . . . . 0.0 109.401 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -138.56 -53.86 0.61 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.07 -1.019 . . . . 0.0 109.725 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 20.3 m -90.03 162.76 15.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.0 109.419 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 76' ' ' SER . 4.1 mp -152.9 84.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.177 -0.952 . . . . 0.0 110.246 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 76' ' ' SER . 0.0 OUTLIER -98.99 98.86 9.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.974 -1.079 . . . . 0.0 108.207 178.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.55 166.56 43.68 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.672 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.17 165.56 32.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.97 . . . . 0.0 108.921 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.404 ' HB3' ' HA ' ' A' ' 67' ' ' TYR . 10.3 ptmt -130.48 -9.26 4.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.954 -1.091 . . . . 0.0 110.403 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.28 -23.36 9.83 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.94 -60.41 1.29 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -1.122 . . . . 0.0 108.945 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -99.82 -169.73 1.79 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 108.86 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.532 ' O ' ' CE1' ' A' ' 100' ' ' TYR . . . -166.94 152.79 21.94 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.567 HG13 ' CE1' ' A' ' 67' ' ' TYR . 14.5 p -135.29 104.07 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -1.097 . . . . 0.0 108.971 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.5 ' CD1' ' HB2' ' A' ' 109' ' ' ALA . 2.0 mt -79.56 107.6 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 109.7 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 46.8 p -111.71 98.89 7.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.305 -0.872 . . . . 0.0 109.346 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.523 HG21 ' CG ' ' A' ' 96' ' ' LEU . 11.4 m -125.75 161.83 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.369 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.66 153.79 17.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 109.659 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.58 ' O ' ' CD1' ' A' ' 125' ' ' PHE . 0.6 OUTLIER -147.09 -92.51 0.09 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.289 -0.882 . . . . 0.0 109.209 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.459 ' HB3' HD23 ' A' ' 120' ' ' LEU . 7.9 p -98.46 66.1 1.69 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 109.102 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.474 ' O ' ' CD1' ' A' ' 24' ' ' LEU . 6.9 mtmt 64.74 27.74 13.03 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.32 -0.862 . . . . 0.0 108.994 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.625 ' HA ' ' CH2' ' A' ' 29' ' ' TRP . 77.7 p -146.73 148.61 32.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.9 . . . . 0.0 109.947 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.556 ' CD1' ' HA3' ' A' ' 23' ' ' GLY . 1.1 mt -105.93 94.61 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 109.531 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.57 HD11 ' CE2' ' A' ' 2' ' ' TRP . 0.3 OUTLIER -56.15 155.12 6.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.966 -1.084 . . . . 0.0 108.6 179.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.513 HG12 ' CG2' ' A' ' 86' ' ' VAL . 73.2 t -135.08 84.61 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.134 -0.979 . . . . 0.0 109.887 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -65.71 92.47 0.16 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -91.72 108.48 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.343 -1.092 . . . . 0.0 108.404 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.536 ' HB3' ' CG1' ' A' ' 16' ' ' VAL . 5.5 p90 -131.31 172.42 12.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.059 -1.026 . . . . 0.0 110.322 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.475 ' OD1' ' HB2' ' A' ' 103' ' ' LYS . 9.0 p30 -102.81 -166.51 1.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.608 -0.682 . . . . 0.0 109.619 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -69.57 -20.44 63.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.892 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.475 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 9.9 mttm -52.95 -41.02 64.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.006 . . . . 0.0 109.468 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 15' ' ' ALA . 1.4 mp -91.61 137.59 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.137 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.19 149.34 65.82 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.544 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.86 -8.03 14.73 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.324 2.016 . . . . 0.0 110.628 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -102.95 -39.54 2.66 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -28.18 69.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.113 -1.228 . . . . 0.0 109.893 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.5 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . . . -87.42 -34.9 18.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.116 -0.99 . . . . 0.0 109.677 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.21 -20.43 62.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.738 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.37 -42.28 25.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 109.704 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.44 -37.26 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.771 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.4 t -74.12 -14.02 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.551 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.25 -34.28 22.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.941 . . . . 0.0 109.603 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -77.74 -51.62 10.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.151 -0.968 . . . . 0.0 109.473 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.522 HD22 ' CD2' ' A' ' 5' ' ' TYR . 1.1 mp -51.41 -48.1 62.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 108.818 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.57 ' O ' HG12 ' A' ' 121' ' ' ILE . . . -62.34 -47.95 81.96 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.123 -0.986 . . . . 0.0 108.413 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.515 ' CA ' HG12 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -38.52 -29.64 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.405 0.621 . . . . 0.0 109.685 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 117' ' ' ALA . 14.9 m-30 -74.28 -49.59 22.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.305 -0.872 . . . . 0.0 109.317 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.488 HD21 ' CE1' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -80.81 -3.17 50.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.864 . . . . 0.0 111.841 -178.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.57 HG12 ' O ' ' A' ' 117' ' ' ALA . 2.1 mm -77.22 -38.47 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.256 -1.527 . . . . 0.0 108.994 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 121' ' ' ILE . . . -41.32 -38.56 2.0 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -84.57 -59.59 2.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -1.102 . . . . 0.0 109.145 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.38 106.32 1.62 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.607 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 1.8 m-85 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.128 -1.219 . . . . 0.0 109.397 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.577 ' CZ3' HD13 ' A' ' 96' ' ' LEU . 6.4 m95 . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -32.57 -82.21 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.798 -0.564 . . . . 0.0 111.536 -178.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.462 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.6 OUTLIER -64.01 -34.61 78.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.065 -1.022 . . . . 0.0 110.87 -178.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 1.1 m-30 -76.62 3.23 11.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.75 -1.219 . . . . 0.0 109.801 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.577 ' HA ' ' CG2' ' A' ' 11' ' ' VAL . 1.1 t -92.82 -46.45 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.406 ' O ' HG21 ' A' ' 8' ' ' THR . 0.9 OUTLIER -91.37 53.57 2.33 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.285 -0.884 . . . . 0.0 110.257 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -171.11 -92.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.738 -1.226 . . . . 0.0 111.687 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 11' ' ' VAL . 3.6 m120 -101.21 -88.34 0.37 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.065 -1.022 . . . . 0.0 112.181 -177.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.536 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -21.13 -44.26 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -177.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.577 ' CG2' ' HA ' ' A' ' 6' ' ' VAL . 41.0 t -94.37 -41.84 12.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.696 -1.252 . . . . 0.0 110.337 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.532 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -45.53 -41.04 8.92 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.532 ' CB ' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 157.83 37.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.681 0.753 . . . . 0.0 109.425 178.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -85.19 19.84 20.18 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 158.92 -25.63 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 13' ' ' THR . 10.8 m -141.11 134.01 30.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.539 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 17.5 p -80.08 10.2 4.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 109.367 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.539 ' CG ' ' O ' ' A' ' 17' ' ' THR . 88.2 mt-30 -162.45 166.31 25.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.432 -0.792 . . . . 0.0 108.931 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.557 ' CB ' HG21 ' A' ' 11' ' ' VAL . . . 179.54 166.48 1.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 110.088 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.472 ' O ' HD22 ' A' ' 22' ' ' LEU . . . -165.03 126.18 2.02 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.488 -0.758 . . . . 0.0 109.324 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.523 ' HA ' ' HA ' ' A' ' 96' ' ' LEU . 2.8 mt -91.01 108.27 19.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.229 -0.919 . . . . 0.0 108.591 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.544 HD22 ' N ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -94.51 101.21 13.1 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.276 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -42.83 169.33 0.01 OUTLIER Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' A' ' 94' ' ' SER . 1.4 pp -119.9 -17.66 8.42 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.415 -1.05 . . . . 0.0 109.428 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.97 -4.69 7.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.394 -0.816 . . . . 0.0 109.437 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.28 -90.85 1.42 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -171.69 -45.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.346 -1.091 . . . . 0.0 109.722 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.7 m -166.16 129.88 2.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.859 . . . . 0.0 109.242 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.558 ' CD2' ' OG ' ' A' ' 94' ' ' SER . 14.8 m0 -96.75 -45.45 6.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.6 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.4 171.4 19.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 109.453 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -160.88 174.77 13.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.597 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.562 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -161.44 135.16 6.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.902 . . . . 0.0 109.581 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 32' ' ' SER . . . 87.12 -16.64 0.38 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . 127.41 -90.25 0.35 Allowed Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.09 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.468 ' CE2' HG23 ' A' ' 99' ' ' VAL . 0.3 OUTLIER 61.49 126.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -1.097 . . . . 0.0 109.105 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' A' ' 63' ' ' ALA . . . -136.7 95.34 3.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 109.849 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.464 ' HB ' ' HG2' ' A' ' 41' ' ' GLN . 3.4 t -105.26 92.34 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.26 -0.9 . . . . 0.0 108.953 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.62 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -93.28 -38.84 0.33 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.513 -0.742 . . . . 0.0 112.684 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 38' ' ' THR . 6.5 Cg_exo -54.91 -73.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.403 1.402 . . . . 0.0 111.806 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.447 ' HB2' ' OG1' ' A' ' 44' ' ' THR . . . -154.0 81.17 1.14 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.826 -1.171 . . . . 0.0 110.111 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.464 ' HG2' ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -75.53 -63.31 1.32 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.264 -1.522 . . . . 0.0 108.659 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -91.79 -7.85 64.19 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.4 -43.27 21.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -1.103 . . . . 0.0 109.457 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.447 ' OG1' ' HB2' ' A' ' 40' ' ' ALA . 17.3 m -76.31 -51.23 12.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 109.56 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.467 HD21 ' CE1' ' A' ' 49' ' ' PHE . 27.0 mt -58.35 -27.74 64.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.509 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -67.45 -42.83 82.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.802 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.9 t -91.42 -3.12 56.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.614 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.91 -14.27 37.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.632 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.467 ' CE1' HD21 ' A' ' 45' ' ' LEU . 18.1 m-30 -87.18 3.18 47.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 109.877 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.58 -41.4 15.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.051 -1.031 . . . . 0.0 109.251 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.465 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -151.46 146.13 25.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -0.872 . . . . 0.0 109.313 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 56' ' ' ARG . . . -89.6 28.97 1.2 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.886 . . . . 0.0 109.901 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.614 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -85.44 -44.66 0.64 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.029 -1.044 . . . . 0.0 110.587 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.2 Cg_endo -68.45 -74.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 121.617 1.545 . . . . 0.0 110.522 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.44 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 0.8 OUTLIER -41.87 -46.04 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.39 -0.818 . . . . 0.0 109.982 -179.449 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 3.1 ttt180 -45.47 -55.04 6.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 109.653 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 58' ' ' SER . . . -86.18 -91.83 0.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.836 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 57' ' ' ALA . 2.9 t -43.41 -76.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.195 -0.94 . . . . 0.0 109.758 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 55' ' ' ILE . . . 121.61 -133.71 9.61 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.643 ' CD1' ' N ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -144.24 153.58 42.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.077 -1.249 . . . . 0.0 109.541 179.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -95.21 128.67 42.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 110.094 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.59 HD22 ' CD2' ' A' ' 60' ' ' PHE . 4.0 mm? -107.59 57.35 0.63 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.499 ' CB ' ' O ' ' A' ' 36' ' ' ALA . . . 50.71 26.79 2.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.476 -0.765 . . . . 0.0 109.42 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.39 -97.01 0.12 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.771 -1.204 . . . . 0.0 110.242 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.9 t -112.76 170.46 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.183 -1.186 . . . . 0.0 110.012 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -85.29 132.7 34.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.736 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.581 ' CE1' ' HA ' ' A' ' 81' ' ' LYS . 25.3 m-85 -107.84 168.89 8.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.039 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 t -109.59 174.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.111 -0.993 . . . . 0.0 110.027 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.8 135.44 54.01 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.433 -0.792 . . . . 0.0 109.323 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.474 ' HB3' ' HD2' ' A' ' 71' ' ' ARG . 11.5 tp -89.94 -55.9 3.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.156 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.551 ' HG2' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -137.23 75.77 1.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 109.048 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 73' ' ' ASP . . . -101.83 81.68 2.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.89 . . . . 0.0 109.549 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 24.9 t70 178.02 -41.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.62 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.43 -81.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 109.806 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.69 -48.81 0.26 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.166 -0.959 . . . . 0.0 109.618 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.647 ' CB ' ' CZ ' ' A' ' 78' ' ' TYR . 0.7 OUTLIER -90.6 -170.51 2.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -0.941 . . . . 0.0 109.726 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.5 ' CG1' ' C ' ' A' ' 76' ' ' SER . 0.1 OUTLIER -163.13 63.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.1 -1.0 . . . . 0.0 110.05 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.647 ' CZ ' ' CB ' ' A' ' 76' ' ' SER . 0.1 OUTLIER -92.14 115.3 27.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.905 -1.122 . . . . 0.0 109.04 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.414 ' C ' HG11 ' A' ' 86' ' ' VAL . . . -96.69 -158.33 31.45 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.25 158.79 34.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -1.191 . . . . 0.0 109.614 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.581 ' HA ' ' CE1' ' A' ' 67' ' ' TYR . 2.1 mtpt -123.92 -178.55 4.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.245 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.18 106.09 1.32 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 55.66 20.47 3.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.153 -1.204 . . . . 0.0 108.9 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.487 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . . . -136.18 -164.15 1.51 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 109.309 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.576 ' HA3' ' CE2' ' A' ' 100' ' ' TYR . . . -147.57 131.05 3.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.414 HG11 ' C ' ' A' ' 79' ' ' GLY . 2.5 p -104.51 131.49 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.215 -1.168 . . . . 0.0 109.43 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.521 ' CD1' ' HB3' ' A' ' 78' ' ' TYR . 47.3 mm -115.14 101.68 12.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.263 -0.898 . . . . 0.0 109.208 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.485 HG23 HG12 ' A' ' 97' ' ' VAL . 7.8 p -117.46 146.16 43.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.071 -1.018 . . . . 0.0 109.603 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.1 t -146.95 141.89 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.768 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -91.3 124.2 35.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.426 -0.796 . . . . 0.0 108.946 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.458 HG23 ' CG1' ' A' ' 121' ' ' ILE . 0.1 OUTLIER -103.25 -60.19 1.59 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.128 -0.982 . . . . 0.0 109.73 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -168.47 -66.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 0.0 109.437 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.65 15.85 11.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.182 -0.949 . . . . 0.0 109.473 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.558 ' OG ' ' CD2' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -154.36 154.44 33.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.169 -0.957 . . . . 0.0 110.014 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.509 ' CD1' ' HB3' ' A' ' 24' ' ' LEU . 54.6 mt -125.61 138.37 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.636 ' CD1' ' N ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -112.29 166.43 11.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.975 -1.078 . . . . 0.0 109.956 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.512 HG23 ' CD1' ' A' ' 22' ' ' LEU . 3.2 t -146.9 77.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -0.917 . . . . 0.0 111.21 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.37 107.09 1.66 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 107.28 -2.328 . . . . 0.0 107.28 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 97' ' ' VAL . 0.2 OUTLIER -115.47 142.55 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.884 -1.363 . . . . 0.0 110.414 -178.102 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.576 ' CE2' ' HA3' ' A' ' 85' ' ' GLY . 16.4 p90 -129.13 171.14 12.7 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.487 ' HA ' ' HB3' ' A' ' 84' ' ' ALA . 5.9 p30 -150.2 115.2 5.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.676 -1.265 . . . . 0.0 111.183 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.48 ' CG ' ' O ' ' A' ' 101' ' ' ASN . 22.1 pt-20 39.06 31.4 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.518 0.675 . . . . 0.0 109.374 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 101' ' ' ASN . 0.0 OUTLIER -133.18 -25.68 1.75 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.693 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.493 HG23 ' O ' ' A' ' 15' ' ' ALA . 1.8 mp -137.79 149.57 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.847 -1.158 . . . . 0.0 110.028 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -99.72 145.0 29.39 Favored Pre-proline 0 C--N 1.307 -1.246 0 O-C-N 121.48 -0.762 . . . . 0.0 109.202 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.35 177.11 3.43 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.088 1.859 . . . . 0.0 110.103 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.35 -0.16 75.97 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 65.1 m -127.06 -45.24 1.57 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.113 -1.227 . . . . 0.0 109.582 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -80.1 -40.76 26.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 109.569 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.72 -17.02 7.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.329 -0.857 . . . . 0.0 109.757 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -78.09 -45.71 22.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.717 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.501 HG11 ' N ' ' A' ' 113' ' ' VAL . 11.1 p -71.54 -22.76 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.949 . . . . 0.0 109.857 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.501 ' N ' HG11 ' A' ' 112' ' ' VAL . 6.0 t -71.26 -33.54 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.056 -1.027 . . . . 0.0 109.598 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.417 ' O ' ' OE1' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -80.13 -17.04 53.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.138 -0.976 . . . . 0.0 109.894 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.556 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -86.11 -59.2 2.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.965 . . . . 0.0 109.692 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.536 ' HG ' ' CD1' ' A' ' 10' ' ' LEU . 2.1 mm? -48.43 -35.85 13.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.095 -1.003 . . . . 0.0 109.308 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.455 ' HA ' ' HG ' ' A' ' 120' ' ' LEU . . . -68.8 -39.13 80.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.966 . . . . 0.0 109.478 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.62 -33.92 48.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 109.561 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.556 ' CD1' ' O ' ' A' ' 115' ' ' LYS . 32.8 m-85 -74.76 -58.6 3.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.083 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.507 HD22 ' CE3' ' A' ' 2' ' ' TRP . 4.5 pp -72.27 2.35 6.17 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.445 -0.785 . . . . 0.0 110.417 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.483 HG13 HD13 ' A' ' 120' ' ' LEU . 5.1 mt -88.96 -23.73 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 108.862 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.08 -30.18 53.79 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -92.77 -75.4 0.49 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.377 -1.073 . . . . 0.0 109.461 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 125' ' ' PHE . . . 132.35 36.77 0.29 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 124' ' ' GLY . 16.0 m-85 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.375 -1.074 . . . . 0.0 109.518 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.583 ' CH2' HD22 ' A' ' 96' ' ' LEU . 7.6 m95 . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -67.13 -80.75 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.13 -0.981 . . . . 0.0 111.366 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.475 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 0.8 OUTLIER -54.6 -22.93 14.83 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.097 -1.002 . . . . 0.0 111.094 -178.373 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 1.9 m-30 -87.58 -25.08 23.79 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.65 -1.281 . . . . 0.0 109.869 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.571 ' HA ' ' CG2' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -63.87 -26.69 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 108.923 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.515 ' OD2' ' CG2' ' A' ' 8' ' ' THR . 1.0 OUTLIER -52.85 -52.58 56.67 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.449 -0.782 . . . . 0.0 111.966 -177.647 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.515 ' CG2' ' OD2' ' A' ' 7' ' ' ASP . 5.0 t -163.38 -27.72 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.531 -1.356 . . . . 0.0 111.116 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 14' ' ' GLY . 1.7 m-80 -64.82 -88.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.656 -1.277 . . . . 0.0 109.764 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -59.94 -23.65 63.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.202 -0.936 . . . . 0.0 110.295 -179.379 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.571 ' CG2' ' HA ' ' A' ' 6' ' ' VAL . 1.5 t -89.21 -60.32 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.868 -1.145 . . . . 0.0 108.999 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -43.67 -36.89 3.62 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.541 ' CB ' ' O ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER 158.49 46.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.948 -0.736 . . . . 0.0 110.105 178.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -92.41 23.19 28.85 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 106.294 -2.723 . . . . 0.0 106.294 177.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 154.0 -28.98 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.526 ' HA ' ' CD1' ' A' ' 104' ' ' ILE . 17.6 m -148.59 139.42 17.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.507 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 8.1 t -79.32 6.3 10.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.979 -1.076 . . . . 0.0 109.11 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.507 ' CG ' ' O ' ' A' ' 17' ' ' THR . 45.9 mt-30 -160.6 155.63 24.41 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.481 ' HA ' HG22 ' A' ' 99' ' ' VAL . . . -168.81 175.9 5.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.019 -1.051 . . . . 0.0 110.286 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -165.2 114.09 1.04 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.55 -0.719 . . . . 0.0 109.181 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.564 HD12 ' CA ' ' A' ' 2' ' ' TRP . 24.8 mt -79.65 80.74 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 120.999 -1.063 . . . . 0.0 108.851 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.547 ' CD1' HG23 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -60.33 -150.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.465 -0.772 . . . . 0.0 108.936 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.61 134.63 4.01 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.465 HD21 HG13 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -80.57 4.71 17.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -1.153 . . . . 0.0 109.561 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.12 -13.8 12.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.567 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . 96.26 81.63 1.58 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.551 ' O ' ' C ' ' A' ' 28' ' ' THR . 1.0 OUTLIER 167.8 55.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -1.146 . . . . 0.0 109.442 -179.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.551 ' C ' ' O ' ' A' ' 27' ' ' ASN . 21.2 m -20.55 130.36 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.37 0.605 . . . . 0.0 111.325 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.561 ' CE3' ' OG ' ' A' ' 94' ' ' SER . 22.2 m0 -88.68 -45.34 9.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.447 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.01 164.53 18.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.939 . . . . 0.0 109.853 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 3.2 t -157.92 177.47 11.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.413 -0.805 . . . . 0.0 108.879 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.505 ' OG ' HG11 ' A' ' 6' ' ' VAL . 15.3 m -167.13 117.26 0.87 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.112 -0.992 . . . . 0.0 110.375 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 32' ' ' SER . . . 34.32 90.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.164 0.507 . . . . 0.0 110.53 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.33 -84.32 0.05 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 3.3 p90 -172.74 159.58 4.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -1.067 . . . . 0.0 109.352 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.77 116.2 28.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.291 -0.881 . . . . 0.0 108.757 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 91.6 t -79.62 108.37 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.147 -0.971 . . . . 0.0 109.582 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.516 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 9.1 m -48.22 139.35 10.26 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.341 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 40' ' ' ALA . 1.8 Cg_endo -63.92 167.7 13.47 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.13 1.887 . . . . 0.0 110.376 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 39' ' ' PRO . . . 82.36 -41.45 0.12 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.649 -0.657 . . . . 0.0 110.293 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -69.29 -31.22 69.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.044 -1.035 . . . . 0.0 109.745 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.31 -38.71 50.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -63.41 -35.7 81.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.175 -1.191 . . . . 0.0 109.923 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.0 m -56.53 -37.28 70.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -0.918 . . . . 0.0 109.791 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.88 -39.5 93.64 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.216 -0.927 . . . . 0.0 109.806 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.4 -26.01 63.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 109.975 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.4 t -88.22 -18.12 29.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.131 -0.98 . . . . 0.0 109.778 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.469 ' HB3' HD13 ' A' ' 55' ' ' ILE . . . -73.18 -30.63 63.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.965 . . . . 0.0 109.571 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -54.9 -47.23 74.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 109.926 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 51' ' ' ASN . 13.7 p30 -79.7 -46.8 16.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.001 -1.062 . . . . 0.0 109.444 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 3.2 t30 -107.58 111.83 24.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 108.855 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.486 ' HA ' HG12 ' A' ' 55' ' ' ILE . . . -108.72 30.67 6.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 109.865 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.547 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -72.19 -55.39 5.01 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.124 -0.985 . . . . 0.0 109.739 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 2.1 Cg_endo -62.47 -11.58 23.73 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.021 1.814 . . . . 0.0 110.344 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -109.7 -17.61 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.156 -0.965 . . . . 0.0 109.185 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 7.2 ttt180 -89.48 -18.43 26.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.172 -0.955 . . . . 0.0 109.551 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.91 43.47 1.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.424 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.35 61.78 2.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.396 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -137.25 60.31 0.61 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.526 ' O ' ' CB ' ' A' ' 67' ' ' TYR . 1.0 OUTLIER -109.21 93.35 4.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -1.172 . . . . 0.0 108.904 179.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -135.43 127.11 29.05 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.384 -0.822 . . . . 0.0 109.722 -179.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 64' ' ' GLY . 1.4 mm? -95.84 -166.38 1.43 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.397 -0.815 . . . . 0.0 109.248 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.438 ' O ' HG21 ' A' ' 65' ' ' VAL . . . -51.97 91.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.185 -0.947 . . . . 0.0 109.067 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 62' ' ' LEU . . . 61.4 52.02 54.17 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 61' ' ' ASP . 2.9 t -141.04 119.44 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.292 -1.122 . . . . 0.0 109.571 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.43 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 34.9 m170 -79.69 124.89 28.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.338 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.526 ' CB ' ' O ' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -149.99 166.43 29.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.11 -0.994 . . . . 0.0 109.934 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.507 ' O ' ' CB ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -115.84 -176.93 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.81 . . . . 0.0 109.016 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.524 ' CB ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -133.64 109.73 9.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.096 -1.002 . . . . 0.0 109.606 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mp -101.72 -25.26 13.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.342 -0.849 . . . . 0.0 109.166 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.441 ' NH2' ' OD2' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -149.38 117.22 6.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.415 -0.803 . . . . 0.0 109.193 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' A' ' 77' ' ' ILE . . . -160.5 74.84 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.087 -1.008 . . . . 0.0 109.847 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 30.0 t70 179.26 -36.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.46 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.441 ' OD2' ' NH2' ' A' ' 71' ' ' ARG . 3.2 m-20 -74.84 -84.63 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.216 -0.927 . . . . 0.0 110.045 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -137.18 -62.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.994 -1.066 . . . . 0.0 110.288 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.639 ' CB ' ' CZ ' ' A' ' 78' ' ' TYR . 0.7 OUTLIER -90.08 163.79 14.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.384 -0.823 . . . . 0.0 110.495 -178.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.484 HG12 ' HA ' ' A' ' 72' ' ' ALA . 3.0 mt -143.41 70.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.607 -0.683 . . . . 0.0 109.329 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.639 ' CZ ' ' CB ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -88.98 103.8 16.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.713 -1.242 . . . . 0.0 108.928 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.47 169.3 33.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -148.77 147.89 29.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -1.102 . . . . 0.0 109.328 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.16 -30.39 1.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.877 . . . . 0.0 109.845 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 123.35 -66.98 0.5 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.507 ' CB ' ' OE2' ' A' ' 102' ' ' GLU . 1.1 p -87.23 -18.8 29.45 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.372 -1.075 . . . . 0.0 108.444 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.31 166.34 27.41 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -160.69 163.95 34.37 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.54 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 9.8 p -129.91 104.8 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -1.113 . . . . 0.0 109.471 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.462 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 4.1 mt -80.48 94.42 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.087 -1.008 . . . . 0.0 109.013 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 2.7 p -101.86 106.01 16.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 110.16 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.434 ' HB ' HD21 ' A' ' 96' ' ' LEU . 25.5 t -116.89 149.31 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 108.895 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.488 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 29.4 mtpt -86.1 151.99 23.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 110.048 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.59 ' CG2' ' CD2' ' A' ' 96' ' ' LEU . 2.3 p -145.57 -159.74 1.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.85 . . . . 0.0 109.075 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.406 ' C ' ' HD3' ' A' ' 93' ' ' LYS . 16.2 t -69.07 85.34 0.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.446 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER 62.17 14.79 6.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.206 -0.934 . . . . 0.0 109.427 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.561 ' OG ' ' CE3' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -128.64 151.61 49.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.485 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 21' ' ' ILE . 48.8 mt -127.52 123.42 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.952 . . . . 0.0 109.417 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.59 ' CD2' ' CG2' ' A' ' 91' ' ' THR . 0.1 OUTLIER -85.38 130.7 34.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 108.889 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.547 HG23 ' CD1' ' A' ' 22' ' ' LEU . 42.4 t -121.87 68.21 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.498 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.433 ' C ' HG13 ' A' ' 16' ' ' VAL . . . -62.0 99.65 0.24 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.481 HG22 ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -101.21 126.76 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -1.223 . . . . 0.0 108.983 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 100' ' ' TYR . 3.7 p90 -141.82 -176.49 4.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 109.733 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 83' ' ' SER . 0.5 OUTLIER -138.1 -116.24 0.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.093 -1.005 . . . . 0.0 110.22 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.507 ' OE2' ' CB ' ' A' ' 83' ' ' SER . 9.9 mm-40 -85.29 -50.64 7.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.843 -1.161 . . . . 0.0 110.276 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -39.16 -27.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 110.574 -179.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 16' ' ' VAL . 12.4 mt -127.86 147.69 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.919 -1.113 . . . . 0.0 110.203 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.423 ' N ' HG21 ' A' ' 104' ' ' ILE . 66.9 mt-30 -127.52 152.71 76.99 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.416 -0.803 . . . . 0.0 108.868 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.43 173.2 1.57 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.992 1.795 . . . . 0.0 110.272 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.74 -51.26 1.2 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 m -94.08 -33.71 13.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.373 -1.075 . . . . 0.0 108.929 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 15' ' ' ALA . . . -80.94 -35.05 32.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.575 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.61 -13.4 59.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.53 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.26 -42.63 12.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.764 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.3 p -70.57 -28.09 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 109.629 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.46 ' O ' HG11 ' A' ' 113' ' ' VAL . 73.6 t -83.94 -20.53 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.501 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.48 -37.55 63.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.885 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.52 ' HG3' ' N ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -77.03 -42.79 37.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.684 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.52 ' N ' ' HG3' ' A' ' 115' ' ' LYS . 25.7 mt -52.23 -57.18 10.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.047 -1.033 . . . . 0.0 109.458 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -64.56 -29.83 70.86 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.131 -0.981 . . . . 0.0 109.095 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -53.78 -21.98 8.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.129 -0.982 . . . . 0.0 109.176 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -90.64 -30.86 16.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.409 -0.807 . . . . 0.0 109.832 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.5 ' CB ' ' O ' ' A' ' 125' ' ' PHE . 0.8 OUTLIER -73.04 -38.78 66.4 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.063 -1.023 . . . . 0.0 109.77 -179.505 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 2.9 mp -64.86 -14.88 17.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.395 -0.816 . . . . 0.0 109.276 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -45.71 -35.4 5.81 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.33 -70.23 0.82 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -1.035 . . . . 0.0 108.974 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -117.39 -77.97 0.64 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.5 ' O ' ' CB ' ' A' ' 120' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.386 -1.067 . . . . 0.0 109.688 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.703 ' CZ3' ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 120.764 0.316 . . . . 0.0 110.394 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -67.49 -59.01 3.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.581 -1.324 . . . . 0.0 108.965 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.475 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.7 OUTLIER -71.82 -31.18 66.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.308 -0.87 . . . . 0.0 108.719 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.703 ' CD2' ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -56.21 -17.12 6.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.451 -0.781 . . . . 0.0 108.925 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.536 ' HA ' ' CG2' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -94.39 -48.96 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.245 -0.91 . . . . 0.0 109.955 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.83 45.95 1.32 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.785 -1.197 . . . . 0.0 110.677 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 4' ' ' THR . 22.5 p -148.63 -104.94 0.08 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.855 -1.153 . . . . 0.0 110.003 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.483 ' O ' ' C ' ' A' ' 10' ' ' LEU . 2.3 t-20 -102.72 -69.14 0.8 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.032 -1.042 . . . . 0.0 111.156 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.491 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -27.77 -45.44 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.234 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.546 HG21 ' CB ' ' A' ' 19' ' ' ALA . 85.2 t -101.24 -25.43 3.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.477 -1.389 . . . . 0.0 110.976 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 11' ' ' VAL . . . -45.58 -27.78 2.19 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 106.544 -2.622 . . . . 0.0 106.544 177.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.711 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -175.22 -44.88 0.01 OUTLIER 'General case' 0 C--O 1.196 -1.718 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.574 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . 14.12 40.45 0.0 OUTLIER Glycine 0 N--CA 1.508 3.435 0 C-N-CA 123.567 0.603 . . . . 0.0 112.79 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.711 ' N ' ' O ' ' A' ' 13' ' ' THR . . . 86.7 -32.12 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.438 -1.036 . . . . 0.0 108.377 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 13' ' ' THR . 0.4 OUTLIER -101.39 132.5 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.179 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.9 OUTLIER -86.25 21.04 2.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.958 -1.089 . . . . 0.0 109.261 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.53 ' CG ' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -176.99 176.1 1.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.546 ' CB ' HG21 ' A' ' 11' ' ' VAL . . . 174.35 166.33 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.004 -1.06 . . . . 0.0 110.1 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -163.66 136.09 5.15 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.571 HG22 ' CD1' ' A' ' 2' ' ' TRP . 1.2 mm -94.33 66.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.036 -1.04 . . . . 0.0 108.453 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.528 ' CD1' HG23 ' A' ' 97' ' ' VAL . 17.5 mt -60.83 109.54 1.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 108.938 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 94' ' ' SER . . . -60.35 159.47 24.87 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.592 ' HB3' ' CG1' ' A' ' 95' ' ' ILE . 1.0 OUTLIER -108.77 -6.9 15.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -1.022 . . . . 0.0 109.4 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -143.7 34.89 1.27 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.355 -0.841 . . . . 0.0 109.312 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.41 29.84 0.09 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 64.63 -144.58 0.26 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.214 -1.168 . . . . 0.0 109.503 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.3 m -77.66 147.95 35.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.153 -0.967 . . . . 0.0 110.019 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.472 ' CE3' ' HB3' ' A' ' 94' ' ' SER . 7.8 m0 -114.12 -47.45 2.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.336 -0.852 . . . . 0.0 108.786 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.35 167.27 30.54 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 10.1 t -160.3 159.79 31.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.957 -1.089 . . . . 0.0 110.055 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.439 ' HB2' HG11 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -150.99 92.99 1.88 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.591 -0.693 . . . . 0.0 109.155 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.469 ' HB3' ' HG2' ' A' ' 18' ' ' GLN . . . 170.78 -54.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.531 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.4 19.48 3.48 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.582 ' CZ ' HG22 ' A' ' 99' ' ' VAL . 10.4 p90 -125.54 134.76 51.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -1.174 . . . . 0.0 109.523 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.59 130.64 55.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.914 . . . . 0.0 109.305 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.1 t -79.62 131.7 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 109.598 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.462 HG21 ' HD2' ' A' ' 39' ' ' PRO . 5.0 m -48.29 125.58 11.89 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 108.994 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.462 ' HD2' HG21 ' A' ' 38' ' ' THR . 4.7 Cg_exo -58.82 -39.42 81.79 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.765 1.643 . . . . 0.0 109.976 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.79 -46.96 86.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.258 -0.901 . . . . 0.0 109.182 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -62.72 -21.18 65.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.273 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.79 -29.33 67.2 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -67.48 -44.62 78.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -1.155 . . . . 0.0 109.428 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.4 m -56.72 -25.71 55.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.285 -0.884 . . . . 0.0 109.372 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.9 tp -73.81 -41.68 62.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.26 -50.2 66.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.228 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.78 -16.45 64.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.18 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.89 -28.24 64.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.339 -0.851 . . . . 0.0 109.458 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -88.26 21.53 2.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.361 -0.837 . . . . 0.0 109.533 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -108.69 -44.47 4.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.356 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.507 ' O ' ' CD1' ' A' ' 55' ' ' ILE . 2.5 m-20 -122.87 141.46 51.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 109.477 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.444 ' HA ' HG13 ' A' ' 55' ' ' ILE . . . -105.82 -3.72 21.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.909 . . . . 0.0 109.611 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.549 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -77.25 -55.37 1.36 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.101 -1.0 . . . . 0.0 110.258 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 2.3 Cg_endo -62.37 -10.33 18.4 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.056 1.837 . . . . 0.0 111.225 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.507 ' CD1' ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -104.85 -23.72 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.946 -1.096 . . . . 0.0 109.62 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -81.98 -12.18 58.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.085 -1.01 . . . . 0.0 109.356 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.96 -75.85 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.6 t -85.73 -39.32 17.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.385 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 55' ' ' ILE . . . 85.69 -161.73 35.36 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.655 ' CE1' ' CG ' ' A' ' 67' ' ' TYR . 4.6 p90 -145.98 -168.99 3.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -1.11 . . . . 0.0 109.035 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 61' ' ' ASP . 26.7 p30 -160.04 157.53 28.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.012 -1.055 . . . . 0.0 110.483 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.5 mt -124.64 -160.04 0.92 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.73 97.75 10.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.973 -1.079 . . . . 0.0 109.733 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.19 -79.47 0.23 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.516 HG11 ' N ' ' A' ' 66' ' ' HIS . 54.1 t -124.8 160.97 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -1.153 . . . . 0.0 109.322 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.516 ' N ' HG11 ' A' ' 65' ' ' VAL . 18.7 m170 -75.9 -171.45 1.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.127 -0.983 . . . . 0.0 109.317 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.655 ' CG ' ' CE1' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -137.39 119.78 15.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 109.831 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.7 t -89.71 -24.6 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -0.843 . . . . 0.0 108.735 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.404 ' CG2' ' CB ' ' A' ' 72' ' ' ALA . 92.6 m 57.52 101.38 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.599 -0.688 . . . . 0.0 110.151 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.38 -23.67 13.16 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -142.85 72.1 1.36 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.5 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . . . -85.4 52.25 2.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 0.0 109.828 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.66 -145.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.241 -0.912 . . . . 0.0 108.835 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.456 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 0.4 OUTLIER -119.66 34.65 5.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.155 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 7.5 mmt180 -136.7 -44.38 0.59 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 110.236 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 14.9 m -145.64 164.88 30.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.929 -1.107 . . . . 0.0 110.31 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.557 ' O ' ' CG2' ' A' ' 77' ' ' ILE . 0.3 OUTLIER -162.24 97.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 76' ' ' SER . 0.0 OUTLIER -115.31 129.81 56.72 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.583 ' HA3' ' CE1' ' A' ' 67' ' ' TYR . . . -101.6 155.7 18.89 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.518 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.512 ' HD2' ' CG ' ' A' ' 106' ' ' PRO . 2.0 pttp -151.0 141.24 22.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -1.089 . . . . 0.0 109.347 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.503 ' CG ' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER 165.13 143.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.933 -1.104 . . . . 0.0 110.565 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.401 ' C ' ' N ' ' A' ' 84' ' ' ALA . . . 63.94 48.94 71.23 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 47.03 21.9 0.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.05 -1.265 . . . . 0.0 109.549 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' LYS . . . -151.3 147.28 26.76 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.318 -0.864 . . . . 0.0 108.759 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.555 ' CA ' ' CE2' ' A' ' 100' ' ' TYR . . . -169.68 -171.43 35.26 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.649 ' CG1' ' CE2' ' A' ' 67' ' ' TYR . 7.3 p -141.62 156.69 20.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.399 -1.059 . . . . 0.0 109.842 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.5 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 75.3 mt -121.37 93.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 11.4 p -107.91 133.24 52.54 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.197 -0.939 . . . . 0.0 110.643 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.573 ' HB ' ' CD2' ' A' ' 96' ' ' LEU . 2.1 t -150.76 156.86 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.234 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -79.99 143.89 33.74 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.459 -0.776 . . . . 0.0 109.192 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.468 ' O ' ' CB ' ' A' ' 125' ' ' PHE . 67.9 p -146.88 -135.82 0.08 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.209 -0.932 . . . . 0.0 109.29 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -75.78 80.43 2.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.969 -1.082 . . . . 0.0 109.955 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 92' ' ' SER . 13.4 mttm 60.68 13.33 4.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.761 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.485 ' HB2' HG21 ' A' ' 21' ' ' ILE . 3.3 p -138.04 165.35 26.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.064 -1.022 . . . . 0.0 109.966 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.592 ' CG1' ' HB3' ' A' ' 24' ' ' LEU . 1.7 mt -128.82 112.99 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.418 -0.801 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.642 ' HB3' ' CE2' ' A' ' 2' ' ' TRP . 1.1 pt? -60.21 164.18 4.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.171 -0.956 . . . . 0.0 108.808 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.534 HG11 ' CG2' ' A' ' 86' ' ' VAL . 71.8 t -150.84 57.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.533 -0.73 . . . . 0.0 109.518 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -49.06 114.89 2.35 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.582 HG22 ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -107.28 143.68 17.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.053 -1.263 . . . . 0.0 109.768 -179.107 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 100' ' ' TYR . 0.1 OUTLIER -142.98 153.32 42.9 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -151.24 6.38 0.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.822 -1.174 . . . . 0.0 111.692 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 103' ' ' LYS . 3.0 mm-40 -100.77 -78.22 0.52 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.586 -1.321 . . . . 0.0 109.817 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 8.4 mmtp -155.11 30.03 0.4 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.428 -0.795 . . . . 0.0 109.255 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.515 HG13 ' HB3' ' A' ' 100' ' ' TYR . 2.2 mm -62.58 149.35 9.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.263 -0.898 . . . . 0.0 109.644 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -106.54 141.52 22.99 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 109.388 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.512 ' CG ' ' HD2' ' A' ' 80' ' ' LYS . 2.1 Cg_endo -62.33 -26.45 77.08 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.078 1.852 . . . . 0.0 110.4 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.45 37.14 3.51 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.9 m -143.03 -46.25 0.3 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -1.132 . . . . 0.0 109.394 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -86.77 -25.47 24.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.414 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.95 -22.23 39.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 109.281 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.86 -39.99 63.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.435 -0.79 . . . . 0.0 109.562 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.461 HG11 ' N ' ' A' ' 113' ' ' VAL . 9.4 p -76.34 -23.44 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.532 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.461 ' N ' HG11 ' A' ' 112' ' ' VAL . 70.0 t -85.63 -18.79 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.867 . . . . 0.0 109.581 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.98 -31.45 39.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.331 -0.856 . . . . 0.0 109.586 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -83.7 -55.13 4.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.855 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.65 -31.02 67.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.912 . . . . 0.0 109.501 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -73.51 -26.82 61.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.204 -0.935 . . . . 0.0 109.471 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -66.57 -26.65 67.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.131 -0.98 . . . . 0.0 109.675 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 8.8 t80 -82.23 -52.37 7.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.88 . . . . 0.0 109.608 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.459 HD12 ' HB ' ' A' ' 91' ' ' THR . 0.5 OUTLIER -63.94 -25.26 68.06 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.22 -0.925 . . . . 0.0 109.943 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 2.8 mt -90.63 -18.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.94 . . . . 0.0 109.193 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.28 -16.67 28.37 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -91.26 -60.77 1.81 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -1.148 . . . . 0.0 109.334 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 125' ' ' PHE . . . 158.38 104.39 0.2 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.988 0 O-C-N 121.19 -1.182 . . . . 0.0 108.905 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.555 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 8.1 m95 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -81.88 -90.57 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.924 -1.11 . . . . 0.0 111.08 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.56 -34.61 7.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.101 -0.999 . . . . 0.0 110.332 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 1.9 m-30 -71.07 -38.17 72.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.049 -1.032 . . . . 0.0 109.601 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.56 ' HA ' ' CG2' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -51.72 -24.15 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 6' ' ' VAL . 20.5 t0 -40.37 -89.91 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.532 -0.73 . . . . 0.0 111.253 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.451 HG21 ' N ' ' A' ' 9' ' ' ASN . 10.2 t -144.05 -23.46 0.56 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.063 -1.023 . . . . 0.0 111.427 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.584 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.4 m120 -75.42 -55.7 5.43 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.674 -1.266 . . . . 0.0 109.504 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 0.6 OUTLIER -76.91 -25.36 52.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.848 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.56 ' CG2' ' HA ' ' A' ' 6' ' ' VAL . 1.8 t -92.36 -55.12 6.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.183 -0.948 . . . . 0.0 108.712 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.516 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -43.69 -39.17 4.57 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 107.952 -2.059 . . . . 0.0 107.952 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.517 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER 159.94 47.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.827 -0.808 . . . . 0.0 110.068 178.579 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 9' ' ' ASN . . . -90.57 20.77 36.2 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 106.918 -2.473 . . . . 0.0 106.918 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 156.43 -32.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 27.5 m -141.93 147.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.479 ' N ' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -80.67 12.58 3.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.944 -1.097 . . . . 0.0 109.209 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.544 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -175.42 -178.32 1.12 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 18' ' ' GLN . . . 161.56 148.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 109.31 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -137.82 160.23 39.84 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.166 -0.959 . . . . 0.0 109.482 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 2' ' ' TRP . 30.8 mt -131.81 95.9 2.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.606 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -89.86 128.08 36.12 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.442 0.639 . . . . 0.0 109.459 -178.029 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.19 167.54 49.12 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.663 ' CD1' ' N ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -71.25 -8.34 52.94 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.52 -0.988 . . . . 0.0 109.515 -179.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -78.83 -27.21 44.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.555 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.29 -3.03 34.91 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -93.5 -155.51 0.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -1.175 . . . . 0.0 109.145 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.22 129.71 56.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.886 -1.134 . . . . 0.0 110.138 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.407 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 3.1 m0 -101.16 -34.04 9.85 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.316 -0.865 . . . . 0.0 108.907 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 29' ' ' TRP . . . 170.33 92.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.433 -0.792 . . . . 0.0 109.063 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 14.1 t -109.31 172.08 7.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 110.105 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.488 ' OG ' HG11 ' A' ' 6' ' ' VAL . 16.1 m -156.41 86.77 1.02 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.481 -0.762 . . . . 0.0 109.366 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.558 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . . . -169.39 -55.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.306 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.94 -43.99 1.29 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.558 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 11.1 p90 -48.08 162.52 0.08 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -1.091 . . . . 0.0 109.591 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.63 121.82 38.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.213 -0.93 . . . . 0.0 109.484 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.6 t -89.94 123.25 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.887 . . . . 0.0 109.427 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.68 127.2 91.17 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.16 -0.962 . . . . 0.0 109.307 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 40' ' ' ALA . 1.9 Cg_endo -62.2 169.41 7.84 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.036 1.824 . . . . 0.0 110.526 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 39' ' ' PRO . . . 83.03 -24.41 0.17 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.721 -0.612 . . . . 0.0 110.345 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.403 ' HB3' HD22 ' A' ' 62' ' ' LEU . 0.8 OUTLIER -81.45 -10.55 59.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.986 -1.072 . . . . 0.0 109.55 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -56.74 -34.5 64.89 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -70.35 -39.36 74.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -1.167 . . . . 0.0 109.656 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.9 m -51.22 -34.17 31.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.541 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.465 HD23 ' HB ' ' A' ' 88' ' ' THR . 21.6 tp -67.35 -48.38 67.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.467 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.17 -7.52 30.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 0.0 109.62 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.61 -29.45 16.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.087 -1.008 . . . . 0.0 109.735 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.89 -24.84 58.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.137 -0.977 . . . . 0.0 109.819 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.479 ' CE1' ' O ' ' A' ' 75' ' ' ARG . 9.1 m-85 -57.11 -29.59 63.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 109.566 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -113.27 -16.72 12.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.101 -0.999 . . . . 0.0 109.465 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -117.46 112.27 20.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 109.21 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.531 ' HA ' ' CG1' ' A' ' 55' ' ' ILE . . . -100.26 -8.77 23.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.608 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.552 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -64.79 -52.6 49.5 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 109.902 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.1 Cg_endo -64.33 -4.84 8.66 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.197 1.931 . . . . 0.0 111.205 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.531 ' CG1' ' HA ' ' A' ' 52' ' ' ALA . 1.9 pp -128.39 0.74 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.932 -1.105 . . . . 0.0 109.684 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -98.27 -34.77 10.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.113 -0.992 . . . . 0.0 109.45 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.46 -23.09 65.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -0.821 . . . . 0.0 109.695 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.9 t -170.47 -38.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.126 -0.984 . . . . 0.0 109.688 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 54' ' ' PRO . . . 132.53 -123.11 3.45 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.529 ' CE1' HD13 ' A' ' 62' ' ' LEU . 34.3 p90 -160.28 170.98 19.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.108 -1.231 . . . . 0.0 109.699 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.33 140.22 43.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.529 HD13 ' CE1' ' A' ' 60' ' ' PHE . 3.0 mt -147.99 115.69 6.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.885 . . . . 0.0 109.61 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.486 ' CB ' ' O ' ' A' ' 62' ' ' LEU . . . 76.62 13.04 2.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 109.753 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.65 29.23 24.58 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 t -130.69 -169.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -1.138 . . . . 0.0 109.2 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.75 126.08 28.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.122 -0.986 . . . . 0.0 110.195 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -112.88 152.46 29.25 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.61 163.8 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.725 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.462 HG22 ' HB1' ' A' ' 72' ' ' ALA . 28.1 m -103.85 135.25 45.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.308 -0.87 . . . . 0.0 109.496 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.462 HD11 ' HD2' ' A' ' 80' ' ' LYS . 2.1 tp -113.91 -50.33 2.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.704 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.31 51.63 1.37 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 109.689 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.462 ' HB1' HG22 ' A' ' 69' ' ' THR . . . -79.28 87.73 4.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.223 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.75 -55.93 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.86 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -81.86 -103.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.064 -1.022 . . . . 0.0 109.716 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.479 ' O ' ' CE1' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -134.59 0.54 3.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.903 -1.123 . . . . 0.0 109.975 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 43.7 m -106.22 142.5 35.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.058 -1.026 . . . . 0.0 109.613 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.3 mt -139.78 88.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.45 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 76' ' ' SER . 1.7 m-85 -90.25 65.98 6.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.051 -1.03 . . . . 0.0 109.575 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -44.85 153.04 0.55 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 11.6 ptpt -151.49 94.53 2.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.022 -1.281 . . . . 0.0 109.844 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -160.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 0.0 109.263 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -46.06 -73.75 0.27 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.45 ' OG ' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -112.2 -24.2 9.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -1.158 . . . . 0.0 109.483 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . . . -89.31 -174.02 4.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.152 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.555 ' N ' ' CE1' ' A' ' 100' ' ' TYR . . . 177.18 152.23 9.75 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.092 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 98' ' ' GLY . 9.5 p -117.86 124.27 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -1.042 . . . . 0.0 108.709 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 67.4 mt -100.62 89.81 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.983 -1.073 . . . . 0.0 110.21 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 11.3 p -101.89 135.24 43.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.131 -0.981 . . . . 0.0 109.64 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.475 ' HB ' HD13 ' A' ' 96' ' ' LEU . 47.2 t -149.16 155.9 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.211 -0.93 . . . . 0.0 109.486 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.82 131.96 47.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.109 -0.994 . . . . 0.0 109.481 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.2 p -107.76 -97.72 0.37 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.252 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.9 p -129.58 -31.92 1.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.017 -1.052 . . . . 0.0 109.484 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.27 51.61 0.53 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.919 . . . . 0.0 109.341 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.47 ' HA ' HD12 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -178.9 159.06 1.0 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.529 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.431 HD11 HG22 ' A' ' 95' ' ' ILE . 25.0 mt -120.38 112.14 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.12 -0.987 . . . . 0.0 109.304 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.515 HD11 ' CH2' ' A' ' 2' ' ' TRP . 8.3 mt -67.54 153.15 44.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.335 -0.853 . . . . 0.0 109.618 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.548 ' CG2' ' HG ' ' A' ' 22' ' ' LEU . 60.5 t -150.58 53.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.844 . . . . 0.0 109.776 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.466 ' O ' HG21 ' A' ' 86' ' ' VAL . . . -45.16 137.44 6.31 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.546 ' CG2' ' O ' ' A' ' 97' ' ' VAL . 2.4 t -139.48 117.72 11.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.044 -1.268 . . . . 0.0 108.649 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.555 ' CE1' ' N ' ' A' ' 85' ' ' GLY . 7.2 p90 -138.31 164.04 30.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.014 -1.054 . . . . 0.0 109.756 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.489 ' HA ' ' HB3' ' A' ' 84' ' ' ALA . 13.0 p-10 -110.64 -145.54 0.4 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 0.0 109.881 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.45 ' HG2' ' OG ' ' A' ' 83' ' ' SER . 10.4 mt-10 -76.05 -7.48 54.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.968 . . . . 0.0 110.104 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -16.44 61.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.074 -1.016 . . . . 0.0 109.758 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 17' ' ' THR . 1.2 mp -136.99 141.05 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.246 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -101.98 150.34 37.34 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 109.559 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.426 ' HB2' ' HE2' ' A' ' 80' ' ' LYS . 1.9 Cg_endo -62.32 161.82 25.82 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.27 1.98 . . . . 0.0 110.444 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.6 -55.91 4.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.1 m -67.94 -31.58 71.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -1.081 . . . . 0.0 109.689 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.439 ' O ' HG11 ' A' ' 112' ' ' VAL . . . -84.24 -36.92 22.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 109.504 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.436 ' HB3' ' CD2' ' A' ' 78' ' ' TYR . . . -62.96 -29.79 71.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.297 -0.877 . . . . 0.0 109.498 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -61.28 -36.37 79.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.982 . . . . 0.0 109.524 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -77.76 -31.62 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.135 -0.978 . . . . 0.0 109.432 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.449 ' N ' HG11 ' A' ' 112' ' ' VAL . 53.5 t -63.61 -23.65 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.086 -1.008 . . . . 0.0 109.451 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -77.85 -43.73 29.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.342 -0.849 . . . . 0.0 109.715 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -80.81 -63.73 1.34 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 109.23 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.2 OUTLIER -42.23 -28.42 0.19 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.495 -0.753 . . . . 0.0 109.661 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.449 ' HB2' HD13 ' A' ' 121' ' ' ILE . . . -73.72 -47.98 35.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.715 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -49.13 -21.39 0.74 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.07 -1.019 . . . . 0.0 110.008 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -85.47 -41.33 15.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.318 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 1.1 mt -78.21 -56.08 4.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.097 -1.002 . . . . 0.0 110.361 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.453 ' C ' ' O ' ' A' ' 120' ' ' LEU . 17.8 mt -39.77 -33.44 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.316 -0.865 . . . . 0.0 109.821 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.58 -51.43 36.43 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -59.65 -71.1 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -1.133 . . . . 0.0 109.475 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 130.27 112.15 1.51 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 120' ' ' LEU . 82.7 m-85 . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.211 -1.17 . . . . 0.0 109.535 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.59 ' CE3' ' HG ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 4' ' ' THR . 35.2 tt0 -77.8 -81.14 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.055 -1.028 . . . . 0.0 108.746 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.483 ' O ' ' CG2' ' A' ' 8' ' ' THR . 1.2 t -48.47 -30.23 4.93 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.619 ' CD2' ' CD2' ' A' ' 10' ' ' LEU . 3.2 m-30 -48.19 -54.67 12.65 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.531 ' HA ' ' CG2' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -50.53 -37.77 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -0.799 . . . . 0.0 109.644 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.45 ' C ' ' CG2' ' A' ' 8' ' ' THR . 1.0 OUTLIER -90.85 51.53 1.99 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.071 -1.018 . . . . 0.0 111.951 -178.422 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.483 ' CG2' ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER 173.28 -87.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.482 -1.386 . . . . 0.0 111.486 178.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 11' ' ' VAL . 4.2 m-20 -90.04 -83.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 111.34 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.619 ' CD2' ' CD2' ' A' ' 5' ' ' TYR . 3.8 mm? -21.12 -44.8 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 9' ' ' ASN . 38.5 t -88.02 -59.22 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.659 -1.276 . . . . 0.0 110.279 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.527 ' O ' ' CG2' ' A' ' 13' ' ' THR . . . -37.8 -41.07 0.84 Allowed Glycine 0 N--CA 1.498 2.805 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 155.95 39.88 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.607 0.718 . . . . 0.0 109.378 178.177 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -83.75 19.32 16.17 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 156.2 -28.08 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 18' ' ' GLN . 2.2 m -151.41 152.08 11.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.542 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -79.66 8.12 7.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.798 -1.189 . . . . 0.0 109.292 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.542 ' CG ' ' O ' ' A' ' 17' ' ' THR . 31.5 mt-30 -162.64 176.6 10.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.501 ' CA ' HG22 ' A' ' 99' ' ' VAL . . . -177.78 155.49 1.02 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.863 -1.148 . . . . 0.0 110.234 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.495 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -148.91 114.63 5.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 0.0 109.576 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.577 HD13 ' CD1' ' A' ' 2' ' ' TRP . 7.9 mm -81.28 114.86 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.84 -1.162 . . . . 0.0 108.693 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.525 HD13 ' CG2' ' A' ' 97' ' ' VAL . 0.6 OUTLIER -108.51 88.37 2.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -0.915 . . . . 0.0 108.994 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.592 ' HA3' ' CD2' ' A' ' 29' ' ' TRP . . . -50.11 -177.51 0.02 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.522 HD22 ' CA ' ' A' ' 94' ' ' SER . 13.0 mt -84.03 -50.93 7.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.384 -1.068 . . . . 0.0 109.408 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.86 13.25 33.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.017 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 28' ' ' THR . . . -130.75 80.31 0.35 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.472 ' C ' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -35.44 -31.04 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.905 -0.762 . . . . 0.0 110.441 -179.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -139.04 99.19 3.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.939 -1.1 . . . . 0.0 110.171 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.592 ' CD2' ' HA3' ' A' ' 23' ' ' GLY . 6.5 m0 -95.85 -24.61 16.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 108.996 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -171.79 145.01 1.87 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.463 HG21 ' HB3' ' A' ' 20' ' ' ALA . 18.5 p -149.82 162.03 41.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.123 -0.986 . . . . 0.0 109.848 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.53 ' OG ' ' CG1' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -166.08 84.6 0.31 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.445 -0.785 . . . . 0.0 109.205 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.427 ' HB3' ' OE1' ' A' ' 18' ' ' GLN . . . -172.4 -67.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 109.295 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 138.6 -23.34 2.96 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.575 ' CZ ' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -62.23 178.71 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.063 -1.257 . . . . 0.0 109.782 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.465 ' O ' HG21 ' A' ' 37' ' ' VAL . . . -107.89 125.84 51.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.024 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.575 HG22 ' CZ ' ' A' ' 35' ' ' PHE . 8.3 t -144.89 103.52 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.57 ' CG2' ' HD3' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -173.66 -59.12 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.176 -0.953 . . . . 0.0 110.175 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.57 ' HD3' ' CG2' ' A' ' 38' ' ' THR . 1.9 Cg_endo -59.4 118.33 5.2 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.708 1.605 . . . . 0.0 110.774 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.474 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . . . 54.95 35.17 23.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.291 -0.881 . . . . 0.0 109.973 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.521 ' NE2' HG12 ' A' ' 37' ' ' VAL . 2.4 mm-40 -90.39 -53.88 4.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.801 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.59 -42.84 16.65 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.474 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 4.0 pp0? -59.7 -26.94 66.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -1.18 . . . . 0.0 109.679 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 40' ' ' ALA . 14.0 m -67.47 -53.66 26.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 109.341 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.556 ' O ' ' CD2' ' A' ' 49' ' ' PHE . 8.5 mp -63.53 -29.71 70.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 109.681 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.16 92.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.952 . . . . 0.0 109.533 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.2 t -86.33 -17.23 35.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.495 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.65 51.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.425 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 45' ' ' LEU . 35.4 m-85 -79.01 -10.38 59.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.175 -0.953 . . . . 0.0 109.642 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -89.38 -0.44 57.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.96 . . . . 0.0 109.578 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.471 ' HB2' ' CD ' ' A' ' 54' ' ' PRO . 1.8 p30 175.28 118.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.069 -1.019 . . . . 0.0 109.839 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 72' ' ' ALA . . . -94.97 -13.35 25.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -0.813 . . . . 0.0 109.259 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.583 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -63.08 -50.17 77.46 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 110.204 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.4 Cg_endo -63.83 -13.63 38.25 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.02 1.814 . . . . 0.0 110.967 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.515 HD13 ' CG2' ' A' ' 69' ' ' THR . 0.3 OUTLIER -91.68 -14.79 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.861 -1.149 . . . . 0.0 109.532 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.603 ' CZ ' ' CB ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -81.29 -48.39 12.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.867 . . . . 0.0 109.477 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 58' ' ' SER . . . -77.01 -86.68 0.05 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.242 -0.911 . . . . 0.0 109.43 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 57' ' ' ALA . 20.2 m -44.36 -57.44 3.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.334 -0.854 . . . . 0.0 109.156 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.89 175.04 18.93 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.53 ' CE1' ' OG1' ' A' ' 69' ' ' THR . 10.7 p90 -124.59 124.44 42.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.436 -1.038 . . . . 0.0 108.984 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.87 161.47 15.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -0.964 . . . . 0.0 110.137 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.61 -142.78 0.24 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.02 -0.59 16.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.24 -0.913 . . . . 0.0 109.557 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.41 -102.09 2.76 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -136.22 -147.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.23 -1.159 . . . . 0.0 109.538 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -82.43 133.79 35.22 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.151 -0.968 . . . . 0.0 109.505 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 60' ' ' PHE . 3.0 m-30 -112.76 147.64 36.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 109.495 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -93.25 143.12 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.136 -0.978 . . . . 0.0 109.321 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.53 ' OG1' ' CE1' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -108.41 119.17 38.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.627 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.415 ' O ' HD11 ' A' ' 70' ' ' LEU . 1.4 pp -111.66 21.3 16.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.583 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.423 ' CG ' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER 177.21 102.29 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.134 -0.979 . . . . 0.0 109.523 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.514 ' CB ' HD12 ' A' ' 55' ' ' ILE . . . -153.7 54.6 0.73 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.108 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.24 -16.82 4.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.136 -0.978 . . . . 0.0 110.142 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -110.84 -104.73 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.0 109.752 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -143.41 27.61 1.54 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.955 -1.09 . . . . 0.0 109.253 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.605 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -143.12 129.24 19.73 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.469 ' O ' ' OG1' ' A' ' 88' ' ' THR . 2.4 mp -133.37 99.4 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.922 -1.111 . . . . 0.0 111.025 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.605 ' CE1' ' HB3' ' A' ' 76' ' ' SER . 0.2 OUTLIER -109.52 96.47 6.3 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.128 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.66 168.98 42.37 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.455 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HG3' ' HA3' ' A' ' 85' ' ' GLY . 19.8 tttt -150.52 154.69 38.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.525 -0.985 . . . . 0.0 109.109 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 -13.42 9.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.012 -1.055 . . . . 0.0 109.737 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.37 -76.91 0.23 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.4 p -94.61 -40.9 9.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -1.219 . . . . 0.0 109.384 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.34 145.27 26.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 0.0 109.359 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.578 ' O ' ' CE1' ' A' ' 100' ' ' TYR . . . -138.65 143.46 14.23 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.502 ' CG2' HG11 ' A' ' 97' ' ' VAL . 2.4 p -110.23 136.05 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -1.099 . . . . 0.0 109.56 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.486 ' HB ' ' HA3' ' A' ' 98' ' ' GLY . 3.2 mt -109.92 91.63 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -0.766 . . . . 0.0 109.011 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 5.0 p -89.33 112.67 23.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.061 -1.024 . . . . 0.0 109.69 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.405 ' O ' HD21 ' A' ' 96' ' ' LEU . 41.6 t -111.48 136.88 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.265 -0.897 . . . . 0.0 108.837 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.29 150.62 23.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.067 -1.021 . . . . 0.0 110.032 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.9 p -132.95 -144.63 0.24 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.398 -0.814 . . . . 0.0 109.048 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.529 ' HB3' ' CA ' ' A' ' 124' ' ' GLY . 47.0 t -87.01 -29.86 21.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.039 -1.038 . . . . 0.0 109.447 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 92' ' ' SER . 17.2 mttt -159.58 55.91 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 0.0 109.796 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.63 ' CB ' ' CG ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -177.73 151.25 0.7 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.869 -1.144 . . . . 0.0 110.213 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 14.7 mt -125.08 126.16 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.59 ' HG ' ' CE3' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -108.24 161.61 14.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.992 -178.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.525 ' CG2' HD13 ' A' ' 22' ' ' LEU . 25.6 t -139.49 125.86 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.61 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.486 ' HA3' ' HB ' ' A' ' 87' ' ' ILE . . . -103.79 101.22 1.98 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 107.875 -2.09 . . . . 0.0 107.875 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.501 HG22 ' CA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -99.23 128.93 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -1.123 . . . . 0.0 109.048 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 100' ' ' TYR . 1.3 p90 -144.48 -170.82 3.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.64 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 101' ' ' ASN . 0.0 OUTLIER -120.19 -159.14 0.77 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.895 . . . . 0.0 109.047 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -76.32 -16.33 59.79 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.3 -0.875 . . . . 0.0 109.567 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -37.9 83.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.387 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.502 HG13 ' HB2' ' A' ' 100' ' ' TYR . 14.8 mm -79.62 150.79 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.294 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -93.76 138.18 22.9 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.144 -0.973 . . . . 0.0 109.188 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.96 -23.95 53.67 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.1 1.867 . . . . 0.0 110.828 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.06 -47.04 4.27 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.879 -1.153 . . . . 0.0 110.512 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.7 m -66.5 -47.44 73.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.004 -1.292 . . . . 0.0 109.89 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.45 -12.13 28.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 0.0 110.023 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.62 -26.44 19.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 0.0 109.942 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -83.7 -42.44 16.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.089 -1.007 . . . . 0.0 109.591 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -67.31 -36.8 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.346 -0.846 . . . . 0.0 110.064 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.508 HG11 ' CH2' ' A' ' 2' ' ' TRP . 88.6 t -76.41 -26.81 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.196 -0.94 . . . . 0.0 109.585 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -60.67 -50.88 71.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.847 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 116' ' ' LEU . 13.9 ptmm? -66.66 -35.08 79.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 109.64 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -44.26 -42.26 6.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 0.0 109.034 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.439 ' C ' HD11 ' A' ' 121' ' ' ILE . . . -75.58 -37.36 59.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -0.889 . . . . 0.0 109.029 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -47.57 -25.65 1.2 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 109.189 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -83.63 -45.97 12.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.811 . . . . 0.0 109.323 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.549 ' HB3' ' CE1' ' A' ' 125' ' ' PHE . 0.5 OUTLIER -87.92 11.03 16.82 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.242 -0.911 . . . . 0.0 109.842 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.439 HD11 ' C ' ' A' ' 117' ' ' ALA . 0.9 OUTLIER -90.41 -22.43 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 109.191 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -71.82 -45.83 41.19 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -84.14 -28.88 27.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -1.176 . . . . 0.0 109.425 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.529 ' CA ' ' HB3' ' A' ' 92' ' ' SER . . . 81.19 48.83 5.82 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.63 ' CG ' ' CB ' ' A' ' 94' ' ' SER . 12.6 m-85 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.405 -1.056 . . . . 0.0 109.876 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.574 ' CH2' ' HB3' ' A' ' 96' ' ' LEU . 2.8 m95 . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.412 0.625 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.427 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 1.9 mm-40 -72.96 -109.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.873 -1.142 . . . . 0.0 110.567 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.546 ' O ' ' CG2' ' A' ' 8' ' ' THR . 5.0 t -48.79 -45.47 40.15 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.725 -1.234 . . . . 0.0 109.022 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.582 ' CD2' HD22 ' A' ' 116' ' ' LEU . 14.9 m-30 -41.71 -46.3 3.74 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.549 0.69 . . . . 0.0 109.409 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.535 HG22 ' N ' ' A' ' 2' ' ' TRP . 1.4 t -52.87 -53.66 20.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.462 -0.774 . . . . 0.0 110.007 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.418 ' N ' HG11 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -91.75 50.76 1.74 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.055 -1.028 . . . . 0.0 112.193 -178.348 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.546 ' CG2' ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -160.12 -101.33 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.43 -1.419 . . . . 0.0 110.416 178.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -102.15 -69.72 0.78 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.965 -1.085 . . . . 0.0 110.988 -178.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -22.94 -40.86 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' A' ' 9' ' ' ASN . 4.9 t -80.98 -70.11 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.509 -1.37 . . . . 0.0 110.377 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -38.18 -31.94 0.12 Allowed Glycine 0 N--CA 1.497 2.756 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.556 ' CB ' ' O ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER 152.14 42.58 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -84.78 22.6 8.91 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 154.62 -31.1 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 18' ' ' GLN . 25.6 m -152.6 147.1 14.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.502 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -78.8 5.76 10.6 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.014 -1.053 . . . . 0.0 108.619 179.293 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 17' ' ' THR . 23.3 mt-30 -163.34 160.71 23.99 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.491 ' O ' ' HB1' ' A' ' 20' ' ' ALA . . . -173.33 -179.83 2.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.068 -1.02 . . . . 0.0 109.027 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.5 ' CB ' HD22 ' A' ' 22' ' ' LEU . . . 176.57 115.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.92 . . . . 0.0 110.36 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.574 HD11 ' N ' ' A' ' 21' ' ' ILE . 1.5 mp -80.71 100.29 4.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.5 HD22 ' CB ' ' A' ' 20' ' ' ALA . 3.0 mt -86.93 111.74 21.11 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.542 -0.724 . . . . 0.0 109.863 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.12 -166.37 0.33 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -116.22 16.19 15.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.381 -1.07 . . . . 0.0 109.481 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -96.35 -29.2 14.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.79 -25.63 3.07 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.7 p30 -100.15 -163.0 0.99 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -1.106 . . . . 0.0 109.449 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.42 HG21 ' O ' ' A' ' 21' ' ' ILE . 20.3 m -129.18 136.57 50.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.109 -0.994 . . . . 0.0 109.608 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -79.93 -45.96 17.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.938 . . . . 0.0 108.93 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.29 136.78 38.32 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.408 HG23 HG23 ' A' ' 28' ' ' THR . 0.4 OUTLIER -143.06 167.73 21.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.979 -1.076 . . . . 0.0 109.888 -179.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.427 ' HB3' HG23 ' A' ' 11' ' ' VAL . 0.3 OUTLIER 176.22 57.2 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' A' ' 18' ' ' GLN . . . -120.71 -145.51 0.36 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.302 -0.874 . . . . 0.0 109.609 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.94 8.07 5.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -134.26 177.36 7.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -1.167 . . . . 0.0 109.479 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.5 120.79 33.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 109.424 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 t -87.66 151.9 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 109.523 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -105.16 158.48 32.01 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.669 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.14 -30.89 75.46 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.15 1.9 . . . . 0.0 110.41 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.98 78.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.172 -0.955 . . . . 0.0 110.101 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -81.11 -9.93 59.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 109.992 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.27 -34.74 50.47 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -79.45 -41.59 27.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.15 -1.206 . . . . 0.0 109.694 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.1 m -53.96 -42.5 68.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.877 . . . . 0.0 109.397 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.16 -40.32 97.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.0 109.496 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.573 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . . . -59.86 -41.76 92.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.191 -0.943 . . . . 0.0 109.314 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.3 p -73.89 -20.67 60.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.335 -0.853 . . . . 0.0 109.121 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 51' ' ' ASN . . . -67.86 -22.54 65.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.407 -0.808 . . . . 0.0 109.477 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CE2' ' HG3' ' A' ' 90' ' ' LYS . 51.8 m-85 -70.79 -23.12 62.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.469 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -91.74 -32.81 15.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 0.0 109.446 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.413 ' O ' ' O ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -120.25 147.87 44.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.642 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 55' ' ' ILE . . . -119.44 8.96 11.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 109.499 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.589 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -78.39 -49.49 1.79 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.279 -0.888 . . . . 0.0 110.337 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.6 Cg_endo -66.02 -9.97 25.31 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.953 1.768 . . . . 0.0 111.115 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -109.05 -13.32 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.955 -1.091 . . . . 0.0 109.886 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.482 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 15.0 ptm180 -97.99 -13.36 21.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 109.464 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -124.99 117.98 25.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.611 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 59' ' ' GLY . 1.5 p 69.11 10.28 7.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.281 -0.887 . . . . 0.0 109.42 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 58' ' ' SER . . . 44.18 -123.09 4.76 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.85 -174.72 4.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -1.111 . . . . 0.0 109.539 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -119.13 125.41 49.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.359 -0.838 . . . . 0.0 109.17 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.523 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -120.66 104.27 9.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.888 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 62' ' ' LEU . . . 77.78 -81.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.35 -0.844 . . . . 0.0 109.831 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.63 16.85 0.48 Allowed Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.653 -1.261 . . . . 0.0 110.139 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 t -123.43 164.86 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.055 -1.262 . . . . 0.0 109.245 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -111.0 123.11 49.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.139 -0.976 . . . . 0.0 109.816 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -120.08 165.89 14.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 108.813 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.533 HG22 ' CG ' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -124.96 -162.19 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.067 -1.021 . . . . 0.0 109.464 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.2 m -155.83 131.31 9.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.925 . . . . 0.0 109.778 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.82 19.89 12.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.9 . . . . 0.0 109.238 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 29.9 ttm180 178.9 78.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.319 -0.863 . . . . 0.0 109.387 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.432 ' HA ' HG12 ' A' ' 77' ' ' ILE . . . -106.99 77.4 1.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.751 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -75.45 176.72 7.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 109.187 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.15 -2.43 55.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 109.545 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.505 ' NH1' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -98.16 -66.07 0.92 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 0.0 109.101 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.521 ' O ' ' CG1' ' A' ' 77' ' ' ILE . 0.7 OUTLIER -127.25 176.46 7.39 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.306 -0.871 . . . . 0.0 109.402 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.521 ' CG1' ' O ' ' A' ' 76' ' ' SER . 29.8 mt -159.49 134.26 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 109.583 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -142.5 81.8 1.75 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.043 179.457 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.52 170.38 42.64 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -150.82 158.71 44.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -1.103 . . . . 0.0 109.606 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.533 ' CG ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER 176.22 105.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 109.448 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.522 ' N ' ' HE3' ' A' ' 81' ' ' LYS . . . 85.82 33.51 15.48 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 82' ' ' GLY . 1.7 p 71.36 4.69 5.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -1.108 . . . . 0.0 109.39 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 100' ' ' TYR . . . -122.47 118.28 27.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.241 -0.912 . . . . 0.0 109.14 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 80' ' ' LYS . . . -126.45 149.76 17.58 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 78' ' ' TYR . 13.4 p -105.18 123.79 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.405 -1.056 . . . . 0.0 109.379 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.526 ' O ' ' CG2' ' A' ' 87' ' ' ILE . 1.3 mt -87.7 79.67 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.303 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 7.4 p -92.24 126.55 37.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -0.864 . . . . 0.0 109.723 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.462 HG21 ' O ' ' A' ' 75' ' ' ARG . 2.1 p -145.68 130.49 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.278 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.582 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -82.48 131.31 35.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.904 . . . . 0.0 109.598 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.418 HG21 HD13 ' A' ' 96' ' ' LEU . 1.9 p -102.75 -95.97 0.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.845 . . . . 0.0 109.401 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.442 ' C ' ' HG2' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -125.81 -43.0 1.87 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.023 -1.048 . . . . 0.0 109.409 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.576 ' HB2' ' CG ' ' A' ' 125' ' ' PHE . 0.9 OUTLIER -146.46 50.37 1.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.915 . . . . 0.0 109.609 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.523 ' N ' HD23 ' A' ' 24' ' ' LEU . 1.2 p 170.73 166.19 0.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.101 -0.999 . . . . 0.0 109.671 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.7 mt -118.91 142.88 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.171 -0.956 . . . . 0.0 109.379 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.574 ' HB3' ' CH2' ' A' ' 2' ' ' TRP . 0.5 OUTLIER -108.4 147.8 31.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.934 . . . . 0.0 108.731 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.477 ' HB ' ' O ' ' A' ' 20' ' ' ALA . 70.3 t -133.04 131.02 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.895 -1.128 . . . . 0.0 110.653 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.462 ' HA3' ' HB ' ' A' ' 87' ' ' ILE . . . -118.97 91.96 0.52 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -94.97 110.01 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.136 -1.214 . . . . 0.0 109.586 -178.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.477 ' HB3' ' HA ' ' A' ' 16' ' ' VAL . 30.7 p90 -119.87 158.27 26.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.424 -0.797 . . . . 0.0 109.79 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.469 ' O ' HG13 ' A' ' 104' ' ' ILE . 7.1 m-20 -131.29 174.46 10.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.278 -0.889 . . . . 0.0 109.56 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 101' ' ' ASN . 16.0 mm-40 70.68 26.34 3.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.695 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.45 78.6 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.963 . . . . 0.0 109.42 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 105' ' ' GLN . 5.1 mt -98.04 54.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.146 -0.971 . . . . 0.0 109.879 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER 41.94 97.09 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.476 -0.765 . . . . 0.0 110.238 179.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.41 -13.94 18.66 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.952 1.768 . . . . 0.0 110.297 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -100.78 -30.04 6.28 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 105' ' ' GLN . 31.4 m -73.21 -31.99 64.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.12 -1.223 . . . . 0.0 109.437 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.464 ' O ' HG11 ' A' ' 112' ' ' VAL . . . -88.23 -15.04 36.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.32 -0.863 . . . . 0.0 109.527 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.98 -31.27 25.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.628 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 114' ' ' GLU . 2.8 m120 -73.55 -39.08 65.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.13 -0.981 . . . . 0.0 109.523 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 109' ' ' ALA . 6.1 p -61.93 -37.78 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 0.0 109.185 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.62 -20.68 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.327 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' A' ' 111' ' ' ASN . 6.5 tt0 -63.79 -61.84 2.04 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.151 -0.968 . . . . 0.0 109.09 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -39.1 89.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.129 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.582 HD22 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -57.27 -27.02 61.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.381 -0.824 . . . . 0.0 109.448 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.463 ' HB3' HD13 ' A' ' 121' ' ' ILE . . . -75.56 -44.2 44.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 0.0 109.49 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -53.26 -19.08 2.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.91 . . . . 0.0 109.472 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -82.58 -58.58 2.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 109.787 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 121' ' ' ILE . 2.6 mt -61.3 -56.56 19.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.952 . . . . 0.0 110.115 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.463 HD13 ' HB3' ' A' ' 117' ' ' ALA . 6.1 mt -41.2 -29.84 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.272 -0.892 . . . . 0.0 109.802 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 123' ' ' GLN . . . -105.61 49.35 0.9 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 122' ' ' GLY . 2.2 mt-30 -173.68 -69.65 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.398 -1.06 . . . . 0.0 109.61 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.452 ' O ' ' OXT' ' A' ' 125' ' ' PHE . . . -133.88 56.13 0.73 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.576 ' CG ' ' HB2' ' A' ' 93' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.397 -1.061 . . . . 0.0 109.588 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 121.461 0.648 . . . . 0.0 109.988 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -83.63 -76.47 0.29 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.083 -1.011 . . . . 0.0 110.583 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.478 HG22 ' CD1' ' A' ' 5' ' ' TYR . 2.1 t -39.56 -28.81 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.208 -0.933 . . . . 0.0 109.737 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.581 ' HB2' ' HB2' ' A' ' 2' ' ' TRP . 18.1 m-30 -86.36 -43.45 12.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 0.0 108.916 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.542 HG11 ' CB ' ' A' ' 32' ' ' SER . 0.9 OUTLIER -46.77 -27.87 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.472 0.653 . . . . 0.0 109.852 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.56 -84.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 111.869 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.91 2.58 3.68 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.681 -1.262 . . . . 0.0 110.801 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.535 ' O ' ' N ' ' A' ' 14' ' ' GLY . 6.0 m-20 -92.87 -90.99 0.18 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.969 -1.082 . . . . 0.0 109.621 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -52.97 -30.2 33.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.155 -0.966 . . . . 0.0 110.081 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.537 ' CG2' ' HA ' ' A' ' 6' ' ' VAL . 21.2 t -88.64 -59.01 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.054 -1.029 . . . . 0.0 109.554 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.572 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -42.38 -30.73 0.87 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 107.944 -2.063 . . . . 0.0 107.944 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.572 ' CB ' ' O ' ' A' ' 12' ' ' GLY . 1.0 OUTLIER 147.66 51.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.12 0.486 . . . . 0.0 109.885 178.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.609 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -90.03 19.22 43.57 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 107.071 -2.411 . . . . 0.0 107.071 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.609 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 144.93 -25.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 34.8 m -139.11 149.94 23.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.52 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 5.5 p -87.29 20.75 2.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.976 -1.077 . . . . 0.0 108.662 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.544 ' HB3' ' CB ' ' A' ' 33' ' ' ALA . 4.7 mp0 -171.21 172.59 5.25 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.578 -0.701 . . . . 0.0 109.256 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.516 ' HB1' ' CG2' ' A' ' 11' ' ' VAL . . . -175.73 135.11 0.3 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.073 -1.017 . . . . 0.0 109.602 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -133.08 121.06 22.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.072 -1.018 . . . . 0.0 110.079 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.575 HD12 ' CA ' ' A' ' 2' ' ' TRP . 8.0 mt -86.16 96.72 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 108.624 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.547 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 3.0 mm? -79.15 -179.92 6.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.373 -0.829 . . . . 0.0 109.18 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 94' ' ' SER . . . -133.35 106.36 0.63 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.505 ' N ' HG13 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -51.82 -38.2 54.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -1.178 . . . . 0.0 109.465 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -138.85 35.61 2.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.482 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.38 -102.32 1.1 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.416 ' O ' ' HB ' ' A' ' 28' ' ' THR . 0.2 OUTLIER 174.57 52.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -1.12 . . . . 0.0 109.401 -179.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 27' ' ' ASN . 1.4 m 59.18 98.93 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.981 -1.074 . . . . 0.0 109.139 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.525 ' CE2' ' OG ' ' A' ' 94' ' ' SER . 38.2 m0 -84.07 -29.27 26.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.88 . . . . 0.0 109.639 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.24 157.99 33.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 109.396 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.457 ' O ' ' OG ' ' A' ' 32' ' ' SER . 0.1 OUTLIER -160.09 152.13 20.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.576 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.542 ' CB ' HG11 ' A' ' 6' ' ' VAL . 73.7 m -169.72 58.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.845 . . . . 0.0 109.402 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.544 ' CB ' ' HB3' ' A' ' 18' ' ' GLN . . . -120.27 -66.38 1.07 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.199 -0.938 . . . . 0.0 109.778 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.6 -37.95 1.88 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.794 -1.723 . . . . 0.0 108.794 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.559 ' CZ ' HG22 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -59.0 177.47 0.15 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.386 -1.067 . . . . 0.0 109.415 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.49 140.47 29.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 110.439 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.559 HG22 ' CZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -149.28 135.64 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.342 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.6 p -132.66 117.0 15.09 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.168 -0.957 . . . . 0.0 109.617 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 40' ' ' ALA . 6.2 Cg_exo -58.07 117.11 3.76 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.952 1.768 . . . . 0.0 110.384 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 39' ' ' PRO . . . 162.91 -63.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 109.005 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -68.08 -12.36 60.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.147 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.88 -24.55 42.13 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -68.69 -52.37 31.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -1.12 . . . . 0.0 109.324 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.9 m -57.86 -25.8 61.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.358 -0.838 . . . . 0.0 109.243 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.504 ' HG ' ' CE1' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -65.13 -43.8 90.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.279 -0.888 . . . . 0.0 109.493 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.71 -30.84 70.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 109.893 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 p -66.11 -30.87 71.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.278 -0.889 . . . . 0.0 110.086 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.07 -10.97 59.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.126 -0.984 . . . . 0.0 109.904 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CE1' ' HG ' ' A' ' 45' ' ' LEU . 4.4 m-85 -90.41 17.61 7.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.928 . . . . 0.0 109.583 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -98.75 5.52 47.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 0.0 109.35 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -176.47 162.66 2.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.317 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 56' ' ' ARG . . . -101.26 -2.02 32.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.545 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 1.4 m-20 -75.7 -54.65 2.19 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 110.129 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.545 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 3.5 Cg_exo -61.57 -11.31 19.62 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.007 1.805 . . . . 0.0 110.686 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.451 HG13 ' HA ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -118.62 -11.08 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.993 . . . . 0.0 109.658 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.511 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -97.89 44.59 1.04 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 0.0 109.264 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -169.85 -58.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.126 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.9 p -94.73 -25.8 16.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.334 -0.854 . . . . 0.0 109.298 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.64 -152.58 20.61 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -142.66 -174.66 4.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -1.073 . . . . 0.0 109.342 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.46 136.37 17.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.144 -0.972 . . . . 0.0 109.812 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.6 mp -82.23 -138.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 108.944 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.5 41.72 0.86 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.942 -1.099 . . . . 0.0 110.328 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.94 0.59 5.57 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.66 140.6 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.175 -1.191 . . . . 0.0 109.748 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.471 ' N ' ' CD2' ' A' ' 66' ' ' HIS . 3.6 m170 -106.14 108.9 20.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 109.565 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.12 166.4 12.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.177 -0.952 . . . . 0.0 109.257 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.0 p -118.57 170.1 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.197 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.485 ' CG2' ' HB3' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -144.88 154.78 42.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 109.432 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 tp -124.36 -67.09 0.94 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.291 -0.88 . . . . 0.0 109.442 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.409 ' O ' ' O ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -107.11 51.63 0.74 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.565 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.485 ' HB3' ' CG2' ' A' ' 69' ' ' THR . . . -54.54 -172.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -145.34 -150.82 0.34 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.545 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -111.61 -52.21 2.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.97 . . . . 0.0 109.527 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.405 HH11 ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -96.79 2.7 52.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 109.785 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.456 ' O ' HG13 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -142.19 140.58 32.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.872 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 76' ' ' SER . 2.2 mp -158.38 104.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 109.247 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.473 ' HB3' ' HA ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -108.15 120.64 42.93 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.273 -0.892 . . . . 0.0 108.659 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.92 157.79 49.09 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.461 ' HE3' ' HG3' ' A' ' 106' ' ' PRO . 1.2 mmmp? -151.12 118.64 6.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -1.085 . . . . 0.0 109.471 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.16 141.8 16.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.994 . . . . 0.0 109.429 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 55.16 -126.22 38.23 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.34 18.1 17.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.139 -1.212 . . . . 0.0 109.661 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.09 128.96 33.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.746 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.536 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -132.73 164.59 24.02 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 78' ' ' TYR . 1.8 m -127.77 149.48 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.022 -1.281 . . . . 0.0 110.165 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.481 ' HB ' ' HA3' ' A' ' 98' ' ' GLY . 6.5 mt -116.5 83.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.7 OUTLIER -89.26 142.2 27.86 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.239 -0.913 . . . . 0.0 110.303 -178.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.4 t -150.13 154.24 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -109.22 121.82 45.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.005 -1.06 . . . . 0.0 109.802 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 92' ' ' SER . 0.0 OUTLIER -92.26 -55.11 3.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.291 -0.881 . . . . 0.0 109.535 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.429 ' HB3' ' C ' ' A' ' 125' ' ' PHE . 9.3 t 171.51 -31.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.067 -1.021 . . . . 0.0 109.95 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.4 mttm -128.75 -28.53 2.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.015 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.525 ' OG ' ' CE2' ' A' ' 29' ' ' TRP . 39.8 m -135.34 152.45 51.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.044 -1.035 . . . . 0.0 109.847 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.505 HG13 ' N ' ' A' ' 24' ' ' LEU . 14.4 mt -94.08 142.33 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.346 -0.846 . . . . 0.0 109.32 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.572 HD21 ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -107.0 148.52 28.58 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.542 ' CG2' HD21 ' A' ' 22' ' ' LEU . 39.8 t -140.25 131.89 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.995 -1.066 . . . . 0.0 110.215 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.481 ' HA3' ' HB ' ' A' ' 87' ' ' ILE . . . -104.86 102.91 2.13 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 107.444 -2.262 . . . . 0.0 107.444 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.495 HG22 ' CA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -96.73 123.42 49.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.248 -1.148 . . . . 0.0 109.238 -178.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.536 ' CZ ' ' HA3' ' A' ' 85' ' ' GLY . 3.4 p90 -132.52 164.2 27.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.298 -0.876 . . . . 0.0 109.491 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -149.22 -170.41 3.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.506 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 60.81 22.14 12.2 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.175 -0.953 . . . . 0.0 109.371 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.43 82.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.589 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.512 HD11 HG22 ' A' ' 104' ' ' ILE . 4.0 mt -97.27 147.66 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.155 -0.966 . . . . 0.0 109.283 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.503 ' N ' HG21 ' A' ' 104' ' ' ILE . 1.7 mp0 -50.88 109.38 1.32 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.307 -0.871 . . . . 0.0 109.546 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.461 ' HG3' ' HE3' ' A' ' 80' ' ' LYS . 2.4 Cg_endo -62.13 -35.26 76.35 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.921 1.748 . . . . 0.0 110.167 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.2 47.18 3.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.6 m -148.36 -39.2 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 109.414 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.521 ' CB ' ' HB2' ' A' ' 15' ' ' ALA . . . -88.12 -18.94 27.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.604 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.53 -46.98 24.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -63.75 -42.04 97.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.429 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 89.3 t -62.74 -26.4 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.239 -0.913 . . . . 0.0 109.565 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.6 t -87.55 -22.86 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.366 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -63.89 -42.41 97.49 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.229 -0.919 . . . . 0.0 109.307 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -78.32 -51.24 10.41 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.363 -0.836 . . . . 0.0 109.226 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.554 HD23 ' CE2' ' A' ' 5' ' ' TYR . 4.1 tp -49.67 -33.09 14.74 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.154 -0.966 . . . . 0.0 109.109 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.532 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -62.24 -47.91 82.31 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.248 -0.907 . . . . 0.0 108.584 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.432 ' HA ' HD11 ' A' ' 121' ' ' ILE . 0.1 OUTLIER -62.09 -15.79 47.69 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.492 -0.755 . . . . 0.0 109.088 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.493 ' CE2' HD13 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -83.65 -47.58 11.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.431 -0.793 . . . . 0.0 108.988 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.493 HD13 ' CE2' ' A' ' 119' ' ' TYR . 0.4 OUTLIER -80.92 -7.67 59.56 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.357 -0.839 . . . . 0.0 109.591 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.532 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 26.6 mt -90.13 -20.94 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.31 -0.869 . . . . 0.0 109.347 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.92 -0.31 25.65 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -140.7 -47.27 0.41 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -1.147 . . . . 0.0 109.472 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.408 ' HA3' ' CD2' ' A' ' 120' ' ' LEU . . . -74.88 -102.31 0.1 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.191 -1.182 . . . . 0.0 109.261 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.596 ' CE2' HD12 ' A' ' 10' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.83 -79.72 0.33 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.734 -1.229 . . . . 0.0 108.219 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -17.59 61.85 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.545 ' HB3' ' HB2' ' A' ' 10' ' ' LEU . 9.9 m-30 -75.35 -39.34 59.41 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.503 ' HB ' ' O ' ' A' ' 2' ' ' TRP . 1.2 t -54.2 -48.42 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.586 -0.696 . . . . 0.0 110.027 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.496 ' O ' HG22 ' A' ' 8' ' ' THR . 5.5 t0 -90.91 52.37 2.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 112.513 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER 176.78 -87.49 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.26 -1.525 . . . . 0.0 112.783 178.465 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 11' ' ' VAL . 14.0 m120 -83.43 -92.06 0.07 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.105 -0.997 . . . . 0.0 112.494 -176.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.596 HD12 ' CE2' ' A' ' 2' ' ' TRP . 3.0 mt -23.79 -41.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' A' ' 9' ' ' ASN . 72.2 t -89.61 -57.42 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.576 -1.327 . . . . 0.0 110.523 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.502 ' C ' ' CG2' ' A' ' 13' ' ' THR . . . -40.65 -47.56 3.89 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 108.741 -1.743 . . . . 0.0 108.741 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.552 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER 166.72 38.63 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.708 -0.878 . . . . 0.0 108.932 178.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -82.67 15.35 31.36 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 157.99 -27.58 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 23.5 m -143.4 154.34 16.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.2 OUTLIER -83.95 17.41 2.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.974 -1.079 . . . . 0.0 109.533 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.538 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 0.3 OUTLIER -176.99 177.47 1.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.548 ' CB ' HG23 ' A' ' 11' ' ' VAL . . . 179.19 158.04 0.58 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.84 -1.162 . . . . 0.0 110.265 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.488 ' O ' HD11 ' A' ' 22' ' ' LEU . . . -153.94 117.71 4.7 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.575 HD12 ' CD1' ' A' ' 2' ' ' TRP . 6.9 mm -82.63 113.39 21.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.221 -0.924 . . . . 0.0 109.19 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.585 ' CD2' ' CG2' ' A' ' 97' ' ' VAL . 0.4 OUTLIER -96.32 117.14 30.21 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.537 -0.727 . . . . 0.0 109.566 -178.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -50.7 179.98 0.03 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -121.37 -8.98 9.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -1.192 . . . . 0.0 109.659 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -111.58 26.96 10.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.932 . . . . 0.0 109.537 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.08 70.44 1.31 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -171.62 -164.99 0.35 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -1.158 . . . . 0.0 109.331 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.05 111.09 7.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.168 -0.957 . . . . 0.0 109.58 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 36.5 m0 -83.91 -33.63 24.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.461 ' HB2' ' CG1' ' A' ' 21' ' ' ILE . . . -164.9 158.98 17.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.285 -0.884 . . . . 0.0 109.399 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.3 t -152.31 141.55 21.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.159 -0.963 . . . . 0.0 109.812 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.558 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -130.13 119.97 23.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.396 -0.815 . . . . 0.0 108.998 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 32' ' ' SER . . . 81.73 159.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.589 -0.694 . . . . 0.0 109.375 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 33' ' ' ALA . . . -43.45 -93.25 0.01 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.522 ' CZ ' HG23 ' A' ' 99' ' ' VAL . 0.9 OUTLIER 68.75 94.73 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -1.139 . . . . 0.0 109.533 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.52 100.3 10.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.385 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.434 ' HB ' ' HG2' ' A' ' 41' ' ' GLN . 1.8 t -109.28 166.24 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.876 . . . . 0.0 109.529 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.472 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -50.22 153.55 2.42 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.372 -0.83 . . . . 0.0 109.545 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.459 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 5.3 Cg_exo -58.97 -16.07 30.55 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.159 1.906 . . . . 0.0 110.436 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.52 56.89 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.222 -0.924 . . . . 0.0 109.48 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 38' ' ' THR . 3.9 mp0 -51.67 -37.05 48.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.026 -1.046 . . . . 0.0 109.265 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.31 -39.58 70.73 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -63.15 -37.41 87.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -1.194 . . . . 0.0 110.033 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.1 m -62.46 -51.66 66.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.186 -0.946 . . . . 0.0 109.668 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.406 HD23 HG23 ' A' ' 95' ' ' ILE . 2.1 mp -65.73 -23.32 66.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 109.75 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.572 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . . . -62.92 -37.15 85.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.94 . . . . 0.0 109.674 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.8 m -76.98 -28.39 55.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.539 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.61 -14.22 62.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.548 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.572 ' CD2' ' HA ' ' A' ' 46' ' ' ALA . 23.2 m-85 -76.51 -39.54 52.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.94 . . . . 0.0 109.398 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -87.48 -66.73 0.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.129 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -117.3 140.73 49.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 0.0 109.117 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB3' HD12 ' A' ' 55' ' ' ILE . . . -135.64 33.57 2.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -0.958 . . . . 0.0 109.767 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.608 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -68.22 -45.28 39.22 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.377 -0.827 . . . . 0.0 110.652 179.707 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 6.3 Cg_exo -59.44 -18.71 47.74 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.524 1.483 . . . . 0.0 110.595 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.602 ' CD1' ' CB ' ' A' ' 72' ' ' ALA . 1.1 pt -105.7 -19.03 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 109.163 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.425 HH11 ' CG ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -76.79 -37.48 55.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.364 -0.835 . . . . 0.0 109.655 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 56' ' ' ARG . . . -43.87 -71.56 0.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 0.0 109.74 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 t -118.83 -47.12 2.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.636 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' A' ' 68' ' ' VAL . . . 166.01 -163.42 36.77 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.94 161.16 17.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -1.146 . . . . 0.0 109.475 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.42 104.79 12.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 109.708 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.88 112.67 25.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.865 . . . . 0.0 109.514 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 49.71 -143.38 0.54 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.567 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.87 46.89 3.75 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.574 HG12 ' CE2' ' A' ' 67' ' ' TYR . 3.4 t -142.34 138.93 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -1.179 . . . . 0.0 108.963 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.407 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 75.9 t60 -121.46 118.91 30.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 0.0 109.77 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.574 ' CE2' HG12 ' A' ' 65' ' ' VAL . 15.9 m-85 -131.73 177.62 7.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 109.241 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.465 ' CG2' ' N ' ' A' ' 69' ' ' THR . 7.7 p -104.42 166.16 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.268 -0.895 . . . . 0.0 109.846 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.465 ' N ' ' CG2' ' A' ' 68' ' ' VAL . 1.4 m -95.49 176.76 6.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.933 . . . . 0.0 109.173 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.446 HD21 ' O ' ' A' ' 69' ' ' THR . 0.2 OUTLIER -141.33 -48.42 0.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.141 -0.974 . . . . 0.0 110.234 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 76' ' ' SER . 13.8 ttm180 -142.8 61.38 1.42 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.947 -1.096 . . . . 0.0 110.153 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.602 ' CB ' ' CD1' ' A' ' 55' ' ' ILE . . . -85.34 81.66 8.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.123 -0.985 . . . . 0.0 109.393 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -154.88 -38.56 0.09 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.284 -0.885 . . . . 0.0 109.477 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.93 -100.18 0.35 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.761 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.452 ' NH1' ' CG ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -129.11 -16.23 4.07 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.882 -1.136 . . . . 0.0 110.106 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.558 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 6.1 m -89.37 131.82 35.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.827 -1.17 . . . . 0.0 109.415 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.465 ' O ' ' CG2' ' A' ' 77' ' ' ILE . 4.7 mp -149.21 60.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 110.116 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.558 ' CE1' ' HB3' ' A' ' 76' ' ' SER . 0.1 OUTLIER -90.51 161.31 15.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.036 -1.04 . . . . 0.0 108.333 179.008 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.82 158.25 14.45 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.444 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 19.3 mtmt -145.34 132.64 20.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -1.09 . . . . 0.0 109.375 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.9 OUTLIER 171.63 128.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 109.508 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 83' ' ' SER . . . 56.96 54.78 34.23 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 82' ' ' GLY . 0.6 OUTLIER 43.79 26.77 0.14 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -1.151 . . . . 0.0 109.61 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.493 ' HA ' ' CE2' ' A' ' 100' ' ' TYR . . . -145.34 153.36 41.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.205 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 179.5 -166.79 36.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.38 179.91 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -1.149 . . . . 0.0 109.649 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.48 ' HB ' ' CA ' ' A' ' 98' ' ' GLY . 36.4 mm -142.85 68.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.104 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 1.2 p -99.93 116.86 32.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 110.028 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.36 150.99 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.428 -0.795 . . . . 0.0 108.963 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.455 ' HG3' HG12 ' A' ' 95' ' ' ILE . 1.8 mtpt -98.35 149.97 22.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.147 -0.97 . . . . 0.0 109.778 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.6 p -123.42 -138.75 0.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.808 . . . . 0.0 108.871 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.461 ' HB2' ' HA ' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -66.64 -17.01 64.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.858 -1.151 . . . . 0.0 109.302 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.562 ' HB2' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER 167.49 66.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 p 176.86 156.58 0.28 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.347 -0.845 . . . . 0.0 109.126 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.455 HG12 ' HG3' ' A' ' 90' ' ' LYS . 14.7 mt -129.39 100.67 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.037 -1.039 . . . . 0.0 109.831 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.492 ' CD2' ' CZ2' ' A' ' 2' ' ' TRP . 2.9 pp -78.42 137.85 38.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 108.954 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.585 ' CG2' ' CD2' ' A' ' 22' ' ' LEU . 11.9 t -117.4 81.28 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.139 -0.976 . . . . 0.0 110.183 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.48 ' CA ' ' HB ' ' A' ' 87' ' ' ILE . . . -74.47 110.5 3.1 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.522 HG23 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.62 127.74 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -1.228 . . . . 0.0 109.44 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.494 ' HB3' HG11 ' A' ' 16' ' ' VAL . 22.4 p90 -130.97 173.01 11.41 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 109.941 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -122.48 -141.49 0.32 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.597 -0.689 . . . . 0.0 109.372 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 103' ' ' LYS . 4.3 pt-20 -79.15 -19.15 51.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.111 -0.993 . . . . 0.0 109.422 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.431 ' N ' ' HG3' ' A' ' 102' ' ' GLU . 65.7 mttt -58.17 -25.28 61.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.387 -0.82 . . . . 0.0 109.833 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.7 mt -127.41 143.47 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.014 -1.054 . . . . 0.0 109.541 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.433 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -102.48 158.26 32.1 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 109.33 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 105' ' ' GLN . 2.1 Cg_endo -61.78 153.87 64.77 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.165 1.91 . . . . 0.0 110.195 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.7 -61.57 0.32 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.5 m -75.68 -22.44 56.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -1.125 . . . . 0.0 109.714 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.68 -38.11 59.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.628 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.96 -38.36 32.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 109.683 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 114' ' ' GLU . 2.6 t30 -63.74 -41.16 98.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.134 -0.979 . . . . 0.0 109.641 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.514 HG12 ' CB ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -65.41 -42.95 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.357 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.93 -15.53 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.896 . . . . 0.0 109.64 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 111' ' ' ASN . 5.3 tp10 -67.79 -63.63 1.02 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.239 -0.913 . . . . 0.0 109.625 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -27.1 66.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.178 -0.951 . . . . 0.0 109.753 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -47.11 87.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.112 -0.993 . . . . 0.0 110.122 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.505 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -78.21 -33.21 50.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 109.937 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -57.25 -17.74 13.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 109.854 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.44 -57.4 2.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 110.065 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -70.66 -1.96 12.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.135 -0.978 . . . . 0.0 110.689 -178.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.505 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -70.03 -36.65 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.965 -1.084 . . . . 0.0 108.97 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 123' ' ' GLN . . . -108.72 42.56 1.92 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 122' ' ' GLY . 53.9 mm-40 -147.01 -84.1 0.11 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -1.166 . . . . 0.0 109.864 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.457 ' O ' ' OXT' ' A' ' 125' ' ' PHE . . . -136.7 63.98 0.57 Allowed Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.253 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.562 ' CD1' ' HB2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.241 -1.153 . . . . 0.0 109.625 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.577 ' CH2' ' HG ' ' A' ' 96' ' ' LEU . 3.4 m95 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 2' ' ' TRP . 3.0 mp0 -39.09 -92.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.405 -0.809 . . . . 0.0 111.408 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 8' ' ' THR . 91.5 m -57.42 -49.14 77.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.347 -0.846 . . . . 0.0 110.961 -178.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.552 ' HB3' ' CB ' ' A' ' 10' ' ' LEU . 15.3 m-30 -50.92 -18.42 0.76 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.156 -0.965 . . . . 0.0 110.23 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.48 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -79.61 -46.85 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.945 -1.097 . . . . 0.0 109.361 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.48 51.42 1.88 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 0.0 111.982 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -166.23 -100.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.36 -1.462 . . . . 0.0 110.892 179.002 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -102.25 -59.35 1.72 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.051 -1.03 . . . . 0.0 110.824 -178.632 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.552 ' CB ' ' HB3' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -33.49 -33.26 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.622 -0.674 . . . . 0.0 110.99 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.546 HG23 ' CB ' ' A' ' 19' ' ' ALA . 2.8 t -99.53 -48.21 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.032 -1.042 . . . . 0.0 109.689 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -40.81 -45.13 3.6 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.527 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER 159.66 39.72 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.88 -0.777 . . . . 0.0 109.601 178.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -84.23 20.04 15.28 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 154.1 -33.55 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.53 ' HA ' ' CD1' ' A' ' 104' ' ' ILE . 11.9 m -136.44 134.56 49.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.554 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 9.2 t -78.4 2.61 18.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.85 -1.156 . . . . 0.0 109.387 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.554 ' CG ' ' O ' ' A' ' 17' ' ' THR . 71.7 mt-30 -162.6 155.34 19.43 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.546 ' CB ' HG23 ' A' ' 11' ' ' VAL . . . -158.9 152.51 23.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.117 -0.989 . . . . 0.0 109.72 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -138.6 142.11 39.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.947 . . . . 0.0 109.455 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.513 HD13 ' N ' ' A' ' 2' ' ' TRP . 0.7 OUTLIER -109.32 79.96 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.144 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.555 ' CD1' HG23 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -62.44 -153.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 108.649 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.423 ' C ' HG13 ' A' ' 95' ' ' ILE . . . -143.1 140.49 9.75 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.565 -1.302 . . . . 0.0 109.986 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.517 ' CD2' HG12 ' A' ' 95' ' ' ILE . 9.1 mt -68.68 -44.19 74.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -1.137 . . . . 0.0 109.263 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -129.27 2.45 5.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.584 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.35 -102.53 2.15 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.447 ' O ' ' OG1' ' A' ' 28' ' ' THR . 22.4 t-20 -176.91 -46.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -1.122 . . . . 0.0 109.576 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 27' ' ' ASN . 7.8 m -167.17 116.81 0.85 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.887 . . . . 0.0 109.666 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.413 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 19.0 m0 -96.78 -34.46 11.31 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.271 -0.893 . . . . 0.0 109.366 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.98 170.72 6.16 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -161.39 -179.27 7.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.059 -1.026 . . . . 0.0 109.945 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.5 ' HB2' HG13 ' A' ' 11' ' ' VAL . 51.9 p 177.74 67.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.531 -0.731 . . . . 0.0 109.23 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.569 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . . . -142.08 -39.39 0.37 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.482 -0.761 . . . . 0.0 109.169 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.3 -52.94 0.95 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.569 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -61.22 162.2 7.86 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -1.094 . . . . 0.0 109.385 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.08 148.54 29.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 109.379 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.465 ' HA ' ' HB1' ' A' ' 63' ' ' ALA . 61.4 t -102.17 158.69 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.193 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.464 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 6.0 t -43.14 147.19 0.72 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.437 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 6.1 Cg_exo -58.77 -14.07 20.57 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.153 1.902 . . . . 0.0 110.311 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.528 ' CB ' ' HB3' ' A' ' 43' ' ' GLN . . . -107.8 59.3 0.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.917 . . . . 0.0 109.409 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -65.56 -52.68 50.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.93 -1.107 . . . . 0.0 109.765 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.88 -12.71 84.33 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.528 ' HB3' ' CB ' ' A' ' 40' ' ' ALA . 1.5 tt0 -89.98 -20.97 22.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -1.149 . . . . 0.0 109.475 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.454 ' O ' ' HB1' ' A' ' 48' ' ' ALA . 98.1 m -90.1 -29.72 18.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.498 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.518 ' O ' ' CD2' ' A' ' 49' ' ' PHE . 4.2 mm? -87.7 -40.55 14.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.726 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.37 -25.26 60.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 109.995 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.3 t -88.59 -19.6 26.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.124 -0.985 . . . . 0.0 109.779 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 44' ' ' THR . . . -85.18 -14.25 47.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.103 -0.998 . . . . 0.0 109.689 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.518 ' CD2' ' O ' ' A' ' 45' ' ' LEU . 19.6 m-85 -74.32 -33.0 63.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.658 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -94.11 -20.78 19.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.939 . . . . 0.0 109.303 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -131.55 120.85 23.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 0.0 109.342 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.454 ' HA ' HD12 ' A' ' 55' ' ' ILE . . . -119.84 28.71 7.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 109.554 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.557 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -76.57 -51.42 2.43 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.333 -0.855 . . . . 0.0 110.458 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.7 Cg_endo -64.61 -4.81 9.0 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.113 1.875 . . . . 0.0 111.357 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.533 ' O ' ' CB ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -112.53 7.62 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.748 -1.22 . . . . 0.0 110.101 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -100.07 -20.38 16.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.891 -1.13 . . . . 0.0 109.604 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.87 -60.9 1.2 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.22 -0.925 . . . . 0.0 109.537 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -78.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.374 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.41 -165.02 28.34 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.48 ' HB2' ' HB2' ' A' ' 67' ' ' TYR . 7.0 m-85 -81.28 170.82 15.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -1.126 . . . . 0.0 109.684 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -141.33 101.04 3.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.495 -0.753 . . . . 0.0 108.973 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.455 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 5.9 mp -127.1 61.17 1.36 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.203 -0.936 . . . . 0.0 109.932 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 64' ' ' GLY . . . 69.47 -83.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.365 -0.834 . . . . 0.0 110.015 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -38.72 -95.54 0.01 OUTLIER Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.77 -148.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.084 -1.245 . . . . 0.0 109.238 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.47 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 31.6 p-80 -122.21 144.03 49.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.153 -0.967 . . . . 0.0 109.73 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.48 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 25.9 m-85 -100.81 -161.94 0.9 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.362 -0.836 . . . . 0.0 109.233 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 80' ' ' LYS . 1.4 p -104.32 -171.22 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.052 -1.03 . . . . 0.0 109.287 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.533 ' CB ' ' O ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -148.56 64.71 1.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.11 -0.994 . . . . 0.0 109.549 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.84 18.33 7.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.92 . . . . 0.0 109.211 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -161.87 55.9 0.25 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.454 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.424 ' CB ' ' CG2' ' A' ' 69' ' ' THR . . . -123.46 66.35 1.01 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.735 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.85 -42.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.938 . . . . 0.0 109.635 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 2.2 m-20 -49.65 -86.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.597 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.525 ' HG2' ' NH1' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -145.22 -59.85 0.35 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.897 . . . . 0.0 109.388 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 78' ' ' TYR . 74.2 m -89.6 -165.41 1.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.416 ' CG1' ' O ' ' A' ' 76' ' ' SER . 13.9 mt -154.61 105.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.009 -1.057 . . . . 0.0 109.704 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 78' ' ' TYR . 0.6 OUTLIER -113.52 97.08 6.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 0.0 109.06 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.455 ' HA3' HG11 ' A' ' 86' ' ' VAL . . . -60.31 141.38 47.88 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.529 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -151.05 124.62 9.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -1.101 . . . . 0.0 109.417 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.67 132.72 1.51 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.141 -0.974 . . . . 0.0 109.676 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.5 -136.07 47.41 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.18 -10.15 24.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -1.114 . . . . 0.0 109.704 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 101' ' ' ASN . . . -109.48 -173.91 2.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 109.463 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.03 171.06 28.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.455 HG11 ' HA3' ' A' ' 79' ' ' GLY . 3.4 p -123.99 153.8 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -1.184 . . . . 0.0 109.55 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.47 HD11 ' HB3' ' A' ' 78' ' ' TYR . 30.2 mm -127.31 94.67 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.033 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 1.4 p -108.97 129.7 55.45 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.143 -0.973 . . . . 0.0 109.985 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.425 ' O ' HD21 ' A' ' 96' ' ' LEU . 2.4 t -142.23 143.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -103.1 120.52 40.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.119 -0.988 . . . . 0.0 109.907 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.52 ' HB ' ' CB ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -96.34 -59.13 1.9 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.412 -0.805 . . . . 0.0 108.969 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.577 ' HB3' ' CD2' ' A' ' 125' ' ' PHE . 0.2 OUTLIER 171.86 -32.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.41 -0.806 . . . . 0.0 109.769 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.5 ' CA ' HD11 ' A' ' 24' ' ' LEU . 2.3 mmmt -135.85 2.51 2.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.045 -1.034 . . . . 0.0 110.13 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.493 ' N ' HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -156.1 146.31 21.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.021 -1.05 . . . . 0.0 109.692 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.517 HG12 ' CD2' ' A' ' 24' ' ' LEU . 15.2 mt -105.9 139.68 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 0.0 109.298 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.577 ' HG ' ' CH2' ' A' ' 2' ' ' TRP . 0.4 OUTLIER -92.46 154.55 18.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.032 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.555 HG23 ' CD1' ' A' ' 22' ' ' LEU . 39.9 t -150.4 68.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.264 -0.897 . . . . 0.0 109.665 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.87 106.91 1.79 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -109.88 127.81 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.958 -1.319 . . . . 0.0 109.538 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.599 ' CD1' ' N ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -142.54 144.15 32.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.396 -0.815 . . . . 0.0 109.428 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.496 ' O ' ' CB ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -150.4 114.48 5.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.067 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.1 OUTLIER 163.45 -61.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.456 -0.777 . . . . 0.0 109.393 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -174.93 33.14 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.397 -0.814 . . . . 0.0 109.906 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.535 ' CD1' ' CB ' ' A' ' 100' ' ' TYR . 48.6 mt -84.27 83.6 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -0.959 . . . . 0.0 108.981 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -54.11 149.69 17.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 109.954 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.77 156.45 61.6 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.309 2.006 . . . . 0.0 110.183 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.55 -2.71 46.06 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.65 -39.67 2.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -1.193 . . . . 0.0 109.505 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 15' ' ' ALA . . . -83.93 -27.69 28.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.287 -0.883 . . . . 0.0 109.446 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.464 ' O ' ' OE1' ' A' ' 114' ' ' GLU . . . -83.07 -21.18 33.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.136 -0.977 . . . . 0.0 109.28 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -78.83 -29.26 44.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 11.5 t -83.08 -39.13 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.301 -0.875 . . . . 0.0 109.39 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.445 ' O ' ' CB ' ' A' ' 117' ' ' ALA . 38.4 t -68.92 -16.25 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.053 -1.029 . . . . 0.0 109.435 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.464 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -81.32 -56.36 4.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.61 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 118' ' ' ASP . 5.4 ttmt -79.0 -52.78 7.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.748 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 1.6 tp -51.87 -47.09 64.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -0.959 . . . . 0.0 109.522 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.526 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -67.93 -35.69 78.86 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.074 -1.016 . . . . 0.0 109.05 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 115' ' ' LYS . 24.1 t0 -47.56 -25.84 1.26 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.134 -0.979 . . . . 0.0 109.266 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -81.32 -51.1 8.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.277 -0.89 . . . . 0.0 109.261 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.488 ' HB3' ' O ' ' A' ' 125' ' ' PHE . 3.8 mt -71.25 -3.1 18.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.399 -0.813 . . . . 0.0 110.072 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 1.2 mp -75.99 -28.41 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.065 -1.022 . . . . 0.0 108.554 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -123.74 29.24 5.23 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.35 57.55 0.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -1.113 . . . . 0.0 109.687 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.507 ' C ' ' CD1' ' A' ' 125' ' ' PHE . . . 104.71 17.72 14.22 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.577 ' CD2' ' HB3' ' A' ' 92' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.743 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.611 ' CD1' ' CD1' ' A' ' 5' ' ' TYR . 1.1 m-90 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.55 -80.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.076 -1.015 . . . . 0.0 109.787 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.545 ' O ' ' CG2' ' A' ' 8' ' ' THR . 8.8 t -59.57 -39.21 83.33 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.617 ' CE1' ' CD1' ' A' ' 10' ' ' LEU . 4.9 t80 -40.14 -36.51 0.51 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.033 0.92 . . . . 0.0 109.172 177.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.506 ' HA ' HG22 ' A' ' 11' ' ' VAL . 39.7 t -99.37 -29.51 3.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 121.046 -1.034 . . . . 0.0 111.325 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -91.75 52.25 1.99 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.702 -1.249 . . . . 0.0 112.826 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.545 ' CG2' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER 179.61 -94.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.21 -1.556 . . . . 0.0 111.322 178.182 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.7 t-20 -101.89 -66.33 0.93 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.197 -0.94 . . . . 0.0 111.124 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.617 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -33.88 -31.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.867 -0.521 . . . . 0.0 111.6 -178.411 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 9' ' ' ASN . 0.6 OUTLIER -95.39 -56.66 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.751 -1.218 . . . . 0.0 109.745 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -38.79 -37.38 0.57 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.831 -1.707 . . . . 0.0 108.831 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.538 ' CB ' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 159.05 39.64 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.95 -0.735 . . . . 0.0 109.196 178.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -81.29 16.55 16.92 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 107.776 -2.13 . . . . 0.0 107.776 177.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 154.99 -27.09 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.413 HG22 ' HB3' ' A' ' 19' ' ' ALA . 5.2 m -140.4 137.29 36.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.483 ' O ' ' OE1' ' A' ' 18' ' ' GLN . 34.5 p -79.38 6.44 10.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.922 -1.111 . . . . 0.0 109.436 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.483 ' OE1' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -167.39 161.95 14.38 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.467 ' HB1' HG21 ' A' ' 11' ' ' VAL . . . -174.01 171.59 3.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.956 -1.09 . . . . 0.0 110.079 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -161.98 157.07 23.13 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.286 -0.884 . . . . 0.0 109.774 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.565 ' CD1' ' HB2' ' A' ' 2' ' ' TRP . 10.9 mt -115.45 94.63 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -85.27 128.55 34.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.666 -0.646 . . . . 0.0 109.284 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.582 ' HA2' ' CZ3' ' A' ' 29' ' ' TRP . . . -48.19 167.0 0.16 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.51 HD21 ' CG1' ' A' ' 95' ' ' ILE . 16.2 mt -77.12 -11.96 59.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.349 -1.089 . . . . 0.0 109.276 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 27' ' ' ASN . 5.3 t70 -120.08 57.79 0.93 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.703 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 52.3 69.72 1.1 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 25' ' ' ASP . 8.4 m120 -147.31 -149.89 0.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.282 -1.128 . . . . 0.0 109.519 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -155.26 158.85 39.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.358 -0.839 . . . . 0.0 109.182 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.582 ' CZ3' ' HA2' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -145.33 -41.04 0.23 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -0.986 . . . . 0.0 109.905 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.467 ' O ' HG13 ' A' ' 21' ' ' ILE . . . -165.1 118.58 1.24 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.999 -1.063 . . . . 0.0 110.15 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 9.3 t -131.86 164.36 26.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.651 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.552 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 3.4 m -147.79 147.55 29.97 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.338 -0.851 . . . . 0.0 109.475 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 32' ' ' SER . . . 81.4 172.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 33' ' ' ALA . . . -60.64 -132.58 0.01 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.544 ' CE2' HG23 ' A' ' 99' ' ' VAL . 91.0 t80 58.81 93.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.031 -1.276 . . . . 0.0 109.203 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.2 124.42 50.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 109.648 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 65.5 t -97.92 106.0 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.514 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -71.22 162.01 75.04 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.285 -0.884 . . . . 0.0 109.529 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.514 ' HD2' ' CG2' ' A' ' 38' ' ' THR . 2.4 Cg_endo -61.58 108.81 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.18 1.92 . . . . 0.0 110.004 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 39' ' ' PRO . . . 176.24 -71.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.217 -0.927 . . . . 0.0 109.496 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.47 -21.71 65.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.667 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.17 -31.62 61.34 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.468 ' O ' ' OG ' ' A' ' 47' ' ' SER . 4.6 tt0 -74.97 -23.04 58.23 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.388 -1.066 . . . . 0.0 109.374 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.45 ' O ' ' CB ' ' A' ' 48' ' ' ALA . 3.5 m -88.42 -32.72 18.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.233 -0.917 . . . . 0.0 109.301 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.429 HD22 HD11 ' A' ' 95' ' ' ILE . 0.9 OUTLIER -61.91 -47.81 83.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -0.916 . . . . 0.0 109.352 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.49 -46.55 89.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 0.0 109.218 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -82.82 -0.21 46.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.364 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.497 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -82.78 -22.66 34.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 109.716 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -74.76 -0.88 19.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.049 -1.032 . . . . 0.0 109.591 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -88.21 -59.84 2.13 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.188 -0.945 . . . . 0.0 109.953 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 53' ' ' ASP . 2.9 t-20 -126.47 6.35 6.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.025 -1.047 . . . . 0.0 110.175 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 51' ' ' ASN . . . 32.25 35.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.234 0.54 . . . . 0.0 110.445 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.592 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 2.7 t0 -73.9 -49.91 5.74 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.896 . . . . 0.0 110.888 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 6.0 Cg_exo -59.98 -9.59 10.33 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.058 1.838 . . . . 0.0 111.317 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.565 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -106.92 -49.46 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.892 -1.13 . . . . 0.0 109.775 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.475 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 3.6 ptm180 -53.87 -19.33 4.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.051 -1.031 . . . . 0.0 110.084 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.419 ' N ' ' HG3' ' A' ' 56' ' ' ARG . . . -120.6 137.94 54.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.093 -1.005 . . . . 0.0 109.925 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 59' ' ' GLY . 0.6 OUTLIER 49.74 27.24 2.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.405 -0.81 . . . . 0.0 109.653 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 58' ' ' SER . . . 43.39 -136.64 4.44 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 60' ' ' PHE . 2.6 p90 -147.33 143.79 28.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.183 -1.186 . . . . 0.0 109.343 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -101.85 126.86 48.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.266 -0.897 . . . . 0.0 109.765 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -94.51 -160.17 0.76 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.53 -0.731 . . . . 0.0 109.475 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.14 95.3 8.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.4 -23.73 14.49 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -125.53 153.0 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -1.14 . . . . 0.0 108.888 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -149.91 153.58 36.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 109.526 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -141.91 -171.92 3.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.335 -0.853 . . . . 0.0 109.276 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 t -116.89 154.13 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.945 . . . . 0.0 109.602 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.437 HG23 HG23 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -121.88 124.94 45.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.484 -0.76 . . . . 0.0 109.54 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.03 -35.92 1.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.592 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.418 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -119.33 70.76 0.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.463 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.78 28.6 6.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.423 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -99.69 0.07 41.15 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.248 -0.908 . . . . 0.0 109.606 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -105.22 -95.74 0.34 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.975 . . . . 0.0 109.926 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.523 ' NH1' ' HG3' ' A' ' 75' ' ' ARG . 1.0 OUTLIER -142.47 -36.51 0.4 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.028 . . . . 0.0 110.058 -179.493 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 0.6 OUTLIER -89.52 149.87 22.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 109.553 -179.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 76' ' ' SER . 4.3 mp -144.53 70.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 0.0 110.335 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 76' ' ' SER . 0.1 OUTLIER -90.01 93.62 9.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.814 -1.179 . . . . 0.0 108.46 178.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.461 ' O ' HG11 ' A' ' 86' ' ' VAL . . . -79.21 128.44 8.56 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.56 146.38 26.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -1.233 . . . . 0.0 109.61 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.88 148.83 0.55 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.559 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.47 -106.85 2.76 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.2 m -135.95 7.92 3.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -1.121 . . . . 0.0 109.511 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -130.82 178.12 6.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 0.0 109.159 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -169.28 177.45 42.93 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.325 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.482 ' CG2' HG11 ' A' ' 97' ' ' VAL . 9.3 p -153.27 123.63 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.976 . . . . 0.0 108.74 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.6 mt -95.53 99.82 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.177 -0.952 . . . . 0.0 109.793 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 8.6 p -105.95 108.48 20.02 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.535 HG21 ' CE2' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -129.01 173.95 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.927 . . . . 0.0 110.054 -179.174 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.441 ' C ' HG21 ' A' ' 91' ' ' THR . 29.7 mtmt -101.39 142.81 32.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.392 -0.817 . . . . 0.0 108.941 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.554 ' CG2' ' CD2' ' A' ' 96' ' ' LEU . 66.5 p -149.12 -137.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.105 -0.997 . . . . 0.0 109.828 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.445 ' HA ' ' OXT' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -67.52 84.04 0.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.948 -1.095 . . . . 0.0 111.178 -178.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.464 ' HA ' HD12 ' A' ' 24' ' ' LEU . 3.0 mttm 51.04 34.01 10.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -0.855 . . . . 0.0 109.778 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.04 167.35 30.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.051 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.51 ' CG1' HD21 ' A' ' 24' ' ' LEU . 34.5 mt -121.89 123.15 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.239 -0.913 . . . . 0.0 109.135 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.626 ' CD1' ' N ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -75.62 165.12 25.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.08 -1.013 . . . . 0.0 108.928 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.495 HG23 ' CD1' ' A' ' 22' ' ' LEU . 54.0 t -150.91 74.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.389 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -63.78 98.73 0.26 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.544 HG23 ' CE2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -97.28 127.64 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -1.15 . . . . 0.0 109.018 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.525 ' HB2' ' CG1' ' A' ' 104' ' ' ILE . 1.5 p90 -146.82 171.19 15.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 109.878 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -113.7 -149.85 0.45 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.394 -0.816 . . . . 0.0 110.023 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -42.5 89.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.47 -0.768 . . . . 0.0 110.221 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.8 -25.05 1.13 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.525 ' CG1' ' HB2' ' A' ' 100' ' ' TYR . 10.6 mm -103.51 105.72 18.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.053 -1.029 . . . . 0.0 109.698 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.57 142.66 49.99 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.26 -0.9 . . . . 0.0 109.137 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -60.7 149.37 87.91 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.119 1.88 . . . . 0.0 110.503 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.86 -35.46 4.92 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.6 m -83.49 -29.6 27.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -1.182 . . . . 0.0 109.613 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.491 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -89.79 -13.98 35.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.809 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.0 -20.63 23.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.142 -0.974 . . . . 0.0 109.559 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -80.72 -32.67 35.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 0.0 109.695 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 88.8 t -90.05 -35.96 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 110.172 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 109' ' ' ALA . 49.1 t -74.35 -17.6 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.148 -0.97 . . . . 0.0 109.768 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -86.97 -42.4 13.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -0.973 . . . . 0.0 109.972 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -74.06 -40.48 62.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.126 -0.984 . . . . 0.0 109.74 -179.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.2 OUTLIER -60.16 -47.31 86.47 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.215 -0.928 . . . . 0.0 109.564 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.528 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -63.92 -25.91 68.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.644 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -69.2 -25.63 64.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.714 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -76.91 -40.32 47.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.22 -0.925 . . . . 0.0 110.074 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.86 -21.03 34.47 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.163 -0.96 . . . . 0.0 110.06 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 8.1 mt -77.62 -22.64 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 109.331 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.13 -24.48 3.41 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.29 -68.88 0.69 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.405 -1.056 . . . . 0.0 109.673 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 125' ' ' PHE . . . 158.33 110.53 0.29 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.478 ' HB3' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.084 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.693 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.629 ' CB ' ' CD1' ' A' ' 21' ' ' ILE . 1.3 m-90 . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -89.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 109.189 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.4 t -60.72 -36.82 79.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 108.899 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.511 ' HB3' ' HB2' ' A' ' 10' ' ' LEU . 10.1 m-30 -52.91 -30.89 36.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.455 -0.778 . . . . 0.0 109.41 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.517 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -69.87 -47.87 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.103 -0.998 . . . . 0.0 108.468 179.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.8 45.28 1.24 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.936 -1.103 . . . . 0.0 109.929 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.459 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 54.3 m -156.96 -100.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.83 -1.169 . . . . 0.0 110.704 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.529 ' O ' ' C ' ' A' ' 10' ' ' LEU . 3.8 m120 -100.86 -59.54 1.68 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.112 -0.992 . . . . 0.0 110.64 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.529 ' C ' ' O ' ' A' ' 9' ' ' ASN . 0.5 OUTLIER -29.56 -48.51 0.08 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.304 0.573 . . . . 0.0 110.516 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.554 HG13 ' CB ' ' A' ' 32' ' ' SER . 1.0 OUTLIER -100.27 -23.37 4.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.342 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.503 ' C ' ' CG2' ' A' ' 13' ' ' THR . . . -83.32 57.57 5.06 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.123 -2.391 . . . . 0.0 107.123 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.519 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER 43.25 51.03 5.83 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.987 0.898 . . . . 0.0 110.281 -178.774 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.559 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -100.59 21.76 42.65 Favored Glycine 0 C--N 1.292 -1.871 0 N-CA-C 105.438 -3.065 . . . . 0.0 105.438 176.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.587 ' CB ' ' CG1' ' A' ' 112' ' ' VAL . . . 152.08 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 100' ' ' TYR . 2.7 m -138.78 147.14 25.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.523 ' C ' ' CG ' ' A' ' 18' ' ' GLN . 2.4 p -79.76 10.27 4.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.876 -1.14 . . . . 0.0 109.165 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.523 ' CG ' ' C ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -170.71 174.07 5.1 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.381 -0.824 . . . . 0.0 109.409 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.534 ' CB ' HG21 ' A' ' 11' ' ' VAL . . . -177.36 163.69 2.04 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.485 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -160.59 122.1 3.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.832 -1.168 . . . . 0.0 110.758 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.629 ' CD1' ' CB ' ' A' ' 2' ' ' TRP . 3.1 mm -89.2 104.62 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.4 OUTLIER -83.29 13.47 4.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.39 -0.819 . . . . 0.0 109.934 -178.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 94' ' ' SER . . . 67.67 157.82 0.9 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.461 ' HA ' HG13 ' A' ' 95' ' ' ILE . 14.5 mt -79.94 -58.21 3.28 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.32 -1.106 . . . . 0.0 109.017 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.4 22.18 3.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.484 -0.76 . . . . 0.0 109.009 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.485 ' O ' ' ND2' ' A' ' 27' ' ' ASN . . . -109.84 -110.35 3.29 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 15.6 m120 -149.5 -145.9 0.18 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -1.141 . . . . 0.0 109.351 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 m -71.43 125.5 27.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.088 -1.008 . . . . 0.0 109.525 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -106.19 -40.92 5.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.06 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.15 155.75 23.36 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.429 ' C ' ' OG ' ' A' ' 32' ' ' SER . 0.7 OUTLIER -160.78 172.13 17.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.954 -1.091 . . . . 0.0 110.113 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.554 ' CB ' HG13 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -176.11 109.97 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.314 -0.866 . . . . 0.0 109.516 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 55.35 41.95 30.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 109.394 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -125.65 138.15 10.7 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -49.61 178.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -1.183 . . . . 0.0 109.417 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.01 107.42 19.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.328 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.599 ' O ' ' CB ' ' A' ' 38' ' ' THR . 3.9 t -104.9 163.72 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 109.899 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.748 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.6 OUTLIER 94.65 15.45 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.748 ' CD ' ' N ' ' A' ' 38' ' ' THR . 1.8 Cg_endo -64.67 -20.07 65.06 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 CA-C-N 119.783 0.958 . . . . 0.0 109.611 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 171.74 -66.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.424 -0.797 . . . . 0.0 109.235 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.445 ' O ' ' HB ' ' A' ' 44' ' ' THR . 3.1 mp0 -56.15 -24.82 43.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.91 . . . . 0.0 109.363 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.86 -45.99 55.24 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -57.52 -35.19 69.94 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.236 -1.155 . . . . 0.0 109.103 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 41' ' ' GLN . 63.4 m -57.3 -35.57 69.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.027 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.28 -48.82 75.84 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.17 -23.27 67.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.403 -0.811 . . . . 0.0 109.141 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.0 -20.19 30.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.6 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.34 -24.11 59.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.441 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.564 ' CE2' ' HG2' ' A' ' 90' ' ' LYS . 5.3 m-30 -51.39 -21.63 2.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.217 -0.927 . . . . 0.0 109.314 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -82.68 -37.3 25.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.285 -0.885 . . . . 0.0 109.756 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.92 142.79 33.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.706 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.441 ' HB3' HD13 ' A' ' 55' ' ' ILE . . . -109.33 24.49 13.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 109.017 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.602 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 23.3 m-20 -67.22 -46.07 50.84 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.488 -0.757 . . . . 0.0 110.932 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.9 Cg_exo -56.54 -70.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 121.487 1.458 . . . . 0.0 110.61 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.456 ' C ' ' O ' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -42.07 -27.68 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.186 -0.946 . . . . 0.0 109.497 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -72.05 -75.31 0.14 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.696 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -104.94 93.84 4.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 0.0 109.527 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 3.8 t 162.82 -78.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.228 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.79 -164.82 33.84 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -124.05 111.98 16.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.472 -1.016 . . . . 0.0 108.796 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -81.2 142.98 32.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 0.0 110.283 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 62' ' ' LEU . 9.8 mt -149.26 -166.46 2.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.189 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB3' ' HG3' ' A' ' 39' ' ' PRO . . . -71.83 90.77 1.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 0.0 110.157 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.11 24.67 68.93 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.96 177.15 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.094 -1.239 . . . . 0.0 108.855 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.502 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 0.7 OUTLIER -159.43 114.43 2.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.162 -0.961 . . . . 0.0 109.744 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.57 ' CE1' ' HG3' ' A' ' 81' ' ' LYS . 11.0 m-30 -100.99 -164.02 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -0.895 . . . . 0.0 109.454 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 t -131.43 164.02 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 108.982 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -123.17 117.45 25.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.156 -0.965 . . . . 0.0 109.835 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.62 24.73 4.05 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.571 ' NH1' ' HG3' ' A' ' 71' ' ' ARG . 0.0 OUTLIER 178.55 57.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.334 -0.854 . . . . 0.0 109.146 -179.655 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.479 ' O ' ' C ' ' A' ' 73' ' ' ASP . . . -90.81 20.69 4.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.192 -0.942 . . . . 0.0 109.263 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER 32.48 -107.09 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.102 -0.374 . . . . 0.0 110.743 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -120.88 -52.42 2.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.754 -1.217 . . . . 0.0 110.479 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.429 ' HA ' ' NE ' ' A' ' 75' ' ' ARG . 6.6 tpm_? -130.45 -9.12 4.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.011 -1.056 . . . . 0.0 110.827 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.601 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -88.77 146.98 24.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.937 -1.102 . . . . 0.0 108.795 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.471 ' HB ' ' OG1' ' A' ' 88' ' ' THR . 0.2 OUTLIER -135.76 79.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.69 -1.256 . . . . 0.0 111.004 -179.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.601 ' CE1' ' HB2' ' A' ' 76' ' ' SER . 1.2 m-85 -90.12 76.67 6.89 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.1 178.2 7.99 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.488 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 15.6 mtpp -135.39 146.29 48.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.663 -0.904 . . . . 0.0 109.085 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.57 ' HG3' ' CE1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -114.92 25.67 10.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.998 -1.064 . . . . 0.0 109.396 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.68 -94.9 1.94 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.6 m -78.55 -25.13 45.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.226 -1.161 . . . . 0.0 109.183 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.407 ' HB1' ' HE3' ' A' ' 81' ' ' LYS . . . -111.87 -165.44 0.99 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.279 -0.888 . . . . 0.0 109.25 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 80' ' ' LYS . . . -167.98 143.69 8.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.445 ' O ' HG11 ' A' ' 86' ' ' VAL . 10.0 p -106.44 133.6 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -1.164 . . . . 0.0 110.034 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 36.0 mm -106.83 83.2 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.471 ' OG1' ' HB ' ' A' ' 77' ' ' ILE . 15.5 p -95.72 117.77 31.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.004 -1.06 . . . . 0.0 110.63 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.572 HG23 ' CE2' ' A' ' 78' ' ' TYR . 11.7 t -150.36 166.52 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.564 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -104.4 159.49 15.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.921 -1.112 . . . . 0.0 109.445 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.506 HG22 ' CD2' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -144.36 -70.17 0.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.611 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 1.2 t -159.87 98.7 1.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.117 -0.989 . . . . 0.0 109.889 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 92' ' ' SER . 25.1 mttm 62.54 34.59 15.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.987 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.474 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 0.3 OUTLIER 177.49 145.13 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.008 -1.057 . . . . 0.0 109.813 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.461 HG13 ' HA ' ' A' ' 24' ' ' LEU . 90.1 mt -105.96 114.68 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.88 . . . . 0.0 109.161 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.588 HD12 ' CH2' ' A' ' 2' ' ' TRP . 0.7 OUTLIER -73.77 139.06 44.94 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.332 -0.855 . . . . 0.0 109.735 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.536 ' CG2' ' HG ' ' A' ' 22' ' ' LEU . 45.8 t -129.89 59.75 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.352 -0.843 . . . . 0.0 109.326 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.474 ' O ' HG12 ' A' ' 87' ' ' ILE . . . -51.66 111.93 1.63 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -110.99 134.63 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.126 -1.22 . . . . 0.0 109.187 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.457 ' HB3' HG11 ' A' ' 16' ' ' VAL . 20.0 p90 -132.27 -178.35 4.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.443 -0.785 . . . . 0.0 109.307 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -118.31 -145.9 0.39 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.598 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 103' ' ' LYS . 7.6 tp10 -80.91 -38.81 27.31 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.145 -0.972 . . . . 0.0 109.665 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 102' ' ' GLU . 0.4 OUTLIER -43.79 -68.26 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.909 . . . . 0.0 109.506 -179.721 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.1 mt -65.99 137.7 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.202 -0.936 . . . . 0.0 109.286 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.77 152.63 75.06 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.775 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.457 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 1.9 Cg_endo -64.62 -17.72 60.46 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.4 2.067 . . . . 0.0 110.515 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.8 -13.03 51.77 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.65 -42.65 14.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -1.122 . . . . 0.0 109.429 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.509 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -78.07 -22.1 49.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.338 -0.851 . . . . 0.0 109.536 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 106' ' ' PRO . . . -84.03 -21.02 31.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 109.566 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -80.91 -39.09 26.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 109.488 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.587 ' CG1' ' CB ' ' A' ' 15' ' ' ALA . 4.1 p -74.62 -27.83 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.684 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.509 ' CG2' ' O ' ' A' ' 109' ' ' ALA . 74.7 t -72.94 -35.04 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.409 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 118' ' ' ASP . 48.2 mt-10 -61.58 -41.9 98.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.462 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 118' ' ' ASP . 3.2 ttpm? -74.49 -38.03 63.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.494 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.04 -53.3 52.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.338 -0.851 . . . . 0.0 109.715 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -75.35 -29.8 60.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 0.0 109.695 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 0.4 OUTLIER -54.02 -25.17 19.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -0.955 . . . . 0.0 109.666 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -85.57 -48.33 9.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.669 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 125' ' ' PHE . 4.5 mt -75.32 -2.61 29.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.881 . . . . 0.0 110.274 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.534 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 0.4 OUTLIER -84.2 -44.7 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.053 -1.029 . . . . 0.0 109.518 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -82.05 9.6 56.41 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -120.75 -87.9 0.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -1.192 . . . . 0.0 109.785 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.17 -90.82 0.92 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.567 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 3.8 m-85 . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.255 -1.144 . . . . 0.0 109.362 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.564 ' CZ3' HD23 ' A' ' 96' ' ' LEU . 15.5 m95 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.54 -87.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.13 -0.981 . . . . 0.0 111.088 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.473 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -60.84 -45.54 94.07 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.025 -1.047 . . . . 0.0 110.465 -178.649 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 2.8 m-30 -50.72 -21.65 1.72 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.87 -1.144 . . . . 0.0 109.466 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.527 ' HA ' ' CG2' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -78.0 -41.24 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 108.692 179.445 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.473 ' OD1' ' O ' ' A' ' 4' ' ' THR . 2.1 p-10 -91.28 18.83 6.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.119 -0.988 . . . . 0.0 110.825 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.415 ' OG1' ' HA ' ' A' ' 5' ' ' TYR . 21.1 p -127.59 -106.58 0.31 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.917 -1.114 . . . . 0.0 110.371 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.4 t-20 -102.02 -68.75 0.81 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.025 -1.047 . . . . 0.0 110.512 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.505 ' C ' ' O ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -24.52 -41.8 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 9' ' ' ASN . 1.1 t -83.91 -65.59 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.728 -1.233 . . . . 0.0 110.057 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.542 ' N ' ' CG1' ' A' ' 11' ' ' VAL . . . -36.84 -40.06 0.46 Allowed Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.527 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER 158.45 40.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.891 -0.77 . . . . 0.0 109.366 178.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -86.06 21.3 16.56 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 154.87 -32.72 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.474 HG11 ' HB3' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -136.63 133.66 48.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.457 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.49 ' CG2' ' HG3' ' A' ' 18' ' ' GLN . 9.0 t -78.83 6.1 9.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.944 -1.097 . . . . 0.0 108.991 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.49 ' HG3' ' CG2' ' A' ' 17' ' ' THR . 17.3 mt-30 -158.91 153.08 23.74 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.481 ' HA ' HG21 ' A' ' 99' ' ' VAL . . . -170.33 152.38 4.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -0.949 . . . . 0.0 109.193 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.491 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . . . -150.55 130.84 13.67 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.554 ' CD1' ' N ' ' A' ' 2' ' ' TRP . 4.6 mm -82.85 92.32 2.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.537 ' CD2' HG23 ' A' ' 97' ' ' VAL . 10.9 mp -74.71 106.7 6.39 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.46 -0.775 . . . . 0.0 109.915 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -45.93 174.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.483 HD23 ' N ' ' A' ' 94' ' ' SER . 0.7 OUTLIER -72.82 -3.16 23.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.331 -1.099 . . . . 0.0 109.859 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.93 8.3 7.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.147 -0.971 . . . . 0.0 109.214 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.32 32.06 58.5 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 28' ' ' THR . 40.4 t-20 -94.97 29.96 2.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.165 -1.197 . . . . 0.0 109.36 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 27' ' ' ASN . 70.3 m 32.31 96.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.559 0.695 . . . . 0.0 110.859 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -79.54 -48.57 13.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.473 -0.767 . . . . 0.0 110.048 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.437 ' O ' HG12 ' A' ' 21' ' ' ILE . . . -158.64 103.06 1.72 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.115 -0.99 . . . . 0.0 109.969 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 20' ' ' ALA . 14.0 t -114.53 166.58 11.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.037 -1.039 . . . . 0.0 110.278 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.521 ' CB ' HG12 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -149.63 143.32 25.45 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.558 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 32' ' ' SER . . . 77.5 171.41 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 0.0 109.16 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -52.17 141.74 24.84 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.591 ' CE2' HG22 ' A' ' 99' ' ' VAL . 0.3 OUTLIER 177.81 117.01 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -1.077 . . . . 0.0 109.134 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.475 ' O ' ' HB1' ' A' ' 63' ' ' ALA . . . -112.68 125.14 53.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.975 . . . . 0.0 110.015 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.484 HG12 ' NE2' ' A' ' 41' ' ' GLN . 60.7 t -147.84 133.39 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.55 ' OG1' ' HD3' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -158.15 -62.81 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.001 -1.062 . . . . 0.0 110.598 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.604 ' O ' ' N ' ' A' ' 41' ' ' GLN . 8.1 Cg_exo -50.89 133.08 39.24 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 120.87 1.047 . . . . 0.0 109.819 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 39' ' ' PRO . . . -30.39 81.76 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 111.593 0.219 . . . . 0.0 111.593 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.604 ' N ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -90.86 -30.71 16.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.269 -1.519 . . . . 0.0 109.31 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.5 -18.91 78.71 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -80.57 -62.44 1.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.152 -1.205 . . . . 0.0 109.371 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.8 m -60.1 -26.99 66.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 109.152 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.88 -46.43 24.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.0 109.312 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.65 -11.09 22.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 109.649 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.48 -28.15 14.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.63 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.62 -23.35 66.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.966 . . . . 0.0 109.643 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -70.05 -7.7 43.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.225 -0.922 . . . . 0.0 110.032 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.1 -70.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 109.721 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -96.58 175.87 6.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.181 -0.949 . . . . 0.0 109.561 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 56' ' ' ARG . . . -123.82 -2.98 8.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.723 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.613 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 43.5 t0 -80.24 -44.81 1.42 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.158 -0.964 . . . . 0.0 110.721 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.6 Cg_endo -65.37 -13.58 40.52 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.553 1.502 . . . . 0.0 110.575 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.581 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -102.55 -54.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.06 -1.025 . . . . 0.0 109.516 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.512 ' HG2' ' NH1' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -50.58 -22.7 2.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.41 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.573 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -114.93 117.82 31.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.653 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 1.9 m 83.83 -52.92 0.14 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.77 -0.581 . . . . 0.0 109.826 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.8 -145.71 21.02 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.549 ' CE2' HD13 ' A' ' 62' ' ' LEU . 6.1 p90 -146.94 -173.17 4.16 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.256 -1.144 . . . . 0.0 109.143 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 1.5 m-20 -139.49 165.19 27.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.153 -0.967 . . . . 0.0 110.028 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.563 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 2.4 mp -136.96 88.25 2.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.42 -0.8 . . . . 0.0 109.268 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 62' ' ' LEU . . . 82.3 -43.17 0.14 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.603 -0.686 . . . . 0.0 109.985 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.06 35.67 0.05 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.644 ' CG1' ' CE1' ' A' ' 67' ' ' TYR . 72.8 t -126.21 111.74 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -1.133 . . . . 0.0 109.447 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.72 86.47 6.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.171 -0.956 . . . . 0.0 110.606 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.644 ' CE1' ' CG1' ' A' ' 65' ' ' VAL . 10.2 m-30 -98.47 162.67 13.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.098 -1.001 . . . . 0.0 109.28 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.41 173.24 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.185 -0.947 . . . . 0.0 109.569 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.6 m -127.39 109.34 11.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.48 3.14 14.83 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 109.6 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -135.21 89.07 2.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -0.94 . . . . 0.0 109.332 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.42 111.32 4.83 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -157.93 -45.55 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -0.9 . . . . 0.0 109.317 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -79.52 -94.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.412 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.444 ' NH1' ' CG ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -150.23 21.6 0.85 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 109.795 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.459 ' OG ' ' CG2' ' A' ' 89' ' ' VAL . 29.7 t -132.57 169.66 16.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.074 -1.016 . . . . 0.0 109.501 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.5 mt -149.5 95.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.865 . . . . 0.0 109.441 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -89.51 85.09 6.43 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -51.05 158.14 2.29 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.46 -173.83 3.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.612 -0.934 . . . . 0.0 108.83 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.45 -30.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.117 -0.989 . . . . 0.0 110.108 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 83' ' ' SER . . . 132.7 92.85 0.53 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 82' ' ' GLY . 0.8 OUTLIER 74.24 4.8 4.59 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.265 -1.138 . . . . 0.0 108.357 -178.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.48 148.62 29.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.495 -0.753 . . . . 0.0 109.086 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -168.62 174.44 43.3 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.481 HG23 ' CG2' ' A' ' 88' ' ' THR . 7.6 p -132.76 138.09 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -1.159 . . . . 0.0 109.348 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.446 HG23 HG12 ' A' ' 113' ' ' VAL . 16.7 mm -98.93 81.21 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 110.021 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.481 ' CG2' HG23 ' A' ' 86' ' ' VAL . 7.6 p -96.8 107.89 20.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.123 -0.986 . . . . 0.0 109.007 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.459 ' CG2' ' OG ' ' A' ' 76' ' ' SER . 59.4 t -127.9 139.97 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 109.794 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.29 127.01 42.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.884 . . . . 0.0 109.219 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.528 ' CG2' HG12 ' A' ' 121' ' ' ILE . 3.0 p -100.85 -82.61 0.46 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.31 -0.869 . . . . 0.0 109.927 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.412 ' C ' ' HG2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -151.46 -42.34 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.945 . . . . 0.0 109.612 -179.689 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 94' ' ' SER . 42.6 mmtt -139.64 40.42 2.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.605 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.483 ' N ' HD23 ' A' ' 24' ' ' LEU . 0.1 OUTLIER 173.25 161.35 0.14 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.912 . . . . 0.0 109.271 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 19.1 mt -133.56 146.72 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.082 -1.011 . . . . 0.0 109.743 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.564 HD23 ' CZ3' ' A' ' 2' ' ' TRP . 0.3 OUTLIER -106.24 158.73 16.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.862 . . . . 0.0 108.807 179.396 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.537 HG23 ' CD2' ' A' ' 22' ' ' LEU . 57.4 t -145.44 71.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.946 . . . . 0.0 110.225 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -56.46 144.52 36.9 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.514 -1.835 . . . . 0.0 108.514 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.591 HG22 ' CE2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -144.75 113.33 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.72 -1.459 . . . . 0.0 109.711 -179.502 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.474 ' HB3' HG11 ' A' ' 16' ' ' VAL . 14.3 p90 -135.43 141.34 45.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.345 -0.847 . . . . 0.0 109.415 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -152.05 117.04 5.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.495 -0.753 . . . . 0.0 109.831 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.2 OUTLIER 160.73 -59.22 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.516 -0.74 . . . . 0.0 109.378 179.637 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 174.97 48.06 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.566 -0.709 . . . . 0.0 109.417 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.6 mt -105.91 129.74 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.368 -0.833 . . . . 0.0 108.843 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -66.08 137.43 95.79 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.725 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -65.96 -25.88 51.75 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.175 1.917 . . . . 0.0 110.403 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.09 0.52 88.57 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.5 m -92.66 -42.82 9.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.142 -1.21 . . . . 0.0 109.383 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -90.09 -19.94 23.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.285 -0.885 . . . . 0.0 109.466 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.12 -24.38 58.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.722 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -81.89 -33.56 30.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.169 -0.957 . . . . 0.0 109.675 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.519 HG23 ' CD1' ' A' ' 116' ' ' LEU . 9.0 p -78.09 -18.71 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.115 -0.991 . . . . 0.0 109.508 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.446 HG12 HG23 ' A' ' 87' ' ' ILE . 38.1 t -90.92 -23.18 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.928 . . . . 0.0 109.887 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -75.79 -38.69 57.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.139 -0.976 . . . . 0.0 109.911 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.69 -58.94 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.944 . . . . 0.0 109.764 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.552 HD21 ' CE2' ' A' ' 5' ' ' TYR . 15.1 mt -51.9 -24.17 5.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 109.511 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.459 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -73.64 -39.64 64.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 109.853 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -63.91 -16.72 62.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.013 . . . . 0.0 109.995 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -81.63 -56.46 4.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.041 -1.037 . . . . 0.0 109.755 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 124' ' ' GLY . 6.1 mt -62.16 -50.15 72.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 109.663 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.528 HG12 ' CG2' ' A' ' 91' ' ' THR . 7.5 mt -59.93 -36.65 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.657 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.12 -14.98 81.74 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -127.09 -68.09 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.254 . . . . 0.0 110.15 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 120' ' ' LEU . . . -85.48 -106.68 0.69 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.348 -1.09 . . . . 0.0 109.166 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.573 ' HB2' ' CD2' ' A' ' 5' ' ' TYR . 29.9 p90 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.588 0.708 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 8.1 tt0 -81.3 -24.07 37.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 109.218 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.458 ' O ' ' CG2' ' A' ' 8' ' ' THR . 85.2 m -65.96 -64.89 0.76 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.375 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CD2' ' HB2' ' A' ' 2' ' ' TRP . 1.0 OUTLIER -50.7 -41.59 56.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -0.95 . . . . 0.0 108.895 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.474 ' HA ' HG22 ' A' ' 11' ' ' VAL . 1.2 t -49.44 -48.8 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.56 -0.713 . . . . 0.0 109.894 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.466 ' O ' ' CB ' ' A' ' 8' ' ' THR . 0.8 OUTLIER -87.52 55.49 3.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.851 -178.598 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.466 ' CB ' ' O ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER 170.53 -86.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.739 -1.225 . . . . 0.0 111.334 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.517 ' O ' ' C ' ' A' ' 10' ' ' LEU . 3.1 m-20 -88.45 -74.55 0.46 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.247 -0.908 . . . . 0.0 111.481 -178.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.565 ' HB2' ' CB ' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -27.54 -46.9 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.917 0.389 . . . . 0.0 111.467 -178.412 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.526 ' CG2' ' HB1' ' A' ' 19' ' ' ALA . 49.5 t -101.6 -28.65 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.861 -1.149 . . . . 0.0 110.669 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 11' ' ' VAL . . . -45.17 -28.83 2.12 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 106.311 -2.716 . . . . 0.0 106.311 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.717 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.6 OUTLIER -176.28 -39.68 0.01 OUTLIER 'General case' 0 C--O 1.193 -1.9 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.599 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . 10.43 44.22 0.0 OUTLIER Glycine 0 N--CA 1.509 3.557 0 C-N-CA 123.671 0.653 . . . . 0.0 112.838 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.717 ' N ' ' O ' ' A' ' 13' ' ' THR . . . 87.58 -34.47 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.638 ' N ' ' O ' ' A' ' 13' ' ' THR . 35.8 m -120.51 139.08 48.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.495 ' C ' ' HG2' ' A' ' 18' ' ' GLN . 9.9 t -79.96 13.3 2.28 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.833 -1.167 . . . . 0.0 109.395 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.535 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 13.1 mm-40 -158.74 169.21 24.9 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.53 ' HA ' ' CG2' ' A' ' 99' ' ' VAL . . . 173.59 140.95 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.494 -1.379 . . . . 0.0 110.822 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.504 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -136.1 142.34 44.28 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.477 HD13 ' O ' ' A' ' 2' ' ' TRP . 2.7 mt -102.32 112.06 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.919 -1.113 . . . . 0.0 108.92 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.535 ' CD2' ' CG2' ' A' ' 97' ' ' VAL . 2.8 mp -98.46 160.37 14.33 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.527 -0.733 . . . . 0.0 109.089 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.92 -178.93 19.18 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.429 HD13 ' C ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -105.08 -48.46 3.72 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.295 -1.12 . . . . 0.0 109.139 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -136.76 40.11 2.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 109.306 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.06 25.22 2.23 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 1.2 m-20 61.43 -146.4 0.43 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.169 -1.194 . . . . 0.0 109.306 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.95 147.5 25.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.12 -0.987 . . . . 0.0 109.738 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -119.2 -26.49 5.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.379 -0.825 . . . . 0.0 109.145 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -178.44 159.22 1.17 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.391 -0.818 . . . . 0.0 109.372 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 1.1 t -160.22 171.54 19.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.314 -0.866 . . . . 0.0 109.503 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.466 ' HB2' HG11 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -178.54 82.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.333 -0.854 . . . . 0.0 109.165 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.04 -69.71 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.856 . . . . 0.0 109.566 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 167.85 -37.78 0.22 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.533 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 14.8 p90 -97.12 160.22 14.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.12 . . . . 0.0 109.482 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.03 -168.91 1.36 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.366 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.474 HG12 ' CD2' ' A' ' 62' ' ' LEU . 16.4 t -142.85 97.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.343 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 p -62.34 143.99 95.36 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.41 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.59 114.92 2.46 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.193 1.929 . . . . 0.0 110.358 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 174.77 -77.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.335 -0.853 . . . . 0.0 109.402 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.59 -11.69 58.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.527 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.33 -43.72 95.49 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.3 -33.9 73.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -1.124 . . . . 0.0 108.936 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.2 m -50.05 -45.76 52.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.295 -0.878 . . . . 0.0 108.799 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mp -54.95 -42.16 71.97 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.13 -38.22 73.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.407 -0.808 . . . . 0.0 108.869 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.93 -26.87 63.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.509 -0.745 . . . . 0.0 109.084 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.463 ' CB ' HD12 ' A' ' 55' ' ' ILE . . . -64.61 -20.2 66.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.371 -0.83 . . . . 0.0 109.334 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.603 ' CE1' ' CE ' ' A' ' 90' ' ' LYS . 22.2 m-85 -59.21 -14.54 11.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 109.365 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -79.58 -68.07 0.7 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 109.677 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -148.37 17.99 1.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.13 -0.981 . . . . 0.0 109.872 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 51' ' ' ASN . . . 36.08 32.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.278 0.561 . . . . 0.0 109.977 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.615 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 39.1 t70 -70.61 -43.98 16.52 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 111.004 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 5.3 Cg_exo -61.55 -10.96 18.02 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.381 1.387 . . . . 0.0 110.796 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.463 HD12 ' CB ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -106.71 -31.25 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.053 -1.029 . . . . 0.0 109.573 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.422 ' CG ' ' HA ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -90.16 20.1 4.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 109.501 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.81 4.57 11.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.55 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 172.5 -55.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.518 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.67 -172.85 33.13 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 67' ' ' TYR . 33.4 p90 -132.46 170.44 15.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -1.164 . . . . 0.0 109.407 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.29 136.93 54.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.567 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.474 ' CD2' HG12 ' A' ' 37' ' ' VAL . 0.6 OUTLIER -103.48 -161.51 0.84 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.248 -0.907 . . . . 0.0 108.93 179.753 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 62' ' ' LEU . . . -46.33 -40.5 11.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.106 -0.996 . . . . 0.0 109.263 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.74 33.63 0.16 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.17 138.02 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -1.108 . . . . 0.0 109.66 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.453 ' N ' ' CD2' ' A' ' 66' ' ' HIS . 7.6 m-70 -96.09 142.24 28.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 109.389 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 60' ' ' PHE . 17.3 m-85 -141.76 162.6 35.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.212 -0.93 . . . . 0.0 109.44 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.42 HG11 ' N ' ' A' ' 69' ' ' THR . 23.9 t -121.49 149.2 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.299 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.42 ' N ' HG11 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -138.67 103.54 4.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.466 -179.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.425 HD22 ' HG2' ' A' ' 71' ' ' ARG . 2.3 pt? -103.08 8.11 38.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.147 -0.97 . . . . 0.0 109.607 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.425 ' HG2' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -148.69 51.47 0.99 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.305 -0.872 . . . . 0.0 109.022 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.88 130.2 41.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.852 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.46 -172.34 4.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.388 -0.82 . . . . 0.0 109.03 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.16 40.04 0.89 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.047 -1.033 . . . . 0.0 109.679 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.549 ' HG2' ' NH1' ' A' ' 75' ' ' ARG . 2.3 tpt180 -145.28 -72.29 0.25 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 108.957 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -113.54 154.1 27.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.352 -0.842 . . . . 0.0 108.738 179.369 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.489 ' CG1' ' O ' ' A' ' 76' ' ' SER . 47.1 mt -156.96 58.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.935 -1.103 . . . . 0.0 110.376 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.559 ' CE2' ' CG2' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -94.36 102.59 14.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.087 . . . . 0.0 108.858 179.167 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 86' ' ' VAL . . . -75.05 175.48 50.64 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.45 133.52 16.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -1.094 . . . . 0.0 109.256 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 0.6 OUTLIER -127.51 70.06 1.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 109.762 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 83' ' ' SER . . . 50.85 -118.13 6.08 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 82' ' ' GLY . 3.8 t -44.59 -84.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -1.212 . . . . 0.0 109.525 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . . . -90.04 156.15 18.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.132 -0.98 . . . . 0.0 109.581 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.474 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -147.92 179.31 24.9 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.434 ' O ' HD12 ' A' ' 87' ' ' ILE . 7.9 p -112.14 159.25 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.062 -1.258 . . . . 0.0 109.974 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 98' ' ' GLY . 14.4 mm -141.83 96.43 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 18.8 p -124.19 153.67 41.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.746 -1.222 . . . . 0.0 110.834 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.559 ' CG2' ' CE2' ' A' ' 78' ' ' TYR . 57.4 t -150.21 135.66 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.603 ' CE ' ' CE1' ' A' ' 49' ' ' PHE . 10.9 mmtm -91.54 150.38 21.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.897 . . . . 0.0 109.65 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.407 HG21 ' C ' ' A' ' 90' ' ' LYS . 57.5 p -142.55 -168.18 2.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 108.959 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 m -47.58 -25.63 1.2 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.248 -0.907 . . . . 0.0 109.109 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.439 ' HB2' ' CB ' ' A' ' 125' ' ' PHE . 5.1 mttt 178.4 67.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -0.824 . . . . 0.0 109.345 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.468 ' HB2' ' CD2' ' A' ' 125' ' ' PHE . 0.6 OUTLIER -173.97 145.9 1.15 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.507 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.528 ' CG2' ' HD3' ' A' ' 90' ' ' LYS . 3.8 mt -136.14 85.22 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.158 -0.964 . . . . 0.0 109.23 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 88' ' ' THR . 0.3 OUTLIER -61.12 165.27 4.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.478 -0.764 . . . . 0.0 109.119 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.535 ' CG2' ' CD2' ' A' ' 22' ' ' LEU . 58.7 t -143.38 47.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.192 -0.942 . . . . 0.0 110.143 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.503 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -41.05 130.7 3.39 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -126.22 118.59 51.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.786 -1.42 . . . . 0.0 108.652 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.548 ' HB3' ' CG1' ' A' ' 16' ' ' VAL . 38.1 p90 -106.51 -179.1 3.84 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.084 -1.01 . . . . 0.0 109.829 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 84' ' ' ALA . 6.4 t-20 -135.06 -155.1 0.62 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 110.029 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -36.96 80.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.484 -0.76 . . . . 0.0 110.053 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.66 -49.99 55.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.95 . . . . 0.0 109.885 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.406 ' CG2' ' O ' ' A' ' 15' ' ' ALA . 4.3 mp -99.87 150.38 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.131 -0.981 . . . . 0.0 109.754 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -117.42 155.46 50.1 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.393 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.04 -166.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.234 1.956 . . . . 0.0 110.252 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 53.97 21.86 18.31 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.6 m -156.6 -41.15 0.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -1.105 . . . . 0.0 109.072 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.471 ' HA ' HG13 ' A' ' 112' ' ' VAL . . . -85.39 -12.88 51.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.358 -0.839 . . . . 0.0 109.133 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.43 -39.01 23.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.414 -0.804 . . . . 0.0 109.45 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -65.1 -40.01 93.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.748 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.471 HG13 ' HA ' ' A' ' 109' ' ' ALA . 5.3 p -69.88 -25.22 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.187 -0.946 . . . . 0.0 109.508 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 109' ' ' ALA . 73.1 t -82.57 -25.06 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.204 -0.935 . . . . 0.0 109.474 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -70.55 -35.93 73.38 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.166 -0.959 . . . . 0.0 109.406 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.491 ' HG3' ' N ' ' A' ' 116' ' ' LEU . 2.5 ptpt -81.52 -39.38 24.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 109.647 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.491 ' N ' ' HG3' ' A' ' 115' ' ' LYS . 59.7 tp -50.83 -33.8 25.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 109.433 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.547 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -79.97 -34.5 38.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.325 -0.859 . . . . 0.0 109.592 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -62.76 -12.17 22.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.028 . . . . 0.0 109.577 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 30.7 t80 -90.31 -54.27 4.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 109.896 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.54 HD12 ' CE2' ' A' ' 125' ' ' PHE . 0.8 OUTLIER -63.94 -34.47 78.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.0 110.098 -179.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.547 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 5.7 mt -63.2 -13.65 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 121' ' ' ILE . . . -46.06 -27.73 2.66 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -103.26 -65.89 0.97 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.422 -1.046 . . . . 0.0 109.205 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.11 109.17 2.73 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.54 ' CE2' HD12 ' A' ' 120' ' ' LEU . 22.5 m-85 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.171 -1.194 . . . . 0.0 109.524 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.601 ' CZ2' HD23 ' A' ' 96' ' ' LEU . 41.8 m95 . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 121.097 0.475 . . . . 0.0 109.723 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -89.98 -86.01 0.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 110.319 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.74 -16.87 2.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.242 -0.911 . . . . 0.0 110.203 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 2.1 m-30 -88.91 -33.92 17.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.026 -1.046 . . . . 0.0 109.747 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.538 ' HA ' ' CG2' ' A' ' 11' ' ' VAL . 1.2 t -56.0 -43.25 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.183 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.63 46.49 1.34 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.387 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.407 ' CG2' ' N ' ' A' ' 9' ' ' ASN . 67.7 m -158.52 -101.58 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.703 -1.248 . . . . 0.0 110.609 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 11' ' ' VAL . 2.2 t-20 -102.1 -72.2 0.69 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.111 -0.993 . . . . 0.0 111.346 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.533 HD23 ' CD2' ' A' ' 116' ' ' LEU . 2.2 mp -25.67 -39.17 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 9' ' ' ASN . 1.7 t -82.11 -66.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.559 -1.338 . . . . 0.0 110.341 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -40.24 -33.83 0.55 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.552 ' CB ' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 156.37 39.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.624 0.726 . . . . 0.0 109.357 179.181 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -83.31 14.28 40.82 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 107.412 -2.275 . . . . 0.0 107.412 177.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 156.93 -25.04 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 99' ' ' VAL . 17.1 m -138.08 152.67 26.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.425 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -81.85 14.86 2.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.978 -1.076 . . . . 0.0 109.127 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.459 ' HG2' ' N ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER 173.28 -178.37 0.08 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.453 ' HA ' HG21 ' A' ' 99' ' ' VAL . . . 178.95 160.52 0.66 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.828 -1.17 . . . . 0.0 109.88 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.488 ' HB2' ' CD1' ' A' ' 22' ' ' LEU . . . -155.59 127.41 7.46 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.236 -0.915 . . . . 0.0 110.239 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.538 HD12 ' N ' ' A' ' 2' ' ' TRP . 2.2 mm -87.73 78.67 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.566 ' CD2' HG23 ' A' ' 97' ' ' VAL . 8.8 mp -52.66 164.22 0.38 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.513 -0.742 . . . . 0.0 109.631 -178.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.22 159.49 15.04 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -110.76 -28.13 8.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -1.087 . . . . 0.0 109.275 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.69 6.38 12.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.828 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -136.56 -86.68 0.2 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.47 ' O ' ' OG1' ' A' ' 28' ' ' THR . 6.7 p30 -170.23 -46.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.356 -1.085 . . . . 0.0 109.281 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 27' ' ' ASN . 34.1 m -170.68 127.86 0.77 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 109.567 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.527 ' CZ2' ' O ' ' A' ' 93' ' ' LYS . 26.1 m0 -84.05 -58.11 2.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.383 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.97 169.78 16.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.347 -0.845 . . . . 0.0 109.304 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -160.48 174.47 14.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 109.978 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.51 ' CB ' HG12 ' A' ' 11' ' ' VAL . 3.1 m -154.28 99.49 2.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.337 -0.852 . . . . 0.0 109.374 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 32' ' ' SER . . . 42.64 -152.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.416 -0.803 . . . . 0.0 109.524 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.459 ' N ' ' HG2' ' A' ' 18' ' ' GLN . . . 90.52 -145.74 18.15 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -103.43 169.26 8.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -1.139 . . . . 0.0 109.471 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.22 116.73 29.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.321 -0.862 . . . . 0.0 109.244 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.1 t -79.4 122.23 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.157 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.9 m -75.67 132.88 74.26 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.92 . . . . 0.0 109.48 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.567 ' O ' ' CB ' ' A' ' 40' ' ' ALA . 3.4 Cg_exo -59.13 171.36 2.31 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.941 1.761 . . . . 0.0 109.778 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.567 ' CB ' ' O ' ' A' ' 39' ' ' PRO . . . 83.56 -46.3 0.12 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.672 -0.643 . . . . 0.0 109.379 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.92 -30.46 68.93 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.146 -0.971 . . . . 0.0 109.02 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.79 -32.79 48.38 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -67.03 -37.7 84.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.376 -1.073 . . . . 0.0 108.874 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.8 m -63.78 -29.86 71.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 108.807 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.523 ' HG ' ' CZ ' ' A' ' 49' ' ' PHE . 11.8 tp -70.89 -39.03 73.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.349 -0.844 . . . . 0.0 109.172 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.09 -46.91 79.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.325 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -24.58 66.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.372 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.85 92.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.268 -0.895 . . . . 0.0 109.15 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.523 ' CZ ' ' HG ' ' A' ' 45' ' ' LEU . 2.9 m-30 -68.94 85.66 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.369 -0.832 . . . . 0.0 109.213 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.53 -64.03 0.22 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.64 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 53' ' ' ASP . 3.7 t-20 -136.66 19.17 3.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.36 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 51' ' ' ASN . . . 41.97 26.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.55 -0.719 . . . . 0.0 109.954 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.541 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -80.88 -53.58 0.8 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.068 -1.02 . . . . 0.0 110.403 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 3.4 Cg_exo -62.34 -22.47 74.15 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.067 1.845 . . . . 0.0 110.893 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -94.61 -51.76 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.862 -1.149 . . . . 0.0 109.238 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -45.09 -27.0 0.52 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.963 . . . . 0.0 108.748 179.577 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . -115.68 -165.59 1.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.474 -0.766 . . . . 0.0 109.055 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 57' ' ' ALA . 75.0 m 44.37 -95.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.193 -0.942 . . . . 0.0 109.536 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 57' ' ' ALA . . . 164.43 175.0 34.82 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.419 ' HB3' ' HB2' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -80.32 155.54 27.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.393 -1.063 . . . . 0.0 109.38 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -154.07 101.92 2.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.048 -1.032 . . . . 0.0 110.061 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -98.73 -163.01 1.0 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 109.274 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.425 ' O ' HG22 ' A' ' 65' ' ' VAL . . . -61.56 94.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.976 . . . . 0.0 109.798 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.446 ' O ' HG21 ' A' ' 65' ' ' VAL . . . 60.77 51.99 55.23 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.61 ' CG1' ' CE1' ' A' ' 67' ' ' TYR . 3.2 t -150.01 136.23 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.244 -1.151 . . . . 0.0 109.413 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -110.24 91.89 3.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 109.744 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.61 ' CE1' ' CG1' ' A' ' 65' ' ' VAL . 6.0 m-30 -100.68 -168.38 1.57 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.16 -0.963 . . . . 0.0 109.083 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 p -131.06 176.59 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.992 -1.068 . . . . 0.0 109.522 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.429 HG23 ' CB ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -136.69 69.42 1.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 109.535 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.1 tp -89.66 2.21 55.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.125 -0.984 . . . . 0.0 109.216 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.463 ' NH1' ' HG3' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -144.93 69.67 1.26 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.36 -0.838 . . . . 0.0 108.85 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.429 ' CB ' HG23 ' A' ' 69' ' ' THR . . . -118.69 91.72 3.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.898 . . . . 0.0 110.125 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -98.49 -162.81 0.98 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.336 -0.852 . . . . 0.0 108.857 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -101.44 41.36 1.21 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.074 -1.016 . . . . 0.0 109.373 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.462 ' NH1' ' CG ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -150.42 -53.64 0.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.816 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.0 m -131.85 136.67 47.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 0.0 109.986 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' A' ' 88' ' ' THR . 11.1 mt -99.92 72.93 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.575 ' CE2' HD12 ' A' ' 87' ' ' ILE . 2.5 t80 -89.6 82.2 6.39 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.422 -0.799 . . . . 0.0 109.193 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.08 176.0 43.54 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.61 -170.74 3.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.335 -1.097 . . . . 0.0 109.697 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.429 ' HD3' ' O ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -164.65 25.09 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.428 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.1 -78.57 1.7 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 102' ' ' GLU . 1.9 m -81.92 -38.89 24.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -1.157 . . . . 0.0 109.863 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -126.6 164.56 20.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.987 . . . . 0.0 109.538 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -159.08 162.48 32.71 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.518 HG21 ' N ' ' A' ' 87' ' ' ILE . 14.9 p -123.79 151.45 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.367 -1.078 . . . . 0.0 109.61 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.575 HD12 ' CE2' ' A' ' 78' ' ' TYR . 54.9 mt -124.8 88.84 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.366 -0.834 . . . . 0.0 108.86 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 41.6 p -105.76 129.33 53.98 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.048 -1.033 . . . . 0.0 109.992 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 88' ' ' THR . 6.1 m -145.23 150.94 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.572 -0.705 . . . . 0.0 109.554 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -97.52 122.67 40.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.202 -0.936 . . . . 0.0 109.653 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -58.15 2.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 109.143 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -175.24 -36.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.807 . . . . 0.0 109.184 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.529 ' HG3' ' CE2' ' A' ' 125' ' ' PHE . 10.3 mttm -145.67 28.51 1.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.842 . . . . 0.0 109.497 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.489 ' N ' HD23 ' A' ' 24' ' ' LEU . 58.3 m -161.3 168.89 23.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.894 . . . . 0.0 109.468 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.435 HG13 ' HG ' ' A' ' 24' ' ' LEU . 83.5 mt -125.43 123.86 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.113 -0.992 . . . . 0.0 109.371 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.601 HD23 ' CZ2' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -81.54 155.47 25.72 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.462 -0.774 . . . . 0.0 109.903 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.566 HG23 ' CD2' ' A' ' 22' ' ' LEU . 48.2 t -151.43 54.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.665 -0.647 . . . . 0.0 109.695 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -55.53 113.88 4.26 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.478 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -111.3 122.95 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.058 -1.26 . . . . 0.0 109.425 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 100' ' ' TYR . 2.8 p90 -131.72 178.12 7.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 109.66 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -121.69 -167.41 1.52 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.69 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -68.07 -17.76 64.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.702 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.12 -10.98 25.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.946 . . . . 0.0 109.446 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.469 HG22 ' O ' ' A' ' 15' ' ' ALA . 28.2 mt -125.63 158.59 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.15 -0.969 . . . . 0.0 109.777 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.518 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 7.3 mt-30 -139.61 160.08 62.77 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.442 -0.786 . . . . 0.0 109.009 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 105' ' ' GLN . 5.9 Cg_exo -56.27 165.0 4.61 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.928 1.752 . . . . 0.0 110.129 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.21 -28.01 17.33 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.7 m -115.55 -48.63 2.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.448 -1.031 . . . . 0.0 109.235 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.44 ' C ' HG11 ' A' ' 112' ' ' VAL . . . -87.36 -19.28 28.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.882 . . . . 0.0 109.279 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.436 ' HA ' ' CE2' ' A' ' 78' ' ' TYR . . . -85.55 -52.07 6.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.304 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -60.69 -36.19 78.16 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.432 -0.792 . . . . 0.0 109.79 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 13.4 p -65.27 -37.14 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.191 -0.943 . . . . 0.0 109.378 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.467 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 93.9 t -73.62 -16.02 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.212 -0.93 . . . . 0.0 109.701 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.9 -44.79 38.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.004 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -84.62 -46.86 11.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.108 -0.995 . . . . 0.0 110.069 -179.49 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.533 ' CD2' HD23 ' A' ' 10' ' ' LEU . 2.6 mp -54.27 -32.65 56.75 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.138 -0.976 . . . . 0.0 109.813 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -72.93 -43.11 62.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -0.946 . . . . 0.0 109.755 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -57.8 -20.99 39.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.85 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -90.08 -56.18 3.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.08 -1.013 . . . . 0.0 109.982 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.44 -0.6 15.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.157 -0.964 . . . . 0.0 109.838 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.518 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER -64.24 -39.08 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.984 -1.072 . . . . 0.0 108.797 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -121.73 45.51 1.21 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -143.11 -73.57 0.28 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.082 -1.246 . . . . 0.0 110.018 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.473 ' C ' ' CG ' ' A' ' 125' ' ' PHE . . . -123.18 -18.46 3.11 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.529 ' CE2' ' HG3' ' A' ' 93' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.202 -1.175 . . . . 0.0 109.374 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.654 ' CZ2' ' CD1' ' A' ' 96' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.456 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 2.5 tt0 -63.56 -51.34 65.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.313 -0.867 . . . . 0.0 109.753 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -40.45 67.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 109.233 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.553 ' HB3' ' CD1' ' A' ' 10' ' ' LEU . 22.1 m-30 -61.9 -33.69 74.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.095 -1.003 . . . . 0.0 108.417 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.55 HG11 ' N ' ' A' ' 7' ' ' ASP . 0.9 OUTLIER -62.15 -56.89 14.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.643 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.55 ' N ' HG11 ' A' ' 6' ' ' VAL . 58.9 m-20 -91.64 50.47 1.72 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.05 -1.032 . . . . 0.0 110.314 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 65.7 m -156.19 -100.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.77 -1.206 . . . . 0.0 110.78 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -101.53 -56.48 2.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.084 -1.01 . . . . 0.0 111.075 -178.354 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.553 ' CD1' ' HB3' ' A' ' 5' ' ' TYR . 6.6 mt -38.16 -30.22 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.142 -0.974 . . . . 0.0 111.158 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.587 ' CG2' ' CB ' ' A' ' 19' ' ' ALA . 47.5 t -101.25 -52.27 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.764 -1.21 . . . . 0.0 110.065 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -40.14 -42.29 2.32 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.514 ' CB ' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 161.18 43.68 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.789 -0.83 . . . . 0.0 109.322 178.437 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -85.69 15.01 49.46 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 177.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 155.68 -27.83 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.548 ' CB ' ' HB3' ' A' ' 100' ' ' TYR . 5.6 m -139.4 155.34 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.516 ' N ' HD13 ' A' ' 104' ' ' ILE . 14.7 t -87.18 21.66 2.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.896 -1.128 . . . . 0.0 108.877 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.528 ' HA ' ' CG1' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -178.45 -176.81 0.52 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 11' ' ' VAL . . . 175.33 154.65 0.16 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.273 -0.892 . . . . 0.0 109.127 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.497 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -148.27 136.83 21.52 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.244 -0.91 . . . . 0.0 109.68 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.447 HG13 ' CG2' ' A' ' 6' ' ' VAL . 1.6 mt -106.61 101.68 12.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.556 HD22 ' N ' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -84.95 22.83 1.31 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.389 -0.819 . . . . 0.0 110.269 -178.089 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' HD13 ' A' ' 95' ' ' ILE . . . 47.43 -164.42 0.18 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.512 HD12 ' CA ' ' A' ' 93' ' ' LYS . 1.1 mt -98.34 -74.33 0.59 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.388 -1.066 . . . . 0.0 109.114 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -135.15 22.04 3.47 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.307 -0.87 . . . . 0.0 108.832 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.7 67.97 0.25 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.5 t30 48.7 -150.25 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -1.108 . . . . 0.0 109.737 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.42 HG21 ' N ' ' A' ' 29' ' ' TRP . 60.8 m -94.12 139.26 31.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.812 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.42 ' N ' HG21 ' A' ' 28' ' ' THR . 12.5 m0 -96.67 -65.31 0.97 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.435 ' O ' ' CG2' ' A' ' 31' ' ' THR . . . -137.53 160.11 40.07 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.435 ' CG2' ' O ' ' A' ' 30' ' ' ALA . 77.4 p -155.13 137.35 14.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.041 -1.037 . . . . 0.0 110.119 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.567 ' CB ' ' CG2' ' A' ' 11' ' ' VAL . 0.4 OUTLIER -108.81 115.78 30.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.516 -0.74 . . . . 0.0 109.068 179.578 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 32' ' ' SER . . . 82.38 166.69 0.13 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 35' ' ' PHE . . . -48.41 -96.9 0.01 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.526 ' CE1' HG13 ' A' ' 99' ' ' VAL . 4.9 t80 74.35 84.99 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.315 -1.109 . . . . 0.0 109.901 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.09 105.69 17.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 109.356 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.529 ' HB ' ' CG ' ' A' ' 41' ' ' GLN . 59.7 t -108.05 56.3 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.655 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER 57.58 156.43 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.269 -0.894 . . . . 0.0 109.851 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.17 -36.52 68.78 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.294 1.996 . . . . 0.0 110.197 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.474 ' HB2' ' OG1' ' A' ' 44' ' ' THR . . . -83.82 60.69 5.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.838 . . . . 0.0 109.442 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.529 ' CG ' ' HB ' ' A' ' 37' ' ' VAL . 2.2 mt-30 -66.44 -47.83 71.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.681 -1.262 . . . . 0.0 110.111 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.64 -29.04 58.32 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.784 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -81.48 -62.86 1.53 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.97 -1.312 . . . . 0.0 109.84 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 40' ' ' ALA . 85.3 m -45.84 -50.76 13.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.84 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -66.45 -30.99 71.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.154 -0.966 . . . . 0.0 109.749 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.03 -18.59 62.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.4 t -74.66 -52.61 11.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -0.872 . . . . 0.0 109.659 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.51 -21.72 52.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.194 -0.941 . . . . 0.0 109.543 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.583 ' CE2' ' CG ' ' A' ' 90' ' ' LYS . 4.2 m-30 -65.88 -37.08 85.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.432 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -88.28 -74.69 0.45 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 109.587 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -71.9 119.25 15.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.172 -0.955 . . . . 0.0 109.521 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.19 17.52 23.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.113 -0.992 . . . . 0.0 109.056 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.589 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -76.61 -50.14 2.66 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.456 -0.777 . . . . 0.0 110.372 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 4.2 Cg_exo -62.82 -8.17 12.94 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.976 1.784 . . . . 0.0 110.933 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.583 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -104.96 -44.05 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.041 -1.037 . . . . 0.0 109.497 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.522 ' CD ' ' HA ' ' A' ' 53' ' ' ASP . 8.3 ptm180 -61.98 -22.15 65.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 109.948 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.427 ' C ' ' OG ' ' A' ' 58' ' ' SER . . . -107.73 108.11 19.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 109.907 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.427 ' OG ' ' C ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER 72.25 -79.52 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.432 -0.792 . . . . 0.0 109.882 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.88 -138.97 5.76 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -155.39 172.5 18.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -1.11 . . . . 0.0 109.573 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.12 160.29 14.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 109.092 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.537 ' HB2' ' CE2' ' A' ' 67' ' ' TYR . 3.4 mt -159.57 98.45 1.38 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.924 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 62' ' ' LEU . . . 74.99 -78.22 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.646 -0.659 . . . . 0.0 110.041 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -159.08 23.28 0.31 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.5 t -137.48 157.36 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -1.145 . . . . 0.0 109.207 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.484 ' CE1' ' HD2' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -100.25 152.66 20.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.153 -0.967 . . . . 0.0 109.472 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.537 ' CE2' ' HB2' ' A' ' 62' ' ' LEU . 92.2 m-85 -137.61 149.44 46.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 109.525 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.54 -156.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 109.241 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.413 HG23 ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -161.88 75.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.94 . . . . 0.0 109.5 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.11 12.15 31.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.907 . . . . 0.0 109.44 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -156.92 64.14 0.51 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.709 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.21 90.32 3.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 109.062 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.88 -108.05 0.35 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.107 -0.996 . . . . 0.0 109.791 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -121.6 -34.12 3.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.778 -1.201 . . . . 0.0 110.648 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.536 ' HG2' ' NH1' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -134.74 31.7 3.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.887 -1.133 . . . . 0.0 110.878 -178.703 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.548 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 1.2 m -150.57 116.24 5.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.984 -1.073 . . . . 0.0 109.476 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 88' ' ' THR . 3.6 mp -144.79 50.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 0.0 109.557 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.548 ' CE1' ' HB3' ' A' ' 76' ' ' SER . 0.0 OUTLIER -91.01 91.5 8.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.092 -1.005 . . . . 0.0 108.612 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.33 170.65 53.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.517 ' HG2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -151.04 147.36 27.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.54 -0.976 . . . . 0.0 109.11 179.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.517 ' N ' ' HG2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -124.7 -170.84 2.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.989 -1.069 . . . . 0.0 109.682 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.29 5.41 77.26 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.455 ' HA ' ' HB2' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -154.82 -67.98 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -1.098 . . . . 0.0 108.887 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 81' ' ' LYS . . . -91.7 164.42 13.73 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.518 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -156.71 150.23 21.35 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.538 -1.315 . . . . 0.0 109.908 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.412 HG23 HG21 ' A' ' 88' ' ' THR . 9.8 p -122.32 147.37 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.329 -1.101 . . . . 0.0 109.448 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.482 HD13 HG13 ' A' ' 16' ' ' VAL . 11.9 mt -120.75 94.02 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 39.2 p -113.29 133.56 55.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.981 -1.074 . . . . 0.0 110.716 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -151.33 152.66 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.042 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.583 ' CG ' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -97.95 117.69 32.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.901 -179.428 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.543 ' O ' ' CB ' ' A' ' 92' ' ' SER . 0.8 OUTLIER -96.38 -69.17 0.77 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 108.764 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 91' ' ' THR . 1.9 m 157.7 -24.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.512 ' CA ' HD12 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -110.99 -12.33 14.23 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.444 -0.785 . . . . 0.0 109.256 179.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.463 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -172.5 168.73 5.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.81 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.473 HD13 ' O ' ' A' ' 23' ' ' GLY . 34.1 mt -105.78 134.64 46.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.398 -0.814 . . . . 0.0 108.973 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.654 ' CD1' ' CZ2' ' A' ' 2' ' ' TRP . 1.6 mt -88.96 148.26 23.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 110.249 -179.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.539 HG23 ' CD1' ' A' ' 22' ' ' LEU . 75.4 t -151.33 58.55 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.458 -0.776 . . . . 0.0 109.632 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -55.57 112.58 3.15 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.526 HG13 ' CE1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.81 125.52 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.992 -1.299 . . . . 0.0 109.119 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.562 ' CD1' ' N ' ' A' ' 100' ' ' TYR . 3.8 p90 -138.82 -178.3 5.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.941 . . . . 0.0 110.14 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.19 -147.3 0.39 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.443 -0.785 . . . . 0.0 109.675 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 83' ' ' SER . 46.8 tt0 -102.91 -29.95 11.12 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.166 -0.959 . . . . 0.0 109.948 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -16.06 23.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 110.193 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 17' ' ' THR . 16.7 mt -85.68 141.3 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.058 -1.026 . . . . 0.0 109.395 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.51 110.0 2.17 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.394 -0.816 . . . . 0.0 109.631 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 104' ' ' ILE . 1.2 Cg_endo -65.69 145.84 82.42 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.092 1.862 . . . . 0.0 110.27 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.33 -43.81 3.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.8 m -74.63 -30.9 61.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -1.184 . . . . 0.0 109.483 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -63.54 -45.02 92.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.874 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.09 -32.52 67.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.146 -0.971 . . . . 0.0 109.846 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.453 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 7.4 t-20 -67.73 -32.54 73.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 0.0 109.724 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.46 ' CG1' ' HB3' ' A' ' 15' ' ' ALA . 1.3 t -79.86 -28.0 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.146 -0.971 . . . . 0.0 109.421 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.469 ' CG1' HD12 ' A' ' 96' ' ' LEU . 18.2 t -82.83 -17.92 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.952 . . . . 0.0 109.694 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.471 ' CD ' ' CZ ' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -78.16 -37.17 46.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.158 -0.964 . . . . 0.0 109.765 -179.697 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 111' ' ' ASN . 1.5 mmmt -71.73 -46.3 59.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.122 -0.986 . . . . 0.0 109.864 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.544 HD12 ' CD2' ' A' ' 5' ' ' TYR . 3.2 tt -54.06 -34.22 59.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.931 -1.106 . . . . 0.0 109.162 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.526 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -62.55 -37.8 87.55 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.077 -1.014 . . . . 0.0 108.887 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -21.77 61.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.904 . . . . 0.0 109.6 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.59 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 0.0 OUTLIER -73.71 -40.73 63.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 109.879 -179.492 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.59 ' HG ' ' CZ ' ' A' ' 119' ' ' TYR . 5.0 mt -81.04 -36.26 30.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.117 -0.989 . . . . 0.0 110.566 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 1.5 mp -64.1 -21.58 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.103 -0.998 . . . . 0.0 109.596 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.538 ' O ' ' CG ' ' A' ' 123' ' ' GLN . . . -97.5 22.48 40.58 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 122' ' ' GLY . 45.7 mt-30 -162.41 -83.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -1.169 . . . . 0.0 109.809 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 125' ' ' PHE . . . -96.1 57.76 1.48 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.496 ' HB3' ' CB ' ' A' ' 92' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.411 -1.052 . . . . 0.0 109.977 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.508 ' NE1' HD21 ' A' ' 96' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.363 0.601 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -72.36 -28.68 63.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.051 -1.031 . . . . 0.0 109.986 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -38.99 86.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.07 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.518 ' HB3' ' HB2' ' A' ' 10' ' ' LEU . 14.6 m-85 -74.81 -23.94 58.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.138 -0.976 . . . . 0.0 109.862 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.569 ' CG2' HG13 ' A' ' 21' ' ' ILE . 2.0 t -72.47 -23.16 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.18 -0.95 . . . . 0.0 110.062 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -46.77 -91.21 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.023 -1.048 . . . . 0.0 110.359 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.69 -2.23 3.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 110.131 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -86.26 -87.06 0.14 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.085 -1.01 . . . . 0.0 109.262 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 2.0 mm? -54.59 -27.5 39.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.996 -1.065 . . . . 0.0 109.669 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.579 ' CG2' ' CB ' ' A' ' 19' ' ' ALA . 4.2 t -90.55 -63.8 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.178 -0.952 . . . . 0.0 109.694 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -39.78 -38.91 1.21 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.531 ' CB ' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 157.02 53.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.977 -0.72 . . . . 0.0 109.839 178.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.599 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -96.1 21.76 43.38 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 106.339 -2.704 . . . . 0.0 106.339 177.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.599 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 144.43 -28.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.511 ' CG1' ' C ' ' A' ' 99' ' ' VAL . 4.3 t -131.72 140.5 48.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.503 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 0.2 OUTLIER -77.78 2.34 17.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.733 -1.229 . . . . 0.0 108.476 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -158.67 -173.68 4.4 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.359 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.579 ' CB ' ' CG2' ' A' ' 11' ' ' VAL . . . 170.78 142.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.007 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -140.4 104.14 4.71 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.058 -1.026 . . . . 0.0 110.305 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.569 HG13 ' CG2' ' A' ' 6' ' ' VAL . 14.4 mt -79.61 106.01 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.529 HD22 ' N ' ' A' ' 22' ' ' LEU . 0.4 OUTLIER -93.5 116.93 29.46 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.492 -0.755 . . . . 0.0 109.463 -178.317 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -49.72 -178.26 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -103.55 -68.94 0.82 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -1.141 . . . . 0.0 109.545 -179.75 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -113.66 11.83 18.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.269 -0.894 . . . . 0.0 109.543 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.71 -83.51 1.65 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -175.92 -65.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.417 -1.049 . . . . 0.0 109.401 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.6 m -158.62 156.54 30.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.94 . . . . 0.0 109.715 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -114.85 -69.97 0.83 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.354 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.456 ' O ' HG12 ' A' ' 6' ' ' VAL . . . -160.8 117.93 2.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.344 -0.848 . . . . 0.0 109.076 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 1.6 p -128.81 168.68 15.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.92 . . . . 0.0 109.81 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.421 ' HB2' HG12 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -171.71 98.32 0.18 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 109.238 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 18' ' ' GLN . . . -166.7 -67.24 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.169 -0.957 . . . . 0.0 109.464 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 139.21 39.61 0.1 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.557 ' CG ' ' O ' ' A' ' 35' ' ' PHE . 1.4 p90 -155.64 117.95 4.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -1.175 . . . . 0.0 109.409 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.91 130.54 41.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.536 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -90.65 161.67 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.373 -0.829 . . . . 0.0 109.353 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -74.11 148.05 86.26 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.293 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.78 -31.91 78.14 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.125 1.883 . . . . 0.0 110.357 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.31 13.38 3.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.196 -0.94 . . . . 0.0 110.285 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 38' ' ' THR . 1.3 mm-40 -90.65 -32.43 16.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.907 -1.121 . . . . 0.0 109.485 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.86 -46.31 94.78 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -21.01 64.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.406 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.453 ' HB ' ' O ' ' A' ' 41' ' ' GLN . 46.1 m -68.28 -34.69 76.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.47 ' HA ' ' HB1' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -69.64 -41.84 75.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.367 -0.833 . . . . 0.0 109.445 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.52 -45.86 91.03 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.921 . . . . 0.0 109.021 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -81.55 -5.86 58.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.352 -0.842 . . . . 0.0 109.114 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.47 ' HB1' ' HA ' ' A' ' 45' ' ' LEU . . . -69.09 -37.92 78.69 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.231 -0.918 . . . . 0.0 109.217 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 6.3 m-30 -74.96 81.89 2.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.52 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 2.1 t-20 -130.37 58.2 1.68 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 108.735 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 50' ' ' ASN . 5.2 t-20 84.77 17.84 0.15 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.578 0.704 . . . . 0.0 109.129 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . 44.18 23.62 0.07 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.467 -0.771 . . . . 0.0 110.17 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.541 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -91.93 -53.65 0.27 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.067 -1.02 . . . . 0.0 110.638 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 2.4 Cg_endo -65.4 -7.71 16.76 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.994 1.796 . . . . 0.0 110.965 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.427 ' CD1' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -109.08 -17.19 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.96 -1.088 . . . . 0.0 109.638 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.503 ' HG2' ' NH1' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -80.3 -46.8 15.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.449 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -107.32 63.47 0.63 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.505 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 4.7 t 167.68 -30.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.43 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.24 -153.3 31.69 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.448 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 6.3 p90 -151.84 -169.27 3.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -1.165 . . . . 0.0 109.169 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.77 146.75 28.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.092 -1.005 . . . . 0.0 110.556 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.5 -166.98 1.44 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.89 -22.08 46.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 109.383 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.72 -111.17 0.14 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.2 t -125.76 -153.67 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -1.195 . . . . 0.0 109.293 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 47.1 p-80 -88.29 114.14 24.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.167 -0.958 . . . . 0.0 109.416 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.445 ' HA ' ' HB2' ' A' ' 81' ' ' LYS . 12.0 m-30 -95.13 162.95 13.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 26.1 t -111.3 169.13 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.897 . . . . 0.0 109.451 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 91.6 m -122.33 130.94 53.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.909 . . . . 0.0 109.616 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.72 19.54 5.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.126 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -177.16 85.18 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.373 -0.829 . . . . 0.0 109.171 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 52' ' ' ALA . . . -141.71 36.95 1.63 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 0.0 109.64 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.44 -25.86 13.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.28 -0.887 . . . . 0.0 109.446 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -90.62 -106.65 0.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -139.64 24.24 2.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.793 -1.192 . . . . 0.0 109.564 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -135.47 156.17 49.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -0.905 . . . . 0.0 109.338 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.423 HG12 ' HB3' ' A' ' 72' ' ' ALA . 10.8 mt -149.27 68.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.174 -0.954 . . . . 0.0 109.429 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 76' ' ' SER . 0.0 OUTLIER -94.17 95.26 8.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.904 . . . . 0.0 108.764 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -113.23 173.32 15.01 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 0.7 OUTLIER -151.23 -170.65 3.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -1.153 . . . . 0.0 109.334 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.503 ' HE2' ' NE2' ' A' ' 66' ' ' HIS . 0.3 OUTLIER 175.62 111.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.189 -0.944 . . . . 0.0 109.58 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.54 -135.0 11.91 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 102' ' ' GLU . 2.4 p -100.24 -4.62 29.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -1.192 . . . . 0.0 109.694 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . . . -113.35 166.95 10.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.368 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.573 ' HA3' ' CE1' ' A' ' 100' ' ' TYR . . . -150.22 157.18 27.09 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.462 HG23 ' CG2' ' A' ' 88' ' ' THR . 11.9 p -135.53 136.64 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -1.18 . . . . 0.0 110.039 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.496 ' CG1' ' HB3' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -110.26 95.58 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.552 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.462 ' CG2' HG23 ' A' ' 86' ' ' VAL . 6.7 p -106.72 115.75 30.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 109.889 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.477 HG21 ' HG ' ' A' ' 96' ' ' LEU . 3.1 m -135.02 134.16 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 109.536 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.494 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -97.35 146.1 25.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.346 -0.846 . . . . 0.0 109.121 179.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.473 ' HB ' HG12 ' A' ' 121' ' ' ILE . 23.4 p -146.17 -145.31 0.17 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 109.913 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 91' ' ' THR . 0.1 OUTLIER -41.41 -74.58 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.295 -0.878 . . . . 0.0 110.548 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.471 ' O ' HD12 ' A' ' 24' ' ' LEU . 1.2 mtpt -149.72 52.85 0.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.993 . . . . 0.0 109.89 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.427 ' N ' HD22 ' A' ' 24' ' ' LEU . 21.2 t -169.86 151.25 4.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.925 . . . . 0.0 109.523 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.462 HG12 ' HG2' ' A' ' 90' ' ' LYS . 12.4 mt -129.32 128.53 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.179 -0.951 . . . . 0.0 109.256 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.508 HD21 ' NE1' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -98.96 154.39 18.11 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.327 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.518 HG23 ' CD1' ' A' ' 22' ' ' LEU . 59.0 t -137.36 64.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.129 -0.982 . . . . 0.0 109.578 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -50.05 118.28 5.66 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.511 ' C ' ' CG1' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -112.31 114.2 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.159 -1.2 . . . . 0.0 109.291 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.573 ' CE1' ' HA3' ' A' ' 85' ' ' GLY . 19.2 p90 -123.98 -168.78 1.84 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.248 -0.907 . . . . 0.0 109.672 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 84' ' ' ALA . 6.9 m120 -132.82 -168.52 2.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 83' ' ' SER . 16.1 pt-20 -66.28 -9.32 31.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.278 -0.889 . . . . 0.0 109.906 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -73.89 -17.54 61.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.917 . . . . 0.0 109.599 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 100' ' ' TYR . 9.5 mt -117.59 103.66 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.935 . . . . 0.0 109.504 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.456 ' HG2' ' HD2' ' A' ' 106' ' ' PRO . 1.7 tt0 -64.29 142.05 98.25 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.266 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.456 ' HD2' ' HG2' ' A' ' 105' ' ' GLN . 2.8 Cg_endo -61.55 152.58 72.45 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.04 1.827 . . . . 0.0 110.079 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.32 -23.05 23.67 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.1 m -98.08 -53.28 3.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -1.123 . . . . 0.0 109.569 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.446 ' O ' HG11 ' A' ' 112' ' ' VAL . . . -73.77 -32.19 63.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.928 . . . . 0.0 109.465 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.44 -27.85 64.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 0.0 109.587 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.453 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -78.2 -49.28 14.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.715 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 7.5 p -59.26 -21.59 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -0.969 . . . . 0.0 109.523 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 109' ' ' ALA . 91.1 t -78.91 -33.32 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.785 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.453 ' OE2' ' HA ' ' A' ' 111' ' ' ASN . 26.3 mt-10 -59.57 -61.12 2.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.931 . . . . 0.0 109.439 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.29 -38.26 88.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.633 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 4.1 mt -57.97 -24.44 58.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.539 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -80.41 -29.74 37.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.289 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.35 -38.7 74.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.072 . . . . 0.0 109.4 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -75.43 -47.43 27.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 109.554 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.495 HD12 ' CD1' ' A' ' 2' ' ' TRP . 0.5 OUTLIER -60.92 -57.52 12.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 109.417 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.539 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 15.7 mt -61.24 -13.81 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.467 -0.771 . . . . 0.0 109.941 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.74 -9.76 40.9 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -119.42 -56.27 2.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -1.185 . . . . 0.0 109.459 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 114.64 112.4 2.94 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.286 -1.126 . . . . 0.0 109.271 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.55 ' CH2' ' CD1' ' A' ' 96' ' ' LEU . 47.7 m95 . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.84 -86.07 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.816 -1.178 . . . . 0.0 109.342 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -63.77 -37.94 89.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.032 -1.042 . . . . 0.0 108.984 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.597 ' CE2' ' HG ' ' A' ' 116' ' ' LEU . 18.7 m-30 -56.34 -39.26 72.56 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.381 -0.825 . . . . 0.0 109.769 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 1.2 t -54.44 -45.56 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.828 -1.17 . . . . 0.0 108.075 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.62 41.12 1.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 110.919 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.487 HG23 ' N ' ' A' ' 9' ' ' ASN . 88.8 m -146.06 -106.01 0.1 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.527 -1.358 . . . . 0.0 109.879 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.9 t-20 -102.1 -70.75 0.74 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.043 -1.036 . . . . 0.0 110.08 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.502 ' C ' ' O ' ' A' ' 9' ' ' ASN . 0.2 OUTLIER -20.53 -45.34 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' A' ' 9' ' ' ASN . 0.9 OUTLIER -77.39 -68.09 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.851 -1.156 . . . . 0.0 110.125 -179.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -38.99 -36.46 0.5 Allowed Glycine 0 N--CA 1.498 2.785 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.533 ' CB ' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 156.61 39.61 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.989 -0.712 . . . . 0.0 109.154 179.011 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -84.47 17.78 27.77 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 177.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 158.44 -32.04 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 31.2 m -138.88 150.55 23.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.565 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.6 OUTLIER -78.97 6.32 9.57 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.113 -0.992 . . . . 0.0 108.872 179.112 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.565 ' CG ' ' O ' ' A' ' 17' ' ' THR . 27.4 mt-30 -168.42 160.87 11.54 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.614 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -163.95 112.4 1.18 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.913 -1.117 . . . . 0.0 112.148 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.499 ' N ' ' HB3' ' A' ' 32' ' ' SER . . . -98.32 144.53 27.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.263 -1.523 . . . . 0.0 109.957 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.544 HD13 ' HA ' ' A' ' 2' ' ' TRP . 45.5 mm -124.07 111.55 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.417 -0.802 . . . . 0.0 109.136 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.593 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -116.24 123.42 47.68 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.044 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.71 -158.62 14.79 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.74 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -106.63 -60.83 1.61 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.349 -1.089 . . . . 0.0 109.977 -179.504 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.83 6.87 14.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.976 -1.078 . . . . 0.0 108.725 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 28' ' ' THR . . . -143.04 88.4 0.18 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.02 -2.032 . . . . 0.0 108.02 179.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' A' ' 26' ' ' GLY . 2.1 t30 -30.68 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.067 -0.666 . . . . 0.0 110.838 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 26' ' ' GLY . 12.3 m -166.56 104.23 0.61 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.05 -1.031 . . . . 0.0 109.845 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.496 ' NE1' ' HA3' ' A' ' 26' ' ' GLY . 19.6 m0 -79.4 -27.93 41.83 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.527 ' HB2' ' CG2' ' A' ' 6' ' ' VAL . . . -147.54 163.59 36.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t -143.98 155.84 44.18 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.11 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 96.6 p -64.63 -9.96 23.21 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.649 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 63.8 66.77 0.65 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.16 -87.47 0.07 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -94.24 148.34 22.3 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.218 -1.166 . . . . 0.0 109.212 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.12 148.57 38.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.599 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -103.29 132.8 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.278 -0.888 . . . . 0.0 109.625 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.1 p -72.04 149.24 92.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.92 . . . . 0.0 109.398 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.56 ' O ' ' CB ' ' A' ' 40' ' ' ALA . 6.1 Cg_exo -60.15 177.62 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.184 1.923 . . . . 0.0 110.202 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 39' ' ' PRO . . . 83.37 -42.23 0.1 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.608 -0.682 . . . . 0.0 109.633 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -68.24 -31.81 71.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.058 -1.026 . . . . 0.0 109.569 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.09 -35.93 60.46 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.3 -33.96 73.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -1.173 . . . . 0.0 109.531 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.2 m -59.14 -31.73 69.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.412 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 mt -68.7 -40.58 79.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 109.398 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.62 -42.01 99.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.383 -0.823 . . . . 0.0 109.454 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.4 t -74.85 -9.98 59.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 109.562 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.38 -16.65 36.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.923 . . . . 0.0 109.729 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -81.89 -15.93 52.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.248 -0.907 . . . . 0.0 109.688 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -117.3 4.51 12.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.271 -0.893 . . . . 0.0 109.239 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -166.44 107.72 0.69 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -0.865 . . . . 0.0 109.468 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 56' ' ' ARG . . . -95.11 47.74 1.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.379 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.577 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -82.59 -49.62 0.8 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 110.721 -179.534 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 4.8 Cg_exo -63.57 -71.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.974 1.783 . . . . 0.0 111.393 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.458 ' HB ' HG23 ' A' ' 69' ' ' THR . 0.1 OUTLIER -45.52 -54.13 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.13 -0.981 . . . . 0.0 110.053 -178.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 5.0 mtp180 -50.83 -53.24 33.85 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.161 -0.962 . . . . 0.0 109.489 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.81 -87.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.54 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.2 -82.96 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.179 -0.95 . . . . 0.0 109.426 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 55' ' ' ILE . . . -179.97 -99.96 0.13 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.472 ' CB ' ' HB2' ' A' ' 67' ' ' TYR . 1.3 m-85 -131.19 133.53 45.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.358 -1.083 . . . . 0.0 109.273 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -129.25 125.61 37.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.194 -0.942 . . . . 0.0 109.483 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.93 -149.78 0.41 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.329 -0.857 . . . . 0.0 109.302 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.25 -75.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.415 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.57 37.14 1.91 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.439 HG13 ' CZ ' ' A' ' 67' ' ' TYR . 2.6 t -138.85 158.52 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -1.145 . . . . 0.0 109.773 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -131.03 143.21 50.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.448 -0.783 . . . . 0.0 109.51 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.472 ' HB2' ' CB ' ' A' ' 60' ' ' PHE . 33.8 m-85 -134.56 -169.51 2.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.326 -0.859 . . . . 0.0 109.34 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.41 136.96 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.964 . . . . 0.0 109.426 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.458 HG23 ' HB ' ' A' ' 55' ' ' ILE . 1.7 m -93.87 103.03 15.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.943 . . . . 0.0 109.266 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 tp -124.0 38.11 4.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.963 . . . . 0.0 109.715 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER 172.53 50.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 179.634 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' A' ' 77' ' ' ILE . . . -113.78 23.38 13.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.866 . . . . 0.0 109.125 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -124.97 -24.02 4.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 109.672 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -75.57 -93.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.119 -0.988 . . . . 0.0 109.253 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.61 -46.9 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 109.254 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.584 ' CB ' ' CZ ' ' A' ' 78' ' ' TYR . 67.7 m -89.39 -164.2 1.11 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.912 . . . . 0.0 108.779 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.494 ' CG1' ' O ' ' A' ' 76' ' ' SER . 45.3 mt -157.73 63.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.983 -1.073 . . . . 0.0 110.212 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.584 ' CZ ' ' CB ' ' A' ' 76' ' ' SER . 1.9 m-85 -90.81 145.22 24.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.996 -1.065 . . . . 0.0 108.432 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -140.61 -171.21 12.38 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.484 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -149.59 -176.66 5.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.584 -0.95 . . . . 0.0 108.944 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER 178.55 34.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.973 . . . . 0.0 109.617 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.431 ' C ' ' OG ' ' A' ' 83' ' ' SER . . . 62.33 95.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 101' ' ' ASN . 0.6 OUTLIER 70.55 6.79 5.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.287 -1.125 . . . . 0.0 109.783 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 81' ' ' LYS . . . -150.35 129.88 13.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.661 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.571 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -150.35 174.8 29.64 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.536 ' CG2' ' CG2' ' A' ' 88' ' ' THR . 7.4 p -148.14 114.26 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -1.177 . . . . 0.0 110.133 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.412 HD13 ' CE1' ' A' ' 100' ' ' TYR . 7.2 mt -90.72 79.34 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.115 -0.991 . . . . 0.0 109.212 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.536 ' CG2' ' CG2' ' A' ' 86' ' ' VAL . 1.2 p -105.56 141.78 36.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.198 -0.939 . . . . 0.0 110.116 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.541 HG21 ' CD2' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -150.49 -178.11 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -114.41 80.3 1.38 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.886 -1.134 . . . . 0.0 110.466 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.533 HG22 ' CG2' ' A' ' 89' ' ' VAL . 19.3 p -98.56 148.65 23.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.935 . . . . 0.0 108.666 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 0.3 OUTLIER 50.85 20.27 0.75 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.341 -0.85 . . . . 0.0 109.754 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 92' ' ' SER . 0.5 OUTLIER 81.95 -18.71 0.46 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.342 -0.849 . . . . 0.0 110.192 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.545 ' HA ' ' CD2' ' A' ' 24' ' ' LEU . 1.4 p -82.28 178.94 7.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.213 -0.93 . . . . 0.0 109.21 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 4.8 mt -130.86 101.65 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.134 -0.979 . . . . 0.0 110.117 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.55 ' CD1' ' CH2' ' A' ' 2' ' ' TRP . 0.3 OUTLIER -71.74 157.78 37.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.299 -0.876 . . . . 0.0 108.743 179.602 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.528 HG22 ' CG ' ' A' ' 22' ' ' LEU . 10.4 t -132.3 68.27 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.952 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -48.26 129.46 19.03 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 107.399 -2.28 . . . . 0.0 107.399 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.54 HG21 ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -132.12 106.0 10.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.715 -1.462 . . . . 0.0 108.73 -178.786 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.571 ' CZ ' ' HA3' ' A' ' 85' ' ' GLY . 22.5 p90 -122.77 164.56 18.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.371 -0.83 . . . . 0.0 109.905 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 102' ' ' GLU . 1.1 m120 -150.68 -164.11 1.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.443 -0.786 . . . . 0.0 109.312 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 101' ' ' ASN . 0.8 OUTLIER 61.49 19.21 10.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.626 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.8 mttt 60.28 62.74 1.52 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.118 -0.989 . . . . 0.0 109.377 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.458 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 6.2 mt -73.68 123.05 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.285 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -44.66 104.86 0.41 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.447 -0.783 . . . . 0.0 109.983 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 104' ' ' ILE . 3.6 Cg_exo -62.08 172.82 3.66 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.053 1.835 . . . . 0.0 110.173 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 111' ' ' ASN . . . 87.9 -19.88 31.56 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.438 ' O ' HG21 ' A' ' 112' ' ' VAL . 17.1 m -106.24 -45.56 4.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -1.18 . . . . 0.0 109.273 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -73.64 -43.31 59.85 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.186 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.71 -30.79 70.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.147 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 107' ' ' GLY . 0.7 OUTLIER -70.09 -40.98 74.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.346 -0.846 . . . . 0.0 109.467 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 108' ' ' THR . 21.6 t -67.2 -26.11 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.124 -0.985 . . . . 0.0 109.33 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 113' ' ' VAL . 38.1 t -76.73 -27.63 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.367 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.38 -43.12 82.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.442 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.2 -54.29 11.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 109.062 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.597 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 5.0 mp -51.55 -22.31 3.14 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.268 -0.895 . . . . 0.0 109.084 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.475 ' HB3' HD13 ' A' ' 121' ' ' ILE . . . -71.25 -43.73 66.69 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.441 -0.787 . . . . 0.0 109.248 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.44 -14.58 29.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.741 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.485 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 1.7 t80 -78.55 -60.76 2.24 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -0.935 . . . . 0.0 109.512 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.58 -50.08 68.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.909 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.529 ' CD1' HG21 ' A' ' 91' ' ' THR . 19.6 mt -51.08 -34.21 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.087 -1.008 . . . . 0.0 109.513 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -45.16 -65.3 1.9 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -46.88 -60.42 2.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -1.12 . . . . 0.0 109.642 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.4 74.09 1.19 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' A' ' 92' ' ' SER . 64.1 m-85 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.256 -1.144 . . . . 0.0 109.482 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.597 ' CZ3' HD13 ' A' ' 96' ' ' LEU . 3.3 m-90 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -74.71 0.18 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.957 -1.09 . . . . 0.0 109.248 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 m -69.61 -8.81 50.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.127 -0.983 . . . . 0.0 109.051 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.555 ' HB3' ' HB2' ' A' ' 10' ' ' LEU . 14.2 m-30 -88.55 -34.43 17.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.356 -0.84 . . . . 0.0 109.098 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' A' ' 2' ' ' TRP . 1.0 OUTLIER -60.99 -33.79 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.311 -0.868 . . . . 0.0 108.746 179.565 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -48.83 -89.58 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.484 -0.76 . . . . 0.0 110.504 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 p -133.64 13.36 4.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.068 -1.02 . . . . 0.0 110.556 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 14' ' ' GLY . 16.9 m-20 -96.59 -82.72 0.39 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.965 -1.084 . . . . 0.0 109.123 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 7.9 mp -65.73 -24.18 66.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.927 -1.108 . . . . 0.0 109.322 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 6' ' ' VAL . 3.6 t -85.18 -57.7 4.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -47.65 -35.97 12.1 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.568 ' CB ' ' O ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER 154.93 49.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 122.032 -0.687 . . . . 0.0 110.628 178.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 9' ' ' ASN . . . -94.87 21.08 45.65 Favored Glycine 0 C--N 1.292 -1.898 0 N-CA-C 106.471 -2.652 . . . . 0.0 106.471 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 153.21 -30.96 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 5.6 m -139.34 153.11 23.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.476 ' O ' ' OE1' ' A' ' 18' ' ' GLN . 63.2 p -80.36 12.24 3.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.898 -1.126 . . . . 0.0 109.114 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.525 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -171.86 176.57 3.56 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.482 ' CB ' ' CG2' ' A' ' 11' ' ' VAL . . . -175.05 159.67 2.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.789 -1.194 . . . . 0.0 109.777 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -153.17 122.56 6.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.15 -0.969 . . . . 0.0 110.0 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.53 ' CD1' ' HB2' ' A' ' 2' ' ' TRP . 5.0 mm -81.58 98.47 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.591 ' CD2' ' CG2' ' A' ' 97' ' ' VAL . 5.4 mp -75.99 -79.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.606 -0.684 . . . . 0.0 110.302 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.45 ' HA3' ' CZ3' ' A' ' 29' ' ' TRP . . . 141.04 148.95 5.18 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.536 ' HB3' ' CG1' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -107.51 -16.82 14.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.08 -1.247 . . . . 0.0 109.863 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.11 31.98 0.84 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.064 -1.022 . . . . 0.0 109.843 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.69 -110.94 0.69 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.75 -63.29 0.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.409 -1.053 . . . . 0.0 109.153 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.571 ' O ' ' CE3' ' A' ' 29' ' ' TRP . 0.2 OUTLIER -134.95 -178.06 4.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.91 . . . . 0.0 109.525 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.571 ' CE3' ' O ' ' A' ' 28' ' ' THR . 0.6 OUTLIER -157.3 -54.38 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.871 . . . . 0.0 109.143 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.495 ' O ' HG12 ' A' ' 21' ' ' ILE . . . -173.76 79.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 17.9 p -79.57 166.52 21.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -0.973 . . . . 0.0 110.481 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.44 ' HB2' HG11 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -171.17 54.92 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.418 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . . . -124.24 -166.4 1.5 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.365 -0.835 . . . . 0.0 109.631 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.31 -25.01 14.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.402 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 4.0 p90 -82.81 -175.44 5.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -1.233 . . . . 0.0 109.453 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.535 ' O ' ' CB ' ' A' ' 63' ' ' ALA . . . -141.8 95.87 2.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 109.636 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 t -84.41 66.6 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 109.377 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.704 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 1.2 t -93.04 -26.87 0.28 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.325 -0.86 . . . . 0.0 112.627 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 38' ' ' THR . 6.3 Cg_exo -59.72 -166.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.739 0 C-N-CA 120.774 0.983 . . . . 0.0 110.37 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.22 47.3 1.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HA ' ' OE1' ' A' ' 41' ' ' GLN . 14.0 mm-40 -81.27 -16.6 52.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.069 -1.02 . . . . 0.0 109.124 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.0 -41.54 92.47 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -27.9 65.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -1.209 . . . . 0.0 109.662 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.3 m -63.32 -22.52 66.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.137 -0.977 . . . . 0.0 109.508 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.456 HD21 ' N ' ' A' ' 45' ' ' LEU . 3.0 mm? -82.93 -43.2 16.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 110.289 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.41 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . . . -72.38 -54.93 7.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.044 -1.035 . . . . 0.0 109.913 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 m -55.05 -29.39 57.36 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.229 -0.92 . . . . 0.0 109.291 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.9 90.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.336 -0.853 . . . . 0.0 109.641 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.41 ' CD2' ' HA ' ' A' ' 46' ' ' ALA . 17.3 m-30 -53.4 -21.27 5.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.27 -0.894 . . . . 0.0 109.853 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -80.55 -58.57 3.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.011 . . . . 0.0 109.535 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -126.91 133.35 50.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 109.514 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.434 ' C ' HG12 ' A' ' 55' ' ' ILE . . . -112.1 29.17 8.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 109.45 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.618 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 5.0 t70 -81.77 -45.63 1.06 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 110.62 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.3 Cg_endo -66.32 -6.33 14.66 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 121.524 1.483 . . . . 0.0 110.368 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -103.32 -31.98 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 0.0 109.709 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 69' ' ' THR . 4.3 ptp180 -71.38 -26.75 62.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.013 -1.054 . . . . 0.0 109.515 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.8 -63.16 1.45 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 109.808 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.04 -32.94 5.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 109.459 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 55' ' ' ILE . . . 111.75 -151.03 18.02 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 21.3 p90 -123.12 166.49 15.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -1.096 . . . . 0.0 109.42 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -127.32 151.65 48.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 109.922 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.516 ' O ' ' C ' ' A' ' 63' ' ' ALA . 25.7 mt -123.62 -141.33 0.31 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.327 -0.858 . . . . 0.0 109.464 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 36' ' ' ALA . . . -28.11 -70.81 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.9 -0.5 . . . . 0.0 111.115 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.76 21.6 0.39 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.57 163.77 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.155 -1.203 . . . . 0.0 109.476 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -102.57 155.91 17.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 109.35 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.448 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 64.6 m-85 -141.81 150.32 41.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.258 -0.901 . . . . 0.0 109.324 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 69' ' ' THR . 49.9 t -97.55 161.2 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.747 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 19.8 m -146.22 91.76 2.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 109.18 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.466 ' O ' ' CG ' ' A' ' 71' ' ' ARG . 1.7 tt -109.36 25.92 11.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.226 -0.921 . . . . 0.0 109.599 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.466 ' CG ' ' O ' ' A' ' 70' ' ' LEU . 7.2 mtm180 -158.87 61.17 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.885 . . . . 0.0 109.42 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 73' ' ' ASP . . . -129.91 119.98 24.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.437 -0.79 . . . . 0.0 109.407 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 72' ' ' ALA . 0.7 OUTLIER 169.38 -61.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 109.498 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.48 ' HB3' ' HD2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -56.34 -83.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.167 -0.958 . . . . 0.0 109.328 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.533 ' HG2' ' N ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -148.67 -34.48 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.028 -1.045 . . . . 0.0 110.264 179.754 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 72.3 m -97.28 162.8 13.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.906 -1.122 . . . . 0.0 109.827 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 76' ' ' SER . 3.4 mp -146.77 83.58 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 109.824 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 76' ' ' SER . 1.1 m-85 -92.65 96.14 10.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.007 -1.058 . . . . 0.0 108.718 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.99 174.65 8.62 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.41 85.27 1.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.338 -1.095 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -59.91 178.05 0.2 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.2 -0.937 . . . . 0.0 109.496 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -51.65 -45.0 54.79 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.63 -19.99 3.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -1.172 . . . . 0.0 110.406 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -99.02 167.42 10.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.898 -1.126 . . . . 0.0 109.86 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.51 153.73 23.19 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.464 HG21 HG11 ' A' ' 97' ' ' VAL . 3.9 p -136.34 132.23 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.134 -1.215 . . . . 0.0 109.846 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 67.6 mt -107.5 112.63 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.328 -0.858 . . . . 0.0 109.229 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.455 ' O ' HG11 ' A' ' 89' ' ' VAL . 1.4 p -120.35 117.69 28.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.622 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.529 ' CG2' HD22 ' A' ' 96' ' ' LEU . 18.1 m -144.59 146.66 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 109.532 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -77.22 151.57 35.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.252 -0.905 . . . . 0.0 109.326 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.542 ' O ' ' CB ' ' A' ' 125' ' ' PHE . 25.1 p -147.34 -111.41 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 109.785 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.72 86.41 5.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.772 -1.205 . . . . 0.0 109.88 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.448 ' O ' ' CZ2' ' A' ' 29' ' ' TRP . 0.6 OUTLIER 51.18 21.72 1.15 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.331 -0.855 . . . . 0.0 109.464 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.493 ' N ' HD22 ' A' ' 24' ' ' LEU . 4.9 t -157.32 147.61 20.95 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.374 -0.829 . . . . 0.0 109.377 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.536 ' CG1' ' HB3' ' A' ' 24' ' ' LEU . 11.0 mt -109.1 154.2 10.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.395 -0.816 . . . . 0.0 109.071 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.597 HD13 ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -114.59 150.81 34.46 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.028 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.591 ' CG2' ' CD2' ' A' ' 22' ' ' LEU . 54.9 t -129.68 77.31 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.291 -0.881 . . . . 0.0 110.159 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.03 143.77 45.44 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -143.15 118.33 4.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.691 -1.476 . . . . 0.0 109.853 -179.078 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.582 ' CE1' ' O ' ' A' ' 104' ' ' ILE . 35.1 p90 -131.89 166.0 22.62 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 103' ' ' LYS . 46.7 t30 -150.31 133.33 16.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.871 -1.143 . . . . 0.0 110.864 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 101' ' ' ASN . 0.0 OUTLIER 38.39 29.74 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.634 179.289 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 101' ' ' ASN . 5.6 mmtp -136.19 -51.31 0.71 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.246 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.582 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 1.7 mp -112.35 75.68 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.127 -0.983 . . . . 0.0 109.841 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.451 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 9.6 mt-30 -54.8 158.1 4.83 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.077 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 105' ' ' GLN . 2.9 Cg_endo -60.03 143.52 99.56 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.088 1.859 . . . . 0.0 110.403 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.16 -22.49 6.7 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.6 m -114.93 -52.87 2.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.125 -1.221 . . . . 0.0 109.499 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -72.37 -29.46 63.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 109.527 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -71.43 -21.82 61.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.572 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -90.08 -50.72 5.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.195 -0.94 . . . . 0.0 109.674 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.05 -38.18 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 109.683 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.413 HG22 HD11 ' A' ' 87' ' ' ILE . 44.8 t -72.72 -31.14 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.133 -0.98 . . . . 0.0 109.601 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 110' ' ' ALA . 6.6 tt0 -65.91 -42.33 90.31 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.171 -0.956 . . . . 0.0 109.824 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -75.87 -36.52 59.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -0.968 . . . . 0.0 109.875 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.463 HD21 ' CZ2' ' A' ' 2' ' ' TRP . 17.1 tp -60.0 -62.52 1.81 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.091 -1.006 . . . . 0.0 108.797 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.536 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -60.36 -21.53 62.23 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.27 -0.894 . . . . 0.0 109.284 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.438 ' HB2' ' HA ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -58.07 -52.0 67.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.281 -0.887 . . . . 0.0 109.539 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -59.27 -29.38 67.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.201 -0.937 . . . . 0.0 108.982 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.4 HD11 ' HB ' ' A' ' 91' ' ' THR . 4.3 mt -80.0 -22.9 41.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 110.025 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.536 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 1.3 mp -87.45 -16.08 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.096 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.15 -27.62 15.65 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -81.78 -71.71 0.47 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.363 -1.081 . . . . 0.0 109.367 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 144.9 94.0 0.17 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.542 ' CB ' ' O ' ' A' ' 91' ' ' THR . 22.6 m-85 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.131 -1.217 . . . . 0.0 109.362 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.536 ' HB2' ' CD1' ' A' ' 120' ' ' LEU . 11.5 t . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.273 0.559 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.57 ' CE2' HD11 ' A' ' 96' ' ' LEU . 1.7 m-90 -75.02 -1.5 23.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 0.0 109.383 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.49 -67.31 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.072 -1.018 . . . . 0.0 109.568 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.503 ' O ' HG23 ' A' ' 8' ' ' THR . 1.8 m -65.81 -30.85 71.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.532 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.534 ' CB ' HD13 ' A' ' 10' ' ' LEU . 6.6 m-30 -81.73 -3.08 52.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.12 -0.987 . . . . 0.0 109.456 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.531 ' HA ' ' CG2' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -83.19 -41.05 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.983 -1.073 . . . . 0.0 108.794 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -90.46 48.29 1.53 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.378 -0.827 . . . . 0.0 111.117 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -165.85 -96.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.708 -1.245 . . . . 0.0 110.792 179.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -101.46 -68.97 0.8 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.982 -1.073 . . . . 0.0 110.925 -178.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.534 HD13 ' CB ' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -23.05 -43.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.561 ' N ' ' O ' ' A' ' 9' ' ' ASN . 48.9 t -91.94 -55.5 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.725 -1.235 . . . . 0.0 110.815 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.491 ' C ' ' CG2' ' A' ' 13' ' ' THR . . . -40.03 -47.78 3.39 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.525 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER 163.62 41.28 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.709 -0.877 . . . . 0.0 108.792 178.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -87.19 22.2 16.57 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 153.97 -34.1 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -134.46 137.94 50.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.509 ' C ' ' CG ' ' A' ' 18' ' ' GLN . 69.2 p -78.21 2.39 18.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.955 -1.091 . . . . 0.0 108.869 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.509 ' CG ' ' C ' ' A' ' 17' ' ' THR . 6.4 mt-30 -161.83 151.11 15.99 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.488 ' CB ' HG23 ' A' ' 11' ' ' VAL . . . -163.47 147.97 10.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.967 -1.083 . . . . 0.0 109.973 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -141.81 152.03 43.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.429 -0.795 . . . . 0.0 108.974 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.484 HD13 ' C ' ' A' ' 2' ' ' TRP . 7.0 mt -120.88 103.22 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.949 . . . . 0.0 109.669 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.48 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -136.55 164.23 28.67 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.578 ' O ' ' CH2' ' A' ' 29' ' ' TRP . . . 132.64 172.79 13.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.504 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.4 mp 60.78 121.0 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.148 0 O-C-N 121.159 -1.2 . . . . 0.0 108.377 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -78.03 39.3 0.3 Allowed 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.806 -0.559 . . . . 0.0 111.448 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -105.98 -32.62 3.74 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER 162.79 -172.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.621 -0.929 . . . . 0.0 109.167 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.45 ' O ' ' CD1' ' A' ' 29' ' ' TRP . 1.3 m -98.56 -174.49 2.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.091 -1.006 . . . . 0.0 108.536 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.625 ' CH2' ' HA ' ' A' ' 94' ' ' SER . 3.8 m-90 -142.8 -54.67 0.41 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.013 -1.055 . . . . 0.0 109.993 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' A' ' 29' ' ' TRP . . . -177.0 134.87 0.2 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.536 -1.266 . . . . 0.0 110.464 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 1.4 t -135.1 157.41 46.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.573 -0.705 . . . . 0.0 109.113 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.474 ' CB ' HG12 ' A' ' 11' ' ' VAL . 13.9 m -159.88 100.59 1.43 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.608 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.523 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . . . -169.81 -164.4 0.43 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 109.161 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -118.13 35.34 4.07 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.523 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 10.7 p90 -141.59 124.3 16.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 109.48 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 63' ' ' ALA . . . -94.0 116.03 28.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.438 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.484 ' CG2' ' CE2' ' A' ' 35' ' ' PHE . 3.5 t -81.78 143.77 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.778 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.535 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 11.2 p -51.05 160.61 0.82 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 0.0 109.444 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 3.9 Cg_exo -59.54 -18.84 49.15 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.128 1.885 . . . . 0.0 110.425 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.4 ' O ' ' OG1' ' A' ' 44' ' ' THR . . . -89.17 50.14 1.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.0 109.536 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.535 ' CG ' ' O ' ' A' ' 38' ' ' THR . 36.5 mt-30 -78.36 -55.15 5.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.103 -0.998 . . . . 0.0 109.805 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.94 -17.39 78.49 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -89.66 -18.21 26.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -1.191 . . . . 0.0 109.478 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 40' ' ' ALA . 53.4 m -89.68 -26.01 20.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.883 . . . . 0.0 109.576 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.9 mt -81.65 -46.53 14.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.81 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.42 87.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.129 -0.982 . . . . 0.0 109.459 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 m -77.56 -39.3 46.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.93 . . . . 0.0 109.421 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.75 -29.86 63.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.322 -0.861 . . . . 0.0 109.25 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -87.31 64.55 8.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 109.446 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.1 -69.51 0.77 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 109.227 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.428 ' CG ' ' O ' ' A' ' 51' ' ' ASN . 19.1 t-20 -138.98 33.35 2.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.0 109.069 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 56' ' ' ARG . . . 49.06 22.42 0.6 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.573 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.571 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -88.51 -57.41 0.28 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.636 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.571 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 1.1 Cg_endo -65.62 -41.35 15.08 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.886 1.724 . . . . 0.0 111.005 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.449 ' O ' ' HA2' ' A' ' 59' ' ' GLY . 0.2 OUTLIER -75.56 -37.2 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.168 -0.957 . . . . 0.0 109.797 -179.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -69.01 -66.94 0.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.0 109.899 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.546 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -77.03 126.03 30.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.107 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 3.5 t 82.52 -42.72 0.13 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.741 -0.599 . . . . 0.0 110.17 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 55' ' ' ILE . . . 95.48 -171.59 29.43 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -126.08 164.02 21.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -1.193 . . . . 0.0 109.55 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 66' ' ' HIS . 54.0 m-20 -128.55 162.51 27.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.881 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.4 mt -137.0 -147.2 0.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.137 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 36' ' ' ALA . . . -53.78 -54.51 37.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.103 -0.998 . . . . 0.0 109.633 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.75 20.23 0.69 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.491 HG13 ' CE1' ' A' ' 67' ' ' TYR . 71.9 t -135.88 149.0 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -1.188 . . . . 0.0 109.36 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.445 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 13.6 p-80 -153.55 160.18 42.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.1 -1.0 . . . . 0.0 109.837 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.567 ' CE1' HG13 ' A' ' 86' ' ' VAL . 52.1 m-85 -139.83 178.47 7.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.355 -0.84 . . . . 0.0 109.481 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.482 ' O ' ' HB ' ' A' ' 69' ' ' THR . 6.0 p -92.03 -29.3 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.212 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 68' ' ' VAL . 98.8 m 63.85 109.08 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.554 -0.716 . . . . 0.0 109.484 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.6 mt -89.91 -67.65 0.83 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.871 . . . . 0.0 109.503 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.37 137.2 50.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.839 . . . . 0.0 109.298 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 73' ' ' ASP . . . -159.07 91.6 1.04 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 109.527 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 46.7 t0 178.08 -31.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 109.624 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.471 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -66.25 -93.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.145 -0.972 . . . . 0.0 109.401 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -138.56 -53.86 0.61 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.07 -1.019 . . . . 0.0 109.725 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 20.3 m -90.03 162.76 15.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.0 109.419 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 76' ' ' SER . 4.1 mp -152.9 84.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.177 -0.952 . . . . 0.0 110.246 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 76' ' ' SER . 0.0 OUTLIER -98.99 98.86 9.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.974 -1.079 . . . . 0.0 108.207 178.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.55 166.56 43.68 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.672 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.17 165.56 32.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.97 . . . . 0.0 108.921 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.404 ' HB3' ' HA ' ' A' ' 67' ' ' TYR . 10.3 ptmt -130.48 -9.26 4.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.954 -1.091 . . . . 0.0 110.403 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.28 -23.36 9.83 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.94 -60.41 1.29 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -1.122 . . . . 0.0 108.945 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -99.82 -169.73 1.79 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 108.86 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.532 ' O ' ' CE1' ' A' ' 100' ' ' TYR . . . -166.94 152.79 21.94 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.567 HG13 ' CE1' ' A' ' 67' ' ' TYR . 14.5 p -135.29 104.07 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -1.097 . . . . 0.0 108.971 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.5 ' CD1' ' HB2' ' A' ' 109' ' ' ALA . 2.0 mt -79.56 107.6 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 109.7 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 46.8 p -111.71 98.89 7.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.305 -0.872 . . . . 0.0 109.346 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.523 HG21 ' CG ' ' A' ' 96' ' ' LEU . 11.4 m -125.75 161.83 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.369 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.66 153.79 17.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 109.659 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.58 ' O ' ' CD1' ' A' ' 125' ' ' PHE . 0.6 OUTLIER -147.09 -92.51 0.09 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.289 -0.882 . . . . 0.0 109.209 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.459 ' HB3' HD23 ' A' ' 120' ' ' LEU . 7.9 p -98.46 66.1 1.69 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 109.102 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.474 ' O ' ' CD1' ' A' ' 24' ' ' LEU . 6.9 mtmt 64.74 27.74 13.03 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.32 -0.862 . . . . 0.0 108.994 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.625 ' HA ' ' CH2' ' A' ' 29' ' ' TRP . 77.7 p -146.73 148.61 32.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.9 . . . . 0.0 109.947 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.556 ' CD1' ' HA3' ' A' ' 23' ' ' GLY . 1.1 mt -105.93 94.61 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 109.531 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.57 HD11 ' CE2' ' A' ' 2' ' ' TRP . 0.3 OUTLIER -56.15 155.12 6.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.966 -1.084 . . . . 0.0 108.6 179.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.513 HG12 ' CG2' ' A' ' 86' ' ' VAL . 73.2 t -135.08 84.61 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.134 -0.979 . . . . 0.0 109.887 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -65.71 92.47 0.16 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -91.72 108.48 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.343 -1.092 . . . . 0.0 108.404 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.536 ' HB3' ' CG1' ' A' ' 16' ' ' VAL . 5.5 p90 -131.31 172.42 12.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.059 -1.026 . . . . 0.0 110.322 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.475 ' OD1' ' HB2' ' A' ' 103' ' ' LYS . 9.0 p30 -102.81 -166.51 1.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.608 -0.682 . . . . 0.0 109.619 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -69.57 -20.44 63.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.892 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.475 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 9.9 mttm -52.95 -41.02 64.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.006 . . . . 0.0 109.468 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 15' ' ' ALA . 1.4 mp -91.61 137.59 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.137 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.19 149.34 65.82 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.544 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.86 -8.03 14.73 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.324 2.016 . . . . 0.0 110.628 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -102.95 -39.54 2.66 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -28.18 69.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.113 -1.228 . . . . 0.0 109.893 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.5 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . . . -87.42 -34.9 18.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.116 -0.99 . . . . 0.0 109.677 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.21 -20.43 62.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.738 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.37 -42.28 25.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 109.704 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.44 -37.26 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.771 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.4 t -74.12 -14.02 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.551 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.25 -34.28 22.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.941 . . . . 0.0 109.603 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -77.74 -51.62 10.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.151 -0.968 . . . . 0.0 109.473 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.522 HD22 ' CD2' ' A' ' 5' ' ' TYR . 1.1 mp -51.41 -48.1 62.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 108.818 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.57 ' O ' HG12 ' A' ' 121' ' ' ILE . . . -62.34 -47.95 81.96 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.123 -0.986 . . . . 0.0 108.413 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.515 ' CA ' HG12 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -38.52 -29.64 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.405 0.621 . . . . 0.0 109.685 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 117' ' ' ALA . 14.9 m-30 -74.28 -49.59 22.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.305 -0.872 . . . . 0.0 109.317 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.536 ' CD1' ' HB2' ' A' ' 1' ' ' SER . 0.7 OUTLIER -80.81 -3.17 50.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.864 . . . . 0.0 111.841 -178.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.57 HG12 ' O ' ' A' ' 117' ' ' ALA . 2.1 mm -77.22 -38.47 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.256 -1.527 . . . . 0.0 108.994 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 121' ' ' ILE . . . -41.32 -38.56 2.0 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -84.57 -59.59 2.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -1.102 . . . . 0.0 109.145 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.38 106.32 1.62 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.607 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 1.8 m-85 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.128 -1.219 . . . . 0.0 109.397 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.609 ' O ' ' CD2' ' A' ' 2' ' ' TRP . 31.5 m . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.609 ' CD2' ' O ' ' A' ' 1' ' ' SER . 6.4 m95 -152.66 140.24 19.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.171 -0.956 . . . . 0.0 109.025 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -32.57 -82.21 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.798 -0.564 . . . . 0.0 111.536 -178.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.462 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.6 OUTLIER -64.01 -34.61 78.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.065 -1.022 . . . . 0.0 110.87 -178.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 1.1 m-30 -76.62 3.23 11.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.75 -1.219 . . . . 0.0 109.801 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.577 ' HA ' ' CG2' ' A' ' 11' ' ' VAL . 1.1 t -92.82 -46.45 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.406 ' O ' HG21 ' A' ' 8' ' ' THR . 0.9 OUTLIER -91.37 53.57 2.33 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.285 -0.884 . . . . 0.0 110.257 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -171.11 -92.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.738 -1.226 . . . . 0.0 111.687 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 11' ' ' VAL . 3.6 m120 -101.21 -88.34 0.37 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.065 -1.022 . . . . 0.0 112.181 -177.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.536 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -21.13 -44.26 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -177.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.577 ' CG2' ' HA ' ' A' ' 6' ' ' VAL . 41.0 t -94.37 -41.84 12.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.696 -1.252 . . . . 0.0 110.337 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.532 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -45.53 -41.04 8.92 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.532 ' CB ' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 157.83 37.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.681 0.753 . . . . 0.0 109.425 178.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -85.19 19.84 20.18 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 158.92 -25.63 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 13' ' ' THR . 10.8 m -141.11 134.01 30.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.539 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 17.5 p -80.08 10.2 4.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 109.367 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.539 ' CG ' ' O ' ' A' ' 17' ' ' THR . 88.2 mt-30 -162.45 166.31 25.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.432 -0.792 . . . . 0.0 108.931 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.557 ' CB ' HG21 ' A' ' 11' ' ' VAL . . . 179.54 166.48 1.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 110.088 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.472 ' O ' HD22 ' A' ' 22' ' ' LEU . . . -165.03 126.18 2.02 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.488 -0.758 . . . . 0.0 109.324 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.523 ' HA ' ' HA ' ' A' ' 96' ' ' LEU . 2.8 mt -91.01 108.27 19.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.229 -0.919 . . . . 0.0 108.591 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.544 HD22 ' N ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -94.51 101.21 13.1 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.276 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -42.83 169.33 0.01 OUTLIER Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' A' ' 94' ' ' SER . 1.4 pp -119.9 -17.66 8.42 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.415 -1.05 . . . . 0.0 109.428 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.97 -4.69 7.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.394 -0.816 . . . . 0.0 109.437 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.28 -90.85 1.42 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -171.69 -45.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.346 -1.091 . . . . 0.0 109.722 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.7 m -166.16 129.88 2.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.859 . . . . 0.0 109.242 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.558 ' CD2' ' OG ' ' A' ' 94' ' ' SER . 14.8 m0 -96.75 -45.45 6.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.6 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.4 171.4 19.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 109.453 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -160.88 174.77 13.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.597 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.562 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -161.44 135.16 6.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.902 . . . . 0.0 109.581 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 32' ' ' SER . . . 87.12 -16.64 0.38 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . 127.41 -90.25 0.35 Allowed Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.09 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.468 ' CE2' HG23 ' A' ' 99' ' ' VAL . 0.3 OUTLIER 61.49 126.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -1.097 . . . . 0.0 109.105 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' A' ' 63' ' ' ALA . . . -136.7 95.34 3.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 109.849 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.464 ' HB ' ' HG2' ' A' ' 41' ' ' GLN . 3.4 t -105.26 92.34 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.26 -0.9 . . . . 0.0 108.953 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.62 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -93.28 -38.84 0.33 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.513 -0.742 . . . . 0.0 112.684 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 38' ' ' THR . 6.5 Cg_exo -54.91 -73.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.403 1.402 . . . . 0.0 111.806 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.447 ' HB2' ' OG1' ' A' ' 44' ' ' THR . . . -154.0 81.17 1.14 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.826 -1.171 . . . . 0.0 110.111 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.464 ' HG2' ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -75.53 -63.31 1.32 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.264 -1.522 . . . . 0.0 108.659 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -91.79 -7.85 64.19 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.4 -43.27 21.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -1.103 . . . . 0.0 109.457 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.447 ' OG1' ' HB2' ' A' ' 40' ' ' ALA . 17.3 m -76.31 -51.23 12.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 109.56 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.467 HD21 ' CE1' ' A' ' 49' ' ' PHE . 27.0 mt -58.35 -27.74 64.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.509 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -67.45 -42.83 82.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.802 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.9 t -91.42 -3.12 56.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.614 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.91 -14.27 37.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.632 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.467 ' CE1' HD21 ' A' ' 45' ' ' LEU . 18.1 m-30 -87.18 3.18 47.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 109.877 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.58 -41.4 15.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.051 -1.031 . . . . 0.0 109.251 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.465 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -151.46 146.13 25.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -0.872 . . . . 0.0 109.313 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 56' ' ' ARG . . . -89.6 28.97 1.2 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.886 . . . . 0.0 109.901 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.614 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -85.44 -44.66 0.64 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.029 -1.044 . . . . 0.0 110.587 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.2 Cg_endo -68.45 -74.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 121.617 1.545 . . . . 0.0 110.522 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.44 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 0.8 OUTLIER -41.87 -46.04 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.39 -0.818 . . . . 0.0 109.982 -179.449 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 3.1 ttt180 -45.47 -55.04 6.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 109.653 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 58' ' ' SER . . . -86.18 -91.83 0.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.836 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 57' ' ' ALA . 2.9 t -43.41 -76.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.195 -0.94 . . . . 0.0 109.758 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 55' ' ' ILE . . . 121.61 -133.71 9.61 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.643 ' CD1' ' N ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -144.24 153.58 42.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.077 -1.249 . . . . 0.0 109.541 179.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -95.21 128.67 42.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 110.094 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.59 HD22 ' CD2' ' A' ' 60' ' ' PHE . 4.0 mm? -107.59 57.35 0.63 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.499 ' CB ' ' O ' ' A' ' 36' ' ' ALA . . . 50.71 26.79 2.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.476 -0.765 . . . . 0.0 109.42 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.39 -97.01 0.12 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.771 -1.204 . . . . 0.0 110.242 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.9 t -112.76 170.46 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.183 -1.186 . . . . 0.0 110.012 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -85.29 132.7 34.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.736 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.581 ' CE1' ' HA ' ' A' ' 81' ' ' LYS . 25.3 m-85 -107.84 168.89 8.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.039 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 t -109.59 174.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.111 -0.993 . . . . 0.0 110.027 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.8 135.44 54.01 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.433 -0.792 . . . . 0.0 109.323 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.474 ' HB3' ' HD2' ' A' ' 71' ' ' ARG . 11.5 tp -89.94 -55.9 3.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.156 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.551 ' HG2' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -137.23 75.77 1.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 109.048 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 73' ' ' ASP . . . -101.83 81.68 2.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.89 . . . . 0.0 109.549 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 24.9 t70 178.02 -41.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.62 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.43 -81.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 109.806 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.69 -48.81 0.26 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.166 -0.959 . . . . 0.0 109.618 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.647 ' CB ' ' CZ ' ' A' ' 78' ' ' TYR . 0.7 OUTLIER -90.6 -170.51 2.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -0.941 . . . . 0.0 109.726 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.5 ' CG1' ' C ' ' A' ' 76' ' ' SER . 0.1 OUTLIER -163.13 63.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.1 -1.0 . . . . 0.0 110.05 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.647 ' CZ ' ' CB ' ' A' ' 76' ' ' SER . 0.1 OUTLIER -92.14 115.3 27.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.905 -1.122 . . . . 0.0 109.04 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.414 ' C ' HG11 ' A' ' 86' ' ' VAL . . . -96.69 -158.33 31.45 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.25 158.79 34.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -1.191 . . . . 0.0 109.614 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.581 ' HA ' ' CE1' ' A' ' 67' ' ' TYR . 2.1 mtpt -123.92 -178.55 4.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.245 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.18 106.09 1.32 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 55.66 20.47 3.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.153 -1.204 . . . . 0.0 108.9 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.487 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . . . -136.18 -164.15 1.51 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 109.309 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.576 ' HA3' ' CE2' ' A' ' 100' ' ' TYR . . . -147.57 131.05 3.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.414 HG11 ' C ' ' A' ' 79' ' ' GLY . 2.5 p -104.51 131.49 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.215 -1.168 . . . . 0.0 109.43 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.521 ' CD1' ' HB3' ' A' ' 78' ' ' TYR . 47.3 mm -115.14 101.68 12.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.263 -0.898 . . . . 0.0 109.208 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.485 HG23 HG12 ' A' ' 97' ' ' VAL . 7.8 p -117.46 146.16 43.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.071 -1.018 . . . . 0.0 109.603 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.1 t -146.95 141.89 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.768 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -91.3 124.2 35.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.426 -0.796 . . . . 0.0 108.946 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.458 HG23 ' CG1' ' A' ' 121' ' ' ILE . 0.1 OUTLIER -103.25 -60.19 1.59 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.128 -0.982 . . . . 0.0 109.73 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -168.47 -66.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 0.0 109.437 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.65 15.85 11.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.182 -0.949 . . . . 0.0 109.473 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.558 ' OG ' ' CD2' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -154.36 154.44 33.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.169 -0.957 . . . . 0.0 110.014 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.509 ' CD1' ' HB3' ' A' ' 24' ' ' LEU . 54.6 mt -125.61 138.37 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.636 ' CD1' ' N ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -112.29 166.43 11.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.975 -1.078 . . . . 0.0 109.956 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.512 HG23 ' CD1' ' A' ' 22' ' ' LEU . 3.2 t -146.9 77.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -0.917 . . . . 0.0 111.21 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.37 107.09 1.66 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 107.28 -2.328 . . . . 0.0 107.28 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 97' ' ' VAL . 0.2 OUTLIER -115.47 142.55 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.884 -1.363 . . . . 0.0 110.414 -178.102 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.576 ' CE2' ' HA3' ' A' ' 85' ' ' GLY . 16.4 p90 -129.13 171.14 12.7 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.487 ' HA ' ' HB3' ' A' ' 84' ' ' ALA . 5.9 p30 -150.2 115.2 5.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.676 -1.265 . . . . 0.0 111.183 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.48 ' CG ' ' O ' ' A' ' 101' ' ' ASN . 22.1 pt-20 39.06 31.4 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.518 0.675 . . . . 0.0 109.374 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 101' ' ' ASN . 0.0 OUTLIER -133.18 -25.68 1.75 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.693 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.493 HG23 ' O ' ' A' ' 15' ' ' ALA . 1.8 mp -137.79 149.57 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.847 -1.158 . . . . 0.0 110.028 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -99.72 145.0 29.39 Favored Pre-proline 0 C--N 1.307 -1.246 0 O-C-N 121.48 -0.762 . . . . 0.0 109.202 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.35 177.11 3.43 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.088 1.859 . . . . 0.0 110.103 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.35 -0.16 75.97 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 65.1 m -127.06 -45.24 1.57 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.113 -1.227 . . . . 0.0 109.582 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -80.1 -40.76 26.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 109.569 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.72 -17.02 7.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.329 -0.857 . . . . 0.0 109.757 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -78.09 -45.71 22.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.717 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.501 HG11 ' N ' ' A' ' 113' ' ' VAL . 11.1 p -71.54 -22.76 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.949 . . . . 0.0 109.857 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.501 ' N ' HG11 ' A' ' 112' ' ' VAL . 6.0 t -71.26 -33.54 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.056 -1.027 . . . . 0.0 109.598 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.417 ' O ' ' OE1' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -80.13 -17.04 53.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.138 -0.976 . . . . 0.0 109.894 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.556 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -86.11 -59.2 2.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.965 . . . . 0.0 109.692 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.536 ' HG ' ' CD1' ' A' ' 10' ' ' LEU . 2.1 mm? -48.43 -35.85 13.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.095 -1.003 . . . . 0.0 109.308 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.455 ' HA ' ' HG ' ' A' ' 120' ' ' LEU . . . -68.8 -39.13 80.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.966 . . . . 0.0 109.478 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.62 -33.92 48.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 109.561 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.556 ' CD1' ' O ' ' A' ' 115' ' ' LYS . 32.8 m-85 -74.76 -58.6 3.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.083 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.507 HD22 ' CE3' ' A' ' 2' ' ' TRP . 4.5 pp -72.27 2.35 6.17 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.445 -0.785 . . . . 0.0 110.417 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.483 HG13 HD13 ' A' ' 120' ' ' LEU . 5.1 mt -88.96 -23.73 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 108.862 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.08 -30.18 53.79 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -92.77 -75.4 0.49 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.377 -1.073 . . . . 0.0 109.461 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 125' ' ' PHE . . . 132.35 36.77 0.29 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 124' ' ' GLY . 16.0 m-85 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.375 -1.074 . . . . 0.0 109.518 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.554 ' CB ' ' HB3' ' A' ' 96' ' ' LEU . 82.1 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.583 ' CH2' HD22 ' A' ' 96' ' ' LEU . 7.6 m95 61.69 154.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.924 . . . . 0.0 108.998 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -67.13 -80.75 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.13 -0.981 . . . . 0.0 111.366 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.475 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 0.8 OUTLIER -54.6 -22.93 14.83 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.097 -1.002 . . . . 0.0 111.094 -178.373 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 1.9 m-30 -87.58 -25.08 23.79 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.65 -1.281 . . . . 0.0 109.869 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.571 ' HA ' ' CG2' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -63.87 -26.69 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 108.923 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.515 ' OD2' ' CG2' ' A' ' 8' ' ' THR . 1.0 OUTLIER -52.85 -52.58 56.67 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.449 -0.782 . . . . 0.0 111.966 -177.647 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.515 ' CG2' ' OD2' ' A' ' 7' ' ' ASP . 5.0 t -163.38 -27.72 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.531 -1.356 . . . . 0.0 111.116 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 14' ' ' GLY . 1.7 m-80 -64.82 -88.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.656 -1.277 . . . . 0.0 109.764 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -59.94 -23.65 63.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.202 -0.936 . . . . 0.0 110.295 -179.379 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.571 ' CG2' ' HA ' ' A' ' 6' ' ' VAL . 1.5 t -89.21 -60.32 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.868 -1.145 . . . . 0.0 108.999 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -43.67 -36.89 3.62 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.541 ' CB ' ' O ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER 158.49 46.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.948 -0.736 . . . . 0.0 110.105 178.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -92.41 23.19 28.85 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 106.294 -2.723 . . . . 0.0 106.294 177.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 154.0 -28.98 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.526 ' HA ' ' CD1' ' A' ' 104' ' ' ILE . 17.6 m -148.59 139.42 17.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.507 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 8.1 t -79.32 6.3 10.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.979 -1.076 . . . . 0.0 109.11 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.507 ' CG ' ' O ' ' A' ' 17' ' ' THR . 45.9 mt-30 -160.6 155.63 24.41 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.481 ' HA ' HG22 ' A' ' 99' ' ' VAL . . . -168.81 175.9 5.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.019 -1.051 . . . . 0.0 110.286 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -165.2 114.09 1.04 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.55 -0.719 . . . . 0.0 109.181 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.564 HD12 ' CA ' ' A' ' 2' ' ' TRP . 24.8 mt -79.65 80.74 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 120.999 -1.063 . . . . 0.0 108.851 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.547 ' CD1' HG23 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -60.33 -150.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.465 -0.772 . . . . 0.0 108.936 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.61 134.63 4.01 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.465 HD21 HG13 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -80.57 4.71 17.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -1.153 . . . . 0.0 109.561 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.12 -13.8 12.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.567 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . 96.26 81.63 1.58 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.551 ' O ' ' C ' ' A' ' 28' ' ' THR . 1.0 OUTLIER 167.8 55.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -1.146 . . . . 0.0 109.442 -179.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.551 ' C ' ' O ' ' A' ' 27' ' ' ASN . 21.2 m -20.55 130.36 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.37 0.605 . . . . 0.0 111.325 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.561 ' CE3' ' OG ' ' A' ' 94' ' ' SER . 22.2 m0 -88.68 -45.34 9.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.447 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.01 164.53 18.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.939 . . . . 0.0 109.853 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 3.2 t -157.92 177.47 11.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.413 -0.805 . . . . 0.0 108.879 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.505 ' OG ' HG11 ' A' ' 6' ' ' VAL . 15.3 m -167.13 117.26 0.87 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.112 -0.992 . . . . 0.0 110.375 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 32' ' ' SER . . . 34.32 90.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.164 0.507 . . . . 0.0 110.53 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.33 -84.32 0.05 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 3.3 p90 -172.74 159.58 4.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -1.067 . . . . 0.0 109.352 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.77 116.2 28.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.291 -0.881 . . . . 0.0 108.757 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 91.6 t -79.62 108.37 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.147 -0.971 . . . . 0.0 109.582 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.516 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 9.1 m -48.22 139.35 10.26 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.341 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 40' ' ' ALA . 1.8 Cg_endo -63.92 167.7 13.47 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.13 1.887 . . . . 0.0 110.376 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 39' ' ' PRO . . . 82.36 -41.45 0.12 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.649 -0.657 . . . . 0.0 110.293 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -69.29 -31.22 69.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.044 -1.035 . . . . 0.0 109.745 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.31 -38.71 50.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -63.41 -35.7 81.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.175 -1.191 . . . . 0.0 109.923 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.0 m -56.53 -37.28 70.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -0.918 . . . . 0.0 109.791 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.88 -39.5 93.64 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.216 -0.927 . . . . 0.0 109.806 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.4 -26.01 63.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 109.975 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.4 t -88.22 -18.12 29.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.131 -0.98 . . . . 0.0 109.778 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.469 ' HB3' HD13 ' A' ' 55' ' ' ILE . . . -73.18 -30.63 63.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.965 . . . . 0.0 109.571 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -54.9 -47.23 74.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 109.926 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 51' ' ' ASN . 13.7 p30 -79.7 -46.8 16.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.001 -1.062 . . . . 0.0 109.444 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 3.2 t30 -107.58 111.83 24.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 108.855 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.486 ' HA ' HG12 ' A' ' 55' ' ' ILE . . . -108.72 30.67 6.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 109.865 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.547 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -72.19 -55.39 5.01 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.124 -0.985 . . . . 0.0 109.739 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 2.1 Cg_endo -62.47 -11.58 23.73 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.021 1.814 . . . . 0.0 110.344 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -109.7 -17.61 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.156 -0.965 . . . . 0.0 109.185 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 7.2 ttt180 -89.48 -18.43 26.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.172 -0.955 . . . . 0.0 109.551 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.91 43.47 1.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.424 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.35 61.78 2.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.396 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -137.25 60.31 0.61 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.526 ' O ' ' CB ' ' A' ' 67' ' ' TYR . 1.0 OUTLIER -109.21 93.35 4.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -1.172 . . . . 0.0 108.904 179.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -135.43 127.11 29.05 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.384 -0.822 . . . . 0.0 109.722 -179.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 64' ' ' GLY . 1.4 mm? -95.84 -166.38 1.43 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.397 -0.815 . . . . 0.0 109.248 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.438 ' O ' HG21 ' A' ' 65' ' ' VAL . . . -51.97 91.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.185 -0.947 . . . . 0.0 109.067 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 62' ' ' LEU . . . 61.4 52.02 54.17 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 61' ' ' ASP . 2.9 t -141.04 119.44 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.292 -1.122 . . . . 0.0 109.571 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.43 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 34.9 m170 -79.69 124.89 28.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.338 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.526 ' CB ' ' O ' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -149.99 166.43 29.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.11 -0.994 . . . . 0.0 109.934 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.507 ' O ' ' CB ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -115.84 -176.93 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.81 . . . . 0.0 109.016 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.524 ' CB ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -133.64 109.73 9.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.096 -1.002 . . . . 0.0 109.606 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mp -101.72 -25.26 13.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.342 -0.849 . . . . 0.0 109.166 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.441 ' NH2' ' OD2' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -149.38 117.22 6.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.415 -0.803 . . . . 0.0 109.193 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' A' ' 77' ' ' ILE . . . -160.5 74.84 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.087 -1.008 . . . . 0.0 109.847 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 30.0 t70 179.26 -36.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.46 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.441 ' OD2' ' NH2' ' A' ' 71' ' ' ARG . 3.2 m-20 -74.84 -84.63 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.216 -0.927 . . . . 0.0 110.045 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -137.18 -62.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.994 -1.066 . . . . 0.0 110.288 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.639 ' CB ' ' CZ ' ' A' ' 78' ' ' TYR . 0.7 OUTLIER -90.08 163.79 14.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.384 -0.823 . . . . 0.0 110.495 -178.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.484 HG12 ' HA ' ' A' ' 72' ' ' ALA . 3.0 mt -143.41 70.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.607 -0.683 . . . . 0.0 109.329 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.639 ' CZ ' ' CB ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -88.98 103.8 16.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.713 -1.242 . . . . 0.0 108.928 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.47 169.3 33.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -148.77 147.89 29.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -1.102 . . . . 0.0 109.328 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.16 -30.39 1.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.877 . . . . 0.0 109.845 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 123.35 -66.98 0.5 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.507 ' CB ' ' OE2' ' A' ' 102' ' ' GLU . 1.1 p -87.23 -18.8 29.45 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.372 -1.075 . . . . 0.0 108.444 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.31 166.34 27.41 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -160.69 163.95 34.37 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.54 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 9.8 p -129.91 104.8 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -1.113 . . . . 0.0 109.471 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.462 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 4.1 mt -80.48 94.42 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.087 -1.008 . . . . 0.0 109.013 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 2.7 p -101.86 106.01 16.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 110.16 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.434 ' HB ' HD21 ' A' ' 96' ' ' LEU . 25.5 t -116.89 149.31 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 108.895 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.488 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 29.4 mtpt -86.1 151.99 23.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 110.048 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.59 ' CG2' ' CD2' ' A' ' 96' ' ' LEU . 2.3 p -145.57 -159.74 1.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.85 . . . . 0.0 109.075 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.406 ' C ' ' HD3' ' A' ' 93' ' ' LYS . 16.2 t -69.07 85.34 0.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.446 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER 62.17 14.79 6.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.206 -0.934 . . . . 0.0 109.427 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.561 ' OG ' ' CE3' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -128.64 151.61 49.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.485 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 21' ' ' ILE . 48.8 mt -127.52 123.42 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.952 . . . . 0.0 109.417 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.59 ' CD2' ' CG2' ' A' ' 91' ' ' THR . 0.1 OUTLIER -85.38 130.7 34.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 108.889 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.547 HG23 ' CD1' ' A' ' 22' ' ' LEU . 42.4 t -121.87 68.21 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.498 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.433 ' C ' HG13 ' A' ' 16' ' ' VAL . . . -62.0 99.65 0.24 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.481 HG22 ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -101.21 126.76 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -1.223 . . . . 0.0 108.983 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 100' ' ' TYR . 3.7 p90 -141.82 -176.49 4.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 109.733 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 83' ' ' SER . 0.5 OUTLIER -138.1 -116.24 0.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.093 -1.005 . . . . 0.0 110.22 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.507 ' OE2' ' CB ' ' A' ' 83' ' ' SER . 9.9 mm-40 -85.29 -50.64 7.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.843 -1.161 . . . . 0.0 110.276 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -39.16 -27.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 110.574 -179.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 16' ' ' VAL . 12.4 mt -127.86 147.69 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.919 -1.113 . . . . 0.0 110.203 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.423 ' N ' HG21 ' A' ' 104' ' ' ILE . 66.9 mt-30 -127.52 152.71 76.99 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.416 -0.803 . . . . 0.0 108.868 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.43 173.2 1.57 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.992 1.795 . . . . 0.0 110.272 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.74 -51.26 1.2 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 m -94.08 -33.71 13.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.373 -1.075 . . . . 0.0 108.929 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 15' ' ' ALA . . . -80.94 -35.05 32.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.575 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.61 -13.4 59.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.53 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.26 -42.63 12.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.764 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.3 p -70.57 -28.09 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 109.629 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.46 ' O ' HG11 ' A' ' 113' ' ' VAL . 73.6 t -83.94 -20.53 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.501 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.48 -37.55 63.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.885 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.52 ' HG3' ' N ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -77.03 -42.79 37.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.684 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.52 ' N ' ' HG3' ' A' ' 115' ' ' LYS . 25.7 mt -52.23 -57.18 10.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.047 -1.033 . . . . 0.0 109.458 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -64.56 -29.83 70.86 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.131 -0.981 . . . . 0.0 109.095 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -53.78 -21.98 8.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.129 -0.982 . . . . 0.0 109.176 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -90.64 -30.86 16.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.409 -0.807 . . . . 0.0 109.832 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.5 ' CB ' ' O ' ' A' ' 125' ' ' PHE . 0.8 OUTLIER -73.04 -38.78 66.4 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.063 -1.023 . . . . 0.0 109.77 -179.505 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 2.9 mp -64.86 -14.88 17.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.395 -0.816 . . . . 0.0 109.276 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -45.71 -35.4 5.81 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.33 -70.23 0.82 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -1.035 . . . . 0.0 108.974 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -117.39 -77.97 0.64 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.5 ' O ' ' CB ' ' A' ' 120' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.386 -1.067 . . . . 0.0 109.688 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 2' ' ' TRP . 84.3 p . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.703 ' CZ3' ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER 79.28 -46.28 0.37 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 120.764 0.316 . . . . 0.0 110.394 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -67.49 -59.01 3.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.581 -1.324 . . . . 0.0 108.965 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.475 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.7 OUTLIER -71.82 -31.18 66.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.308 -0.87 . . . . 0.0 108.719 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.703 ' CD2' ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -56.21 -17.12 6.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.451 -0.781 . . . . 0.0 108.925 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.536 ' HA ' ' CG2' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -94.39 -48.96 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.245 -0.91 . . . . 0.0 109.955 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.83 45.95 1.32 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.785 -1.197 . . . . 0.0 110.677 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 4' ' ' THR . 22.5 p -148.63 -104.94 0.08 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.855 -1.153 . . . . 0.0 110.003 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.483 ' O ' ' C ' ' A' ' 10' ' ' LEU . 2.3 t-20 -102.72 -69.14 0.8 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.032 -1.042 . . . . 0.0 111.156 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.491 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -27.77 -45.44 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.234 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.546 HG21 ' CB ' ' A' ' 19' ' ' ALA . 85.2 t -101.24 -25.43 3.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.477 -1.389 . . . . 0.0 110.976 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 11' ' ' VAL . . . -45.58 -27.78 2.19 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 106.544 -2.622 . . . . 0.0 106.544 177.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.711 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -175.22 -44.88 0.01 OUTLIER 'General case' 0 C--O 1.196 -1.718 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.574 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . 14.12 40.45 0.0 OUTLIER Glycine 0 N--CA 1.508 3.435 0 C-N-CA 123.567 0.603 . . . . 0.0 112.79 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.711 ' N ' ' O ' ' A' ' 13' ' ' THR . . . 86.7 -32.12 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.438 -1.036 . . . . 0.0 108.377 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 13' ' ' THR . 0.4 OUTLIER -101.39 132.5 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.179 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.9 OUTLIER -86.25 21.04 2.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.958 -1.089 . . . . 0.0 109.261 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.53 ' CG ' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -176.99 176.1 1.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.546 ' CB ' HG21 ' A' ' 11' ' ' VAL . . . 174.35 166.33 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.004 -1.06 . . . . 0.0 110.1 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -163.66 136.09 5.15 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.571 HG22 ' CD1' ' A' ' 2' ' ' TRP . 1.2 mm -94.33 66.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.036 -1.04 . . . . 0.0 108.453 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.528 ' CD1' HG23 ' A' ' 97' ' ' VAL . 17.5 mt -60.83 109.54 1.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 108.938 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 94' ' ' SER . . . -60.35 159.47 24.87 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.592 ' HB3' ' CG1' ' A' ' 95' ' ' ILE . 1.0 OUTLIER -108.77 -6.9 15.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -1.022 . . . . 0.0 109.4 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -143.7 34.89 1.27 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.355 -0.841 . . . . 0.0 109.312 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.41 29.84 0.09 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 64.63 -144.58 0.26 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.214 -1.168 . . . . 0.0 109.503 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.3 m -77.66 147.95 35.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.153 -0.967 . . . . 0.0 110.019 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.472 ' CE3' ' HB3' ' A' ' 94' ' ' SER . 7.8 m0 -114.12 -47.45 2.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.336 -0.852 . . . . 0.0 108.786 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.35 167.27 30.54 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 10.1 t -160.3 159.79 31.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.957 -1.089 . . . . 0.0 110.055 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.439 ' HB2' HG11 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -150.99 92.99 1.88 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.591 -0.693 . . . . 0.0 109.155 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.469 ' HB3' ' HG2' ' A' ' 18' ' ' GLN . . . 170.78 -54.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.531 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.4 19.48 3.48 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.582 ' CZ ' HG22 ' A' ' 99' ' ' VAL . 10.4 p90 -125.54 134.76 51.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -1.174 . . . . 0.0 109.523 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.59 130.64 55.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.914 . . . . 0.0 109.305 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.1 t -79.62 131.7 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 109.598 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.462 HG21 ' HD2' ' A' ' 39' ' ' PRO . 5.0 m -48.29 125.58 11.89 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 108.994 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.462 ' HD2' HG21 ' A' ' 38' ' ' THR . 4.7 Cg_exo -58.82 -39.42 81.79 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.765 1.643 . . . . 0.0 109.976 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.79 -46.96 86.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.258 -0.901 . . . . 0.0 109.182 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -62.72 -21.18 65.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.273 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.79 -29.33 67.2 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -67.48 -44.62 78.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -1.155 . . . . 0.0 109.428 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.4 m -56.72 -25.71 55.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.285 -0.884 . . . . 0.0 109.372 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.9 tp -73.81 -41.68 62.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.26 -50.2 66.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.228 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.78 -16.45 64.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.18 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.89 -28.24 64.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.339 -0.851 . . . . 0.0 109.458 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -88.26 21.53 2.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.361 -0.837 . . . . 0.0 109.533 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -108.69 -44.47 4.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.356 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.507 ' O ' ' CD1' ' A' ' 55' ' ' ILE . 2.5 m-20 -122.87 141.46 51.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 109.477 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.444 ' HA ' HG13 ' A' ' 55' ' ' ILE . . . -105.82 -3.72 21.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.909 . . . . 0.0 109.611 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.549 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -77.25 -55.37 1.36 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.101 -1.0 . . . . 0.0 110.258 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 2.3 Cg_endo -62.37 -10.33 18.4 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.056 1.837 . . . . 0.0 111.225 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.507 ' CD1' ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -104.85 -23.72 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.946 -1.096 . . . . 0.0 109.62 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -81.98 -12.18 58.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.085 -1.01 . . . . 0.0 109.356 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.96 -75.85 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.6 t -85.73 -39.32 17.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.385 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 55' ' ' ILE . . . 85.69 -161.73 35.36 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.655 ' CE1' ' CG ' ' A' ' 67' ' ' TYR . 4.6 p90 -145.98 -168.99 3.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -1.11 . . . . 0.0 109.035 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 61' ' ' ASP . 26.7 p30 -160.04 157.53 28.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.012 -1.055 . . . . 0.0 110.483 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.5 mt -124.64 -160.04 0.92 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.73 97.75 10.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.973 -1.079 . . . . 0.0 109.733 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.19 -79.47 0.23 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.516 HG11 ' N ' ' A' ' 66' ' ' HIS . 54.1 t -124.8 160.97 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -1.153 . . . . 0.0 109.322 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.516 ' N ' HG11 ' A' ' 65' ' ' VAL . 18.7 m170 -75.9 -171.45 1.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.127 -0.983 . . . . 0.0 109.317 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.655 ' CG ' ' CE1' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -137.39 119.78 15.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 109.831 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.7 t -89.71 -24.6 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -0.843 . . . . 0.0 108.735 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.404 ' CG2' ' CB ' ' A' ' 72' ' ' ALA . 92.6 m 57.52 101.38 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.599 -0.688 . . . . 0.0 110.151 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.38 -23.67 13.16 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -142.85 72.1 1.36 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.5 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . . . -85.4 52.25 2.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 0.0 109.828 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.66 -145.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.241 -0.912 . . . . 0.0 108.835 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.456 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 0.4 OUTLIER -119.66 34.65 5.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.155 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 7.5 mmt180 -136.7 -44.38 0.59 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 110.236 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 14.9 m -145.64 164.88 30.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.929 -1.107 . . . . 0.0 110.31 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.557 ' O ' ' CG2' ' A' ' 77' ' ' ILE . 0.3 OUTLIER -162.24 97.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 76' ' ' SER . 0.0 OUTLIER -115.31 129.81 56.72 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.583 ' HA3' ' CE1' ' A' ' 67' ' ' TYR . . . -101.6 155.7 18.89 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.518 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.512 ' HD2' ' CG ' ' A' ' 106' ' ' PRO . 2.0 pttp -151.0 141.24 22.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -1.089 . . . . 0.0 109.347 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.503 ' CG ' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER 165.13 143.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.933 -1.104 . . . . 0.0 110.565 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.401 ' C ' ' N ' ' A' ' 84' ' ' ALA . . . 63.94 48.94 71.23 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 47.03 21.9 0.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.05 -1.265 . . . . 0.0 109.549 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' LYS . . . -151.3 147.28 26.76 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.318 -0.864 . . . . 0.0 108.759 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.555 ' CA ' ' CE2' ' A' ' 100' ' ' TYR . . . -169.68 -171.43 35.26 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.649 ' CG1' ' CE2' ' A' ' 67' ' ' TYR . 7.3 p -141.62 156.69 20.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.399 -1.059 . . . . 0.0 109.842 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.5 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 75.3 mt -121.37 93.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 11.4 p -107.91 133.24 52.54 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.197 -0.939 . . . . 0.0 110.643 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.573 ' HB ' ' CD2' ' A' ' 96' ' ' LEU . 2.1 t -150.76 156.86 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.234 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -79.99 143.89 33.74 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.459 -0.776 . . . . 0.0 109.192 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.468 ' O ' ' CB ' ' A' ' 125' ' ' PHE . 67.9 p -146.88 -135.82 0.08 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.209 -0.932 . . . . 0.0 109.29 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -75.78 80.43 2.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.969 -1.082 . . . . 0.0 109.955 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 92' ' ' SER . 13.4 mttm 60.68 13.33 4.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.761 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.485 ' HB2' HG21 ' A' ' 21' ' ' ILE . 3.3 p -138.04 165.35 26.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.064 -1.022 . . . . 0.0 109.966 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.592 ' CG1' ' HB3' ' A' ' 24' ' ' LEU . 1.7 mt -128.82 112.99 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.418 -0.801 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.642 ' HB3' ' CE2' ' A' ' 2' ' ' TRP . 1.1 pt? -60.21 164.18 4.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.171 -0.956 . . . . 0.0 108.808 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.534 HG11 ' CG2' ' A' ' 86' ' ' VAL . 71.8 t -150.84 57.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.533 -0.73 . . . . 0.0 109.518 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -49.06 114.89 2.35 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.582 HG22 ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -107.28 143.68 17.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.053 -1.263 . . . . 0.0 109.768 -179.107 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 100' ' ' TYR . 0.1 OUTLIER -142.98 153.32 42.9 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -151.24 6.38 0.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.822 -1.174 . . . . 0.0 111.692 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 103' ' ' LYS . 3.0 mm-40 -100.77 -78.22 0.52 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.586 -1.321 . . . . 0.0 109.817 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 8.4 mmtp -155.11 30.03 0.4 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.428 -0.795 . . . . 0.0 109.255 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.515 HG13 ' HB3' ' A' ' 100' ' ' TYR . 2.2 mm -62.58 149.35 9.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.263 -0.898 . . . . 0.0 109.644 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -106.54 141.52 22.99 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 109.388 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.512 ' CG ' ' HD2' ' A' ' 80' ' ' LYS . 2.1 Cg_endo -62.33 -26.45 77.08 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.078 1.852 . . . . 0.0 110.4 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.45 37.14 3.51 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.9 m -143.03 -46.25 0.3 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -1.132 . . . . 0.0 109.394 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -86.77 -25.47 24.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.414 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.95 -22.23 39.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 109.281 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.86 -39.99 63.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.435 -0.79 . . . . 0.0 109.562 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.461 HG11 ' N ' ' A' ' 113' ' ' VAL . 9.4 p -76.34 -23.44 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.532 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.461 ' N ' HG11 ' A' ' 112' ' ' VAL . 70.0 t -85.63 -18.79 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.867 . . . . 0.0 109.581 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.98 -31.45 39.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.331 -0.856 . . . . 0.0 109.586 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -83.7 -55.13 4.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.855 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.65 -31.02 67.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.912 . . . . 0.0 109.501 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -73.51 -26.82 61.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.204 -0.935 . . . . 0.0 109.471 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -66.57 -26.65 67.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.131 -0.98 . . . . 0.0 109.675 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 8.8 t80 -82.23 -52.37 7.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.88 . . . . 0.0 109.608 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.459 HD12 ' HB ' ' A' ' 91' ' ' THR . 0.5 OUTLIER -63.94 -25.26 68.06 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.22 -0.925 . . . . 0.0 109.943 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 2.8 mt -90.63 -18.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.94 . . . . 0.0 109.193 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.28 -16.67 28.37 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -91.26 -60.77 1.81 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -1.148 . . . . 0.0 109.334 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 125' ' ' PHE . . . 158.38 104.39 0.2 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.988 0 O-C-N 121.19 -1.182 . . . . 0.0 108.905 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.546 ' C ' ' CG ' ' A' ' 2' ' ' TRP . 1.2 p . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.555 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 8.1 m95 74.28 173.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.365 -0.834 . . . . 0.0 109.335 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -81.88 -90.57 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.924 -1.11 . . . . 0.0 111.08 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.56 -34.61 7.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.101 -0.999 . . . . 0.0 110.332 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 1.9 m-30 -71.07 -38.17 72.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.049 -1.032 . . . . 0.0 109.601 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.56 ' HA ' ' CG2' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -51.72 -24.15 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 6' ' ' VAL . 20.5 t0 -40.37 -89.91 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.532 -0.73 . . . . 0.0 111.253 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.451 HG21 ' N ' ' A' ' 9' ' ' ASN . 10.2 t -144.05 -23.46 0.56 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.063 -1.023 . . . . 0.0 111.427 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.584 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.4 m120 -75.42 -55.7 5.43 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.674 -1.266 . . . . 0.0 109.504 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 0.6 OUTLIER -76.91 -25.36 52.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.848 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.56 ' CG2' ' HA ' ' A' ' 6' ' ' VAL . 1.8 t -92.36 -55.12 6.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.183 -0.948 . . . . 0.0 108.712 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.516 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -43.69 -39.17 4.57 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 107.952 -2.059 . . . . 0.0 107.952 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.517 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER 159.94 47.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.827 -0.808 . . . . 0.0 110.068 178.579 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 9' ' ' ASN . . . -90.57 20.77 36.2 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 106.918 -2.473 . . . . 0.0 106.918 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 156.43 -32.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 27.5 m -141.93 147.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.479 ' N ' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -80.67 12.58 3.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.944 -1.097 . . . . 0.0 109.209 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.544 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -175.42 -178.32 1.12 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 18' ' ' GLN . . . 161.56 148.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 109.31 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -137.82 160.23 39.84 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.166 -0.959 . . . . 0.0 109.482 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 2' ' ' TRP . 30.8 mt -131.81 95.9 2.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.606 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -89.86 128.08 36.12 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.442 0.639 . . . . 0.0 109.459 -178.029 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.19 167.54 49.12 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.663 ' CD1' ' N ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -71.25 -8.34 52.94 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.52 -0.988 . . . . 0.0 109.515 -179.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -78.83 -27.21 44.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.555 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.29 -3.03 34.91 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -93.5 -155.51 0.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -1.175 . . . . 0.0 109.145 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.22 129.71 56.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.886 -1.134 . . . . 0.0 110.138 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.407 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 3.1 m0 -101.16 -34.04 9.85 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.316 -0.865 . . . . 0.0 108.907 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 29' ' ' TRP . . . 170.33 92.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.433 -0.792 . . . . 0.0 109.063 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 14.1 t -109.31 172.08 7.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 110.105 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.488 ' OG ' HG11 ' A' ' 6' ' ' VAL . 16.1 m -156.41 86.77 1.02 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.481 -0.762 . . . . 0.0 109.366 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.558 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . . . -169.39 -55.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.306 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.94 -43.99 1.29 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.558 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 11.1 p90 -48.08 162.52 0.08 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -1.091 . . . . 0.0 109.591 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.63 121.82 38.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.213 -0.93 . . . . 0.0 109.484 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.6 t -89.94 123.25 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.887 . . . . 0.0 109.427 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.68 127.2 91.17 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.16 -0.962 . . . . 0.0 109.307 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 40' ' ' ALA . 1.9 Cg_endo -62.2 169.41 7.84 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.036 1.824 . . . . 0.0 110.526 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 39' ' ' PRO . . . 83.03 -24.41 0.17 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.721 -0.612 . . . . 0.0 110.345 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.403 ' HB3' HD22 ' A' ' 62' ' ' LEU . 0.8 OUTLIER -81.45 -10.55 59.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.986 -1.072 . . . . 0.0 109.55 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -56.74 -34.5 64.89 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -70.35 -39.36 74.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -1.167 . . . . 0.0 109.656 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.9 m -51.22 -34.17 31.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.541 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.465 HD23 ' HB ' ' A' ' 88' ' ' THR . 21.6 tp -67.35 -48.38 67.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.467 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.17 -7.52 30.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 0.0 109.62 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.61 -29.45 16.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.087 -1.008 . . . . 0.0 109.735 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.89 -24.84 58.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.137 -0.977 . . . . 0.0 109.819 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.479 ' CE1' ' O ' ' A' ' 75' ' ' ARG . 9.1 m-85 -57.11 -29.59 63.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 109.566 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -113.27 -16.72 12.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.101 -0.999 . . . . 0.0 109.465 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -117.46 112.27 20.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 109.21 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.531 ' HA ' ' CG1' ' A' ' 55' ' ' ILE . . . -100.26 -8.77 23.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.608 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.552 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -64.79 -52.6 49.5 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 109.902 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.1 Cg_endo -64.33 -4.84 8.66 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.197 1.931 . . . . 0.0 111.205 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.531 ' CG1' ' HA ' ' A' ' 52' ' ' ALA . 1.9 pp -128.39 0.74 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.932 -1.105 . . . . 0.0 109.684 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -98.27 -34.77 10.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.113 -0.992 . . . . 0.0 109.45 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.46 -23.09 65.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -0.821 . . . . 0.0 109.695 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.9 t -170.47 -38.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.126 -0.984 . . . . 0.0 109.688 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 54' ' ' PRO . . . 132.53 -123.11 3.45 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.529 ' CE1' HD13 ' A' ' 62' ' ' LEU . 34.3 p90 -160.28 170.98 19.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.108 -1.231 . . . . 0.0 109.699 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.33 140.22 43.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.529 HD13 ' CE1' ' A' ' 60' ' ' PHE . 3.0 mt -147.99 115.69 6.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.885 . . . . 0.0 109.61 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.486 ' CB ' ' O ' ' A' ' 62' ' ' LEU . . . 76.62 13.04 2.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 109.753 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.65 29.23 24.58 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 t -130.69 -169.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -1.138 . . . . 0.0 109.2 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.75 126.08 28.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.122 -0.986 . . . . 0.0 110.195 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -112.88 152.46 29.25 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.61 163.8 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.725 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.462 HG22 ' HB1' ' A' ' 72' ' ' ALA . 28.1 m -103.85 135.25 45.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.308 -0.87 . . . . 0.0 109.496 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.462 HD11 ' HD2' ' A' ' 80' ' ' LYS . 2.1 tp -113.91 -50.33 2.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.704 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.31 51.63 1.37 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 109.689 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.462 ' HB1' HG22 ' A' ' 69' ' ' THR . . . -79.28 87.73 4.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.223 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.75 -55.93 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.86 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -81.86 -103.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.064 -1.022 . . . . 0.0 109.716 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.479 ' O ' ' CE1' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -134.59 0.54 3.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.903 -1.123 . . . . 0.0 109.975 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 43.7 m -106.22 142.5 35.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.058 -1.026 . . . . 0.0 109.613 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.3 mt -139.78 88.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.45 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 76' ' ' SER . 1.7 m-85 -90.25 65.98 6.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.051 -1.03 . . . . 0.0 109.575 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -44.85 153.04 0.55 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 11.6 ptpt -151.49 94.53 2.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.022 -1.281 . . . . 0.0 109.844 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -160.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 0.0 109.263 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -46.06 -73.75 0.27 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.45 ' OG ' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -112.2 -24.2 9.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -1.158 . . . . 0.0 109.483 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . . . -89.31 -174.02 4.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.152 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.555 ' N ' ' CE1' ' A' ' 100' ' ' TYR . . . 177.18 152.23 9.75 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.092 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 98' ' ' GLY . 9.5 p -117.86 124.27 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -1.042 . . . . 0.0 108.709 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 67.4 mt -100.62 89.81 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.983 -1.073 . . . . 0.0 110.21 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 11.3 p -101.89 135.24 43.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.131 -0.981 . . . . 0.0 109.64 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.475 ' HB ' HD13 ' A' ' 96' ' ' LEU . 47.2 t -149.16 155.9 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.211 -0.93 . . . . 0.0 109.486 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.82 131.96 47.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.109 -0.994 . . . . 0.0 109.481 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.2 p -107.76 -97.72 0.37 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.252 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.9 p -129.58 -31.92 1.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.017 -1.052 . . . . 0.0 109.484 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.27 51.61 0.53 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.919 . . . . 0.0 109.341 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.47 ' HA ' HD12 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -178.9 159.06 1.0 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.529 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.431 HD11 HG22 ' A' ' 95' ' ' ILE . 25.0 mt -120.38 112.14 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.12 -0.987 . . . . 0.0 109.304 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.515 HD11 ' CH2' ' A' ' 2' ' ' TRP . 8.3 mt -67.54 153.15 44.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.335 -0.853 . . . . 0.0 109.618 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.548 ' CG2' ' HG ' ' A' ' 22' ' ' LEU . 60.5 t -150.58 53.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.844 . . . . 0.0 109.776 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.466 ' O ' HG21 ' A' ' 86' ' ' VAL . . . -45.16 137.44 6.31 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.546 ' CG2' ' O ' ' A' ' 97' ' ' VAL . 2.4 t -139.48 117.72 11.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.044 -1.268 . . . . 0.0 108.649 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.555 ' CE1' ' N ' ' A' ' 85' ' ' GLY . 7.2 p90 -138.31 164.04 30.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.014 -1.054 . . . . 0.0 109.756 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.489 ' HA ' ' HB3' ' A' ' 84' ' ' ALA . 13.0 p-10 -110.64 -145.54 0.4 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 0.0 109.881 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.45 ' HG2' ' OG ' ' A' ' 83' ' ' SER . 10.4 mt-10 -76.05 -7.48 54.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.968 . . . . 0.0 110.104 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -16.44 61.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.074 -1.016 . . . . 0.0 109.758 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 17' ' ' THR . 1.2 mp -136.99 141.05 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.246 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -101.98 150.34 37.34 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 109.559 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.426 ' HB2' ' HE2' ' A' ' 80' ' ' LYS . 1.9 Cg_endo -62.32 161.82 25.82 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.27 1.98 . . . . 0.0 110.444 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.6 -55.91 4.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.1 m -67.94 -31.58 71.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -1.081 . . . . 0.0 109.689 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.439 ' O ' HG11 ' A' ' 112' ' ' VAL . . . -84.24 -36.92 22.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 109.504 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.436 ' HB3' ' CD2' ' A' ' 78' ' ' TYR . . . -62.96 -29.79 71.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.297 -0.877 . . . . 0.0 109.498 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -61.28 -36.37 79.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.982 . . . . 0.0 109.524 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -77.76 -31.62 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.135 -0.978 . . . . 0.0 109.432 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.449 ' N ' HG11 ' A' ' 112' ' ' VAL . 53.5 t -63.61 -23.65 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.086 -1.008 . . . . 0.0 109.451 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -77.85 -43.73 29.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.342 -0.849 . . . . 0.0 109.715 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -80.81 -63.73 1.34 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 109.23 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.2 OUTLIER -42.23 -28.42 0.19 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.495 -0.753 . . . . 0.0 109.661 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.449 ' HB2' HD13 ' A' ' 121' ' ' ILE . . . -73.72 -47.98 35.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.715 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -49.13 -21.39 0.74 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.07 -1.019 . . . . 0.0 110.008 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -85.47 -41.33 15.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.318 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 1.1 mt -78.21 -56.08 4.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.097 -1.002 . . . . 0.0 110.361 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.453 ' C ' ' O ' ' A' ' 120' ' ' LEU . 17.8 mt -39.77 -33.44 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.316 -0.865 . . . . 0.0 109.821 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.58 -51.43 36.43 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -59.65 -71.1 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -1.133 . . . . 0.0 109.475 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 130.27 112.15 1.51 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 120' ' ' LEU . 82.7 m-85 . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.211 -1.17 . . . . 0.0 109.535 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 2' ' ' TRP . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.59 ' CE3' ' HG ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER 78.28 -6.62 1.92 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.329 -0.857 . . . . 0.0 109.435 -179.524 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 4' ' ' THR . 35.2 tt0 -77.8 -81.14 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.055 -1.028 . . . . 0.0 108.746 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.483 ' O ' ' CG2' ' A' ' 8' ' ' THR . 1.2 t -48.47 -30.23 4.93 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.619 ' CD2' ' CD2' ' A' ' 10' ' ' LEU . 3.2 m-30 -48.19 -54.67 12.65 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.531 ' HA ' ' CG2' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -50.53 -37.77 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -0.799 . . . . 0.0 109.644 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.45 ' C ' ' CG2' ' A' ' 8' ' ' THR . 1.0 OUTLIER -90.85 51.53 1.99 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.071 -1.018 . . . . 0.0 111.951 -178.422 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.483 ' CG2' ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER 173.28 -87.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.482 -1.386 . . . . 0.0 111.486 178.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 11' ' ' VAL . 4.2 m-20 -90.04 -83.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 111.34 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.619 ' CD2' ' CD2' ' A' ' 5' ' ' TYR . 3.8 mm? -21.12 -44.8 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 9' ' ' ASN . 38.5 t -88.02 -59.22 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.659 -1.276 . . . . 0.0 110.279 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.527 ' O ' ' CG2' ' A' ' 13' ' ' THR . . . -37.8 -41.07 0.84 Allowed Glycine 0 N--CA 1.498 2.805 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 155.95 39.88 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.607 0.718 . . . . 0.0 109.378 178.177 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -83.75 19.32 16.17 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 156.2 -28.08 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 18' ' ' GLN . 2.2 m -151.41 152.08 11.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.542 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -79.66 8.12 7.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.798 -1.189 . . . . 0.0 109.292 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.542 ' CG ' ' O ' ' A' ' 17' ' ' THR . 31.5 mt-30 -162.64 176.6 10.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.501 ' CA ' HG22 ' A' ' 99' ' ' VAL . . . -177.78 155.49 1.02 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.863 -1.148 . . . . 0.0 110.234 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.495 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -148.91 114.63 5.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 0.0 109.576 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.577 HD13 ' CD1' ' A' ' 2' ' ' TRP . 7.9 mm -81.28 114.86 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.84 -1.162 . . . . 0.0 108.693 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.525 HD13 ' CG2' ' A' ' 97' ' ' VAL . 0.6 OUTLIER -108.51 88.37 2.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -0.915 . . . . 0.0 108.994 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.592 ' HA3' ' CD2' ' A' ' 29' ' ' TRP . . . -50.11 -177.51 0.02 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.522 HD22 ' CA ' ' A' ' 94' ' ' SER . 13.0 mt -84.03 -50.93 7.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.384 -1.068 . . . . 0.0 109.408 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.86 13.25 33.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.017 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 28' ' ' THR . . . -130.75 80.31 0.35 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.472 ' C ' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -35.44 -31.04 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.905 -0.762 . . . . 0.0 110.441 -179.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -139.04 99.19 3.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.939 -1.1 . . . . 0.0 110.171 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.592 ' CD2' ' HA3' ' A' ' 23' ' ' GLY . 6.5 m0 -95.85 -24.61 16.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 108.996 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -171.79 145.01 1.87 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.463 HG21 ' HB3' ' A' ' 20' ' ' ALA . 18.5 p -149.82 162.03 41.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.123 -0.986 . . . . 0.0 109.848 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.53 ' OG ' ' CG1' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -166.08 84.6 0.31 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.445 -0.785 . . . . 0.0 109.205 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.427 ' HB3' ' OE1' ' A' ' 18' ' ' GLN . . . -172.4 -67.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 109.295 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 138.6 -23.34 2.96 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.575 ' CZ ' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -62.23 178.71 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.063 -1.257 . . . . 0.0 109.782 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.465 ' O ' HG21 ' A' ' 37' ' ' VAL . . . -107.89 125.84 51.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.024 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.575 HG22 ' CZ ' ' A' ' 35' ' ' PHE . 8.3 t -144.89 103.52 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.57 ' CG2' ' HD3' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -173.66 -59.12 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.176 -0.953 . . . . 0.0 110.175 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.57 ' HD3' ' CG2' ' A' ' 38' ' ' THR . 1.9 Cg_endo -59.4 118.33 5.2 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.708 1.605 . . . . 0.0 110.774 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.474 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . . . 54.95 35.17 23.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.291 -0.881 . . . . 0.0 109.973 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.521 ' NE2' HG12 ' A' ' 37' ' ' VAL . 2.4 mm-40 -90.39 -53.88 4.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.801 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.59 -42.84 16.65 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.474 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 4.0 pp0? -59.7 -26.94 66.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -1.18 . . . . 0.0 109.679 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 40' ' ' ALA . 14.0 m -67.47 -53.66 26.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 109.341 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.556 ' O ' ' CD2' ' A' ' 49' ' ' PHE . 8.5 mp -63.53 -29.71 70.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 109.681 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.16 92.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.952 . . . . 0.0 109.533 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.2 t -86.33 -17.23 35.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.495 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.65 51.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.425 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 45' ' ' LEU . 35.4 m-85 -79.01 -10.38 59.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.175 -0.953 . . . . 0.0 109.642 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -89.38 -0.44 57.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.96 . . . . 0.0 109.578 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.471 ' HB2' ' CD ' ' A' ' 54' ' ' PRO . 1.8 p30 175.28 118.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.069 -1.019 . . . . 0.0 109.839 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 72' ' ' ALA . . . -94.97 -13.35 25.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -0.813 . . . . 0.0 109.259 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.583 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -63.08 -50.17 77.46 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 110.204 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.4 Cg_endo -63.83 -13.63 38.25 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.02 1.814 . . . . 0.0 110.967 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.515 HD13 ' CG2' ' A' ' 69' ' ' THR . 0.3 OUTLIER -91.68 -14.79 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.861 -1.149 . . . . 0.0 109.532 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.603 ' CZ ' ' CB ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -81.29 -48.39 12.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.867 . . . . 0.0 109.477 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 58' ' ' SER . . . -77.01 -86.68 0.05 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.242 -0.911 . . . . 0.0 109.43 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 57' ' ' ALA . 20.2 m -44.36 -57.44 3.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.334 -0.854 . . . . 0.0 109.156 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.89 175.04 18.93 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.53 ' CE1' ' OG1' ' A' ' 69' ' ' THR . 10.7 p90 -124.59 124.44 42.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.436 -1.038 . . . . 0.0 108.984 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.87 161.47 15.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -0.964 . . . . 0.0 110.137 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.61 -142.78 0.24 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.02 -0.59 16.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.24 -0.913 . . . . 0.0 109.557 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.41 -102.09 2.76 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -136.22 -147.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.23 -1.159 . . . . 0.0 109.538 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -82.43 133.79 35.22 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.151 -0.968 . . . . 0.0 109.505 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 60' ' ' PHE . 3.0 m-30 -112.76 147.64 36.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 109.495 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -93.25 143.12 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.136 -0.978 . . . . 0.0 109.321 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.53 ' OG1' ' CE1' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -108.41 119.17 38.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.627 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.415 ' O ' HD11 ' A' ' 70' ' ' LEU . 1.4 pp -111.66 21.3 16.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.583 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.423 ' CG ' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER 177.21 102.29 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.134 -0.979 . . . . 0.0 109.523 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.514 ' CB ' HD12 ' A' ' 55' ' ' ILE . . . -153.7 54.6 0.73 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.108 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.24 -16.82 4.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.136 -0.978 . . . . 0.0 110.142 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -110.84 -104.73 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.0 109.752 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -143.41 27.61 1.54 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.955 -1.09 . . . . 0.0 109.253 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.605 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -143.12 129.24 19.73 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.469 ' O ' ' OG1' ' A' ' 88' ' ' THR . 2.4 mp -133.37 99.4 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.922 -1.111 . . . . 0.0 111.025 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.605 ' CE1' ' HB3' ' A' ' 76' ' ' SER . 0.2 OUTLIER -109.52 96.47 6.3 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.128 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.66 168.98 42.37 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.455 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HG3' ' HA3' ' A' ' 85' ' ' GLY . 19.8 tttt -150.52 154.69 38.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.525 -0.985 . . . . 0.0 109.109 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 -13.42 9.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.012 -1.055 . . . . 0.0 109.737 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.37 -76.91 0.23 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.4 p -94.61 -40.9 9.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -1.219 . . . . 0.0 109.384 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.34 145.27 26.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 0.0 109.359 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.578 ' O ' ' CE1' ' A' ' 100' ' ' TYR . . . -138.65 143.46 14.23 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.502 ' CG2' HG11 ' A' ' 97' ' ' VAL . 2.4 p -110.23 136.05 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -1.099 . . . . 0.0 109.56 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.486 ' HB ' ' HA3' ' A' ' 98' ' ' GLY . 3.2 mt -109.92 91.63 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -0.766 . . . . 0.0 109.011 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 5.0 p -89.33 112.67 23.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.061 -1.024 . . . . 0.0 109.69 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.405 ' O ' HD21 ' A' ' 96' ' ' LEU . 41.6 t -111.48 136.88 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.265 -0.897 . . . . 0.0 108.837 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.29 150.62 23.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.067 -1.021 . . . . 0.0 110.032 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.9 p -132.95 -144.63 0.24 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.398 -0.814 . . . . 0.0 109.048 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.529 ' HB3' ' CA ' ' A' ' 124' ' ' GLY . 47.0 t -87.01 -29.86 21.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.039 -1.038 . . . . 0.0 109.447 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 92' ' ' SER . 17.2 mttt -159.58 55.91 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 0.0 109.796 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.63 ' CB ' ' CG ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -177.73 151.25 0.7 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.869 -1.144 . . . . 0.0 110.213 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 14.7 mt -125.08 126.16 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.59 ' HG ' ' CE3' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -108.24 161.61 14.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.992 -178.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.525 ' CG2' HD13 ' A' ' 22' ' ' LEU . 25.6 t -139.49 125.86 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.61 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.486 ' HA3' ' HB ' ' A' ' 87' ' ' ILE . . . -103.79 101.22 1.98 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 107.875 -2.09 . . . . 0.0 107.875 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.501 HG22 ' CA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -99.23 128.93 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -1.123 . . . . 0.0 109.048 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 100' ' ' TYR . 1.3 p90 -144.48 -170.82 3.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.64 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 101' ' ' ASN . 0.0 OUTLIER -120.19 -159.14 0.77 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.895 . . . . 0.0 109.047 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -76.32 -16.33 59.79 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.3 -0.875 . . . . 0.0 109.567 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -37.9 83.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.387 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.502 HG13 ' HB2' ' A' ' 100' ' ' TYR . 14.8 mm -79.62 150.79 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.294 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -93.76 138.18 22.9 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.144 -0.973 . . . . 0.0 109.188 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.96 -23.95 53.67 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.1 1.867 . . . . 0.0 110.828 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.06 -47.04 4.27 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.879 -1.153 . . . . 0.0 110.512 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.7 m -66.5 -47.44 73.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.004 -1.292 . . . . 0.0 109.89 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.45 -12.13 28.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 0.0 110.023 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.62 -26.44 19.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 0.0 109.942 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -83.7 -42.44 16.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.089 -1.007 . . . . 0.0 109.591 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -67.31 -36.8 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.346 -0.846 . . . . 0.0 110.064 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.508 HG11 ' CH2' ' A' ' 2' ' ' TRP . 88.6 t -76.41 -26.81 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.196 -0.94 . . . . 0.0 109.585 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -60.67 -50.88 71.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.847 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 116' ' ' LEU . 13.9 ptmm? -66.66 -35.08 79.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 109.64 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -44.26 -42.26 6.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 0.0 109.034 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.439 ' C ' HD11 ' A' ' 121' ' ' ILE . . . -75.58 -37.36 59.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -0.889 . . . . 0.0 109.029 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -47.57 -25.65 1.2 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 109.189 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -83.63 -45.97 12.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.811 . . . . 0.0 109.323 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.549 ' HB3' ' CE1' ' A' ' 125' ' ' PHE . 0.5 OUTLIER -87.92 11.03 16.82 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.242 -0.911 . . . . 0.0 109.842 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.439 HD11 ' C ' ' A' ' 117' ' ' ALA . 0.9 OUTLIER -90.41 -22.43 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 109.191 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -71.82 -45.83 41.19 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -84.14 -28.88 27.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -1.176 . . . . 0.0 109.425 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.529 ' CA ' ' HB3' ' A' ' 92' ' ' SER . . . 81.19 48.83 5.82 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.63 ' CG ' ' CB ' ' A' ' 94' ' ' SER . 12.6 m-85 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.405 -1.056 . . . . 0.0 109.876 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.594 ' N ' ' HA ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 121.011 0.434 . . . . 0.0 110.282 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.574 ' CH2' ' HB3' ' A' ' 96' ' ' LEU . 2.8 m95 -88.53 -160.29 0.63 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.986 -1.071 . . . . 0.0 110.242 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.427 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 1.9 mm-40 -72.96 -109.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.873 -1.142 . . . . 0.0 110.567 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.546 ' O ' ' CG2' ' A' ' 8' ' ' THR . 5.0 t -48.79 -45.47 40.15 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.725 -1.234 . . . . 0.0 109.022 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.582 ' CD2' HD22 ' A' ' 116' ' ' LEU . 14.9 m-30 -41.71 -46.3 3.74 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.549 0.69 . . . . 0.0 109.409 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.549 ' CG2' ' HB2' ' A' ' 1' ' ' SER . 1.4 t -52.87 -53.66 20.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.462 -0.774 . . . . 0.0 110.007 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.418 ' N ' HG11 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -91.75 50.76 1.74 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.055 -1.028 . . . . 0.0 112.193 -178.348 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.546 ' CG2' ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -160.12 -101.33 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.43 -1.419 . . . . 0.0 110.416 178.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -102.15 -69.72 0.78 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.965 -1.085 . . . . 0.0 110.988 -178.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -22.94 -40.86 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' A' ' 9' ' ' ASN . 4.9 t -80.98 -70.11 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.509 -1.37 . . . . 0.0 110.377 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -38.18 -31.94 0.12 Allowed Glycine 0 N--CA 1.497 2.756 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.556 ' CB ' ' O ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER 152.14 42.58 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -84.78 22.6 8.91 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 154.62 -31.1 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 18' ' ' GLN . 25.6 m -152.6 147.1 14.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.502 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -78.8 5.76 10.6 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.014 -1.053 . . . . 0.0 108.619 179.293 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 17' ' ' THR . 23.3 mt-30 -163.34 160.71 23.99 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.491 ' O ' ' HB1' ' A' ' 20' ' ' ALA . . . -173.33 -179.83 2.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.068 -1.02 . . . . 0.0 109.027 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.594 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . 176.57 115.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.92 . . . . 0.0 110.36 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.574 HD11 ' N ' ' A' ' 21' ' ' ILE . 1.5 mp -80.71 100.29 4.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.5 HD22 ' CB ' ' A' ' 20' ' ' ALA . 3.0 mt -86.93 111.74 21.11 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.542 -0.724 . . . . 0.0 109.863 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.12 -166.37 0.33 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -116.22 16.19 15.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.381 -1.07 . . . . 0.0 109.481 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -96.35 -29.2 14.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.79 -25.63 3.07 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.7 p30 -100.15 -163.0 0.99 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -1.106 . . . . 0.0 109.449 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.42 HG21 ' O ' ' A' ' 21' ' ' ILE . 20.3 m -129.18 136.57 50.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.109 -0.994 . . . . 0.0 109.608 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -79.93 -45.96 17.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.938 . . . . 0.0 108.93 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.29 136.78 38.32 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.408 HG23 HG23 ' A' ' 28' ' ' THR . 0.4 OUTLIER -143.06 167.73 21.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.979 -1.076 . . . . 0.0 109.888 -179.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.427 ' HB3' HG23 ' A' ' 11' ' ' VAL . 0.3 OUTLIER 176.22 57.2 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' A' ' 18' ' ' GLN . . . -120.71 -145.51 0.36 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.302 -0.874 . . . . 0.0 109.609 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.94 8.07 5.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -134.26 177.36 7.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -1.167 . . . . 0.0 109.479 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.5 120.79 33.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 109.424 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 t -87.66 151.9 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 109.523 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -105.16 158.48 32.01 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.669 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.14 -30.89 75.46 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.15 1.9 . . . . 0.0 110.41 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.98 78.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.172 -0.955 . . . . 0.0 110.101 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -81.11 -9.93 59.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 109.992 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.27 -34.74 50.47 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -79.45 -41.59 27.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.15 -1.206 . . . . 0.0 109.694 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.1 m -53.96 -42.5 68.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.877 . . . . 0.0 109.397 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.16 -40.32 97.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.0 109.496 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.573 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . . . -59.86 -41.76 92.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.191 -0.943 . . . . 0.0 109.314 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.3 p -73.89 -20.67 60.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.335 -0.853 . . . . 0.0 109.121 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 51' ' ' ASN . . . -67.86 -22.54 65.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.407 -0.808 . . . . 0.0 109.477 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CE2' ' HG3' ' A' ' 90' ' ' LYS . 51.8 m-85 -70.79 -23.12 62.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.469 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -91.74 -32.81 15.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 0.0 109.446 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.413 ' O ' ' O ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -120.25 147.87 44.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.642 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 55' ' ' ILE . . . -119.44 8.96 11.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 109.499 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.589 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -78.39 -49.49 1.79 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.279 -0.888 . . . . 0.0 110.337 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.6 Cg_endo -66.02 -9.97 25.31 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.953 1.768 . . . . 0.0 111.115 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -109.05 -13.32 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.955 -1.091 . . . . 0.0 109.886 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.482 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 15.0 ptm180 -97.99 -13.36 21.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 109.464 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -124.99 117.98 25.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.611 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 59' ' ' GLY . 1.5 p 69.11 10.28 7.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.281 -0.887 . . . . 0.0 109.42 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 58' ' ' SER . . . 44.18 -123.09 4.76 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.85 -174.72 4.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -1.111 . . . . 0.0 109.539 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -119.13 125.41 49.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.359 -0.838 . . . . 0.0 109.17 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.523 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -120.66 104.27 9.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.888 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 62' ' ' LEU . . . 77.78 -81.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.35 -0.844 . . . . 0.0 109.831 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.63 16.85 0.48 Allowed Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.653 -1.261 . . . . 0.0 110.139 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 t -123.43 164.86 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.055 -1.262 . . . . 0.0 109.245 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -111.0 123.11 49.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.139 -0.976 . . . . 0.0 109.816 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -120.08 165.89 14.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 108.813 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.533 HG22 ' CG ' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -124.96 -162.19 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.067 -1.021 . . . . 0.0 109.464 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.2 m -155.83 131.31 9.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.925 . . . . 0.0 109.778 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.82 19.89 12.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.9 . . . . 0.0 109.238 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 29.9 ttm180 178.9 78.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.319 -0.863 . . . . 0.0 109.387 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.432 ' HA ' HG12 ' A' ' 77' ' ' ILE . . . -106.99 77.4 1.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.751 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -75.45 176.72 7.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 109.187 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.15 -2.43 55.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 109.545 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.505 ' NH1' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -98.16 -66.07 0.92 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 0.0 109.101 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.521 ' O ' ' CG1' ' A' ' 77' ' ' ILE . 0.7 OUTLIER -127.25 176.46 7.39 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.306 -0.871 . . . . 0.0 109.402 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.521 ' CG1' ' O ' ' A' ' 76' ' ' SER . 29.8 mt -159.49 134.26 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 109.583 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -142.5 81.8 1.75 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.043 179.457 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.52 170.38 42.64 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -150.82 158.71 44.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -1.103 . . . . 0.0 109.606 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.533 ' CG ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER 176.22 105.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 109.448 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.522 ' N ' ' HE3' ' A' ' 81' ' ' LYS . . . 85.82 33.51 15.48 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 82' ' ' GLY . 1.7 p 71.36 4.69 5.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -1.108 . . . . 0.0 109.39 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 100' ' ' TYR . . . -122.47 118.28 27.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.241 -0.912 . . . . 0.0 109.14 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 80' ' ' LYS . . . -126.45 149.76 17.58 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 78' ' ' TYR . 13.4 p -105.18 123.79 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.405 -1.056 . . . . 0.0 109.379 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.526 ' O ' ' CG2' ' A' ' 87' ' ' ILE . 1.3 mt -87.7 79.67 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.303 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 7.4 p -92.24 126.55 37.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -0.864 . . . . 0.0 109.723 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.462 HG21 ' O ' ' A' ' 75' ' ' ARG . 2.1 p -145.68 130.49 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.278 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.582 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -82.48 131.31 35.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.904 . . . . 0.0 109.598 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.418 HG21 HD13 ' A' ' 96' ' ' LEU . 1.9 p -102.75 -95.97 0.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.845 . . . . 0.0 109.401 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.442 ' C ' ' HG2' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -125.81 -43.0 1.87 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.023 -1.048 . . . . 0.0 109.409 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.576 ' HB2' ' CG ' ' A' ' 125' ' ' PHE . 0.9 OUTLIER -146.46 50.37 1.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.915 . . . . 0.0 109.609 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.523 ' N ' HD23 ' A' ' 24' ' ' LEU . 1.2 p 170.73 166.19 0.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.101 -0.999 . . . . 0.0 109.671 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.7 mt -118.91 142.88 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.171 -0.956 . . . . 0.0 109.379 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.574 ' HB3' ' CH2' ' A' ' 2' ' ' TRP . 0.5 OUTLIER -108.4 147.8 31.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.934 . . . . 0.0 108.731 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.477 ' HB ' ' O ' ' A' ' 20' ' ' ALA . 70.3 t -133.04 131.02 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.895 -1.128 . . . . 0.0 110.653 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.462 ' HA3' ' HB ' ' A' ' 87' ' ' ILE . . . -118.97 91.96 0.52 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -94.97 110.01 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.136 -1.214 . . . . 0.0 109.586 -178.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.477 ' HB3' ' HA ' ' A' ' 16' ' ' VAL . 30.7 p90 -119.87 158.27 26.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.424 -0.797 . . . . 0.0 109.79 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.469 ' O ' HG13 ' A' ' 104' ' ' ILE . 7.1 m-20 -131.29 174.46 10.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.278 -0.889 . . . . 0.0 109.56 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 101' ' ' ASN . 16.0 mm-40 70.68 26.34 3.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.695 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.45 78.6 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.963 . . . . 0.0 109.42 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 105' ' ' GLN . 5.1 mt -98.04 54.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.146 -0.971 . . . . 0.0 109.879 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER 41.94 97.09 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.476 -0.765 . . . . 0.0 110.238 179.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.41 -13.94 18.66 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.952 1.768 . . . . 0.0 110.297 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -100.78 -30.04 6.28 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 105' ' ' GLN . 31.4 m -73.21 -31.99 64.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.12 -1.223 . . . . 0.0 109.437 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.464 ' O ' HG11 ' A' ' 112' ' ' VAL . . . -88.23 -15.04 36.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.32 -0.863 . . . . 0.0 109.527 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.98 -31.27 25.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.628 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 114' ' ' GLU . 2.8 m120 -73.55 -39.08 65.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.13 -0.981 . . . . 0.0 109.523 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 109' ' ' ALA . 6.1 p -61.93 -37.78 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 0.0 109.185 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.62 -20.68 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.327 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' A' ' 111' ' ' ASN . 6.5 tt0 -63.79 -61.84 2.04 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.151 -0.968 . . . . 0.0 109.09 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -39.1 89.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.129 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.582 HD22 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -57.27 -27.02 61.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.381 -0.824 . . . . 0.0 109.448 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.463 ' HB3' HD13 ' A' ' 121' ' ' ILE . . . -75.56 -44.2 44.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 0.0 109.49 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -53.26 -19.08 2.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.91 . . . . 0.0 109.472 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -82.58 -58.58 2.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 109.787 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 121' ' ' ILE . 2.6 mt -61.3 -56.56 19.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.952 . . . . 0.0 110.115 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.463 HD13 ' HB3' ' A' ' 117' ' ' ALA . 6.1 mt -41.2 -29.84 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.272 -0.892 . . . . 0.0 109.802 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 123' ' ' GLN . . . -105.61 49.35 0.9 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 122' ' ' GLY . 2.2 mt-30 -173.68 -69.65 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.398 -1.06 . . . . 0.0 109.61 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.452 ' O ' ' OXT' ' A' ' 125' ' ' PHE . . . -133.88 56.13 0.73 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.576 ' CG ' ' HB2' ' A' ' 93' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.397 -1.061 . . . . 0.0 109.588 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.566 ' C ' ' CG ' ' A' ' 2' ' ' TRP . 1.5 t . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER 57.67 146.13 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.17 -0.956 . . . . 0.0 109.988 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -83.63 -76.47 0.29 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.083 -1.011 . . . . 0.0 110.583 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.478 HG22 ' CD1' ' A' ' 5' ' ' TYR . 2.1 t -39.56 -28.81 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.208 -0.933 . . . . 0.0 109.737 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.581 ' HB2' ' HB2' ' A' ' 2' ' ' TRP . 18.1 m-30 -86.36 -43.45 12.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 0.0 108.916 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.542 HG11 ' CB ' ' A' ' 32' ' ' SER . 0.9 OUTLIER -46.77 -27.87 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.472 0.653 . . . . 0.0 109.852 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.56 -84.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 111.869 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.91 2.58 3.68 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.681 -1.262 . . . . 0.0 110.801 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.535 ' O ' ' N ' ' A' ' 14' ' ' GLY . 6.0 m-20 -92.87 -90.99 0.18 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.969 -1.082 . . . . 0.0 109.621 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -52.97 -30.2 33.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.155 -0.966 . . . . 0.0 110.081 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.537 ' CG2' ' HA ' ' A' ' 6' ' ' VAL . 21.2 t -88.64 -59.01 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.054 -1.029 . . . . 0.0 109.554 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.572 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -42.38 -30.73 0.87 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 107.944 -2.063 . . . . 0.0 107.944 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.572 ' CB ' ' O ' ' A' ' 12' ' ' GLY . 1.0 OUTLIER 147.66 51.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.12 0.486 . . . . 0.0 109.885 178.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.609 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -90.03 19.22 43.57 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 107.071 -2.411 . . . . 0.0 107.071 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.609 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 144.93 -25.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 34.8 m -139.11 149.94 23.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.52 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 5.5 p -87.29 20.75 2.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.976 -1.077 . . . . 0.0 108.662 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.544 ' HB3' ' CB ' ' A' ' 33' ' ' ALA . 4.7 mp0 -171.21 172.59 5.25 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.578 -0.701 . . . . 0.0 109.256 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.516 ' HB1' ' CG2' ' A' ' 11' ' ' VAL . . . -175.73 135.11 0.3 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.073 -1.017 . . . . 0.0 109.602 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -133.08 121.06 22.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.072 -1.018 . . . . 0.0 110.079 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.575 HD12 ' CA ' ' A' ' 2' ' ' TRP . 8.0 mt -86.16 96.72 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 108.624 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.547 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 3.0 mm? -79.15 -179.92 6.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.373 -0.829 . . . . 0.0 109.18 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 94' ' ' SER . . . -133.35 106.36 0.63 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.505 ' N ' HG13 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -51.82 -38.2 54.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -1.178 . . . . 0.0 109.465 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -138.85 35.61 2.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.482 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.38 -102.32 1.1 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.416 ' O ' ' HB ' ' A' ' 28' ' ' THR . 0.2 OUTLIER 174.57 52.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -1.12 . . . . 0.0 109.401 -179.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 27' ' ' ASN . 1.4 m 59.18 98.93 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.981 -1.074 . . . . 0.0 109.139 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.525 ' CE2' ' OG ' ' A' ' 94' ' ' SER . 38.2 m0 -84.07 -29.27 26.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.88 . . . . 0.0 109.639 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.24 157.99 33.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 109.396 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.457 ' O ' ' OG ' ' A' ' 32' ' ' SER . 0.1 OUTLIER -160.09 152.13 20.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.576 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.542 ' CB ' HG11 ' A' ' 6' ' ' VAL . 73.7 m -169.72 58.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.845 . . . . 0.0 109.402 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.544 ' CB ' ' HB3' ' A' ' 18' ' ' GLN . . . -120.27 -66.38 1.07 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.199 -0.938 . . . . 0.0 109.778 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.6 -37.95 1.88 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.794 -1.723 . . . . 0.0 108.794 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.559 ' CZ ' HG22 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -59.0 177.47 0.15 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.386 -1.067 . . . . 0.0 109.415 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.49 140.47 29.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 110.439 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.559 HG22 ' CZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -149.28 135.64 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.342 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.6 p -132.66 117.0 15.09 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.168 -0.957 . . . . 0.0 109.617 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 40' ' ' ALA . 6.2 Cg_exo -58.07 117.11 3.76 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.952 1.768 . . . . 0.0 110.384 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 39' ' ' PRO . . . 162.91 -63.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 109.005 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -68.08 -12.36 60.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.147 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.88 -24.55 42.13 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -68.69 -52.37 31.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -1.12 . . . . 0.0 109.324 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.9 m -57.86 -25.8 61.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.358 -0.838 . . . . 0.0 109.243 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.504 ' HG ' ' CE1' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -65.13 -43.8 90.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.279 -0.888 . . . . 0.0 109.493 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.71 -30.84 70.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 109.893 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 p -66.11 -30.87 71.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.278 -0.889 . . . . 0.0 110.086 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.07 -10.97 59.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.126 -0.984 . . . . 0.0 109.904 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CE1' ' HG ' ' A' ' 45' ' ' LEU . 4.4 m-85 -90.41 17.61 7.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.928 . . . . 0.0 109.583 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -98.75 5.52 47.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 0.0 109.35 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -176.47 162.66 2.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.317 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 56' ' ' ARG . . . -101.26 -2.02 32.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.545 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 1.4 m-20 -75.7 -54.65 2.19 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 110.129 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.545 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 3.5 Cg_exo -61.57 -11.31 19.62 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.007 1.805 . . . . 0.0 110.686 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.451 HG13 ' HA ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -118.62 -11.08 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.993 . . . . 0.0 109.658 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.511 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -97.89 44.59 1.04 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 0.0 109.264 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -169.85 -58.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.126 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.9 p -94.73 -25.8 16.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.334 -0.854 . . . . 0.0 109.298 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.64 -152.58 20.61 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -142.66 -174.66 4.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -1.073 . . . . 0.0 109.342 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.46 136.37 17.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.144 -0.972 . . . . 0.0 109.812 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.6 mp -82.23 -138.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 108.944 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.5 41.72 0.86 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.942 -1.099 . . . . 0.0 110.328 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.94 0.59 5.57 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.66 140.6 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.175 -1.191 . . . . 0.0 109.748 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.471 ' N ' ' CD2' ' A' ' 66' ' ' HIS . 3.6 m170 -106.14 108.9 20.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 109.565 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.12 166.4 12.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.177 -0.952 . . . . 0.0 109.257 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.0 p -118.57 170.1 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.197 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.485 ' CG2' ' HB3' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -144.88 154.78 42.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 109.432 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 tp -124.36 -67.09 0.94 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.291 -0.88 . . . . 0.0 109.442 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.409 ' O ' ' O ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -107.11 51.63 0.74 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.565 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.485 ' HB3' ' CG2' ' A' ' 69' ' ' THR . . . -54.54 -172.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -145.34 -150.82 0.34 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.545 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -111.61 -52.21 2.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.97 . . . . 0.0 109.527 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.405 HH11 ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -96.79 2.7 52.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 109.785 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.456 ' O ' HG13 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -142.19 140.58 32.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.872 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 76' ' ' SER . 2.2 mp -158.38 104.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 109.247 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.473 ' HB3' ' HA ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -108.15 120.64 42.93 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.273 -0.892 . . . . 0.0 108.659 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.92 157.79 49.09 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.461 ' HE3' ' HG3' ' A' ' 106' ' ' PRO . 1.2 mmmp? -151.12 118.64 6.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -1.085 . . . . 0.0 109.471 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.16 141.8 16.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.994 . . . . 0.0 109.429 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 55.16 -126.22 38.23 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.34 18.1 17.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.139 -1.212 . . . . 0.0 109.661 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.09 128.96 33.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.746 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.536 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -132.73 164.59 24.02 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 78' ' ' TYR . 1.8 m -127.77 149.48 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.022 -1.281 . . . . 0.0 110.165 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.481 ' HB ' ' HA3' ' A' ' 98' ' ' GLY . 6.5 mt -116.5 83.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.7 OUTLIER -89.26 142.2 27.86 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.239 -0.913 . . . . 0.0 110.303 -178.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.4 t -150.13 154.24 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -109.22 121.82 45.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.005 -1.06 . . . . 0.0 109.802 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 92' ' ' SER . 0.0 OUTLIER -92.26 -55.11 3.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.291 -0.881 . . . . 0.0 109.535 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.429 ' HB3' ' C ' ' A' ' 125' ' ' PHE . 9.3 t 171.51 -31.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.067 -1.021 . . . . 0.0 109.95 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.4 mttm -128.75 -28.53 2.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.015 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.525 ' OG ' ' CE2' ' A' ' 29' ' ' TRP . 39.8 m -135.34 152.45 51.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.044 -1.035 . . . . 0.0 109.847 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.505 HG13 ' N ' ' A' ' 24' ' ' LEU . 14.4 mt -94.08 142.33 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.346 -0.846 . . . . 0.0 109.32 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.572 HD21 ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -107.0 148.52 28.58 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.542 ' CG2' HD21 ' A' ' 22' ' ' LEU . 39.8 t -140.25 131.89 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.995 -1.066 . . . . 0.0 110.215 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.481 ' HA3' ' HB ' ' A' ' 87' ' ' ILE . . . -104.86 102.91 2.13 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 107.444 -2.262 . . . . 0.0 107.444 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.495 HG22 ' CA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -96.73 123.42 49.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.248 -1.148 . . . . 0.0 109.238 -178.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.536 ' CZ ' ' HA3' ' A' ' 85' ' ' GLY . 3.4 p90 -132.52 164.2 27.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.298 -0.876 . . . . 0.0 109.491 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -149.22 -170.41 3.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.506 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 60.81 22.14 12.2 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.175 -0.953 . . . . 0.0 109.371 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.43 82.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.589 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.512 HD11 HG22 ' A' ' 104' ' ' ILE . 4.0 mt -97.27 147.66 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.155 -0.966 . . . . 0.0 109.283 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.503 ' N ' HG21 ' A' ' 104' ' ' ILE . 1.7 mp0 -50.88 109.38 1.32 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.307 -0.871 . . . . 0.0 109.546 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.461 ' HG3' ' HE3' ' A' ' 80' ' ' LYS . 2.4 Cg_endo -62.13 -35.26 76.35 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.921 1.748 . . . . 0.0 110.167 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.2 47.18 3.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.6 m -148.36 -39.2 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 109.414 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.521 ' CB ' ' HB2' ' A' ' 15' ' ' ALA . . . -88.12 -18.94 27.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.604 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.53 -46.98 24.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -63.75 -42.04 97.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.429 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 89.3 t -62.74 -26.4 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.239 -0.913 . . . . 0.0 109.565 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.6 t -87.55 -22.86 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.366 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -63.89 -42.41 97.49 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.229 -0.919 . . . . 0.0 109.307 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -78.32 -51.24 10.41 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.363 -0.836 . . . . 0.0 109.226 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.554 HD23 ' CE2' ' A' ' 5' ' ' TYR . 4.1 tp -49.67 -33.09 14.74 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.154 -0.966 . . . . 0.0 109.109 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.532 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -62.24 -47.91 82.31 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.248 -0.907 . . . . 0.0 108.584 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.432 ' HA ' HD11 ' A' ' 121' ' ' ILE . 0.1 OUTLIER -62.09 -15.79 47.69 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.492 -0.755 . . . . 0.0 109.088 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.493 ' CE2' HD13 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -83.65 -47.58 11.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.431 -0.793 . . . . 0.0 108.988 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.493 HD13 ' CE2' ' A' ' 119' ' ' TYR . 0.4 OUTLIER -80.92 -7.67 59.56 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.357 -0.839 . . . . 0.0 109.591 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.532 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 26.6 mt -90.13 -20.94 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.31 -0.869 . . . . 0.0 109.347 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.92 -0.31 25.65 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -140.7 -47.27 0.41 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -1.147 . . . . 0.0 109.472 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.408 ' HA3' ' CD2' ' A' ' 120' ' ' LEU . . . -74.88 -102.31 0.1 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.191 -1.182 . . . . 0.0 109.261 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.43 ' CB ' HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.596 ' CE2' HD12 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -67.2 94.52 0.36 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.11 -0.994 . . . . 0.0 109.675 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.83 -79.72 0.33 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.734 -1.229 . . . . 0.0 108.219 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -17.59 61.85 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.545 ' HB3' ' HB2' ' A' ' 10' ' ' LEU . 9.9 m-30 -75.35 -39.34 59.41 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.503 ' HB ' ' O ' ' A' ' 2' ' ' TRP . 1.2 t -54.2 -48.42 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.586 -0.696 . . . . 0.0 110.027 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.496 ' O ' HG22 ' A' ' 8' ' ' THR . 5.5 t0 -90.91 52.37 2.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 112.513 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER 176.78 -87.49 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.26 -1.525 . . . . 0.0 112.783 178.465 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 11' ' ' VAL . 14.0 m120 -83.43 -92.06 0.07 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.105 -0.997 . . . . 0.0 112.494 -176.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.596 HD12 ' CE2' ' A' ' 2' ' ' TRP . 3.0 mt -23.79 -41.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' A' ' 9' ' ' ASN . 72.2 t -89.61 -57.42 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.576 -1.327 . . . . 0.0 110.523 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.502 ' C ' ' CG2' ' A' ' 13' ' ' THR . . . -40.65 -47.56 3.89 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 108.741 -1.743 . . . . 0.0 108.741 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.552 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER 166.72 38.63 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.708 -0.878 . . . . 0.0 108.932 178.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -82.67 15.35 31.36 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 157.99 -27.58 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 23.5 m -143.4 154.34 16.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.2 OUTLIER -83.95 17.41 2.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.974 -1.079 . . . . 0.0 109.533 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.538 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 0.3 OUTLIER -176.99 177.47 1.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.548 ' CB ' HG23 ' A' ' 11' ' ' VAL . . . 179.19 158.04 0.58 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.84 -1.162 . . . . 0.0 110.265 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.488 ' O ' HD11 ' A' ' 22' ' ' LEU . . . -153.94 117.71 4.7 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.575 HD12 ' CD1' ' A' ' 2' ' ' TRP . 6.9 mm -82.63 113.39 21.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.221 -0.924 . . . . 0.0 109.19 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.585 ' CD2' ' CG2' ' A' ' 97' ' ' VAL . 0.4 OUTLIER -96.32 117.14 30.21 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.537 -0.727 . . . . 0.0 109.566 -178.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -50.7 179.98 0.03 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -121.37 -8.98 9.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -1.192 . . . . 0.0 109.659 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -111.58 26.96 10.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.932 . . . . 0.0 109.537 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.08 70.44 1.31 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -171.62 -164.99 0.35 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -1.158 . . . . 0.0 109.331 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.05 111.09 7.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.168 -0.957 . . . . 0.0 109.58 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 36.5 m0 -83.91 -33.63 24.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.461 ' HB2' ' CG1' ' A' ' 21' ' ' ILE . . . -164.9 158.98 17.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.285 -0.884 . . . . 0.0 109.399 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.3 t -152.31 141.55 21.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.159 -0.963 . . . . 0.0 109.812 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.558 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -130.13 119.97 23.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.396 -0.815 . . . . 0.0 108.998 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 32' ' ' SER . . . 81.73 159.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.589 -0.694 . . . . 0.0 109.375 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 33' ' ' ALA . . . -43.45 -93.25 0.01 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.522 ' CZ ' HG23 ' A' ' 99' ' ' VAL . 0.9 OUTLIER 68.75 94.73 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -1.139 . . . . 0.0 109.533 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.52 100.3 10.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.385 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.434 ' HB ' ' HG2' ' A' ' 41' ' ' GLN . 1.8 t -109.28 166.24 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.876 . . . . 0.0 109.529 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.472 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -50.22 153.55 2.42 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.372 -0.83 . . . . 0.0 109.545 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.459 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 5.3 Cg_exo -58.97 -16.07 30.55 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.159 1.906 . . . . 0.0 110.436 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.52 56.89 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.222 -0.924 . . . . 0.0 109.48 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 38' ' ' THR . 3.9 mp0 -51.67 -37.05 48.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.026 -1.046 . . . . 0.0 109.265 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.31 -39.58 70.73 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -63.15 -37.41 87.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -1.194 . . . . 0.0 110.033 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.1 m -62.46 -51.66 66.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.186 -0.946 . . . . 0.0 109.668 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.406 HD23 HG23 ' A' ' 95' ' ' ILE . 2.1 mp -65.73 -23.32 66.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 109.75 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.572 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . . . -62.92 -37.15 85.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.94 . . . . 0.0 109.674 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.8 m -76.98 -28.39 55.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.539 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.61 -14.22 62.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.548 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.572 ' CD2' ' HA ' ' A' ' 46' ' ' ALA . 23.2 m-85 -76.51 -39.54 52.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.94 . . . . 0.0 109.398 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -87.48 -66.73 0.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.129 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -117.3 140.73 49.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 0.0 109.117 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB3' HD12 ' A' ' 55' ' ' ILE . . . -135.64 33.57 2.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -0.958 . . . . 0.0 109.767 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.608 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -68.22 -45.28 39.22 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.377 -0.827 . . . . 0.0 110.652 179.707 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 6.3 Cg_exo -59.44 -18.71 47.74 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.524 1.483 . . . . 0.0 110.595 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.602 ' CD1' ' CB ' ' A' ' 72' ' ' ALA . 1.1 pt -105.7 -19.03 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 109.163 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.425 HH11 ' CG ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -76.79 -37.48 55.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.364 -0.835 . . . . 0.0 109.655 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 56' ' ' ARG . . . -43.87 -71.56 0.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 0.0 109.74 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 t -118.83 -47.12 2.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.636 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' A' ' 68' ' ' VAL . . . 166.01 -163.42 36.77 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.94 161.16 17.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -1.146 . . . . 0.0 109.475 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.42 104.79 12.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 109.708 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.88 112.67 25.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.865 . . . . 0.0 109.514 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 49.71 -143.38 0.54 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.567 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.87 46.89 3.75 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.574 HG12 ' CE2' ' A' ' 67' ' ' TYR . 3.4 t -142.34 138.93 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -1.179 . . . . 0.0 108.963 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.407 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 75.9 t60 -121.46 118.91 30.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 0.0 109.77 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.574 ' CE2' HG12 ' A' ' 65' ' ' VAL . 15.9 m-85 -131.73 177.62 7.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 109.241 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.465 ' CG2' ' N ' ' A' ' 69' ' ' THR . 7.7 p -104.42 166.16 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.268 -0.895 . . . . 0.0 109.846 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.465 ' N ' ' CG2' ' A' ' 68' ' ' VAL . 1.4 m -95.49 176.76 6.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.933 . . . . 0.0 109.173 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.446 HD21 ' O ' ' A' ' 69' ' ' THR . 0.2 OUTLIER -141.33 -48.42 0.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.141 -0.974 . . . . 0.0 110.234 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 76' ' ' SER . 13.8 ttm180 -142.8 61.38 1.42 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.947 -1.096 . . . . 0.0 110.153 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.602 ' CB ' ' CD1' ' A' ' 55' ' ' ILE . . . -85.34 81.66 8.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.123 -0.985 . . . . 0.0 109.393 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -154.88 -38.56 0.09 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.284 -0.885 . . . . 0.0 109.477 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.93 -100.18 0.35 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.761 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.452 ' NH1' ' CG ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -129.11 -16.23 4.07 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.882 -1.136 . . . . 0.0 110.106 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.558 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 6.1 m -89.37 131.82 35.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.827 -1.17 . . . . 0.0 109.415 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.465 ' O ' ' CG2' ' A' ' 77' ' ' ILE . 4.7 mp -149.21 60.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 110.116 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.558 ' CE1' ' HB3' ' A' ' 76' ' ' SER . 0.1 OUTLIER -90.51 161.31 15.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.036 -1.04 . . . . 0.0 108.333 179.008 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.82 158.25 14.45 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.444 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 19.3 mtmt -145.34 132.64 20.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -1.09 . . . . 0.0 109.375 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.9 OUTLIER 171.63 128.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 109.508 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 83' ' ' SER . . . 56.96 54.78 34.23 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 82' ' ' GLY . 0.6 OUTLIER 43.79 26.77 0.14 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -1.151 . . . . 0.0 109.61 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.493 ' HA ' ' CE2' ' A' ' 100' ' ' TYR . . . -145.34 153.36 41.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.205 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 179.5 -166.79 36.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.38 179.91 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -1.149 . . . . 0.0 109.649 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.48 ' HB ' ' CA ' ' A' ' 98' ' ' GLY . 36.4 mm -142.85 68.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.104 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 1.2 p -99.93 116.86 32.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 110.028 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.36 150.99 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.428 -0.795 . . . . 0.0 108.963 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.455 ' HG3' HG12 ' A' ' 95' ' ' ILE . 1.8 mtpt -98.35 149.97 22.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.147 -0.97 . . . . 0.0 109.778 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.6 p -123.42 -138.75 0.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.808 . . . . 0.0 108.871 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.461 ' HB2' ' HA ' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -66.64 -17.01 64.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.858 -1.151 . . . . 0.0 109.302 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.562 ' HB2' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER 167.49 66.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 p 176.86 156.58 0.28 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.347 -0.845 . . . . 0.0 109.126 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.455 HG12 ' HG3' ' A' ' 90' ' ' LYS . 14.7 mt -129.39 100.67 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.037 -1.039 . . . . 0.0 109.831 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.492 ' CD2' ' CZ2' ' A' ' 2' ' ' TRP . 2.9 pp -78.42 137.85 38.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 108.954 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.585 ' CG2' ' CD2' ' A' ' 22' ' ' LEU . 11.9 t -117.4 81.28 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.139 -0.976 . . . . 0.0 110.183 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.48 ' CA ' ' HB ' ' A' ' 87' ' ' ILE . . . -74.47 110.5 3.1 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.522 HG23 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.62 127.74 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -1.228 . . . . 0.0 109.44 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.494 ' HB3' HG11 ' A' ' 16' ' ' VAL . 22.4 p90 -130.97 173.01 11.41 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 109.941 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -122.48 -141.49 0.32 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.597 -0.689 . . . . 0.0 109.372 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 103' ' ' LYS . 4.3 pt-20 -79.15 -19.15 51.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.111 -0.993 . . . . 0.0 109.422 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.431 ' N ' ' HG3' ' A' ' 102' ' ' GLU . 65.7 mttt -58.17 -25.28 61.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.387 -0.82 . . . . 0.0 109.833 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.7 mt -127.41 143.47 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.014 -1.054 . . . . 0.0 109.541 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.433 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -102.48 158.26 32.1 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 109.33 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 105' ' ' GLN . 2.1 Cg_endo -61.78 153.87 64.77 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.165 1.91 . . . . 0.0 110.195 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.7 -61.57 0.32 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.5 m -75.68 -22.44 56.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -1.125 . . . . 0.0 109.714 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.68 -38.11 59.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.628 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.96 -38.36 32.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 109.683 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 114' ' ' GLU . 2.6 t30 -63.74 -41.16 98.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.134 -0.979 . . . . 0.0 109.641 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.514 HG12 ' CB ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -65.41 -42.95 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.357 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.93 -15.53 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.896 . . . . 0.0 109.64 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 111' ' ' ASN . 5.3 tp10 -67.79 -63.63 1.02 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.239 -0.913 . . . . 0.0 109.625 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -27.1 66.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.178 -0.951 . . . . 0.0 109.753 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -47.11 87.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.112 -0.993 . . . . 0.0 110.122 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.505 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -78.21 -33.21 50.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 109.937 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -57.25 -17.74 13.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 109.854 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.44 -57.4 2.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 110.065 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -70.66 -1.96 12.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.135 -0.978 . . . . 0.0 110.689 -178.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.505 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -70.03 -36.65 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.965 -1.084 . . . . 0.0 108.97 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 123' ' ' GLN . . . -108.72 42.56 1.92 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 122' ' ' GLY . 53.9 mm-40 -147.01 -84.1 0.11 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -1.166 . . . . 0.0 109.864 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.457 ' O ' ' OXT' ' A' ' 125' ' ' PHE . . . -136.7 63.98 0.57 Allowed Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.253 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.562 ' CD1' ' HB2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.241 -1.153 . . . . 0.0 109.625 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.491 ' HB3' HG12 ' A' ' 21' ' ' ILE . 37.4 m . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.577 ' CH2' ' HG ' ' A' ' 96' ' ' LEU . 3.4 m95 -147.73 155.77 42.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.403 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 2' ' ' TRP . 3.0 mp0 -39.09 -92.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.405 -0.809 . . . . 0.0 111.408 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 8' ' ' THR . 91.5 m -57.42 -49.14 77.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.347 -0.846 . . . . 0.0 110.961 -178.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.552 ' HB3' ' CB ' ' A' ' 10' ' ' LEU . 15.3 m-30 -50.92 -18.42 0.76 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.156 -0.965 . . . . 0.0 110.23 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.48 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -79.61 -46.85 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.945 -1.097 . . . . 0.0 109.361 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.48 51.42 1.88 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 0.0 111.982 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -166.23 -100.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.36 -1.462 . . . . 0.0 110.892 179.002 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -102.25 -59.35 1.72 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.051 -1.03 . . . . 0.0 110.824 -178.632 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.552 ' CB ' ' HB3' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -33.49 -33.26 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.622 -0.674 . . . . 0.0 110.99 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.546 HG23 ' CB ' ' A' ' 19' ' ' ALA . 2.8 t -99.53 -48.21 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.032 -1.042 . . . . 0.0 109.689 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -40.81 -45.13 3.6 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.527 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER 159.66 39.72 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.88 -0.777 . . . . 0.0 109.601 178.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -84.23 20.04 15.28 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 154.1 -33.55 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.53 ' HA ' ' CD1' ' A' ' 104' ' ' ILE . 11.9 m -136.44 134.56 49.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.554 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 9.2 t -78.4 2.61 18.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.85 -1.156 . . . . 0.0 109.387 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.554 ' CG ' ' O ' ' A' ' 17' ' ' THR . 71.7 mt-30 -162.6 155.34 19.43 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.546 ' CB ' HG23 ' A' ' 11' ' ' VAL . . . -158.9 152.51 23.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.117 -0.989 . . . . 0.0 109.72 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -138.6 142.11 39.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.947 . . . . 0.0 109.455 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.513 HD13 ' N ' ' A' ' 2' ' ' TRP . 0.7 OUTLIER -109.32 79.96 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.144 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.555 ' CD1' HG23 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -62.44 -153.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 108.649 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.423 ' C ' HG13 ' A' ' 95' ' ' ILE . . . -143.1 140.49 9.75 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.565 -1.302 . . . . 0.0 109.986 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.517 ' CD2' HG12 ' A' ' 95' ' ' ILE . 9.1 mt -68.68 -44.19 74.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -1.137 . . . . 0.0 109.263 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -129.27 2.45 5.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.584 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.35 -102.53 2.15 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.447 ' O ' ' OG1' ' A' ' 28' ' ' THR . 22.4 t-20 -176.91 -46.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -1.122 . . . . 0.0 109.576 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 27' ' ' ASN . 7.8 m -167.17 116.81 0.85 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.887 . . . . 0.0 109.666 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.413 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 19.0 m0 -96.78 -34.46 11.31 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.271 -0.893 . . . . 0.0 109.366 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.98 170.72 6.16 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -161.39 -179.27 7.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.059 -1.026 . . . . 0.0 109.945 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.5 ' HB2' HG13 ' A' ' 11' ' ' VAL . 51.9 p 177.74 67.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.531 -0.731 . . . . 0.0 109.23 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.569 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . . . -142.08 -39.39 0.37 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.482 -0.761 . . . . 0.0 109.169 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.3 -52.94 0.95 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.569 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -61.22 162.2 7.86 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -1.094 . . . . 0.0 109.385 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.08 148.54 29.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 109.379 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.465 ' HA ' ' HB1' ' A' ' 63' ' ' ALA . 61.4 t -102.17 158.69 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.193 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.464 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 6.0 t -43.14 147.19 0.72 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.437 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 6.1 Cg_exo -58.77 -14.07 20.57 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.153 1.902 . . . . 0.0 110.311 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' CB ' ' HB3' ' A' ' 43' ' ' GLN . . . -107.8 59.3 0.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.917 . . . . 0.0 109.409 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -65.56 -52.68 50.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.93 -1.107 . . . . 0.0 109.765 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.88 -12.71 84.33 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.528 ' HB3' ' CB ' ' A' ' 40' ' ' ALA . 1.5 tt0 -89.98 -20.97 22.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -1.149 . . . . 0.0 109.475 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.454 ' O ' ' HB1' ' A' ' 48' ' ' ALA . 98.1 m -90.1 -29.72 18.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.498 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.518 ' O ' ' CD2' ' A' ' 49' ' ' PHE . 4.2 mm? -87.7 -40.55 14.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.726 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.37 -25.26 60.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 109.995 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.3 t -88.59 -19.6 26.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.124 -0.985 . . . . 0.0 109.779 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 44' ' ' THR . . . -85.18 -14.25 47.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.103 -0.998 . . . . 0.0 109.689 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.518 ' CD2' ' O ' ' A' ' 45' ' ' LEU . 19.6 m-85 -74.32 -33.0 63.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.658 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -94.11 -20.78 19.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.939 . . . . 0.0 109.303 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -131.55 120.85 23.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 0.0 109.342 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.454 ' HA ' HD12 ' A' ' 55' ' ' ILE . . . -119.84 28.71 7.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 109.554 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.557 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -76.57 -51.42 2.43 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.333 -0.855 . . . . 0.0 110.458 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.7 Cg_endo -64.61 -4.81 9.0 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.113 1.875 . . . . 0.0 111.357 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.533 ' O ' ' CB ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -112.53 7.62 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.748 -1.22 . . . . 0.0 110.101 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -100.07 -20.38 16.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.891 -1.13 . . . . 0.0 109.604 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.87 -60.9 1.2 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.22 -0.925 . . . . 0.0 109.537 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -78.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.374 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.41 -165.02 28.34 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.48 ' HB2' ' HB2' ' A' ' 67' ' ' TYR . 7.0 m-85 -81.28 170.82 15.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -1.126 . . . . 0.0 109.684 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -141.33 101.04 3.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.495 -0.753 . . . . 0.0 108.973 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.455 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 5.9 mp -127.1 61.17 1.36 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.203 -0.936 . . . . 0.0 109.932 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 64' ' ' GLY . . . 69.47 -83.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.365 -0.834 . . . . 0.0 110.015 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -38.72 -95.54 0.01 OUTLIER Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.77 -148.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.084 -1.245 . . . . 0.0 109.238 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.47 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 31.6 p-80 -122.21 144.03 49.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.153 -0.967 . . . . 0.0 109.73 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.48 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 25.9 m-85 -100.81 -161.94 0.9 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.362 -0.836 . . . . 0.0 109.233 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 80' ' ' LYS . 1.4 p -104.32 -171.22 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.052 -1.03 . . . . 0.0 109.287 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.533 ' CB ' ' O ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -148.56 64.71 1.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.11 -0.994 . . . . 0.0 109.549 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.84 18.33 7.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.92 . . . . 0.0 109.211 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -161.87 55.9 0.25 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.454 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.424 ' CB ' ' CG2' ' A' ' 69' ' ' THR . . . -123.46 66.35 1.01 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.735 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.85 -42.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.938 . . . . 0.0 109.635 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 2.2 m-20 -49.65 -86.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.597 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.525 ' HG2' ' NH1' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -145.22 -59.85 0.35 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.897 . . . . 0.0 109.388 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 78' ' ' TYR . 74.2 m -89.6 -165.41 1.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.416 ' CG1' ' O ' ' A' ' 76' ' ' SER . 13.9 mt -154.61 105.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.009 -1.057 . . . . 0.0 109.704 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 78' ' ' TYR . 0.6 OUTLIER -113.52 97.08 6.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 0.0 109.06 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.455 ' HA3' HG11 ' A' ' 86' ' ' VAL . . . -60.31 141.38 47.88 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.529 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -151.05 124.62 9.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -1.101 . . . . 0.0 109.417 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.67 132.72 1.51 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.141 -0.974 . . . . 0.0 109.676 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.5 -136.07 47.41 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.18 -10.15 24.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -1.114 . . . . 0.0 109.704 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 101' ' ' ASN . . . -109.48 -173.91 2.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 109.463 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.03 171.06 28.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.455 HG11 ' HA3' ' A' ' 79' ' ' GLY . 3.4 p -123.99 153.8 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -1.184 . . . . 0.0 109.55 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.47 HD11 ' HB3' ' A' ' 78' ' ' TYR . 30.2 mm -127.31 94.67 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.033 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 1.4 p -108.97 129.7 55.45 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.143 -0.973 . . . . 0.0 109.985 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.425 ' O ' HD21 ' A' ' 96' ' ' LEU . 2.4 t -142.23 143.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -103.1 120.52 40.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.119 -0.988 . . . . 0.0 109.907 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.52 ' HB ' ' CB ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -96.34 -59.13 1.9 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.412 -0.805 . . . . 0.0 108.969 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.577 ' HB3' ' CD2' ' A' ' 125' ' ' PHE . 0.2 OUTLIER 171.86 -32.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.41 -0.806 . . . . 0.0 109.769 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.5 ' CA ' HD11 ' A' ' 24' ' ' LEU . 2.3 mmmt -135.85 2.51 2.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.045 -1.034 . . . . 0.0 110.13 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.493 ' N ' HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -156.1 146.31 21.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.021 -1.05 . . . . 0.0 109.692 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.517 HG12 ' CD2' ' A' ' 24' ' ' LEU . 15.2 mt -105.9 139.68 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 0.0 109.298 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.577 ' HG ' ' CH2' ' A' ' 2' ' ' TRP . 0.4 OUTLIER -92.46 154.55 18.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.032 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.555 HG23 ' CD1' ' A' ' 22' ' ' LEU . 39.9 t -150.4 68.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.264 -0.897 . . . . 0.0 109.665 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.87 106.91 1.79 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -109.88 127.81 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.958 -1.319 . . . . 0.0 109.538 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.599 ' CD1' ' N ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -142.54 144.15 32.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.396 -0.815 . . . . 0.0 109.428 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.496 ' O ' ' CB ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -150.4 114.48 5.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.067 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.1 OUTLIER 163.45 -61.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.456 -0.777 . . . . 0.0 109.393 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -174.93 33.14 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.397 -0.814 . . . . 0.0 109.906 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.535 ' CD1' ' CB ' ' A' ' 100' ' ' TYR . 48.6 mt -84.27 83.6 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -0.959 . . . . 0.0 108.981 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -54.11 149.69 17.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 109.954 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.77 156.45 61.6 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.309 2.006 . . . . 0.0 110.183 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.55 -2.71 46.06 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.65 -39.67 2.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -1.193 . . . . 0.0 109.505 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 15' ' ' ALA . . . -83.93 -27.69 28.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.287 -0.883 . . . . 0.0 109.446 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.464 ' O ' ' OE1' ' A' ' 114' ' ' GLU . . . -83.07 -21.18 33.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.136 -0.977 . . . . 0.0 109.28 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -78.83 -29.26 44.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 11.5 t -83.08 -39.13 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.301 -0.875 . . . . 0.0 109.39 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.445 ' O ' ' CB ' ' A' ' 117' ' ' ALA . 38.4 t -68.92 -16.25 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.053 -1.029 . . . . 0.0 109.435 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.464 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -81.32 -56.36 4.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.61 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 118' ' ' ASP . 5.4 ttmt -79.0 -52.78 7.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.748 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 1.6 tp -51.87 -47.09 64.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -0.959 . . . . 0.0 109.522 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.526 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -67.93 -35.69 78.86 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.074 -1.016 . . . . 0.0 109.05 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 115' ' ' LYS . 24.1 t0 -47.56 -25.84 1.26 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.134 -0.979 . . . . 0.0 109.266 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -81.32 -51.1 8.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.277 -0.89 . . . . 0.0 109.261 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.488 ' HB3' ' O ' ' A' ' 125' ' ' PHE . 3.8 mt -71.25 -3.1 18.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.399 -0.813 . . . . 0.0 110.072 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 1.2 mp -75.99 -28.41 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.065 -1.022 . . . . 0.0 108.554 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -123.74 29.24 5.23 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.35 57.55 0.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -1.113 . . . . 0.0 109.687 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.507 ' C ' ' CD1' ' A' ' 125' ' ' PHE . . . 104.71 17.72 14.22 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.577 ' CD2' ' HB3' ' A' ' 92' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.743 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.344 0.592 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.611 ' CD1' ' CD1' ' A' ' 5' ' ' TYR . 1.1 m-90 -105.66 23.96 13.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.421 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.55 -80.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.076 -1.015 . . . . 0.0 109.787 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.545 ' O ' ' CG2' ' A' ' 8' ' ' THR . 8.8 t -59.57 -39.21 83.33 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.617 ' CE1' ' CD1' ' A' ' 10' ' ' LEU . 4.9 t80 -40.14 -36.51 0.51 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.033 0.92 . . . . 0.0 109.172 177.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.506 ' HA ' HG22 ' A' ' 11' ' ' VAL . 39.7 t -99.37 -29.51 3.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 121.046 -1.034 . . . . 0.0 111.325 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -91.75 52.25 1.99 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.702 -1.249 . . . . 0.0 112.826 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.545 ' CG2' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER 179.61 -94.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.21 -1.556 . . . . 0.0 111.322 178.182 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.7 t-20 -101.89 -66.33 0.93 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.197 -0.94 . . . . 0.0 111.124 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.617 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -33.88 -31.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.867 -0.521 . . . . 0.0 111.6 -178.411 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 9' ' ' ASN . 0.6 OUTLIER -95.39 -56.66 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.751 -1.218 . . . . 0.0 109.745 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -38.79 -37.38 0.57 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.831 -1.707 . . . . 0.0 108.831 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.538 ' CB ' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 159.05 39.64 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.95 -0.735 . . . . 0.0 109.196 178.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -81.29 16.55 16.92 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 107.776 -2.13 . . . . 0.0 107.776 177.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 154.99 -27.09 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.413 HG22 ' HB3' ' A' ' 19' ' ' ALA . 5.2 m -140.4 137.29 36.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.483 ' O ' ' OE1' ' A' ' 18' ' ' GLN . 34.5 p -79.38 6.44 10.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.922 -1.111 . . . . 0.0 109.436 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.483 ' OE1' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -167.39 161.95 14.38 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.467 ' HB1' HG21 ' A' ' 11' ' ' VAL . . . -174.01 171.59 3.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.956 -1.09 . . . . 0.0 110.079 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -161.98 157.07 23.13 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.286 -0.884 . . . . 0.0 109.774 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.565 ' CD1' ' HB2' ' A' ' 2' ' ' TRP . 10.9 mt -115.45 94.63 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -85.27 128.55 34.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.666 -0.646 . . . . 0.0 109.284 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.582 ' HA2' ' CZ3' ' A' ' 29' ' ' TRP . . . -48.19 167.0 0.16 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.51 HD21 ' CG1' ' A' ' 95' ' ' ILE . 16.2 mt -77.12 -11.96 59.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.349 -1.089 . . . . 0.0 109.276 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 27' ' ' ASN . 5.3 t70 -120.08 57.79 0.93 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.703 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 52.3 69.72 1.1 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 25' ' ' ASP . 8.4 m120 -147.31 -149.89 0.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.282 -1.128 . . . . 0.0 109.519 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -155.26 158.85 39.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.358 -0.839 . . . . 0.0 109.182 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.582 ' CZ3' ' HA2' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -145.33 -41.04 0.23 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -0.986 . . . . 0.0 109.905 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.467 ' O ' HG13 ' A' ' 21' ' ' ILE . . . -165.1 118.58 1.24 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.999 -1.063 . . . . 0.0 110.15 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 9.3 t -131.86 164.36 26.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.651 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.552 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 3.4 m -147.79 147.55 29.97 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.338 -0.851 . . . . 0.0 109.475 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 32' ' ' SER . . . 81.4 172.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 33' ' ' ALA . . . -60.64 -132.58 0.01 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.544 ' CE2' HG23 ' A' ' 99' ' ' VAL . 91.0 t80 58.81 93.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.031 -1.276 . . . . 0.0 109.203 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.2 124.42 50.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 109.648 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 65.5 t -97.92 106.0 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.514 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -71.22 162.01 75.04 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.285 -0.884 . . . . 0.0 109.529 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.514 ' HD2' ' CG2' ' A' ' 38' ' ' THR . 2.4 Cg_endo -61.58 108.81 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.18 1.92 . . . . 0.0 110.004 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 39' ' ' PRO . . . 176.24 -71.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.217 -0.927 . . . . 0.0 109.496 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.47 -21.71 65.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.667 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.17 -31.62 61.34 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.468 ' O ' ' OG ' ' A' ' 47' ' ' SER . 4.6 tt0 -74.97 -23.04 58.23 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.388 -1.066 . . . . 0.0 109.374 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.45 ' O ' ' CB ' ' A' ' 48' ' ' ALA . 3.5 m -88.42 -32.72 18.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.233 -0.917 . . . . 0.0 109.301 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.429 HD22 HD11 ' A' ' 95' ' ' ILE . 0.9 OUTLIER -61.91 -47.81 83.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -0.916 . . . . 0.0 109.352 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.49 -46.55 89.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 0.0 109.218 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -82.82 -0.21 46.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.364 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.497 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -82.78 -22.66 34.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 109.716 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -74.76 -0.88 19.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.049 -1.032 . . . . 0.0 109.591 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -88.21 -59.84 2.13 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.188 -0.945 . . . . 0.0 109.953 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 53' ' ' ASP . 2.9 t-20 -126.47 6.35 6.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.025 -1.047 . . . . 0.0 110.175 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 51' ' ' ASN . . . 32.25 35.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.234 0.54 . . . . 0.0 110.445 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.592 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 2.7 t0 -73.9 -49.91 5.74 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.896 . . . . 0.0 110.888 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 6.0 Cg_exo -59.98 -9.59 10.33 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.058 1.838 . . . . 0.0 111.317 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.565 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -106.92 -49.46 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.892 -1.13 . . . . 0.0 109.775 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.475 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 3.6 ptm180 -53.87 -19.33 4.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.051 -1.031 . . . . 0.0 110.084 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.419 ' N ' ' HG3' ' A' ' 56' ' ' ARG . . . -120.6 137.94 54.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.093 -1.005 . . . . 0.0 109.925 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 59' ' ' GLY . 0.6 OUTLIER 49.74 27.24 2.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.405 -0.81 . . . . 0.0 109.653 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 58' ' ' SER . . . 43.39 -136.64 4.44 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 60' ' ' PHE . 2.6 p90 -147.33 143.79 28.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.183 -1.186 . . . . 0.0 109.343 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -101.85 126.86 48.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.266 -0.897 . . . . 0.0 109.765 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -94.51 -160.17 0.76 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.53 -0.731 . . . . 0.0 109.475 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.14 95.3 8.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.4 -23.73 14.49 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -125.53 153.0 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -1.14 . . . . 0.0 108.888 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -149.91 153.58 36.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 109.526 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -141.91 -171.92 3.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.335 -0.853 . . . . 0.0 109.276 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 t -116.89 154.13 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.945 . . . . 0.0 109.602 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.437 HG23 HG23 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -121.88 124.94 45.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.484 -0.76 . . . . 0.0 109.54 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.03 -35.92 1.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.592 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.418 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -119.33 70.76 0.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.463 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.78 28.6 6.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.423 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -99.69 0.07 41.15 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.248 -0.908 . . . . 0.0 109.606 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -105.22 -95.74 0.34 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.975 . . . . 0.0 109.926 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.523 ' NH1' ' HG3' ' A' ' 75' ' ' ARG . 1.0 OUTLIER -142.47 -36.51 0.4 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.028 . . . . 0.0 110.058 -179.493 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 0.6 OUTLIER -89.52 149.87 22.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 109.553 -179.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 76' ' ' SER . 4.3 mp -144.53 70.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 0.0 110.335 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 76' ' ' SER . 0.1 OUTLIER -90.01 93.62 9.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.814 -1.179 . . . . 0.0 108.46 178.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.461 ' O ' HG11 ' A' ' 86' ' ' VAL . . . -79.21 128.44 8.56 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.56 146.38 26.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -1.233 . . . . 0.0 109.61 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.88 148.83 0.55 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.559 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.47 -106.85 2.76 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.2 m -135.95 7.92 3.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -1.121 . . . . 0.0 109.511 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -130.82 178.12 6.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 0.0 109.159 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -169.28 177.45 42.93 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.325 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.482 ' CG2' HG11 ' A' ' 97' ' ' VAL . 9.3 p -153.27 123.63 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.976 . . . . 0.0 108.74 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.6 mt -95.53 99.82 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.177 -0.952 . . . . 0.0 109.793 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 8.6 p -105.95 108.48 20.02 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.535 HG21 ' CE2' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -129.01 173.95 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.927 . . . . 0.0 110.054 -179.174 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.441 ' C ' HG21 ' A' ' 91' ' ' THR . 29.7 mtmt -101.39 142.81 32.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.392 -0.817 . . . . 0.0 108.941 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.554 ' CG2' ' CD2' ' A' ' 96' ' ' LEU . 66.5 p -149.12 -137.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.105 -0.997 . . . . 0.0 109.828 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.445 ' HA ' ' OXT' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -67.52 84.04 0.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.948 -1.095 . . . . 0.0 111.178 -178.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.464 ' HA ' HD12 ' A' ' 24' ' ' LEU . 3.0 mttm 51.04 34.01 10.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -0.855 . . . . 0.0 109.778 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.04 167.35 30.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.051 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.51 ' CG1' HD21 ' A' ' 24' ' ' LEU . 34.5 mt -121.89 123.15 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.239 -0.913 . . . . 0.0 109.135 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.626 ' CD1' ' N ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -75.62 165.12 25.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.08 -1.013 . . . . 0.0 108.928 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.495 HG23 ' CD1' ' A' ' 22' ' ' LEU . 54.0 t -150.91 74.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.389 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -63.78 98.73 0.26 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.544 HG23 ' CE2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -97.28 127.64 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -1.15 . . . . 0.0 109.018 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.525 ' HB2' ' CG1' ' A' ' 104' ' ' ILE . 1.5 p90 -146.82 171.19 15.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 109.878 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -113.7 -149.85 0.45 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.394 -0.816 . . . . 0.0 110.023 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -42.5 89.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.47 -0.768 . . . . 0.0 110.221 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.8 -25.05 1.13 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.525 ' CG1' ' HB2' ' A' ' 100' ' ' TYR . 10.6 mm -103.51 105.72 18.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.053 -1.029 . . . . 0.0 109.698 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.57 142.66 49.99 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.26 -0.9 . . . . 0.0 109.137 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -60.7 149.37 87.91 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.119 1.88 . . . . 0.0 110.503 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.86 -35.46 4.92 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.6 m -83.49 -29.6 27.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -1.182 . . . . 0.0 109.613 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.491 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -89.79 -13.98 35.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.809 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.0 -20.63 23.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.142 -0.974 . . . . 0.0 109.559 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -80.72 -32.67 35.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 0.0 109.695 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 88.8 t -90.05 -35.96 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 110.172 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 109' ' ' ALA . 49.1 t -74.35 -17.6 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.148 -0.97 . . . . 0.0 109.768 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -86.97 -42.4 13.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -0.973 . . . . 0.0 109.972 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -74.06 -40.48 62.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.126 -0.984 . . . . 0.0 109.74 -179.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.2 OUTLIER -60.16 -47.31 86.47 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.215 -0.928 . . . . 0.0 109.564 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.528 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -63.92 -25.91 68.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.644 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -69.2 -25.63 64.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.714 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -76.91 -40.32 47.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.22 -0.925 . . . . 0.0 110.074 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.86 -21.03 34.47 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.163 -0.96 . . . . 0.0 110.06 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 8.1 mt -77.62 -22.64 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 109.331 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.13 -24.48 3.41 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.29 -68.88 0.69 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.405 -1.056 . . . . 0.0 109.673 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 125' ' ' PHE . . . 158.33 110.53 0.29 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.478 ' HB3' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.084 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.693 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.504 ' HB2' ' CD1' ' A' ' 120' ' ' LEU . 3.3 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.629 ' CB ' ' CD1' ' A' ' 21' ' ' ILE . 1.3 m-90 -82.87 7.46 15.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.174 -0.954 . . . . 0.0 109.371 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -89.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 109.189 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.4 t -60.72 -36.82 79.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 108.899 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.511 ' HB3' ' HB2' ' A' ' 10' ' ' LEU . 10.1 m-30 -52.91 -30.89 36.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.455 -0.778 . . . . 0.0 109.41 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.517 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -69.87 -47.87 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.103 -0.998 . . . . 0.0 108.468 179.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.8 45.28 1.24 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.936 -1.103 . . . . 0.0 109.929 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.459 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 54.3 m -156.96 -100.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.83 -1.169 . . . . 0.0 110.704 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.529 ' O ' ' C ' ' A' ' 10' ' ' LEU . 3.8 m120 -100.86 -59.54 1.68 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.112 -0.992 . . . . 0.0 110.64 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.529 ' C ' ' O ' ' A' ' 9' ' ' ASN . 0.5 OUTLIER -29.56 -48.51 0.08 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.304 0.573 . . . . 0.0 110.516 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.554 HG13 ' CB ' ' A' ' 32' ' ' SER . 1.0 OUTLIER -100.27 -23.37 4.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.342 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.503 ' C ' ' CG2' ' A' ' 13' ' ' THR . . . -83.32 57.57 5.06 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.123 -2.391 . . . . 0.0 107.123 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.519 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER 43.25 51.03 5.83 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.987 0.898 . . . . 0.0 110.281 -178.774 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.559 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -100.59 21.76 42.65 Favored Glycine 0 C--N 1.292 -1.871 0 N-CA-C 105.438 -3.065 . . . . 0.0 105.438 176.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.587 ' CB ' ' CG1' ' A' ' 112' ' ' VAL . . . 152.08 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 100' ' ' TYR . 2.7 m -138.78 147.14 25.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.523 ' C ' ' CG ' ' A' ' 18' ' ' GLN . 2.4 p -79.76 10.27 4.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.876 -1.14 . . . . 0.0 109.165 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.523 ' CG ' ' C ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -170.71 174.07 5.1 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.381 -0.824 . . . . 0.0 109.409 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.534 ' CB ' HG21 ' A' ' 11' ' ' VAL . . . -177.36 163.69 2.04 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.485 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -160.59 122.1 3.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.832 -1.168 . . . . 0.0 110.758 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.629 ' CD1' ' CB ' ' A' ' 2' ' ' TRP . 3.1 mm -89.2 104.62 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.4 OUTLIER -83.29 13.47 4.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.39 -0.819 . . . . 0.0 109.934 -178.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 94' ' ' SER . . . 67.67 157.82 0.9 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.461 ' HA ' HG13 ' A' ' 95' ' ' ILE . 14.5 mt -79.94 -58.21 3.28 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.32 -1.106 . . . . 0.0 109.017 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.4 22.18 3.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.484 -0.76 . . . . 0.0 109.009 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.485 ' O ' ' ND2' ' A' ' 27' ' ' ASN . . . -109.84 -110.35 3.29 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 15.6 m120 -149.5 -145.9 0.18 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -1.141 . . . . 0.0 109.351 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 m -71.43 125.5 27.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.088 -1.008 . . . . 0.0 109.525 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -106.19 -40.92 5.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.06 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.15 155.75 23.36 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.429 ' C ' ' OG ' ' A' ' 32' ' ' SER . 0.7 OUTLIER -160.78 172.13 17.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.954 -1.091 . . . . 0.0 110.113 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.554 ' CB ' HG13 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -176.11 109.97 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.314 -0.866 . . . . 0.0 109.516 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 55.35 41.95 30.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 109.394 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -125.65 138.15 10.7 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -49.61 178.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -1.183 . . . . 0.0 109.417 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.01 107.42 19.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.328 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.599 ' O ' ' CB ' ' A' ' 38' ' ' THR . 3.9 t -104.9 163.72 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 109.899 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.748 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.6 OUTLIER 94.65 15.45 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.748 ' CD ' ' N ' ' A' ' 38' ' ' THR . 1.8 Cg_endo -64.67 -20.07 65.06 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 CA-C-N 119.783 0.958 . . . . 0.0 109.611 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 171.74 -66.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.424 -0.797 . . . . 0.0 109.235 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.445 ' O ' ' HB ' ' A' ' 44' ' ' THR . 3.1 mp0 -56.15 -24.82 43.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.91 . . . . 0.0 109.363 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.86 -45.99 55.24 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -57.52 -35.19 69.94 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.236 -1.155 . . . . 0.0 109.103 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 41' ' ' GLN . 63.4 m -57.3 -35.57 69.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.027 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.28 -48.82 75.84 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.17 -23.27 67.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.403 -0.811 . . . . 0.0 109.141 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.0 -20.19 30.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.6 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.34 -24.11 59.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.441 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.564 ' CE2' ' HG2' ' A' ' 90' ' ' LYS . 5.3 m-30 -51.39 -21.63 2.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.217 -0.927 . . . . 0.0 109.314 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -82.68 -37.3 25.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.285 -0.885 . . . . 0.0 109.756 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.92 142.79 33.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.706 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.441 ' HB3' HD13 ' A' ' 55' ' ' ILE . . . -109.33 24.49 13.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 109.017 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.602 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 23.3 m-20 -67.22 -46.07 50.84 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.488 -0.757 . . . . 0.0 110.932 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.9 Cg_exo -56.54 -70.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 121.487 1.458 . . . . 0.0 110.61 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.456 ' C ' ' O ' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -42.07 -27.68 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.186 -0.946 . . . . 0.0 109.497 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -72.05 -75.31 0.14 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.696 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -104.94 93.84 4.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 0.0 109.527 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 3.8 t 162.82 -78.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.228 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.79 -164.82 33.84 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -124.05 111.98 16.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.472 -1.016 . . . . 0.0 108.796 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -81.2 142.98 32.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 0.0 110.283 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 62' ' ' LEU . 9.8 mt -149.26 -166.46 2.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.189 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB3' ' HG3' ' A' ' 39' ' ' PRO . . . -71.83 90.77 1.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 0.0 110.157 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.11 24.67 68.93 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.96 177.15 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.094 -1.239 . . . . 0.0 108.855 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.502 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 0.7 OUTLIER -159.43 114.43 2.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.162 -0.961 . . . . 0.0 109.744 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.57 ' CE1' ' HG3' ' A' ' 81' ' ' LYS . 11.0 m-30 -100.99 -164.02 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -0.895 . . . . 0.0 109.454 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 t -131.43 164.02 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 108.982 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -123.17 117.45 25.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.156 -0.965 . . . . 0.0 109.835 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.62 24.73 4.05 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.571 ' NH1' ' HG3' ' A' ' 71' ' ' ARG . 0.0 OUTLIER 178.55 57.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.334 -0.854 . . . . 0.0 109.146 -179.655 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.479 ' O ' ' C ' ' A' ' 73' ' ' ASP . . . -90.81 20.69 4.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.192 -0.942 . . . . 0.0 109.263 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER 32.48 -107.09 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.102 -0.374 . . . . 0.0 110.743 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -120.88 -52.42 2.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.754 -1.217 . . . . 0.0 110.479 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.429 ' HA ' ' NE ' ' A' ' 75' ' ' ARG . 6.6 tpm_? -130.45 -9.12 4.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.011 -1.056 . . . . 0.0 110.827 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.601 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -88.77 146.98 24.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.937 -1.102 . . . . 0.0 108.795 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.471 ' HB ' ' OG1' ' A' ' 88' ' ' THR . 0.2 OUTLIER -135.76 79.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.69 -1.256 . . . . 0.0 111.004 -179.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.601 ' CE1' ' HB2' ' A' ' 76' ' ' SER . 1.2 m-85 -90.12 76.67 6.89 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.1 178.2 7.99 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.488 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 15.6 mtpp -135.39 146.29 48.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.663 -0.904 . . . . 0.0 109.085 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.57 ' HG3' ' CE1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -114.92 25.67 10.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.998 -1.064 . . . . 0.0 109.396 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.68 -94.9 1.94 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.6 m -78.55 -25.13 45.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.226 -1.161 . . . . 0.0 109.183 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.407 ' HB1' ' HE3' ' A' ' 81' ' ' LYS . . . -111.87 -165.44 0.99 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.279 -0.888 . . . . 0.0 109.25 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 80' ' ' LYS . . . -167.98 143.69 8.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.445 ' O ' HG11 ' A' ' 86' ' ' VAL . 10.0 p -106.44 133.6 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -1.164 . . . . 0.0 110.034 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 36.0 mm -106.83 83.2 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.471 ' OG1' ' HB ' ' A' ' 77' ' ' ILE . 15.5 p -95.72 117.77 31.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.004 -1.06 . . . . 0.0 110.63 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.572 HG23 ' CE2' ' A' ' 78' ' ' TYR . 11.7 t -150.36 166.52 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.564 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -104.4 159.49 15.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.921 -1.112 . . . . 0.0 109.445 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.506 HG22 ' CD2' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -144.36 -70.17 0.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.611 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 1.2 t -159.87 98.7 1.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.117 -0.989 . . . . 0.0 109.889 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 92' ' ' SER . 25.1 mttm 62.54 34.59 15.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.987 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.474 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 0.3 OUTLIER 177.49 145.13 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.008 -1.057 . . . . 0.0 109.813 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.461 HG13 ' HA ' ' A' ' 24' ' ' LEU . 90.1 mt -105.96 114.68 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.88 . . . . 0.0 109.161 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.588 HD12 ' CH2' ' A' ' 2' ' ' TRP . 0.7 OUTLIER -73.77 139.06 44.94 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.332 -0.855 . . . . 0.0 109.735 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.536 ' CG2' ' HG ' ' A' ' 22' ' ' LEU . 45.8 t -129.89 59.75 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.352 -0.843 . . . . 0.0 109.326 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.474 ' O ' HG12 ' A' ' 87' ' ' ILE . . . -51.66 111.93 1.63 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -110.99 134.63 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.126 -1.22 . . . . 0.0 109.187 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.457 ' HB3' HG11 ' A' ' 16' ' ' VAL . 20.0 p90 -132.27 -178.35 4.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.443 -0.785 . . . . 0.0 109.307 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -118.31 -145.9 0.39 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.598 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 103' ' ' LYS . 7.6 tp10 -80.91 -38.81 27.31 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.145 -0.972 . . . . 0.0 109.665 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 102' ' ' GLU . 0.4 OUTLIER -43.79 -68.26 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.909 . . . . 0.0 109.506 -179.721 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.1 mt -65.99 137.7 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.202 -0.936 . . . . 0.0 109.286 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.77 152.63 75.06 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.775 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.457 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 1.9 Cg_endo -64.62 -17.72 60.46 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.4 2.067 . . . . 0.0 110.515 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.8 -13.03 51.77 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.65 -42.65 14.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -1.122 . . . . 0.0 109.429 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.509 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -78.07 -22.1 49.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.338 -0.851 . . . . 0.0 109.536 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 106' ' ' PRO . . . -84.03 -21.02 31.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 109.566 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -80.91 -39.09 26.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 109.488 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.587 ' CG1' ' CB ' ' A' ' 15' ' ' ALA . 4.1 p -74.62 -27.83 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.684 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.509 ' CG2' ' O ' ' A' ' 109' ' ' ALA . 74.7 t -72.94 -35.04 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.409 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 118' ' ' ASP . 48.2 mt-10 -61.58 -41.9 98.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.462 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 118' ' ' ASP . 3.2 ttpm? -74.49 -38.03 63.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.494 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.04 -53.3 52.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.338 -0.851 . . . . 0.0 109.715 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -75.35 -29.8 60.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 0.0 109.695 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 0.4 OUTLIER -54.02 -25.17 19.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -0.955 . . . . 0.0 109.666 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -85.57 -48.33 9.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.669 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.504 ' CD1' ' HB2' ' A' ' 1' ' ' SER . 4.5 mt -75.32 -2.61 29.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.881 . . . . 0.0 110.274 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.534 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 0.4 OUTLIER -84.2 -44.7 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.053 -1.029 . . . . 0.0 109.518 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -82.05 9.6 56.41 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -120.75 -87.9 0.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -1.192 . . . . 0.0 109.785 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.17 -90.82 0.92 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.567 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 3.8 m-85 . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.255 -1.144 . . . . 0.0 109.362 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.562 ' O ' ' CD2' ' A' ' 2' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.564 ' CZ3' HD23 ' A' ' 96' ' ' LEU . 15.5 m95 -146.96 173.35 12.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.295 -0.878 . . . . 0.0 109.4 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.54 -87.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.13 -0.981 . . . . 0.0 111.088 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.473 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -60.84 -45.54 94.07 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.025 -1.047 . . . . 0.0 110.465 -178.649 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 2.8 m-30 -50.72 -21.65 1.72 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.87 -1.144 . . . . 0.0 109.466 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.527 ' HA ' ' CG2' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -78.0 -41.24 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 108.692 179.445 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.473 ' OD1' ' O ' ' A' ' 4' ' ' THR . 2.1 p-10 -91.28 18.83 6.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.119 -0.988 . . . . 0.0 110.825 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.415 ' OG1' ' HA ' ' A' ' 5' ' ' TYR . 21.1 p -127.59 -106.58 0.31 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.917 -1.114 . . . . 0.0 110.371 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.4 t-20 -102.02 -68.75 0.81 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.025 -1.047 . . . . 0.0 110.512 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.505 ' C ' ' O ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -24.52 -41.8 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 9' ' ' ASN . 1.1 t -83.91 -65.59 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.728 -1.233 . . . . 0.0 110.057 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.542 ' N ' ' CG1' ' A' ' 11' ' ' VAL . . . -36.84 -40.06 0.46 Allowed Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.527 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER 158.45 40.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.891 -0.77 . . . . 0.0 109.366 178.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -86.06 21.3 16.56 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 154.87 -32.72 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.474 HG11 ' HB3' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -136.63 133.66 48.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.457 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.49 ' CG2' ' HG3' ' A' ' 18' ' ' GLN . 9.0 t -78.83 6.1 9.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.944 -1.097 . . . . 0.0 108.991 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.49 ' HG3' ' CG2' ' A' ' 17' ' ' THR . 17.3 mt-30 -158.91 153.08 23.74 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.481 ' HA ' HG21 ' A' ' 99' ' ' VAL . . . -170.33 152.38 4.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -0.949 . . . . 0.0 109.193 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.491 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . . . -150.55 130.84 13.67 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.554 ' CD1' ' N ' ' A' ' 2' ' ' TRP . 4.6 mm -82.85 92.32 2.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.537 ' CD2' HG23 ' A' ' 97' ' ' VAL . 10.9 mp -74.71 106.7 6.39 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.46 -0.775 . . . . 0.0 109.915 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -45.93 174.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.483 HD23 ' N ' ' A' ' 94' ' ' SER . 0.7 OUTLIER -72.82 -3.16 23.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.331 -1.099 . . . . 0.0 109.859 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.93 8.3 7.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.147 -0.971 . . . . 0.0 109.214 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.32 32.06 58.5 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 28' ' ' THR . 40.4 t-20 -94.97 29.96 2.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.165 -1.197 . . . . 0.0 109.36 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 27' ' ' ASN . 70.3 m 32.31 96.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.559 0.695 . . . . 0.0 110.859 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -79.54 -48.57 13.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.473 -0.767 . . . . 0.0 110.048 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' O ' HG12 ' A' ' 21' ' ' ILE . . . -158.64 103.06 1.72 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.115 -0.99 . . . . 0.0 109.969 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 20' ' ' ALA . 14.0 t -114.53 166.58 11.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.037 -1.039 . . . . 0.0 110.278 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.521 ' CB ' HG12 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -149.63 143.32 25.45 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.558 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 32' ' ' SER . . . 77.5 171.41 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 0.0 109.16 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -52.17 141.74 24.84 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.591 ' CE2' HG22 ' A' ' 99' ' ' VAL . 0.3 OUTLIER 177.81 117.01 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -1.077 . . . . 0.0 109.134 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.475 ' O ' ' HB1' ' A' ' 63' ' ' ALA . . . -112.68 125.14 53.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.975 . . . . 0.0 110.015 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.484 HG12 ' NE2' ' A' ' 41' ' ' GLN . 60.7 t -147.84 133.39 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.55 ' OG1' ' HD3' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -158.15 -62.81 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.001 -1.062 . . . . 0.0 110.598 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.604 ' O ' ' N ' ' A' ' 41' ' ' GLN . 8.1 Cg_exo -50.89 133.08 39.24 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 120.87 1.047 . . . . 0.0 109.819 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 39' ' ' PRO . . . -30.39 81.76 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 111.593 0.219 . . . . 0.0 111.593 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.604 ' N ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -90.86 -30.71 16.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.269 -1.519 . . . . 0.0 109.31 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.5 -18.91 78.71 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -80.57 -62.44 1.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.152 -1.205 . . . . 0.0 109.371 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.8 m -60.1 -26.99 66.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 109.152 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.88 -46.43 24.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.0 109.312 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.65 -11.09 22.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 109.649 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.48 -28.15 14.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.63 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.62 -23.35 66.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.966 . . . . 0.0 109.643 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -70.05 -7.7 43.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.225 -0.922 . . . . 0.0 110.032 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.1 -70.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 109.721 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -96.58 175.87 6.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.181 -0.949 . . . . 0.0 109.561 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 56' ' ' ARG . . . -123.82 -2.98 8.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.723 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.613 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 43.5 t0 -80.24 -44.81 1.42 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.158 -0.964 . . . . 0.0 110.721 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.6 Cg_endo -65.37 -13.58 40.52 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.553 1.502 . . . . 0.0 110.575 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.581 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -102.55 -54.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.06 -1.025 . . . . 0.0 109.516 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.512 ' HG2' ' NH1' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -50.58 -22.7 2.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.41 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.573 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -114.93 117.82 31.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.653 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 1.9 m 83.83 -52.92 0.14 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.77 -0.581 . . . . 0.0 109.826 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.8 -145.71 21.02 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.549 ' CE2' HD13 ' A' ' 62' ' ' LEU . 6.1 p90 -146.94 -173.17 4.16 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.256 -1.144 . . . . 0.0 109.143 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 1.5 m-20 -139.49 165.19 27.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.153 -0.967 . . . . 0.0 110.028 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.563 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 2.4 mp -136.96 88.25 2.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.42 -0.8 . . . . 0.0 109.268 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 62' ' ' LEU . . . 82.3 -43.17 0.14 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.603 -0.686 . . . . 0.0 109.985 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.06 35.67 0.05 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.644 ' CG1' ' CE1' ' A' ' 67' ' ' TYR . 72.8 t -126.21 111.74 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -1.133 . . . . 0.0 109.447 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.72 86.47 6.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.171 -0.956 . . . . 0.0 110.606 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.644 ' CE1' ' CG1' ' A' ' 65' ' ' VAL . 10.2 m-30 -98.47 162.67 13.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.098 -1.001 . . . . 0.0 109.28 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.41 173.24 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.185 -0.947 . . . . 0.0 109.569 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.6 m -127.39 109.34 11.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.48 3.14 14.83 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 109.6 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -135.21 89.07 2.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -0.94 . . . . 0.0 109.332 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.42 111.32 4.83 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -157.93 -45.55 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -0.9 . . . . 0.0 109.317 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -79.52 -94.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.412 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.444 ' NH1' ' CG ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -150.23 21.6 0.85 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 109.795 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.459 ' OG ' ' CG2' ' A' ' 89' ' ' VAL . 29.7 t -132.57 169.66 16.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.074 -1.016 . . . . 0.0 109.501 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.5 mt -149.5 95.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.865 . . . . 0.0 109.441 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -89.51 85.09 6.43 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -51.05 158.14 2.29 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.46 -173.83 3.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.612 -0.934 . . . . 0.0 108.83 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.45 -30.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.117 -0.989 . . . . 0.0 110.108 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 83' ' ' SER . . . 132.7 92.85 0.53 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 82' ' ' GLY . 0.8 OUTLIER 74.24 4.8 4.59 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.265 -1.138 . . . . 0.0 108.357 -178.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.48 148.62 29.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.495 -0.753 . . . . 0.0 109.086 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -168.62 174.44 43.3 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.481 HG23 ' CG2' ' A' ' 88' ' ' THR . 7.6 p -132.76 138.09 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -1.159 . . . . 0.0 109.348 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.446 HG23 HG12 ' A' ' 113' ' ' VAL . 16.7 mm -98.93 81.21 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 110.021 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.481 ' CG2' HG23 ' A' ' 86' ' ' VAL . 7.6 p -96.8 107.89 20.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.123 -0.986 . . . . 0.0 109.007 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.459 ' CG2' ' OG ' ' A' ' 76' ' ' SER . 59.4 t -127.9 139.97 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 109.794 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.29 127.01 42.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.884 . . . . 0.0 109.219 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.528 ' CG2' HG12 ' A' ' 121' ' ' ILE . 3.0 p -100.85 -82.61 0.46 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.31 -0.869 . . . . 0.0 109.927 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.412 ' C ' ' HG2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -151.46 -42.34 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.945 . . . . 0.0 109.612 -179.689 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 94' ' ' SER . 42.6 mmtt -139.64 40.42 2.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.605 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.483 ' N ' HD23 ' A' ' 24' ' ' LEU . 0.1 OUTLIER 173.25 161.35 0.14 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.912 . . . . 0.0 109.271 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 19.1 mt -133.56 146.72 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.082 -1.011 . . . . 0.0 109.743 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.564 HD23 ' CZ3' ' A' ' 2' ' ' TRP . 0.3 OUTLIER -106.24 158.73 16.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.862 . . . . 0.0 108.807 179.396 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.537 HG23 ' CD2' ' A' ' 22' ' ' LEU . 57.4 t -145.44 71.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.946 . . . . 0.0 110.225 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -56.46 144.52 36.9 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.514 -1.835 . . . . 0.0 108.514 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.591 HG22 ' CE2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -144.75 113.33 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.72 -1.459 . . . . 0.0 109.711 -179.502 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.474 ' HB3' HG11 ' A' ' 16' ' ' VAL . 14.3 p90 -135.43 141.34 45.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.345 -0.847 . . . . 0.0 109.415 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -152.05 117.04 5.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.495 -0.753 . . . . 0.0 109.831 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.2 OUTLIER 160.73 -59.22 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.516 -0.74 . . . . 0.0 109.378 179.637 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 174.97 48.06 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.566 -0.709 . . . . 0.0 109.417 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.6 mt -105.91 129.74 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.368 -0.833 . . . . 0.0 108.843 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -66.08 137.43 95.79 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.725 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -65.96 -25.88 51.75 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.175 1.917 . . . . 0.0 110.403 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.09 0.52 88.57 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.5 m -92.66 -42.82 9.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.142 -1.21 . . . . 0.0 109.383 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -90.09 -19.94 23.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.285 -0.885 . . . . 0.0 109.466 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.12 -24.38 58.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.722 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -81.89 -33.56 30.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.169 -0.957 . . . . 0.0 109.675 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.519 HG23 ' CD1' ' A' ' 116' ' ' LEU . 9.0 p -78.09 -18.71 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.115 -0.991 . . . . 0.0 109.508 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.446 HG12 HG23 ' A' ' 87' ' ' ILE . 38.1 t -90.92 -23.18 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.928 . . . . 0.0 109.887 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -75.79 -38.69 57.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.139 -0.976 . . . . 0.0 109.911 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.69 -58.94 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.944 . . . . 0.0 109.764 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.552 HD21 ' CE2' ' A' ' 5' ' ' TYR . 15.1 mt -51.9 -24.17 5.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 109.511 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.459 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -73.64 -39.64 64.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 109.853 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -63.91 -16.72 62.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.013 . . . . 0.0 109.995 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -81.63 -56.46 4.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.041 -1.037 . . . . 0.0 109.755 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 124' ' ' GLY . 6.1 mt -62.16 -50.15 72.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 109.663 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.528 HG12 ' CG2' ' A' ' 91' ' ' THR . 7.5 mt -59.93 -36.65 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.657 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.12 -14.98 81.74 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -127.09 -68.09 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.254 . . . . 0.0 110.15 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 120' ' ' LEU . . . -85.48 -106.68 0.69 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.348 -1.09 . . . . 0.0 109.166 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.573 ' HB2' ' CD2' ' A' ' 5' ' ' TYR . 29.9 p90 -92.59 97.13 10.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.125 -0.984 . . . . 0.0 109.905 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 8.1 tt0 -81.3 -24.07 37.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 109.218 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.458 ' O ' ' CG2' ' A' ' 8' ' ' THR . 85.2 m -65.96 -64.89 0.76 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.375 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CD2' ' HB2' ' A' ' 2' ' ' TRP . 1.0 OUTLIER -50.7 -41.59 56.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -0.95 . . . . 0.0 108.895 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.474 ' HA ' HG22 ' A' ' 11' ' ' VAL . 1.2 t -49.44 -48.8 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.56 -0.713 . . . . 0.0 109.894 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.466 ' O ' ' CB ' ' A' ' 8' ' ' THR . 0.8 OUTLIER -87.52 55.49 3.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.851 -178.598 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.466 ' CB ' ' O ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER 170.53 -86.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.739 -1.225 . . . . 0.0 111.334 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.517 ' O ' ' C ' ' A' ' 10' ' ' LEU . 3.1 m-20 -88.45 -74.55 0.46 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.247 -0.908 . . . . 0.0 111.481 -178.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.565 ' HB2' ' CB ' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -27.54 -46.9 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.917 0.389 . . . . 0.0 111.467 -178.412 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.526 ' CG2' ' HB1' ' A' ' 19' ' ' ALA . 49.5 t -101.6 -28.65 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.861 -1.149 . . . . 0.0 110.669 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 11' ' ' VAL . . . -45.17 -28.83 2.12 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 106.311 -2.716 . . . . 0.0 106.311 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.717 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.6 OUTLIER -176.28 -39.68 0.01 OUTLIER 'General case' 0 C--O 1.193 -1.9 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.599 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . 10.43 44.22 0.0 OUTLIER Glycine 0 N--CA 1.509 3.557 0 C-N-CA 123.671 0.653 . . . . 0.0 112.838 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.717 ' N ' ' O ' ' A' ' 13' ' ' THR . . . 87.58 -34.47 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.638 ' N ' ' O ' ' A' ' 13' ' ' THR . 35.8 m -120.51 139.08 48.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.495 ' C ' ' HG2' ' A' ' 18' ' ' GLN . 9.9 t -79.96 13.3 2.28 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.833 -1.167 . . . . 0.0 109.395 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.535 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 13.1 mm-40 -158.74 169.21 24.9 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.53 ' HA ' ' CG2' ' A' ' 99' ' ' VAL . . . 173.59 140.95 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.494 -1.379 . . . . 0.0 110.822 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.504 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -136.1 142.34 44.28 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.477 HD13 ' O ' ' A' ' 2' ' ' TRP . 2.7 mt -102.32 112.06 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.919 -1.113 . . . . 0.0 108.92 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.535 ' CD2' ' CG2' ' A' ' 97' ' ' VAL . 2.8 mp -98.46 160.37 14.33 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.527 -0.733 . . . . 0.0 109.089 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.92 -178.93 19.18 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.429 HD13 ' C ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -105.08 -48.46 3.72 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.295 -1.12 . . . . 0.0 109.139 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -136.76 40.11 2.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 109.306 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.06 25.22 2.23 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 1.2 m-20 61.43 -146.4 0.43 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.169 -1.194 . . . . 0.0 109.306 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.95 147.5 25.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.12 -0.987 . . . . 0.0 109.738 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -119.2 -26.49 5.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.379 -0.825 . . . . 0.0 109.145 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -178.44 159.22 1.17 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.391 -0.818 . . . . 0.0 109.372 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 1.1 t -160.22 171.54 19.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.314 -0.866 . . . . 0.0 109.503 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.466 ' HB2' HG11 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -178.54 82.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.333 -0.854 . . . . 0.0 109.165 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.04 -69.71 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.856 . . . . 0.0 109.566 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 167.85 -37.78 0.22 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.533 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 14.8 p90 -97.12 160.22 14.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.12 . . . . 0.0 109.482 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.03 -168.91 1.36 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.366 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.474 HG12 ' CD2' ' A' ' 62' ' ' LEU . 16.4 t -142.85 97.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.343 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 p -62.34 143.99 95.36 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.41 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.59 114.92 2.46 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.193 1.929 . . . . 0.0 110.358 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 174.77 -77.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.335 -0.853 . . . . 0.0 109.402 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.59 -11.69 58.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.527 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.33 -43.72 95.49 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.3 -33.9 73.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -1.124 . . . . 0.0 108.936 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.2 m -50.05 -45.76 52.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.295 -0.878 . . . . 0.0 108.799 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mp -54.95 -42.16 71.97 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.13 -38.22 73.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.407 -0.808 . . . . 0.0 108.869 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.93 -26.87 63.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.509 -0.745 . . . . 0.0 109.084 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.463 ' CB ' HD12 ' A' ' 55' ' ' ILE . . . -64.61 -20.2 66.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.371 -0.83 . . . . 0.0 109.334 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.603 ' CE1' ' CE ' ' A' ' 90' ' ' LYS . 22.2 m-85 -59.21 -14.54 11.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 109.365 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -79.58 -68.07 0.7 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 109.677 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -148.37 17.99 1.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.13 -0.981 . . . . 0.0 109.872 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 51' ' ' ASN . . . 36.08 32.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.278 0.561 . . . . 0.0 109.977 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.615 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 39.1 t70 -70.61 -43.98 16.52 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 111.004 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 5.3 Cg_exo -61.55 -10.96 18.02 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.381 1.387 . . . . 0.0 110.796 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.463 HD12 ' CB ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -106.71 -31.25 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.053 -1.029 . . . . 0.0 109.573 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.422 ' CG ' ' HA ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -90.16 20.1 4.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 109.501 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.81 4.57 11.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.55 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 172.5 -55.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.518 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.67 -172.85 33.13 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 67' ' ' TYR . 33.4 p90 -132.46 170.44 15.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -1.164 . . . . 0.0 109.407 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.29 136.93 54.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.567 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.474 ' CD2' HG12 ' A' ' 37' ' ' VAL . 0.6 OUTLIER -103.48 -161.51 0.84 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.248 -0.907 . . . . 0.0 108.93 179.753 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 62' ' ' LEU . . . -46.33 -40.5 11.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.106 -0.996 . . . . 0.0 109.263 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.74 33.63 0.16 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.17 138.02 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -1.108 . . . . 0.0 109.66 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.453 ' N ' ' CD2' ' A' ' 66' ' ' HIS . 7.6 m-70 -96.09 142.24 28.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 109.389 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 60' ' ' PHE . 17.3 m-85 -141.76 162.6 35.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.212 -0.93 . . . . 0.0 109.44 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.42 HG11 ' N ' ' A' ' 69' ' ' THR . 23.9 t -121.49 149.2 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.299 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.42 ' N ' HG11 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -138.67 103.54 4.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.466 -179.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.425 HD22 ' HG2' ' A' ' 71' ' ' ARG . 2.3 pt? -103.08 8.11 38.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.147 -0.97 . . . . 0.0 109.607 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.425 ' HG2' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -148.69 51.47 0.99 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.305 -0.872 . . . . 0.0 109.022 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.88 130.2 41.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.852 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.46 -172.34 4.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.388 -0.82 . . . . 0.0 109.03 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.16 40.04 0.89 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.047 -1.033 . . . . 0.0 109.679 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.549 ' HG2' ' NH1' ' A' ' 75' ' ' ARG . 2.3 tpt180 -145.28 -72.29 0.25 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 108.957 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -113.54 154.1 27.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.352 -0.842 . . . . 0.0 108.738 179.369 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.489 ' CG1' ' O ' ' A' ' 76' ' ' SER . 47.1 mt -156.96 58.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.935 -1.103 . . . . 0.0 110.376 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.559 ' CE2' ' CG2' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -94.36 102.59 14.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.087 . . . . 0.0 108.858 179.167 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 86' ' ' VAL . . . -75.05 175.48 50.64 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.45 133.52 16.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -1.094 . . . . 0.0 109.256 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 0.6 OUTLIER -127.51 70.06 1.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 109.762 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 83' ' ' SER . . . 50.85 -118.13 6.08 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 82' ' ' GLY . 3.8 t -44.59 -84.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -1.212 . . . . 0.0 109.525 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . . . -90.04 156.15 18.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.132 -0.98 . . . . 0.0 109.581 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.474 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -147.92 179.31 24.9 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.434 ' O ' HD12 ' A' ' 87' ' ' ILE . 7.9 p -112.14 159.25 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.062 -1.258 . . . . 0.0 109.974 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 98' ' ' GLY . 14.4 mm -141.83 96.43 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 18.8 p -124.19 153.67 41.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.746 -1.222 . . . . 0.0 110.834 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.559 ' CG2' ' CE2' ' A' ' 78' ' ' TYR . 57.4 t -150.21 135.66 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.603 ' CE ' ' CE1' ' A' ' 49' ' ' PHE . 10.9 mmtm -91.54 150.38 21.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.897 . . . . 0.0 109.65 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.407 HG21 ' C ' ' A' ' 90' ' ' LYS . 57.5 p -142.55 -168.18 2.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 108.959 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 m -47.58 -25.63 1.2 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.248 -0.907 . . . . 0.0 109.109 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.439 ' HB2' ' CB ' ' A' ' 125' ' ' PHE . 5.1 mttt 178.4 67.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -0.824 . . . . 0.0 109.345 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.468 ' HB2' ' CD2' ' A' ' 125' ' ' PHE . 0.6 OUTLIER -173.97 145.9 1.15 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.507 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.528 ' CG2' ' HD3' ' A' ' 90' ' ' LYS . 3.8 mt -136.14 85.22 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.158 -0.964 . . . . 0.0 109.23 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 88' ' ' THR . 0.3 OUTLIER -61.12 165.27 4.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.478 -0.764 . . . . 0.0 109.119 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.535 ' CG2' ' CD2' ' A' ' 22' ' ' LEU . 58.7 t -143.38 47.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.192 -0.942 . . . . 0.0 110.143 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.503 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -41.05 130.7 3.39 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -126.22 118.59 51.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.786 -1.42 . . . . 0.0 108.652 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.548 ' HB3' ' CG1' ' A' ' 16' ' ' VAL . 38.1 p90 -106.51 -179.1 3.84 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.084 -1.01 . . . . 0.0 109.829 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 84' ' ' ALA . 6.4 t-20 -135.06 -155.1 0.62 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 110.029 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -36.96 80.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.484 -0.76 . . . . 0.0 110.053 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.66 -49.99 55.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.95 . . . . 0.0 109.885 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.406 ' CG2' ' O ' ' A' ' 15' ' ' ALA . 4.3 mp -99.87 150.38 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.131 -0.981 . . . . 0.0 109.754 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -117.42 155.46 50.1 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.393 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.04 -166.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.234 1.956 . . . . 0.0 110.252 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 53.97 21.86 18.31 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.6 m -156.6 -41.15 0.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -1.105 . . . . 0.0 109.072 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.471 ' HA ' HG13 ' A' ' 112' ' ' VAL . . . -85.39 -12.88 51.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.358 -0.839 . . . . 0.0 109.133 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.43 -39.01 23.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.414 -0.804 . . . . 0.0 109.45 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -65.1 -40.01 93.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.748 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.471 HG13 ' HA ' ' A' ' 109' ' ' ALA . 5.3 p -69.88 -25.22 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.187 -0.946 . . . . 0.0 109.508 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 109' ' ' ALA . 73.1 t -82.57 -25.06 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.204 -0.935 . . . . 0.0 109.474 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -70.55 -35.93 73.38 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.166 -0.959 . . . . 0.0 109.406 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.491 ' HG3' ' N ' ' A' ' 116' ' ' LEU . 2.5 ptpt -81.52 -39.38 24.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 109.647 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.491 ' N ' ' HG3' ' A' ' 115' ' ' LYS . 59.7 tp -50.83 -33.8 25.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 109.433 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.547 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -79.97 -34.5 38.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.325 -0.859 . . . . 0.0 109.592 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -62.76 -12.17 22.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.028 . . . . 0.0 109.577 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 30.7 t80 -90.31 -54.27 4.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 109.896 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.54 HD12 ' CE2' ' A' ' 125' ' ' PHE . 0.8 OUTLIER -63.94 -34.47 78.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.0 110.098 -179.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.547 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 5.7 mt -63.2 -13.65 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 121' ' ' ILE . . . -46.06 -27.73 2.66 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -103.26 -65.89 0.97 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.422 -1.046 . . . . 0.0 109.205 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.11 109.17 2.73 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.54 ' CE2' HD12 ' A' ' 120' ' ' LEU . 22.5 m-85 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.171 -1.194 . . . . 0.0 109.524 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.531 ' HB2' ' CB ' ' A' ' 19' ' ' ALA . 1.4 m . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.601 ' CZ2' HD23 ' A' ' 96' ' ' LEU . 41.8 m95 -154.5 -167.43 2.62 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.144 -0.973 . . . . 0.0 109.723 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -89.98 -86.01 0.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 110.319 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.74 -16.87 2.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.242 -0.911 . . . . 0.0 110.203 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 2.1 m-30 -88.91 -33.92 17.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.026 -1.046 . . . . 0.0 109.747 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.538 ' HA ' ' CG2' ' A' ' 11' ' ' VAL . 1.2 t -56.0 -43.25 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.183 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.63 46.49 1.34 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.387 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.407 ' CG2' ' N ' ' A' ' 9' ' ' ASN . 67.7 m -158.52 -101.58 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.703 -1.248 . . . . 0.0 110.609 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 11' ' ' VAL . 2.2 t-20 -102.1 -72.2 0.69 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.111 -0.993 . . . . 0.0 111.346 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.533 HD23 ' CD2' ' A' ' 116' ' ' LEU . 2.2 mp -25.67 -39.17 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 9' ' ' ASN . 1.7 t -82.11 -66.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.559 -1.338 . . . . 0.0 110.341 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -40.24 -33.83 0.55 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.552 ' CB ' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 156.37 39.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.624 0.726 . . . . 0.0 109.357 179.181 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -83.31 14.28 40.82 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 107.412 -2.275 . . . . 0.0 107.412 177.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 156.93 -25.04 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 99' ' ' VAL . 17.1 m -138.08 152.67 26.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.425 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -81.85 14.86 2.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.978 -1.076 . . . . 0.0 109.127 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.459 ' HG2' ' N ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER 173.28 -178.37 0.08 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' A' ' 1' ' ' SER . . . 178.95 160.52 0.66 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.828 -1.17 . . . . 0.0 109.88 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.488 ' HB2' ' CD1' ' A' ' 22' ' ' LEU . . . -155.59 127.41 7.46 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.236 -0.915 . . . . 0.0 110.239 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.538 HD12 ' N ' ' A' ' 2' ' ' TRP . 2.2 mm -87.73 78.67 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.566 ' CD2' HG23 ' A' ' 97' ' ' VAL . 8.8 mp -52.66 164.22 0.38 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.513 -0.742 . . . . 0.0 109.631 -178.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.22 159.49 15.04 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -110.76 -28.13 8.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -1.087 . . . . 0.0 109.275 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.69 6.38 12.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.828 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -136.56 -86.68 0.2 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.47 ' O ' ' OG1' ' A' ' 28' ' ' THR . 6.7 p30 -170.23 -46.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.356 -1.085 . . . . 0.0 109.281 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 27' ' ' ASN . 34.1 m -170.68 127.86 0.77 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 109.567 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.527 ' CZ2' ' O ' ' A' ' 93' ' ' LYS . 26.1 m0 -84.05 -58.11 2.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.383 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.97 169.78 16.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.347 -0.845 . . . . 0.0 109.304 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -160.48 174.47 14.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 109.978 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.51 ' CB ' HG12 ' A' ' 11' ' ' VAL . 3.1 m -154.28 99.49 2.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.337 -0.852 . . . . 0.0 109.374 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 32' ' ' SER . . . 42.64 -152.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.416 -0.803 . . . . 0.0 109.524 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.459 ' N ' ' HG2' ' A' ' 18' ' ' GLN . . . 90.52 -145.74 18.15 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -103.43 169.26 8.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -1.139 . . . . 0.0 109.471 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.22 116.73 29.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.321 -0.862 . . . . 0.0 109.244 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.1 t -79.4 122.23 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.157 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.9 m -75.67 132.88 74.26 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.92 . . . . 0.0 109.48 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.567 ' O ' ' CB ' ' A' ' 40' ' ' ALA . 3.4 Cg_exo -59.13 171.36 2.31 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.941 1.761 . . . . 0.0 109.778 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.567 ' CB ' ' O ' ' A' ' 39' ' ' PRO . . . 83.56 -46.3 0.12 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.672 -0.643 . . . . 0.0 109.379 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.92 -30.46 68.93 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.146 -0.971 . . . . 0.0 109.02 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.79 -32.79 48.38 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -67.03 -37.7 84.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.376 -1.073 . . . . 0.0 108.874 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.8 m -63.78 -29.86 71.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 108.807 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.523 ' HG ' ' CZ ' ' A' ' 49' ' ' PHE . 11.8 tp -70.89 -39.03 73.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.349 -0.844 . . . . 0.0 109.172 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.09 -46.91 79.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.325 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -24.58 66.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.372 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.85 92.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.268 -0.895 . . . . 0.0 109.15 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.523 ' CZ ' ' HG ' ' A' ' 45' ' ' LEU . 2.9 m-30 -68.94 85.66 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.369 -0.832 . . . . 0.0 109.213 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.53 -64.03 0.22 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.64 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 53' ' ' ASP . 3.7 t-20 -136.66 19.17 3.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.36 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 51' ' ' ASN . . . 41.97 26.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.55 -0.719 . . . . 0.0 109.954 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.541 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -80.88 -53.58 0.8 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.068 -1.02 . . . . 0.0 110.403 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 3.4 Cg_exo -62.34 -22.47 74.15 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.067 1.845 . . . . 0.0 110.893 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -94.61 -51.76 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.862 -1.149 . . . . 0.0 109.238 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -45.09 -27.0 0.52 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.963 . . . . 0.0 108.748 179.577 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . -115.68 -165.59 1.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.474 -0.766 . . . . 0.0 109.055 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 57' ' ' ALA . 75.0 m 44.37 -95.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.193 -0.942 . . . . 0.0 109.536 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 57' ' ' ALA . . . 164.43 175.0 34.82 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.419 ' HB3' ' HB2' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -80.32 155.54 27.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.393 -1.063 . . . . 0.0 109.38 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -154.07 101.92 2.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.048 -1.032 . . . . 0.0 110.061 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -98.73 -163.01 1.0 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 109.274 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.425 ' O ' HG22 ' A' ' 65' ' ' VAL . . . -61.56 94.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.976 . . . . 0.0 109.798 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.446 ' O ' HG21 ' A' ' 65' ' ' VAL . . . 60.77 51.99 55.23 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.61 ' CG1' ' CE1' ' A' ' 67' ' ' TYR . 3.2 t -150.01 136.23 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.244 -1.151 . . . . 0.0 109.413 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -110.24 91.89 3.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 109.744 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.61 ' CE1' ' CG1' ' A' ' 65' ' ' VAL . 6.0 m-30 -100.68 -168.38 1.57 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.16 -0.963 . . . . 0.0 109.083 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 p -131.06 176.59 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.992 -1.068 . . . . 0.0 109.522 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.429 HG23 ' CB ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -136.69 69.42 1.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 109.535 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.1 tp -89.66 2.21 55.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.125 -0.984 . . . . 0.0 109.216 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.463 ' NH1' ' HG3' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -144.93 69.67 1.26 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.36 -0.838 . . . . 0.0 108.85 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.429 ' CB ' HG23 ' A' ' 69' ' ' THR . . . -118.69 91.72 3.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.898 . . . . 0.0 110.125 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -98.49 -162.81 0.98 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.336 -0.852 . . . . 0.0 108.857 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -101.44 41.36 1.21 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.074 -1.016 . . . . 0.0 109.373 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.462 ' NH1' ' CG ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -150.42 -53.64 0.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.816 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.0 m -131.85 136.67 47.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 0.0 109.986 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' A' ' 88' ' ' THR . 11.1 mt -99.92 72.93 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.575 ' CE2' HD12 ' A' ' 87' ' ' ILE . 2.5 t80 -89.6 82.2 6.39 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.422 -0.799 . . . . 0.0 109.193 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.08 176.0 43.54 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.61 -170.74 3.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.335 -1.097 . . . . 0.0 109.697 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.429 ' HD3' ' O ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -164.65 25.09 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.428 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.1 -78.57 1.7 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 102' ' ' GLU . 1.9 m -81.92 -38.89 24.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -1.157 . . . . 0.0 109.863 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -126.6 164.56 20.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.987 . . . . 0.0 109.538 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -159.08 162.48 32.71 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.518 HG21 ' N ' ' A' ' 87' ' ' ILE . 14.9 p -123.79 151.45 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.367 -1.078 . . . . 0.0 109.61 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.575 HD12 ' CE2' ' A' ' 78' ' ' TYR . 54.9 mt -124.8 88.84 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.366 -0.834 . . . . 0.0 108.86 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 41.6 p -105.76 129.33 53.98 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.048 -1.033 . . . . 0.0 109.992 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 88' ' ' THR . 6.1 m -145.23 150.94 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.572 -0.705 . . . . 0.0 109.554 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -97.52 122.67 40.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.202 -0.936 . . . . 0.0 109.653 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -58.15 2.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 109.143 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -175.24 -36.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.807 . . . . 0.0 109.184 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.529 ' HG3' ' CE2' ' A' ' 125' ' ' PHE . 10.3 mttm -145.67 28.51 1.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.842 . . . . 0.0 109.497 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.489 ' N ' HD23 ' A' ' 24' ' ' LEU . 58.3 m -161.3 168.89 23.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.894 . . . . 0.0 109.468 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.435 HG13 ' HG ' ' A' ' 24' ' ' LEU . 83.5 mt -125.43 123.86 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.113 -0.992 . . . . 0.0 109.371 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.601 HD23 ' CZ2' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -81.54 155.47 25.72 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.462 -0.774 . . . . 0.0 109.903 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.566 HG23 ' CD2' ' A' ' 22' ' ' LEU . 48.2 t -151.43 54.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.665 -0.647 . . . . 0.0 109.695 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -55.53 113.88 4.26 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.478 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -111.3 122.95 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.058 -1.26 . . . . 0.0 109.425 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 100' ' ' TYR . 2.8 p90 -131.72 178.12 7.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 109.66 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -121.69 -167.41 1.52 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.69 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -68.07 -17.76 64.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.702 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.12 -10.98 25.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.946 . . . . 0.0 109.446 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.469 HG22 ' O ' ' A' ' 15' ' ' ALA . 28.2 mt -125.63 158.59 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.15 -0.969 . . . . 0.0 109.777 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.518 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 7.3 mt-30 -139.61 160.08 62.77 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.442 -0.786 . . . . 0.0 109.009 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 105' ' ' GLN . 5.9 Cg_exo -56.27 165.0 4.61 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.928 1.752 . . . . 0.0 110.129 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.21 -28.01 17.33 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.7 m -115.55 -48.63 2.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.448 -1.031 . . . . 0.0 109.235 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.44 ' C ' HG11 ' A' ' 112' ' ' VAL . . . -87.36 -19.28 28.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.882 . . . . 0.0 109.279 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.436 ' HA ' ' CE2' ' A' ' 78' ' ' TYR . . . -85.55 -52.07 6.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.304 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -60.69 -36.19 78.16 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.432 -0.792 . . . . 0.0 109.79 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 13.4 p -65.27 -37.14 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.191 -0.943 . . . . 0.0 109.378 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.467 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 93.9 t -73.62 -16.02 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.212 -0.93 . . . . 0.0 109.701 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.9 -44.79 38.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.004 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -84.62 -46.86 11.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.108 -0.995 . . . . 0.0 110.069 -179.49 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.533 ' CD2' HD23 ' A' ' 10' ' ' LEU . 2.6 mp -54.27 -32.65 56.75 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.138 -0.976 . . . . 0.0 109.813 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -72.93 -43.11 62.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -0.946 . . . . 0.0 109.755 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -57.8 -20.99 39.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.85 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -90.08 -56.18 3.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.08 -1.013 . . . . 0.0 109.982 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.44 -0.6 15.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.157 -0.964 . . . . 0.0 109.838 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.518 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER -64.24 -39.08 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.984 -1.072 . . . . 0.0 108.797 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -121.73 45.51 1.21 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -143.11 -73.57 0.28 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.082 -1.246 . . . . 0.0 110.018 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.473 ' C ' ' CG ' ' A' ' 125' ' ' PHE . . . -123.18 -18.46 3.11 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.529 ' CE2' ' HG3' ' A' ' 93' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.202 -1.175 . . . . 0.0 109.374 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.3 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.259 0.552 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.654 ' CZ2' ' CD1' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -92.52 -21.45 20.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.973 . . . . 0.0 109.245 179.82 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.456 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 2.5 tt0 -63.56 -51.34 65.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.313 -0.867 . . . . 0.0 109.753 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -40.45 67.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 109.233 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.553 ' HB3' ' CD1' ' A' ' 10' ' ' LEU . 22.1 m-30 -61.9 -33.69 74.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.095 -1.003 . . . . 0.0 108.417 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.55 HG11 ' N ' ' A' ' 7' ' ' ASP . 0.9 OUTLIER -62.15 -56.89 14.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.643 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.55 ' N ' HG11 ' A' ' 6' ' ' VAL . 58.9 m-20 -91.64 50.47 1.72 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.05 -1.032 . . . . 0.0 110.314 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 65.7 m -156.19 -100.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.77 -1.206 . . . . 0.0 110.78 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -101.53 -56.48 2.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.084 -1.01 . . . . 0.0 111.075 -178.354 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.553 ' CD1' ' HB3' ' A' ' 5' ' ' TYR . 6.6 mt -38.16 -30.22 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.142 -0.974 . . . . 0.0 111.158 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.587 ' CG2' ' CB ' ' A' ' 19' ' ' ALA . 47.5 t -101.25 -52.27 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.764 -1.21 . . . . 0.0 110.065 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -40.14 -42.29 2.32 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.514 ' CB ' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 161.18 43.68 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.789 -0.83 . . . . 0.0 109.322 178.437 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -85.69 15.01 49.46 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 177.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 155.68 -27.83 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.548 ' CB ' ' HB3' ' A' ' 100' ' ' TYR . 5.6 m -139.4 155.34 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.516 ' N ' HD13 ' A' ' 104' ' ' ILE . 14.7 t -87.18 21.66 2.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.896 -1.128 . . . . 0.0 108.877 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.528 ' HA ' ' CG1' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -178.45 -176.81 0.52 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 11' ' ' VAL . . . 175.33 154.65 0.16 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.273 -0.892 . . . . 0.0 109.127 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.497 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -148.27 136.83 21.52 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.244 -0.91 . . . . 0.0 109.68 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.447 HG13 ' CG2' ' A' ' 6' ' ' VAL . 1.6 mt -106.61 101.68 12.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.556 HD22 ' N ' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -84.95 22.83 1.31 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.389 -0.819 . . . . 0.0 110.269 -178.089 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' HD13 ' A' ' 95' ' ' ILE . . . 47.43 -164.42 0.18 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.512 HD12 ' CA ' ' A' ' 93' ' ' LYS . 1.1 mt -98.34 -74.33 0.59 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.388 -1.066 . . . . 0.0 109.114 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -135.15 22.04 3.47 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.307 -0.87 . . . . 0.0 108.832 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.7 67.97 0.25 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.5 t30 48.7 -150.25 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -1.108 . . . . 0.0 109.737 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.42 HG21 ' N ' ' A' ' 29' ' ' TRP . 60.8 m -94.12 139.26 31.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.812 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.42 ' N ' HG21 ' A' ' 28' ' ' THR . 12.5 m0 -96.67 -65.31 0.97 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.435 ' O ' ' CG2' ' A' ' 31' ' ' THR . . . -137.53 160.11 40.07 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.435 ' CG2' ' O ' ' A' ' 30' ' ' ALA . 77.4 p -155.13 137.35 14.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.041 -1.037 . . . . 0.0 110.119 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.567 ' CB ' ' CG2' ' A' ' 11' ' ' VAL . 0.4 OUTLIER -108.81 115.78 30.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.516 -0.74 . . . . 0.0 109.068 179.578 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 32' ' ' SER . . . 82.38 166.69 0.13 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 35' ' ' PHE . . . -48.41 -96.9 0.01 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.526 ' CE1' HG13 ' A' ' 99' ' ' VAL . 4.9 t80 74.35 84.99 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.315 -1.109 . . . . 0.0 109.901 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.09 105.69 17.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 109.356 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.529 ' HB ' ' CG ' ' A' ' 41' ' ' GLN . 59.7 t -108.05 56.3 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.655 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER 57.58 156.43 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.269 -0.894 . . . . 0.0 109.851 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.17 -36.52 68.78 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.294 1.996 . . . . 0.0 110.197 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.474 ' HB2' ' OG1' ' A' ' 44' ' ' THR . . . -83.82 60.69 5.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.838 . . . . 0.0 109.442 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.529 ' CG ' ' HB ' ' A' ' 37' ' ' VAL . 2.2 mt-30 -66.44 -47.83 71.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.681 -1.262 . . . . 0.0 110.111 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.64 -29.04 58.32 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.784 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -81.48 -62.86 1.53 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.97 -1.312 . . . . 0.0 109.84 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 40' ' ' ALA . 85.3 m -45.84 -50.76 13.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.84 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -66.45 -30.99 71.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.154 -0.966 . . . . 0.0 109.749 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.03 -18.59 62.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.4 t -74.66 -52.61 11.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -0.872 . . . . 0.0 109.659 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.51 -21.72 52.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.194 -0.941 . . . . 0.0 109.543 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.583 ' CE2' ' CG ' ' A' ' 90' ' ' LYS . 4.2 m-30 -65.88 -37.08 85.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.432 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -88.28 -74.69 0.45 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 109.587 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -71.9 119.25 15.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.172 -0.955 . . . . 0.0 109.521 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.19 17.52 23.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.113 -0.992 . . . . 0.0 109.056 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.589 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -76.61 -50.14 2.66 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.456 -0.777 . . . . 0.0 110.372 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 4.2 Cg_exo -62.82 -8.17 12.94 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.976 1.784 . . . . 0.0 110.933 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.583 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -104.96 -44.05 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.041 -1.037 . . . . 0.0 109.497 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.522 ' CD ' ' HA ' ' A' ' 53' ' ' ASP . 8.3 ptm180 -61.98 -22.15 65.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 109.948 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.427 ' C ' ' OG ' ' A' ' 58' ' ' SER . . . -107.73 108.11 19.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 109.907 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.427 ' OG ' ' C ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER 72.25 -79.52 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.432 -0.792 . . . . 0.0 109.882 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.88 -138.97 5.76 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -155.39 172.5 18.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -1.11 . . . . 0.0 109.573 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.12 160.29 14.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 109.092 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.537 ' HB2' ' CE2' ' A' ' 67' ' ' TYR . 3.4 mt -159.57 98.45 1.38 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.924 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 62' ' ' LEU . . . 74.99 -78.22 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.646 -0.659 . . . . 0.0 110.041 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -159.08 23.28 0.31 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.5 t -137.48 157.36 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -1.145 . . . . 0.0 109.207 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.484 ' CE1' ' HD2' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -100.25 152.66 20.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.153 -0.967 . . . . 0.0 109.472 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.537 ' CE2' ' HB2' ' A' ' 62' ' ' LEU . 92.2 m-85 -137.61 149.44 46.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 109.525 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.54 -156.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 109.241 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.413 HG23 ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -161.88 75.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.94 . . . . 0.0 109.5 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.11 12.15 31.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.907 . . . . 0.0 109.44 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -156.92 64.14 0.51 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.709 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.21 90.32 3.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 109.062 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.88 -108.05 0.35 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.107 -0.996 . . . . 0.0 109.791 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -121.6 -34.12 3.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.778 -1.201 . . . . 0.0 110.648 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.536 ' HG2' ' NH1' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -134.74 31.7 3.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.887 -1.133 . . . . 0.0 110.878 -178.703 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.548 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 1.2 m -150.57 116.24 5.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.984 -1.073 . . . . 0.0 109.476 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 88' ' ' THR . 3.6 mp -144.79 50.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 0.0 109.557 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.548 ' CE1' ' HB3' ' A' ' 76' ' ' SER . 0.0 OUTLIER -91.01 91.5 8.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.092 -1.005 . . . . 0.0 108.612 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.33 170.65 53.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.517 ' HG2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -151.04 147.36 27.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.54 -0.976 . . . . 0.0 109.11 179.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.517 ' N ' ' HG2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -124.7 -170.84 2.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.989 -1.069 . . . . 0.0 109.682 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.29 5.41 77.26 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.455 ' HA ' ' HB2' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -154.82 -67.98 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -1.098 . . . . 0.0 108.887 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 81' ' ' LYS . . . -91.7 164.42 13.73 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.518 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -156.71 150.23 21.35 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.538 -1.315 . . . . 0.0 109.908 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.412 HG23 HG21 ' A' ' 88' ' ' THR . 9.8 p -122.32 147.37 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.329 -1.101 . . . . 0.0 109.448 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.482 HD13 HG13 ' A' ' 16' ' ' VAL . 11.9 mt -120.75 94.02 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 39.2 p -113.29 133.56 55.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.981 -1.074 . . . . 0.0 110.716 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -151.33 152.66 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.042 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.583 ' CG ' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -97.95 117.69 32.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.901 -179.428 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.543 ' O ' ' CB ' ' A' ' 92' ' ' SER . 0.8 OUTLIER -96.38 -69.17 0.77 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 108.764 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 91' ' ' THR . 1.9 m 157.7 -24.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.512 ' CA ' HD12 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -110.99 -12.33 14.23 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.444 -0.785 . . . . 0.0 109.256 179.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.463 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -172.5 168.73 5.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.81 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.473 HD13 ' O ' ' A' ' 23' ' ' GLY . 34.1 mt -105.78 134.64 46.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.398 -0.814 . . . . 0.0 108.973 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.654 ' CD1' ' CZ2' ' A' ' 2' ' ' TRP . 1.6 mt -88.96 148.26 23.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 110.249 -179.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.539 HG23 ' CD1' ' A' ' 22' ' ' LEU . 75.4 t -151.33 58.55 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.458 -0.776 . . . . 0.0 109.632 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -55.57 112.58 3.15 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.526 HG13 ' CE1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.81 125.52 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.992 -1.299 . . . . 0.0 109.119 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.562 ' CD1' ' N ' ' A' ' 100' ' ' TYR . 3.8 p90 -138.82 -178.3 5.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.941 . . . . 0.0 110.14 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.19 -147.3 0.39 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.443 -0.785 . . . . 0.0 109.675 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 83' ' ' SER . 46.8 tt0 -102.91 -29.95 11.12 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.166 -0.959 . . . . 0.0 109.948 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -16.06 23.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 110.193 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 17' ' ' THR . 16.7 mt -85.68 141.3 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.058 -1.026 . . . . 0.0 109.395 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.51 110.0 2.17 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.394 -0.816 . . . . 0.0 109.631 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 104' ' ' ILE . 1.2 Cg_endo -65.69 145.84 82.42 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.092 1.862 . . . . 0.0 110.27 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.33 -43.81 3.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.8 m -74.63 -30.9 61.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -1.184 . . . . 0.0 109.483 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -63.54 -45.02 92.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.874 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.09 -32.52 67.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.146 -0.971 . . . . 0.0 109.846 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.453 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 7.4 t-20 -67.73 -32.54 73.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 0.0 109.724 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.46 ' CG1' ' HB3' ' A' ' 15' ' ' ALA . 1.3 t -79.86 -28.0 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.146 -0.971 . . . . 0.0 109.421 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.469 ' CG1' HD12 ' A' ' 96' ' ' LEU . 18.2 t -82.83 -17.92 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.952 . . . . 0.0 109.694 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.471 ' CD ' ' CZ ' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -78.16 -37.17 46.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.158 -0.964 . . . . 0.0 109.765 -179.697 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 111' ' ' ASN . 1.5 mmmt -71.73 -46.3 59.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.122 -0.986 . . . . 0.0 109.864 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.544 HD12 ' CD2' ' A' ' 5' ' ' TYR . 3.2 tt -54.06 -34.22 59.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.931 -1.106 . . . . 0.0 109.162 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.526 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -62.55 -37.8 87.55 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.077 -1.014 . . . . 0.0 108.887 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -21.77 61.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.904 . . . . 0.0 109.6 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.59 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 0.0 OUTLIER -73.71 -40.73 63.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 109.879 -179.492 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.59 ' HG ' ' CZ ' ' A' ' 119' ' ' TYR . 5.0 mt -81.04 -36.26 30.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.117 -0.989 . . . . 0.0 110.566 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 1.5 mp -64.1 -21.58 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.103 -0.998 . . . . 0.0 109.596 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.538 ' O ' ' CG ' ' A' ' 123' ' ' GLN . . . -97.5 22.48 40.58 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 122' ' ' GLY . 45.7 mt-30 -162.41 -83.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -1.169 . . . . 0.0 109.809 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 125' ' ' PHE . . . -96.1 57.76 1.48 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.496 ' HB3' ' CB ' ' A' ' 92' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.411 -1.052 . . . . 0.0 109.977 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.587 ' O ' ' CE2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.508 ' NE1' HD21 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -99.81 -36.97 9.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -0.907 . . . . 0.0 109.501 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -72.36 -28.68 63.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.051 -1.031 . . . . 0.0 109.986 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -38.99 86.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.07 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.587 ' CE2' ' O ' ' A' ' 1' ' ' SER . 14.6 m-85 -74.81 -23.94 58.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.138 -0.976 . . . . 0.0 109.862 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.569 ' CG2' HG13 ' A' ' 21' ' ' ILE . 2.0 t -72.47 -23.16 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.18 -0.95 . . . . 0.0 110.062 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -46.77 -91.21 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.023 -1.048 . . . . 0.0 110.359 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.69 -2.23 3.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 110.131 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -86.26 -87.06 0.14 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.085 -1.01 . . . . 0.0 109.262 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 2.0 mm? -54.59 -27.5 39.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.996 -1.065 . . . . 0.0 109.669 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.579 ' CG2' ' CB ' ' A' ' 19' ' ' ALA . 4.2 t -90.55 -63.8 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.178 -0.952 . . . . 0.0 109.694 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -39.78 -38.91 1.21 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.531 ' CB ' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 157.02 53.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.977 -0.72 . . . . 0.0 109.839 178.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.599 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -96.1 21.76 43.38 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 106.339 -2.704 . . . . 0.0 106.339 177.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.599 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 144.43 -28.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.511 ' CG1' ' C ' ' A' ' 99' ' ' VAL . 4.3 t -131.72 140.5 48.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.503 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 0.2 OUTLIER -77.78 2.34 17.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.733 -1.229 . . . . 0.0 108.476 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -158.67 -173.68 4.4 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.359 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.579 ' CB ' ' CG2' ' A' ' 11' ' ' VAL . . . 170.78 142.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.007 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -140.4 104.14 4.71 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.058 -1.026 . . . . 0.0 110.305 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.569 HG13 ' CG2' ' A' ' 6' ' ' VAL . 14.4 mt -79.61 106.01 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.529 HD22 ' N ' ' A' ' 22' ' ' LEU . 0.4 OUTLIER -93.5 116.93 29.46 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.492 -0.755 . . . . 0.0 109.463 -178.317 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -49.72 -178.26 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -103.55 -68.94 0.82 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -1.141 . . . . 0.0 109.545 -179.75 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -113.66 11.83 18.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.269 -0.894 . . . . 0.0 109.543 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.71 -83.51 1.65 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -175.92 -65.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.417 -1.049 . . . . 0.0 109.401 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.6 m -158.62 156.54 30.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.94 . . . . 0.0 109.715 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -114.85 -69.97 0.83 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.354 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.456 ' O ' HG12 ' A' ' 6' ' ' VAL . . . -160.8 117.93 2.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.344 -0.848 . . . . 0.0 109.076 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 1.6 p -128.81 168.68 15.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.92 . . . . 0.0 109.81 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.421 ' HB2' HG12 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -171.71 98.32 0.18 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 109.238 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 18' ' ' GLN . . . -166.7 -67.24 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.169 -0.957 . . . . 0.0 109.464 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 139.21 39.61 0.1 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.557 ' CG ' ' O ' ' A' ' 35' ' ' PHE . 1.4 p90 -155.64 117.95 4.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -1.175 . . . . 0.0 109.409 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.91 130.54 41.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.536 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -90.65 161.67 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.373 -0.829 . . . . 0.0 109.353 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -74.11 148.05 86.26 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.293 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.78 -31.91 78.14 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.125 1.883 . . . . 0.0 110.357 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.31 13.38 3.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.196 -0.94 . . . . 0.0 110.285 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 38' ' ' THR . 1.3 mm-40 -90.65 -32.43 16.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.907 -1.121 . . . . 0.0 109.485 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.86 -46.31 94.78 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -21.01 64.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.406 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.453 ' HB ' ' O ' ' A' ' 41' ' ' GLN . 46.1 m -68.28 -34.69 76.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.47 ' HA ' ' HB1' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -69.64 -41.84 75.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.367 -0.833 . . . . 0.0 109.445 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.52 -45.86 91.03 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.921 . . . . 0.0 109.021 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -81.55 -5.86 58.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.352 -0.842 . . . . 0.0 109.114 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.47 ' HB1' ' HA ' ' A' ' 45' ' ' LEU . . . -69.09 -37.92 78.69 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.231 -0.918 . . . . 0.0 109.217 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 6.3 m-30 -74.96 81.89 2.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.52 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 2.1 t-20 -130.37 58.2 1.68 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 108.735 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 50' ' ' ASN . 5.2 t-20 84.77 17.84 0.15 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.578 0.704 . . . . 0.0 109.129 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . 44.18 23.62 0.07 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.467 -0.771 . . . . 0.0 110.17 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.541 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -91.93 -53.65 0.27 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.067 -1.02 . . . . 0.0 110.638 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 2.4 Cg_endo -65.4 -7.71 16.76 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.994 1.796 . . . . 0.0 110.965 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.427 ' CD1' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -109.08 -17.19 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.96 -1.088 . . . . 0.0 109.638 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.503 ' HG2' ' NH1' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -80.3 -46.8 15.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.449 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -107.32 63.47 0.63 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.505 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 4.7 t 167.68 -30.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.43 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.24 -153.3 31.69 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.448 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 6.3 p90 -151.84 -169.27 3.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -1.165 . . . . 0.0 109.169 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.77 146.75 28.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.092 -1.005 . . . . 0.0 110.556 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.5 -166.98 1.44 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.89 -22.08 46.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 109.383 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.72 -111.17 0.14 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.2 t -125.76 -153.67 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -1.195 . . . . 0.0 109.293 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 47.1 p-80 -88.29 114.14 24.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.167 -0.958 . . . . 0.0 109.416 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.445 ' HA ' ' HB2' ' A' ' 81' ' ' LYS . 12.0 m-30 -95.13 162.95 13.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 26.1 t -111.3 169.13 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.897 . . . . 0.0 109.451 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 91.6 m -122.33 130.94 53.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.909 . . . . 0.0 109.616 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.72 19.54 5.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.126 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -177.16 85.18 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.373 -0.829 . . . . 0.0 109.171 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 52' ' ' ALA . . . -141.71 36.95 1.63 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 0.0 109.64 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.44 -25.86 13.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.28 -0.887 . . . . 0.0 109.446 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -90.62 -106.65 0.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -139.64 24.24 2.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.793 -1.192 . . . . 0.0 109.564 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -135.47 156.17 49.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -0.905 . . . . 0.0 109.338 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.423 HG12 ' HB3' ' A' ' 72' ' ' ALA . 10.8 mt -149.27 68.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.174 -0.954 . . . . 0.0 109.429 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 76' ' ' SER . 0.0 OUTLIER -94.17 95.26 8.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.904 . . . . 0.0 108.764 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -113.23 173.32 15.01 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 0.7 OUTLIER -151.23 -170.65 3.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -1.153 . . . . 0.0 109.334 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.503 ' HE2' ' NE2' ' A' ' 66' ' ' HIS . 0.3 OUTLIER 175.62 111.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.189 -0.944 . . . . 0.0 109.58 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.54 -135.0 11.91 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 102' ' ' GLU . 2.4 p -100.24 -4.62 29.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -1.192 . . . . 0.0 109.694 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . . . -113.35 166.95 10.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.368 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.573 ' HA3' ' CE1' ' A' ' 100' ' ' TYR . . . -150.22 157.18 27.09 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.462 HG23 ' CG2' ' A' ' 88' ' ' THR . 11.9 p -135.53 136.64 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -1.18 . . . . 0.0 110.039 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.496 ' CG1' ' HB3' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -110.26 95.58 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.552 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.462 ' CG2' HG23 ' A' ' 86' ' ' VAL . 6.7 p -106.72 115.75 30.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 109.889 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.477 HG21 ' HG ' ' A' ' 96' ' ' LEU . 3.1 m -135.02 134.16 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 109.536 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.494 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -97.35 146.1 25.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.346 -0.846 . . . . 0.0 109.121 179.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.473 ' HB ' HG12 ' A' ' 121' ' ' ILE . 23.4 p -146.17 -145.31 0.17 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 109.913 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 91' ' ' THR . 0.1 OUTLIER -41.41 -74.58 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.295 -0.878 . . . . 0.0 110.548 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.471 ' O ' HD12 ' A' ' 24' ' ' LEU . 1.2 mtpt -149.72 52.85 0.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.993 . . . . 0.0 109.89 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.427 ' N ' HD22 ' A' ' 24' ' ' LEU . 21.2 t -169.86 151.25 4.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.925 . . . . 0.0 109.523 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.462 HG12 ' HG2' ' A' ' 90' ' ' LYS . 12.4 mt -129.32 128.53 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.179 -0.951 . . . . 0.0 109.256 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.508 HD21 ' NE1' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -98.96 154.39 18.11 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.327 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.518 HG23 ' CD1' ' A' ' 22' ' ' LEU . 59.0 t -137.36 64.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.129 -0.982 . . . . 0.0 109.578 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -50.05 118.28 5.66 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.511 ' C ' ' CG1' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -112.31 114.2 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.159 -1.2 . . . . 0.0 109.291 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.573 ' CE1' ' HA3' ' A' ' 85' ' ' GLY . 19.2 p90 -123.98 -168.78 1.84 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.248 -0.907 . . . . 0.0 109.672 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 84' ' ' ALA . 6.9 m120 -132.82 -168.52 2.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 83' ' ' SER . 16.1 pt-20 -66.28 -9.32 31.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.278 -0.889 . . . . 0.0 109.906 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -73.89 -17.54 61.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.917 . . . . 0.0 109.599 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 100' ' ' TYR . 9.5 mt -117.59 103.66 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.935 . . . . 0.0 109.504 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.456 ' HG2' ' HD2' ' A' ' 106' ' ' PRO . 1.7 tt0 -64.29 142.05 98.25 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.266 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.456 ' HD2' ' HG2' ' A' ' 105' ' ' GLN . 2.8 Cg_endo -61.55 152.58 72.45 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.04 1.827 . . . . 0.0 110.079 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.32 -23.05 23.67 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.1 m -98.08 -53.28 3.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -1.123 . . . . 0.0 109.569 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.446 ' O ' HG11 ' A' ' 112' ' ' VAL . . . -73.77 -32.19 63.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.928 . . . . 0.0 109.465 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.44 -27.85 64.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 0.0 109.587 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.453 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -78.2 -49.28 14.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.715 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 7.5 p -59.26 -21.59 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -0.969 . . . . 0.0 109.523 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 109' ' ' ALA . 91.1 t -78.91 -33.32 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.785 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.453 ' OE2' ' HA ' ' A' ' 111' ' ' ASN . 26.3 mt-10 -59.57 -61.12 2.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.931 . . . . 0.0 109.439 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.29 -38.26 88.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.633 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 4.1 mt -57.97 -24.44 58.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.539 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -80.41 -29.74 37.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.289 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.35 -38.7 74.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.072 . . . . 0.0 109.4 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -75.43 -47.43 27.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 109.554 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.495 HD12 ' CD1' ' A' ' 2' ' ' TRP . 0.5 OUTLIER -60.92 -57.52 12.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 109.417 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.539 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 15.7 mt -61.24 -13.81 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.467 -0.771 . . . . 0.0 109.941 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.74 -9.76 40.9 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -119.42 -56.27 2.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -1.185 . . . . 0.0 109.459 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 114.64 112.4 2.94 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.286 -1.126 . . . . 0.0 109.271 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.606 ' O ' ' CG ' ' A' ' 2' ' ' TRP . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.606 ' CG ' ' O ' ' A' ' 1' ' ' SER . 47.7 m95 -159.25 -149.24 0.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.559 -0.713 . . . . 0.0 109.219 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.84 -86.07 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.816 -1.178 . . . . 0.0 109.342 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -63.77 -37.94 89.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.032 -1.042 . . . . 0.0 108.984 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.597 ' CE2' ' HG ' ' A' ' 116' ' ' LEU . 18.7 m-30 -56.34 -39.26 72.56 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.381 -0.825 . . . . 0.0 109.769 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 1.2 t -54.44 -45.56 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.828 -1.17 . . . . 0.0 108.075 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.62 41.12 1.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 110.919 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.487 HG23 ' N ' ' A' ' 9' ' ' ASN . 88.8 m -146.06 -106.01 0.1 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.527 -1.358 . . . . 0.0 109.879 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.9 t-20 -102.1 -70.75 0.74 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.043 -1.036 . . . . 0.0 110.08 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.502 ' C ' ' O ' ' A' ' 9' ' ' ASN . 0.2 OUTLIER -20.53 -45.34 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' A' ' 9' ' ' ASN . 0.9 OUTLIER -77.39 -68.09 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.851 -1.156 . . . . 0.0 110.125 -179.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -38.99 -36.46 0.5 Allowed Glycine 0 N--CA 1.498 2.785 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.533 ' CB ' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 156.61 39.61 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.989 -0.712 . . . . 0.0 109.154 179.011 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 15' ' ' ALA . . . -84.47 17.78 27.77 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 177.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 158.44 -32.04 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 31.2 m -138.88 150.55 23.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.565 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.6 OUTLIER -78.97 6.32 9.57 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.113 -0.992 . . . . 0.0 108.872 179.112 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.565 ' CG ' ' O ' ' A' ' 17' ' ' THR . 27.4 mt-30 -168.42 160.87 11.54 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.614 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -163.95 112.4 1.18 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.913 -1.117 . . . . 0.0 112.148 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.499 ' N ' ' HB3' ' A' ' 32' ' ' SER . . . -98.32 144.53 27.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.263 -1.523 . . . . 0.0 109.957 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.544 HD13 ' HA ' ' A' ' 2' ' ' TRP . 45.5 mm -124.07 111.55 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.417 -0.802 . . . . 0.0 109.136 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.593 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -116.24 123.42 47.68 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.044 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.71 -158.62 14.79 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.74 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -106.63 -60.83 1.61 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.349 -1.089 . . . . 0.0 109.977 -179.504 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.83 6.87 14.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.976 -1.078 . . . . 0.0 108.725 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 28' ' ' THR . . . -143.04 88.4 0.18 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.02 -2.032 . . . . 0.0 108.02 179.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' A' ' 26' ' ' GLY . 2.1 t30 -30.68 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.067 -0.666 . . . . 0.0 110.838 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 26' ' ' GLY . 12.3 m -166.56 104.23 0.61 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.05 -1.031 . . . . 0.0 109.845 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.496 ' NE1' ' HA3' ' A' ' 26' ' ' GLY . 19.6 m0 -79.4 -27.93 41.83 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.527 ' HB2' ' CG2' ' A' ' 6' ' ' VAL . . . -147.54 163.59 36.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t -143.98 155.84 44.18 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.11 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 96.6 p -64.63 -9.96 23.21 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.649 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 63.8 66.77 0.65 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.16 -87.47 0.07 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -94.24 148.34 22.3 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.218 -1.166 . . . . 0.0 109.212 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.12 148.57 38.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.599 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -103.29 132.8 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.278 -0.888 . . . . 0.0 109.625 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.1 p -72.04 149.24 92.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.92 . . . . 0.0 109.398 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.56 ' O ' ' CB ' ' A' ' 40' ' ' ALA . 6.1 Cg_exo -60.15 177.62 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.184 1.923 . . . . 0.0 110.202 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 39' ' ' PRO . . . 83.37 -42.23 0.1 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.608 -0.682 . . . . 0.0 109.633 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -68.24 -31.81 71.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.058 -1.026 . . . . 0.0 109.569 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.09 -35.93 60.46 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.3 -33.96 73.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -1.173 . . . . 0.0 109.531 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.2 m -59.14 -31.73 69.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.412 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 mt -68.7 -40.58 79.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 109.398 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.62 -42.01 99.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.383 -0.823 . . . . 0.0 109.454 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.4 t -74.85 -9.98 59.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 109.562 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.38 -16.65 36.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.923 . . . . 0.0 109.729 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -81.89 -15.93 52.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.248 -0.907 . . . . 0.0 109.688 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -117.3 4.51 12.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.271 -0.893 . . . . 0.0 109.239 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -166.44 107.72 0.69 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -0.865 . . . . 0.0 109.468 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 56' ' ' ARG . . . -95.11 47.74 1.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.379 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.577 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -82.59 -49.62 0.8 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 110.721 -179.534 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 4.8 Cg_exo -63.57 -71.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.974 1.783 . . . . 0.0 111.393 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.458 ' HB ' HG23 ' A' ' 69' ' ' THR . 0.1 OUTLIER -45.52 -54.13 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.13 -0.981 . . . . 0.0 110.053 -178.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 5.0 mtp180 -50.83 -53.24 33.85 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.161 -0.962 . . . . 0.0 109.489 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.81 -87.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.54 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.2 -82.96 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.179 -0.95 . . . . 0.0 109.426 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 55' ' ' ILE . . . -179.97 -99.96 0.13 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.472 ' CB ' ' HB2' ' A' ' 67' ' ' TYR . 1.3 m-85 -131.19 133.53 45.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.358 -1.083 . . . . 0.0 109.273 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -129.25 125.61 37.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.194 -0.942 . . . . 0.0 109.483 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.93 -149.78 0.41 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.329 -0.857 . . . . 0.0 109.302 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.25 -75.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.415 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.57 37.14 1.91 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.439 HG13 ' CZ ' ' A' ' 67' ' ' TYR . 2.6 t -138.85 158.52 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -1.145 . . . . 0.0 109.773 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -131.03 143.21 50.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.448 -0.783 . . . . 0.0 109.51 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.472 ' HB2' ' CB ' ' A' ' 60' ' ' PHE . 33.8 m-85 -134.56 -169.51 2.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.326 -0.859 . . . . 0.0 109.34 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.41 136.96 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.964 . . . . 0.0 109.426 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.458 HG23 ' HB ' ' A' ' 55' ' ' ILE . 1.7 m -93.87 103.03 15.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.943 . . . . 0.0 109.266 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 tp -124.0 38.11 4.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.963 . . . . 0.0 109.715 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER 172.53 50.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 179.634 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' A' ' 77' ' ' ILE . . . -113.78 23.38 13.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.866 . . . . 0.0 109.125 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -124.97 -24.02 4.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 109.672 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -75.57 -93.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.119 -0.988 . . . . 0.0 109.253 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.61 -46.9 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 109.254 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.584 ' CB ' ' CZ ' ' A' ' 78' ' ' TYR . 67.7 m -89.39 -164.2 1.11 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.912 . . . . 0.0 108.779 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.494 ' CG1' ' O ' ' A' ' 76' ' ' SER . 45.3 mt -157.73 63.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.983 -1.073 . . . . 0.0 110.212 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.584 ' CZ ' ' CB ' ' A' ' 76' ' ' SER . 1.9 m-85 -90.81 145.22 24.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.996 -1.065 . . . . 0.0 108.432 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -140.61 -171.21 12.38 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.484 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -149.59 -176.66 5.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.584 -0.95 . . . . 0.0 108.944 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER 178.55 34.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.973 . . . . 0.0 109.617 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.431 ' C ' ' OG ' ' A' ' 83' ' ' SER . . . 62.33 95.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 101' ' ' ASN . 0.6 OUTLIER 70.55 6.79 5.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.287 -1.125 . . . . 0.0 109.783 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 81' ' ' LYS . . . -150.35 129.88 13.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.661 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.571 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -150.35 174.8 29.64 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.536 ' CG2' ' CG2' ' A' ' 88' ' ' THR . 7.4 p -148.14 114.26 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -1.177 . . . . 0.0 110.133 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.412 HD13 ' CE1' ' A' ' 100' ' ' TYR . 7.2 mt -90.72 79.34 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.115 -0.991 . . . . 0.0 109.212 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.536 ' CG2' ' CG2' ' A' ' 86' ' ' VAL . 1.2 p -105.56 141.78 36.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.198 -0.939 . . . . 0.0 110.116 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.541 HG21 ' CD2' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -150.49 -178.11 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -114.41 80.3 1.38 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.886 -1.134 . . . . 0.0 110.466 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.533 HG22 ' CG2' ' A' ' 89' ' ' VAL . 19.3 p -98.56 148.65 23.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.935 . . . . 0.0 108.666 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 0.3 OUTLIER 50.85 20.27 0.75 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.341 -0.85 . . . . 0.0 109.754 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 92' ' ' SER . 0.5 OUTLIER 81.95 -18.71 0.46 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.342 -0.849 . . . . 0.0 110.192 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.545 ' HA ' ' CD2' ' A' ' 24' ' ' LEU . 1.4 p -82.28 178.94 7.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.213 -0.93 . . . . 0.0 109.21 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 4.8 mt -130.86 101.65 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.134 -0.979 . . . . 0.0 110.117 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.55 ' CD1' ' CH2' ' A' ' 2' ' ' TRP . 0.3 OUTLIER -71.74 157.78 37.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.299 -0.876 . . . . 0.0 108.743 179.602 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.528 HG22 ' CG ' ' A' ' 22' ' ' LEU . 10.4 t -132.3 68.27 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.952 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -48.26 129.46 19.03 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 107.399 -2.28 . . . . 0.0 107.399 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.54 HG21 ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -132.12 106.0 10.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.715 -1.462 . . . . 0.0 108.73 -178.786 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.571 ' CZ ' ' HA3' ' A' ' 85' ' ' GLY . 22.5 p90 -122.77 164.56 18.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.371 -0.83 . . . . 0.0 109.905 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 102' ' ' GLU . 1.1 m120 -150.68 -164.11 1.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.443 -0.786 . . . . 0.0 109.312 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 101' ' ' ASN . 0.8 OUTLIER 61.49 19.21 10.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.626 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.8 mttt 60.28 62.74 1.52 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.118 -0.989 . . . . 0.0 109.377 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.458 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 6.2 mt -73.68 123.05 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.285 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -44.66 104.86 0.41 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.447 -0.783 . . . . 0.0 109.983 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 104' ' ' ILE . 3.6 Cg_exo -62.08 172.82 3.66 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.053 1.835 . . . . 0.0 110.173 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 111' ' ' ASN . . . 87.9 -19.88 31.56 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.438 ' O ' HG21 ' A' ' 112' ' ' VAL . 17.1 m -106.24 -45.56 4.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -1.18 . . . . 0.0 109.273 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -73.64 -43.31 59.85 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.186 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.71 -30.79 70.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.147 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 107' ' ' GLY . 0.7 OUTLIER -70.09 -40.98 74.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.346 -0.846 . . . . 0.0 109.467 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 108' ' ' THR . 21.6 t -67.2 -26.11 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.124 -0.985 . . . . 0.0 109.33 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 113' ' ' VAL . 38.1 t -76.73 -27.63 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.367 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.38 -43.12 82.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.442 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.2 -54.29 11.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 109.062 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.597 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 5.0 mp -51.55 -22.31 3.14 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.268 -0.895 . . . . 0.0 109.084 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.475 ' HB3' HD13 ' A' ' 121' ' ' ILE . . . -71.25 -43.73 66.69 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.441 -0.787 . . . . 0.0 109.248 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.44 -14.58 29.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.741 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.485 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 1.7 t80 -78.55 -60.76 2.24 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -0.935 . . . . 0.0 109.512 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.58 -50.08 68.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.909 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.529 ' CD1' HG21 ' A' ' 91' ' ' THR . 19.6 mt -51.08 -34.21 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.087 -1.008 . . . . 0.0 109.513 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -45.16 -65.3 1.9 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -46.88 -60.42 2.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -1.12 . . . . 0.0 109.642 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.4 74.09 1.19 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' A' ' 92' ' ' SER . 64.1 m-85 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.256 -1.144 . . . . 0.0 109.482 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 2' ' ' TRP . 2.4 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.597 ' CZ3' HD13 ' A' ' 96' ' ' LEU . 3.3 m-90 43.25 30.61 0.31 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.376 -0.827 . . . . 0.0 109.501 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -74.71 0.18 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.957 -1.09 . . . . 0.0 109.248 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 m -69.61 -8.81 50.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.127 -0.983 . . . . 0.0 109.051 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.555 ' HB3' ' HB2' ' A' ' 10' ' ' LEU . 14.2 m-30 -88.55 -34.43 17.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.356 -0.84 . . . . 0.0 109.098 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' A' ' 2' ' ' TRP . 1.0 OUTLIER -60.99 -33.79 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.311 -0.868 . . . . 0.0 108.746 179.565 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -48.83 -89.58 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.484 -0.76 . . . . 0.0 110.504 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 p -133.64 13.36 4.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.068 -1.02 . . . . 0.0 110.556 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 14' ' ' GLY . 16.9 m-20 -96.59 -82.72 0.39 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.965 -1.084 . . . . 0.0 109.123 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 7.9 mp -65.73 -24.18 66.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.927 -1.108 . . . . 0.0 109.322 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 6' ' ' VAL . 3.6 t -85.18 -57.7 4.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 13' ' ' THR . . . -47.65 -35.97 12.1 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.568 ' CB ' ' O ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER 154.93 49.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 122.032 -0.687 . . . . 0.0 110.628 178.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 9' ' ' ASN . . . -94.87 21.08 45.65 Favored Glycine 0 C--N 1.292 -1.898 0 N-CA-C 106.471 -2.652 . . . . 0.0 106.471 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 14' ' ' GLY . . . 153.21 -30.96 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 5.6 m -139.34 153.11 23.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.476 ' O ' ' OE1' ' A' ' 18' ' ' GLN . 63.2 p -80.36 12.24 3.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.898 -1.126 . . . . 0.0 109.114 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.525 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -171.86 176.57 3.56 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.482 ' CB ' ' CG2' ' A' ' 11' ' ' VAL . . . -175.05 159.67 2.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.789 -1.194 . . . . 0.0 109.777 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -153.17 122.56 6.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.15 -0.969 . . . . 0.0 110.0 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.53 ' CD1' ' HB2' ' A' ' 2' ' ' TRP . 5.0 mm -81.58 98.47 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.591 ' CD2' ' CG2' ' A' ' 97' ' ' VAL . 5.4 mp -75.99 -79.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.606 -0.684 . . . . 0.0 110.302 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.45 ' HA3' ' CZ3' ' A' ' 29' ' ' TRP . . . 141.04 148.95 5.18 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.536 ' HB3' ' CG1' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -107.51 -16.82 14.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.08 -1.247 . . . . 0.0 109.863 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.11 31.98 0.84 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.064 -1.022 . . . . 0.0 109.843 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.69 -110.94 0.69 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.75 -63.29 0.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.409 -1.053 . . . . 0.0 109.153 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.571 ' O ' ' CE3' ' A' ' 29' ' ' TRP . 0.2 OUTLIER -134.95 -178.06 4.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.91 . . . . 0.0 109.525 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.571 ' CE3' ' O ' ' A' ' 28' ' ' THR . 0.6 OUTLIER -157.3 -54.38 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.871 . . . . 0.0 109.143 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.495 ' O ' HG12 ' A' ' 21' ' ' ILE . . . -173.76 79.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 17.9 p -79.57 166.52 21.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -0.973 . . . . 0.0 110.481 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.44 ' HB2' HG11 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -171.17 54.92 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.418 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . . . -124.24 -166.4 1.5 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.365 -0.835 . . . . 0.0 109.631 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.31 -25.01 14.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.402 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 4.0 p90 -82.81 -175.44 5.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -1.233 . . . . 0.0 109.453 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.535 ' O ' ' CB ' ' A' ' 63' ' ' ALA . . . -141.8 95.87 2.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 109.636 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 t -84.41 66.6 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 109.377 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.704 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 1.2 t -93.04 -26.87 0.28 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.325 -0.86 . . . . 0.0 112.627 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 38' ' ' THR . 6.3 Cg_exo -59.72 -166.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.739 0 C-N-CA 120.774 0.983 . . . . 0.0 110.37 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.22 47.3 1.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HA ' ' OE1' ' A' ' 41' ' ' GLN . 14.0 mm-40 -81.27 -16.6 52.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.069 -1.02 . . . . 0.0 109.124 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.0 -41.54 92.47 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -27.9 65.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -1.209 . . . . 0.0 109.662 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.3 m -63.32 -22.52 66.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.137 -0.977 . . . . 0.0 109.508 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.456 HD21 ' N ' ' A' ' 45' ' ' LEU . 3.0 mm? -82.93 -43.2 16.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 110.289 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.41 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . . . -72.38 -54.93 7.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.044 -1.035 . . . . 0.0 109.913 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 m -55.05 -29.39 57.36 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.229 -0.92 . . . . 0.0 109.291 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.9 90.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.336 -0.853 . . . . 0.0 109.641 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.41 ' CD2' ' HA ' ' A' ' 46' ' ' ALA . 17.3 m-30 -53.4 -21.27 5.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.27 -0.894 . . . . 0.0 109.853 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -80.55 -58.57 3.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.011 . . . . 0.0 109.535 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -126.91 133.35 50.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 109.514 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.434 ' C ' HG12 ' A' ' 55' ' ' ILE . . . -112.1 29.17 8.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 109.45 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.618 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 5.0 t70 -81.77 -45.63 1.06 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 110.62 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.3 Cg_endo -66.32 -6.33 14.66 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 121.524 1.483 . . . . 0.0 110.368 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -103.32 -31.98 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 0.0 109.709 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 69' ' ' THR . 4.3 ptp180 -71.38 -26.75 62.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.013 -1.054 . . . . 0.0 109.515 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.8 -63.16 1.45 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 109.808 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.04 -32.94 5.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 109.459 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 55' ' ' ILE . . . 111.75 -151.03 18.02 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 21.3 p90 -123.12 166.49 15.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -1.096 . . . . 0.0 109.42 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -127.32 151.65 48.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 109.922 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.516 ' O ' ' C ' ' A' ' 63' ' ' ALA . 25.7 mt -123.62 -141.33 0.31 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.327 -0.858 . . . . 0.0 109.464 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 36' ' ' ALA . . . -28.11 -70.81 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.9 -0.5 . . . . 0.0 111.115 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.76 21.6 0.39 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.57 163.77 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.155 -1.203 . . . . 0.0 109.476 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -102.57 155.91 17.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 109.35 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.448 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 64.6 m-85 -141.81 150.32 41.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.258 -0.901 . . . . 0.0 109.324 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 69' ' ' THR . 49.9 t -97.55 161.2 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.747 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 19.8 m -146.22 91.76 2.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 109.18 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.466 ' O ' ' CG ' ' A' ' 71' ' ' ARG . 1.7 tt -109.36 25.92 11.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.226 -0.921 . . . . 0.0 109.599 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.466 ' CG ' ' O ' ' A' ' 70' ' ' LEU . 7.2 mtm180 -158.87 61.17 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.885 . . . . 0.0 109.42 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 73' ' ' ASP . . . -129.91 119.98 24.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.437 -0.79 . . . . 0.0 109.407 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 72' ' ' ALA . 0.7 OUTLIER 169.38 -61.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 109.498 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.48 ' HB3' ' HD2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -56.34 -83.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.167 -0.958 . . . . 0.0 109.328 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.533 ' HG2' ' N ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -148.67 -34.48 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.028 -1.045 . . . . 0.0 110.264 179.754 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 72.3 m -97.28 162.8 13.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.906 -1.122 . . . . 0.0 109.827 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 76' ' ' SER . 3.4 mp -146.77 83.58 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 109.824 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 76' ' ' SER . 1.1 m-85 -92.65 96.14 10.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.007 -1.058 . . . . 0.0 108.718 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.99 174.65 8.62 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.41 85.27 1.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.338 -1.095 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -59.91 178.05 0.2 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.2 -0.937 . . . . 0.0 109.496 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -51.65 -45.0 54.79 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.63 -19.99 3.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -1.172 . . . . 0.0 110.406 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -99.02 167.42 10.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.898 -1.126 . . . . 0.0 109.86 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.51 153.73 23.19 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.464 HG21 HG11 ' A' ' 97' ' ' VAL . 3.9 p -136.34 132.23 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.134 -1.215 . . . . 0.0 109.846 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 67.6 mt -107.5 112.63 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.328 -0.858 . . . . 0.0 109.229 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.455 ' O ' HG11 ' A' ' 89' ' ' VAL . 1.4 p -120.35 117.69 28.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.622 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.529 ' CG2' HD22 ' A' ' 96' ' ' LEU . 18.1 m -144.59 146.66 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 109.532 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -77.22 151.57 35.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.252 -0.905 . . . . 0.0 109.326 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.542 ' O ' ' CB ' ' A' ' 125' ' ' PHE . 25.1 p -147.34 -111.41 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 109.785 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.72 86.41 5.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.772 -1.205 . . . . 0.0 109.88 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.448 ' O ' ' CZ2' ' A' ' 29' ' ' TRP . 0.6 OUTLIER 51.18 21.72 1.15 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.331 -0.855 . . . . 0.0 109.464 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.493 ' N ' HD22 ' A' ' 24' ' ' LEU . 4.9 t -157.32 147.61 20.95 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.374 -0.829 . . . . 0.0 109.377 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.536 ' CG1' ' HB3' ' A' ' 24' ' ' LEU . 11.0 mt -109.1 154.2 10.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.395 -0.816 . . . . 0.0 109.071 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.597 HD13 ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -114.59 150.81 34.46 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.028 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.591 ' CG2' ' CD2' ' A' ' 22' ' ' LEU . 54.9 t -129.68 77.31 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.291 -0.881 . . . . 0.0 110.159 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.03 143.77 45.44 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -143.15 118.33 4.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.691 -1.476 . . . . 0.0 109.853 -179.078 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.582 ' CE1' ' O ' ' A' ' 104' ' ' ILE . 35.1 p90 -131.89 166.0 22.62 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 103' ' ' LYS . 46.7 t30 -150.31 133.33 16.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.871 -1.143 . . . . 0.0 110.864 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 101' ' ' ASN . 0.0 OUTLIER 38.39 29.74 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.634 179.289 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 101' ' ' ASN . 5.6 mmtp -136.19 -51.31 0.71 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.246 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.582 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 1.7 mp -112.35 75.68 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.127 -0.983 . . . . 0.0 109.841 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.451 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 9.6 mt-30 -54.8 158.1 4.83 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.077 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 105' ' ' GLN . 2.9 Cg_endo -60.03 143.52 99.56 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.088 1.859 . . . . 0.0 110.403 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.16 -22.49 6.7 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.6 m -114.93 -52.87 2.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.125 -1.221 . . . . 0.0 109.499 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -72.37 -29.46 63.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 109.527 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -71.43 -21.82 61.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.572 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -90.08 -50.72 5.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.195 -0.94 . . . . 0.0 109.674 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.05 -38.18 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 109.683 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.413 HG22 HD11 ' A' ' 87' ' ' ILE . 44.8 t -72.72 -31.14 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.133 -0.98 . . . . 0.0 109.601 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 110' ' ' ALA . 6.6 tt0 -65.91 -42.33 90.31 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.171 -0.956 . . . . 0.0 109.824 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -75.87 -36.52 59.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -0.968 . . . . 0.0 109.875 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.463 HD21 ' CZ2' ' A' ' 2' ' ' TRP . 17.1 tp -60.0 -62.52 1.81 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.091 -1.006 . . . . 0.0 108.797 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.536 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . -60.36 -21.53 62.23 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.27 -0.894 . . . . 0.0 109.284 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.438 ' HB2' ' HA ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -58.07 -52.0 67.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.281 -0.887 . . . . 0.0 109.539 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -59.27 -29.38 67.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.201 -0.937 . . . . 0.0 108.982 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.4 HD11 ' HB ' ' A' ' 91' ' ' THR . 4.3 mt -80.0 -22.9 41.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 110.025 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.536 ' CD1' ' O ' ' A' ' 117' ' ' ALA . 1.3 mp -87.45 -16.08 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.096 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.15 -27.62 15.65 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -81.78 -71.71 0.47 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.363 -1.081 . . . . 0.0 109.367 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 144.9 94.0 0.17 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.542 ' CB ' ' O ' ' A' ' 91' ' ' THR . 22.6 m-85 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.131 -1.217 . . . . 0.0 109.362 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 1.073 ' CZ3' HD22 ' A' ' 96' ' ' LEU . 1.7 m-90 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.49 -67.31 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.072 -1.018 . . . . 0.0 109.568 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -65.81 -30.85 71.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.532 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.967 ' CB ' HD12 ' A' ' 10' ' ' LEU . 6.6 m-30 -81.73 -3.08 52.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.12 -0.987 . . . . 0.0 109.456 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.719 ' HA ' HG23 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -83.19 -41.05 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.983 -1.073 . . . . 0.0 108.794 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -90.46 48.29 1.53 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.378 -0.827 . . . . 0.0 111.117 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.504 HG23 ' H ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -165.85 -96.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.708 -1.245 . . . . 0.0 110.792 179.215 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -101.46 -68.97 0.8 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.982 -1.073 . . . . 0.0 110.925 -178.628 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.967 HD12 ' CB ' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -23.05 -43.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.65 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.026 HG22 ' HB3' ' A' ' 19' ' ' ALA . 48.9 t -91.94 -55.5 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.725 -1.235 . . . . 0.0 110.815 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.736 ' C ' HG22 ' A' ' 13' ' ' THR . . . -40.03 -47.78 3.39 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.736 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 163.62 41.28 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.709 -0.877 . . . . 0.0 108.792 178.478 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.706 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -87.19 22.2 16.57 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 153.97 -34.1 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.914 HG12 ' HB3' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -134.46 137.94 50.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.587 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.72 HG23 ' CD1' ' A' ' 104' ' ' ILE . 69.2 p -78.21 2.39 18.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.955 -1.091 . . . . 0.0 108.869 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.509 ' CG ' ' C ' ' A' ' 17' ' ' THR . 6.4 mt-30 -161.83 151.11 15.99 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 1.026 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -163.47 147.97 10.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.967 -1.083 . . . . 0.0 109.973 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -141.81 152.03 43.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.429 -0.795 . . . . 0.0 108.974 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.842 HG22 ' HE3' ' A' ' 29' ' ' TRP . 7.0 mt -120.88 103.22 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.949 . . . . 0.0 109.669 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.723 HD23 ' C ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -136.55 164.23 28.67 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.588 ' HA3' ' CD1' ' A' ' 95' ' ' ILE . . . 132.64 172.79 13.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.887 HD13 ' O ' ' A' ' 93' ' ' LYS . 1.4 mp 60.78 121.0 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.148 0 O-C-N 121.159 -1.2 . . . . 0.0 108.377 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -78.03 39.3 0.3 Allowed 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.806 -0.559 . . . . 0.0 111.448 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -105.98 -32.62 3.74 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER 162.79 -172.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.621 -0.929 . . . . 0.0 109.167 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.655 HG22 ' H ' ' A' ' 29' ' ' TRP . 1.3 m -98.56 -174.49 2.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.091 -1.006 . . . . 0.0 108.536 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.842 ' HE3' HG22 ' A' ' 21' ' ' ILE . 3.8 m-90 -142.8 -54.67 0.41 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.013 -1.055 . . . . 0.0 109.993 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.0 134.87 0.2 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.536 -1.266 . . . . 0.0 110.464 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 1.4 t -135.1 157.41 46.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.573 -0.705 . . . . 0.0 109.113 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.473 ' CB ' HG11 ' A' ' 11' ' ' VAL . 13.9 m -159.88 100.59 1.43 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.608 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.532 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . . . -169.81 -164.4 0.43 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 109.161 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -118.13 35.34 4.07 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.532 ' CE1' ' HB3' ' A' ' 33' ' ' ALA . 10.7 p90 -141.59 124.3 16.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 109.48 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.0 116.03 28.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.438 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.707 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 3.5 t -81.78 143.77 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.778 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.535 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 11.2 p -51.05 160.61 0.82 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 0.0 109.444 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 3.9 Cg_exo -59.54 -18.84 49.15 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.128 1.885 . . . . 0.0 110.425 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.17 50.14 1.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.0 109.536 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.535 ' CG ' ' O ' ' A' ' 38' ' ' THR . 36.5 mt-30 -78.36 -55.15 5.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.103 -0.998 . . . . 0.0 109.805 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.94 -17.39 78.49 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -89.66 -18.21 26.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -1.191 . . . . 0.0 109.478 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 53.4 m -89.68 -26.01 20.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.883 . . . . 0.0 109.576 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.9 mt -81.65 -46.53 14.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.81 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.42 87.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.129 -0.982 . . . . 0.0 109.459 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 m -77.56 -39.3 46.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.93 . . . . 0.0 109.421 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 44' ' ' THR . . . -56.75 -29.86 63.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.322 -0.861 . . . . 0.0 109.25 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -87.31 64.55 8.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 109.446 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -101.1 -69.51 0.77 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 109.227 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.428 ' CG ' ' O ' ' A' ' 51' ' ' ASN . 36.4 t30 -138.98 33.35 2.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.0 109.069 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 56' ' ' ARG . . . 49.06 22.42 0.6 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.573 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.586 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -88.51 -57.41 0.28 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.636 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.586 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 1.1 Cg_endo -65.62 -41.35 15.08 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.886 1.724 . . . . 0.0 111.005 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.556 ' HB ' HG21 ' A' ' 69' ' ' THR . 0.2 OUTLIER -75.56 -37.2 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.168 -0.957 . . . . 0.0 109.797 -179.538 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -69.01 -66.94 0.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.0 109.899 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.546 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -77.03 126.03 30.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.107 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 3.5 t 82.52 -42.72 0.13 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.741 -0.599 . . . . 0.0 110.17 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 55' ' ' ILE . . . 95.48 -171.59 29.43 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.418 ' HE1' HD11 ' A' ' 62' ' ' LEU . 46.1 p90 -126.08 164.02 21.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -1.193 . . . . 0.0 109.55 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.465 ' HA ' ' HB3' ' A' ' 66' ' ' HIS . 54.0 m-20 -128.55 162.51 27.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.881 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.418 HD11 ' HE1' ' A' ' 60' ' ' PHE . 61.4 mt -137.0 -147.2 0.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.137 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.707 ' HB2' ' HA ' ' A' ' 37' ' ' VAL . . . -53.78 -54.51 37.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.103 -0.998 . . . . 0.0 109.633 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.75 20.23 0.69 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.465 HG12 ' CE1' ' A' ' 67' ' ' TYR . 71.9 t -135.88 149.0 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -1.188 . . . . 0.0 109.36 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 13.6 p-80 -153.55 160.18 42.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.1 -1.0 . . . . 0.0 109.837 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.465 ' CE1' HG12 ' A' ' 65' ' ' VAL . 52.1 m-85 -139.83 178.47 7.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.355 -0.84 . . . . 0.0 109.481 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.485 ' O ' ' HB ' ' A' ' 69' ' ' THR . 6.0 p -92.03 -29.3 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.212 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.556 HG21 ' HB ' ' A' ' 55' ' ' ILE . 98.8 m 63.85 109.08 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.554 -0.716 . . . . 0.0 109.484 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.6 mt -89.91 -67.65 0.83 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.871 . . . . 0.0 109.503 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.37 137.2 50.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.839 . . . . 0.0 109.298 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 73' ' ' ASP . . . -159.07 91.6 1.04 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 109.527 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 46.7 t0 178.08 -31.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 109.624 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.462 ' O ' ' CD ' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -66.25 -93.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.145 -0.972 . . . . 0.0 109.401 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.462 ' CD ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -138.56 -53.86 0.61 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.07 -1.019 . . . . 0.0 109.725 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.71 ' C ' HD12 ' A' ' 77' ' ' ILE . 20.3 m -90.03 162.76 15.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.0 109.419 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.71 HD12 ' C ' ' A' ' 76' ' ' SER . 4.1 mp -152.9 84.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.177 -0.952 . . . . 0.0 110.246 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.791 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -98.99 98.86 9.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.974 -1.079 . . . . 0.0 108.207 178.748 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.55 166.56 43.68 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.672 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.17 165.56 32.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.97 . . . . 0.0 108.921 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.54 ' HD3' ' HB3' ' A' ' 84' ' ' ALA . 10.3 ptmt -130.48 -9.26 4.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.954 -1.091 . . . . 0.0 110.403 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.28 -23.36 9.83 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.94 -60.41 1.29 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -1.122 . . . . 0.0 108.945 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.54 ' HB3' ' HD3' ' A' ' 81' ' ' LYS . . . -99.82 -169.73 1.79 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 108.86 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.532 ' O ' ' CE1' ' A' ' 100' ' ' TYR . . . -166.94 152.79 21.94 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 86' ' ' VAL . 14.5 p -135.29 104.07 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -1.097 . . . . 0.0 108.971 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.791 HG23 ' HD2' ' A' ' 78' ' ' TYR . 2.0 mt -79.56 107.6 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 109.7 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.667 HG22 HG22 ' A' ' 97' ' ' VAL . 46.8 p -111.71 98.89 7.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.305 -0.872 . . . . 0.0 109.346 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.867 HG23 HD21 ' A' ' 96' ' ' LEU . 11.4 m -125.75 161.83 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.369 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.66 153.79 17.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 109.659 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.682 HG21 ' HZ3' ' A' ' 2' ' ' TRP . 0.6 OUTLIER -147.09 -92.51 0.09 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.289 -0.882 . . . . 0.0 109.209 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.9 p -98.46 66.1 1.69 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 109.102 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.887 ' O ' HD13 ' A' ' 24' ' ' LEU . 6.9 mtmt 64.74 27.74 13.03 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.32 -0.862 . . . . 0.0 108.994 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.636 ' HA ' ' CH2' ' A' ' 29' ' ' TRP . 77.7 p -146.73 148.61 32.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.9 . . . . 0.0 109.947 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.588 ' CD1' ' HA3' ' A' ' 23' ' ' GLY . 1.1 mt -105.93 94.61 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 109.531 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.073 HD22 ' CZ3' ' A' ' 2' ' ' TRP . 0.3 OUTLIER -56.15 155.12 6.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.966 -1.084 . . . . 0.0 108.6 179.543 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.667 HG22 HG22 ' A' ' 88' ' ' THR . 73.2 t -135.08 84.61 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.134 -0.979 . . . . 0.0 109.887 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.447 ' CA ' HG11 ' A' ' 16' ' ' VAL . . . -65.71 92.47 0.16 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.539 HG22 HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -91.72 108.48 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.343 -1.092 . . . . 0.0 108.404 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.914 ' HB3' HG12 ' A' ' 16' ' ' VAL . 5.5 p90 -131.31 172.42 12.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.059 -1.026 . . . . 0.0 110.322 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.473 ' OD1' ' HB2' ' A' ' 103' ' ' LYS . 9.0 p30 -102.81 -166.51 1.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.608 -0.682 . . . . 0.0 109.619 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -69.57 -20.44 63.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.892 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 9.9 mttm -52.95 -41.02 64.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.006 . . . . 0.0 109.468 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.72 ' CD1' HG23 ' A' ' 17' ' ' THR . 1.4 mp -91.61 137.59 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.137 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.19 149.34 65.82 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.544 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.86 -8.03 14.73 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.324 2.016 . . . . 0.0 110.628 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -102.95 -39.54 2.66 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -28.18 69.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.113 -1.228 . . . . 0.0 109.893 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.42 -34.9 18.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.116 -0.99 . . . . 0.0 109.677 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.21 -20.43 62.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.738 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -79.37 -42.28 25.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 109.704 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.44 -37.26 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.771 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.716 HG11 HG21 ' A' ' 87' ' ' ILE . 85.4 t -74.12 -14.02 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.551 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.25 -34.28 22.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.941 . . . . 0.0 109.603 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 118' ' ' ASP . 3.8 mttm -77.74 -51.62 10.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.151 -0.968 . . . . 0.0 109.473 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.46 HD21 ' CD2' ' A' ' 5' ' ' TYR . 1.1 mp -51.41 -48.1 62.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 108.818 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.837 ' HB1' HD11 ' A' ' 121' ' ' ILE . . . -62.34 -47.95 81.96 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.123 -0.986 . . . . 0.0 108.413 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.538 ' CA ' HG12 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -38.52 -29.64 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.405 0.621 . . . . 0.0 109.685 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 117' ' ' ALA . 14.9 m-30 -74.28 -49.59 22.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.305 -0.872 . . . . 0.0 109.317 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.474 HD23 ' CE1' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -80.81 -3.17 50.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.864 . . . . 0.0 111.841 -178.688 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.837 HD11 ' HB1' ' A' ' 117' ' ' ALA . 2.1 mm -77.22 -38.47 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.256 -1.527 . . . . 0.0 108.994 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 121' ' ' ILE . . . -41.32 -38.56 2.0 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -84.57 -59.59 2.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -1.102 . . . . 0.0 109.145 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.38 106.32 1.62 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.607 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 1.8 m-85 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.128 -1.219 . . . . 0.0 109.397 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.85 ' CD1' HD13 ' A' ' 10' ' ' LEU . 6.4 m95 . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -32.57 -82.21 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.798 -0.564 . . . . 0.0 111.536 -178.443 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.462 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.6 OUTLIER -64.01 -34.61 78.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.065 -1.022 . . . . 0.0 110.87 -178.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.834 ' CE2' HD12 ' A' ' 116' ' ' LEU . 1.1 m-30 -76.62 3.23 11.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.75 -1.219 . . . . 0.0 109.801 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.928 HG22 HG21 ' A' ' 11' ' ' VAL . 1.1 t -92.82 -46.45 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 8' ' ' THR . 0.9 OUTLIER -91.37 53.57 2.33 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.285 -0.884 . . . . 0.0 110.257 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -171.11 -92.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.738 -1.226 . . . . 0.0 111.687 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 11' ' ' VAL . 3.6 m120 -101.21 -88.34 0.37 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.065 -1.022 . . . . 0.0 112.181 -177.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.85 HD13 ' CD1' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -21.13 -44.26 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -177.802 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.928 HG21 HG22 ' A' ' 6' ' ' VAL . 41.0 t -94.37 -41.84 12.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.696 -1.252 . . . . 0.0 110.337 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.763 ' C ' HG22 ' A' ' 13' ' ' THR . . . -45.53 -41.04 8.92 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.763 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 157.83 37.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.681 0.753 . . . . 0.0 109.425 178.655 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.699 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -85.19 19.84 20.18 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 158.92 -25.63 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 13' ' ' THR . 10.8 m -141.11 134.01 30.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.539 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 17.5 p -80.08 10.2 4.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 109.367 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.539 ' CG ' ' O ' ' A' ' 17' ' ' THR . 88.2 mt-30 -162.45 166.31 25.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.432 -0.792 . . . . 0.0 108.931 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.76 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . 179.54 166.48 1.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 110.088 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -165.03 126.18 2.02 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.488 -0.758 . . . . 0.0 109.324 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.634 HD11 ' CA ' ' A' ' 2' ' ' TRP . 2.8 mt -91.01 108.27 19.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.229 -0.919 . . . . 0.0 108.591 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.755 HD11 HG21 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -94.51 101.21 13.1 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.276 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -42.83 169.33 0.01 OUTLIER Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.733 HD21 ' N ' ' A' ' 94' ' ' SER . 1.4 pp -119.9 -17.66 8.42 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.415 -1.05 . . . . 0.0 109.428 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.726 ' N ' HD12 ' A' ' 24' ' ' LEU . 1.9 m-20 -124.97 -4.69 7.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.394 -0.816 . . . . 0.0 109.437 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.28 -90.85 1.42 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -171.69 -45.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.346 -1.091 . . . . 0.0 109.722 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.7 m -166.16 129.88 2.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.859 . . . . 0.0 109.242 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.549 ' CD2' ' OG ' ' A' ' 94' ' ' SER . 14.8 m0 -96.75 -45.45 6.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.6 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.4 171.4 19.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 109.453 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -160.88 174.77 13.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.597 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.829 ' HB2' HG11 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -161.44 135.16 6.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.902 . . . . 0.0 109.581 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 87.12 -16.64 0.38 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . 127.41 -90.25 0.35 Allowed Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.09 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.699 ' CE2' HG21 ' A' ' 99' ' ' VAL . 0.3 OUTLIER 61.49 126.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -1.097 . . . . 0.0 109.105 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' A' ' 63' ' ' ALA . . . -136.7 95.34 3.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 109.849 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.49 ' HB ' ' HG2' ' A' ' 41' ' ' GLN . 3.4 t -105.26 92.34 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.26 -0.9 . . . . 0.0 108.953 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.62 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -93.28 -38.84 0.33 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.513 -0.742 . . . . 0.0 112.684 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 38' ' ' THR . 6.5 Cg_exo -54.91 -73.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.403 1.402 . . . . 0.0 111.806 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.537 ' HB1' ' HB3' ' A' ' 43' ' ' GLN . . . -154.0 81.17 1.14 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.826 -1.171 . . . . 0.0 110.111 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.49 ' HG2' ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -75.53 -63.31 1.32 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.264 -1.522 . . . . 0.0 108.659 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -91.79 -7.85 64.19 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.537 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -80.4 -43.27 21.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -1.103 . . . . 0.0 109.457 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 40' ' ' ALA . 17.3 m -76.31 -51.23 12.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 109.56 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.0 mt -58.35 -27.74 64.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.509 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -67.45 -42.83 82.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.802 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.9 t -91.42 -3.12 56.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.614 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.91 -14.27 37.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.632 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.45 ' CE2' ' HG3' ' A' ' 90' ' ' LYS . 18.1 m-30 -87.18 3.18 47.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 109.877 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.58 -41.4 15.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.051 -1.031 . . . . 0.0 109.251 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.48 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -151.46 146.13 25.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -0.872 . . . . 0.0 109.313 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 56' ' ' ARG . . . -89.6 28.97 1.2 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.886 . . . . 0.0 109.901 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.614 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -85.44 -44.66 0.64 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.029 -1.044 . . . . 0.0 110.587 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.2 Cg_endo -68.45 -74.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 121.617 1.545 . . . . 0.0 110.522 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.438 HD12 ' CB ' ' A' ' 72' ' ' ALA . 0.8 OUTLIER -41.87 -46.04 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.39 -0.818 . . . . 0.0 109.982 -179.449 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 3.1 ttt180 -45.47 -55.04 6.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 109.653 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 58' ' ' SER . . . -86.18 -91.83 0.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.836 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 57' ' ' ALA . 2.9 t -43.41 -76.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.195 -0.94 . . . . 0.0 109.758 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 55' ' ' ILE . . . 121.61 -133.71 9.61 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.964 ' CD2' HD21 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -144.24 153.58 42.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.077 -1.249 . . . . 0.0 109.541 179.56 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.634 ' C ' HD22 ' A' ' 62' ' ' LEU . 1.8 m-20 -95.21 128.67 42.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 110.094 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.964 HD21 ' CD2' ' A' ' 60' ' ' PHE . 4.0 mm? -107.59 57.35 0.63 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.499 ' CB ' ' O ' ' A' ' 36' ' ' ALA . . . 50.71 26.79 2.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.476 -0.765 . . . . 0.0 109.42 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.39 -97.01 0.12 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.771 -1.204 . . . . 0.0 110.242 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.594 HG12 ' N ' ' A' ' 66' ' ' HIS . 25.9 t -112.76 170.46 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.183 -1.186 . . . . 0.0 110.012 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.594 ' N ' HG12 ' A' ' 65' ' ' VAL . 74.0 m80 -85.29 132.7 34.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.736 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.586 ' CE1' ' HA ' ' A' ' 81' ' ' LYS . 25.3 m-85 -107.84 168.89 8.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.039 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.549 HG12 ' H ' ' A' ' 69' ' ' THR . 1.9 t -109.59 174.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.111 -0.993 . . . . 0.0 110.027 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.617 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -115.8 135.44 54.01 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.433 -0.792 . . . . 0.0 109.323 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.517 HD23 ' NE ' ' A' ' 71' ' ' ARG . 11.5 tp -89.94 -55.9 3.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.156 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.544 ' HG2' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -137.23 75.77 1.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 109.048 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.658 ' HA ' HG23 ' A' ' 77' ' ' ILE . . . -101.83 81.68 2.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.89 . . . . 0.0 109.549 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 24.9 t70 178.02 -41.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.62 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.43 -81.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 109.806 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.69 -48.81 0.26 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.166 -0.959 . . . . 0.0 109.618 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.647 ' CB ' ' CZ ' ' A' ' 78' ' ' TYR . 0.7 OUTLIER -90.6 -170.51 2.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -0.941 . . . . 0.0 109.726 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.658 HG23 ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -163.13 63.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.1 -1.0 . . . . 0.0 110.05 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.844 ' HB3' HD13 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -92.14 115.3 27.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.905 -1.122 . . . . 0.0 109.04 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.401 ' C ' ' CG1' ' A' ' 86' ' ' VAL . . . -96.69 -158.33 31.45 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.25 158.79 34.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -1.191 . . . . 0.0 109.614 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 2.1 mtpt -123.92 -178.55 4.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.245 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.18 106.09 1.32 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 55.66 20.47 3.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.153 -1.204 . . . . 0.0 108.9 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.647 ' HB1' ' O ' ' A' ' 100' ' ' TYR . . . -136.18 -164.15 1.51 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 109.309 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 100' ' ' TYR . . . -147.57 131.05 3.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.607 HG22 HG23 ' A' ' 88' ' ' THR . 2.5 p -104.51 131.49 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.215 -1.168 . . . . 0.0 109.43 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.844 HD13 ' HB3' ' A' ' 78' ' ' TYR . 47.3 mm -115.14 101.68 12.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.263 -0.898 . . . . 0.0 109.208 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.971 HG22 HG13 ' A' ' 97' ' ' VAL . 7.8 p -117.46 146.16 43.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.071 -1.018 . . . . 0.0 109.603 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.551 ' HB ' HD21 ' A' ' 96' ' ' LEU . 2.1 t -146.95 141.89 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.768 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.45 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -91.3 124.2 35.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.426 -0.796 . . . . 0.0 108.946 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.682 HG21 HD11 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -103.25 -60.19 1.59 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.128 -0.982 . . . . 0.0 109.73 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -168.47 -66.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 0.0 109.437 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.727 ' HA ' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -120.65 15.85 11.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.182 -0.949 . . . . 0.0 109.473 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.733 ' N ' HD21 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -154.36 154.44 33.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.169 -0.957 . . . . 0.0 110.014 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.523 ' CD1' ' HB3' ' A' ' 24' ' ' LEU . 54.6 mt -125.61 138.37 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.916 ' N ' HD13 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -112.29 166.43 11.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.975 -1.078 . . . . 0.0 109.956 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.971 HG13 HG22 ' A' ' 88' ' ' THR . 3.2 t -146.9 77.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -0.917 . . . . 0.0 111.21 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.37 107.09 1.66 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 107.28 -2.328 . . . . 0.0 107.28 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.699 HG21 ' CE2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -115.47 142.55 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.884 -1.363 . . . . 0.0 110.414 -178.102 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.647 ' O ' ' HB1' ' A' ' 84' ' ' ALA . 16.4 p90 -129.13 171.14 12.7 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.48 ' O ' ' CG ' ' A' ' 102' ' ' GLU . 5.9 p30 -150.2 115.2 5.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.676 -1.265 . . . . 0.0 111.183 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.48 ' CG ' ' O ' ' A' ' 101' ' ' ASN . 22.1 pt-20 39.06 31.4 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.518 0.675 . . . . 0.0 109.374 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.817 ' C ' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -133.18 -25.68 1.75 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.693 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.817 HD12 ' C ' ' A' ' 103' ' ' LYS . 1.8 mp -137.79 149.57 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.847 -1.158 . . . . 0.0 110.028 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 5.4 pm0 -99.72 145.0 29.39 Favored Pre-proline 0 C--N 1.307 -1.246 0 O-C-N 121.48 -0.762 . . . . 0.0 109.202 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 105' ' ' GLN . 1.1 Cg_endo -66.35 177.11 3.43 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.088 1.859 . . . . 0.0 110.103 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.35 -0.16 75.97 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 65.1 m -127.06 -45.24 1.57 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.113 -1.227 . . . . 0.0 109.582 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.795 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -80.1 -40.76 26.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 109.569 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.416 ' HB2' HD12 ' A' ' 87' ' ' ILE . . . -56.72 -17.02 7.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.329 -0.857 . . . . 0.0 109.757 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -78.09 -45.71 22.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.717 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 109' ' ' ALA . 11.1 p -71.54 -22.76 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.949 . . . . 0.0 109.857 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.817 HG21 HG21 ' A' ' 87' ' ' ILE . 6.0 t -71.26 -33.54 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.056 -1.027 . . . . 0.0 109.598 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.417 ' O ' ' OE1' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -80.13 -17.04 53.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.138 -0.976 . . . . 0.0 109.894 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.556 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -86.11 -59.2 2.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.965 . . . . 0.0 109.692 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.834 HD12 ' CE2' ' A' ' 5' ' ' TYR . 2.1 mm? -48.43 -35.85 13.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.095 -1.003 . . . . 0.0 109.308 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.763 ' HB2' ' CH2' ' A' ' 2' ' ' TRP . . . -68.8 -39.13 80.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.966 . . . . 0.0 109.478 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.62 -33.92 48.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 109.561 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.556 ' CD1' ' O ' ' A' ' 115' ' ' LYS . 32.8 m-85 -74.76 -58.6 3.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.083 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.736 ' C ' HD12 ' A' ' 120' ' ' LEU . 4.5 pp -72.27 2.35 6.17 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.445 -0.785 . . . . 0.0 110.417 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.473 ' CG1' HG22 ' A' ' 91' ' ' THR . 5.1 mt -88.96 -23.73 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 108.862 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.08 -30.18 53.79 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -92.77 -75.4 0.49 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.377 -1.073 . . . . 0.0 109.461 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 125' ' ' PHE . . . 132.35 36.77 0.29 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.523 ' CE2' HD13 ' A' ' 120' ' ' LEU . 16.0 m-85 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.375 -1.074 . . . . 0.0 109.518 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.888 ' CD1' HD13 ' A' ' 10' ' ' LEU . 7.6 m95 . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -67.13 -80.75 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.13 -0.981 . . . . 0.0 111.366 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.475 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 0.8 OUTLIER -54.6 -22.93 14.83 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.097 -1.002 . . . . 0.0 111.094 -178.373 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 1.9 m-30 -87.58 -25.08 23.79 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.65 -1.281 . . . . 0.0 109.869 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.61 HG13 ' OG ' ' A' ' 32' ' ' SER . 0.9 OUTLIER -63.87 -26.69 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 108.923 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 1.034 ' OD2' HG22 ' A' ' 8' ' ' THR . 1.0 OUTLIER -52.85 -52.58 56.67 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.449 -0.782 . . . . 0.0 111.966 -177.647 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 1.034 HG22 ' OD2' ' A' ' 7' ' ' ASP . 5.0 t -163.38 -27.72 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.531 -1.356 . . . . 0.0 111.116 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 14' ' ' GLY . 1.7 m-80 -64.82 -88.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.656 -1.277 . . . . 0.0 109.764 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.888 HD13 ' CD1' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -59.94 -23.65 63.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.202 -0.936 . . . . 0.0 110.295 -179.379 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.599 HG23 ' HA ' ' A' ' 6' ' ' VAL . 1.5 t -89.21 -60.32 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.868 -1.145 . . . . 0.0 108.999 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.741 ' C ' HG22 ' A' ' 13' ' ' THR . . . -43.67 -36.89 3.62 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.741 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER 158.49 46.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.948 -0.736 . . . . 0.0 110.105 178.908 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.701 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -92.41 23.19 28.85 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 106.294 -2.723 . . . . 0.0 106.294 177.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 1.057 ' O ' HG21 ' A' ' 104' ' ' ILE . . . 154.0 -28.98 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.887 ' HA ' HD13 ' A' ' 104' ' ' ILE . 17.6 m -148.59 139.42 17.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.664 HG23 ' HG3' ' A' ' 18' ' ' GLN . 8.1 t -79.32 6.3 10.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.979 -1.076 . . . . 0.0 109.11 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.664 ' HG3' HG23 ' A' ' 17' ' ' THR . 45.9 mt-30 -160.6 155.63 24.41 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -168.81 175.9 5.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.019 -1.051 . . . . 0.0 110.286 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -165.2 114.09 1.04 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.55 -0.719 . . . . 0.0 109.181 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.751 HD11 ' C ' ' A' ' 2' ' ' TRP . 24.8 mt -79.65 80.74 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 120.999 -1.063 . . . . 0.0 108.851 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -60.33 -150.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.465 -0.772 . . . . 0.0 108.936 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.61 134.63 4.01 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.573 HD23 HG13 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -80.57 4.71 17.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -1.153 . . . . 0.0 109.561 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.12 -13.8 12.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.567 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . 96.26 81.63 1.58 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.551 ' O ' ' C ' ' A' ' 28' ' ' THR . 1.0 OUTLIER 167.8 55.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -1.146 . . . . 0.0 109.442 -179.595 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.551 ' C ' ' O ' ' A' ' 27' ' ' ASN . 21.2 m -20.55 130.36 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.37 0.605 . . . . 0.0 111.325 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.536 ' CE3' ' OG ' ' A' ' 94' ' ' SER . 22.2 m0 -88.68 -45.34 9.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.447 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.01 164.53 18.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.939 . . . . 0.0 109.853 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 3.2 t -157.92 177.47 11.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.413 -0.805 . . . . 0.0 108.879 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.61 ' OG ' HG13 ' A' ' 6' ' ' VAL . 15.3 m -167.13 117.26 0.87 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.112 -0.992 . . . . 0.0 110.375 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 32' ' ' SER . . . 34.32 90.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.164 0.507 . . . . 0.0 110.53 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.33 -84.32 0.05 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.668 ' CE2' HG22 ' A' ' 37' ' ' VAL . 3.3 p90 -172.74 159.58 4.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -1.067 . . . . 0.0 109.352 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.77 116.2 28.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.291 -0.881 . . . . 0.0 108.757 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.668 HG22 ' CE2' ' A' ' 35' ' ' PHE . 91.6 t -79.62 108.37 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.147 -0.971 . . . . 0.0 109.582 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.522 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 9.1 m -48.22 139.35 10.26 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.341 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.722 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 1.8 Cg_endo -63.92 167.7 13.47 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.13 1.887 . . . . 0.0 110.376 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 39' ' ' PRO . . . 82.36 -41.45 0.12 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.649 -0.657 . . . . 0.0 110.293 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -69.29 -31.22 69.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.044 -1.035 . . . . 0.0 109.745 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.31 -38.71 50.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -63.41 -35.7 81.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.175 -1.191 . . . . 0.0 109.923 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.0 m -56.53 -37.28 70.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -0.918 . . . . 0.0 109.791 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.88 -39.5 93.64 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.216 -0.927 . . . . 0.0 109.806 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.4 -26.01 63.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 109.975 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.4 t -88.22 -18.12 29.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.131 -0.98 . . . . 0.0 109.778 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' ASN . . . -73.18 -30.63 63.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.965 . . . . 0.0 109.571 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -54.9 -47.23 74.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 109.926 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 51' ' ' ASN . 13.7 p30 -79.7 -46.8 16.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.001 -1.062 . . . . 0.0 109.444 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 2.2 t-20 -107.58 111.83 24.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 108.855 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.511 ' HA ' HG12 ' A' ' 55' ' ' ILE . . . -108.72 30.67 6.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 109.865 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.562 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -72.19 -55.39 5.01 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.124 -0.985 . . . . 0.0 109.739 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.1 Cg_endo -62.47 -11.58 23.73 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.021 1.814 . . . . 0.0 110.344 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.786 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -109.7 -17.61 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.156 -0.965 . . . . 0.0 109.185 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 7.2 ttt180 -89.48 -18.43 26.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.172 -0.955 . . . . 0.0 109.551 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.91 43.47 1.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.424 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.35 61.78 2.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.396 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -137.25 60.31 0.61 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.711 ' HD1' HG22 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -109.21 93.35 4.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -1.172 . . . . 0.0 108.904 179.468 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -135.43 127.11 29.05 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.384 -0.822 . . . . 0.0 109.722 -179.443 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 64' ' ' GLY . 1.4 mm? -95.84 -166.38 1.43 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.397 -0.815 . . . . 0.0 109.248 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.97 91.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.185 -0.947 . . . . 0.0 109.067 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 62' ' ' LEU . . . 61.4 52.02 54.17 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 61' ' ' ASP . 2.9 t -141.04 119.44 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.292 -1.122 . . . . 0.0 109.571 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.43 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 34.9 m170 -79.69 124.89 28.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.338 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.526 ' CB ' ' O ' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -149.99 166.43 29.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.11 -0.994 . . . . 0.0 109.934 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.507 ' O ' ' CB ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -115.84 -176.93 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.81 . . . . 0.0 109.016 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.524 ' CB ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -133.64 109.73 9.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.096 -1.002 . . . . 0.0 109.606 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mp -101.72 -25.26 13.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.342 -0.849 . . . . 0.0 109.166 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.511 ' O ' HG23 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -149.38 117.22 6.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.415 -0.803 . . . . 0.0 109.193 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.515 ' HA ' HG12 ' A' ' 77' ' ' ILE . . . -160.5 74.84 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.087 -1.008 . . . . 0.0 109.847 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 30.0 t70 179.26 -36.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.46 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.441 ' OD2' ' NH2' ' A' ' 71' ' ' ARG . 3.2 m-20 -74.84 -84.63 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.216 -0.927 . . . . 0.0 110.045 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -137.18 -62.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.994 -1.066 . . . . 0.0 110.288 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.639 ' CB ' ' CZ ' ' A' ' 78' ' ' TYR . 0.7 OUTLIER -90.08 163.79 14.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.384 -0.823 . . . . 0.0 110.495 -178.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.515 HG12 ' HA ' ' A' ' 72' ' ' ALA . 3.0 mt -143.41 70.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.607 -0.683 . . . . 0.0 109.329 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.787 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -88.98 103.8 16.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.713 -1.242 . . . . 0.0 108.928 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.47 169.3 33.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -148.77 147.89 29.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -1.102 . . . . 0.0 109.328 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.16 -30.39 1.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.877 . . . . 0.0 109.845 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 123.35 -66.98 0.5 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.507 ' CB ' ' OE2' ' A' ' 102' ' ' GLU . 1.1 p -87.23 -18.8 29.45 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.372 -1.075 . . . . 0.0 108.444 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.31 166.34 27.41 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -160.69 163.95 34.37 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.759 HG13 ' O ' ' A' ' 86' ' ' VAL . 9.8 p -129.91 104.8 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -1.113 . . . . 0.0 109.471 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.787 HG23 ' HD2' ' A' ' 78' ' ' TYR . 4.1 mt -80.48 94.42 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.087 -1.008 . . . . 0.0 109.013 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 2.7 p -101.86 106.01 16.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 110.16 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.421 HG22 ' CE2' ' A' ' 78' ' ' TYR . 25.5 t -116.89 149.31 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 108.895 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.509 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 29.4 mtpt -86.1 151.99 23.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 110.048 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.81 ' CG2' HD21 ' A' ' 96' ' ' LEU . 2.3 p -145.57 -159.74 1.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.85 . . . . 0.0 109.075 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.402 ' C ' ' HD3' ' A' ' 93' ' ' LYS . 16.2 t -69.07 85.34 0.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.446 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER 62.17 14.79 6.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.206 -0.934 . . . . 0.0 109.427 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.536 ' OG ' ' CE3' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -128.64 151.61 49.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.485 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.573 HG13 HD23 ' A' ' 24' ' ' LEU . 48.8 mt -127.52 123.42 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.952 . . . . 0.0 109.417 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.861 ' N ' HD13 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -85.38 130.7 34.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 108.889 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.817 HG12 HG22 ' A' ' 99' ' ' VAL . 42.4 t -121.87 68.21 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.498 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.423 ' C ' HG11 ' A' ' 16' ' ' VAL . . . -62.0 99.65 0.24 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.817 HG22 HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -101.21 126.76 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -1.223 . . . . 0.0 108.983 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.608 ' CD1' HG12 ' A' ' 16' ' ' VAL . 3.7 p90 -141.82 -176.49 4.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 109.733 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 83' ' ' SER . 0.5 OUTLIER -138.1 -116.24 0.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.093 -1.005 . . . . 0.0 110.22 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.507 ' OE2' ' CB ' ' A' ' 83' ' ' SER . 9.9 mm-40 -85.29 -50.64 7.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.843 -1.161 . . . . 0.0 110.276 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -39.16 -27.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 110.574 -179.093 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.057 HG21 ' O ' ' A' ' 15' ' ' ALA . 12.4 mt -127.86 147.69 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.919 -1.113 . . . . 0.0 110.203 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -127.52 152.71 76.99 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.416 -0.803 . . . . 0.0 108.868 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.43 173.2 1.57 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.992 1.795 . . . . 0.0 110.272 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.74 -51.26 1.2 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 m -94.08 -33.71 13.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.373 -1.075 . . . . 0.0 108.929 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.76 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . . . -80.94 -35.05 32.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.575 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.61 -13.4 59.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.53 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.26 -42.63 12.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.764 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.3 p -70.57 -28.09 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 109.629 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.835 HG13 ' HZ2' ' A' ' 2' ' ' TRP . 73.6 t -83.94 -20.53 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.501 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.48 -37.55 63.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.885 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.534 ' HG3' ' N ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -77.03 -42.79 37.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.684 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.534 ' N ' ' HG3' ' A' ' 115' ' ' LYS . 25.7 mt -52.23 -57.18 10.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.047 -1.033 . . . . 0.0 109.458 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.556 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -64.56 -29.83 70.86 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.131 -0.981 . . . . 0.0 109.095 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -53.78 -21.98 8.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.129 -0.982 . . . . 0.0 109.176 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -90.64 -30.86 16.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.409 -0.807 . . . . 0.0 109.832 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.672 HD22 ' HB ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -73.04 -38.78 66.4 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.063 -1.023 . . . . 0.0 109.77 -179.505 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.556 HD12 ' O ' ' A' ' 117' ' ' ALA . 2.9 mp -64.86 -14.88 17.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.395 -0.816 . . . . 0.0 109.276 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -45.71 -35.4 5.81 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.33 -70.23 0.82 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -1.035 . . . . 0.0 108.974 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -117.39 -77.97 0.64 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.386 -1.067 . . . . 0.0 109.688 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.88 ' HZ2' HD22 ' A' ' 96' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 120.764 0.316 . . . . 0.0 110.394 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -67.49 -59.01 3.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.581 -1.324 . . . . 0.0 108.965 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.42 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.7 OUTLIER -71.82 -31.18 66.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.308 -0.87 . . . . 0.0 108.719 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.923 ' CD2' HD13 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -56.21 -17.12 6.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.451 -0.781 . . . . 0.0 108.925 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.702 HG23 HD11 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -94.39 -48.96 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.245 -0.91 . . . . 0.0 109.955 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.424 ' N ' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -89.83 45.95 1.32 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.785 -1.197 . . . . 0.0 110.677 -178.492 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 4' ' ' THR . 22.5 p -148.63 -104.94 0.08 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.855 -1.153 . . . . 0.0 110.003 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.483 ' O ' ' C ' ' A' ' 10' ' ' LEU . 2.3 t-20 -102.72 -69.14 0.8 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.032 -1.042 . . . . 0.0 111.156 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.923 HD13 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -27.77 -45.44 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.234 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.692 HG21 HG22 ' A' ' 6' ' ' VAL . 85.2 t -101.24 -25.43 3.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.477 -1.389 . . . . 0.0 110.976 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 11' ' ' VAL . . . -45.58 -27.78 2.19 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 106.544 -2.622 . . . . 0.0 106.544 177.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.711 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -175.22 -44.88 0.01 OUTLIER 'General case' 0 C--O 1.196 -1.718 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.837 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.716 ' O ' ' HB3' ' A' ' 15' ' ' ALA . . . 14.12 40.45 0.0 OUTLIER Glycine 0 N--CA 1.508 3.435 0 C-N-CA 123.567 0.603 . . . . 0.0 112.79 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 14' ' ' GLY . . . 86.7 -32.12 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.438 -1.036 . . . . 0.0 108.377 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.624 HG13 ' HB1' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -101.39 132.5 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.179 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.9 OUTLIER -86.25 21.04 2.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.958 -1.089 . . . . 0.0 109.261 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -176.99 176.1 1.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.633 ' HB3' ' CG1' ' A' ' 11' ' ' VAL . . . 174.35 166.33 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.004 -1.06 . . . . 0.0 110.1 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.469 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -163.66 136.09 5.15 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.702 HD11 HG23 ' A' ' 6' ' ' VAL . 1.2 mm -94.33 66.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.036 -1.04 . . . . 0.0 108.453 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.713 ' HG ' HG21 ' A' ' 97' ' ' VAL . 17.5 mt -60.83 109.54 1.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 108.938 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 94' ' ' SER . . . -60.35 159.47 24.87 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.681 ' CB ' HD11 ' A' ' 95' ' ' ILE . 1.0 OUTLIER -108.77 -6.9 15.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -1.022 . . . . 0.0 109.4 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -143.7 34.89 1.27 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.355 -0.841 . . . . 0.0 109.312 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.41 29.84 0.09 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 64.63 -144.58 0.26 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.214 -1.168 . . . . 0.0 109.503 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.3 m -77.66 147.95 35.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.153 -0.967 . . . . 0.0 110.019 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.483 ' CE3' ' HB3' ' A' ' 94' ' ' SER . 7.8 m0 -114.12 -47.45 2.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.336 -0.852 . . . . 0.0 108.786 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.35 167.27 30.54 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 10.1 t -160.3 159.79 31.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.957 -1.089 . . . . 0.0 110.055 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.632 ' HB2' HG13 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -150.99 92.99 1.88 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.591 -0.693 . . . . 0.0 109.155 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 32' ' ' SER . . . 170.78 -54.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.531 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.4 19.48 3.48 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.653 ' CZ ' HG21 ' A' ' 99' ' ' VAL . 10.4 p90 -125.54 134.76 51.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -1.174 . . . . 0.0 109.523 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.59 130.64 55.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.914 . . . . 0.0 109.305 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.1 t -79.62 131.7 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 109.598 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 m -48.29 125.58 11.89 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 108.994 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.82 -39.42 81.79 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.765 1.643 . . . . 0.0 109.976 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.79 -46.96 86.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.258 -0.901 . . . . 0.0 109.182 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -62.72 -21.18 65.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.273 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.79 -29.33 67.2 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -67.48 -44.62 78.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -1.155 . . . . 0.0 109.428 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.4 m -56.72 -25.71 55.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.285 -0.884 . . . . 0.0 109.372 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.528 HD13 HD11 ' A' ' 62' ' ' LEU . 9.9 tp -73.81 -41.68 62.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.26 -50.2 66.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.228 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.78 -16.45 64.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.18 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.89 -28.24 64.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.339 -0.851 . . . . 0.0 109.458 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -88.26 21.53 2.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.361 -0.837 . . . . 0.0 109.533 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -108.69 -44.47 4.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.356 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.89 ' O ' HD11 ' A' ' 55' ' ' ILE . 2.5 m-20 -122.87 141.46 51.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 109.477 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.455 ' HA ' HG13 ' A' ' 55' ' ' ILE . . . -105.82 -3.72 21.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.909 . . . . 0.0 109.611 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.562 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -77.25 -55.37 1.36 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.101 -1.0 . . . . 0.0 110.258 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 2.3 Cg_endo -62.37 -10.33 18.4 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.056 1.837 . . . . 0.0 111.225 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.89 HD11 ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -104.85 -23.72 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.946 -1.096 . . . . 0.0 109.62 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -81.98 -12.18 58.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.085 -1.01 . . . . 0.0 109.356 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.96 -75.85 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.6 t -85.73 -39.32 17.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.385 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 55' ' ' ILE . . . 85.69 -161.73 35.36 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.655 ' CE1' ' CG ' ' A' ' 67' ' ' TYR . 4.6 p90 -145.98 -168.99 3.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -1.11 . . . . 0.0 109.035 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 61' ' ' ASP . 26.7 p30 -160.04 157.53 28.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.012 -1.055 . . . . 0.0 110.483 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.528 HD11 HD13 ' A' ' 45' ' ' LEU . 96.5 mt -124.64 -160.04 0.92 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.73 97.75 10.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.973 -1.079 . . . . 0.0 109.733 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.19 -79.47 0.23 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.513 HG21 ' CB ' ' A' ' 84' ' ' ALA . 54.1 t -124.8 160.97 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -1.153 . . . . 0.0 109.322 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.5 ' N ' HG12 ' A' ' 65' ' ' VAL . 18.7 m170 -75.9 -171.45 1.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.127 -0.983 . . . . 0.0 109.317 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.86 ' OH ' HG13 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -137.39 119.78 15.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 109.831 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.409 HG21 ' HG3' ' A' ' 81' ' ' LYS . 82.7 t -89.71 -24.6 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -0.843 . . . . 0.0 108.735 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.895 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 92.6 m 57.52 101.38 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.599 -0.688 . . . . 0.0 110.151 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.38 -23.67 13.16 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -142.85 72.1 1.36 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.895 ' HB2' ' CG2' ' A' ' 69' ' ' THR . . . -85.4 52.25 2.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 0.0 109.828 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.66 -145.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.241 -0.912 . . . . 0.0 108.835 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.44 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 0.4 OUTLIER -119.66 34.65 5.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.155 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 7.5 mmt180 -136.7 -44.38 0.59 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 110.236 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.669 ' HA ' HG22 ' A' ' 89' ' ' VAL . 14.9 m -145.64 164.88 30.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.929 -1.107 . . . . 0.0 110.31 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 77' ' ' ILE . 0.3 OUTLIER -162.24 97.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.774 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -115.31 129.81 56.72 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.593 ' HA3' ' CE1' ' A' ' 67' ' ' TYR . . . -101.6 155.7 18.89 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.518 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.528 ' HD2' ' CG ' ' A' ' 106' ' ' PRO . 2.0 pttp -151.0 141.24 22.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -1.089 . . . . 0.0 109.347 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.503 ' CG ' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER 165.13 143.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.933 -1.104 . . . . 0.0 110.565 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.401 ' C ' ' N ' ' A' ' 84' ' ' ALA . . . 63.94 48.94 71.23 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 47.03 21.9 0.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.05 -1.265 . . . . 0.0 109.549 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.513 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -151.3 147.28 26.76 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.318 -0.864 . . . . 0.0 108.759 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.555 ' CA ' ' CE2' ' A' ' 100' ' ' TYR . . . -169.68 -171.43 35.26 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.86 HG13 ' OH ' ' A' ' 67' ' ' TYR . 7.3 p -141.62 156.69 20.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.399 -1.059 . . . . 0.0 109.842 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.774 HG23 ' HD2' ' A' ' 78' ' ' TYR . 75.3 mt -121.37 93.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 11.4 p -107.91 133.24 52.54 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.197 -0.939 . . . . 0.0 110.643 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 1.091 ' HB ' HD21 ' A' ' 96' ' ' LEU . 2.1 t -150.76 156.86 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.234 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -79.99 143.89 33.74 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.459 -0.776 . . . . 0.0 109.192 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.601 HG21 ' CE2' ' A' ' 2' ' ' TRP . 67.9 p -146.88 -135.82 0.08 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.209 -0.932 . . . . 0.0 109.29 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -75.78 80.43 2.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.969 -1.082 . . . . 0.0 109.955 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 92' ' ' SER . 13.4 mttm 60.68 13.33 4.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.761 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.547 ' HB2' HG22 ' A' ' 21' ' ' ILE . 3.3 p -138.04 165.35 26.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.064 -1.022 . . . . 0.0 109.966 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.681 HD11 ' CB ' ' A' ' 24' ' ' LEU . 1.7 mt -128.82 112.99 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.418 -0.801 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.091 HD21 ' HB ' ' A' ' 89' ' ' VAL . 1.1 pt? -60.21 164.18 4.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.171 -0.956 . . . . 0.0 108.808 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.725 ' O ' HG12 ' A' ' 97' ' ' VAL . 71.8 t -150.84 57.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.533 -0.73 . . . . 0.0 109.518 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -49.06 114.89 2.35 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.653 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -107.28 143.68 17.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.053 -1.263 . . . . 0.0 109.768 -179.107 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 100' ' ' TYR . 0.1 OUTLIER -142.98 153.32 42.9 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -151.24 6.38 0.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.822 -1.174 . . . . 0.0 111.692 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 103' ' ' LYS . 3.0 mm-40 -100.77 -78.22 0.52 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.586 -1.321 . . . . 0.0 109.817 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 8.4 mmtp -155.11 30.03 0.4 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.428 -0.795 . . . . 0.0 109.255 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.728 ' N ' HD13 ' A' ' 104' ' ' ILE . 2.2 mm -62.58 149.35 9.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.263 -0.898 . . . . 0.0 109.644 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -106.54 141.52 22.99 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 109.388 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.528 ' CG ' ' HD2' ' A' ' 80' ' ' LYS . 2.1 Cg_endo -62.33 -26.45 77.08 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.078 1.852 . . . . 0.0 110.4 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.45 37.14 3.51 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.9 m -143.03 -46.25 0.3 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -1.132 . . . . 0.0 109.394 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.624 ' HB1' HG13 ' A' ' 16' ' ' VAL . . . -86.77 -25.47 24.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.414 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.95 -22.23 39.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 109.281 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.86 -39.99 63.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.435 -0.79 . . . . 0.0 109.562 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.4 p -76.34 -23.44 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.532 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 109' ' ' ALA . 70.0 t -85.63 -18.79 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.867 . . . . 0.0 109.581 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.98 -31.45 39.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.331 -0.856 . . . . 0.0 109.586 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -83.7 -55.13 4.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.855 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.454 HD22 HD11 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -58.65 -31.02 67.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.912 . . . . 0.0 109.501 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.945 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -73.51 -26.82 61.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.204 -0.935 . . . . 0.0 109.471 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -66.57 -26.65 67.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.131 -0.98 . . . . 0.0 109.675 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 8.8 t80 -82.23 -52.37 7.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.88 . . . . 0.0 109.608 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.501 HD23 ' HA ' ' A' ' 117' ' ' ALA . 0.5 OUTLIER -63.94 -25.26 68.06 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.22 -0.925 . . . . 0.0 109.943 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.945 HD12 ' O ' ' A' ' 117' ' ' ALA . 2.8 mt -90.63 -18.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.94 . . . . 0.0 109.193 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.28 -16.67 28.37 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -91.26 -60.77 1.81 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -1.148 . . . . 0.0 109.334 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 125' ' ' PHE . . . 158.38 104.39 0.2 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.988 0 O-C-N 121.19 -1.182 . . . . 0.0 108.905 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 1.019 ' N ' HD11 ' A' ' 21' ' ' ILE . 8.1 m95 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -81.88 -90.57 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.924 -1.11 . . . . 0.0 111.08 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.56 -34.61 7.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.101 -0.999 . . . . 0.0 110.332 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 1.9 m-30 -71.07 -38.17 72.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.049 -1.032 . . . . 0.0 109.601 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.836 ' HA ' HG23 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -51.72 -24.15 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 6' ' ' VAL . 20.5 t0 -40.37 -89.91 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.532 -0.73 . . . . 0.0 111.253 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.2 t -144.05 -23.46 0.56 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.063 -1.023 . . . . 0.0 111.427 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.584 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.4 m120 -75.42 -55.7 5.43 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.674 -1.266 . . . . 0.0 109.504 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 0.6 OUTLIER -76.91 -25.36 52.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.848 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.836 HG23 ' HA ' ' A' ' 6' ' ' VAL . 1.8 t -92.36 -55.12 6.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.183 -0.948 . . . . 0.0 108.712 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.742 ' C ' HG22 ' A' ' 13' ' ' THR . . . -43.69 -39.17 4.57 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 107.952 -2.059 . . . . 0.0 107.952 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.742 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 159.94 47.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.827 -0.808 . . . . 0.0 110.068 178.579 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.707 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -90.57 20.77 36.2 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 106.918 -2.473 . . . . 0.0 106.918 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.707 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 156.43 -32.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 27.5 m -141.93 147.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.647 ' N ' HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -80.67 12.58 3.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.944 -1.097 . . . . 0.0 109.209 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.712 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -175.42 -178.32 1.12 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 18' ' ' GLN . . . 161.56 148.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 109.31 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.521 ' HB2' ' OG1' ' A' ' 31' ' ' THR . . . -137.82 160.23 39.84 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.166 -0.959 . . . . 0.0 109.482 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 1.019 HD11 ' N ' ' A' ' 2' ' ' TRP . 30.8 mt -131.81 95.9 2.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.832 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -89.86 128.08 36.12 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.442 0.639 . . . . 0.0 109.459 -178.029 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.19 167.54 49.12 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.981 ' N ' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -71.25 -8.34 52.94 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.52 -0.988 . . . . 0.0 109.515 -179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -78.83 -27.21 44.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.555 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.29 -3.03 34.91 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -93.5 -155.51 0.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -1.175 . . . . 0.0 109.145 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.22 129.71 56.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.886 -1.134 . . . . 0.0 110.138 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.577 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 3.1 m0 -101.16 -34.04 9.85 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.316 -0.865 . . . . 0.0 108.907 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 29' ' ' TRP . . . 170.33 92.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.433 -0.792 . . . . 0.0 109.063 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.521 ' OG1' ' HB2' ' A' ' 20' ' ' ALA . 14.1 t -109.31 172.08 7.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 110.105 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.791 ' OG ' HG13 ' A' ' 6' ' ' VAL . 16.1 m -156.41 86.77 1.02 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.481 -0.762 . . . . 0.0 109.366 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.543 ' HB3' ' CE2' ' A' ' 35' ' ' PHE . . . -169.39 -55.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.306 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.94 -43.99 1.29 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.543 ' CE2' ' HB3' ' A' ' 33' ' ' ALA . 11.1 p90 -48.08 162.52 0.08 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -1.091 . . . . 0.0 109.591 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.63 121.82 38.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.213 -0.93 . . . . 0.0 109.484 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.408 HG13 HD22 ' A' ' 62' ' ' LEU . 75.6 t -89.94 123.25 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.887 . . . . 0.0 109.427 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.68 127.2 91.17 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.16 -0.962 . . . . 0.0 109.307 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.737 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 1.9 Cg_endo -62.2 169.41 7.84 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.036 1.824 . . . . 0.0 110.526 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.737 ' HB3' ' O ' ' A' ' 39' ' ' PRO . . . 83.03 -24.41 0.17 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.721 -0.612 . . . . 0.0 110.345 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.471 ' HB3' HD21 ' A' ' 62' ' ' LEU . 0.8 OUTLIER -81.45 -10.55 59.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.986 -1.072 . . . . 0.0 109.55 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -56.74 -34.5 64.89 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -70.35 -39.36 74.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -1.167 . . . . 0.0 109.656 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.9 m -51.22 -34.17 31.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.541 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.6 tp -67.35 -48.38 67.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.467 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.17 -7.52 30.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 0.0 109.62 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.61 -29.45 16.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.087 -1.008 . . . . 0.0 109.735 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.89 -24.84 58.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.137 -0.977 . . . . 0.0 109.819 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.479 ' CE1' ' O ' ' A' ' 75' ' ' ARG . 9.1 m-85 -57.11 -29.59 63.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 109.566 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -113.27 -16.72 12.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.101 -0.999 . . . . 0.0 109.465 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -117.46 112.27 20.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 109.21 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.646 ' HA ' HD11 ' A' ' 55' ' ' ILE . . . -100.26 -8.77 23.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.608 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.573 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -64.79 -52.6 49.5 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 109.902 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.1 Cg_endo -64.33 -4.84 8.66 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.197 1.931 . . . . 0.0 111.205 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.646 HD11 ' HA ' ' A' ' 52' ' ' ALA . 1.9 pp -128.39 0.74 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.932 -1.105 . . . . 0.0 109.684 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -98.27 -34.77 10.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.113 -0.992 . . . . 0.0 109.45 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.46 -23.09 65.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -0.821 . . . . 0.0 109.695 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.9 t -170.47 -38.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.126 -0.984 . . . . 0.0 109.688 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 54' ' ' PRO . . . 132.53 -123.11 3.45 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.667 ' CE1' HD12 ' A' ' 62' ' ' LEU . 34.3 p90 -160.28 170.98 19.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.108 -1.231 . . . . 0.0 109.699 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.33 140.22 43.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.705 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 3.0 mt -147.99 115.69 6.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.885 . . . . 0.0 109.61 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.705 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . 76.62 13.04 2.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 109.753 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.65 29.23 24.58 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.657 HG12 ' H ' ' A' ' 66' ' ' HIS . 1.5 t -130.69 -169.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -1.138 . . . . 0.0 109.2 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.657 ' H ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -134.75 126.08 28.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.122 -0.986 . . . . 0.0 110.195 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -112.88 152.46 29.25 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.61 163.8 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.725 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.1 m -103.85 135.25 45.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.308 -0.87 . . . . 0.0 109.496 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.565 HD13 ' CD ' ' A' ' 80' ' ' LYS . 2.1 tp -113.91 -50.33 2.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.704 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.31 51.63 1.37 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 109.689 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.645 ' HB3' HD13 ' A' ' 55' ' ' ILE . . . -79.28 87.73 4.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.223 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.75 -55.93 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.86 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -81.86 -103.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.064 -1.022 . . . . 0.0 109.716 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.479 ' O ' ' CE1' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -134.59 0.54 3.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.903 -1.123 . . . . 0.0 109.975 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 43.7 m -106.22 142.5 35.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.058 -1.026 . . . . 0.0 109.613 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.448 HG22 ' O ' ' A' ' 77' ' ' ILE . 36.3 mt -139.78 88.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.45 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 76' ' ' SER . 1.7 m-85 -90.25 65.98 6.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.051 -1.03 . . . . 0.0 109.575 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -44.85 153.04 0.55 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.565 ' CD ' HD13 ' A' ' 70' ' ' LEU . 11.6 ptpt -151.49 94.53 2.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.022 -1.281 . . . . 0.0 109.844 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -160.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 0.0 109.263 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -46.06 -73.75 0.27 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.468 ' OG ' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -112.2 -24.2 9.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -1.158 . . . . 0.0 109.483 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.31 -174.02 4.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.152 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.555 ' N ' ' CE1' ' A' ' 100' ' ' TYR . . . 177.18 152.23 9.75 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.092 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 86' ' ' VAL . 9.5 p -117.86 124.27 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -1.042 . . . . 0.0 108.709 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.693 HG21 HG21 ' A' ' 113' ' ' VAL . 67.4 mt -100.62 89.81 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.983 -1.073 . . . . 0.0 110.21 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 11.3 p -101.89 135.24 43.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.131 -0.981 . . . . 0.0 109.64 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.419 ' HB ' HD12 ' A' ' 96' ' ' LEU . 47.2 t -149.16 155.9 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.211 -0.93 . . . . 0.0 109.486 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.405 ' N ' HG12 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -101.82 131.96 47.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.109 -0.994 . . . . 0.0 109.481 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.2 p -107.76 -97.72 0.37 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.252 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.9 p -129.58 -31.92 1.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.017 -1.052 . . . . 0.0 109.484 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.27 51.61 0.53 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.919 . . . . 0.0 109.341 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.605 ' CA ' HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -178.9 159.06 1.0 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.529 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.558 HG13 HD12 ' A' ' 24' ' ' LEU . 25.0 mt -120.38 112.14 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.12 -0.987 . . . . 0.0 109.304 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.863 HD13 ' CH2' ' A' ' 2' ' ' TRP . 8.3 mt -67.54 153.15 44.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.335 -0.853 . . . . 0.0 109.618 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.768 HG21 ' HG ' ' A' ' 22' ' ' LEU . 60.5 t -150.58 53.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.844 . . . . 0.0 109.776 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -45.16 137.44 6.31 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 97' ' ' VAL . 2.4 t -139.48 117.72 11.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.044 -1.268 . . . . 0.0 108.649 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.555 ' CE1' ' N ' ' A' ' 85' ' ' GLY . 7.2 p90 -138.31 164.04 30.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.014 -1.054 . . . . 0.0 109.756 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -110.64 -145.54 0.4 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 0.0 109.881 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.468 ' HG2' ' OG ' ' A' ' 83' ' ' SER . 10.4 mt-10 -76.05 -7.48 54.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.968 . . . . 0.0 110.104 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -16.44 61.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.074 -1.016 . . . . 0.0 109.758 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.647 HD13 ' N ' ' A' ' 17' ' ' THR . 1.2 mp -136.99 141.05 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.246 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -101.98 150.34 37.34 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 109.559 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.458 ' HB2' ' HE2' ' A' ' 80' ' ' LYS . 1.9 Cg_endo -62.32 161.82 25.82 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.27 1.98 . . . . 0.0 110.444 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.6 -55.91 4.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.1 m -67.94 -31.58 71.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -1.081 . . . . 0.0 109.689 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.615 ' O ' HG12 ' A' ' 112' ' ' VAL . . . -84.24 -36.92 22.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 109.504 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.96 -29.79 71.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.297 -0.877 . . . . 0.0 109.498 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -61.28 -36.37 79.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.982 . . . . 0.0 109.524 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.804 HG22 HD13 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -77.76 -31.62 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.135 -0.978 . . . . 0.0 109.432 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.693 HG21 HG21 ' A' ' 87' ' ' ILE . 53.5 t -63.61 -23.65 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.086 -1.008 . . . . 0.0 109.451 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -77.85 -43.73 29.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.342 -0.849 . . . . 0.0 109.715 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -80.81 -63.73 1.34 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 109.23 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.804 HD13 HG22 ' A' ' 112' ' ' VAL . 0.2 OUTLIER -42.23 -28.42 0.19 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.495 -0.753 . . . . 0.0 109.661 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 113' ' ' VAL . . . -73.72 -47.98 35.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.715 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -49.13 -21.39 0.74 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.07 -1.019 . . . . 0.0 110.008 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -85.47 -41.33 15.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.318 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 1.1 mt -78.21 -56.08 4.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.097 -1.002 . . . . 0.0 110.361 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.453 ' C ' ' O ' ' A' ' 120' ' ' LEU . 17.8 mt -39.77 -33.44 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.316 -0.865 . . . . 0.0 109.821 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.58 -51.43 36.43 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -59.65 -71.1 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -1.133 . . . . 0.0 109.475 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 130.27 112.15 1.51 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 120' ' ' LEU . 82.7 m-85 . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.211 -1.17 . . . . 0.0 109.535 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.603 ' CE3' ' HG ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 4' ' ' THR . 35.2 tt0 -77.8 -81.14 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.055 -1.028 . . . . 0.0 108.746 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.652 ' O ' HG22 ' A' ' 8' ' ' THR . 1.2 t -48.47 -30.23 4.93 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.619 ' CD2' ' CD2' ' A' ' 10' ' ' LEU . 3.2 m-30 -48.19 -54.67 12.65 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.841 ' HA ' HG23 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -50.53 -37.77 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -0.799 . . . . 0.0 109.644 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.684 ' C ' HG22 ' A' ' 8' ' ' THR . 1.0 OUTLIER -90.85 51.53 1.99 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.071 -1.018 . . . . 0.0 111.951 -178.422 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.684 HG22 ' C ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER 173.28 -87.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.482 -1.386 . . . . 0.0 111.486 178.625 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 11' ' ' VAL . 4.2 m-20 -90.04 -83.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 111.34 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.619 ' CD2' ' CD2' ' A' ' 5' ' ' TYR . 3.8 mm? -21.12 -44.8 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.889 HG13 ' HA ' ' A' ' 18' ' ' GLN . 38.5 t -88.02 -59.22 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.659 -1.276 . . . . 0.0 110.279 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.77 ' C ' HG22 ' A' ' 13' ' ' THR . . . -37.8 -41.07 0.84 Allowed Glycine 0 N--CA 1.498 2.805 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.77 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 155.95 39.88 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.607 0.718 . . . . 0.0 109.378 178.177 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.678 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -83.75 19.32 16.17 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 156.2 -28.08 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 13' ' ' THR . 2.2 m -151.41 152.08 11.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.542 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -79.66 8.12 7.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.798 -1.189 . . . . 0.0 109.292 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.889 ' HA ' HG13 ' A' ' 11' ' ' VAL . 31.5 mt-30 -162.64 176.6 10.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.623 ' HA ' HG23 ' A' ' 99' ' ' VAL . . . -177.78 155.49 1.02 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.863 -1.148 . . . . 0.0 110.234 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.506 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -148.91 114.63 5.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 0.0 109.576 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.62 ' C ' HD23 ' A' ' 22' ' ' LEU . 7.9 mm -81.28 114.86 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.84 -1.162 . . . . 0.0 108.693 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.881 HD11 HG21 ' A' ' 97' ' ' VAL . 0.6 OUTLIER -108.51 88.37 2.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -0.915 . . . . 0.0 108.994 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.609 ' HA3' ' CD2' ' A' ' 29' ' ' TRP . . . -50.11 -177.51 0.02 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.794 HD11 ' CA ' ' A' ' 93' ' ' LYS . 13.0 mt -84.03 -50.93 7.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.384 -1.068 . . . . 0.0 109.408 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.86 13.25 33.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.017 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 28' ' ' THR . . . -130.75 80.31 0.35 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.472 ' C ' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -35.44 -31.04 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.905 -0.762 . . . . 0.0 110.441 -179.435 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -139.04 99.19 3.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.939 -1.1 . . . . 0.0 110.171 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.609 ' CD2' ' HA3' ' A' ' 23' ' ' GLY . 6.5 m0 -95.85 -24.61 16.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 108.996 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -171.79 145.01 1.87 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.42 HG22 ' HB1' ' A' ' 20' ' ' ALA . 18.5 p -149.82 162.03 41.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.123 -0.986 . . . . 0.0 109.848 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.838 ' OG ' HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -166.08 84.6 0.31 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.445 -0.785 . . . . 0.0 109.205 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.4 -67.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 109.295 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 138.6 -23.34 2.96 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.5 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -62.23 178.71 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.063 -1.257 . . . . 0.0 109.782 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 63' ' ' ALA . . . -107.89 125.84 51.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.024 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.777 HG13 ' CD ' ' A' ' 41' ' ' GLN . 8.3 t -144.89 103.52 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.768 HG23 ' HD3' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -173.66 -59.12 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.176 -0.953 . . . . 0.0 110.175 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.768 ' HD3' HG23 ' A' ' 38' ' ' THR . 1.9 Cg_endo -59.4 118.33 5.2 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.708 1.605 . . . . 0.0 110.774 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.507 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . . . 54.95 35.17 23.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.291 -0.881 . . . . 0.0 109.973 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.777 ' CD ' HG13 ' A' ' 37' ' ' VAL . 2.4 mm-40 -90.39 -53.88 4.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.801 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.59 -42.84 16.65 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.507 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 4.0 pp0? -59.7 -26.94 66.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -1.18 . . . . 0.0 109.679 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.0 m -67.47 -53.66 26.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 109.341 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.556 ' O ' ' CD2' ' A' ' 49' ' ' PHE . 8.5 mp -63.53 -29.71 70.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 109.681 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.16 92.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.952 . . . . 0.0 109.533 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.2 t -86.33 -17.23 35.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.495 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.65 51.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.425 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 45' ' ' LEU . 35.4 m-85 -79.01 -10.38 59.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.175 -0.953 . . . . 0.0 109.642 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.455 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 0.4 OUTLIER -89.38 -0.44 57.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.96 . . . . 0.0 109.578 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.576 ' ND2' ' HG2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER 175.28 118.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.069 -1.019 . . . . 0.0 109.839 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 72' ' ' ALA . . . -94.97 -13.35 25.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -0.813 . . . . 0.0 109.259 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.61 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -63.08 -50.17 77.46 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 110.204 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.4 Cg_endo -63.83 -13.63 38.25 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.02 1.814 . . . . 0.0 110.967 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.799 HD11 ' CB ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -91.68 -14.79 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.861 -1.149 . . . . 0.0 109.532 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.603 ' CZ ' ' CB ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -81.29 -48.39 12.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.867 . . . . 0.0 109.477 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 58' ' ' SER . . . -77.01 -86.68 0.05 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.242 -0.911 . . . . 0.0 109.43 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 57' ' ' ALA . 20.2 m -44.36 -57.44 3.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.334 -0.854 . . . . 0.0 109.156 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.89 175.04 18.93 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.495 ' CE1' ' OG1' ' A' ' 69' ' ' THR . 10.7 p90 -124.59 124.44 42.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.436 -1.038 . . . . 0.0 108.984 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.87 161.47 15.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -0.964 . . . . 0.0 110.137 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.61 -142.78 0.24 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 36' ' ' ALA . . . -74.02 -0.59 16.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.24 -0.913 . . . . 0.0 109.557 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.41 -102.09 2.76 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 66' ' ' HIS . 0.9 OUTLIER -136.22 -147.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.23 -1.159 . . . . 0.0 109.538 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.432 ' H ' HG12 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -82.43 133.79 35.22 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.151 -0.968 . . . . 0.0 109.505 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' A' ' 60' ' ' PHE . 3.0 m-30 -112.76 147.64 36.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 109.495 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -93.25 143.12 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.136 -0.978 . . . . 0.0 109.321 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.633 HG21 ' CD1' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -108.41 119.17 38.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.627 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 70' ' ' LEU . 1.4 pp -111.66 21.3 16.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.583 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.423 ' CG ' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER 177.21 102.29 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.134 -0.979 . . . . 0.0 109.523 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.799 ' CB ' HD11 ' A' ' 55' ' ' ILE . . . -153.7 54.6 0.73 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.108 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.24 -16.82 4.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.136 -0.978 . . . . 0.0 110.142 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -110.84 -104.73 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.0 109.752 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -143.41 27.61 1.54 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.955 -1.09 . . . . 0.0 109.253 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.615 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -143.12 129.24 19.73 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.469 ' O ' ' OG1' ' A' ' 88' ' ' THR . 2.4 mp -133.37 99.4 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.922 -1.111 . . . . 0.0 111.025 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.656 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -109.52 96.47 6.3 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.128 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.66 168.98 42.37 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.455 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.451 ' HG3' ' HA3' ' A' ' 85' ' ' GLY . 19.8 tttt -150.52 154.69 38.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.525 -0.985 . . . . 0.0 109.109 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 -13.42 9.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.012 -1.055 . . . . 0.0 109.737 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.37 -76.91 0.23 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.4 p -94.61 -40.9 9.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -1.219 . . . . 0.0 109.384 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.34 145.27 26.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 0.0 109.359 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.578 ' O ' ' CE1' ' A' ' 100' ' ' TYR . . . -138.65 143.46 14.23 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.986 HG23 HG13 ' A' ' 97' ' ' VAL . 2.4 p -110.23 136.05 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -1.099 . . . . 0.0 109.56 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.692 ' O ' HG22 ' A' ' 87' ' ' ILE . 3.2 mt -109.92 91.63 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -0.766 . . . . 0.0 109.011 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 5.0 p -89.33 112.67 23.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.061 -1.024 . . . . 0.0 109.69 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.48 136.88 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.265 -0.897 . . . . 0.0 108.837 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.29 150.62 23.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.067 -1.021 . . . . 0.0 110.032 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.9 p -132.95 -144.63 0.24 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.398 -0.814 . . . . 0.0 109.048 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.543 ' HB3' ' CA ' ' A' ' 124' ' ' GLY . 47.0 t -87.01 -29.86 21.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.039 -1.038 . . . . 0.0 109.447 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.794 ' CA ' HD11 ' A' ' 24' ' ' LEU . 17.2 mttt -159.58 55.91 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 0.0 109.796 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.63 ' CB ' ' CG ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -177.73 151.25 0.7 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.869 -1.144 . . . . 0.0 110.213 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.7 ' C ' HD13 ' A' ' 96' ' ' LEU . 14.7 mt -125.08 126.16 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.805 HD22 ' N ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -108.24 161.61 14.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.992 -178.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.986 HG13 HG23 ' A' ' 86' ' ' VAL . 25.6 t -139.49 125.86 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.61 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.474 ' HA3' ' HB ' ' A' ' 87' ' ' ILE . . . -103.79 101.22 1.98 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 107.875 -2.09 . . . . 0.0 107.875 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.623 HG23 ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -99.23 128.93 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -1.123 . . . . 0.0 109.048 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 100' ' ' TYR . 1.3 p90 -144.48 -170.82 3.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.64 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 101' ' ' ASN . 0.0 OUTLIER -120.19 -159.14 0.77 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.895 . . . . 0.0 109.047 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -76.32 -16.33 59.79 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.3 -0.875 . . . . 0.0 109.567 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -37.9 83.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.387 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.553 HG13 ' HB2' ' A' ' 100' ' ' TYR . 14.8 mm -79.62 150.79 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.294 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -93.76 138.18 22.9 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.144 -0.973 . . . . 0.0 109.188 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.96 -23.95 53.67 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.1 1.867 . . . . 0.0 110.828 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.06 -47.04 4.27 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.879 -1.153 . . . . 0.0 110.512 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 112' ' ' VAL . 15.7 m -66.5 -47.44 73.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.004 -1.292 . . . . 0.0 109.89 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.45 -12.13 28.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 0.0 110.023 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.62 -26.44 19.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 0.0 109.942 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -83.7 -42.44 16.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.089 -1.007 . . . . 0.0 109.591 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 108' ' ' THR . 2.5 t -67.31 -36.8 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.346 -0.846 . . . . 0.0 110.064 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.679 HG11 HG21 ' A' ' 87' ' ' ILE . 88.6 t -76.41 -26.81 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.196 -0.94 . . . . 0.0 109.585 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -60.67 -50.88 71.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.847 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 116' ' ' LEU . 13.9 ptmm? -66.66 -35.08 79.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 109.64 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -44.26 -42.26 6.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 0.0 109.034 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.497 ' C ' HD12 ' A' ' 121' ' ' ILE . . . -75.58 -37.36 59.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -0.889 . . . . 0.0 109.029 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 115' ' ' LYS . 2.6 m-20 -47.57 -25.65 1.2 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 109.189 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -83.63 -45.97 12.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.811 . . . . 0.0 109.323 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.572 ' HB3' ' CE1' ' A' ' 125' ' ' PHE . 0.5 OUTLIER -87.92 11.03 16.82 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.242 -0.911 . . . . 0.0 109.842 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.497 HD12 ' C ' ' A' ' 117' ' ' ALA . 0.9 OUTLIER -90.41 -22.43 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 109.191 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -71.82 -45.83 41.19 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -84.14 -28.88 27.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -1.176 . . . . 0.0 109.425 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.543 ' CA ' ' HB3' ' A' ' 92' ' ' SER . . . 81.19 48.83 5.82 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.63 ' CG ' ' CB ' ' A' ' 94' ' ' SER . 12.6 m-85 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.405 -1.056 . . . . 0.0 109.876 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.734 ' CH2' HD13 ' A' ' 96' ' ' LEU . 2.8 m95 . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.412 0.625 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.439 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 1.9 mm-40 -72.96 -109.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.873 -1.142 . . . . 0.0 110.567 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.994 ' O ' HG22 ' A' ' 8' ' ' THR . 5.0 t -48.79 -45.47 40.15 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.725 -1.234 . . . . 0.0 109.022 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.003 ' CD2' HD21 ' A' ' 116' ' ' LEU . 14.9 m-30 -41.71 -46.3 3.74 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.549 0.69 . . . . 0.0 109.409 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.659 ' HA ' HG23 ' A' ' 11' ' ' VAL . 1.4 t -52.87 -53.66 20.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.462 -0.774 . . . . 0.0 110.007 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.75 50.76 1.74 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.055 -1.028 . . . . 0.0 112.193 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.994 HG22 ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -160.12 -101.33 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.43 -1.419 . . . . 0.0 110.416 178.566 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -102.15 -69.72 0.78 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.965 -1.085 . . . . 0.0 110.988 -178.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.731 HD13 ' HB3' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -22.94 -40.86 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.286 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.659 HG23 ' HA ' ' A' ' 6' ' ' VAL . 4.9 t -80.98 -70.11 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.509 -1.37 . . . . 0.0 110.377 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.741 ' C ' HG22 ' A' ' 13' ' ' THR . . . -38.18 -31.94 0.12 Allowed Glycine 0 N--CA 1.497 2.756 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.741 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER 152.14 42.58 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.701 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -84.78 22.6 8.91 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 154.62 -31.1 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.626 HG12 ' HB3' ' A' ' 100' ' ' TYR . 25.6 m -152.6 147.1 14.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.525 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -78.8 5.76 10.6 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.014 -1.053 . . . . 0.0 108.619 179.293 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.525 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . 23.3 mt-30 -163.34 160.71 23.99 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.493 ' HA ' HG23 ' A' ' 99' ' ' VAL . . . -173.33 -179.83 2.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.068 -1.02 . . . . 0.0 109.027 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 19' ' ' ALA . . . 176.57 115.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.92 . . . . 0.0 110.36 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.675 HD11 ' CD2' ' A' ' 2' ' ' TRP . 1.5 mp -80.71 100.29 4.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.732 HD11 HG21 ' A' ' 97' ' ' VAL . 3.0 mt -86.93 111.74 21.11 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.542 -0.724 . . . . 0.0 109.863 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.12 -166.37 0.33 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.974 HD11 ' O ' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -116.22 16.19 15.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.381 -1.07 . . . . 0.0 109.481 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -96.35 -29.2 14.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.79 -25.63 3.07 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.7 p30 -100.15 -163.0 0.99 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -1.106 . . . . 0.0 109.449 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.3 m -129.18 136.57 50.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.109 -0.994 . . . . 0.0 109.608 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -79.93 -45.96 17.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.938 . . . . 0.0 108.93 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.29 136.78 38.32 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.06 167.73 21.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.979 -1.076 . . . . 0.0 109.888 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.22 57.2 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 18' ' ' GLN . . . -120.71 -145.51 0.36 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.302 -0.874 . . . . 0.0 109.609 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.94 8.07 5.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.428 ' CZ ' HG11 ' A' ' 99' ' ' VAL . 20.6 p90 -134.26 177.36 7.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -1.167 . . . . 0.0 109.479 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.5 120.79 33.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 109.424 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 t -87.66 151.9 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 109.523 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -105.16 158.48 32.01 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.669 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.14 -30.89 75.46 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.15 1.9 . . . . 0.0 110.41 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.98 78.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.172 -0.955 . . . . 0.0 110.101 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -81.11 -9.93 59.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 109.992 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.27 -34.74 50.47 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -79.45 -41.59 27.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.15 -1.206 . . . . 0.0 109.694 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.1 m -53.96 -42.5 68.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.877 . . . . 0.0 109.397 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.418 HD23 ' CZ ' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -63.16 -40.32 97.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.0 109.496 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.581 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . . . -59.86 -41.76 92.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.191 -0.943 . . . . 0.0 109.314 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.3 p -73.89 -20.67 60.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.335 -0.853 . . . . 0.0 109.121 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 51' ' ' ASN . . . -67.86 -22.54 65.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.407 -0.808 . . . . 0.0 109.477 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.599 ' CE2' ' HG3' ' A' ' 90' ' ' LYS . 51.8 m-85 -70.79 -23.12 62.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.469 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -91.74 -32.81 15.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 0.0 109.446 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.413 ' O ' ' O ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -120.25 147.87 44.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.642 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.615 ' HA ' HD11 ' A' ' 55' ' ' ILE . . . -119.44 8.96 11.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 109.499 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.589 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -78.39 -49.49 1.79 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.279 -0.888 . . . . 0.0 110.337 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.6 Cg_endo -66.02 -9.97 25.31 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.953 1.768 . . . . 0.0 111.115 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -109.05 -13.32 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.955 -1.091 . . . . 0.0 109.886 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.506 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 15.0 ptm180 -97.99 -13.36 21.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 109.464 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -124.99 117.98 25.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.611 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 59' ' ' GLY . 1.5 p 69.11 10.28 7.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.281 -0.887 . . . . 0.0 109.42 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 68' ' ' VAL . . . 44.18 -123.09 4.76 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.402 ' CD2' HG22 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -157.85 -174.72 4.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -1.111 . . . . 0.0 109.539 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -119.13 125.41 49.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.359 -0.838 . . . . 0.0 109.17 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.699 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -120.66 104.27 9.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.888 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . 77.78 -81.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.35 -0.844 . . . . 0.0 109.831 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.63 16.85 0.48 Allowed Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.653 -1.261 . . . . 0.0 110.139 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 66' ' ' HIS . 7.3 t -123.43 164.86 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.055 -1.262 . . . . 0.0 109.245 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.437 ' N ' HG12 ' A' ' 65' ' ' VAL . 5.2 m170 -111.0 123.11 49.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.139 -0.976 . . . . 0.0 109.816 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -120.08 165.89 14.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 108.813 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 69' ' ' THR . 0.9 OUTLIER -124.96 -162.19 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.067 -1.021 . . . . 0.0 109.464 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.794 HG21 ' HB2' ' A' ' 72' ' ' ALA . 57.2 m -155.83 131.31 9.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.925 . . . . 0.0 109.778 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.54 HD22 ' O ' ' A' ' 69' ' ' THR . 2.9 mm? -119.82 19.89 12.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.9 . . . . 0.0 109.238 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.48 ' H ' HG22 ' A' ' 69' ' ' THR . 29.9 ttm180 178.9 78.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.319 -0.863 . . . . 0.0 109.387 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.794 ' HB2' HG21 ' A' ' 69' ' ' THR . . . -106.99 77.4 1.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.751 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -75.45 176.72 7.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 109.187 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.15 -2.43 55.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 109.545 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.486 ' NH1' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -98.16 -66.07 0.92 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 0.0 109.101 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.54 ' HA ' HG23 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -127.25 176.46 7.39 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.306 -0.871 . . . . 0.0 109.402 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.521 ' CG1' ' O ' ' A' ' 76' ' ' SER . 29.8 mt -159.49 134.26 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 109.583 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.68 ' CD1' HG23 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -142.5 81.8 1.75 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.043 179.457 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.52 170.38 42.64 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.49 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -150.82 158.71 44.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -1.103 . . . . 0.0 109.606 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.551 ' HG3' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER 176.22 105.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 109.448 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.544 ' N ' ' HE3' ' A' ' 81' ' ' LYS . . . 85.82 33.51 15.48 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 82' ' ' GLY . 1.7 p 71.36 4.69 5.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -1.108 . . . . 0.0 109.39 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 100' ' ' TYR . . . -122.47 118.28 27.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.241 -0.912 . . . . 0.0 109.14 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 80' ' ' LYS . . . -126.45 149.76 17.58 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.861 HG23 HG13 ' A' ' 97' ' ' VAL . 13.4 p -105.18 123.79 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.405 -1.056 . . . . 0.0 109.379 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.785 ' O ' HG22 ' A' ' 87' ' ' ILE . 1.3 mt -87.7 79.67 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.303 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 7.4 p -92.24 126.55 37.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -0.864 . . . . 0.0 109.723 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.642 HG13 HD12 ' A' ' 96' ' ' LEU . 2.1 p -145.68 130.49 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.278 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.599 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -82.48 131.31 35.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.904 . . . . 0.0 109.598 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.451 ' CG2' HD11 ' A' ' 96' ' ' LEU . 1.9 p -102.75 -95.97 0.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.845 . . . . 0.0 109.401 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.44 ' C ' ' HG2' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -125.81 -43.0 1.87 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.023 -1.048 . . . . 0.0 109.409 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.974 ' O ' HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -146.46 50.37 1.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.915 . . . . 0.0 109.609 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.569 ' N ' HD21 ' A' ' 24' ' ' LEU . 1.2 p 170.73 166.19 0.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.101 -0.999 . . . . 0.0 109.671 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.7 mt -118.91 142.88 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.171 -0.956 . . . . 0.0 109.379 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.734 HD13 ' CH2' ' A' ' 2' ' ' TRP . 0.5 OUTLIER -108.4 147.8 31.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.934 . . . . 0.0 108.731 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.861 HG13 HG23 ' A' ' 86' ' ' VAL . 70.3 t -133.04 131.02 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.895 -1.128 . . . . 0.0 110.653 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.447 ' HA3' ' HB ' ' A' ' 87' ' ' ILE . . . -118.97 91.96 0.52 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -94.97 110.01 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.136 -1.214 . . . . 0.0 109.586 -178.476 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.626 ' HB3' HG12 ' A' ' 16' ' ' VAL . 30.7 p90 -119.87 158.27 26.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.424 -0.797 . . . . 0.0 109.79 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.492 ' O ' HG13 ' A' ' 104' ' ' ILE . 7.1 m-20 -131.29 174.46 10.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.278 -0.889 . . . . 0.0 109.56 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 16.0 mm-40 70.68 26.34 3.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.695 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.45 78.6 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.963 . . . . 0.0 109.42 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.623 ' O ' HG22 ' A' ' 104' ' ' ILE . 5.1 mt -98.04 54.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.146 -0.971 . . . . 0.0 109.879 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER 41.94 97.09 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.476 -0.765 . . . . 0.0 110.238 179.583 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.41 -13.94 18.66 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.952 1.768 . . . . 0.0 110.297 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -100.78 -30.04 6.28 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 105' ' ' GLN . 31.4 m -73.21 -31.99 64.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.12 -1.223 . . . . 0.0 109.437 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -88.23 -15.04 36.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.32 -0.863 . . . . 0.0 109.527 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.98 -31.27 25.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.628 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.473 ' O ' ' HB3' ' A' ' 114' ' ' GLU . 2.8 m120 -73.55 -39.08 65.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.13 -0.981 . . . . 0.0 109.523 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.564 HG11 ' HB1' ' A' ' 15' ' ' ALA . 6.1 p -61.93 -37.78 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 0.0 109.185 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 109' ' ' ALA . 21.9 t -68.62 -20.68 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.327 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 111' ' ' ASN . 6.5 tt0 -63.79 -61.84 2.04 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.151 -0.968 . . . . 0.0 109.09 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -39.1 89.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.129 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 1.003 HD21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -57.27 -27.02 61.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.381 -0.824 . . . . 0.0 109.448 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.518 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -75.56 -44.2 44.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 0.0 109.49 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -53.26 -19.08 2.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.91 . . . . 0.0 109.472 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -82.58 -58.58 2.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 109.787 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.618 HD22 ' OXT' ' A' ' 125' ' ' PHE . 2.6 mt -61.3 -56.56 19.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.952 . . . . 0.0 110.115 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 117' ' ' ALA . 6.1 mt -41.2 -29.84 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.272 -0.892 . . . . 0.0 109.802 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 123' ' ' GLN . . . -105.61 49.35 0.9 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 122' ' ' GLY . 1.1 mt-30 -173.68 -69.65 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.398 -1.06 . . . . 0.0 109.61 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.452 ' O ' ' OXT' ' A' ' 125' ' ' PHE . . . -133.88 56.13 0.73 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.618 ' OXT' HD22 ' A' ' 120' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.397 -1.061 . . . . 0.0 109.588 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.995 ' C ' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 121.461 0.648 . . . . 0.0 109.988 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.632 ' N ' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -83.63 -76.47 0.29 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.083 -1.011 . . . . 0.0 110.583 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.527 HG23 ' CD1' ' A' ' 5' ' ' TYR . 2.1 t -39.56 -28.81 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.208 -0.933 . . . . 0.0 109.737 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.597 ' HB2' ' HB2' ' A' ' 2' ' ' TRP . 18.1 m-30 -86.36 -43.45 12.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 0.0 108.916 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.809 HG13 ' HB2' ' A' ' 32' ' ' SER . 0.9 OUTLIER -46.77 -27.87 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.472 0.653 . . . . 0.0 109.852 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.56 -84.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 111.869 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.91 2.58 3.68 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.681 -1.262 . . . . 0.0 110.801 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.535 ' O ' ' N ' ' A' ' 14' ' ' GLY . 6.0 m-20 -92.87 -90.99 0.18 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.969 -1.082 . . . . 0.0 109.621 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -52.97 -30.2 33.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.155 -0.966 . . . . 0.0 110.081 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.828 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 21.2 t -88.64 -59.01 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.054 -1.029 . . . . 0.0 109.554 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.744 ' C ' HG22 ' A' ' 13' ' ' THR . . . -42.38 -30.73 0.87 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 107.944 -2.063 . . . . 0.0 107.944 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.744 HG22 ' C ' ' A' ' 12' ' ' GLY . 1.0 OUTLIER 147.66 51.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.12 0.486 . . . . 0.0 109.885 178.418 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.699 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -90.03 19.22 43.57 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 107.071 -2.411 . . . . 0.0 107.071 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 144.93 -25.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 34.8 m -139.11 149.94 23.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.52 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 5.5 p -87.29 20.75 2.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.976 -1.077 . . . . 0.0 108.662 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.543 ' HB3' ' CB ' ' A' ' 33' ' ' ALA . 4.7 mp0 -171.21 172.59 5.25 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.578 -0.701 . . . . 0.0 109.256 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.828 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . -175.73 135.11 0.3 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.073 -1.017 . . . . 0.0 109.602 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.526 ' O ' HD22 ' A' ' 22' ' ' LEU . . . -133.08 121.06 22.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.072 -1.018 . . . . 0.0 110.079 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.995 HD11 ' C ' ' A' ' 2' ' ' TRP . 8.0 mt -86.16 96.72 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 108.624 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.801 HD23 ' CG2' ' A' ' 97' ' ' VAL . 3.0 mm? -79.15 -179.92 6.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.373 -0.829 . . . . 0.0 109.18 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 94' ' ' SER . . . -133.35 106.36 0.63 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.576 HD23 ' C ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -51.82 -38.2 54.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -1.178 . . . . 0.0 109.465 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -138.85 35.61 2.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.482 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.38 -102.32 1.1 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.424 ' O ' ' HB ' ' A' ' 28' ' ' THR . 1.2 p30 174.57 52.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -1.12 . . . . 0.0 109.401 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 28' ' ' THR . 1.4 m 59.18 98.93 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.981 -1.074 . . . . 0.0 109.139 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.525 ' CE2' ' OG ' ' A' ' 94' ' ' SER . 38.2 m0 -84.07 -29.27 26.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.88 . . . . 0.0 109.639 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.24 157.99 33.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 109.396 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.457 ' O ' ' OG ' ' A' ' 32' ' ' SER . 0.1 OUTLIER -160.09 152.13 20.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.576 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.809 ' HB2' HG13 ' A' ' 6' ' ' VAL . 73.7 m -169.72 58.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.845 . . . . 0.0 109.402 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 18' ' ' GLN . . . -120.27 -66.38 1.07 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.199 -0.938 . . . . 0.0 109.778 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.6 -37.95 1.88 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.794 -1.723 . . . . 0.0 108.794 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.506 ' CZ ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -59.0 177.47 0.15 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.386 -1.067 . . . . 0.0 109.415 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.49 140.47 29.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 110.439 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.506 ' CG2' ' CZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -149.28 135.64 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.342 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.408 ' OG1' ' HB1' ' A' ' 63' ' ' ALA . 43.6 p -132.66 117.0 15.09 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.168 -0.957 . . . . 0.0 109.617 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.706 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 6.2 Cg_exo -58.07 117.11 3.76 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.952 1.768 . . . . 0.0 110.384 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 39' ' ' PRO . . . 162.91 -63.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 109.005 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 63' ' ' ALA . 14.4 mm100 -68.08 -12.36 60.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.147 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.88 -24.55 42.13 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -68.69 -52.37 31.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -1.12 . . . . 0.0 109.324 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.9 m -57.86 -25.8 61.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.358 -0.838 . . . . 0.0 109.243 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.511 ' HG ' ' CE1' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -65.13 -43.8 90.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.279 -0.888 . . . . 0.0 109.493 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.71 -30.84 70.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 109.893 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 p -66.11 -30.87 71.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.278 -0.889 . . . . 0.0 110.086 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.07 -10.97 59.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.126 -0.984 . . . . 0.0 109.904 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.708 ' CD2' HD13 ' A' ' 77' ' ' ILE . 4.4 m-85 -90.41 17.61 7.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.928 . . . . 0.0 109.583 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -98.75 5.52 47.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 0.0 109.35 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.539 ' O ' HD11 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -176.47 162.66 2.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.317 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 56' ' ' ARG . . . -101.26 -2.02 32.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.562 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 1.4 m-20 -75.7 -54.65 2.19 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 110.129 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 3.5 Cg_exo -61.57 -11.31 19.62 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.007 1.805 . . . . 0.0 110.686 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.539 HD11 ' O ' ' A' ' 51' ' ' ASN . 0.7 OUTLIER -118.62 -11.08 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.993 . . . . 0.0 109.658 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.511 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -97.89 44.59 1.04 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 0.0 109.264 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -169.85 -58.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.126 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.9 p -94.73 -25.8 16.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.334 -0.854 . . . . 0.0 109.298 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.64 -152.58 20.61 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -142.66 -174.66 4.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -1.073 . . . . 0.0 109.342 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.46 136.37 17.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.144 -0.972 . . . . 0.0 109.812 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.6 mp -82.23 -138.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 108.944 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 41' ' ' GLN . . . -84.5 41.72 0.86 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.942 -1.099 . . . . 0.0 110.328 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.94 0.59 5.57 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.66 140.6 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.175 -1.191 . . . . 0.0 109.748 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -106.14 108.9 20.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 109.565 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.12 166.4 12.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.177 -0.952 . . . . 0.0 109.257 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.603 HG22 ' N ' ' A' ' 69' ' ' THR . 12.0 p -118.57 170.1 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.197 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.624 HG21 ' HB2' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -144.88 154.78 42.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 109.432 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 tp -124.36 -67.09 0.94 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.291 -0.88 . . . . 0.0 109.442 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.409 ' O ' ' O ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -107.11 51.63 0.74 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.565 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.624 ' HB2' HG21 ' A' ' 69' ' ' THR . . . -54.54 -172.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -145.34 -150.82 0.34 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.545 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -111.61 -52.21 2.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.97 . . . . 0.0 109.527 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.417 ' HG3' HH11 ' A' ' 75' ' ' ARG . 0.0 OUTLIER -96.79 2.7 52.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 109.785 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.689 ' C ' HD12 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -142.19 140.58 32.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.872 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.708 HD13 ' CD2' ' A' ' 49' ' ' PHE . 2.2 mp -158.38 104.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 109.247 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.765 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -108.15 120.64 42.93 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.273 -0.892 . . . . 0.0 108.659 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.92 157.79 49.09 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.484 ' HE3' ' HG3' ' A' ' 106' ' ' PRO . 1.2 mmmp? -151.12 118.64 6.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -1.085 . . . . 0.0 109.471 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.16 141.8 16.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.994 . . . . 0.0 109.429 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 55.16 -126.22 38.23 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.34 18.1 17.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.139 -1.212 . . . . 0.0 109.661 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.09 128.96 33.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.746 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -132.73 164.59 24.02 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 78' ' ' TYR . 1.8 m -127.77 149.48 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.022 -1.281 . . . . 0.0 110.165 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.765 HG23 ' HD2' ' A' ' 78' ' ' TYR . 6.5 mt -116.5 83.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.7 OUTLIER -89.26 142.2 27.86 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.239 -0.913 . . . . 0.0 110.303 -178.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.726 ' HB ' HD12 ' A' ' 96' ' ' LEU . 85.4 t -150.13 154.24 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -109.22 121.82 45.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.005 -1.06 . . . . 0.0 109.802 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.788 HG22 HG13 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -92.26 -55.11 3.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.291 -0.881 . . . . 0.0 109.535 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 91' ' ' THR . 9.3 t 171.51 -31.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.067 -1.021 . . . . 0.0 109.95 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.4 mttm -128.75 -28.53 2.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.015 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.576 ' C ' HD23 ' A' ' 24' ' ' LEU . 39.8 m -135.34 152.45 51.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.044 -1.035 . . . . 0.0 109.847 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.508 HG13 ' N ' ' A' ' 24' ' ' LEU . 14.4 mt -94.08 142.33 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.346 -0.846 . . . . 0.0 109.32 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.82 HD22 ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -107.0 148.52 28.58 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.801 ' CG2' HD23 ' A' ' 22' ' ' LEU . 39.8 t -140.25 131.89 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.995 -1.066 . . . . 0.0 110.215 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.474 ' HA3' ' HB ' ' A' ' 87' ' ' ILE . . . -104.86 102.91 2.13 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 107.444 -2.262 . . . . 0.0 107.444 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -96.73 123.42 49.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.248 -1.148 . . . . 0.0 109.238 -178.712 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.537 ' HB2' HD12 ' A' ' 104' ' ' ILE . 3.4 p90 -132.52 164.2 27.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.298 -0.876 . . . . 0.0 109.491 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -149.22 -170.41 3.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.506 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 60.81 22.14 12.2 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.175 -0.953 . . . . 0.0 109.371 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.43 82.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.589 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' ' 100' ' ' TYR . 4.0 mt -97.27 147.66 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.155 -0.966 . . . . 0.0 109.283 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -50.88 109.38 1.32 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.307 -0.871 . . . . 0.0 109.546 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.484 ' HG3' ' HE3' ' A' ' 80' ' ' LYS . 2.4 Cg_endo -62.13 -35.26 76.35 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.921 1.748 . . . . 0.0 110.167 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.2 47.18 3.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 112' ' ' VAL . 16.6 m -148.36 -39.2 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 109.414 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.486 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -88.12 -18.94 27.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.604 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.53 -46.98 24.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -63.75 -42.04 97.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.429 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 108' ' ' THR . 89.3 t -62.74 -26.4 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.239 -0.913 . . . . 0.0 109.565 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.543 HG21 HG21 ' A' ' 87' ' ' ILE . 47.6 t -87.55 -22.86 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.366 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -63.89 -42.41 97.49 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.229 -0.919 . . . . 0.0 109.307 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -78.32 -51.24 10.41 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.363 -0.836 . . . . 0.0 109.226 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.593 HD21 ' CE2' ' A' ' 5' ' ' TYR . 4.1 tp -49.67 -33.09 14.74 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.154 -0.966 . . . . 0.0 109.109 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.744 ' C ' HD12 ' A' ' 121' ' ' ILE . . . -62.24 -47.91 82.31 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.248 -0.907 . . . . 0.0 108.584 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -15.79 47.69 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.492 -0.755 . . . . 0.0 109.088 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -83.65 -47.58 11.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.431 -0.793 . . . . 0.0 108.988 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.959 HD23 ' HA3' ' A' ' 124' ' ' GLY . 0.4 OUTLIER -80.92 -7.67 59.56 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.357 -0.839 . . . . 0.0 109.591 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.788 HG13 HG22 ' A' ' 91' ' ' THR . 26.6 mt -90.13 -20.94 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.31 -0.869 . . . . 0.0 109.347 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 123' ' ' GLN . . . -112.92 -0.31 25.65 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 122' ' ' GLY . 1.8 mt-30 -140.7 -47.27 0.41 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -1.147 . . . . 0.0 109.472 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.959 ' HA3' HD23 ' A' ' 120' ' ' LEU . . . -74.88 -102.31 0.1 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.191 -1.182 . . . . 0.0 109.261 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.952 ' CZ2' HD22 ' A' ' 96' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.83 -79.72 0.33 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.734 -1.229 . . . . 0.0 108.219 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -17.59 61.85 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.691 ' CD2' HD12 ' A' ' 10' ' ' LEU . 9.9 m-30 -75.35 -39.34 59.41 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.929 HG23 ' HB2' ' A' ' 2' ' ' TRP . 1.2 t -54.2 -48.42 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.586 -0.696 . . . . 0.0 110.027 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.627 ' O ' HG23 ' A' ' 8' ' ' THR . 5.5 t0 -90.91 52.37 2.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 112.513 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER 176.78 -87.49 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.26 -1.525 . . . . 0.0 112.783 178.465 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 11' ' ' VAL . 14.0 m120 -83.43 -92.06 0.07 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.105 -0.997 . . . . 0.0 112.494 -176.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.691 HD12 ' CD2' ' A' ' 5' ' ' TYR . 3.0 mt -23.79 -41.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.978 HG22 ' HB3' ' A' ' 19' ' ' ALA . 72.2 t -89.61 -57.42 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.576 -1.327 . . . . 0.0 110.523 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.756 ' C ' HG22 ' A' ' 13' ' ' THR . . . -40.65 -47.56 3.89 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 108.741 -1.743 . . . . 0.0 108.741 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.756 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER 166.72 38.63 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.708 -0.878 . . . . 0.0 108.932 178.68 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.694 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -82.67 15.35 31.36 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.886 ' HB2' HG11 ' A' ' 112' ' ' VAL . . . 157.99 -27.58 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.626 HG12 ' HB3' ' A' ' 100' ' ' TYR . 23.5 m -143.4 154.34 16.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.2 OUTLIER -83.95 17.41 2.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.974 -1.079 . . . . 0.0 109.533 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.572 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -176.99 177.47 1.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.978 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . 179.19 158.04 0.58 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.84 -1.162 . . . . 0.0 110.265 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.513 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -153.94 117.71 4.7 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.674 HD11 ' CG ' ' A' ' 2' ' ' TRP . 6.9 mm -82.63 113.39 21.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.221 -0.924 . . . . 0.0 109.19 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.119 HD22 ' CG2' ' A' ' 97' ' ' VAL . 0.4 OUTLIER -96.32 117.14 30.21 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.537 -0.727 . . . . 0.0 109.566 -178.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -50.7 179.98 0.03 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.551 ' H ' HD23 ' A' ' 24' ' ' LEU . 1.2 pt? -121.37 -8.98 9.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -1.192 . . . . 0.0 109.659 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -111.58 26.96 10.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.932 . . . . 0.0 109.537 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.08 70.44 1.31 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -171.62 -164.99 0.35 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -1.158 . . . . 0.0 109.331 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.05 111.09 7.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.168 -0.957 . . . . 0.0 109.58 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 36.5 m0 -83.91 -33.63 24.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.428 ' HB3' ' CG1' ' A' ' 21' ' ' ILE . . . -164.9 158.98 17.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.285 -0.884 . . . . 0.0 109.399 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.3 t -152.31 141.55 21.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.159 -0.963 . . . . 0.0 109.812 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.777 ' CB ' HG21 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -130.13 119.97 23.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.396 -0.815 . . . . 0.0 108.998 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 81.73 159.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.589 -0.694 . . . . 0.0 109.375 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 33' ' ' ALA . . . -43.45 -93.25 0.01 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.414 ' CE1' HG21 ' A' ' 99' ' ' VAL . 0.9 OUTLIER 68.75 94.73 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -1.139 . . . . 0.0 109.533 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.564 ' O ' ' HB2' ' A' ' 63' ' ' ALA . . . -102.52 100.3 10.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.385 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.466 ' HB ' ' HG2' ' A' ' 41' ' ' GLN . 1.8 t -109.28 166.24 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.876 . . . . 0.0 109.529 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.479 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -50.22 153.55 2.42 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.372 -0.83 . . . . 0.0 109.545 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.456 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 5.3 Cg_exo -58.97 -16.07 30.55 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.159 1.906 . . . . 0.0 110.436 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 43' ' ' GLN . . . -122.52 56.89 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.222 -0.924 . . . . 0.0 109.48 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 38' ' ' THR . 3.9 mp0 -51.67 -37.05 48.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.026 -1.046 . . . . 0.0 109.265 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.31 -39.58 70.73 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.539 ' HB2' ' HB1' ' A' ' 40' ' ' ALA . 1.3 tm0? -63.15 -37.41 87.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -1.194 . . . . 0.0 110.033 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.1 m -62.46 -51.66 66.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.186 -0.946 . . . . 0.0 109.668 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.899 HD22 HG21 ' A' ' 95' ' ' ILE . 2.1 mp -65.73 -23.32 66.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 109.75 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.582 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . . . -62.92 -37.15 85.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.94 . . . . 0.0 109.674 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.8 m -76.98 -28.39 55.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.539 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.61 -14.22 62.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.548 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CD2' ' HA ' ' A' ' 46' ' ' ALA . 23.2 m-85 -76.51 -39.54 52.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.94 . . . . 0.0 109.398 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -87.48 -66.73 0.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.129 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -117.3 140.73 49.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 0.0 109.117 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.469 ' O ' HG12 ' A' ' 55' ' ' ILE . . . -135.64 33.57 2.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -0.958 . . . . 0.0 109.767 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.638 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -68.22 -45.28 39.22 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.377 -0.827 . . . . 0.0 110.652 179.707 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 6.3 Cg_exo -59.44 -18.71 47.74 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.524 1.483 . . . . 0.0 110.595 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.127 HD11 ' CB ' ' A' ' 72' ' ' ALA . 1.1 pt -105.7 -19.03 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 109.163 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.438 HH11 ' CG ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -76.79 -37.48 55.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.364 -0.835 . . . . 0.0 109.655 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 56' ' ' ARG . . . -43.87 -71.56 0.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 0.0 109.74 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.464 ' O ' HG23 ' A' ' 68' ' ' VAL . 1.9 t -118.83 -47.12 2.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.636 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 68' ' ' VAL . . . 166.01 -163.42 36.77 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.42 ' HE2' HG23 ' A' ' 69' ' ' THR . 0.3 OUTLIER -112.94 161.16 17.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -1.146 . . . . 0.0 109.475 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.42 104.79 12.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 109.708 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.88 112.67 25.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.865 . . . . 0.0 109.514 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 36' ' ' ALA . . . 49.71 -143.38 0.54 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.567 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.87 46.89 3.75 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.539 HG11 ' CE2' ' A' ' 67' ' ' TYR . 3.4 t -142.34 138.93 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -1.179 . . . . 0.0 108.963 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.407 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 75.9 t60 -121.46 118.91 30.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 0.0 109.77 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.539 ' CE2' HG11 ' A' ' 65' ' ' VAL . 15.9 m-85 -131.73 177.62 7.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 109.241 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.614 HG22 ' N ' ' A' ' 69' ' ' THR . 7.7 p -104.42 166.16 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.268 -0.895 . . . . 0.0 109.846 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.614 ' N ' HG22 ' A' ' 68' ' ' VAL . 1.4 m -95.49 176.76 6.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.933 . . . . 0.0 109.173 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.556 ' H ' HG22 ' A' ' 69' ' ' THR . 0.2 OUTLIER -141.33 -48.42 0.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.141 -0.974 . . . . 0.0 110.234 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 76' ' ' SER . 13.8 ttm180 -142.8 61.38 1.42 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.947 -1.096 . . . . 0.0 110.153 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 1.127 ' CB ' HD11 ' A' ' 55' ' ' ILE . . . -85.34 81.66 8.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.123 -0.985 . . . . 0.0 109.393 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -154.88 -38.56 0.09 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.284 -0.885 . . . . 0.0 109.477 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.93 -100.18 0.35 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.761 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.452 ' NH1' ' CG ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -129.11 -16.23 4.07 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.882 -1.136 . . . . 0.0 110.106 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.627 ' C ' HD12 ' A' ' 77' ' ' ILE . 6.1 m -89.37 131.82 35.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.827 -1.17 . . . . 0.0 109.415 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 77' ' ' ILE . 4.7 mp -149.21 60.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 110.116 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.847 ' HB3' HD13 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -90.51 161.31 15.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.036 -1.04 . . . . 0.0 108.333 179.008 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.82 158.25 14.45 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.444 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 19.3 mtmt -145.34 132.64 20.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -1.09 . . . . 0.0 109.375 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.9 OUTLIER 171.63 128.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 109.508 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 83' ' ' SER . . . 56.96 54.78 34.23 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 82' ' ' GLY . 0.6 OUTLIER 43.79 26.77 0.14 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -1.151 . . . . 0.0 109.61 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.497 ' HA ' ' CE2' ' A' ' 100' ' ' TYR . . . -145.34 153.36 41.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.205 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 179.5 -166.79 36.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.406 ' O ' HD13 ' A' ' 87' ' ' ILE . 2.5 m -122.38 179.91 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -1.149 . . . . 0.0 109.649 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.847 HD13 ' HB3' ' A' ' 78' ' ' TYR . 36.4 mm -142.85 68.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.104 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.798 HG22 HG13 ' A' ' 97' ' ' VAL . 1.2 p -99.93 116.86 32.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 110.028 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.36 150.99 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.428 -0.795 . . . . 0.0 108.963 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.5 ' HG3' HG12 ' A' ' 95' ' ' ILE . 1.8 mtpt -98.35 149.97 22.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.147 -0.97 . . . . 0.0 109.778 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.6 p -123.42 -138.75 0.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.808 . . . . 0.0 108.871 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.503 ' HB2' ' HA ' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -66.64 -17.01 64.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.858 -1.151 . . . . 0.0 109.302 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.583 ' HB2' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER 167.49 66.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 p 176.86 156.58 0.28 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.347 -0.845 . . . . 0.0 109.126 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.899 HG21 HD22 ' A' ' 45' ' ' LEU . 14.7 mt -129.39 100.67 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.037 -1.039 . . . . 0.0 109.831 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.952 HD22 ' CZ2' ' A' ' 2' ' ' TRP . 2.9 pp -78.42 137.85 38.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 108.954 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 1.119 ' CG2' HD22 ' A' ' 22' ' ' LEU . 11.9 t -117.4 81.28 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.139 -0.976 . . . . 0.0 110.183 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.49 ' CA ' ' HB ' ' A' ' 87' ' ' ILE . . . -74.47 110.5 3.1 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.476 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -111.62 127.74 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -1.228 . . . . 0.0 109.44 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.626 ' HB3' HG12 ' A' ' 16' ' ' VAL . 22.4 p90 -130.97 173.01 11.41 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 109.941 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -122.48 -141.49 0.32 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.597 -0.689 . . . . 0.0 109.372 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.438 ' HG3' ' N ' ' A' ' 103' ' ' LYS . 4.3 pt-20 -79.15 -19.15 51.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.111 -0.993 . . . . 0.0 109.422 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.484 ' CD ' HG21 ' A' ' 17' ' ' THR . 65.7 mttt -58.17 -25.28 61.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.387 -0.82 . . . . 0.0 109.833 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 16' ' ' VAL . 4.7 mt -127.41 143.47 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.014 -1.054 . . . . 0.0 109.541 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.443 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -102.48 158.26 32.1 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 109.33 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 105' ' ' GLN . 2.1 Cg_endo -61.78 153.87 64.77 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.165 1.91 . . . . 0.0 110.195 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.7 -61.57 0.32 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.5 m -75.68 -22.44 56.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -1.125 . . . . 0.0 109.714 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.599 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -75.68 -38.11 59.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.628 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.96 -38.36 32.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 109.683 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.48 ' O ' ' HB3' ' A' ' 114' ' ' GLU . 2.6 t30 -63.74 -41.16 98.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.134 -0.979 . . . . 0.0 109.641 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.886 HG11 ' HB2' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -65.41 -42.95 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.357 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.826 HG21 HG21 ' A' ' 87' ' ' ILE . 51.8 t -67.93 -15.53 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.896 . . . . 0.0 109.64 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 111' ' ' ASN . 5.3 tp10 -67.79 -63.63 1.02 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.239 -0.913 . . . . 0.0 109.625 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -27.1 66.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.178 -0.951 . . . . 0.0 109.753 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.609 HD11 ' HE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -61.34 -47.11 87.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.112 -0.993 . . . . 0.0 110.122 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.538 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -78.21 -33.21 50.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 109.937 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -57.25 -17.74 13.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 109.854 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.44 -57.4 2.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 110.065 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -70.66 -1.96 12.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.135 -0.978 . . . . 0.0 110.689 -178.649 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.538 HD12 ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -70.03 -36.65 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.965 -1.084 . . . . 0.0 108.97 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.406 ' O ' ' HG2' ' A' ' 123' ' ' GLN . . . -108.72 42.56 1.92 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 122' ' ' GLY . 53.9 mm-40 -147.01 -84.1 0.11 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -1.166 . . . . 0.0 109.864 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.457 ' O ' ' OXT' ' A' ' 125' ' ' PHE . . . -136.7 63.98 0.57 Allowed Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.253 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.583 ' CD1' ' HB2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.241 -1.153 . . . . 0.0 109.625 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.634 ' CH2' ' HB2' ' A' ' 117' ' ' ALA . 3.4 m95 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.43 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 3.0 mp0 -39.09 -92.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.405 -0.809 . . . . 0.0 111.408 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.794 ' O ' HG22 ' A' ' 8' ' ' THR . 91.5 m -57.42 -49.14 77.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.347 -0.846 . . . . 0.0 110.961 -178.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.691 ' CD2' HD21 ' A' ' 116' ' ' LEU . 15.3 m-30 -50.92 -18.42 0.76 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.156 -0.965 . . . . 0.0 110.23 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.517 ' HA ' HG23 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -79.61 -46.85 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.945 -1.097 . . . . 0.0 109.361 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.48 51.42 1.88 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 0.0 111.982 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.794 HG22 ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -166.23 -100.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.36 -1.462 . . . . 0.0 110.892 179.002 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.515 ' H ' HG23 ' A' ' 8' ' ' THR . 1.0 OUTLIER -102.25 -59.35 1.72 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.051 -1.03 . . . . 0.0 110.824 -178.632 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.564 ' CB ' ' HB3' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -33.49 -33.26 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.622 -0.674 . . . . 0.0 110.99 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.842 HG22 ' HB3' ' A' ' 19' ' ' ALA . 2.8 t -99.53 -48.21 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.032 -1.042 . . . . 0.0 109.689 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.768 ' C ' HG22 ' A' ' 13' ' ' THR . . . -40.81 -45.13 3.6 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.768 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 159.66 39.72 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.88 -0.777 . . . . 0.0 109.601 178.549 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.703 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -84.23 20.04 15.28 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 154.1 -33.55 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.576 ' HA ' HD13 ' A' ' 104' ' ' ILE . 11.9 m -136.44 134.56 49.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.777 HG23 ' HG3' ' A' ' 18' ' ' GLN . 9.2 t -78.4 2.61 18.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.85 -1.156 . . . . 0.0 109.387 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.777 ' HG3' HG23 ' A' ' 17' ' ' THR . 71.7 mt-30 -162.6 155.34 19.43 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.842 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -158.9 152.51 23.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.117 -0.989 . . . . 0.0 109.72 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.5 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -138.6 142.11 39.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.947 . . . . 0.0 109.455 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.597 HD11 ' N ' ' A' ' 2' ' ' TRP . 0.7 OUTLIER -109.32 79.96 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.144 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -62.44 -153.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 108.649 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.425 ' C ' HG13 ' A' ' 95' ' ' ILE . . . -143.1 140.49 9.75 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.565 -1.302 . . . . 0.0 109.986 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 94' ' ' SER . 9.1 mt -68.68 -44.19 74.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -1.137 . . . . 0.0 109.263 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -129.27 2.45 5.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.584 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.35 -102.53 2.15 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -176.91 -46.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -1.122 . . . . 0.0 109.576 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.8 m -167.17 116.81 0.85 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.887 . . . . 0.0 109.666 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.413 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 19.0 m0 -96.78 -34.46 11.31 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.271 -0.893 . . . . 0.0 109.366 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.98 170.72 6.16 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -161.39 -179.27 7.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.059 -1.026 . . . . 0.0 109.945 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.647 ' OG ' HG21 ' A' ' 11' ' ' VAL . 51.9 p 177.74 67.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.531 -0.731 . . . . 0.0 109.23 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.455 ' CB ' ' CE1' ' A' ' 35' ' ' PHE . . . -142.08 -39.39 0.37 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.482 -0.761 . . . . 0.0 109.169 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.3 -52.94 0.95 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.455 ' CE1' ' CB ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -61.22 162.2 7.86 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -1.094 . . . . 0.0 109.385 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.08 148.54 29.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 109.379 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 38' ' ' THR . 61.4 t -102.17 158.69 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.193 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.468 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 6.0 t -43.14 147.19 0.72 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.437 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.468 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 6.1 Cg_exo -58.77 -14.07 20.57 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.153 1.902 . . . . 0.0 110.311 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.949 ' HB1' ' HB3' ' A' ' 43' ' ' GLN . . . -107.8 59.3 0.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.917 . . . . 0.0 109.409 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -65.56 -52.68 50.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.93 -1.107 . . . . 0.0 109.765 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.88 -12.71 84.33 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.949 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 1.5 tt0 -89.98 -20.97 22.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -1.149 . . . . 0.0 109.475 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.1 m -90.1 -29.72 18.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.498 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.518 ' O ' ' CD2' ' A' ' 49' ' ' PHE . 4.2 mm? -87.7 -40.55 14.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.726 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.37 -25.26 60.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 109.995 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.3 t -88.59 -19.6 26.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.124 -0.985 . . . . 0.0 109.779 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.18 -14.25 47.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.103 -0.998 . . . . 0.0 109.689 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.518 ' CD2' ' O ' ' A' ' 45' ' ' LEU . 19.6 m-85 -74.32 -33.0 63.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.658 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -94.11 -20.78 19.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.939 . . . . 0.0 109.303 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -131.55 120.85 23.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 0.0 109.342 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.545 ' HA ' HD11 ' A' ' 55' ' ' ILE . . . -119.84 28.71 7.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 109.554 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.569 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -76.57 -51.42 2.43 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.333 -0.855 . . . . 0.0 110.458 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 1.7 Cg_endo -64.61 -4.81 9.0 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.113 1.875 . . . . 0.0 111.357 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.717 ' HB ' HG21 ' A' ' 69' ' ' THR . 0.0 OUTLIER -112.53 7.62 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.748 -1.22 . . . . 0.0 110.101 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -100.07 -20.38 16.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.891 -1.13 . . . . 0.0 109.604 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.87 -60.9 1.2 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.22 -0.925 . . . . 0.0 109.537 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -78.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.374 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.41 -165.02 28.34 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.486 ' HB2' ' HB2' ' A' ' 67' ' ' TYR . 7.0 m-85 -81.28 170.82 15.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -1.126 . . . . 0.0 109.684 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.509 ' C ' HD12 ' A' ' 62' ' ' LEU . 1.3 m-20 -141.33 101.04 3.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.495 -0.753 . . . . 0.0 108.973 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.569 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 5.9 mp -127.1 61.17 1.36 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.203 -0.936 . . . . 0.0 109.932 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . 69.47 -83.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.365 -0.834 . . . . 0.0 110.015 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -38.72 -95.54 0.01 OUTLIER Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.465 HG12 ' H ' ' A' ' 66' ' ' HIS . 1.3 t -129.77 -148.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.084 -1.245 . . . . 0.0 109.238 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 60' ' ' PHE . 33.6 p80 -122.21 144.03 49.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.153 -0.967 . . . . 0.0 109.73 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.486 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 25.9 m-85 -100.81 -161.94 0.9 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.362 -0.836 . . . . 0.0 109.233 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.703 HG22 ' H ' ' A' ' 69' ' ' THR . 1.4 p -104.32 -171.22 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.052 -1.03 . . . . 0.0 109.287 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.717 HG21 ' HB ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -148.56 64.71 1.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.11 -0.994 . . . . 0.0 109.549 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 70' ' ' LEU . 0.8 OUTLIER -91.84 18.33 7.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.92 . . . . 0.0 109.211 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -161.87 55.9 0.25 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.454 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.588 ' CB ' HG22 ' A' ' 69' ' ' THR . . . -123.46 66.35 1.01 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.735 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.85 -42.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.938 . . . . 0.0 109.635 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 2.2 m-20 -49.65 -86.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.597 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.512 ' NH1' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -145.22 -59.85 0.35 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.897 . . . . 0.0 109.388 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 78' ' ' TYR . 74.2 m -89.6 -165.41 1.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.416 ' CG1' ' O ' ' A' ' 76' ' ' SER . 13.9 mt -154.61 105.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.009 -1.057 . . . . 0.0 109.704 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 78' ' ' TYR . 0.6 OUTLIER -113.52 97.08 6.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 0.0 109.06 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 86' ' ' VAL . . . -60.31 141.38 47.88 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.529 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -151.05 124.62 9.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -1.101 . . . . 0.0 109.417 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.67 132.72 1.51 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.141 -0.974 . . . . 0.0 109.676 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.5 -136.07 47.41 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.18 -10.15 24.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -1.114 . . . . 0.0 109.704 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.48 -173.91 2.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 109.463 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.03 171.06 28.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 79' ' ' GLY . 3.4 p -123.99 153.8 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -1.184 . . . . 0.0 109.55 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.717 HG21 HG21 ' A' ' 113' ' ' VAL . 30.2 mm -127.31 94.67 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.033 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 1.4 p -108.97 129.7 55.45 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.143 -0.973 . . . . 0.0 109.985 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.836 ' HB ' HD23 ' A' ' 96' ' ' LEU . 2.4 t -142.23 143.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -103.1 120.52 40.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.119 -0.988 . . . . 0.0 109.907 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.534 ' HB ' ' CB ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -96.34 -59.13 1.9 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.412 -0.805 . . . . 0.0 108.969 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.599 ' HB3' ' CD2' ' A' ' 125' ' ' PHE . 0.2 OUTLIER 171.86 -32.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.41 -0.806 . . . . 0.0 109.769 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.54 ' C ' HD12 ' A' ' 24' ' ' LEU . 2.3 mmmt -135.85 2.51 2.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.045 -1.034 . . . . 0.0 110.13 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.735 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -156.1 146.31 21.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.021 -1.05 . . . . 0.0 109.692 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.595 HD11 ' HA ' ' A' ' 24' ' ' LEU . 15.2 mt -105.9 139.68 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 0.0 109.298 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.836 HD23 ' HB ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -92.46 154.55 18.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.032 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.779 ' O ' HG12 ' A' ' 97' ' ' VAL . 39.9 t -150.4 68.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.264 -0.897 . . . . 0.0 109.665 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.87 106.91 1.79 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.682 HG22 HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -109.88 127.81 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.958 -1.319 . . . . 0.0 109.538 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 1.043 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -142.54 144.15 32.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.396 -0.815 . . . . 0.0 109.428 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.496 ' O ' ' CB ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -150.4 114.48 5.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.067 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.1 OUTLIER 163.45 -61.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.456 -0.777 . . . . 0.0 109.393 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -174.93 33.14 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.397 -0.814 . . . . 0.0 109.906 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.043 HD12 ' HB2' ' A' ' 100' ' ' TYR . 48.6 mt -84.27 83.6 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -0.959 . . . . 0.0 108.981 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -54.11 149.69 17.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 109.954 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.77 156.45 61.6 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.309 2.006 . . . . 0.0 110.183 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.55 -2.71 46.06 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.65 -39.67 2.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -1.193 . . . . 0.0 109.505 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.544 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -83.93 -27.69 28.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.287 -0.883 . . . . 0.0 109.446 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.464 ' O ' ' OE1' ' A' ' 114' ' ' GLU . . . -83.07 -21.18 33.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.136 -0.977 . . . . 0.0 109.28 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -78.83 -29.26 44.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.537 HG11 HD11 ' A' ' 10' ' ' LEU . 11.5 t -83.08 -39.13 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.301 -0.875 . . . . 0.0 109.39 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.717 HG21 HG21 ' A' ' 87' ' ' ILE . 38.4 t -68.92 -16.25 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.053 -1.029 . . . . 0.0 109.435 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.464 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -81.32 -56.36 4.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.61 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 118' ' ' ASP . 5.4 ttmt -79.0 -52.78 7.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.748 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.691 HD21 ' CD2' ' A' ' 5' ' ' TYR . 1.6 tp -51.87 -47.09 64.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -0.959 . . . . 0.0 109.522 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.75 ' O ' HD13 ' A' ' 121' ' ' ILE . . . -67.93 -35.69 78.86 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.074 -1.016 . . . . 0.0 109.05 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 115' ' ' LYS . 24.1 t0 -47.56 -25.84 1.26 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.134 -0.979 . . . . 0.0 109.266 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -81.32 -51.1 8.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.277 -0.89 . . . . 0.0 109.261 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' ' 125' ' ' PHE . 3.8 mt -71.25 -3.1 18.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.399 -0.813 . . . . 0.0 110.072 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.75 HD13 ' O ' ' A' ' 117' ' ' ALA . 1.2 mp -75.99 -28.41 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.065 -1.022 . . . . 0.0 108.554 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -123.74 29.24 5.23 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.35 57.55 0.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -1.113 . . . . 0.0 109.687 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.507 ' C ' ' CD1' ' A' ' 125' ' ' PHE . . . 104.71 17.72 14.22 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.599 ' CD2' ' HB3' ' A' ' 92' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.743 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.769 ' CB ' HD11 ' A' ' 21' ' ' ILE . 1.1 m-90 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.55 -80.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.076 -1.015 . . . . 0.0 109.787 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.66 ' O ' HG22 ' A' ' 8' ' ' THR . 8.8 t -59.57 -39.21 83.33 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.765 ' CE1' HD12 ' A' ' 10' ' ' LEU . 4.9 t80 -40.14 -36.51 0.51 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.033 0.92 . . . . 0.0 109.172 177.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.109 HG13 HG21 ' A' ' 11' ' ' VAL . 39.7 t -99.37 -29.51 3.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 121.046 -1.034 . . . . 0.0 111.325 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.48 ' C ' HG22 ' A' ' 8' ' ' THR . 77.9 m-20 -91.75 52.25 1.99 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.702 -1.249 . . . . 0.0 112.826 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER 179.61 -94.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.21 -1.556 . . . . 0.0 111.322 178.182 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.7 t-20 -101.89 -66.33 0.93 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.197 -0.94 . . . . 0.0 111.124 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.765 HD12 ' CE1' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -33.88 -31.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.867 -0.521 . . . . 0.0 111.6 -178.411 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.109 HG21 HG13 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -95.39 -56.66 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.751 -1.218 . . . . 0.0 109.745 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.746 ' C ' HG22 ' A' ' 13' ' ' THR . . . -38.79 -37.38 0.57 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.831 -1.707 . . . . 0.0 108.831 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.746 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 159.05 39.64 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.95 -0.735 . . . . 0.0 109.196 178.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.706 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -81.29 16.55 16.92 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 107.776 -2.13 . . . . 0.0 107.776 177.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.716 ' HB1' ' HA ' ' A' ' 109' ' ' ALA . . . 154.99 -27.09 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.419 HG21 ' HB2' ' A' ' 19' ' ' ALA . 5.2 m -140.4 137.29 36.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.041 HG23 HD11 ' A' ' 104' ' ' ILE . 34.5 p -79.38 6.44 10.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.922 -1.111 . . . . 0.0 109.436 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.483 ' OE1' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -167.39 161.95 14.38 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.624 ' HA ' HG23 ' A' ' 99' ' ' VAL . . . -174.01 171.59 3.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.956 -1.09 . . . . 0.0 110.079 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -161.98 157.07 23.13 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.286 -0.884 . . . . 0.0 109.774 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.769 HD11 ' CB ' ' A' ' 2' ' ' TRP . 10.9 mt -115.45 94.63 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.805 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -85.27 128.55 34.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.666 -0.646 . . . . 0.0 109.284 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.6 ' HA2' ' CZ3' ' A' ' 29' ' ' TRP . . . -48.19 167.0 0.16 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.657 HD23 ' CG1' ' A' ' 95' ' ' ILE . 16.2 mt -77.12 -11.96 59.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.349 -1.089 . . . . 0.0 109.276 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 27' ' ' ASN . 5.3 t70 -120.08 57.79 0.93 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.703 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 52.3 69.72 1.1 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 25' ' ' ASP . 8.4 m120 -147.31 -149.89 0.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.282 -1.128 . . . . 0.0 109.519 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -155.26 158.85 39.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.358 -0.839 . . . . 0.0 109.182 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.6 ' CZ3' ' HA2' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -145.33 -41.04 0.23 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -0.986 . . . . 0.0 109.905 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.501 ' HB3' HD12 ' A' ' 21' ' ' ILE . . . -165.1 118.58 1.24 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.999 -1.063 . . . . 0.0 110.15 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 9.3 t -131.86 164.36 26.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.651 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.707 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 3.4 m -147.79 147.55 29.97 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.338 -0.851 . . . . 0.0 109.475 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 81.4 172.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 33' ' ' ALA . . . -60.64 -132.58 0.01 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.651 ' CE1' HG11 ' A' ' 99' ' ' VAL . 91.0 t80 58.81 93.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.031 -1.276 . . . . 0.0 109.203 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.2 124.42 50.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 109.648 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 65.5 t -97.92 106.0 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.833 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -71.22 162.01 75.04 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.285 -0.884 . . . . 0.0 109.529 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.833 ' HD2' HG22 ' A' ' 38' ' ' THR . 2.4 Cg_endo -61.58 108.81 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.18 1.92 . . . . 0.0 110.004 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 39' ' ' PRO . . . 176.24 -71.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.217 -0.927 . . . . 0.0 109.496 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.47 -21.71 65.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.667 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.17 -31.62 61.34 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.468 ' O ' ' OG ' ' A' ' 47' ' ' SER . 4.6 tt0 -74.97 -23.04 58.23 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.388 -1.066 . . . . 0.0 109.374 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.667 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 3.5 m -88.42 -32.72 18.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.233 -0.917 . . . . 0.0 109.301 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.91 -47.81 83.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -0.916 . . . . 0.0 109.352 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 25' ' ' ASP . . . -61.49 -46.55 89.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 0.0 109.218 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -82.82 -0.21 46.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.364 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 44' ' ' THR . . . -82.78 -22.66 34.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 109.716 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -74.76 -0.88 19.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.049 -1.032 . . . . 0.0 109.591 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -88.21 -59.84 2.13 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.188 -0.945 . . . . 0.0 109.953 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 53' ' ' ASP . 0.5 OUTLIER -126.47 6.35 6.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.025 -1.047 . . . . 0.0 110.175 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 51' ' ' ASN . . . 32.25 35.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.234 0.54 . . . . 0.0 110.445 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.618 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 2.7 t0 -73.9 -49.91 5.74 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.896 . . . . 0.0 110.888 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 6.0 Cg_exo -59.98 -9.59 10.33 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.058 1.838 . . . . 0.0 111.317 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.775 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -106.92 -49.46 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.892 -1.13 . . . . 0.0 109.775 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.506 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 3.6 ptm180 -53.87 -19.33 4.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.051 -1.031 . . . . 0.0 110.084 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 56' ' ' ARG . . . -120.6 137.94 54.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.093 -1.005 . . . . 0.0 109.925 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 59' ' ' GLY . 0.6 OUTLIER 49.74 27.24 2.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.405 -0.81 . . . . 0.0 109.653 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 58' ' ' SER . . . 43.39 -136.64 4.44 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 60' ' ' PHE . 2.6 p90 -147.33 143.79 28.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.183 -1.186 . . . . 0.0 109.343 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -101.85 126.86 48.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.266 -0.897 . . . . 0.0 109.765 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -94.51 -160.17 0.76 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.53 -0.731 . . . . 0.0 109.475 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.14 95.3 8.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.4 -23.73 14.49 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -125.53 153.0 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -1.14 . . . . 0.0 108.888 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -149.91 153.58 36.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 109.526 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -141.91 -171.92 3.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.335 -0.853 . . . . 0.0 109.276 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 t -116.89 154.13 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.945 . . . . 0.0 109.602 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.88 124.94 45.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.484 -0.76 . . . . 0.0 109.54 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.03 -35.92 1.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.592 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.434 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -119.33 70.76 0.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.463 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.78 28.6 6.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.423 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -99.69 0.07 41.15 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.248 -0.908 . . . . 0.0 109.606 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -105.22 -95.74 0.34 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.975 . . . . 0.0 109.926 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.526 ' NH1' ' HG3' ' A' ' 75' ' ' ARG . 1.0 OUTLIER -142.47 -36.51 0.4 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.028 . . . . 0.0 110.058 -179.493 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 0.6 OUTLIER -89.52 149.87 22.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 109.553 -179.559 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 76' ' ' SER . 4.3 mp -144.53 70.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 0.0 110.335 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.756 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -90.01 93.62 9.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.814 -1.179 . . . . 0.0 108.46 178.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.422 ' O ' HG12 ' A' ' 86' ' ' VAL . . . -79.21 128.44 8.56 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.56 146.38 26.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -1.233 . . . . 0.0 109.61 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.88 148.83 0.55 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.559 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.47 -106.85 2.76 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.2 m -135.95 7.92 3.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -1.121 . . . . 0.0 109.511 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -130.82 178.12 6.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 0.0 109.159 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -169.28 177.45 42.93 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.325 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 86' ' ' VAL . 9.3 p -153.27 123.63 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.976 . . . . 0.0 108.74 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.821 HG21 HG11 ' A' ' 113' ' ' VAL . 10.6 mt -95.53 99.82 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.177 -0.952 . . . . 0.0 109.793 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 8.6 p -105.95 108.48 20.02 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.566 HG22 ' CE2' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -129.01 173.95 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.927 . . . . 0.0 110.054 -179.174 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.439 ' H ' HG12 ' A' ' 89' ' ' VAL . 29.7 mtmt -101.39 142.81 32.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.392 -0.817 . . . . 0.0 108.941 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 1.088 ' CG2' HD21 ' A' ' 96' ' ' LEU . 66.5 p -149.12 -137.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.105 -0.997 . . . . 0.0 109.828 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.465 ' HA ' ' OXT' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -67.52 84.04 0.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.948 -1.095 . . . . 0.0 111.178 -178.777 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.561 ' HA ' HD11 ' A' ' 24' ' ' LEU . 3.0 mttm 51.04 34.01 10.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -0.855 . . . . 0.0 109.778 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.04 167.35 30.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.051 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.657 ' CG1' HD23 ' A' ' 24' ' ' LEU . 34.5 mt -121.89 123.15 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.239 -0.913 . . . . 0.0 109.135 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.088 HD21 ' CG2' ' A' ' 91' ' ' THR . 0.0 OUTLIER -75.62 165.12 25.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.08 -1.013 . . . . 0.0 108.928 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.785 HG12 HG22 ' A' ' 99' ' ' VAL . 54.0 t -150.91 74.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.389 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -63.78 98.73 0.26 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.785 HG22 HG12 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -97.28 127.64 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -1.15 . . . . 0.0 109.018 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.549 ' HB2' ' CG1' ' A' ' 104' ' ' ILE . 1.5 p90 -146.82 171.19 15.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 109.878 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -113.7 -149.85 0.45 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.394 -0.816 . . . . 0.0 110.023 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -42.5 89.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.47 -0.768 . . . . 0.0 110.221 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.8 -25.05 1.13 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.041 HD11 HG23 ' A' ' 17' ' ' THR . 10.6 mm -103.51 105.72 18.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.053 -1.029 . . . . 0.0 109.698 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.57 142.66 49.99 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.26 -0.9 . . . . 0.0 109.137 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -60.7 149.37 87.91 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.119 1.88 . . . . 0.0 110.503 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.86 -35.46 4.92 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.6 m -83.49 -29.6 27.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -1.182 . . . . 0.0 109.613 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.716 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -89.79 -13.98 35.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.809 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.0 -20.63 23.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.142 -0.974 . . . . 0.0 109.559 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -80.72 -32.67 35.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 0.0 109.695 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 88.8 t -90.05 -35.96 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 110.172 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.821 HG11 HG21 ' A' ' 87' ' ' ILE . 49.1 t -74.35 -17.6 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.148 -0.97 . . . . 0.0 109.768 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -86.97 -42.4 13.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -0.973 . . . . 0.0 109.972 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.06 -40.48 62.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.126 -0.984 . . . . 0.0 109.74 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.729 HD22 ' CE2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -60.16 -47.31 86.47 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.215 -0.928 . . . . 0.0 109.564 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.891 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -63.92 -25.91 68.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.644 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -69.2 -25.63 64.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.714 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -76.91 -40.32 47.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.22 -0.925 . . . . 0.0 110.074 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.571 ' O ' HD12 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -82.86 -21.03 34.47 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.163 -0.96 . . . . 0.0 110.06 -179.449 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.891 HD12 ' O ' ' A' ' 117' ' ' ALA . 8.1 mt -77.62 -22.64 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 109.331 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.13 -24.48 3.41 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.29 -68.88 0.69 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.405 -1.056 . . . . 0.0 109.673 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 125' ' ' PHE . . . 158.33 110.53 0.29 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.493 ' HB3' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.084 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.693 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.869 ' CZ2' HD13 ' A' ' 96' ' ' LEU . 1.3 m-90 . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -89.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 109.189 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.429 HG23 ' N ' ' A' ' 5' ' ' TYR . 14.4 t -60.72 -36.82 79.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 108.899 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.76 ' CE2' HD11 ' A' ' 116' ' ' LEU . 10.1 m-30 -52.91 -30.89 36.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.455 -0.778 . . . . 0.0 109.41 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.535 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -69.87 -47.87 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.103 -0.998 . . . . 0.0 108.468 179.449 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.8 45.28 1.24 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.936 -1.103 . . . . 0.0 109.929 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.628 HG22 ' N ' ' A' ' 9' ' ' ASN . 54.3 m -156.96 -100.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.83 -1.169 . . . . 0.0 110.704 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.628 ' N ' HG22 ' A' ' 8' ' ' THR . 3.8 m120 -100.86 -59.54 1.68 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.112 -0.992 . . . . 0.0 110.64 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.529 ' C ' ' O ' ' A' ' 9' ' ' ASN . 0.5 OUTLIER -29.56 -48.51 0.08 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.304 0.573 . . . . 0.0 110.516 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.991 HG23 ' HB3' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -100.27 -23.37 4.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.342 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 13' ' ' THR . . . -83.32 57.57 5.06 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.123 -2.391 . . . . 0.0 107.123 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 43.25 51.03 5.83 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.987 0.898 . . . . 0.0 110.281 -178.774 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.704 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -100.59 21.76 42.65 Favored Glycine 0 C--N 1.292 -1.871 0 N-CA-C 105.438 -3.065 . . . . 0.0 105.438 176.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 1.118 ' CB ' HG11 ' A' ' 112' ' ' VAL . . . 152.08 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.722 ' HA ' HD13 ' A' ' 104' ' ' ILE . 2.7 m -138.78 147.14 25.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.703 HG23 HD11 ' A' ' 104' ' ' ILE . 2.4 p -79.76 10.27 4.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.876 -1.14 . . . . 0.0 109.165 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.523 ' CG ' ' C ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -170.71 174.07 5.1 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.381 -0.824 . . . . 0.0 109.409 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.991 ' HB3' HG23 ' A' ' 11' ' ' VAL . . . -177.36 163.69 2.04 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.497 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -160.59 122.1 3.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.832 -1.168 . . . . 0.0 110.758 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.676 HD11 ' CD1' ' A' ' 2' ' ' TRP . 3.1 mm -89.2 104.62 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.777 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.4 OUTLIER -83.29 13.47 4.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.39 -0.819 . . . . 0.0 109.934 -178.788 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 94' ' ' SER . . . 67.67 157.82 0.9 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.723 HD21 ' HB3' ' A' ' 90' ' ' LYS . 14.5 mt -79.94 -58.21 3.28 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.32 -1.106 . . . . 0.0 109.017 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.4 22.18 3.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.484 -0.76 . . . . 0.0 109.009 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -109.84 -110.35 3.29 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -149.5 -145.9 0.18 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -1.141 . . . . 0.0 109.351 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 m -71.43 125.5 27.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.088 -1.008 . . . . 0.0 109.525 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -106.19 -40.92 5.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.06 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.15 155.75 23.36 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.429 ' C ' ' OG ' ' A' ' 32' ' ' SER . 0.7 OUTLIER -160.78 172.13 17.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.954 -1.091 . . . . 0.0 110.113 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.706 ' CB ' HG11 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -176.11 109.97 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.314 -0.866 . . . . 0.0 109.516 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 55.35 41.95 30.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 109.394 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -125.65 138.15 10.7 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -49.61 178.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -1.183 . . . . 0.0 109.417 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.01 107.42 19.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.328 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.692 ' O ' HG22 ' A' ' 38' ' ' THR . 3.9 t -104.9 163.72 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 109.899 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.748 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.6 OUTLIER 94.65 15.45 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.748 ' CD ' ' N ' ' A' ' 38' ' ' THR . 1.8 Cg_endo -64.67 -20.07 65.06 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 CA-C-N 119.783 0.958 . . . . 0.0 109.611 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 39' ' ' PRO . . . 171.74 -66.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.424 -0.797 . . . . 0.0 109.235 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.454 ' O ' ' HB ' ' A' ' 44' ' ' THR . 3.1 mp0 -56.15 -24.82 43.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.91 . . . . 0.0 109.363 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.86 -45.99 55.24 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -57.52 -35.19 69.94 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.236 -1.155 . . . . 0.0 109.103 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 41' ' ' GLN . 63.4 m -57.3 -35.57 69.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.027 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.28 -48.82 75.84 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.17 -23.27 67.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.403 -0.811 . . . . 0.0 109.141 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.0 -20.19 30.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.6 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.34 -24.11 59.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.441 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.583 ' CE2' ' HG2' ' A' ' 90' ' ' LYS . 5.3 m-30 -51.39 -21.63 2.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.217 -0.927 . . . . 0.0 109.314 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -82.68 -37.3 25.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.285 -0.885 . . . . 0.0 109.756 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.92 142.79 33.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.706 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.33 24.49 13.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 109.017 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.631 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 23.3 m-20 -67.22 -46.07 50.84 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.488 -0.757 . . . . 0.0 110.932 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.9 Cg_exo -56.54 -70.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 121.487 1.458 . . . . 0.0 110.61 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.641 ' HB ' HG21 ' A' ' 69' ' ' THR . 0.1 OUTLIER -42.07 -27.68 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.186 -0.946 . . . . 0.0 109.497 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -72.05 -75.31 0.14 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.696 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -104.94 93.84 4.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 0.0 109.527 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 3.8 t 162.82 -78.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.228 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.79 -164.82 33.84 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -124.05 111.98 16.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.472 -1.016 . . . . 0.0 108.796 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -81.2 142.98 32.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 0.0 110.283 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.44 ' HA ' HD23 ' A' ' 62' ' ' LEU . 9.8 mt -149.26 -166.46 2.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.189 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.652 ' HB2' ' HA ' ' A' ' 37' ' ' VAL . . . -71.83 90.77 1.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 0.0 110.157 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.11 24.67 68.93 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -138.96 177.15 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.094 -1.239 . . . . 0.0 108.855 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 3.9 p-80 -159.43 114.43 2.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.162 -0.961 . . . . 0.0 109.744 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.588 ' CE1' ' HG3' ' A' ' 81' ' ' LYS . 11.0 m-30 -100.99 -164.02 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -0.895 . . . . 0.0 109.454 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 t -131.43 164.02 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 108.982 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.641 HG21 ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -123.17 117.45 25.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.156 -0.965 . . . . 0.0 109.835 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.62 24.73 4.05 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.576 ' NH1' ' HG3' ' A' ' 71' ' ' ARG . 0.0 OUTLIER 178.55 57.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.334 -0.854 . . . . 0.0 109.146 -179.655 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.479 ' O ' ' C ' ' A' ' 73' ' ' ASP . . . -90.81 20.69 4.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.192 -0.942 . . . . 0.0 109.263 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER 32.48 -107.09 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.102 -0.374 . . . . 0.0 110.743 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -120.88 -52.42 2.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.754 -1.217 . . . . 0.0 110.479 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.421 ' HA ' ' NE ' ' A' ' 75' ' ' ARG . 6.6 tpm_? -130.45 -9.12 4.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.011 -1.056 . . . . 0.0 110.827 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.63 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -88.77 146.98 24.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.937 -1.102 . . . . 0.0 108.795 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.495 ' HB ' ' OG1' ' A' ' 88' ' ' THR . 0.2 OUTLIER -135.76 79.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.69 -1.256 . . . . 0.0 111.004 -179.276 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.856 ' HD2' HG23 ' A' ' 87' ' ' ILE . 1.2 m-85 -90.12 76.67 6.89 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.1 178.2 7.99 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.521 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 15.6 mtpp -135.39 146.29 48.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.663 -0.904 . . . . 0.0 109.085 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.588 ' HG3' ' CE1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -114.92 25.67 10.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.998 -1.064 . . . . 0.0 109.396 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.68 -94.9 1.94 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.6 m -78.55 -25.13 45.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.226 -1.161 . . . . 0.0 109.183 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 100' ' ' TYR . . . -111.87 -165.44 0.99 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.279 -0.888 . . . . 0.0 109.25 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 80' ' ' LYS . . . -167.98 143.69 8.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 86' ' ' VAL . 10.0 p -106.44 133.6 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -1.164 . . . . 0.0 110.034 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.856 HG23 ' HD2' ' A' ' 78' ' ' TYR . 36.0 mm -106.83 83.2 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.495 ' OG1' ' HB ' ' A' ' 77' ' ' ILE . 15.5 p -95.72 117.77 31.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.004 -1.06 . . . . 0.0 110.63 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.557 HG21 ' CE2' ' A' ' 78' ' ' TYR . 11.7 t -150.36 166.52 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.723 ' HB3' HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -104.4 159.49 15.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.921 -1.112 . . . . 0.0 109.445 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.489 HG21 ' HZ3' ' A' ' 2' ' ' TRP . 0.1 OUTLIER -144.36 -70.17 0.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.611 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 1.2 t -159.87 98.7 1.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.117 -0.989 . . . . 0.0 109.889 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.472 ' CA ' HD12 ' A' ' 24' ' ' LEU . 25.1 mttm 62.54 34.59 15.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.987 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.48 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 0.3 OUTLIER 177.49 145.13 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.008 -1.057 . . . . 0.0 109.813 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.567 ' CG1' HD23 ' A' ' 24' ' ' LEU . 90.1 mt -105.96 114.68 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.88 . . . . 0.0 109.161 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.869 HD13 ' CZ2' ' A' ' 2' ' ' TRP . 0.7 OUTLIER -73.77 139.06 44.94 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.332 -0.855 . . . . 0.0 109.735 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.619 ' O ' HG22 ' A' ' 99' ' ' VAL . 45.8 t -129.89 59.75 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.352 -0.843 . . . . 0.0 109.326 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.485 ' O ' HG12 ' A' ' 87' ' ' ILE . . . -51.66 111.93 1.63 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.619 HG22 ' O ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -110.99 134.63 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.126 -1.22 . . . . 0.0 109.187 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.718 ' HB3' HG12 ' A' ' 16' ' ' VAL . 20.0 p90 -132.27 -178.35 4.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.443 -0.785 . . . . 0.0 109.307 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -118.31 -145.9 0.39 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.598 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 103' ' ' LYS . 7.6 tp10 -80.91 -38.81 27.31 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.145 -0.972 . . . . 0.0 109.665 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 102' ' ' GLU . 0.4 OUTLIER -43.79 -68.26 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.909 . . . . 0.0 109.506 -179.721 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.722 HD13 ' HA ' ' A' ' 16' ' ' VAL . 7.1 mt -65.99 137.7 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.202 -0.936 . . . . 0.0 109.286 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.416 ' HB2' ' OG1' ' A' ' 108' ' ' THR . 0.9 OUTLIER -79.77 152.63 75.06 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.775 -179.747 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.62 -17.72 60.46 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.4 2.067 . . . . 0.0 110.515 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.8 -13.03 51.77 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 105' ' ' GLN . 0.2 OUTLIER -85.65 -42.65 14.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -1.122 . . . . 0.0 109.429 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.86 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -78.07 -22.1 49.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.338 -0.851 . . . . 0.0 109.536 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.03 -21.02 31.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 109.566 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -80.91 -39.09 26.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 109.488 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 1.118 HG11 ' CB ' ' A' ' 15' ' ' ALA . 4.1 p -74.62 -27.83 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.684 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 109' ' ' ALA . 74.7 t -72.94 -35.04 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.409 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 118' ' ' ASP . 48.2 mt-10 -61.58 -41.9 98.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.462 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 118' ' ' ASP . 3.2 ttpm? -74.49 -38.03 63.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.494 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.76 HD11 ' CE2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -53.04 -53.3 52.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.338 -0.851 . . . . 0.0 109.715 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.609 ' HB1' ' CD1' ' A' ' 121' ' ' ILE . . . -75.35 -29.8 60.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 0.0 109.695 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 0.4 OUTLIER -54.02 -25.17 19.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -0.955 . . . . 0.0 109.666 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -85.57 -48.33 9.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.669 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 125' ' ' PHE . 4.5 mt -75.32 -2.61 29.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.881 . . . . 0.0 110.274 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.609 ' CD1' ' HB1' ' A' ' 117' ' ' ALA . 0.4 OUTLIER -84.2 -44.7 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.053 -1.029 . . . . 0.0 109.518 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -82.05 9.6 56.41 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -120.75 -87.9 0.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -1.192 . . . . 0.0 109.785 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.17 -90.82 0.92 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.567 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 3.8 m-85 . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.255 -1.144 . . . . 0.0 109.362 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 1.006 ' CH2' HD13 ' A' ' 96' ' ' LEU . 15.5 m95 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.404 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -64.54 -87.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.13 -0.981 . . . . 0.0 111.088 -178.459 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.473 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -60.84 -45.54 94.07 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.025 -1.047 . . . . 0.0 110.465 -178.649 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.813 ' CE2' HD22 ' A' ' 116' ' ' LEU . 2.8 m-30 -50.72 -21.65 1.72 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.87 -1.144 . . . . 0.0 109.466 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.827 HG22 HG21 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -78.0 -41.24 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 108.692 179.445 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.473 ' OD1' ' O ' ' A' ' 4' ' ' THR . 2.1 p-10 -91.28 18.83 6.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.119 -0.988 . . . . 0.0 110.825 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.42 ' OG1' ' HA ' ' A' ' 5' ' ' TYR . 21.1 p -127.59 -106.58 0.31 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.917 -1.114 . . . . 0.0 110.371 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.4 t-20 -102.02 -68.75 0.81 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.025 -1.047 . . . . 0.0 110.512 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.505 ' C ' ' O ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -24.52 -41.8 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.482 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.833 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 1.1 t -83.91 -65.59 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.728 -1.233 . . . . 0.0 110.057 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.751 ' C ' HG22 ' A' ' 13' ' ' THR . . . -36.84 -40.06 0.46 Allowed Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.751 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 158.45 40.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.891 -0.77 . . . . 0.0 109.366 178.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.703 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -86.06 21.3 16.56 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 154.87 -32.72 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.805 HG12 ' HB3' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -136.63 133.66 48.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.457 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.969 HG23 ' HG3' ' A' ' 18' ' ' GLN . 9.0 t -78.83 6.1 9.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.944 -1.097 . . . . 0.0 108.991 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.969 ' HG3' HG23 ' A' ' 17' ' ' THR . 17.3 mt-30 -158.91 153.08 23.74 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.833 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . -170.33 152.38 4.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -0.949 . . . . 0.0 109.193 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.572 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . . . -150.55 130.84 13.67 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.633 HD11 ' N ' ' A' ' 2' ' ' TRP . 4.6 mm -82.85 92.32 2.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.877 HD13 ' CG2' ' A' ' 97' ' ' VAL . 10.9 mp -74.71 106.7 6.39 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.46 -0.775 . . . . 0.0 109.915 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -45.93 174.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.644 HD11 ' C ' ' A' ' 93' ' ' LYS . 0.7 OUTLIER -72.82 -3.16 23.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.331 -1.099 . . . . 0.0 109.859 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.93 8.3 7.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.147 -0.971 . . . . 0.0 109.214 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.32 32.06 58.5 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 28' ' ' THR . 40.4 t-20 -94.97 29.96 2.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.165 -1.197 . . . . 0.0 109.36 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 27' ' ' ASN . 70.3 m 32.31 96.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.559 0.695 . . . . 0.0 110.859 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -79.54 -48.57 13.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.473 -0.767 . . . . 0.0 110.048 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.454 ' O ' HG12 ' A' ' 21' ' ' ILE . . . -158.64 103.06 1.72 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.115 -0.99 . . . . 0.0 109.969 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 14.0 t -114.53 166.58 11.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.037 -1.039 . . . . 0.0 110.278 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.717 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -149.63 143.32 25.45 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.558 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 77.5 171.41 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 0.0 109.16 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -52.17 141.74 24.84 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.683 ' CE2' HG21 ' A' ' 99' ' ' VAL . 0.3 OUTLIER 177.81 117.01 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -1.077 . . . . 0.0 109.134 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.68 125.14 53.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.975 . . . . 0.0 110.015 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.432 HG13 ' OE1' ' A' ' 41' ' ' GLN . 60.7 t -147.84 133.39 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.717 HG23 ' CD ' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -158.15 -62.81 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.001 -1.062 . . . . 0.0 110.598 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.717 ' CD ' HG23 ' A' ' 38' ' ' THR . 8.1 Cg_exo -50.89 133.08 39.24 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 120.87 1.047 . . . . 0.0 109.819 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 39' ' ' PRO . . . -30.39 81.76 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 111.593 0.219 . . . . 0.0 111.593 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.604 ' N ' ' O ' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -90.86 -30.71 16.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.269 -1.519 . . . . 0.0 109.31 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.5 -18.91 78.71 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -80.57 -62.44 1.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.152 -1.205 . . . . 0.0 109.371 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.8 m -60.1 -26.99 66.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 109.152 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.88 -46.43 24.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.0 109.312 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.65 -11.09 22.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 109.649 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.48 -28.15 14.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.63 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.437 ' HB1' HD12 ' A' ' 55' ' ' ILE . . . -66.62 -23.35 66.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.966 . . . . 0.0 109.643 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -70.05 -7.7 43.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.225 -0.922 . . . . 0.0 110.032 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -81.1 -70.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 109.721 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -96.58 175.87 6.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.181 -0.949 . . . . 0.0 109.561 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 56' ' ' ARG . . . -123.82 -2.98 8.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.723 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.613 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 43.5 t0 -80.24 -44.81 1.42 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.158 -0.964 . . . . 0.0 110.721 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.6 Cg_endo -65.37 -13.58 40.52 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.553 1.502 . . . . 0.0 110.575 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.798 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -102.55 -54.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.06 -1.025 . . . . 0.0 109.516 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.502 ' HG2' ' NH1' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -50.58 -22.7 2.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.41 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.573 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -114.93 117.82 31.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.653 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 1.9 m 83.83 -52.92 0.14 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.77 -0.581 . . . . 0.0 109.826 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.8 -145.71 21.02 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.91 ' CE2' HD11 ' A' ' 62' ' ' LEU . 6.1 p90 -146.94 -173.17 4.16 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.256 -1.144 . . . . 0.0 109.143 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 1.5 m-20 -139.49 165.19 27.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.153 -0.967 . . . . 0.0 110.028 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.91 HD11 ' CE2' ' A' ' 60' ' ' PHE . 2.4 mp -136.96 88.25 2.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.42 -0.8 . . . . 0.0 109.268 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . 82.3 -43.17 0.14 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.603 -0.686 . . . . 0.0 109.985 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.06 35.67 0.05 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.644 ' CG1' ' CE1' ' A' ' 67' ' ' TYR . 72.8 t -126.21 111.74 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -1.133 . . . . 0.0 109.447 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.72 86.47 6.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.171 -0.956 . . . . 0.0 110.606 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.644 ' CE1' ' CG1' ' A' ' 65' ' ' VAL . 10.2 m-30 -98.47 162.67 13.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.098 -1.001 . . . . 0.0 109.28 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.617 HG22 ' H ' ' A' ' 69' ' ' THR . 7.3 p -107.41 173.24 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.185 -0.947 . . . . 0.0 109.569 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.617 ' H ' HG22 ' A' ' 68' ' ' VAL . 46.6 m -127.39 109.34 11.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.48 3.14 14.83 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 109.6 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -135.21 89.07 2.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -0.94 . . . . 0.0 109.332 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.42 111.32 4.83 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -157.93 -45.55 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -0.9 . . . . 0.0 109.317 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -79.52 -94.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.412 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.444 ' NH1' ' CG ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -150.23 21.6 0.85 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 109.795 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.978 ' OG ' HG22 ' A' ' 89' ' ' VAL . 29.7 t -132.57 169.66 16.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.074 -1.016 . . . . 0.0 109.501 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.458 ' O ' HG22 ' A' ' 77' ' ' ILE . 23.5 mt -149.5 95.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.865 . . . . 0.0 109.441 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.485 ' HD2' HG23 ' A' ' 87' ' ' ILE . 3.4 m-85 -89.51 85.09 6.43 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -51.05 158.14 2.29 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.46 -173.83 3.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.612 -0.934 . . . . 0.0 108.83 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.45 -30.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.117 -0.989 . . . . 0.0 110.108 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 83' ' ' SER . . . 132.7 92.85 0.53 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 82' ' ' GLY . 0.8 OUTLIER 74.24 4.8 4.59 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.265 -1.138 . . . . 0.0 108.357 -178.3 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.48 148.62 29.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.495 -0.753 . . . . 0.0 109.086 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -168.62 174.44 43.3 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.6 p -132.76 138.09 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -1.159 . . . . 0.0 109.348 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.485 HG23 ' HD2' ' A' ' 78' ' ' TYR . 16.7 mm -98.93 81.21 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 110.021 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 7.6 p -96.8 107.89 20.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.123 -0.986 . . . . 0.0 109.007 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.978 HG22 ' OG ' ' A' ' 76' ' ' SER . 59.4 t -127.9 139.97 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 109.794 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.29 127.01 42.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.884 . . . . 0.0 109.219 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.761 HG22 HG12 ' A' ' 121' ' ' ILE . 3.0 p -100.85 -82.61 0.46 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.31 -0.869 . . . . 0.0 109.927 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.405 ' C ' ' HG2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -151.46 -42.34 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.945 . . . . 0.0 109.612 -179.689 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.644 ' C ' HD11 ' A' ' 24' ' ' LEU . 42.6 mmtt -139.64 40.42 2.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.605 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.595 ' N ' HD21 ' A' ' 24' ' ' LEU . 0.1 OUTLIER 173.25 161.35 0.14 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.912 . . . . 0.0 109.271 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 19.1 mt -133.56 146.72 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.082 -1.011 . . . . 0.0 109.743 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.006 HD13 ' CH2' ' A' ' 2' ' ' TRP . 0.3 OUTLIER -106.24 158.73 16.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.862 . . . . 0.0 108.807 179.396 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.877 ' CG2' HD13 ' A' ' 22' ' ' LEU . 57.4 t -145.44 71.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.946 . . . . 0.0 110.225 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -56.46 144.52 36.9 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.514 -1.835 . . . . 0.0 108.514 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.683 HG21 ' CE2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -144.75 113.33 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.72 -1.459 . . . . 0.0 109.711 -179.502 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.805 ' HB3' HG12 ' A' ' 16' ' ' VAL . 14.3 p90 -135.43 141.34 45.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.345 -0.847 . . . . 0.0 109.415 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -152.05 117.04 5.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.495 -0.753 . . . . 0.0 109.831 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.2 OUTLIER 160.73 -59.22 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.516 -0.74 . . . . 0.0 109.378 179.637 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 174.97 48.06 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.566 -0.709 . . . . 0.0 109.417 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.6 mt -105.91 129.74 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.368 -0.833 . . . . 0.0 108.843 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -66.08 137.43 95.79 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.725 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -65.96 -25.88 51.75 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.175 1.917 . . . . 0.0 110.403 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.09 0.52 88.57 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.5 m -92.66 -42.82 9.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.142 -1.21 . . . . 0.0 109.383 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 112' ' ' VAL . . . -90.09 -19.94 23.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.285 -0.885 . . . . 0.0 109.466 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.12 -24.38 58.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.722 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -81.89 -33.56 30.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.169 -0.957 . . . . 0.0 109.675 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.896 HG22 HD12 ' A' ' 116' ' ' LEU . 9.0 p -78.09 -18.71 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.115 -0.991 . . . . 0.0 109.508 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.774 HG13 ' HZ2' ' A' ' 2' ' ' TRP . 38.1 t -90.92 -23.18 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.928 . . . . 0.0 109.887 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -75.79 -38.69 57.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.139 -0.976 . . . . 0.0 109.911 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.69 -58.94 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.944 . . . . 0.0 109.764 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.896 HD12 HG22 ' A' ' 112' ' ' VAL . 15.1 mt -51.9 -24.17 5.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 109.511 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.905 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -73.64 -39.64 64.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 109.853 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -63.91 -16.72 62.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.013 . . . . 0.0 109.995 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -81.63 -56.46 4.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.041 -1.037 . . . . 0.0 109.755 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.472 ' HA ' HD23 ' A' ' 120' ' ' LEU . 6.1 mt -62.16 -50.15 72.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 109.663 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.905 HD12 ' O ' ' A' ' 117' ' ' ALA . 7.5 mt -59.93 -36.65 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.657 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.12 -14.98 81.74 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -127.09 -68.09 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.254 . . . . 0.0 110.15 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 120' ' ' LEU . . . -85.48 -106.68 0.69 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.348 -1.09 . . . . 0.0 109.166 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.666 ' HH2' HD22 ' A' ' 96' ' ' LEU . 29.9 p90 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.588 0.708 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 8.1 tt0 -81.3 -24.07 37.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 109.218 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.497 ' O ' HG22 ' A' ' 8' ' ' THR . 85.2 m -65.96 -64.89 0.76 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.375 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.84 ' HB3' HD23 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -50.7 -41.59 56.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -0.95 . . . . 0.0 108.895 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.655 ' HA ' HG23 ' A' ' 11' ' ' VAL . 1.2 t -49.44 -48.8 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.56 -0.713 . . . . 0.0 109.894 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.725 ' C ' HG22 ' A' ' 8' ' ' THR . 0.8 OUTLIER -87.52 55.49 3.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.851 -178.598 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.725 HG22 ' C ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER 170.53 -86.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.739 -1.225 . . . . 0.0 111.334 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.56 ' H ' HG23 ' A' ' 8' ' ' THR . 3.1 m-20 -88.45 -74.55 0.46 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.247 -0.908 . . . . 0.0 111.481 -178.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.84 HD23 ' HB3' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -27.54 -46.9 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.917 0.389 . . . . 0.0 111.467 -178.412 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.024 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 49.5 t -101.6 -28.65 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.861 -1.149 . . . . 0.0 110.669 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.615 ' C ' HG22 ' A' ' 13' ' ' THR . . . -45.17 -28.83 2.12 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 106.311 -2.716 . . . . 0.0 106.311 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.717 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.6 OUTLIER -176.28 -39.68 0.01 OUTLIER 'General case' 0 C--O 1.193 -1.9 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.575 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.722 ' O ' ' HB3' ' A' ' 15' ' ' ALA . . . 10.43 44.22 0.0 OUTLIER Glycine 0 N--CA 1.509 3.557 0 C-N-CA 123.671 0.653 . . . . 0.0 112.838 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.903 ' O ' HG21 ' A' ' 104' ' ' ILE . . . 87.58 -34.47 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.941 HG12 ' HB3' ' A' ' 100' ' ' TYR . 35.8 m -120.51 139.08 48.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.771 HG23 ' HG2' ' A' ' 18' ' ' GLN . 9.9 t -79.96 13.3 2.28 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.833 -1.167 . . . . 0.0 109.395 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.771 ' HG2' HG23 ' A' ' 17' ' ' THR . 13.1 mm-40 -158.74 169.21 24.9 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 1.024 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . 173.59 140.95 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.494 -1.379 . . . . 0.0 110.822 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.516 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -136.1 142.34 44.28 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.548 HG13 HG21 ' A' ' 6' ' ' VAL . 2.7 mt -102.32 112.06 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.919 -1.113 . . . . 0.0 108.92 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.054 HD22 ' CG2' ' A' ' 97' ' ' VAL . 2.8 mp -98.46 160.37 14.33 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.527 -0.733 . . . . 0.0 109.089 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.92 -178.93 19.18 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.541 HD11 ' C ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -105.08 -48.46 3.72 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.295 -1.12 . . . . 0.0 109.139 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -136.76 40.11 2.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 109.306 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.06 25.22 2.23 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 1.2 m-20 61.43 -146.4 0.43 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.169 -1.194 . . . . 0.0 109.306 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.95 147.5 25.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.12 -0.987 . . . . 0.0 109.738 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -119.2 -26.49 5.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.379 -0.825 . . . . 0.0 109.145 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -178.44 159.22 1.17 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.391 -0.818 . . . . 0.0 109.372 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 1.1 t -160.22 171.54 19.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.314 -0.866 . . . . 0.0 109.503 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.647 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -178.54 82.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.333 -0.854 . . . . 0.0 109.165 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.04 -69.71 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.856 . . . . 0.0 109.566 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 167.85 -37.78 0.22 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.533 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 14.8 p90 -97.12 160.22 14.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.12 . . . . 0.0 109.482 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.03 -168.91 1.36 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.366 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.717 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 16.4 t -142.85 97.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.343 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.43 HG23 ' H ' ' A' ' 38' ' ' THR . 9.7 p -62.34 143.99 95.36 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.41 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 2.5 Cg_endo -61.59 114.92 2.46 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.193 1.929 . . . . 0.0 110.358 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 39' ' ' PRO . . . 174.77 -77.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.335 -0.853 . . . . 0.0 109.402 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.407 ' NE2' ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -67.59 -11.69 58.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.527 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.33 -43.72 95.49 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.3 -33.9 73.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -1.124 . . . . 0.0 108.936 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.2 m -50.05 -45.76 52.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.295 -0.878 . . . . 0.0 108.799 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.551 ' CD2' HG21 ' A' ' 95' ' ' ILE . 1.3 mp -54.95 -42.16 71.97 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.13 -38.22 73.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.407 -0.808 . . . . 0.0 108.869 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.93 -26.87 63.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.509 -0.745 . . . . 0.0 109.084 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.604 ' HB1' HD11 ' A' ' 55' ' ' ILE . . . -64.61 -20.2 66.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.371 -0.83 . . . . 0.0 109.334 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.603 ' CE1' ' CE ' ' A' ' 90' ' ' LYS . 22.2 m-85 -59.21 -14.54 11.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 109.365 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -79.58 -68.07 0.7 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 109.677 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -148.37 17.99 1.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.13 -0.981 . . . . 0.0 109.872 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 51' ' ' ASN . . . 36.08 32.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.278 0.561 . . . . 0.0 109.977 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.615 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 39.1 t70 -70.61 -43.98 16.52 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 111.004 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 5.3 Cg_exo -61.55 -10.96 18.02 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.381 1.387 . . . . 0.0 110.796 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.604 HD11 ' HB1' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -106.71 -31.25 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.053 -1.029 . . . . 0.0 109.573 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.437 ' CG ' ' HA ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -90.16 20.1 4.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 109.501 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.81 4.57 11.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.55 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 172.5 -55.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.518 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.67 -172.85 33.13 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 67' ' ' TYR . 33.4 p90 -132.46 170.44 15.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -1.164 . . . . 0.0 109.407 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.407 ' HB3' ' NE2' ' A' ' 41' ' ' GLN . 0.2 OUTLIER -122.29 136.93 54.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.567 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.53 ' CD2' HG13 ' A' ' 37' ' ' VAL . 0.6 OUTLIER -103.48 -161.51 0.84 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.248 -0.907 . . . . 0.0 108.93 179.753 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 37' ' ' VAL . . . -46.33 -40.5 11.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.106 -0.996 . . . . 0.0 109.263 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.74 33.63 0.16 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.17 138.02 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -1.108 . . . . 0.0 109.66 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -96.09 142.24 28.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 109.389 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 60' ' ' PHE . 17.3 m-85 -141.76 162.6 35.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.212 -0.93 . . . . 0.0 109.44 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.9 t -121.49 149.2 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.299 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.659 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -138.67 103.54 4.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.466 -179.781 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.745 ' H ' HD23 ' A' ' 70' ' ' LEU . 2.3 pt? -103.08 8.11 38.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.147 -0.97 . . . . 0.0 109.607 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 51.47 0.99 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.305 -0.872 . . . . 0.0 109.022 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.659 ' HB2' ' CG2' ' A' ' 69' ' ' THR . . . -94.88 130.2 41.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.852 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.46 -172.34 4.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.388 -0.82 . . . . 0.0 109.03 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.16 40.04 0.89 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.047 -1.033 . . . . 0.0 109.679 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.552 ' HG2' ' NH1' ' A' ' 75' ' ' ARG . 2.3 tpt180 -145.28 -72.29 0.25 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 108.957 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -113.54 154.1 27.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.352 -0.842 . . . . 0.0 108.738 179.369 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.704 HG22 ' O ' ' A' ' 77' ' ' ILE . 47.1 mt -156.96 58.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.935 -1.103 . . . . 0.0 110.376 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.559 ' CE2' ' CG2' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -94.36 102.59 14.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.087 . . . . 0.0 108.858 179.167 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.491 ' H ' HG13 ' A' ' 86' ' ' VAL . . . -75.05 175.48 50.64 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.45 133.52 16.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -1.094 . . . . 0.0 109.256 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 0.6 OUTLIER -127.51 70.06 1.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 109.762 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 83' ' ' SER . . . 50.85 -118.13 6.08 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 82' ' ' GLY . 3.8 t -44.59 -84.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -1.212 . . . . 0.0 109.525 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . . . -90.04 156.15 18.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.132 -0.98 . . . . 0.0 109.581 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.462 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -147.92 179.31 24.9 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.567 HG22 HG23 ' A' ' 88' ' ' THR . 7.9 p -112.14 159.25 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.062 -1.258 . . . . 0.0 109.974 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.739 HG21 HG21 ' A' ' 113' ' ' VAL . 14.4 mm -141.83 96.43 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.672 HG22 ' HA ' ' A' ' 97' ' ' VAL . 18.8 p -124.19 153.67 41.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.746 -1.222 . . . . 0.0 110.834 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.909 ' HB ' HD21 ' A' ' 96' ' ' LEU . 57.4 t -150.21 135.66 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.835 ' HD3' HG23 ' A' ' 95' ' ' ILE . 10.9 mmtm -91.54 150.38 21.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.897 . . . . 0.0 109.65 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.5 p -142.55 -168.18 2.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 108.959 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 m -47.58 -25.63 1.2 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.248 -0.907 . . . . 0.0 109.109 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.541 ' C ' HD11 ' A' ' 24' ' ' LEU . 5.1 mttt 178.4 67.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -0.824 . . . . 0.0 109.345 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.465 ' HB2' ' CD2' ' A' ' 125' ' ' PHE . 0.6 OUTLIER -173.97 145.9 1.15 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.507 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.835 HG23 ' HD3' ' A' ' 90' ' ' LYS . 3.8 mt -136.14 85.22 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.158 -0.964 . . . . 0.0 109.23 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.909 HD21 ' HB ' ' A' ' 89' ' ' VAL . 0.3 OUTLIER -61.12 165.27 4.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.478 -0.764 . . . . 0.0 109.119 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 1.054 ' CG2' HD22 ' A' ' 22' ' ' LEU . 58.7 t -143.38 47.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.192 -0.942 . . . . 0.0 110.143 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -41.05 130.7 3.39 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.752 HG23 ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -126.22 118.59 51.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.786 -1.42 . . . . 0.0 108.652 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.941 ' HB3' HG12 ' A' ' 16' ' ' VAL . 38.1 p90 -106.51 -179.1 3.84 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.084 -1.01 . . . . 0.0 109.829 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 84' ' ' ALA . 6.4 t-20 -135.06 -155.1 0.62 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 110.029 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -36.96 80.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.484 -0.76 . . . . 0.0 110.053 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.66 -49.99 55.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.95 . . . . 0.0 109.885 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.903 HG21 ' O ' ' A' ' 15' ' ' ALA . 4.3 mp -99.87 150.38 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.131 -0.981 . . . . 0.0 109.754 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -117.42 155.46 50.1 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.393 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.04 -166.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.234 1.956 . . . . 0.0 110.252 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 53.97 21.86 18.31 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.6 m -156.6 -41.15 0.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -1.105 . . . . 0.0 109.072 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.617 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -85.39 -12.88 51.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.358 -0.839 . . . . 0.0 109.133 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.43 -39.01 23.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.414 -0.804 . . . . 0.0 109.45 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -65.1 -40.01 93.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.748 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.483 HG11 ' HB2' ' A' ' 15' ' ' ALA . 5.3 p -69.88 -25.22 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.187 -0.946 . . . . 0.0 109.508 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.739 HG21 HG21 ' A' ' 87' ' ' ILE . 73.1 t -82.57 -25.06 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.204 -0.935 . . . . 0.0 109.474 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -70.55 -35.93 73.38 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.166 -0.959 . . . . 0.0 109.406 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 116' ' ' LEU . 2.5 ptpt -81.52 -39.38 24.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 109.647 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.504 ' N ' ' HG3' ' A' ' 115' ' ' LYS . 59.7 tp -50.83 -33.8 25.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 109.433 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 1.024 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -79.97 -34.5 38.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.325 -0.859 . . . . 0.0 109.592 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -62.76 -12.17 22.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.028 . . . . 0.0 109.577 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 30.7 t80 -90.31 -54.27 4.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 109.896 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.7 ' C ' HD12 ' A' ' 120' ' ' LEU . 0.8 OUTLIER -63.94 -34.47 78.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.0 110.098 -179.642 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.024 HD12 ' O ' ' A' ' 117' ' ' ALA . 5.7 mt -63.2 -13.65 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 121' ' ' ILE . . . -46.06 -27.73 2.66 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -103.26 -65.89 0.97 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.422 -1.046 . . . . 0.0 109.205 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.11 109.17 2.73 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.465 ' CD2' ' HB2' ' A' ' 94' ' ' SER . 22.5 m-85 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.171 -1.194 . . . . 0.0 109.524 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.76 ' CD1' HD23 ' A' ' 10' ' ' LEU . 41.8 m95 . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 121.097 0.475 . . . . 0.0 109.723 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -89.98 -86.01 0.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 110.319 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.74 -16.87 2.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.242 -0.911 . . . . 0.0 110.203 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 2.1 m-30 -88.91 -33.92 17.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.026 -1.046 . . . . 0.0 109.747 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.642 HG22 HG21 ' A' ' 11' ' ' VAL . 1.2 t -56.0 -43.25 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.183 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.63 46.49 1.34 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.387 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 9' ' ' ASN . 67.7 m -158.52 -101.58 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.703 -1.248 . . . . 0.0 110.609 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.604 ' N ' HG22 ' A' ' 8' ' ' THR . 2.2 t-20 -102.1 -72.2 0.69 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.111 -0.993 . . . . 0.0 111.346 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.76 HD23 ' CD1' ' A' ' 2' ' ' TRP . 2.2 mp -25.67 -39.17 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.642 HG21 HG22 ' A' ' 6' ' ' VAL . 1.7 t -82.11 -66.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.559 -1.338 . . . . 0.0 110.341 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.758 ' C ' HG22 ' A' ' 13' ' ' THR . . . -40.24 -33.83 0.55 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.758 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 156.37 39.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.624 0.726 . . . . 0.0 109.357 179.181 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.709 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -83.31 14.28 40.82 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 107.412 -2.275 . . . . 0.0 107.412 177.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 156.93 -25.04 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.605 HG12 ' HB3' ' A' ' 100' ' ' TYR . 17.1 m -138.08 152.67 26.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.425 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -81.85 14.86 2.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.978 -1.076 . . . . 0.0 109.127 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER 173.28 -178.37 0.08 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.533 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . 178.95 160.52 0.66 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.828 -1.17 . . . . 0.0 109.88 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -155.59 127.41 7.46 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.236 -0.915 . . . . 0.0 110.239 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.72 HD11 ' C ' ' A' ' 2' ' ' TRP . 2.2 mm -87.73 78.67 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.004 HD13 HG21 ' A' ' 97' ' ' VAL . 8.8 mp -52.66 164.22 0.38 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.513 -0.742 . . . . 0.0 109.631 -178.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.618 ' O ' HD12 ' A' ' 95' ' ' ILE . . . -106.22 159.49 15.04 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.778 HD11 ' C ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -110.76 -28.13 8.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -1.087 . . . . 0.0 109.275 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.69 6.38 12.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.828 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -136.56 -86.68 0.2 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.467 ' O ' ' OG1' ' A' ' 28' ' ' THR . 6.7 p30 -170.23 -46.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.356 -1.085 . . . . 0.0 109.281 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 27' ' ' ASN . 34.1 m -170.68 127.86 0.77 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 109.567 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.527 ' CZ2' ' O ' ' A' ' 93' ' ' LYS . 26.1 m0 -84.05 -58.11 2.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.383 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.97 169.78 16.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.347 -0.845 . . . . 0.0 109.304 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -160.48 174.47 14.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 109.978 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.525 ' OG ' HG13 ' A' ' 6' ' ' VAL . 3.1 m -154.28 99.49 2.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.337 -0.852 . . . . 0.0 109.374 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 32' ' ' SER . . . 42.64 -152.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.416 -0.803 . . . . 0.0 109.524 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.458 ' N ' ' HG2' ' A' ' 18' ' ' GLN . . . 90.52 -145.74 18.15 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.563 ' CE2' HG11 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -103.43 169.26 8.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -1.139 . . . . 0.0 109.471 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.22 116.73 29.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.321 -0.862 . . . . 0.0 109.244 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.1 t -79.4 122.23 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.157 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.9 m -75.67 132.88 74.26 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.92 . . . . 0.0 109.48 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.736 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 3.4 Cg_exo -59.13 171.36 2.31 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.941 1.761 . . . . 0.0 109.778 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 39' ' ' PRO . . . 83.56 -46.3 0.12 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.672 -0.643 . . . . 0.0 109.379 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.92 -30.46 68.93 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.146 -0.971 . . . . 0.0 109.02 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.79 -32.79 48.38 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -67.03 -37.7 84.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.376 -1.073 . . . . 0.0 108.874 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.8 m -63.78 -29.86 71.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 108.807 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.529 ' HG ' ' CZ ' ' A' ' 49' ' ' PHE . 11.8 tp -70.89 -39.03 73.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.349 -0.844 . . . . 0.0 109.172 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.09 -46.91 79.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.325 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -24.58 66.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.372 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.85 92.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.268 -0.895 . . . . 0.0 109.15 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.529 ' CZ ' ' HG ' ' A' ' 45' ' ' LEU . 2.9 m-30 -68.94 85.66 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.369 -0.832 . . . . 0.0 109.213 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.53 -64.03 0.22 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.64 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 53' ' ' ASP . 9.8 t30 -136.66 19.17 3.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.36 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 51' ' ' ASN . . . 41.97 26.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.55 -0.719 . . . . 0.0 109.954 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.566 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -80.88 -53.58 0.8 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.068 -1.02 . . . . 0.0 110.403 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 3.4 Cg_exo -62.34 -22.47 74.15 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.067 1.845 . . . . 0.0 110.893 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -94.61 -51.76 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.862 -1.149 . . . . 0.0 109.238 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -45.09 -27.0 0.52 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.963 . . . . 0.0 108.748 179.577 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . -115.68 -165.59 1.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.474 -0.766 . . . . 0.0 109.055 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 57' ' ' ALA . 75.0 m 44.37 -95.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.193 -0.942 . . . . 0.0 109.536 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 57' ' ' ALA . . . 164.43 175.0 34.82 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.454 ' HB3' ' HB2' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -80.32 155.54 27.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.393 -1.063 . . . . 0.0 109.38 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -154.07 101.92 2.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.048 -1.032 . . . . 0.0 110.061 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -98.73 -163.01 1.0 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 109.274 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.508 ' O ' HG23 ' A' ' 65' ' ' VAL . . . -61.56 94.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.976 . . . . 0.0 109.798 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.77 51.99 55.23 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.61 ' CG1' ' CE1' ' A' ' 67' ' ' TYR . 3.2 t -150.01 136.23 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.244 -1.151 . . . . 0.0 109.413 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -110.24 91.89 3.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 109.744 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.61 ' CE1' ' CG1' ' A' ' 65' ' ' VAL . 6.0 m-30 -100.68 -168.38 1.57 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.16 -0.963 . . . . 0.0 109.083 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 80' ' ' LYS . 4.4 p -131.06 176.59 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.992 -1.068 . . . . 0.0 109.522 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.852 HG22 ' HB2' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -136.69 69.42 1.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 109.535 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 70' ' ' LEU . 15.1 tp -89.66 2.21 55.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.125 -0.984 . . . . 0.0 109.216 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.468 ' NH1' ' HG3' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -144.93 69.67 1.26 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.36 -0.838 . . . . 0.0 108.85 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.852 ' HB2' HG22 ' A' ' 69' ' ' THR . . . -118.69 91.72 3.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.898 . . . . 0.0 110.125 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -98.49 -162.81 0.98 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.336 -0.852 . . . . 0.0 108.857 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -101.44 41.36 1.21 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.074 -1.016 . . . . 0.0 109.373 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.462 ' NH1' ' CG ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -150.42 -53.64 0.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.816 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.602 ' HA ' HG12 ' A' ' 89' ' ' VAL . 27.0 m -131.85 136.67 47.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 0.0 109.986 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 77' ' ' ILE . 11.1 mt -99.92 72.93 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.576 ' OH ' HD11 ' A' ' 87' ' ' ILE . 2.5 t80 -89.6 82.2 6.39 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.422 -0.799 . . . . 0.0 109.193 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.409 ' O ' ' HG2' ' A' ' 80' ' ' LYS . . . -89.08 176.0 43.54 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.751 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -150.61 -170.74 3.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.335 -1.097 . . . . 0.0 109.697 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -164.65 25.09 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.428 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.1 -78.57 1.7 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 102' ' ' GLU . 1.9 m -81.92 -38.89 24.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -1.157 . . . . 0.0 109.863 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -126.6 164.56 20.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.987 . . . . 0.0 109.538 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -159.08 162.48 32.71 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.482 HG22 HG23 ' A' ' 88' ' ' THR . 14.9 p -123.79 151.45 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.367 -1.078 . . . . 0.0 109.61 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.576 HD11 ' OH ' ' A' ' 78' ' ' TYR . 54.9 mt -124.8 88.84 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.366 -0.834 . . . . 0.0 108.86 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 41.6 p -105.76 129.33 53.98 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.048 -1.033 . . . . 0.0 109.992 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 76' ' ' SER . 6.1 m -145.23 150.94 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.572 -0.705 . . . . 0.0 109.554 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -97.52 122.67 40.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.202 -0.936 . . . . 0.0 109.653 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -58.15 2.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 109.143 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -175.24 -36.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.807 . . . . 0.0 109.184 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.778 ' C ' HD11 ' A' ' 24' ' ' LEU . 10.3 mttm -145.67 28.51 1.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.842 . . . . 0.0 109.497 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.739 ' N ' HD21 ' A' ' 24' ' ' LEU . 58.3 m -161.3 168.89 23.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.894 . . . . 0.0 109.468 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.618 HD12 ' O ' ' A' ' 23' ' ' GLY . 83.5 mt -125.43 123.86 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.113 -0.992 . . . . 0.0 109.371 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.74 HD11 ' CE3' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -81.54 155.47 25.72 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.462 -0.774 . . . . 0.0 109.903 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 1.004 HG21 HD13 ' A' ' 22' ' ' LEU . 48.2 t -151.43 54.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.665 -0.647 . . . . 0.0 109.695 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -55.53 113.88 4.26 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.563 HG11 ' CE2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -111.3 122.95 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.058 -1.26 . . . . 0.0 109.425 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.605 ' HB3' HG12 ' A' ' 16' ' ' VAL . 2.8 p90 -131.72 178.12 7.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 109.66 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -121.69 -167.41 1.52 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.69 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -68.07 -17.76 64.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.702 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.12 -10.98 25.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.946 . . . . 0.0 109.446 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.585 HD13 ' O ' ' A' ' 15' ' ' ALA . 28.2 mt -125.63 158.59 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.15 -0.969 . . . . 0.0 109.777 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.533 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 7.3 mt-30 -139.61 160.08 62.77 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.442 -0.786 . . . . 0.0 109.009 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 105' ' ' GLN . 5.9 Cg_exo -56.27 165.0 4.61 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.928 1.752 . . . . 0.0 110.129 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.21 -28.01 17.33 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.7 m -115.55 -48.63 2.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.448 -1.031 . . . . 0.0 109.235 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.621 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -87.36 -19.28 28.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.882 . . . . 0.0 109.279 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.446 ' HA ' ' CE2' ' A' ' 78' ' ' TYR . . . -85.55 -52.07 6.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.304 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -60.69 -36.19 78.16 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.432 -0.792 . . . . 0.0 109.79 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 13.4 p -65.27 -37.14 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.191 -0.943 . . . . 0.0 109.378 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 87' ' ' ILE . 93.9 t -73.62 -16.02 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.212 -0.93 . . . . 0.0 109.701 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.9 -44.79 38.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.004 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.499 ' HG3' ' N ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -84.62 -46.86 11.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.108 -0.995 . . . . 0.0 110.069 -179.49 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.605 HD22 HD21 ' A' ' 10' ' ' LEU . 2.6 mp -54.27 -32.65 56.75 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.138 -0.976 . . . . 0.0 109.813 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.728 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -72.93 -43.11 62.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -0.946 . . . . 0.0 109.755 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -57.8 -20.99 39.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.85 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -90.08 -56.18 3.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.08 -1.013 . . . . 0.0 109.982 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -73.44 -0.6 15.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.157 -0.964 . . . . 0.0 109.838 -179.604 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.728 HD12 ' O ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER -64.24 -39.08 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.984 -1.072 . . . . 0.0 108.797 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -121.73 45.51 1.21 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -143.11 -73.57 0.28 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.082 -1.246 . . . . 0.0 110.018 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.483 ' H ' HD23 ' A' ' 120' ' ' LEU . . . -123.18 -18.46 3.11 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.517 ' CE2' ' HG3' ' A' ' 93' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.202 -1.175 . . . . 0.0 109.374 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.985 ' CZ2' HD11 ' A' ' 96' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.49 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 2.5 tt0 -63.56 -51.34 65.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.313 -0.867 . . . . 0.0 109.753 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.403 HG22 ' H ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -54.12 -40.45 67.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 109.233 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.89 ' HB3' HD12 ' A' ' 10' ' ' LEU . 22.1 m-30 -61.9 -33.69 74.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.095 -1.003 . . . . 0.0 108.417 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.719 HG21 HG13 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -62.15 -56.89 14.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.643 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.494 ' N ' HG12 ' A' ' 6' ' ' VAL . 58.9 m-20 -91.64 50.47 1.72 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.05 -1.032 . . . . 0.0 110.314 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 9' ' ' ASN . 65.7 m -156.19 -100.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.77 -1.206 . . . . 0.0 110.78 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.622 ' N ' HG22 ' A' ' 8' ' ' THR . 0.8 OUTLIER -101.53 -56.48 2.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.084 -1.01 . . . . 0.0 111.075 -178.354 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.993 HD11 HD13 ' A' ' 116' ' ' LEU . 6.6 mt -38.16 -30.22 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.142 -0.974 . . . . 0.0 111.158 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.032 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 47.5 t -101.25 -52.27 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.764 -1.21 . . . . 0.0 110.065 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.764 ' C ' HG22 ' A' ' 13' ' ' THR . . . -40.14 -42.29 2.32 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.764 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 161.18 43.68 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.789 -0.83 . . . . 0.0 109.322 178.437 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.717 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -85.69 15.01 49.46 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 177.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.718 ' HB2' HG11 ' A' ' 112' ' ' VAL . . . 155.68 -27.83 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.638 HG12 ' CD1' ' A' ' 100' ' ' TYR . 5.6 m -139.4 155.34 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.652 HG22 ' HA ' ' A' ' 100' ' ' TYR . 14.7 t -87.18 21.66 2.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.896 -1.128 . . . . 0.0 108.877 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.921 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -178.45 -176.81 0.52 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 1.032 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . 175.33 154.65 0.16 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.273 -0.892 . . . . 0.0 109.127 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.507 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -148.27 136.83 21.52 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.244 -0.91 . . . . 0.0 109.68 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.719 HG13 HG21 ' A' ' 6' ' ' VAL . 1.6 mt -106.61 101.68 12.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.811 HD11 HG21 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -84.95 22.83 1.31 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.389 -0.819 . . . . 0.0 110.269 -178.089 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.502 ' O ' HD12 ' A' ' 95' ' ' ILE . . . 47.43 -164.42 0.18 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.738 HD11 ' C ' ' A' ' 93' ' ' LYS . 1.1 mt -98.34 -74.33 0.59 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.388 -1.066 . . . . 0.0 109.114 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -135.15 22.04 3.47 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.307 -0.87 . . . . 0.0 108.832 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.7 67.97 0.25 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.5 t30 48.7 -150.25 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -1.108 . . . . 0.0 109.737 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 60.8 m -94.12 139.26 31.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.812 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -96.67 -65.31 0.97 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.441 ' C ' HG23 ' A' ' 31' ' ' THR . . . -137.53 160.11 40.07 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.441 HG23 ' C ' ' A' ' 30' ' ' ALA . 77.4 p -155.13 137.35 14.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.041 -1.037 . . . . 0.0 110.119 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . 1.008 ' CB ' HG21 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -108.81 115.78 30.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.516 -0.74 . . . . 0.0 109.068 179.578 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 82.38 166.69 0.13 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 35' ' ' PHE . . . -48.41 -96.9 0.01 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.957 ' CE1' HG11 ' A' ' 99' ' ' VAL . 4.9 t80 74.35 84.99 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.315 -1.109 . . . . 0.0 109.901 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.09 105.69 17.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 109.356 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 37' ' ' VAL . 59.7 t -108.05 56.3 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.655 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.562 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 57.58 156.43 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.269 -0.894 . . . . 0.0 109.851 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.562 ' HD2' HG22 ' A' ' 38' ' ' THR . 2.7 Cg_endo -62.17 -36.52 68.78 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.294 1.996 . . . . 0.0 110.197 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' A' ' 43' ' ' GLN . . . -83.82 60.69 5.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.838 . . . . 0.0 109.442 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.539 ' CG ' ' HB ' ' A' ' 37' ' ' VAL . 2.2 mt-30 -66.44 -47.83 71.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.681 -1.262 . . . . 0.0 110.111 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -76.64 -29.04 58.32 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.784 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.618 ' HB2' ' HB1' ' A' ' 40' ' ' ALA . 3.4 mt-30 -81.48 -62.86 1.53 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.97 -1.312 . . . . 0.0 109.84 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.3 m -45.84 -50.76 13.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.84 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -66.45 -30.99 71.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.154 -0.966 . . . . 0.0 109.749 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -71.03 -18.59 62.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.4 t -74.66 -52.61 11.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -0.872 . . . . 0.0 109.659 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.51 -21.72 52.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.194 -0.941 . . . . 0.0 109.543 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.583 ' CE2' ' CG ' ' A' ' 90' ' ' LYS . 4.2 m-30 -65.88 -37.08 85.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.432 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -88.28 -74.69 0.45 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 109.587 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -71.9 119.25 15.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.172 -0.955 . . . . 0.0 109.521 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.412 ' C ' HG12 ' A' ' 55' ' ' ILE . . . -104.19 17.52 23.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.113 -0.992 . . . . 0.0 109.056 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.589 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -76.61 -50.14 2.66 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.456 -0.777 . . . . 0.0 110.372 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 4.2 Cg_exo -62.82 -8.17 12.94 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.976 1.784 . . . . 0.0 110.933 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.788 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -104.96 -44.05 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.041 -1.037 . . . . 0.0 109.497 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.534 ' CD ' ' HA ' ' A' ' 53' ' ' ASP . 8.3 ptm180 -61.98 -22.15 65.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 109.948 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.427 ' C ' ' OG ' ' A' ' 58' ' ' SER . . . -107.73 108.11 19.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 109.907 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.427 ' OG ' ' C ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER 72.25 -79.52 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.432 -0.792 . . . . 0.0 109.882 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.88 -138.97 5.76 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.618 ' HE1' HD12 ' A' ' 62' ' ' LEU . 20.5 p90 -155.39 172.5 18.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -1.11 . . . . 0.0 109.573 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.12 160.29 14.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 109.092 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.619 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 3.4 mt -159.57 98.45 1.38 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.924 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . 74.99 -78.22 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.646 -0.659 . . . . 0.0 110.041 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -159.08 23.28 0.31 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 66' ' ' HIS . 66.5 t -137.48 157.36 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -1.145 . . . . 0.0 109.207 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.487 ' CE1' ' HD2' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -100.25 152.66 20.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.153 -0.967 . . . . 0.0 109.472 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.561 ' CE2' ' HB2' ' A' ' 62' ' ' LEU . 92.2 m-85 -137.61 149.44 46.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 109.525 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 69' ' ' THR . 0.9 OUTLIER -93.54 -156.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 109.241 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.552 ' H ' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -161.88 75.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.94 . . . . 0.0 109.5 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.11 12.15 31.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.907 . . . . 0.0 109.44 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -156.92 64.14 0.51 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.709 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 69' ' ' THR . . . -106.21 90.32 3.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 109.062 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.88 -108.05 0.35 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.107 -0.996 . . . . 0.0 109.791 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -121.6 -34.12 3.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.778 -1.201 . . . . 0.0 110.648 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.53 ' HG2' ' NH1' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -134.74 31.7 3.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.887 -1.133 . . . . 0.0 110.878 -178.703 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.55 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 1.2 m -150.57 116.24 5.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.984 -1.073 . . . . 0.0 109.476 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 77' ' ' ILE . 3.6 mp -144.79 50.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 0.0 109.557 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.653 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -91.01 91.5 8.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.092 -1.005 . . . . 0.0 108.612 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.33 170.65 53.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.511 ' HG2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -151.04 147.36 27.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.54 -0.976 . . . . 0.0 109.11 179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.511 ' N ' ' HG2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -124.7 -170.84 2.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.989 -1.069 . . . . 0.0 109.682 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.29 5.41 77.26 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -154.82 -67.98 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -1.098 . . . . 0.0 108.887 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 81' ' ' LYS . . . -91.7 164.42 13.73 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.506 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -156.71 150.23 21.35 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.538 -1.315 . . . . 0.0 109.908 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.8 p -122.32 147.37 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.329 -1.101 . . . . 0.0 109.448 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.653 HG23 ' HD2' ' A' ' 78' ' ' TYR . 11.9 mt -120.75 94.02 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 39.2 p -113.29 133.56 55.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.981 -1.074 . . . . 0.0 110.716 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.594 HG13 ' HB2' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -151.33 152.66 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.042 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.583 ' CG ' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -97.95 117.69 32.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.901 -179.428 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.854 HG21 ' HZ3' ' A' ' 2' ' ' TRP . 0.8 OUTLIER -96.38 -69.17 0.77 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 108.764 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 91' ' ' THR . 1.9 m 157.7 -24.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.738 ' C ' HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -110.99 -12.33 14.23 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.444 -0.785 . . . . 0.0 109.256 179.713 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.484 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -172.5 168.73 5.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.81 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.502 HD12 ' O ' ' A' ' 23' ' ' GLY . 34.1 mt -105.78 134.64 46.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.398 -0.814 . . . . 0.0 108.973 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.985 HD11 ' CZ2' ' A' ' 2' ' ' TRP . 1.6 mt -88.96 148.26 23.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 110.249 -179.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.811 HG21 HD11 ' A' ' 22' ' ' LEU . 75.4 t -151.33 58.55 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.458 -0.776 . . . . 0.0 109.632 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -55.57 112.58 3.15 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.957 HG11 ' CE1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.81 125.52 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.992 -1.299 . . . . 0.0 109.119 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.735 ' HB2' HD12 ' A' ' 104' ' ' ILE . 3.8 p90 -138.82 -178.3 5.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.941 . . . . 0.0 110.14 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -105.19 -147.3 0.39 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.443 -0.785 . . . . 0.0 109.675 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 83' ' ' SER . 46.8 tt0 -102.91 -29.95 11.12 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.166 -0.959 . . . . 0.0 109.948 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -16.06 23.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 110.193 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.735 HD12 ' HB2' ' A' ' 100' ' ' TYR . 16.7 mt -85.68 141.3 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.058 -1.026 . . . . 0.0 109.395 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.51 110.0 2.17 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.394 -0.816 . . . . 0.0 109.631 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 104' ' ' ILE . 1.2 Cg_endo -65.69 145.84 82.42 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.092 1.862 . . . . 0.0 110.27 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.33 -43.81 3.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.8 m -74.63 -30.9 61.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -1.184 . . . . 0.0 109.483 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.808 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -63.54 -45.02 92.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.874 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.09 -32.52 67.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.146 -0.971 . . . . 0.0 109.846 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 7.4 t-20 -67.73 -32.54 73.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 0.0 109.724 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.718 HG11 ' HB2' ' A' ' 15' ' ' ALA . 1.3 t -79.86 -28.0 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.146 -0.971 . . . . 0.0 109.421 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 109' ' ' ALA . 18.2 t -82.83 -17.92 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.952 . . . . 0.0 109.694 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.471 ' CD ' ' CZ ' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -78.16 -37.17 46.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.158 -0.964 . . . . 0.0 109.765 -179.697 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 111' ' ' ASN . 1.5 mmmt -71.73 -46.3 59.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.122 -0.986 . . . . 0.0 109.864 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.993 HD13 HD11 ' A' ' 10' ' ' LEU . 3.2 tt -54.06 -34.22 59.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.931 -1.106 . . . . 0.0 109.162 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 1.0 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -62.55 -37.8 87.55 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.077 -1.014 . . . . 0.0 108.887 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -21.77 61.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.904 . . . . 0.0 109.6 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.603 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 0.0 OUTLIER -73.71 -40.73 63.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 109.879 -179.492 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.687 HD12 ' CE3' ' A' ' 2' ' ' TRP . 5.0 mt -81.04 -36.26 30.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.117 -0.989 . . . . 0.0 110.566 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.0 HD12 ' O ' ' A' ' 117' ' ' ALA . 1.5 mp -64.1 -21.58 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.103 -0.998 . . . . 0.0 109.596 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.538 ' O ' ' CG ' ' A' ' 123' ' ' GLN . . . -97.5 22.48 40.58 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 122' ' ' GLY . 45.7 mt-30 -162.41 -83.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -1.169 . . . . 0.0 109.809 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 125' ' ' PHE . . . -96.1 57.76 1.48 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.543 ' HB3' ' HB3' ' A' ' 92' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.411 -1.052 . . . . 0.0 109.977 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.825 ' CE2' HD22 ' A' ' 96' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.363 0.601 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -72.36 -28.68 63.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.051 -1.031 . . . . 0.0 109.986 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -38.99 86.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.07 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.542 ' HB3' ' HB2' ' A' ' 10' ' ' LEU . 14.6 m-85 -74.81 -23.94 58.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.138 -0.976 . . . . 0.0 109.862 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.911 HG21 HG13 ' A' ' 21' ' ' ILE . 2.0 t -72.47 -23.16 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.18 -0.95 . . . . 0.0 110.062 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -46.77 -91.21 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.023 -1.048 . . . . 0.0 110.359 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.69 -2.23 3.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 110.131 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 14' ' ' GLY . 6.5 m-20 -86.26 -87.06 0.14 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.085 -1.01 . . . . 0.0 109.262 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 2.0 mm? -54.59 -27.5 39.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.996 -1.065 . . . . 0.0 109.669 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.088 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 4.2 t -90.55 -63.8 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.178 -0.952 . . . . 0.0 109.694 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.754 ' C ' HG22 ' A' ' 13' ' ' THR . . . -39.78 -38.91 1.21 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.754 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 157.02 53.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.977 -0.72 . . . . 0.0 109.839 178.689 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.676 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -96.1 21.76 43.38 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 106.339 -2.704 . . . . 0.0 106.339 177.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 144.43 -28.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.901 HG13 ' HB3' ' A' ' 100' ' ' TYR . 4.3 t -131.72 140.5 48.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.517 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 0.2 OUTLIER -77.78 2.34 17.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.733 -1.229 . . . . 0.0 108.476 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.58 ' HB3' ' HB2' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -158.67 -173.68 4.4 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.359 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 1.088 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . 170.78 142.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.007 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -140.4 104.14 4.71 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.058 -1.026 . . . . 0.0 110.305 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.911 HG13 HG21 ' A' ' 6' ' ' VAL . 14.4 mt -79.61 106.01 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.612 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.4 OUTLIER -93.5 116.93 29.46 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.492 -0.755 . . . . 0.0 109.463 -178.317 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -49.72 -178.26 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.796 HD21 ' N ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -103.55 -68.94 0.82 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -1.141 . . . . 0.0 109.545 -179.75 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -113.66 11.83 18.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.269 -0.894 . . . . 0.0 109.543 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.71 -83.51 1.65 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -175.92 -65.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.417 -1.049 . . . . 0.0 109.401 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.6 m -158.62 156.54 30.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.94 . . . . 0.0 109.715 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -114.85 -69.97 0.83 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.354 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.444 ' O ' HG11 ' A' ' 6' ' ' VAL . . . -160.8 117.93 2.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.344 -0.848 . . . . 0.0 109.076 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 1.6 p -128.81 168.68 15.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.92 . . . . 0.0 109.81 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.4 ' HB2' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -171.71 98.32 0.18 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 109.238 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.58 ' HB2' ' HB3' ' A' ' 18' ' ' GLN . . . -166.7 -67.24 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.169 -0.957 . . . . 0.0 109.464 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 139.21 39.61 0.1 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.557 ' CG ' ' O ' ' A' ' 35' ' ' PHE . 1.4 p90 -155.64 117.95 4.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -1.175 . . . . 0.0 109.409 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.91 130.54 41.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.536 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -90.65 161.67 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.373 -0.829 . . . . 0.0 109.353 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -74.11 148.05 86.26 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.293 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.78 -31.91 78.14 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.125 1.883 . . . . 0.0 110.357 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.31 13.38 3.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.196 -0.94 . . . . 0.0 110.285 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 38' ' ' THR . 1.3 mm-40 -90.65 -32.43 16.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.907 -1.121 . . . . 0.0 109.485 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.86 -46.31 94.78 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -21.01 64.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.406 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 46.1 m -68.28 -34.69 76.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -41.84 75.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.367 -0.833 . . . . 0.0 109.445 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.52 -45.86 91.03 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.921 . . . . 0.0 109.021 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -81.55 -5.86 58.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.352 -0.842 . . . . 0.0 109.114 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.648 ' O ' HD11 ' A' ' 55' ' ' ILE . . . -69.09 -37.92 78.69 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.231 -0.918 . . . . 0.0 109.217 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 6.3 m-30 -74.96 81.89 2.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.52 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 2.1 t-20 -130.37 58.2 1.68 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 108.735 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 50' ' ' ASN . 5.2 t-20 84.77 17.84 0.15 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.578 0.704 . . . . 0.0 109.129 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 44.18 23.62 0.07 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.467 -0.771 . . . . 0.0 110.17 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.549 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -91.93 -53.65 0.27 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.067 -1.02 . . . . 0.0 110.638 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 2.4 Cg_endo -65.4 -7.71 16.76 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.994 1.796 . . . . 0.0 110.965 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.648 HD11 ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -109.08 -17.19 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.96 -1.088 . . . . 0.0 109.638 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.489 ' HG2' ' NH1' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -80.3 -46.8 15.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.449 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -107.32 63.47 0.63 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.505 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 4.7 t 167.68 -30.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.43 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.24 -153.3 31.69 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.448 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 6.3 p90 -151.84 -169.27 3.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -1.165 . . . . 0.0 109.169 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.77 146.75 28.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.092 -1.005 . . . . 0.0 110.556 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.5 -166.98 1.44 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.89 -22.08 46.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 109.383 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.72 -111.17 0.14 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 66' ' ' HIS . 1.2 t -125.76 -153.67 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -1.195 . . . . 0.0 109.293 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 47.1 p-80 -88.29 114.14 24.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.167 -0.958 . . . . 0.0 109.416 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.46 ' HA ' ' HB2' ' A' ' 81' ' ' LYS . 12.0 m-30 -95.13 162.95 13.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.586 HG12 ' N ' ' A' ' 69' ' ' THR . 26.1 t -111.3 169.13 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.897 . . . . 0.0 109.451 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.586 ' N ' HG12 ' A' ' 68' ' ' VAL . 91.6 m -122.33 130.94 53.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.909 . . . . 0.0 109.616 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.72 19.54 5.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.126 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -177.16 85.18 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.373 -0.829 . . . . 0.0 109.171 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.71 36.95 1.63 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 0.0 109.64 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.44 -25.86 13.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.28 -0.887 . . . . 0.0 109.446 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.489 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -90.62 -106.65 0.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -139.64 24.24 2.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.793 -1.192 . . . . 0.0 109.564 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -135.47 156.17 49.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -0.905 . . . . 0.0 109.338 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 77' ' ' ILE . 10.8 mt -149.27 68.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.174 -0.954 . . . . 0.0 109.429 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.651 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -94.17 95.26 8.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.904 . . . . 0.0 108.764 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -113.23 173.32 15.01 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 0.7 OUTLIER -151.23 -170.65 3.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -1.153 . . . . 0.0 109.334 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.507 ' HE2' ' NE2' ' A' ' 66' ' ' HIS . 0.3 OUTLIER 175.62 111.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.189 -0.944 . . . . 0.0 109.58 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.54 -135.0 11.91 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 102' ' ' GLU . 2.4 p -100.24 -4.62 29.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -1.192 . . . . 0.0 109.694 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . . . -113.35 166.95 10.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.368 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.566 ' HA3' ' CE1' ' A' ' 100' ' ' TYR . . . -150.22 157.18 27.09 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.689 ' CG2' HG13 ' A' ' 97' ' ' VAL . 11.9 p -135.53 136.64 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -1.18 . . . . 0.0 110.039 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.651 HG23 ' HD2' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -110.26 95.58 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.552 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 6.7 p -106.72 115.75 30.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 109.889 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.724 ' CG2' HD21 ' A' ' 96' ' ' LEU . 3.1 m -135.02 134.16 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 109.536 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.517 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -97.35 146.1 25.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.346 -0.846 . . . . 0.0 109.121 179.785 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.489 ' HB ' HG12 ' A' ' 121' ' ' ILE . 23.4 p -146.17 -145.31 0.17 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 109.913 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 91' ' ' THR . 0.1 OUTLIER -41.41 -74.58 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.295 -0.878 . . . . 0.0 110.548 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.769 ' O ' HD11 ' A' ' 24' ' ' LEU . 1.2 mtpt -149.72 52.85 0.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.993 . . . . 0.0 109.89 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.796 ' N ' HD21 ' A' ' 24' ' ' LEU . 21.2 t -169.86 151.25 4.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.925 . . . . 0.0 109.523 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.461 HD11 ' HD3' ' A' ' 90' ' ' LYS . 12.4 mt -129.32 128.53 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.179 -0.951 . . . . 0.0 109.256 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.825 HD22 ' CE2' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -98.96 154.39 18.11 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.327 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.689 HG13 ' CG2' ' A' ' 86' ' ' VAL . 59.0 t -137.36 64.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.129 -0.982 . . . . 0.0 109.578 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -50.05 118.28 5.66 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.663 ' O ' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -112.31 114.2 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.159 -1.2 . . . . 0.0 109.291 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.901 ' HB3' HG13 ' A' ' 16' ' ' VAL . 19.2 p90 -123.98 -168.78 1.84 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.248 -0.907 . . . . 0.0 109.672 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' ALA . 6.9 m120 -132.82 -168.52 2.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 83' ' ' SER . 16.1 pt-20 -66.28 -9.32 31.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.278 -0.889 . . . . 0.0 109.906 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -73.89 -17.54 61.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.917 . . . . 0.0 109.599 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 16' ' ' VAL . 9.5 mt -117.59 103.66 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.935 . . . . 0.0 109.504 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.475 ' HG2' ' HD2' ' A' ' 106' ' ' PRO . 1.7 tt0 -64.29 142.05 98.25 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.266 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.475 ' HD2' ' HG2' ' A' ' 105' ' ' GLN . 2.8 Cg_endo -61.55 152.58 72.45 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.04 1.827 . . . . 0.0 110.079 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.32 -23.05 23.67 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.1 m -98.08 -53.28 3.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -1.123 . . . . 0.0 109.569 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.761 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -73.77 -32.19 63.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.928 . . . . 0.0 109.465 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.44 -27.85 64.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 0.0 109.587 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.463 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -78.2 -49.28 14.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.715 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 7.5 p -59.26 -21.59 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -0.969 . . . . 0.0 109.523 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 109' ' ' ALA . 91.1 t -78.91 -33.32 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.785 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.463 ' OE2' ' HA ' ' A' ' 111' ' ' ASN . 26.3 mt-10 -59.57 -61.12 2.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.931 . . . . 0.0 109.439 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.29 -38.26 88.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.633 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 4.1 mt -57.97 -24.44 58.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.869 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -80.41 -29.74 37.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.289 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.35 -38.7 74.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.072 . . . . 0.0 109.4 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -75.43 -47.43 27.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 109.554 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.5 OUTLIER -60.92 -57.52 12.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 109.417 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.869 HD12 ' O ' ' A' ' 117' ' ' ALA . 15.7 mt -61.24 -13.81 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.467 -0.771 . . . . 0.0 109.941 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.74 -9.76 40.9 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -119.42 -56.27 2.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -1.185 . . . . 0.0 109.459 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 114.64 112.4 2.94 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.286 -1.126 . . . . 0.0 109.271 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.943 ' CZ3' HD22 ' A' ' 96' ' ' LEU . 47.7 m95 . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.84 -86.07 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.816 -1.178 . . . . 0.0 109.342 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -63.77 -37.94 89.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.032 -1.042 . . . . 0.0 108.984 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.604 ' CE2' ' HG ' ' A' ' 116' ' ' LEU . 18.7 m-30 -56.34 -39.26 72.56 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.381 -0.825 . . . . 0.0 109.769 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.549 HG21 ' HB1' ' A' ' 30' ' ' ALA . 1.2 t -54.44 -45.56 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.828 -1.17 . . . . 0.0 108.075 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.407 ' N ' HG12 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -91.62 41.12 1.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 110.919 -179.338 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.505 HG22 ' N ' ' A' ' 9' ' ' ASN . 88.8 m -146.06 -106.01 0.1 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.527 -1.358 . . . . 0.0 109.879 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.9 t-20 -102.1 -70.75 0.74 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.043 -1.036 . . . . 0.0 110.08 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.696 HD22 ' CD1' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -20.53 -45.34 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.929 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.775 HG23 ' HB3' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -77.39 -68.09 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.851 -1.156 . . . . 0.0 110.125 -179.291 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.769 ' C ' HG22 ' A' ' 13' ' ' THR . . . -38.99 -36.46 0.5 Allowed Glycine 0 N--CA 1.498 2.785 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.769 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 156.61 39.61 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.989 -0.712 . . . . 0.0 109.154 179.011 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.685 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -84.47 17.78 27.77 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 177.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 158.44 -32.04 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.749 HG12 ' HB3' ' A' ' 100' ' ' TYR . 31.2 m -138.88 150.55 23.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.565 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.6 OUTLIER -78.97 6.32 9.57 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.113 -0.992 . . . . 0.0 108.872 179.112 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.589 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 27.4 mt-30 -168.42 160.87 11.54 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.775 ' HB3' HG23 ' A' ' 11' ' ' VAL . . . -163.95 112.4 1.18 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.913 -1.117 . . . . 0.0 112.148 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.531 ' O ' HD13 ' A' ' 21' ' ' ILE . . . -98.32 144.53 27.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.263 -1.523 . . . . 0.0 109.957 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.787 ' C ' HD23 ' A' ' 22' ' ' LEU . 45.5 mm -124.07 111.55 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.417 -0.802 . . . . 0.0 109.136 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.874 HD11 HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -116.24 123.42 47.68 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.044 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.71 -158.62 14.79 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.74 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.572 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -106.63 -60.83 1.61 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.349 -1.089 . . . . 0.0 109.977 -179.504 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.83 6.87 14.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.976 -1.078 . . . . 0.0 108.725 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 28' ' ' THR . . . -143.04 88.4 0.18 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.02 -2.032 . . . . 0.0 108.02 179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' A' ' 26' ' ' GLY . 2.1 t30 -30.68 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.067 -0.666 . . . . 0.0 110.838 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 26' ' ' GLY . 12.3 m -166.56 104.23 0.61 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.05 -1.031 . . . . 0.0 109.845 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.51 ' NE1' ' HA3' ' A' ' 26' ' ' GLY . 19.6 m0 -79.4 -27.93 41.83 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.576 ' HB3' ' CG1' ' A' ' 21' ' ' ILE . . . -147.54 163.59 36.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t -143.98 155.84 44.18 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.11 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 96.6 p -64.63 -9.96 23.21 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.649 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 63.8 66.77 0.65 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.16 -87.47 0.07 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -94.24 148.34 22.3 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.218 -1.166 . . . . 0.0 109.212 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.12 148.57 38.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.599 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -103.29 132.8 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.278 -0.888 . . . . 0.0 109.625 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.1 p -72.04 149.24 92.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.92 . . . . 0.0 109.398 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.722 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 6.1 Cg_exo -60.15 177.62 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.184 1.923 . . . . 0.0 110.202 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 39' ' ' PRO . . . 83.37 -42.23 0.1 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.608 -0.682 . . . . 0.0 109.633 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -68.24 -31.81 71.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.058 -1.026 . . . . 0.0 109.569 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.09 -35.93 60.46 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -69.3 -33.96 73.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -1.173 . . . . 0.0 109.531 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.2 m -59.14 -31.73 69.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.412 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 mt -68.7 -40.58 79.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 109.398 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.62 -42.01 99.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.383 -0.823 . . . . 0.0 109.454 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.4 t -74.85 -9.98 59.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 109.562 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.38 -16.65 36.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.923 . . . . 0.0 109.729 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -81.89 -15.93 52.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.248 -0.907 . . . . 0.0 109.688 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -117.3 4.51 12.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.271 -0.893 . . . . 0.0 109.239 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -166.44 107.72 0.69 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -0.865 . . . . 0.0 109.468 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 56' ' ' ARG . . . -95.11 47.74 1.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.379 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.577 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -82.59 -49.62 0.8 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 110.721 -179.534 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 4.8 Cg_exo -63.57 -71.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.974 1.783 . . . . 0.0 111.393 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.769 HG22 ' O ' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -45.52 -54.13 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.13 -0.981 . . . . 0.0 110.053 -178.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 5.0 mtp180 -50.83 -53.24 33.85 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.161 -0.962 . . . . 0.0 109.489 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.81 -87.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.54 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.2 -82.96 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.179 -0.95 . . . . 0.0 109.426 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.769 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -179.97 -99.96 0.13 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.477 ' CB ' ' HB2' ' A' ' 67' ' ' TYR . 1.3 m-85 -131.19 133.53 45.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.358 -1.083 . . . . 0.0 109.273 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -129.25 125.61 37.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.194 -0.942 . . . . 0.0 109.483 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.93 -149.78 0.41 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.329 -0.857 . . . . 0.0 109.302 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.25 -75.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.415 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.57 37.14 1.91 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.85 158.52 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -1.145 . . . . 0.0 109.773 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -131.03 143.21 50.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.448 -0.783 . . . . 0.0 109.51 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.477 ' HB2' ' CB ' ' A' ' 60' ' ' PHE . 33.8 m-85 -134.56 -169.51 2.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.326 -0.859 . . . . 0.0 109.34 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.41 136.96 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.964 . . . . 0.0 109.426 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.642 HG21 ' HB ' ' A' ' 55' ' ' ILE . 1.7 m -93.87 103.03 15.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.943 . . . . 0.0 109.266 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 70' ' ' LEU . 4.0 tp -124.0 38.11 4.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.963 . . . . 0.0 109.715 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER 172.53 50.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 179.634 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.451 ' HA ' HG12 ' A' ' 77' ' ' ILE . . . -113.78 23.38 13.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.866 . . . . 0.0 109.125 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -124.97 -24.02 4.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 109.672 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -75.57 -93.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.119 -0.988 . . . . 0.0 109.253 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.61 -46.9 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 109.254 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.584 ' CB ' ' CZ ' ' A' ' 78' ' ' TYR . 67.7 m -89.39 -164.2 1.11 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.912 . . . . 0.0 108.779 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.714 HG22 ' O ' ' A' ' 77' ' ' ILE . 45.3 mt -157.73 63.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.983 -1.073 . . . . 0.0 110.212 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.861 ' CD1' HG23 ' A' ' 87' ' ' ILE . 1.9 m-85 -90.81 145.22 24.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.996 -1.065 . . . . 0.0 108.432 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -140.61 -171.21 12.38 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.484 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -149.59 -176.66 5.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.584 -0.95 . . . . 0.0 108.944 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER 178.55 34.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.973 . . . . 0.0 109.617 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.431 ' C ' ' OG ' ' A' ' 83' ' ' SER . . . 62.33 95.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 101' ' ' ASN . 0.6 OUTLIER 70.55 6.79 5.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.287 -1.125 . . . . 0.0 109.783 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 81' ' ' LYS . . . -150.35 129.88 13.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.661 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.561 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -150.35 174.8 29.64 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.867 HG22 ' CG2' ' A' ' 88' ' ' THR . 7.4 p -148.14 114.26 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -1.177 . . . . 0.0 110.133 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.861 HG23 ' CD1' ' A' ' 78' ' ' TYR . 7.2 mt -90.72 79.34 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.115 -0.991 . . . . 0.0 109.212 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.867 ' CG2' HG22 ' A' ' 86' ' ' VAL . 1.2 p -105.56 141.78 36.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.198 -0.939 . . . . 0.0 110.116 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 1.026 HG22 HD21 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -150.49 -178.11 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.493 ' N ' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.41 80.3 1.38 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.886 -1.134 . . . . 0.0 110.466 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . 1.034 HG22 HD11 ' A' ' 121' ' ' ILE . 19.3 p -98.56 148.65 23.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.935 . . . . 0.0 108.666 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 0.3 OUTLIER 50.85 20.27 0.75 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.341 -0.85 . . . . 0.0 109.754 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 92' ' ' SER . 0.5 OUTLIER 81.95 -18.71 0.46 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.342 -0.849 . . . . 0.0 110.192 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.556 ' HA ' ' CD2' ' A' ' 24' ' ' LEU . 1.4 p -82.28 178.94 7.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.213 -0.93 . . . . 0.0 109.21 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 4.8 mt -130.86 101.65 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.134 -0.979 . . . . 0.0 110.117 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.026 HD21 HG22 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -71.74 157.78 37.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.299 -0.876 . . . . 0.0 108.743 179.602 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.874 HG21 HD11 ' A' ' 22' ' ' LEU . 10.4 t -132.3 68.27 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.952 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -48.26 129.46 19.03 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 107.399 -2.28 . . . . 0.0 107.399 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -132.12 106.0 10.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.715 -1.462 . . . . 0.0 108.73 -178.786 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.868 ' HB2' HD12 ' A' ' 104' ' ' ILE . 22.5 p90 -122.77 164.56 18.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.371 -0.83 . . . . 0.0 109.905 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 102' ' ' GLU . 1.1 m120 -150.68 -164.11 1.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.443 -0.786 . . . . 0.0 109.312 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 101' ' ' ASN . 0.8 OUTLIER 61.49 19.21 10.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.626 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.8 mttt 60.28 62.74 1.52 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.118 -0.989 . . . . 0.0 109.377 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.868 HD12 ' HB2' ' A' ' 100' ' ' TYR . 6.2 mt -73.68 123.05 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.285 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -44.66 104.86 0.41 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.447 -0.783 . . . . 0.0 109.983 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 104' ' ' ILE . 3.6 Cg_exo -62.08 172.82 3.66 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.053 1.835 . . . . 0.0 110.173 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 111' ' ' ASN . . . 87.9 -19.88 31.56 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.846 ' O ' HG23 ' A' ' 112' ' ' VAL . 17.1 m -106.24 -45.56 4.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -1.18 . . . . 0.0 109.273 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.529 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -73.64 -43.31 59.85 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.186 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.71 -30.79 70.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.147 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 107' ' ' GLY . 0.7 OUTLIER -70.09 -40.98 74.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.346 -0.846 . . . . 0.0 109.467 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 108' ' ' THR . 21.6 t -67.2 -26.11 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.124 -0.985 . . . . 0.0 109.33 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.774 HG13 ' HZ2' ' A' ' 2' ' ' TRP . 38.1 t -76.73 -27.63 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.367 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.38 -43.12 82.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.442 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.2 -54.29 11.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 109.062 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.604 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 5.0 mp -51.55 -22.31 3.14 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.268 -0.895 . . . . 0.0 109.084 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.655 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -71.25 -43.73 66.69 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.441 -0.787 . . . . 0.0 109.248 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.44 -14.58 29.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.741 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.485 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 1.7 t80 -78.55 -60.76 2.24 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -0.935 . . . . 0.0 109.512 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.58 -50.08 68.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.909 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.034 HD11 HG22 ' A' ' 91' ' ' THR . 19.6 mt -51.08 -34.21 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.087 -1.008 . . . . 0.0 109.513 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -45.16 -65.3 1.9 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -46.88 -60.42 2.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -1.12 . . . . 0.0 109.642 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.4 74.09 1.19 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 92' ' ' SER . 64.1 m-85 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.256 -1.144 . . . . 0.0 109.482 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.856 ' NE1' HD23 ' A' ' 10' ' ' LEU . 3.3 m-90 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -74.71 0.18 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.957 -1.09 . . . . 0.0 109.248 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 m -69.61 -8.81 50.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.127 -0.983 . . . . 0.0 109.051 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.626 ' HB3' HD13 ' A' ' 10' ' ' LEU . 14.2 m-30 -88.55 -34.43 17.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.356 -0.84 . . . . 0.0 109.098 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.667 ' HA ' HG23 ' A' ' 11' ' ' VAL . 1.0 OUTLIER -60.99 -33.79 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.311 -0.868 . . . . 0.0 108.746 179.565 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -48.83 -89.58 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.484 -0.76 . . . . 0.0 110.504 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 p -133.64 13.36 4.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.068 -1.02 . . . . 0.0 110.556 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 14' ' ' GLY . 16.9 m-20 -96.59 -82.72 0.39 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.965 -1.084 . . . . 0.0 109.123 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.856 HD23 ' NE1' ' A' ' 2' ' ' TRP . 7.9 mp -65.73 -24.18 66.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.927 -1.108 . . . . 0.0 109.322 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.928 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 3.6 t -85.18 -57.7 4.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.748 ' C ' HG22 ' A' ' 13' ' ' THR . . . -47.65 -35.97 12.1 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.748 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER 154.93 49.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 122.032 -0.687 . . . . 0.0 110.628 178.992 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.72 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -94.87 21.08 45.65 Favored Glycine 0 C--N 1.292 -1.898 0 N-CA-C 106.471 -2.652 . . . . 0.0 106.471 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.758 ' O ' HG21 ' A' ' 104' ' ' ILE . . . 153.21 -30.96 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 5.6 m -139.34 153.11 23.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.476 ' O ' ' OE1' ' A' ' 18' ' ' GLN . 63.2 p -80.36 12.24 3.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.898 -1.126 . . . . 0.0 109.114 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.525 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -171.86 176.57 3.56 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.928 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . -175.05 159.67 2.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.789 -1.194 . . . . 0.0 109.777 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.801 ' HB1' HG22 ' A' ' 31' ' ' THR . . . -153.17 122.56 6.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.15 -0.969 . . . . 0.0 110.0 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.554 ' CD1' ' HB2' ' A' ' 2' ' ' TRP . 5.0 mm -81.58 98.47 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.039 HD22 HG21 ' A' ' 97' ' ' VAL . 5.4 mp -75.99 -79.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.606 -0.684 . . . . 0.0 110.302 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.482 ' HA3' ' CZ3' ' A' ' 29' ' ' TRP . . . 141.04 148.95 5.18 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.532 ' HB3' ' CG1' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -107.51 -16.82 14.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.08 -1.247 . . . . 0.0 109.863 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.11 31.98 0.84 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.064 -1.022 . . . . 0.0 109.843 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.69 -110.94 0.69 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.75 -63.29 0.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.409 -1.053 . . . . 0.0 109.153 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.571 ' O ' ' CE3' ' A' ' 29' ' ' TRP . 0.2 OUTLIER -134.95 -178.06 4.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.91 . . . . 0.0 109.525 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.571 ' CE3' ' O ' ' A' ' 28' ' ' THR . 0.6 OUTLIER -157.3 -54.38 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.871 . . . . 0.0 109.143 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.518 ' O ' HG12 ' A' ' 21' ' ' ILE . . . -173.76 79.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.801 HG22 ' HB1' ' A' ' 20' ' ' ALA . 17.9 p -79.57 166.52 21.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -0.973 . . . . 0.0 110.481 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.501 ' HB2' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -171.17 54.92 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.436 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . . . -124.24 -166.4 1.5 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.365 -0.835 . . . . 0.0 109.631 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.31 -25.01 14.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.412 ' HE2' HG11 ' A' ' 99' ' ' VAL . 4.0 p90 -82.81 -175.44 5.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -1.233 . . . . 0.0 109.453 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.817 ' O ' ' HB2' ' A' ' 63' ' ' ALA . . . -141.8 95.87 2.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 109.636 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 t -84.41 66.6 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 109.377 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.704 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 1.2 t -93.04 -26.87 0.28 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.325 -0.86 . . . . 0.0 112.627 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 38' ' ' THR . 6.3 Cg_exo -59.72 -166.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.739 0 C-N-CA 120.774 0.983 . . . . 0.0 110.37 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.22 47.3 1.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.456 ' HA ' ' OE1' ' A' ' 41' ' ' GLN . 14.0 mm-40 -81.27 -16.6 52.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.069 -1.02 . . . . 0.0 109.124 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.0 -41.54 92.47 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -27.9 65.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -1.209 . . . . 0.0 109.662 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.3 m -63.32 -22.52 66.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.137 -0.977 . . . . 0.0 109.508 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.93 -43.2 16.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 110.289 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . . . -72.38 -54.93 7.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.044 -1.035 . . . . 0.0 109.913 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 m -55.05 -29.39 57.36 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.229 -0.92 . . . . 0.0 109.291 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.9 90.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.336 -0.853 . . . . 0.0 109.641 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 46' ' ' ALA . 17.3 m-30 -53.4 -21.27 5.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.27 -0.894 . . . . 0.0 109.853 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -80.55 -58.57 3.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.011 . . . . 0.0 109.535 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -126.91 133.35 50.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 109.514 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.447 ' C ' HG12 ' A' ' 55' ' ' ILE . . . -112.1 29.17 8.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 109.45 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.618 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 5.0 t70 -81.77 -45.63 1.06 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 110.62 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.3 Cg_endo -66.32 -6.33 14.66 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 121.524 1.483 . . . . 0.0 110.368 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.814 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -103.32 -31.98 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 0.0 109.709 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 69' ' ' THR . 4.3 ptp180 -71.38 -26.75 62.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.013 -1.054 . . . . 0.0 109.515 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.8 -63.16 1.45 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 109.808 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.04 -32.94 5.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 109.459 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 55' ' ' ILE . . . 111.75 -151.03 18.02 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.52 ' HZ ' HG11 ' A' ' 86' ' ' VAL . 21.3 p90 -123.12 166.49 15.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -1.096 . . . . 0.0 109.42 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.674 ' O ' HD23 ' A' ' 62' ' ' LEU . 1.2 p30 -127.32 151.65 48.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 109.922 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 61' ' ' ASP . 25.7 mt -123.62 -141.33 0.31 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.327 -0.858 . . . . 0.0 109.464 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.817 ' HB2' ' O ' ' A' ' 36' ' ' ALA . . . -28.11 -70.81 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.9 -0.5 . . . . 0.0 111.115 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.76 21.6 0.39 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.57 163.77 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.155 -1.203 . . . . 0.0 109.476 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -102.57 155.91 17.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 109.35 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.452 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 64.6 m-85 -141.81 150.32 41.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.258 -0.901 . . . . 0.0 109.324 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 69' ' ' THR . 49.9 t -97.55 161.2 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.747 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.507 ' N ' HG12 ' A' ' 68' ' ' VAL . 19.8 m -146.22 91.76 2.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 109.18 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.84 ' O ' HD23 ' A' ' 70' ' ' LEU . 1.7 tt -109.36 25.92 11.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.226 -0.921 . . . . 0.0 109.599 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.466 ' CG ' ' O ' ' A' ' 70' ' ' LEU . 7.2 mtm180 -158.87 61.17 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.885 . . . . 0.0 109.42 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 73' ' ' ASP . . . -129.91 119.98 24.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.437 -0.79 . . . . 0.0 109.407 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 72' ' ' ALA . 0.7 OUTLIER 169.38 -61.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 109.498 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.526 ' HB3' ' HD2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -56.34 -83.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.167 -0.958 . . . . 0.0 109.328 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.526 ' HD2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -148.67 -34.48 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.028 -1.045 . . . . 0.0 110.264 179.754 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 72.3 m -97.28 162.8 13.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.906 -1.122 . . . . 0.0 109.827 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 76' ' ' SER . 3.4 mp -146.77 83.58 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 109.824 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.862 ' CD2' HG23 ' A' ' 87' ' ' ILE . 1.1 m-85 -92.65 96.14 10.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.007 -1.058 . . . . 0.0 108.718 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.99 174.65 8.62 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.41 85.27 1.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.338 -1.095 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -59.91 178.05 0.2 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.2 -0.937 . . . . 0.0 109.496 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -51.65 -45.0 54.79 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.63 -19.99 3.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -1.172 . . . . 0.0 110.406 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -99.02 167.42 10.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.898 -1.126 . . . . 0.0 109.86 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.51 153.73 23.19 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.573 HG23 HG13 ' A' ' 97' ' ' VAL . 3.9 p -136.34 132.23 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.134 -1.215 . . . . 0.0 109.846 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.862 HG23 ' CD2' ' A' ' 78' ' ' TYR . 67.6 mt -107.5 112.63 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.328 -0.858 . . . . 0.0 109.229 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.422 ' OG1' ' HB ' ' A' ' 77' ' ' ILE . 1.4 p -120.35 117.69 28.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.622 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 1.042 HG22 HD21 ' A' ' 96' ' ' LEU . 18.1 m -144.59 146.66 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 109.532 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -77.22 151.57 35.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.252 -0.905 . . . . 0.0 109.326 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.542 ' O ' ' CB ' ' A' ' 125' ' ' PHE . 25.1 p -147.34 -111.41 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 109.785 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.72 86.41 5.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.772 -1.205 . . . . 0.0 109.88 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.448 ' O ' ' CZ2' ' A' ' 29' ' ' TRP . 0.6 OUTLIER 51.18 21.72 1.15 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.331 -0.855 . . . . 0.0 109.464 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.451 ' O ' ' OG1' ' A' ' 91' ' ' THR . 4.9 t -157.32 147.61 20.95 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.374 -0.829 . . . . 0.0 109.377 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 89' ' ' VAL . 11.0 mt -109.1 154.2 10.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.395 -0.816 . . . . 0.0 109.071 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.042 HD21 HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.59 150.81 34.46 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.028 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 1.039 HG21 HD22 ' A' ' 22' ' ' LEU . 54.9 t -129.68 77.31 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.291 -0.881 . . . . 0.0 110.159 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.03 143.77 45.44 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.457 HG22 HG12 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -143.15 118.33 4.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.691 -1.476 . . . . 0.0 109.853 -179.078 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.582 ' CE1' ' O ' ' A' ' 104' ' ' ILE . 35.1 p90 -131.89 166.0 22.62 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 103' ' ' LYS . 46.7 t30 -150.31 133.33 16.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.871 -1.143 . . . . 0.0 110.864 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 101' ' ' ASN . 0.0 OUTLIER 38.39 29.74 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.634 179.289 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 101' ' ' ASN . 5.6 mmtp -136.19 -51.31 0.71 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.246 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.775 ' O ' HG22 ' A' ' 104' ' ' ILE . 1.7 mp -112.35 75.68 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.127 -0.983 . . . . 0.0 109.841 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.458 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 9.6 mt-30 -54.8 158.1 4.83 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.077 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 105' ' ' GLN . 2.9 Cg_endo -60.03 143.52 99.56 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.088 1.859 . . . . 0.0 110.403 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.16 -22.49 6.7 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.6 m -114.93 -52.87 2.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.125 -1.221 . . . . 0.0 109.499 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.513 ' HB2' HG21 ' A' ' 104' ' ' ILE . . . -72.37 -29.46 63.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 109.527 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -71.43 -21.82 61.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.572 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -90.08 -50.72 5.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.195 -0.94 . . . . 0.0 109.674 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 109' ' ' ALA . 7.1 p -61.05 -38.18 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 109.683 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.778 HG11 HG21 ' A' ' 87' ' ' ILE . 44.8 t -72.72 -31.14 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.133 -0.98 . . . . 0.0 109.601 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 110' ' ' ALA . 6.6 tt0 -65.91 -42.33 90.31 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.171 -0.956 . . . . 0.0 109.824 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -75.87 -36.52 59.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -0.968 . . . . 0.0 109.875 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.554 HD23 ' CH2' ' A' ' 2' ' ' TRP . 17.1 tp -60.0 -62.52 1.81 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.091 -1.006 . . . . 0.0 108.797 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 1.072 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -60.36 -21.53 62.23 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.27 -0.894 . . . . 0.0 109.284 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.465 ' HB2' ' HA ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -58.07 -52.0 67.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.281 -0.887 . . . . 0.0 109.539 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -59.27 -29.38 67.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.201 -0.937 . . . . 0.0 108.982 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.413 HD13 ' HB ' ' A' ' 91' ' ' THR . 4.3 mt -80.0 -22.9 41.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 110.025 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.072 HD12 ' O ' ' A' ' 117' ' ' ALA . 1.3 mp -87.45 -16.08 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.096 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.15 -27.62 15.65 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -81.78 -71.71 0.47 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.363 -1.081 . . . . 0.0 109.367 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 144.9 94.0 0.17 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.542 ' CB ' ' O ' ' A' ' 91' ' ' THR . 22.6 m-85 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.131 -1.217 . . . . 0.0 109.362 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.54 ' HB2' ' CD1' ' A' ' 120' ' ' LEU . 11.5 t . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.273 0.559 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 1.073 ' CZ3' HD22 ' A' ' 96' ' ' LEU . 1.7 m-90 -75.02 -1.5 23.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 0.0 109.383 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.49 -67.31 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.072 -1.018 . . . . 0.0 109.568 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -65.81 -30.85 71.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.532 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.967 ' CB ' HD12 ' A' ' 10' ' ' LEU . 6.6 m-30 -81.73 -3.08 52.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.12 -0.987 . . . . 0.0 109.456 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.719 ' HA ' HG23 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -83.19 -41.05 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.983 -1.073 . . . . 0.0 108.794 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -90.46 48.29 1.53 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.378 -0.827 . . . . 0.0 111.117 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.504 HG23 ' H ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -165.85 -96.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.708 -1.245 . . . . 0.0 110.792 179.215 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -101.46 -68.97 0.8 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.982 -1.073 . . . . 0.0 110.925 -178.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.967 HD12 ' CB ' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -23.05 -43.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.65 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.026 HG22 ' HB3' ' A' ' 19' ' ' ALA . 48.9 t -91.94 -55.5 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.725 -1.235 . . . . 0.0 110.815 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.736 ' C ' HG22 ' A' ' 13' ' ' THR . . . -40.03 -47.78 3.39 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.736 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 163.62 41.28 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.709 -0.877 . . . . 0.0 108.792 178.478 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.706 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -87.19 22.2 16.57 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 153.97 -34.1 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.914 HG12 ' HB3' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -134.46 137.94 50.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.587 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.72 HG23 ' CD1' ' A' ' 104' ' ' ILE . 69.2 p -78.21 2.39 18.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.955 -1.091 . . . . 0.0 108.869 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.509 ' CG ' ' C ' ' A' ' 17' ' ' THR . 6.4 mt-30 -161.83 151.11 15.99 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 1.026 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -163.47 147.97 10.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.967 -1.083 . . . . 0.0 109.973 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -141.81 152.03 43.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.429 -0.795 . . . . 0.0 108.974 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.842 HG22 ' HE3' ' A' ' 29' ' ' TRP . 7.0 mt -120.88 103.22 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.949 . . . . 0.0 109.669 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.723 HD23 ' C ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -136.55 164.23 28.67 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.588 ' HA3' ' CD1' ' A' ' 95' ' ' ILE . . . 132.64 172.79 13.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.887 HD13 ' O ' ' A' ' 93' ' ' LYS . 1.4 mp 60.78 121.0 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.148 0 O-C-N 121.159 -1.2 . . . . 0.0 108.377 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -78.03 39.3 0.3 Allowed 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.806 -0.559 . . . . 0.0 111.448 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -105.98 -32.62 3.74 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER 162.79 -172.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.621 -0.929 . . . . 0.0 109.167 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.655 HG22 ' H ' ' A' ' 29' ' ' TRP . 1.3 m -98.56 -174.49 2.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.091 -1.006 . . . . 0.0 108.536 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.842 ' HE3' HG22 ' A' ' 21' ' ' ILE . 3.8 m-90 -142.8 -54.67 0.41 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.013 -1.055 . . . . 0.0 109.993 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.0 134.87 0.2 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.536 -1.266 . . . . 0.0 110.464 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 1.4 t -135.1 157.41 46.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.573 -0.705 . . . . 0.0 109.113 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.473 ' CB ' HG11 ' A' ' 11' ' ' VAL . 13.9 m -159.88 100.59 1.43 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.608 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.532 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . . . -169.81 -164.4 0.43 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 109.161 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -118.13 35.34 4.07 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.532 ' CE1' ' HB3' ' A' ' 33' ' ' ALA . 10.7 p90 -141.59 124.3 16.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 109.48 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.0 116.03 28.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.438 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.707 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 3.5 t -81.78 143.77 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.778 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.535 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 11.2 p -51.05 160.61 0.82 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 0.0 109.444 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 3.9 Cg_exo -59.54 -18.84 49.15 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.128 1.885 . . . . 0.0 110.425 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.17 50.14 1.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.0 109.536 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.535 ' CG ' ' O ' ' A' ' 38' ' ' THR . 36.5 mt-30 -78.36 -55.15 5.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.103 -0.998 . . . . 0.0 109.805 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.94 -17.39 78.49 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -89.66 -18.21 26.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -1.191 . . . . 0.0 109.478 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 53.4 m -89.68 -26.01 20.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.883 . . . . 0.0 109.576 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.9 mt -81.65 -46.53 14.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.81 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.42 87.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.129 -0.982 . . . . 0.0 109.459 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 m -77.56 -39.3 46.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.93 . . . . 0.0 109.421 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 44' ' ' THR . . . -56.75 -29.86 63.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.322 -0.861 . . . . 0.0 109.25 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -87.31 64.55 8.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 109.446 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -101.1 -69.51 0.77 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 109.227 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.428 ' CG ' ' O ' ' A' ' 51' ' ' ASN . 36.4 t30 -138.98 33.35 2.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.0 109.069 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 56' ' ' ARG . . . 49.06 22.42 0.6 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.573 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.586 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -88.51 -57.41 0.28 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.636 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.586 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 1.1 Cg_endo -65.62 -41.35 15.08 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.886 1.724 . . . . 0.0 111.005 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.556 ' HB ' HG21 ' A' ' 69' ' ' THR . 0.2 OUTLIER -75.56 -37.2 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.168 -0.957 . . . . 0.0 109.797 -179.538 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -69.01 -66.94 0.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.0 109.899 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.546 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -77.03 126.03 30.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.107 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 3.5 t 82.52 -42.72 0.13 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.741 -0.599 . . . . 0.0 110.17 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 55' ' ' ILE . . . 95.48 -171.59 29.43 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.418 ' HE1' HD11 ' A' ' 62' ' ' LEU . 46.1 p90 -126.08 164.02 21.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -1.193 . . . . 0.0 109.55 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.465 ' HA ' ' HB3' ' A' ' 66' ' ' HIS . 54.0 m-20 -128.55 162.51 27.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.881 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.418 HD11 ' HE1' ' A' ' 60' ' ' PHE . 61.4 mt -137.0 -147.2 0.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.137 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.707 ' HB2' ' HA ' ' A' ' 37' ' ' VAL . . . -53.78 -54.51 37.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.103 -0.998 . . . . 0.0 109.633 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.75 20.23 0.69 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.465 HG12 ' CE1' ' A' ' 67' ' ' TYR . 71.9 t -135.88 149.0 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -1.188 . . . . 0.0 109.36 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 13.6 p-80 -153.55 160.18 42.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.1 -1.0 . . . . 0.0 109.837 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.465 ' CE1' HG12 ' A' ' 65' ' ' VAL . 52.1 m-85 -139.83 178.47 7.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.355 -0.84 . . . . 0.0 109.481 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.485 ' O ' ' HB ' ' A' ' 69' ' ' THR . 6.0 p -92.03 -29.3 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.212 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.556 HG21 ' HB ' ' A' ' 55' ' ' ILE . 98.8 m 63.85 109.08 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.554 -0.716 . . . . 0.0 109.484 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.6 mt -89.91 -67.65 0.83 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.871 . . . . 0.0 109.503 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.37 137.2 50.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.839 . . . . 0.0 109.298 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 73' ' ' ASP . . . -159.07 91.6 1.04 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 109.527 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 46.7 t0 178.08 -31.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 109.624 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.462 ' O ' ' CD ' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -66.25 -93.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.145 -0.972 . . . . 0.0 109.401 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.462 ' CD ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -138.56 -53.86 0.61 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.07 -1.019 . . . . 0.0 109.725 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.71 ' C ' HD12 ' A' ' 77' ' ' ILE . 20.3 m -90.03 162.76 15.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.0 109.419 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.71 HD12 ' C ' ' A' ' 76' ' ' SER . 4.1 mp -152.9 84.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.177 -0.952 . . . . 0.0 110.246 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.791 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -98.99 98.86 9.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.974 -1.079 . . . . 0.0 108.207 178.748 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.55 166.56 43.68 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.672 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.17 165.56 32.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.97 . . . . 0.0 108.921 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.54 ' HD3' ' HB3' ' A' ' 84' ' ' ALA . 10.3 ptmt -130.48 -9.26 4.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.954 -1.091 . . . . 0.0 110.403 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.28 -23.36 9.83 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.94 -60.41 1.29 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -1.122 . . . . 0.0 108.945 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.54 ' HB3' ' HD3' ' A' ' 81' ' ' LYS . . . -99.82 -169.73 1.79 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 108.86 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.532 ' O ' ' CE1' ' A' ' 100' ' ' TYR . . . -166.94 152.79 21.94 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 86' ' ' VAL . 14.5 p -135.29 104.07 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -1.097 . . . . 0.0 108.971 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.791 HG23 ' HD2' ' A' ' 78' ' ' TYR . 2.0 mt -79.56 107.6 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 109.7 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.667 HG22 HG22 ' A' ' 97' ' ' VAL . 46.8 p -111.71 98.89 7.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.305 -0.872 . . . . 0.0 109.346 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.867 HG23 HD21 ' A' ' 96' ' ' LEU . 11.4 m -125.75 161.83 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.369 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.66 153.79 17.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 109.659 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.682 HG21 ' HZ3' ' A' ' 2' ' ' TRP . 0.6 OUTLIER -147.09 -92.51 0.09 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.289 -0.882 . . . . 0.0 109.209 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.9 p -98.46 66.1 1.69 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 109.102 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.887 ' O ' HD13 ' A' ' 24' ' ' LEU . 6.9 mtmt 64.74 27.74 13.03 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.32 -0.862 . . . . 0.0 108.994 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.636 ' HA ' ' CH2' ' A' ' 29' ' ' TRP . 77.7 p -146.73 148.61 32.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.9 . . . . 0.0 109.947 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.588 ' CD1' ' HA3' ' A' ' 23' ' ' GLY . 1.1 mt -105.93 94.61 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 109.531 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.073 HD22 ' CZ3' ' A' ' 2' ' ' TRP . 0.3 OUTLIER -56.15 155.12 6.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.966 -1.084 . . . . 0.0 108.6 179.543 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.667 HG22 HG22 ' A' ' 88' ' ' THR . 73.2 t -135.08 84.61 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.134 -0.979 . . . . 0.0 109.887 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.447 ' CA ' HG11 ' A' ' 16' ' ' VAL . . . -65.71 92.47 0.16 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.539 HG22 HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -91.72 108.48 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.343 -1.092 . . . . 0.0 108.404 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.914 ' HB3' HG12 ' A' ' 16' ' ' VAL . 5.5 p90 -131.31 172.42 12.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.059 -1.026 . . . . 0.0 110.322 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.473 ' OD1' ' HB2' ' A' ' 103' ' ' LYS . 9.0 p30 -102.81 -166.51 1.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.608 -0.682 . . . . 0.0 109.619 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -69.57 -20.44 63.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.892 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 9.9 mttm -52.95 -41.02 64.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.006 . . . . 0.0 109.468 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.72 ' CD1' HG23 ' A' ' 17' ' ' THR . 1.4 mp -91.61 137.59 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.137 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.19 149.34 65.82 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.544 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.86 -8.03 14.73 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.324 2.016 . . . . 0.0 110.628 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -102.95 -39.54 2.66 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -28.18 69.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.113 -1.228 . . . . 0.0 109.893 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.42 -34.9 18.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.116 -0.99 . . . . 0.0 109.677 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.21 -20.43 62.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.738 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -79.37 -42.28 25.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 109.704 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.44 -37.26 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.771 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.716 HG11 HG21 ' A' ' 87' ' ' ILE . 85.4 t -74.12 -14.02 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.551 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.25 -34.28 22.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.941 . . . . 0.0 109.603 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 118' ' ' ASP . 3.8 mttm -77.74 -51.62 10.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.151 -0.968 . . . . 0.0 109.473 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.46 HD21 ' CD2' ' A' ' 5' ' ' TYR . 1.1 mp -51.41 -48.1 62.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 108.818 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.837 ' HB1' HD11 ' A' ' 121' ' ' ILE . . . -62.34 -47.95 81.96 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.123 -0.986 . . . . 0.0 108.413 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.538 ' CA ' HG12 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -38.52 -29.64 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.405 0.621 . . . . 0.0 109.685 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 117' ' ' ALA . 14.9 m-30 -74.28 -49.59 22.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.305 -0.872 . . . . 0.0 109.317 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 1' ' ' SER . 0.7 OUTLIER -80.81 -3.17 50.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.864 . . . . 0.0 111.841 -178.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.837 HD11 ' HB1' ' A' ' 117' ' ' ALA . 2.1 mm -77.22 -38.47 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.256 -1.527 . . . . 0.0 108.994 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 121' ' ' ILE . . . -41.32 -38.56 2.0 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -84.57 -59.59 2.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -1.102 . . . . 0.0 109.145 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.38 106.32 1.62 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.607 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 1.8 m-85 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.128 -1.219 . . . . 0.0 109.397 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.609 ' O ' ' CD2' ' A' ' 2' ' ' TRP . 31.5 m . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.85 ' CD1' HD13 ' A' ' 10' ' ' LEU . 6.4 m95 -152.66 140.24 19.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.171 -0.956 . . . . 0.0 109.025 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -32.57 -82.21 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.798 -0.564 . . . . 0.0 111.536 -178.443 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.462 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.6 OUTLIER -64.01 -34.61 78.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.065 -1.022 . . . . 0.0 110.87 -178.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.834 ' CE2' HD12 ' A' ' 116' ' ' LEU . 1.1 m-30 -76.62 3.23 11.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.75 -1.219 . . . . 0.0 109.801 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.928 HG22 HG21 ' A' ' 11' ' ' VAL . 1.1 t -92.82 -46.45 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 8' ' ' THR . 0.9 OUTLIER -91.37 53.57 2.33 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.285 -0.884 . . . . 0.0 110.257 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -171.11 -92.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.738 -1.226 . . . . 0.0 111.687 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 11' ' ' VAL . 3.6 m120 -101.21 -88.34 0.37 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.065 -1.022 . . . . 0.0 112.181 -177.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.85 HD13 ' CD1' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -21.13 -44.26 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -177.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.928 HG21 HG22 ' A' ' 6' ' ' VAL . 41.0 t -94.37 -41.84 12.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.696 -1.252 . . . . 0.0 110.337 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.763 ' C ' HG22 ' A' ' 13' ' ' THR . . . -45.53 -41.04 8.92 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.763 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 157.83 37.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.681 0.753 . . . . 0.0 109.425 178.655 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.699 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -85.19 19.84 20.18 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 158.92 -25.63 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 13' ' ' THR . 10.8 m -141.11 134.01 30.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.539 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 17.5 p -80.08 10.2 4.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 109.367 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.539 ' CG ' ' O ' ' A' ' 17' ' ' THR . 88.2 mt-30 -162.45 166.31 25.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.432 -0.792 . . . . 0.0 108.931 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.76 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . 179.54 166.48 1.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 110.088 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -165.03 126.18 2.02 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.488 -0.758 . . . . 0.0 109.324 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.634 HD11 ' CA ' ' A' ' 2' ' ' TRP . 2.8 mt -91.01 108.27 19.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.229 -0.919 . . . . 0.0 108.591 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.755 HD11 HG21 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -94.51 101.21 13.1 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.276 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -42.83 169.33 0.01 OUTLIER Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.733 HD21 ' N ' ' A' ' 94' ' ' SER . 1.4 pp -119.9 -17.66 8.42 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.415 -1.05 . . . . 0.0 109.428 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.726 ' N ' HD12 ' A' ' 24' ' ' LEU . 1.9 m-20 -124.97 -4.69 7.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.394 -0.816 . . . . 0.0 109.437 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.28 -90.85 1.42 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -171.69 -45.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.346 -1.091 . . . . 0.0 109.722 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.7 m -166.16 129.88 2.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.859 . . . . 0.0 109.242 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.549 ' CD2' ' OG ' ' A' ' 94' ' ' SER . 14.8 m0 -96.75 -45.45 6.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.6 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.4 171.4 19.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 109.453 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -160.88 174.77 13.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.597 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.829 ' HB2' HG11 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -161.44 135.16 6.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.902 . . . . 0.0 109.581 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 87.12 -16.64 0.38 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . 127.41 -90.25 0.35 Allowed Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.09 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.699 ' CE2' HG21 ' A' ' 99' ' ' VAL . 0.3 OUTLIER 61.49 126.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -1.097 . . . . 0.0 109.105 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' A' ' 63' ' ' ALA . . . -136.7 95.34 3.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 109.849 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.49 ' HB ' ' HG2' ' A' ' 41' ' ' GLN . 3.4 t -105.26 92.34 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.26 -0.9 . . . . 0.0 108.953 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.62 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -93.28 -38.84 0.33 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.513 -0.742 . . . . 0.0 112.684 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 38' ' ' THR . 6.5 Cg_exo -54.91 -73.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.403 1.402 . . . . 0.0 111.806 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.537 ' HB1' ' HB3' ' A' ' 43' ' ' GLN . . . -154.0 81.17 1.14 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.826 -1.171 . . . . 0.0 110.111 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.49 ' HG2' ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -75.53 -63.31 1.32 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.264 -1.522 . . . . 0.0 108.659 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -91.79 -7.85 64.19 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.537 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -80.4 -43.27 21.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -1.103 . . . . 0.0 109.457 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 40' ' ' ALA . 17.3 m -76.31 -51.23 12.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 109.56 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.0 mt -58.35 -27.74 64.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.509 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -67.45 -42.83 82.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.802 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.9 t -91.42 -3.12 56.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.614 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.91 -14.27 37.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.632 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.45 ' CE2' ' HG3' ' A' ' 90' ' ' LYS . 18.1 m-30 -87.18 3.18 47.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 109.877 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.58 -41.4 15.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.051 -1.031 . . . . 0.0 109.251 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.48 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -151.46 146.13 25.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -0.872 . . . . 0.0 109.313 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 56' ' ' ARG . . . -89.6 28.97 1.2 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.886 . . . . 0.0 109.901 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.614 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -85.44 -44.66 0.64 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.029 -1.044 . . . . 0.0 110.587 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.2 Cg_endo -68.45 -74.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 121.617 1.545 . . . . 0.0 110.522 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.438 HD12 ' CB ' ' A' ' 72' ' ' ALA . 0.8 OUTLIER -41.87 -46.04 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.39 -0.818 . . . . 0.0 109.982 -179.449 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 3.1 ttt180 -45.47 -55.04 6.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 109.653 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 58' ' ' SER . . . -86.18 -91.83 0.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.836 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 57' ' ' ALA . 2.9 t -43.41 -76.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.195 -0.94 . . . . 0.0 109.758 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 55' ' ' ILE . . . 121.61 -133.71 9.61 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.964 ' CD2' HD21 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -144.24 153.58 42.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.077 -1.249 . . . . 0.0 109.541 179.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.634 ' C ' HD22 ' A' ' 62' ' ' LEU . 1.8 m-20 -95.21 128.67 42.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 110.094 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.964 HD21 ' CD2' ' A' ' 60' ' ' PHE . 4.0 mm? -107.59 57.35 0.63 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.499 ' CB ' ' O ' ' A' ' 36' ' ' ALA . . . 50.71 26.79 2.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.476 -0.765 . . . . 0.0 109.42 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.39 -97.01 0.12 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.771 -1.204 . . . . 0.0 110.242 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.594 HG12 ' N ' ' A' ' 66' ' ' HIS . 25.9 t -112.76 170.46 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.183 -1.186 . . . . 0.0 110.012 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.594 ' N ' HG12 ' A' ' 65' ' ' VAL . 74.0 m80 -85.29 132.7 34.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.736 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.586 ' CE1' ' HA ' ' A' ' 81' ' ' LYS . 25.3 m-85 -107.84 168.89 8.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.039 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.549 HG12 ' H ' ' A' ' 69' ' ' THR . 1.9 t -109.59 174.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.111 -0.993 . . . . 0.0 110.027 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.617 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -115.8 135.44 54.01 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.433 -0.792 . . . . 0.0 109.323 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.517 HD23 ' NE ' ' A' ' 71' ' ' ARG . 11.5 tp -89.94 -55.9 3.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.156 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.544 ' HG2' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -137.23 75.77 1.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 109.048 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.658 ' HA ' HG23 ' A' ' 77' ' ' ILE . . . -101.83 81.68 2.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.89 . . . . 0.0 109.549 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 24.9 t70 178.02 -41.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.62 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.43 -81.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 109.806 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.69 -48.81 0.26 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.166 -0.959 . . . . 0.0 109.618 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.647 ' CB ' ' CZ ' ' A' ' 78' ' ' TYR . 0.7 OUTLIER -90.6 -170.51 2.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -0.941 . . . . 0.0 109.726 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.658 HG23 ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -163.13 63.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.1 -1.0 . . . . 0.0 110.05 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.844 ' HB3' HD13 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -92.14 115.3 27.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.905 -1.122 . . . . 0.0 109.04 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.401 ' C ' ' CG1' ' A' ' 86' ' ' VAL . . . -96.69 -158.33 31.45 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.25 158.79 34.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -1.191 . . . . 0.0 109.614 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 2.1 mtpt -123.92 -178.55 4.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.245 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.18 106.09 1.32 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 55.66 20.47 3.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.153 -1.204 . . . . 0.0 108.9 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.647 ' HB1' ' O ' ' A' ' 100' ' ' TYR . . . -136.18 -164.15 1.51 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 109.309 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 100' ' ' TYR . . . -147.57 131.05 3.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.607 HG22 HG23 ' A' ' 88' ' ' THR . 2.5 p -104.51 131.49 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.215 -1.168 . . . . 0.0 109.43 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.844 HD13 ' HB3' ' A' ' 78' ' ' TYR . 47.3 mm -115.14 101.68 12.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.263 -0.898 . . . . 0.0 109.208 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.971 HG22 HG13 ' A' ' 97' ' ' VAL . 7.8 p -117.46 146.16 43.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.071 -1.018 . . . . 0.0 109.603 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.551 ' HB ' HD21 ' A' ' 96' ' ' LEU . 2.1 t -146.95 141.89 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.768 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.45 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -91.3 124.2 35.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.426 -0.796 . . . . 0.0 108.946 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.682 HG21 HD11 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -103.25 -60.19 1.59 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.128 -0.982 . . . . 0.0 109.73 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -168.47 -66.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 0.0 109.437 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.727 ' HA ' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -120.65 15.85 11.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.182 -0.949 . . . . 0.0 109.473 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.733 ' N ' HD21 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -154.36 154.44 33.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.169 -0.957 . . . . 0.0 110.014 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.523 ' CD1' ' HB3' ' A' ' 24' ' ' LEU . 54.6 mt -125.61 138.37 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.916 HD13 ' N ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -112.29 166.43 11.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.975 -1.078 . . . . 0.0 109.956 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.971 HG13 HG22 ' A' ' 88' ' ' THR . 3.2 t -146.9 77.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -0.917 . . . . 0.0 111.21 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.37 107.09 1.66 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 107.28 -2.328 . . . . 0.0 107.28 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.699 HG21 ' CE2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -115.47 142.55 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.884 -1.363 . . . . 0.0 110.414 -178.102 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.647 ' O ' ' HB1' ' A' ' 84' ' ' ALA . 16.4 p90 -129.13 171.14 12.7 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.48 ' O ' ' CG ' ' A' ' 102' ' ' GLU . 5.9 p30 -150.2 115.2 5.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.676 -1.265 . . . . 0.0 111.183 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.48 ' CG ' ' O ' ' A' ' 101' ' ' ASN . 22.1 pt-20 39.06 31.4 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.518 0.675 . . . . 0.0 109.374 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.817 ' C ' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -133.18 -25.68 1.75 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.693 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.817 HD12 ' C ' ' A' ' 103' ' ' LYS . 1.8 mp -137.79 149.57 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.847 -1.158 . . . . 0.0 110.028 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 5.4 pm0 -99.72 145.0 29.39 Favored Pre-proline 0 C--N 1.307 -1.246 0 O-C-N 121.48 -0.762 . . . . 0.0 109.202 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 105' ' ' GLN . 1.1 Cg_endo -66.35 177.11 3.43 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.088 1.859 . . . . 0.0 110.103 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.35 -0.16 75.97 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 65.1 m -127.06 -45.24 1.57 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.113 -1.227 . . . . 0.0 109.582 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.795 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -80.1 -40.76 26.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 109.569 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.416 ' HB2' HD12 ' A' ' 87' ' ' ILE . . . -56.72 -17.02 7.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.329 -0.857 . . . . 0.0 109.757 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -78.09 -45.71 22.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.717 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 109' ' ' ALA . 11.1 p -71.54 -22.76 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.949 . . . . 0.0 109.857 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.817 HG21 HG21 ' A' ' 87' ' ' ILE . 6.0 t -71.26 -33.54 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.056 -1.027 . . . . 0.0 109.598 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.417 ' O ' ' OE1' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -80.13 -17.04 53.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.138 -0.976 . . . . 0.0 109.894 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.556 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -86.11 -59.2 2.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.965 . . . . 0.0 109.692 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.834 HD12 ' CE2' ' A' ' 5' ' ' TYR . 2.1 mm? -48.43 -35.85 13.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.095 -1.003 . . . . 0.0 109.308 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.763 ' HB2' ' CH2' ' A' ' 2' ' ' TRP . . . -68.8 -39.13 80.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.966 . . . . 0.0 109.478 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.62 -33.92 48.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 109.561 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.556 ' CD1' ' O ' ' A' ' 115' ' ' LYS . 32.8 m-85 -74.76 -58.6 3.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.083 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.736 HD12 ' C ' ' A' ' 120' ' ' LEU . 4.5 pp -72.27 2.35 6.17 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.445 -0.785 . . . . 0.0 110.417 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.473 ' CG1' HG22 ' A' ' 91' ' ' THR . 5.1 mt -88.96 -23.73 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 108.862 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.08 -30.18 53.79 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -92.77 -75.4 0.49 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.377 -1.073 . . . . 0.0 109.461 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 125' ' ' PHE . . . 132.35 36.77 0.29 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.523 ' CE2' HD13 ' A' ' 120' ' ' LEU . 16.0 m-85 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.375 -1.074 . . . . 0.0 109.518 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.593 ' C ' HG23 ' A' ' 6' ' ' VAL . 82.1 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.888 ' CD1' HD13 ' A' ' 10' ' ' LEU . 7.6 m95 61.69 154.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.924 . . . . 0.0 108.998 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -67.13 -80.75 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.13 -0.981 . . . . 0.0 111.366 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.475 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 0.8 OUTLIER -54.6 -22.93 14.83 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.097 -1.002 . . . . 0.0 111.094 -178.373 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 1.9 m-30 -87.58 -25.08 23.79 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.65 -1.281 . . . . 0.0 109.869 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.61 HG13 ' OG ' ' A' ' 32' ' ' SER . 0.9 OUTLIER -63.87 -26.69 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 108.923 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 1.034 ' OD2' HG22 ' A' ' 8' ' ' THR . 1.0 OUTLIER -52.85 -52.58 56.67 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.449 -0.782 . . . . 0.0 111.966 -177.647 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 1.034 HG22 ' OD2' ' A' ' 7' ' ' ASP . 5.0 t -163.38 -27.72 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.531 -1.356 . . . . 0.0 111.116 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 14' ' ' GLY . 1.7 m-80 -64.82 -88.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.656 -1.277 . . . . 0.0 109.764 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.888 HD13 ' CD1' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -59.94 -23.65 63.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.202 -0.936 . . . . 0.0 110.295 -179.379 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.599 HG23 ' HA ' ' A' ' 6' ' ' VAL . 1.5 t -89.21 -60.32 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.868 -1.145 . . . . 0.0 108.999 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.741 ' C ' HG22 ' A' ' 13' ' ' THR . . . -43.67 -36.89 3.62 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.741 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER 158.49 46.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.948 -0.736 . . . . 0.0 110.105 178.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.701 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -92.41 23.19 28.85 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 106.294 -2.723 . . . . 0.0 106.294 177.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 1.057 ' O ' HG21 ' A' ' 104' ' ' ILE . . . 154.0 -28.98 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.887 ' HA ' HD13 ' A' ' 104' ' ' ILE . 17.6 m -148.59 139.42 17.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.664 HG23 ' HG3' ' A' ' 18' ' ' GLN . 8.1 t -79.32 6.3 10.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.979 -1.076 . . . . 0.0 109.11 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.664 ' HG3' HG23 ' A' ' 17' ' ' THR . 45.9 mt-30 -160.6 155.63 24.41 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -168.81 175.9 5.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.019 -1.051 . . . . 0.0 110.286 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -165.2 114.09 1.04 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.55 -0.719 . . . . 0.0 109.181 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.751 HD11 ' C ' ' A' ' 2' ' ' TRP . 24.8 mt -79.65 80.74 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 120.999 -1.063 . . . . 0.0 108.851 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -60.33 -150.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.465 -0.772 . . . . 0.0 108.936 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.61 134.63 4.01 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.573 HD23 HG13 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -80.57 4.71 17.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -1.153 . . . . 0.0 109.561 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.12 -13.8 12.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.567 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . 96.26 81.63 1.58 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.551 ' O ' ' C ' ' A' ' 28' ' ' THR . 1.0 OUTLIER 167.8 55.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -1.146 . . . . 0.0 109.442 -179.595 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.551 ' C ' ' O ' ' A' ' 27' ' ' ASN . 21.2 m -20.55 130.36 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.37 0.605 . . . . 0.0 111.325 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.536 ' CE3' ' OG ' ' A' ' 94' ' ' SER . 22.2 m0 -88.68 -45.34 9.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.447 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.01 164.53 18.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.939 . . . . 0.0 109.853 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 3.2 t -157.92 177.47 11.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.413 -0.805 . . . . 0.0 108.879 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.61 ' OG ' HG13 ' A' ' 6' ' ' VAL . 15.3 m -167.13 117.26 0.87 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.112 -0.992 . . . . 0.0 110.375 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 32' ' ' SER . . . 34.32 90.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.164 0.507 . . . . 0.0 110.53 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.33 -84.32 0.05 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.668 ' CE2' HG22 ' A' ' 37' ' ' VAL . 3.3 p90 -172.74 159.58 4.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -1.067 . . . . 0.0 109.352 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.77 116.2 28.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.291 -0.881 . . . . 0.0 108.757 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.668 HG22 ' CE2' ' A' ' 35' ' ' PHE . 91.6 t -79.62 108.37 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.147 -0.971 . . . . 0.0 109.582 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.522 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 9.1 m -48.22 139.35 10.26 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.341 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.722 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 1.8 Cg_endo -63.92 167.7 13.47 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.13 1.887 . . . . 0.0 110.376 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 39' ' ' PRO . . . 82.36 -41.45 0.12 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.649 -0.657 . . . . 0.0 110.293 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -69.29 -31.22 69.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.044 -1.035 . . . . 0.0 109.745 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.31 -38.71 50.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -63.41 -35.7 81.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.175 -1.191 . . . . 0.0 109.923 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.0 m -56.53 -37.28 70.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -0.918 . . . . 0.0 109.791 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.88 -39.5 93.64 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.216 -0.927 . . . . 0.0 109.806 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.4 -26.01 63.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 109.975 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.4 t -88.22 -18.12 29.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.131 -0.98 . . . . 0.0 109.778 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' ASN . . . -73.18 -30.63 63.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.965 . . . . 0.0 109.571 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -54.9 -47.23 74.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 109.926 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 51' ' ' ASN . 13.7 p30 -79.7 -46.8 16.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.001 -1.062 . . . . 0.0 109.444 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 2.2 t-20 -107.58 111.83 24.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 108.855 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.511 ' HA ' HG12 ' A' ' 55' ' ' ILE . . . -108.72 30.67 6.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 109.865 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.562 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -72.19 -55.39 5.01 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.124 -0.985 . . . . 0.0 109.739 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.1 Cg_endo -62.47 -11.58 23.73 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.021 1.814 . . . . 0.0 110.344 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.786 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -109.7 -17.61 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.156 -0.965 . . . . 0.0 109.185 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 7.2 ttt180 -89.48 -18.43 26.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.172 -0.955 . . . . 0.0 109.551 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.91 43.47 1.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.424 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.35 61.78 2.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.396 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -137.25 60.31 0.61 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.711 ' HD1' HG22 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -109.21 93.35 4.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -1.172 . . . . 0.0 108.904 179.468 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -135.43 127.11 29.05 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.384 -0.822 . . . . 0.0 109.722 -179.443 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 64' ' ' GLY . 1.4 mm? -95.84 -166.38 1.43 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.397 -0.815 . . . . 0.0 109.248 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.97 91.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.185 -0.947 . . . . 0.0 109.067 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 62' ' ' LEU . . . 61.4 52.02 54.17 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 61' ' ' ASP . 2.9 t -141.04 119.44 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.292 -1.122 . . . . 0.0 109.571 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.43 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 34.9 m170 -79.69 124.89 28.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.338 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.526 ' CB ' ' O ' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -149.99 166.43 29.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.11 -0.994 . . . . 0.0 109.934 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.507 ' O ' ' CB ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -115.84 -176.93 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.81 . . . . 0.0 109.016 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.524 ' CB ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -133.64 109.73 9.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.096 -1.002 . . . . 0.0 109.606 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mp -101.72 -25.26 13.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.342 -0.849 . . . . 0.0 109.166 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.511 ' O ' HG23 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -149.38 117.22 6.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.415 -0.803 . . . . 0.0 109.193 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.515 ' HA ' HG12 ' A' ' 77' ' ' ILE . . . -160.5 74.84 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.087 -1.008 . . . . 0.0 109.847 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 30.0 t70 179.26 -36.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.46 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.441 ' OD2' ' NH2' ' A' ' 71' ' ' ARG . 3.2 m-20 -74.84 -84.63 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.216 -0.927 . . . . 0.0 110.045 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -137.18 -62.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.994 -1.066 . . . . 0.0 110.288 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.639 ' CB ' ' CZ ' ' A' ' 78' ' ' TYR . 0.7 OUTLIER -90.08 163.79 14.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.384 -0.823 . . . . 0.0 110.495 -178.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.515 HG12 ' HA ' ' A' ' 72' ' ' ALA . 3.0 mt -143.41 70.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.607 -0.683 . . . . 0.0 109.329 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.787 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -88.98 103.8 16.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.713 -1.242 . . . . 0.0 108.928 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.47 169.3 33.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -148.77 147.89 29.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -1.102 . . . . 0.0 109.328 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.16 -30.39 1.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.877 . . . . 0.0 109.845 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 123.35 -66.98 0.5 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.507 ' CB ' ' OE2' ' A' ' 102' ' ' GLU . 1.1 p -87.23 -18.8 29.45 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.372 -1.075 . . . . 0.0 108.444 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.31 166.34 27.41 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -160.69 163.95 34.37 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.759 HG13 ' O ' ' A' ' 86' ' ' VAL . 9.8 p -129.91 104.8 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -1.113 . . . . 0.0 109.471 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.787 HG23 ' HD2' ' A' ' 78' ' ' TYR . 4.1 mt -80.48 94.42 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.087 -1.008 . . . . 0.0 109.013 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 2.7 p -101.86 106.01 16.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 110.16 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.421 HG22 ' CE2' ' A' ' 78' ' ' TYR . 25.5 t -116.89 149.31 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 108.895 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.509 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 29.4 mtpt -86.1 151.99 23.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 110.048 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.81 ' CG2' HD21 ' A' ' 96' ' ' LEU . 2.3 p -145.57 -159.74 1.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.85 . . . . 0.0 109.075 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.402 ' C ' ' HD3' ' A' ' 93' ' ' LYS . 16.2 t -69.07 85.34 0.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.446 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER 62.17 14.79 6.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.206 -0.934 . . . . 0.0 109.427 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.536 ' OG ' ' CE3' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -128.64 151.61 49.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.485 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.573 HG13 HD23 ' A' ' 24' ' ' LEU . 48.8 mt -127.52 123.42 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.952 . . . . 0.0 109.417 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.861 ' N ' HD13 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -85.38 130.7 34.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 108.889 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.817 HG12 HG22 ' A' ' 99' ' ' VAL . 42.4 t -121.87 68.21 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.498 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.423 ' C ' HG11 ' A' ' 16' ' ' VAL . . . -62.0 99.65 0.24 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.817 HG22 HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -101.21 126.76 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -1.223 . . . . 0.0 108.983 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.608 ' CD1' HG12 ' A' ' 16' ' ' VAL . 3.7 p90 -141.82 -176.49 4.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 109.733 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 83' ' ' SER . 0.5 OUTLIER -138.1 -116.24 0.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.093 -1.005 . . . . 0.0 110.22 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.507 ' OE2' ' CB ' ' A' ' 83' ' ' SER . 9.9 mm-40 -85.29 -50.64 7.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.843 -1.161 . . . . 0.0 110.276 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -39.16 -27.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 110.574 -179.093 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.057 HG21 ' O ' ' A' ' 15' ' ' ALA . 12.4 mt -127.86 147.69 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.919 -1.113 . . . . 0.0 110.203 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -127.52 152.71 76.99 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.416 -0.803 . . . . 0.0 108.868 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.43 173.2 1.57 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.992 1.795 . . . . 0.0 110.272 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.74 -51.26 1.2 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 m -94.08 -33.71 13.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.373 -1.075 . . . . 0.0 108.929 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.76 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . . . -80.94 -35.05 32.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.575 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.61 -13.4 59.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.53 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.26 -42.63 12.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.764 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.3 p -70.57 -28.09 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 109.629 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.835 HG13 ' HZ2' ' A' ' 2' ' ' TRP . 73.6 t -83.94 -20.53 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.501 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.48 -37.55 63.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.885 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.534 ' HG3' ' N ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -77.03 -42.79 37.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.684 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.534 ' N ' ' HG3' ' A' ' 115' ' ' LYS . 25.7 mt -52.23 -57.18 10.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.047 -1.033 . . . . 0.0 109.458 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.556 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -64.56 -29.83 70.86 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.131 -0.981 . . . . 0.0 109.095 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -53.78 -21.98 8.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.129 -0.982 . . . . 0.0 109.176 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -90.64 -30.86 16.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.409 -0.807 . . . . 0.0 109.832 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.672 HD22 ' HB ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -73.04 -38.78 66.4 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.063 -1.023 . . . . 0.0 109.77 -179.505 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.556 HD12 ' O ' ' A' ' 117' ' ' ALA . 2.9 mp -64.86 -14.88 17.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.395 -0.816 . . . . 0.0 109.276 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -45.71 -35.4 5.81 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.33 -70.23 0.82 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -1.035 . . . . 0.0 108.974 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -117.39 -77.97 0.64 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.386 -1.067 . . . . 0.0 109.688 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.596 ' O ' ' HB2' ' A' ' 2' ' ' TRP . 84.3 p . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.88 ' HZ2' HD22 ' A' ' 96' ' ' LEU . 0.1 OUTLIER 79.28 -46.28 0.37 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 120.764 0.316 . . . . 0.0 110.394 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -67.49 -59.01 3.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.581 -1.324 . . . . 0.0 108.965 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.42 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.7 OUTLIER -71.82 -31.18 66.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.308 -0.87 . . . . 0.0 108.719 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.923 ' CD2' HD13 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -56.21 -17.12 6.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.451 -0.781 . . . . 0.0 108.925 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.702 HG23 HD11 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -94.39 -48.96 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.245 -0.91 . . . . 0.0 109.955 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.424 ' N ' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -89.83 45.95 1.32 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.785 -1.197 . . . . 0.0 110.677 -178.492 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 4' ' ' THR . 22.5 p -148.63 -104.94 0.08 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.855 -1.153 . . . . 0.0 110.003 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.483 ' O ' ' C ' ' A' ' 10' ' ' LEU . 2.3 t-20 -102.72 -69.14 0.8 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.032 -1.042 . . . . 0.0 111.156 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.923 HD13 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -27.77 -45.44 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.234 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.692 HG21 HG22 ' A' ' 6' ' ' VAL . 85.2 t -101.24 -25.43 3.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.477 -1.389 . . . . 0.0 110.976 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 11' ' ' VAL . . . -45.58 -27.78 2.19 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 106.544 -2.622 . . . . 0.0 106.544 177.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.711 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -175.22 -44.88 0.01 OUTLIER 'General case' 0 C--O 1.196 -1.718 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.837 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.716 ' O ' ' HB3' ' A' ' 15' ' ' ALA . . . 14.12 40.45 0.0 OUTLIER Glycine 0 N--CA 1.508 3.435 0 C-N-CA 123.567 0.603 . . . . 0.0 112.79 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 14' ' ' GLY . . . 86.7 -32.12 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.438 -1.036 . . . . 0.0 108.377 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.624 HG13 ' HB1' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -101.39 132.5 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.179 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.9 OUTLIER -86.25 21.04 2.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.958 -1.089 . . . . 0.0 109.261 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -176.99 176.1 1.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.633 ' HB3' ' CG1' ' A' ' 11' ' ' VAL . . . 174.35 166.33 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.004 -1.06 . . . . 0.0 110.1 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.469 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -163.66 136.09 5.15 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.702 HD11 HG23 ' A' ' 6' ' ' VAL . 1.2 mm -94.33 66.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.036 -1.04 . . . . 0.0 108.453 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.713 ' HG ' HG21 ' A' ' 97' ' ' VAL . 17.5 mt -60.83 109.54 1.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 108.938 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 94' ' ' SER . . . -60.35 159.47 24.87 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.681 ' CB ' HD11 ' A' ' 95' ' ' ILE . 1.0 OUTLIER -108.77 -6.9 15.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -1.022 . . . . 0.0 109.4 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -143.7 34.89 1.27 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.355 -0.841 . . . . 0.0 109.312 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.41 29.84 0.09 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 64.63 -144.58 0.26 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.214 -1.168 . . . . 0.0 109.503 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.3 m -77.66 147.95 35.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.153 -0.967 . . . . 0.0 110.019 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.483 ' CE3' ' HB3' ' A' ' 94' ' ' SER . 7.8 m0 -114.12 -47.45 2.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.336 -0.852 . . . . 0.0 108.786 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.35 167.27 30.54 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 10.1 t -160.3 159.79 31.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.957 -1.089 . . . . 0.0 110.055 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.632 ' HB2' HG13 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -150.99 92.99 1.88 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.591 -0.693 . . . . 0.0 109.155 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 32' ' ' SER . . . 170.78 -54.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.531 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.4 19.48 3.48 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.653 ' CZ ' HG21 ' A' ' 99' ' ' VAL . 10.4 p90 -125.54 134.76 51.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -1.174 . . . . 0.0 109.523 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.59 130.64 55.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.914 . . . . 0.0 109.305 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.1 t -79.62 131.7 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 109.598 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 m -48.29 125.58 11.89 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 108.994 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.82 -39.42 81.79 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.765 1.643 . . . . 0.0 109.976 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.79 -46.96 86.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.258 -0.901 . . . . 0.0 109.182 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -62.72 -21.18 65.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.273 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.79 -29.33 67.2 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -67.48 -44.62 78.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -1.155 . . . . 0.0 109.428 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.4 m -56.72 -25.71 55.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.285 -0.884 . . . . 0.0 109.372 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.528 HD13 HD11 ' A' ' 62' ' ' LEU . 9.9 tp -73.81 -41.68 62.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.26 -50.2 66.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.228 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.78 -16.45 64.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.18 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.89 -28.24 64.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.339 -0.851 . . . . 0.0 109.458 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -88.26 21.53 2.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.361 -0.837 . . . . 0.0 109.533 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -108.69 -44.47 4.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.356 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.89 ' O ' HD11 ' A' ' 55' ' ' ILE . 2.5 m-20 -122.87 141.46 51.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 109.477 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.455 ' HA ' HG13 ' A' ' 55' ' ' ILE . . . -105.82 -3.72 21.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.909 . . . . 0.0 109.611 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.562 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -77.25 -55.37 1.36 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.101 -1.0 . . . . 0.0 110.258 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 2.3 Cg_endo -62.37 -10.33 18.4 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.056 1.837 . . . . 0.0 111.225 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.89 HD11 ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -104.85 -23.72 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.946 -1.096 . . . . 0.0 109.62 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -81.98 -12.18 58.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.085 -1.01 . . . . 0.0 109.356 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.96 -75.85 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.6 t -85.73 -39.32 17.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.385 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 55' ' ' ILE . . . 85.69 -161.73 35.36 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.655 ' CE1' ' CG ' ' A' ' 67' ' ' TYR . 4.6 p90 -145.98 -168.99 3.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -1.11 . . . . 0.0 109.035 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 61' ' ' ASP . 26.7 p30 -160.04 157.53 28.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.012 -1.055 . . . . 0.0 110.483 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.528 HD11 HD13 ' A' ' 45' ' ' LEU . 96.5 mt -124.64 -160.04 0.92 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.73 97.75 10.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.973 -1.079 . . . . 0.0 109.733 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.19 -79.47 0.23 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.513 HG21 ' CB ' ' A' ' 84' ' ' ALA . 54.1 t -124.8 160.97 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -1.153 . . . . 0.0 109.322 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.5 ' N ' HG12 ' A' ' 65' ' ' VAL . 18.7 m170 -75.9 -171.45 1.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.127 -0.983 . . . . 0.0 109.317 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.86 ' OH ' HG13 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -137.39 119.78 15.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 109.831 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.409 HG21 ' HG3' ' A' ' 81' ' ' LYS . 82.7 t -89.71 -24.6 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -0.843 . . . . 0.0 108.735 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.895 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 92.6 m 57.52 101.38 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.599 -0.688 . . . . 0.0 110.151 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.38 -23.67 13.16 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -142.85 72.1 1.36 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.895 ' HB2' ' CG2' ' A' ' 69' ' ' THR . . . -85.4 52.25 2.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 0.0 109.828 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.66 -145.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.241 -0.912 . . . . 0.0 108.835 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.44 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 0.4 OUTLIER -119.66 34.65 5.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.155 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 7.5 mmt180 -136.7 -44.38 0.59 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 110.236 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.669 ' HA ' HG22 ' A' ' 89' ' ' VAL . 14.9 m -145.64 164.88 30.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.929 -1.107 . . . . 0.0 110.31 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 77' ' ' ILE . 0.3 OUTLIER -162.24 97.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.774 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -115.31 129.81 56.72 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.593 ' HA3' ' CE1' ' A' ' 67' ' ' TYR . . . -101.6 155.7 18.89 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.518 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.528 ' HD2' ' CG ' ' A' ' 106' ' ' PRO . 2.0 pttp -151.0 141.24 22.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -1.089 . . . . 0.0 109.347 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.503 ' CG ' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER 165.13 143.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.933 -1.104 . . . . 0.0 110.565 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.401 ' C ' ' N ' ' A' ' 84' ' ' ALA . . . 63.94 48.94 71.23 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 47.03 21.9 0.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.05 -1.265 . . . . 0.0 109.549 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.513 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -151.3 147.28 26.76 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.318 -0.864 . . . . 0.0 108.759 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.555 ' CA ' ' CE2' ' A' ' 100' ' ' TYR . . . -169.68 -171.43 35.26 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.86 HG13 ' OH ' ' A' ' 67' ' ' TYR . 7.3 p -141.62 156.69 20.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.399 -1.059 . . . . 0.0 109.842 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.774 HG23 ' HD2' ' A' ' 78' ' ' TYR . 75.3 mt -121.37 93.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 11.4 p -107.91 133.24 52.54 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.197 -0.939 . . . . 0.0 110.643 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 1.091 ' HB ' HD21 ' A' ' 96' ' ' LEU . 2.1 t -150.76 156.86 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.234 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -79.99 143.89 33.74 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.459 -0.776 . . . . 0.0 109.192 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.601 HG21 ' CE2' ' A' ' 2' ' ' TRP . 67.9 p -146.88 -135.82 0.08 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.209 -0.932 . . . . 0.0 109.29 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -75.78 80.43 2.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.969 -1.082 . . . . 0.0 109.955 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 92' ' ' SER . 13.4 mttm 60.68 13.33 4.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.761 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.547 ' HB2' HG22 ' A' ' 21' ' ' ILE . 3.3 p -138.04 165.35 26.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.064 -1.022 . . . . 0.0 109.966 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.681 HD11 ' CB ' ' A' ' 24' ' ' LEU . 1.7 mt -128.82 112.99 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.418 -0.801 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.091 HD21 ' HB ' ' A' ' 89' ' ' VAL . 1.1 pt? -60.21 164.18 4.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.171 -0.956 . . . . 0.0 108.808 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.725 ' O ' HG12 ' A' ' 97' ' ' VAL . 71.8 t -150.84 57.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.533 -0.73 . . . . 0.0 109.518 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -49.06 114.89 2.35 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.653 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -107.28 143.68 17.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.053 -1.263 . . . . 0.0 109.768 -179.107 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 100' ' ' TYR . 0.1 OUTLIER -142.98 153.32 42.9 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -151.24 6.38 0.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.822 -1.174 . . . . 0.0 111.692 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 103' ' ' LYS . 3.0 mm-40 -100.77 -78.22 0.52 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.586 -1.321 . . . . 0.0 109.817 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 8.4 mmtp -155.11 30.03 0.4 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.428 -0.795 . . . . 0.0 109.255 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.728 ' N ' HD13 ' A' ' 104' ' ' ILE . 2.2 mm -62.58 149.35 9.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.263 -0.898 . . . . 0.0 109.644 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -106.54 141.52 22.99 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 109.388 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.528 ' CG ' ' HD2' ' A' ' 80' ' ' LYS . 2.1 Cg_endo -62.33 -26.45 77.08 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.078 1.852 . . . . 0.0 110.4 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.45 37.14 3.51 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.9 m -143.03 -46.25 0.3 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -1.132 . . . . 0.0 109.394 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.624 ' HB1' HG13 ' A' ' 16' ' ' VAL . . . -86.77 -25.47 24.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.414 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.95 -22.23 39.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 109.281 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.86 -39.99 63.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.435 -0.79 . . . . 0.0 109.562 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.4 p -76.34 -23.44 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.532 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 109' ' ' ALA . 70.0 t -85.63 -18.79 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.867 . . . . 0.0 109.581 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.98 -31.45 39.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.331 -0.856 . . . . 0.0 109.586 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -83.7 -55.13 4.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.855 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.454 HD22 HD11 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -58.65 -31.02 67.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.912 . . . . 0.0 109.501 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.945 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -73.51 -26.82 61.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.204 -0.935 . . . . 0.0 109.471 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -66.57 -26.65 67.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.131 -0.98 . . . . 0.0 109.675 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 8.8 t80 -82.23 -52.37 7.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.88 . . . . 0.0 109.608 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.501 HD23 ' HA ' ' A' ' 117' ' ' ALA . 0.5 OUTLIER -63.94 -25.26 68.06 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.22 -0.925 . . . . 0.0 109.943 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.945 HD12 ' O ' ' A' ' 117' ' ' ALA . 2.8 mt -90.63 -18.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.94 . . . . 0.0 109.193 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.28 -16.67 28.37 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -91.26 -60.77 1.81 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -1.148 . . . . 0.0 109.334 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 125' ' ' PHE . . . 158.38 104.39 0.2 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.988 0 O-C-N 121.19 -1.182 . . . . 0.0 108.905 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.546 ' C ' ' CG ' ' A' ' 2' ' ' TRP . 1.2 p . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 1.019 ' N ' HD11 ' A' ' 21' ' ' ILE . 8.1 m95 74.28 173.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.365 -0.834 . . . . 0.0 109.335 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -81.88 -90.57 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.924 -1.11 . . . . 0.0 111.08 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.56 -34.61 7.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.101 -0.999 . . . . 0.0 110.332 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 1.9 m-30 -71.07 -38.17 72.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.049 -1.032 . . . . 0.0 109.601 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.836 ' HA ' HG23 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -51.72 -24.15 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 6' ' ' VAL . 20.5 t0 -40.37 -89.91 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.532 -0.73 . . . . 0.0 111.253 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.2 t -144.05 -23.46 0.56 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.063 -1.023 . . . . 0.0 111.427 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.584 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.4 m120 -75.42 -55.7 5.43 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.674 -1.266 . . . . 0.0 109.504 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 0.6 OUTLIER -76.91 -25.36 52.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.848 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.836 HG23 ' HA ' ' A' ' 6' ' ' VAL . 1.8 t -92.36 -55.12 6.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.183 -0.948 . . . . 0.0 108.712 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.742 ' C ' HG22 ' A' ' 13' ' ' THR . . . -43.69 -39.17 4.57 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 107.952 -2.059 . . . . 0.0 107.952 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.742 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 159.94 47.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.827 -0.808 . . . . 0.0 110.068 178.579 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.707 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -90.57 20.77 36.2 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 106.918 -2.473 . . . . 0.0 106.918 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.707 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 156.43 -32.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 27.5 m -141.93 147.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.647 ' N ' HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -80.67 12.58 3.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.944 -1.097 . . . . 0.0 109.209 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.712 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -175.42 -178.32 1.12 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 18' ' ' GLN . . . 161.56 148.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 109.31 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.521 ' HB2' ' OG1' ' A' ' 31' ' ' THR . . . -137.82 160.23 39.84 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.166 -0.959 . . . . 0.0 109.482 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 1.019 HD11 ' N ' ' A' ' 2' ' ' TRP . 30.8 mt -131.81 95.9 2.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.832 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -89.86 128.08 36.12 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.442 0.639 . . . . 0.0 109.459 -178.029 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.19 167.54 49.12 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.981 ' N ' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -71.25 -8.34 52.94 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.52 -0.988 . . . . 0.0 109.515 -179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -78.83 -27.21 44.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.555 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.29 -3.03 34.91 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -93.5 -155.51 0.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -1.175 . . . . 0.0 109.145 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.22 129.71 56.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.886 -1.134 . . . . 0.0 110.138 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.577 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 3.1 m0 -101.16 -34.04 9.85 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.316 -0.865 . . . . 0.0 108.907 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 29' ' ' TRP . . . 170.33 92.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.433 -0.792 . . . . 0.0 109.063 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.521 ' OG1' ' HB2' ' A' ' 20' ' ' ALA . 14.1 t -109.31 172.08 7.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 110.105 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.791 ' OG ' HG13 ' A' ' 6' ' ' VAL . 16.1 m -156.41 86.77 1.02 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.481 -0.762 . . . . 0.0 109.366 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.543 ' HB3' ' CE2' ' A' ' 35' ' ' PHE . . . -169.39 -55.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.306 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.94 -43.99 1.29 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.543 ' CE2' ' HB3' ' A' ' 33' ' ' ALA . 11.1 p90 -48.08 162.52 0.08 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -1.091 . . . . 0.0 109.591 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.63 121.82 38.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.213 -0.93 . . . . 0.0 109.484 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.408 HG13 HD22 ' A' ' 62' ' ' LEU . 75.6 t -89.94 123.25 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.887 . . . . 0.0 109.427 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.68 127.2 91.17 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.16 -0.962 . . . . 0.0 109.307 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.737 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 1.9 Cg_endo -62.2 169.41 7.84 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.036 1.824 . . . . 0.0 110.526 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.737 ' HB3' ' O ' ' A' ' 39' ' ' PRO . . . 83.03 -24.41 0.17 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.721 -0.612 . . . . 0.0 110.345 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.471 ' HB3' HD21 ' A' ' 62' ' ' LEU . 0.8 OUTLIER -81.45 -10.55 59.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.986 -1.072 . . . . 0.0 109.55 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -56.74 -34.5 64.89 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -70.35 -39.36 74.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -1.167 . . . . 0.0 109.656 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.9 m -51.22 -34.17 31.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.541 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.6 tp -67.35 -48.38 67.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.467 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.17 -7.52 30.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 0.0 109.62 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.61 -29.45 16.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.087 -1.008 . . . . 0.0 109.735 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.89 -24.84 58.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.137 -0.977 . . . . 0.0 109.819 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.479 ' CE1' ' O ' ' A' ' 75' ' ' ARG . 9.1 m-85 -57.11 -29.59 63.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 109.566 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -113.27 -16.72 12.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.101 -0.999 . . . . 0.0 109.465 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -117.46 112.27 20.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 109.21 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.646 ' HA ' HD11 ' A' ' 55' ' ' ILE . . . -100.26 -8.77 23.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.608 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.573 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -64.79 -52.6 49.5 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 109.902 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.1 Cg_endo -64.33 -4.84 8.66 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.197 1.931 . . . . 0.0 111.205 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.646 HD11 ' HA ' ' A' ' 52' ' ' ALA . 1.9 pp -128.39 0.74 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.932 -1.105 . . . . 0.0 109.684 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -98.27 -34.77 10.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.113 -0.992 . . . . 0.0 109.45 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.46 -23.09 65.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -0.821 . . . . 0.0 109.695 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.9 t -170.47 -38.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.126 -0.984 . . . . 0.0 109.688 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 54' ' ' PRO . . . 132.53 -123.11 3.45 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.667 ' CE1' HD12 ' A' ' 62' ' ' LEU . 34.3 p90 -160.28 170.98 19.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.108 -1.231 . . . . 0.0 109.699 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.33 140.22 43.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.705 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 3.0 mt -147.99 115.69 6.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.885 . . . . 0.0 109.61 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.705 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . 76.62 13.04 2.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 109.753 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.65 29.23 24.58 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.657 HG12 ' H ' ' A' ' 66' ' ' HIS . 1.5 t -130.69 -169.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -1.138 . . . . 0.0 109.2 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.657 ' H ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -134.75 126.08 28.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.122 -0.986 . . . . 0.0 110.195 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -112.88 152.46 29.25 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.61 163.8 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.725 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.1 m -103.85 135.25 45.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.308 -0.87 . . . . 0.0 109.496 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.565 HD13 ' CD ' ' A' ' 80' ' ' LYS . 2.1 tp -113.91 -50.33 2.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.704 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.31 51.63 1.37 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 109.689 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.645 ' HB3' HD13 ' A' ' 55' ' ' ILE . . . -79.28 87.73 4.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.223 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.75 -55.93 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.86 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -81.86 -103.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.064 -1.022 . . . . 0.0 109.716 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.479 ' O ' ' CE1' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -134.59 0.54 3.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.903 -1.123 . . . . 0.0 109.975 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 43.7 m -106.22 142.5 35.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.058 -1.026 . . . . 0.0 109.613 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.448 HG22 ' O ' ' A' ' 77' ' ' ILE . 36.3 mt -139.78 88.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.45 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 76' ' ' SER . 1.7 m-85 -90.25 65.98 6.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.051 -1.03 . . . . 0.0 109.575 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -44.85 153.04 0.55 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.565 ' CD ' HD13 ' A' ' 70' ' ' LEU . 11.6 ptpt -151.49 94.53 2.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.022 -1.281 . . . . 0.0 109.844 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -160.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 0.0 109.263 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -46.06 -73.75 0.27 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.468 ' OG ' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -112.2 -24.2 9.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -1.158 . . . . 0.0 109.483 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.31 -174.02 4.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.152 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.555 ' N ' ' CE1' ' A' ' 100' ' ' TYR . . . 177.18 152.23 9.75 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.092 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 86' ' ' VAL . 9.5 p -117.86 124.27 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -1.042 . . . . 0.0 108.709 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.693 HG21 HG21 ' A' ' 113' ' ' VAL . 67.4 mt -100.62 89.81 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.983 -1.073 . . . . 0.0 110.21 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 11.3 p -101.89 135.24 43.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.131 -0.981 . . . . 0.0 109.64 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.419 ' HB ' HD12 ' A' ' 96' ' ' LEU . 47.2 t -149.16 155.9 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.211 -0.93 . . . . 0.0 109.486 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.405 ' N ' HG12 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -101.82 131.96 47.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.109 -0.994 . . . . 0.0 109.481 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.2 p -107.76 -97.72 0.37 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.252 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.9 p -129.58 -31.92 1.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.017 -1.052 . . . . 0.0 109.484 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.27 51.61 0.53 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.919 . . . . 0.0 109.341 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.605 ' CA ' HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -178.9 159.06 1.0 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.529 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.558 HG13 HD12 ' A' ' 24' ' ' LEU . 25.0 mt -120.38 112.14 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.12 -0.987 . . . . 0.0 109.304 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.863 HD13 ' CH2' ' A' ' 2' ' ' TRP . 8.3 mt -67.54 153.15 44.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.335 -0.853 . . . . 0.0 109.618 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.768 HG21 ' HG ' ' A' ' 22' ' ' LEU . 60.5 t -150.58 53.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.844 . . . . 0.0 109.776 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -45.16 137.44 6.31 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 97' ' ' VAL . 2.4 t -139.48 117.72 11.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.044 -1.268 . . . . 0.0 108.649 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.555 ' CE1' ' N ' ' A' ' 85' ' ' GLY . 7.2 p90 -138.31 164.04 30.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.014 -1.054 . . . . 0.0 109.756 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -110.64 -145.54 0.4 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 0.0 109.881 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.468 ' HG2' ' OG ' ' A' ' 83' ' ' SER . 10.4 mt-10 -76.05 -7.48 54.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.968 . . . . 0.0 110.104 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -16.44 61.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.074 -1.016 . . . . 0.0 109.758 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.647 HD13 ' N ' ' A' ' 17' ' ' THR . 1.2 mp -136.99 141.05 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.246 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -101.98 150.34 37.34 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 109.559 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.458 ' HB2' ' HE2' ' A' ' 80' ' ' LYS . 1.9 Cg_endo -62.32 161.82 25.82 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.27 1.98 . . . . 0.0 110.444 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.6 -55.91 4.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.1 m -67.94 -31.58 71.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -1.081 . . . . 0.0 109.689 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.615 ' O ' HG12 ' A' ' 112' ' ' VAL . . . -84.24 -36.92 22.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 109.504 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.96 -29.79 71.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.297 -0.877 . . . . 0.0 109.498 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -61.28 -36.37 79.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.982 . . . . 0.0 109.524 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.804 HG22 HD13 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -77.76 -31.62 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.135 -0.978 . . . . 0.0 109.432 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.693 HG21 HG21 ' A' ' 87' ' ' ILE . 53.5 t -63.61 -23.65 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.086 -1.008 . . . . 0.0 109.451 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -77.85 -43.73 29.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.342 -0.849 . . . . 0.0 109.715 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -80.81 -63.73 1.34 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 109.23 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.804 HD13 HG22 ' A' ' 112' ' ' VAL . 0.2 OUTLIER -42.23 -28.42 0.19 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.495 -0.753 . . . . 0.0 109.661 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 113' ' ' VAL . . . -73.72 -47.98 35.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.715 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -49.13 -21.39 0.74 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.07 -1.019 . . . . 0.0 110.008 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -85.47 -41.33 15.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.318 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 1.1 mt -78.21 -56.08 4.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.097 -1.002 . . . . 0.0 110.361 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.453 ' C ' ' O ' ' A' ' 120' ' ' LEU . 17.8 mt -39.77 -33.44 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.316 -0.865 . . . . 0.0 109.821 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.58 -51.43 36.43 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -59.65 -71.1 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -1.133 . . . . 0.0 109.475 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 130.27 112.15 1.51 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 120' ' ' LEU . 82.7 m-85 . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.211 -1.17 . . . . 0.0 109.535 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.759 ' HA ' HD11 ' A' ' 120' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.603 ' CE3' ' HG ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER 78.28 -6.62 1.92 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.329 -0.857 . . . . 0.0 109.435 -179.524 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 4' ' ' THR . 35.2 tt0 -77.8 -81.14 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.055 -1.028 . . . . 0.0 108.746 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.652 ' O ' HG22 ' A' ' 8' ' ' THR . 1.2 t -48.47 -30.23 4.93 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.619 ' CD2' ' CD2' ' A' ' 10' ' ' LEU . 3.2 m-30 -48.19 -54.67 12.65 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.841 ' HA ' HG23 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -50.53 -37.77 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -0.799 . . . . 0.0 109.644 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.684 ' C ' HG22 ' A' ' 8' ' ' THR . 1.0 OUTLIER -90.85 51.53 1.99 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.071 -1.018 . . . . 0.0 111.951 -178.422 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.684 HG22 ' C ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER 173.28 -87.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.482 -1.386 . . . . 0.0 111.486 178.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 11' ' ' VAL . 4.2 m-20 -90.04 -83.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 111.34 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.619 ' CD2' ' CD2' ' A' ' 5' ' ' TYR . 3.8 mm? -21.12 -44.8 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.889 HG13 ' HA ' ' A' ' 18' ' ' GLN . 38.5 t -88.02 -59.22 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.659 -1.276 . . . . 0.0 110.279 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.77 ' C ' HG22 ' A' ' 13' ' ' THR . . . -37.8 -41.07 0.84 Allowed Glycine 0 N--CA 1.498 2.805 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.77 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 155.95 39.88 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.607 0.718 . . . . 0.0 109.378 178.177 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.678 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -83.75 19.32 16.17 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 156.2 -28.08 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 13' ' ' THR . 2.2 m -151.41 152.08 11.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.542 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -79.66 8.12 7.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.798 -1.189 . . . . 0.0 109.292 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.889 ' HA ' HG13 ' A' ' 11' ' ' VAL . 31.5 mt-30 -162.64 176.6 10.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.623 ' HA ' HG23 ' A' ' 99' ' ' VAL . . . -177.78 155.49 1.02 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.863 -1.148 . . . . 0.0 110.234 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.506 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -148.91 114.63 5.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 0.0 109.576 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.62 ' C ' HD23 ' A' ' 22' ' ' LEU . 7.9 mm -81.28 114.86 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.84 -1.162 . . . . 0.0 108.693 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.881 HD11 HG21 ' A' ' 97' ' ' VAL . 0.6 OUTLIER -108.51 88.37 2.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -0.915 . . . . 0.0 108.994 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.609 ' HA3' ' CD2' ' A' ' 29' ' ' TRP . . . -50.11 -177.51 0.02 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.794 HD11 ' CA ' ' A' ' 93' ' ' LYS . 13.0 mt -84.03 -50.93 7.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.384 -1.068 . . . . 0.0 109.408 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.86 13.25 33.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.017 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 28' ' ' THR . . . -130.75 80.31 0.35 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.472 ' C ' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -35.44 -31.04 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.905 -0.762 . . . . 0.0 110.441 -179.435 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -139.04 99.19 3.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.939 -1.1 . . . . 0.0 110.171 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.609 ' CD2' ' HA3' ' A' ' 23' ' ' GLY . 6.5 m0 -95.85 -24.61 16.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 108.996 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -171.79 145.01 1.87 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.42 HG22 ' HB1' ' A' ' 20' ' ' ALA . 18.5 p -149.82 162.03 41.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.123 -0.986 . . . . 0.0 109.848 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.838 ' OG ' HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -166.08 84.6 0.31 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.445 -0.785 . . . . 0.0 109.205 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.4 -67.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 109.295 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 138.6 -23.34 2.96 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.5 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -62.23 178.71 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.063 -1.257 . . . . 0.0 109.782 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 63' ' ' ALA . . . -107.89 125.84 51.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.024 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.777 HG13 ' CD ' ' A' ' 41' ' ' GLN . 8.3 t -144.89 103.52 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.768 HG23 ' HD3' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -173.66 -59.12 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.176 -0.953 . . . . 0.0 110.175 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.768 ' HD3' HG23 ' A' ' 38' ' ' THR . 1.9 Cg_endo -59.4 118.33 5.2 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.708 1.605 . . . . 0.0 110.774 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.507 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . . . 54.95 35.17 23.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.291 -0.881 . . . . 0.0 109.973 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.777 ' CD ' HG13 ' A' ' 37' ' ' VAL . 2.4 mm-40 -90.39 -53.88 4.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.801 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.59 -42.84 16.65 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.507 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 4.0 pp0? -59.7 -26.94 66.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -1.18 . . . . 0.0 109.679 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.0 m -67.47 -53.66 26.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 109.341 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.556 ' O ' ' CD2' ' A' ' 49' ' ' PHE . 8.5 mp -63.53 -29.71 70.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 109.681 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.16 92.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.952 . . . . 0.0 109.533 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.2 t -86.33 -17.23 35.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.495 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.65 51.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.425 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 45' ' ' LEU . 35.4 m-85 -79.01 -10.38 59.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.175 -0.953 . . . . 0.0 109.642 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.455 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 0.4 OUTLIER -89.38 -0.44 57.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.96 . . . . 0.0 109.578 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.576 ' ND2' ' HG2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER 175.28 118.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.069 -1.019 . . . . 0.0 109.839 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 72' ' ' ALA . . . -94.97 -13.35 25.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -0.813 . . . . 0.0 109.259 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.61 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -63.08 -50.17 77.46 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 110.204 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.4 Cg_endo -63.83 -13.63 38.25 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.02 1.814 . . . . 0.0 110.967 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.799 HD11 ' CB ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -91.68 -14.79 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.861 -1.149 . . . . 0.0 109.532 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.603 ' CZ ' ' CB ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -81.29 -48.39 12.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.867 . . . . 0.0 109.477 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 58' ' ' SER . . . -77.01 -86.68 0.05 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.242 -0.911 . . . . 0.0 109.43 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 57' ' ' ALA . 20.2 m -44.36 -57.44 3.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.334 -0.854 . . . . 0.0 109.156 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.89 175.04 18.93 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.495 ' CE1' ' OG1' ' A' ' 69' ' ' THR . 10.7 p90 -124.59 124.44 42.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.436 -1.038 . . . . 0.0 108.984 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.87 161.47 15.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -0.964 . . . . 0.0 110.137 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.61 -142.78 0.24 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 36' ' ' ALA . . . -74.02 -0.59 16.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.24 -0.913 . . . . 0.0 109.557 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.41 -102.09 2.76 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 66' ' ' HIS . 0.9 OUTLIER -136.22 -147.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.23 -1.159 . . . . 0.0 109.538 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.432 ' H ' HG12 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -82.43 133.79 35.22 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.151 -0.968 . . . . 0.0 109.505 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' A' ' 60' ' ' PHE . 3.0 m-30 -112.76 147.64 36.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 109.495 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -93.25 143.12 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.136 -0.978 . . . . 0.0 109.321 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.633 HG21 ' CD1' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -108.41 119.17 38.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.627 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 70' ' ' LEU . 1.4 pp -111.66 21.3 16.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.583 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.423 ' CG ' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER 177.21 102.29 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.134 -0.979 . . . . 0.0 109.523 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.799 ' CB ' HD11 ' A' ' 55' ' ' ILE . . . -153.7 54.6 0.73 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.108 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.24 -16.82 4.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.136 -0.978 . . . . 0.0 110.142 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -110.84 -104.73 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.0 109.752 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -143.41 27.61 1.54 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.955 -1.09 . . . . 0.0 109.253 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.615 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -143.12 129.24 19.73 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.469 ' O ' ' OG1' ' A' ' 88' ' ' THR . 2.4 mp -133.37 99.4 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.922 -1.111 . . . . 0.0 111.025 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.656 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -109.52 96.47 6.3 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.128 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.66 168.98 42.37 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.455 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.451 ' HG3' ' HA3' ' A' ' 85' ' ' GLY . 19.8 tttt -150.52 154.69 38.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.525 -0.985 . . . . 0.0 109.109 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 -13.42 9.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.012 -1.055 . . . . 0.0 109.737 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.37 -76.91 0.23 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.4 p -94.61 -40.9 9.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -1.219 . . . . 0.0 109.384 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.34 145.27 26.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 0.0 109.359 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.578 ' O ' ' CE1' ' A' ' 100' ' ' TYR . . . -138.65 143.46 14.23 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.986 HG23 HG13 ' A' ' 97' ' ' VAL . 2.4 p -110.23 136.05 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -1.099 . . . . 0.0 109.56 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.692 ' O ' HG22 ' A' ' 87' ' ' ILE . 3.2 mt -109.92 91.63 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -0.766 . . . . 0.0 109.011 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 5.0 p -89.33 112.67 23.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.061 -1.024 . . . . 0.0 109.69 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.48 136.88 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.265 -0.897 . . . . 0.0 108.837 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.29 150.62 23.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.067 -1.021 . . . . 0.0 110.032 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.9 p -132.95 -144.63 0.24 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.398 -0.814 . . . . 0.0 109.048 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.543 ' HB3' ' CA ' ' A' ' 124' ' ' GLY . 47.0 t -87.01 -29.86 21.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.039 -1.038 . . . . 0.0 109.447 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.794 ' CA ' HD11 ' A' ' 24' ' ' LEU . 17.2 mttt -159.58 55.91 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 0.0 109.796 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.63 ' CB ' ' CG ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -177.73 151.25 0.7 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.869 -1.144 . . . . 0.0 110.213 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.7 ' C ' HD13 ' A' ' 96' ' ' LEU . 14.7 mt -125.08 126.16 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.805 HD22 ' N ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -108.24 161.61 14.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.992 -178.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.986 HG13 HG23 ' A' ' 86' ' ' VAL . 25.6 t -139.49 125.86 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.61 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.474 ' HA3' ' HB ' ' A' ' 87' ' ' ILE . . . -103.79 101.22 1.98 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 107.875 -2.09 . . . . 0.0 107.875 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.623 HG23 ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -99.23 128.93 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -1.123 . . . . 0.0 109.048 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 100' ' ' TYR . 1.3 p90 -144.48 -170.82 3.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.64 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 101' ' ' ASN . 0.0 OUTLIER -120.19 -159.14 0.77 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.895 . . . . 0.0 109.047 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -76.32 -16.33 59.79 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.3 -0.875 . . . . 0.0 109.567 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -37.9 83.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.387 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.553 HG13 ' HB2' ' A' ' 100' ' ' TYR . 14.8 mm -79.62 150.79 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.294 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -93.76 138.18 22.9 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.144 -0.973 . . . . 0.0 109.188 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.96 -23.95 53.67 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.1 1.867 . . . . 0.0 110.828 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.06 -47.04 4.27 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.879 -1.153 . . . . 0.0 110.512 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 112' ' ' VAL . 15.7 m -66.5 -47.44 73.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.004 -1.292 . . . . 0.0 109.89 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.45 -12.13 28.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 0.0 110.023 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.62 -26.44 19.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 0.0 109.942 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -83.7 -42.44 16.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.089 -1.007 . . . . 0.0 109.591 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 108' ' ' THR . 2.5 t -67.31 -36.8 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.346 -0.846 . . . . 0.0 110.064 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.679 HG11 HG21 ' A' ' 87' ' ' ILE . 88.6 t -76.41 -26.81 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.196 -0.94 . . . . 0.0 109.585 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -60.67 -50.88 71.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.847 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 116' ' ' LEU . 13.9 ptmm? -66.66 -35.08 79.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 109.64 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -44.26 -42.26 6.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 0.0 109.034 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.497 ' C ' HD12 ' A' ' 121' ' ' ILE . . . -75.58 -37.36 59.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -0.889 . . . . 0.0 109.029 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 115' ' ' LYS . 2.6 m-20 -47.57 -25.65 1.2 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 109.189 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -83.63 -45.97 12.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.811 . . . . 0.0 109.323 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.759 HD11 ' HA ' ' A' ' 1' ' ' SER . 0.5 OUTLIER -87.92 11.03 16.82 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.242 -0.911 . . . . 0.0 109.842 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.497 HD12 ' C ' ' A' ' 117' ' ' ALA . 0.9 OUTLIER -90.41 -22.43 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 109.191 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -71.82 -45.83 41.19 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -84.14 -28.88 27.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -1.176 . . . . 0.0 109.425 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.543 ' CA ' ' HB3' ' A' ' 92' ' ' SER . . . 81.19 48.83 5.82 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.63 ' CG ' ' CB ' ' A' ' 94' ' ' SER . 12.6 m-85 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.405 -1.056 . . . . 0.0 109.876 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.937 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 121.011 0.434 . . . . 0.0 110.282 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.734 ' CH2' HD13 ' A' ' 96' ' ' LEU . 2.8 m95 -88.53 -160.29 0.63 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.986 -1.071 . . . . 0.0 110.242 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.439 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 1.9 mm-40 -72.96 -109.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.873 -1.142 . . . . 0.0 110.567 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.994 ' O ' HG22 ' A' ' 8' ' ' THR . 5.0 t -48.79 -45.47 40.15 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.725 -1.234 . . . . 0.0 109.022 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.003 ' CD2' HD21 ' A' ' 116' ' ' LEU . 14.9 m-30 -41.71 -46.3 3.74 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.549 0.69 . . . . 0.0 109.409 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.669 HG23 ' HB2' ' A' ' 1' ' ' SER . 1.4 t -52.87 -53.66 20.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.462 -0.774 . . . . 0.0 110.007 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.75 50.76 1.74 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.055 -1.028 . . . . 0.0 112.193 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.994 HG22 ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -160.12 -101.33 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.43 -1.419 . . . . 0.0 110.416 178.566 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -102.15 -69.72 0.78 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.965 -1.085 . . . . 0.0 110.988 -178.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.731 HD13 ' HB3' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -22.94 -40.86 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.286 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.659 HG23 ' HA ' ' A' ' 6' ' ' VAL . 4.9 t -80.98 -70.11 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.509 -1.37 . . . . 0.0 110.377 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.741 ' C ' HG22 ' A' ' 13' ' ' THR . . . -38.18 -31.94 0.12 Allowed Glycine 0 N--CA 1.497 2.756 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.741 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER 152.14 42.58 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.701 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -84.78 22.6 8.91 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 154.62 -31.1 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.626 HG12 ' HB3' ' A' ' 100' ' ' TYR . 25.6 m -152.6 147.1 14.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.525 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -78.8 5.76 10.6 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.014 -1.053 . . . . 0.0 108.619 179.293 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.525 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . 23.3 mt-30 -163.34 160.71 23.99 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.815 ' HB3' ' OG ' ' A' ' 1' ' ' SER . . . -173.33 -179.83 2.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.068 -1.02 . . . . 0.0 109.027 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.651 ' HA ' ' H1 ' ' A' ' 1' ' ' SER . . . 176.57 115.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.92 . . . . 0.0 110.36 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.937 HD13 ' C ' ' A' ' 1' ' ' SER . 1.5 mp -80.71 100.29 4.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.732 HD11 HG21 ' A' ' 97' ' ' VAL . 3.0 mt -86.93 111.74 21.11 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.542 -0.724 . . . . 0.0 109.863 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.12 -166.37 0.33 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.974 HD11 ' O ' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -116.22 16.19 15.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.381 -1.07 . . . . 0.0 109.481 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -96.35 -29.2 14.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.79 -25.63 3.07 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.7 p30 -100.15 -163.0 0.99 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -1.106 . . . . 0.0 109.449 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.3 m -129.18 136.57 50.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.109 -0.994 . . . . 0.0 109.608 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -79.93 -45.96 17.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.938 . . . . 0.0 108.93 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 1' ' ' SER . . . -137.29 136.78 38.32 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.06 167.73 21.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.979 -1.076 . . . . 0.0 109.888 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.22 57.2 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 18' ' ' GLN . . . -120.71 -145.51 0.36 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.302 -0.874 . . . . 0.0 109.609 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.94 8.07 5.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.428 ' CZ ' HG11 ' A' ' 99' ' ' VAL . 20.6 p90 -134.26 177.36 7.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -1.167 . . . . 0.0 109.479 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.5 120.79 33.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 109.424 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 t -87.66 151.9 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 109.523 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -105.16 158.48 32.01 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.669 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.14 -30.89 75.46 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.15 1.9 . . . . 0.0 110.41 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.98 78.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.172 -0.955 . . . . 0.0 110.101 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -81.11 -9.93 59.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 109.992 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.27 -34.74 50.47 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -79.45 -41.59 27.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.15 -1.206 . . . . 0.0 109.694 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.1 m -53.96 -42.5 68.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.877 . . . . 0.0 109.397 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.418 HD23 ' CZ ' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -63.16 -40.32 97.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.0 109.496 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.581 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . . . -59.86 -41.76 92.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.191 -0.943 . . . . 0.0 109.314 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.3 p -73.89 -20.67 60.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.335 -0.853 . . . . 0.0 109.121 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 51' ' ' ASN . . . -67.86 -22.54 65.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.407 -0.808 . . . . 0.0 109.477 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.599 ' CE2' ' HG3' ' A' ' 90' ' ' LYS . 51.8 m-85 -70.79 -23.12 62.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.469 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -91.74 -32.81 15.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 0.0 109.446 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.413 ' O ' ' O ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -120.25 147.87 44.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.642 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.615 ' HA ' HD11 ' A' ' 55' ' ' ILE . . . -119.44 8.96 11.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 109.499 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.589 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -78.39 -49.49 1.79 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.279 -0.888 . . . . 0.0 110.337 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.6 Cg_endo -66.02 -9.97 25.31 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.953 1.768 . . . . 0.0 111.115 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -109.05 -13.32 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.955 -1.091 . . . . 0.0 109.886 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.506 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 15.0 ptm180 -97.99 -13.36 21.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 109.464 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -124.99 117.98 25.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.611 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 59' ' ' GLY . 1.5 p 69.11 10.28 7.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.281 -0.887 . . . . 0.0 109.42 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 68' ' ' VAL . . . 44.18 -123.09 4.76 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.402 ' CD2' HG22 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -157.85 -174.72 4.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -1.111 . . . . 0.0 109.539 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -119.13 125.41 49.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.359 -0.838 . . . . 0.0 109.17 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.699 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -120.66 104.27 9.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.888 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . 77.78 -81.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.35 -0.844 . . . . 0.0 109.831 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.63 16.85 0.48 Allowed Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.653 -1.261 . . . . 0.0 110.139 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 66' ' ' HIS . 7.3 t -123.43 164.86 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.055 -1.262 . . . . 0.0 109.245 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.437 ' N ' HG12 ' A' ' 65' ' ' VAL . 5.2 m170 -111.0 123.11 49.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.139 -0.976 . . . . 0.0 109.816 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -120.08 165.89 14.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 108.813 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 69' ' ' THR . 0.9 OUTLIER -124.96 -162.19 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.067 -1.021 . . . . 0.0 109.464 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.794 HG21 ' HB2' ' A' ' 72' ' ' ALA . 57.2 m -155.83 131.31 9.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.925 . . . . 0.0 109.778 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.54 HD22 ' O ' ' A' ' 69' ' ' THR . 2.9 mm? -119.82 19.89 12.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.9 . . . . 0.0 109.238 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.48 ' H ' HG22 ' A' ' 69' ' ' THR . 29.9 ttm180 178.9 78.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.319 -0.863 . . . . 0.0 109.387 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.794 ' HB2' HG21 ' A' ' 69' ' ' THR . . . -106.99 77.4 1.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.751 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -75.45 176.72 7.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 109.187 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.15 -2.43 55.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 109.545 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.486 ' NH1' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -98.16 -66.07 0.92 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 0.0 109.101 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.54 ' HA ' HG23 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -127.25 176.46 7.39 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.306 -0.871 . . . . 0.0 109.402 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.521 ' CG1' ' O ' ' A' ' 76' ' ' SER . 29.8 mt -159.49 134.26 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 109.583 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.68 ' CD1' HG23 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -142.5 81.8 1.75 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.043 179.457 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.52 170.38 42.64 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.49 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -150.82 158.71 44.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -1.103 . . . . 0.0 109.606 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.551 ' HG3' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER 176.22 105.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 109.448 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.544 ' N ' ' HE3' ' A' ' 81' ' ' LYS . . . 85.82 33.51 15.48 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 82' ' ' GLY . 1.7 p 71.36 4.69 5.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -1.108 . . . . 0.0 109.39 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 100' ' ' TYR . . . -122.47 118.28 27.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.241 -0.912 . . . . 0.0 109.14 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 80' ' ' LYS . . . -126.45 149.76 17.58 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.861 HG23 HG13 ' A' ' 97' ' ' VAL . 13.4 p -105.18 123.79 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.405 -1.056 . . . . 0.0 109.379 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.785 HG22 ' O ' ' A' ' 87' ' ' ILE . 1.3 mt -87.7 79.67 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.303 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 7.4 p -92.24 126.55 37.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -0.864 . . . . 0.0 109.723 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.642 HG13 HD12 ' A' ' 96' ' ' LEU . 2.1 p -145.68 130.49 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.278 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.599 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -82.48 131.31 35.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.904 . . . . 0.0 109.598 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.451 ' CG2' HD11 ' A' ' 96' ' ' LEU . 1.9 p -102.75 -95.97 0.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.845 . . . . 0.0 109.401 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.44 ' C ' ' HG2' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -125.81 -43.0 1.87 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.023 -1.048 . . . . 0.0 109.409 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.974 ' O ' HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -146.46 50.37 1.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.915 . . . . 0.0 109.609 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.569 ' N ' HD21 ' A' ' 24' ' ' LEU . 1.2 p 170.73 166.19 0.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.101 -0.999 . . . . 0.0 109.671 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.7 mt -118.91 142.88 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.171 -0.956 . . . . 0.0 109.379 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.734 HD13 ' CH2' ' A' ' 2' ' ' TRP . 0.5 OUTLIER -108.4 147.8 31.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.934 . . . . 0.0 108.731 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.861 HG13 HG23 ' A' ' 86' ' ' VAL . 70.3 t -133.04 131.02 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.895 -1.128 . . . . 0.0 110.653 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.447 ' HA3' ' HB ' ' A' ' 87' ' ' ILE . . . -118.97 91.96 0.52 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -94.97 110.01 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.136 -1.214 . . . . 0.0 109.586 -178.476 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.626 ' HB3' HG12 ' A' ' 16' ' ' VAL . 30.7 p90 -119.87 158.27 26.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.424 -0.797 . . . . 0.0 109.79 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.492 ' O ' HG13 ' A' ' 104' ' ' ILE . 7.1 m-20 -131.29 174.46 10.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.278 -0.889 . . . . 0.0 109.56 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 16.0 mm-40 70.68 26.34 3.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.695 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.45 78.6 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.963 . . . . 0.0 109.42 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.623 HG22 ' O ' ' A' ' 104' ' ' ILE . 5.1 mt -98.04 54.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.146 -0.971 . . . . 0.0 109.879 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER 41.94 97.09 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.476 -0.765 . . . . 0.0 110.238 179.583 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.41 -13.94 18.66 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.952 1.768 . . . . 0.0 110.297 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -100.78 -30.04 6.28 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 105' ' ' GLN . 31.4 m -73.21 -31.99 64.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.12 -1.223 . . . . 0.0 109.437 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -88.23 -15.04 36.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.32 -0.863 . . . . 0.0 109.527 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.98 -31.27 25.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.628 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.473 ' O ' ' HB3' ' A' ' 114' ' ' GLU . 2.8 m120 -73.55 -39.08 65.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.13 -0.981 . . . . 0.0 109.523 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.564 HG11 ' HB1' ' A' ' 15' ' ' ALA . 6.1 p -61.93 -37.78 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 0.0 109.185 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 109' ' ' ALA . 21.9 t -68.62 -20.68 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.327 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 111' ' ' ASN . 6.5 tt0 -63.79 -61.84 2.04 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.151 -0.968 . . . . 0.0 109.09 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -39.1 89.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.129 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.003 HD21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -57.27 -27.02 61.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.381 -0.824 . . . . 0.0 109.448 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.518 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -75.56 -44.2 44.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 0.0 109.49 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -53.26 -19.08 2.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.91 . . . . 0.0 109.472 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -82.58 -58.58 2.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 109.787 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.618 HD22 ' OXT' ' A' ' 125' ' ' PHE . 2.6 mt -61.3 -56.56 19.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.952 . . . . 0.0 110.115 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 117' ' ' ALA . 6.1 mt -41.2 -29.84 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.272 -0.892 . . . . 0.0 109.802 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 123' ' ' GLN . . . -105.61 49.35 0.9 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 122' ' ' GLY . 1.1 mt-30 -173.68 -69.65 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.398 -1.06 . . . . 0.0 109.61 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.452 ' O ' ' OXT' ' A' ' 125' ' ' PHE . . . -133.88 56.13 0.73 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.618 ' OXT' HD22 ' A' ' 120' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.397 -1.061 . . . . 0.0 109.588 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.566 ' C ' ' CG ' ' A' ' 2' ' ' TRP . 1.5 t . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.995 ' C ' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER 57.67 146.13 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.17 -0.956 . . . . 0.0 109.988 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.632 ' N ' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -83.63 -76.47 0.29 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.083 -1.011 . . . . 0.0 110.583 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.527 HG23 ' CD1' ' A' ' 5' ' ' TYR . 2.1 t -39.56 -28.81 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.208 -0.933 . . . . 0.0 109.737 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.597 ' HB2' ' HB2' ' A' ' 2' ' ' TRP . 18.1 m-30 -86.36 -43.45 12.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 0.0 108.916 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.809 HG13 ' HB2' ' A' ' 32' ' ' SER . 0.9 OUTLIER -46.77 -27.87 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.472 0.653 . . . . 0.0 109.852 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.56 -84.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 111.869 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.91 2.58 3.68 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.681 -1.262 . . . . 0.0 110.801 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.535 ' O ' ' N ' ' A' ' 14' ' ' GLY . 6.0 m-20 -92.87 -90.99 0.18 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.969 -1.082 . . . . 0.0 109.621 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -52.97 -30.2 33.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.155 -0.966 . . . . 0.0 110.081 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.828 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 21.2 t -88.64 -59.01 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.054 -1.029 . . . . 0.0 109.554 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.744 ' C ' HG22 ' A' ' 13' ' ' THR . . . -42.38 -30.73 0.87 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 107.944 -2.063 . . . . 0.0 107.944 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.744 HG22 ' C ' ' A' ' 12' ' ' GLY . 1.0 OUTLIER 147.66 51.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.12 0.486 . . . . 0.0 109.885 178.418 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.699 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -90.03 19.22 43.57 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 107.071 -2.411 . . . . 0.0 107.071 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 144.93 -25.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 34.8 m -139.11 149.94 23.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.52 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 5.5 p -87.29 20.75 2.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.976 -1.077 . . . . 0.0 108.662 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.543 ' HB3' ' CB ' ' A' ' 33' ' ' ALA . 4.7 mp0 -171.21 172.59 5.25 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.578 -0.701 . . . . 0.0 109.256 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.828 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . -175.73 135.11 0.3 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.073 -1.017 . . . . 0.0 109.602 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.526 ' O ' HD22 ' A' ' 22' ' ' LEU . . . -133.08 121.06 22.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.072 -1.018 . . . . 0.0 110.079 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.995 HD11 ' C ' ' A' ' 2' ' ' TRP . 8.0 mt -86.16 96.72 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 108.624 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.801 HD23 ' CG2' ' A' ' 97' ' ' VAL . 3.0 mm? -79.15 -179.92 6.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.373 -0.829 . . . . 0.0 109.18 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 94' ' ' SER . . . -133.35 106.36 0.63 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.576 HD23 ' C ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -51.82 -38.2 54.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -1.178 . . . . 0.0 109.465 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -138.85 35.61 2.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.482 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.38 -102.32 1.1 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.424 ' O ' ' HB ' ' A' ' 28' ' ' THR . 1.2 p30 174.57 52.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -1.12 . . . . 0.0 109.401 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 28' ' ' THR . 1.4 m 59.18 98.93 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.981 -1.074 . . . . 0.0 109.139 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.525 ' CE2' ' OG ' ' A' ' 94' ' ' SER . 38.2 m0 -84.07 -29.27 26.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.88 . . . . 0.0 109.639 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.24 157.99 33.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 109.396 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.457 ' O ' ' OG ' ' A' ' 32' ' ' SER . 0.1 OUTLIER -160.09 152.13 20.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.576 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.809 ' HB2' HG13 ' A' ' 6' ' ' VAL . 73.7 m -169.72 58.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.845 . . . . 0.0 109.402 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 18' ' ' GLN . . . -120.27 -66.38 1.07 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.199 -0.938 . . . . 0.0 109.778 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.6 -37.95 1.88 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.794 -1.723 . . . . 0.0 108.794 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.506 ' CZ ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -59.0 177.47 0.15 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.386 -1.067 . . . . 0.0 109.415 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.49 140.47 29.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 110.439 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.506 ' CG2' ' CZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -149.28 135.64 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.342 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.408 ' OG1' ' HB1' ' A' ' 63' ' ' ALA . 43.6 p -132.66 117.0 15.09 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.168 -0.957 . . . . 0.0 109.617 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.706 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 6.2 Cg_exo -58.07 117.11 3.76 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.952 1.768 . . . . 0.0 110.384 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 39' ' ' PRO . . . 162.91 -63.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 109.005 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 63' ' ' ALA . 14.4 mm100 -68.08 -12.36 60.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.147 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.88 -24.55 42.13 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -68.69 -52.37 31.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -1.12 . . . . 0.0 109.324 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.9 m -57.86 -25.8 61.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.358 -0.838 . . . . 0.0 109.243 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.511 ' HG ' ' CE1' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -65.13 -43.8 90.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.279 -0.888 . . . . 0.0 109.493 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.71 -30.84 70.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 109.893 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 p -66.11 -30.87 71.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.278 -0.889 . . . . 0.0 110.086 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.07 -10.97 59.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.126 -0.984 . . . . 0.0 109.904 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.708 ' CD2' HD13 ' A' ' 77' ' ' ILE . 4.4 m-85 -90.41 17.61 7.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.928 . . . . 0.0 109.583 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -98.75 5.52 47.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 0.0 109.35 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.539 ' O ' HD11 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -176.47 162.66 2.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.317 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 56' ' ' ARG . . . -101.26 -2.02 32.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.562 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 1.4 m-20 -75.7 -54.65 2.19 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 110.129 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 3.5 Cg_exo -61.57 -11.31 19.62 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.007 1.805 . . . . 0.0 110.686 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.539 HD11 ' O ' ' A' ' 51' ' ' ASN . 0.7 OUTLIER -118.62 -11.08 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.993 . . . . 0.0 109.658 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.511 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -97.89 44.59 1.04 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 0.0 109.264 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -169.85 -58.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.126 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.9 p -94.73 -25.8 16.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.334 -0.854 . . . . 0.0 109.298 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.64 -152.58 20.61 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -142.66 -174.66 4.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -1.073 . . . . 0.0 109.342 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.46 136.37 17.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.144 -0.972 . . . . 0.0 109.812 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.6 mp -82.23 -138.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 108.944 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 41' ' ' GLN . . . -84.5 41.72 0.86 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.942 -1.099 . . . . 0.0 110.328 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.94 0.59 5.57 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.66 140.6 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.175 -1.191 . . . . 0.0 109.748 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -106.14 108.9 20.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 109.565 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.12 166.4 12.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.177 -0.952 . . . . 0.0 109.257 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.603 HG22 ' N ' ' A' ' 69' ' ' THR . 12.0 p -118.57 170.1 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.197 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.624 HG21 ' HB2' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -144.88 154.78 42.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 109.432 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 tp -124.36 -67.09 0.94 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.291 -0.88 . . . . 0.0 109.442 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.409 ' O ' ' O ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -107.11 51.63 0.74 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.565 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.624 ' HB2' HG21 ' A' ' 69' ' ' THR . . . -54.54 -172.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -145.34 -150.82 0.34 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.545 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -111.61 -52.21 2.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.97 . . . . 0.0 109.527 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.417 ' HG3' HH11 ' A' ' 75' ' ' ARG . 0.0 OUTLIER -96.79 2.7 52.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 109.785 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.689 ' C ' HD12 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -142.19 140.58 32.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.872 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.708 HD13 ' CD2' ' A' ' 49' ' ' PHE . 2.2 mp -158.38 104.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 109.247 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.765 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -108.15 120.64 42.93 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.273 -0.892 . . . . 0.0 108.659 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.92 157.79 49.09 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.484 ' HE3' ' HG3' ' A' ' 106' ' ' PRO . 1.2 mmmp? -151.12 118.64 6.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -1.085 . . . . 0.0 109.471 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.16 141.8 16.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.994 . . . . 0.0 109.429 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 55.16 -126.22 38.23 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.34 18.1 17.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.139 -1.212 . . . . 0.0 109.661 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.09 128.96 33.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.746 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -132.73 164.59 24.02 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 78' ' ' TYR . 1.8 m -127.77 149.48 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.022 -1.281 . . . . 0.0 110.165 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.765 HG23 ' HD2' ' A' ' 78' ' ' TYR . 6.5 mt -116.5 83.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.7 OUTLIER -89.26 142.2 27.86 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.239 -0.913 . . . . 0.0 110.303 -178.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.726 ' HB ' HD12 ' A' ' 96' ' ' LEU . 85.4 t -150.13 154.24 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -109.22 121.82 45.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.005 -1.06 . . . . 0.0 109.802 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.788 HG22 HG13 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -92.26 -55.11 3.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.291 -0.881 . . . . 0.0 109.535 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 91' ' ' THR . 9.3 t 171.51 -31.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.067 -1.021 . . . . 0.0 109.95 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.4 mttm -128.75 -28.53 2.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.015 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.576 ' C ' HD23 ' A' ' 24' ' ' LEU . 39.8 m -135.34 152.45 51.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.044 -1.035 . . . . 0.0 109.847 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.508 HG13 ' N ' ' A' ' 24' ' ' LEU . 14.4 mt -94.08 142.33 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.346 -0.846 . . . . 0.0 109.32 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.82 HD22 ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -107.0 148.52 28.58 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.801 ' CG2' HD23 ' A' ' 22' ' ' LEU . 39.8 t -140.25 131.89 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.995 -1.066 . . . . 0.0 110.215 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.474 ' HA3' ' HB ' ' A' ' 87' ' ' ILE . . . -104.86 102.91 2.13 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 107.444 -2.262 . . . . 0.0 107.444 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -96.73 123.42 49.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.248 -1.148 . . . . 0.0 109.238 -178.712 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.537 ' HB2' HD12 ' A' ' 104' ' ' ILE . 3.4 p90 -132.52 164.2 27.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.298 -0.876 . . . . 0.0 109.491 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -149.22 -170.41 3.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.506 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 60.81 22.14 12.2 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.175 -0.953 . . . . 0.0 109.371 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.43 82.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.589 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' ' 100' ' ' TYR . 4.0 mt -97.27 147.66 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.155 -0.966 . . . . 0.0 109.283 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -50.88 109.38 1.32 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.307 -0.871 . . . . 0.0 109.546 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.484 ' HG3' ' HE3' ' A' ' 80' ' ' LYS . 2.4 Cg_endo -62.13 -35.26 76.35 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.921 1.748 . . . . 0.0 110.167 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.2 47.18 3.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 112' ' ' VAL . 16.6 m -148.36 -39.2 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 109.414 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.486 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -88.12 -18.94 27.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.604 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.53 -46.98 24.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -63.75 -42.04 97.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.429 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 108' ' ' THR . 89.3 t -62.74 -26.4 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.239 -0.913 . . . . 0.0 109.565 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.543 HG21 HG21 ' A' ' 87' ' ' ILE . 47.6 t -87.55 -22.86 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.366 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -63.89 -42.41 97.49 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.229 -0.919 . . . . 0.0 109.307 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -78.32 -51.24 10.41 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.363 -0.836 . . . . 0.0 109.226 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.593 HD21 ' CE2' ' A' ' 5' ' ' TYR . 4.1 tp -49.67 -33.09 14.74 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.154 -0.966 . . . . 0.0 109.109 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.744 ' C ' HD12 ' A' ' 121' ' ' ILE . . . -62.24 -47.91 82.31 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.248 -0.907 . . . . 0.0 108.584 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -15.79 47.69 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.492 -0.755 . . . . 0.0 109.088 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -83.65 -47.58 11.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.431 -0.793 . . . . 0.0 108.988 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.959 HD23 ' HA3' ' A' ' 124' ' ' GLY . 0.4 OUTLIER -80.92 -7.67 59.56 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.357 -0.839 . . . . 0.0 109.591 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.788 HG13 HG22 ' A' ' 91' ' ' THR . 26.6 mt -90.13 -20.94 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.31 -0.869 . . . . 0.0 109.347 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 123' ' ' GLN . . . -112.92 -0.31 25.65 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 122' ' ' GLY . 1.8 mt-30 -140.7 -47.27 0.41 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -1.147 . . . . 0.0 109.472 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.959 ' HA3' HD23 ' A' ' 120' ' ' LEU . . . -74.88 -102.31 0.1 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.191 -1.182 . . . . 0.0 109.261 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.569 ' HB3' HG21 ' A' ' 21' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.952 ' CZ2' HD22 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -67.2 94.52 0.36 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.11 -0.994 . . . . 0.0 109.675 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.83 -79.72 0.33 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.734 -1.229 . . . . 0.0 108.219 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -17.59 61.85 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.691 ' CD2' HD12 ' A' ' 10' ' ' LEU . 9.9 m-30 -75.35 -39.34 59.41 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.929 HG23 ' HB2' ' A' ' 2' ' ' TRP . 1.2 t -54.2 -48.42 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.586 -0.696 . . . . 0.0 110.027 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.627 ' O ' HG23 ' A' ' 8' ' ' THR . 5.5 t0 -90.91 52.37 2.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 112.513 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER 176.78 -87.49 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.26 -1.525 . . . . 0.0 112.783 178.465 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 11' ' ' VAL . 14.0 m120 -83.43 -92.06 0.07 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.105 -0.997 . . . . 0.0 112.494 -176.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.691 HD12 ' CD2' ' A' ' 5' ' ' TYR . 3.0 mt -23.79 -41.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.978 HG22 ' HB3' ' A' ' 19' ' ' ALA . 72.2 t -89.61 -57.42 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.576 -1.327 . . . . 0.0 110.523 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.756 ' C ' HG22 ' A' ' 13' ' ' THR . . . -40.65 -47.56 3.89 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 108.741 -1.743 . . . . 0.0 108.741 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.756 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER 166.72 38.63 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.708 -0.878 . . . . 0.0 108.932 178.68 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.694 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -82.67 15.35 31.36 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.886 ' HB2' HG11 ' A' ' 112' ' ' VAL . . . 157.99 -27.58 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.626 HG12 ' HB3' ' A' ' 100' ' ' TYR . 23.5 m -143.4 154.34 16.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.2 OUTLIER -83.95 17.41 2.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.974 -1.079 . . . . 0.0 109.533 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.572 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -176.99 177.47 1.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.978 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . 179.19 158.04 0.58 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.84 -1.162 . . . . 0.0 110.265 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.513 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -153.94 117.71 4.7 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.674 HD11 ' CG ' ' A' ' 2' ' ' TRP . 6.9 mm -82.63 113.39 21.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.221 -0.924 . . . . 0.0 109.19 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.119 HD22 ' CG2' ' A' ' 97' ' ' VAL . 0.4 OUTLIER -96.32 117.14 30.21 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.537 -0.727 . . . . 0.0 109.566 -178.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -50.7 179.98 0.03 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.551 ' H ' HD23 ' A' ' 24' ' ' LEU . 1.2 pt? -121.37 -8.98 9.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -1.192 . . . . 0.0 109.659 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -111.58 26.96 10.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.932 . . . . 0.0 109.537 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.08 70.44 1.31 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -171.62 -164.99 0.35 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -1.158 . . . . 0.0 109.331 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.05 111.09 7.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.168 -0.957 . . . . 0.0 109.58 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 36.5 m0 -83.91 -33.63 24.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.428 ' HB3' ' CG1' ' A' ' 21' ' ' ILE . . . -164.9 158.98 17.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.285 -0.884 . . . . 0.0 109.399 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.3 t -152.31 141.55 21.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.159 -0.963 . . . . 0.0 109.812 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.777 ' CB ' HG21 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -130.13 119.97 23.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.396 -0.815 . . . . 0.0 108.998 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 81.73 159.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.589 -0.694 . . . . 0.0 109.375 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 33' ' ' ALA . . . -43.45 -93.25 0.01 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.414 ' CE1' HG21 ' A' ' 99' ' ' VAL . 0.9 OUTLIER 68.75 94.73 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -1.139 . . . . 0.0 109.533 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.564 ' O ' ' HB2' ' A' ' 63' ' ' ALA . . . -102.52 100.3 10.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.385 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.466 ' HB ' ' HG2' ' A' ' 41' ' ' GLN . 1.8 t -109.28 166.24 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.876 . . . . 0.0 109.529 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.479 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -50.22 153.55 2.42 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.372 -0.83 . . . . 0.0 109.545 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.456 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 5.3 Cg_exo -58.97 -16.07 30.55 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.159 1.906 . . . . 0.0 110.436 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 43' ' ' GLN . . . -122.52 56.89 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.222 -0.924 . . . . 0.0 109.48 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 38' ' ' THR . 3.9 mp0 -51.67 -37.05 48.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.026 -1.046 . . . . 0.0 109.265 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.31 -39.58 70.73 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.539 ' HB2' ' HB1' ' A' ' 40' ' ' ALA . 1.3 tm0? -63.15 -37.41 87.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -1.194 . . . . 0.0 110.033 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.1 m -62.46 -51.66 66.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.186 -0.946 . . . . 0.0 109.668 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.899 HD22 HG21 ' A' ' 95' ' ' ILE . 2.1 mp -65.73 -23.32 66.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 109.75 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.582 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . . . -62.92 -37.15 85.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.94 . . . . 0.0 109.674 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.8 m -76.98 -28.39 55.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.539 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.61 -14.22 62.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.548 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CD2' ' HA ' ' A' ' 46' ' ' ALA . 23.2 m-85 -76.51 -39.54 52.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.94 . . . . 0.0 109.398 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -87.48 -66.73 0.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.129 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -117.3 140.73 49.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 0.0 109.117 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.469 ' O ' HG12 ' A' ' 55' ' ' ILE . . . -135.64 33.57 2.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -0.958 . . . . 0.0 109.767 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.638 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -68.22 -45.28 39.22 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.377 -0.827 . . . . 0.0 110.652 179.707 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 6.3 Cg_exo -59.44 -18.71 47.74 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.524 1.483 . . . . 0.0 110.595 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.127 HD11 ' CB ' ' A' ' 72' ' ' ALA . 1.1 pt -105.7 -19.03 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 109.163 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.438 HH11 ' CG ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -76.79 -37.48 55.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.364 -0.835 . . . . 0.0 109.655 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 56' ' ' ARG . . . -43.87 -71.56 0.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 0.0 109.74 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.464 ' O ' HG23 ' A' ' 68' ' ' VAL . 1.9 t -118.83 -47.12 2.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.636 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 68' ' ' VAL . . . 166.01 -163.42 36.77 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.42 ' HE2' HG23 ' A' ' 69' ' ' THR . 0.3 OUTLIER -112.94 161.16 17.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -1.146 . . . . 0.0 109.475 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.42 104.79 12.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 109.708 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.88 112.67 25.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.865 . . . . 0.0 109.514 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 36' ' ' ALA . . . 49.71 -143.38 0.54 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.567 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.87 46.89 3.75 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.539 HG11 ' CE2' ' A' ' 67' ' ' TYR . 3.4 t -142.34 138.93 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -1.179 . . . . 0.0 108.963 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.407 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 75.9 t60 -121.46 118.91 30.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 0.0 109.77 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.539 ' CE2' HG11 ' A' ' 65' ' ' VAL . 15.9 m-85 -131.73 177.62 7.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 109.241 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.614 HG22 ' N ' ' A' ' 69' ' ' THR . 7.7 p -104.42 166.16 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.268 -0.895 . . . . 0.0 109.846 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.614 ' N ' HG22 ' A' ' 68' ' ' VAL . 1.4 m -95.49 176.76 6.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.933 . . . . 0.0 109.173 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.556 ' H ' HG22 ' A' ' 69' ' ' THR . 0.2 OUTLIER -141.33 -48.42 0.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.141 -0.974 . . . . 0.0 110.234 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 76' ' ' SER . 13.8 ttm180 -142.8 61.38 1.42 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.947 -1.096 . . . . 0.0 110.153 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 1.127 ' CB ' HD11 ' A' ' 55' ' ' ILE . . . -85.34 81.66 8.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.123 -0.985 . . . . 0.0 109.393 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -154.88 -38.56 0.09 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.284 -0.885 . . . . 0.0 109.477 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.93 -100.18 0.35 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.761 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.452 ' NH1' ' CG ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -129.11 -16.23 4.07 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.882 -1.136 . . . . 0.0 110.106 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.627 ' C ' HD12 ' A' ' 77' ' ' ILE . 6.1 m -89.37 131.82 35.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.827 -1.17 . . . . 0.0 109.415 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 77' ' ' ILE . 4.7 mp -149.21 60.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 110.116 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.847 ' HB3' HD13 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -90.51 161.31 15.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.036 -1.04 . . . . 0.0 108.333 179.008 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.82 158.25 14.45 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.444 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 19.3 mtmt -145.34 132.64 20.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -1.09 . . . . 0.0 109.375 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.9 OUTLIER 171.63 128.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 109.508 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 83' ' ' SER . . . 56.96 54.78 34.23 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 82' ' ' GLY . 0.6 OUTLIER 43.79 26.77 0.14 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -1.151 . . . . 0.0 109.61 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.497 ' HA ' ' CE2' ' A' ' 100' ' ' TYR . . . -145.34 153.36 41.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.205 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 179.5 -166.79 36.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.406 ' O ' HD13 ' A' ' 87' ' ' ILE . 2.5 m -122.38 179.91 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -1.149 . . . . 0.0 109.649 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.847 HD13 ' HB3' ' A' ' 78' ' ' TYR . 36.4 mm -142.85 68.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.104 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.798 HG22 HG13 ' A' ' 97' ' ' VAL . 1.2 p -99.93 116.86 32.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 110.028 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.36 150.99 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.428 -0.795 . . . . 0.0 108.963 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.5 ' HG3' HG12 ' A' ' 95' ' ' ILE . 1.8 mtpt -98.35 149.97 22.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.147 -0.97 . . . . 0.0 109.778 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.6 p -123.42 -138.75 0.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.808 . . . . 0.0 108.871 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.503 ' HB2' ' HA ' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -66.64 -17.01 64.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.858 -1.151 . . . . 0.0 109.302 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.583 ' HB2' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER 167.49 66.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 p 176.86 156.58 0.28 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.347 -0.845 . . . . 0.0 109.126 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.899 HG21 HD22 ' A' ' 45' ' ' LEU . 14.7 mt -129.39 100.67 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.037 -1.039 . . . . 0.0 109.831 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.952 HD22 ' CZ2' ' A' ' 2' ' ' TRP . 2.9 pp -78.42 137.85 38.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 108.954 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 1.119 ' CG2' HD22 ' A' ' 22' ' ' LEU . 11.9 t -117.4 81.28 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.139 -0.976 . . . . 0.0 110.183 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.49 ' CA ' ' HB ' ' A' ' 87' ' ' ILE . . . -74.47 110.5 3.1 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.476 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -111.62 127.74 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -1.228 . . . . 0.0 109.44 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.626 ' HB3' HG12 ' A' ' 16' ' ' VAL . 22.4 p90 -130.97 173.01 11.41 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 109.941 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -122.48 -141.49 0.32 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.597 -0.689 . . . . 0.0 109.372 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.438 ' HG3' ' N ' ' A' ' 103' ' ' LYS . 4.3 pt-20 -79.15 -19.15 51.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.111 -0.993 . . . . 0.0 109.422 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.484 ' CD ' HG21 ' A' ' 17' ' ' THR . 65.7 mttt -58.17 -25.28 61.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.387 -0.82 . . . . 0.0 109.833 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 16' ' ' VAL . 4.7 mt -127.41 143.47 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.014 -1.054 . . . . 0.0 109.541 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.443 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -102.48 158.26 32.1 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 109.33 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 105' ' ' GLN . 2.1 Cg_endo -61.78 153.87 64.77 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.165 1.91 . . . . 0.0 110.195 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.7 -61.57 0.32 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.5 m -75.68 -22.44 56.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -1.125 . . . . 0.0 109.714 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.599 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -75.68 -38.11 59.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.628 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.96 -38.36 32.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 109.683 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.48 ' O ' ' HB3' ' A' ' 114' ' ' GLU . 2.6 t30 -63.74 -41.16 98.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.134 -0.979 . . . . 0.0 109.641 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.886 HG11 ' HB2' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -65.41 -42.95 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.357 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.826 HG21 HG21 ' A' ' 87' ' ' ILE . 51.8 t -67.93 -15.53 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.896 . . . . 0.0 109.64 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 111' ' ' ASN . 5.3 tp10 -67.79 -63.63 1.02 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.239 -0.913 . . . . 0.0 109.625 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -27.1 66.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.178 -0.951 . . . . 0.0 109.753 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.609 HD11 ' HE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -61.34 -47.11 87.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.112 -0.993 . . . . 0.0 110.122 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.538 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -78.21 -33.21 50.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 109.937 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -57.25 -17.74 13.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 109.854 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.44 -57.4 2.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 110.065 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -70.66 -1.96 12.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.135 -0.978 . . . . 0.0 110.689 -178.649 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.538 HD12 ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -70.03 -36.65 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.965 -1.084 . . . . 0.0 108.97 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.406 ' O ' ' HG2' ' A' ' 123' ' ' GLN . . . -108.72 42.56 1.92 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 122' ' ' GLY . 53.9 mm-40 -147.01 -84.1 0.11 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -1.166 . . . . 0.0 109.864 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.457 ' O ' ' OXT' ' A' ' 125' ' ' PHE . . . -136.7 63.98 0.57 Allowed Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.253 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.583 ' CD1' ' HB2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.241 -1.153 . . . . 0.0 109.625 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.5 ' O ' HD12 ' A' ' 96' ' ' LEU . 37.4 m . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.634 ' CH2' ' HB2' ' A' ' 117' ' ' ALA . 3.4 m95 -147.73 155.77 42.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.403 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.43 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 3.0 mp0 -39.09 -92.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.405 -0.809 . . . . 0.0 111.408 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.794 ' O ' HG22 ' A' ' 8' ' ' THR . 91.5 m -57.42 -49.14 77.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.347 -0.846 . . . . 0.0 110.961 -178.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.691 ' CD2' HD21 ' A' ' 116' ' ' LEU . 15.3 m-30 -50.92 -18.42 0.76 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.156 -0.965 . . . . 0.0 110.23 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.517 ' HA ' HG23 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -79.61 -46.85 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.945 -1.097 . . . . 0.0 109.361 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.48 51.42 1.88 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 0.0 111.982 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.794 HG22 ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -166.23 -100.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.36 -1.462 . . . . 0.0 110.892 179.002 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.515 ' H ' HG23 ' A' ' 8' ' ' THR . 1.0 OUTLIER -102.25 -59.35 1.72 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.051 -1.03 . . . . 0.0 110.824 -178.632 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.564 ' CB ' ' HB3' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -33.49 -33.26 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.622 -0.674 . . . . 0.0 110.99 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.842 HG22 ' HB3' ' A' ' 19' ' ' ALA . 2.8 t -99.53 -48.21 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.032 -1.042 . . . . 0.0 109.689 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.768 ' C ' HG22 ' A' ' 13' ' ' THR . . . -40.81 -45.13 3.6 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.768 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 159.66 39.72 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.88 -0.777 . . . . 0.0 109.601 178.549 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.703 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -84.23 20.04 15.28 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 154.1 -33.55 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.576 ' HA ' HD13 ' A' ' 104' ' ' ILE . 11.9 m -136.44 134.56 49.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.777 HG23 ' HG3' ' A' ' 18' ' ' GLN . 9.2 t -78.4 2.61 18.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.85 -1.156 . . . . 0.0 109.387 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.777 ' HG3' HG23 ' A' ' 17' ' ' THR . 71.7 mt-30 -162.6 155.34 19.43 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.842 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -158.9 152.51 23.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.117 -0.989 . . . . 0.0 109.72 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.5 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -138.6 142.11 39.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.947 . . . . 0.0 109.455 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.597 HD11 ' N ' ' A' ' 2' ' ' TRP . 0.7 OUTLIER -109.32 79.96 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.144 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -62.44 -153.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 108.649 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.425 ' C ' HG13 ' A' ' 95' ' ' ILE . . . -143.1 140.49 9.75 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.565 -1.302 . . . . 0.0 109.986 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 94' ' ' SER . 9.1 mt -68.68 -44.19 74.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -1.137 . . . . 0.0 109.263 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -129.27 2.45 5.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.584 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.35 -102.53 2.15 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -176.91 -46.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -1.122 . . . . 0.0 109.576 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.8 m -167.17 116.81 0.85 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.887 . . . . 0.0 109.666 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.413 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 19.0 m0 -96.78 -34.46 11.31 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.271 -0.893 . . . . 0.0 109.366 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.98 170.72 6.16 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -161.39 -179.27 7.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.059 -1.026 . . . . 0.0 109.945 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.647 ' OG ' HG21 ' A' ' 11' ' ' VAL . 51.9 p 177.74 67.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.531 -0.731 . . . . 0.0 109.23 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.455 ' CB ' ' CE1' ' A' ' 35' ' ' PHE . . . -142.08 -39.39 0.37 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.482 -0.761 . . . . 0.0 109.169 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.3 -52.94 0.95 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.455 ' CE1' ' CB ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -61.22 162.2 7.86 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -1.094 . . . . 0.0 109.385 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.08 148.54 29.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 109.379 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 38' ' ' THR . 61.4 t -102.17 158.69 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.193 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.468 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 6.0 t -43.14 147.19 0.72 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.437 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.468 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 6.1 Cg_exo -58.77 -14.07 20.57 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.153 1.902 . . . . 0.0 110.311 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.949 ' HB1' ' HB3' ' A' ' 43' ' ' GLN . . . -107.8 59.3 0.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.917 . . . . 0.0 109.409 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -65.56 -52.68 50.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.93 -1.107 . . . . 0.0 109.765 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.88 -12.71 84.33 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.949 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 1.5 tt0 -89.98 -20.97 22.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -1.149 . . . . 0.0 109.475 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.1 m -90.1 -29.72 18.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.498 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.518 ' O ' ' CD2' ' A' ' 49' ' ' PHE . 4.2 mm? -87.7 -40.55 14.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.726 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.37 -25.26 60.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 109.995 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.3 t -88.59 -19.6 26.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.124 -0.985 . . . . 0.0 109.779 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.18 -14.25 47.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.103 -0.998 . . . . 0.0 109.689 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.518 ' CD2' ' O ' ' A' ' 45' ' ' LEU . 19.6 m-85 -74.32 -33.0 63.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.658 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -94.11 -20.78 19.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.939 . . . . 0.0 109.303 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -131.55 120.85 23.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 0.0 109.342 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.545 ' HA ' HD11 ' A' ' 55' ' ' ILE . . . -119.84 28.71 7.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 109.554 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.569 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -76.57 -51.42 2.43 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.333 -0.855 . . . . 0.0 110.458 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 1.7 Cg_endo -64.61 -4.81 9.0 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.113 1.875 . . . . 0.0 111.357 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.717 ' HB ' HG21 ' A' ' 69' ' ' THR . 0.0 OUTLIER -112.53 7.62 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.748 -1.22 . . . . 0.0 110.101 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -100.07 -20.38 16.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.891 -1.13 . . . . 0.0 109.604 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.87 -60.9 1.2 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.22 -0.925 . . . . 0.0 109.537 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -78.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.374 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.41 -165.02 28.34 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.486 ' HB2' ' HB2' ' A' ' 67' ' ' TYR . 7.0 m-85 -81.28 170.82 15.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -1.126 . . . . 0.0 109.684 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.509 ' C ' HD12 ' A' ' 62' ' ' LEU . 1.3 m-20 -141.33 101.04 3.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.495 -0.753 . . . . 0.0 108.973 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.569 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 5.9 mp -127.1 61.17 1.36 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.203 -0.936 . . . . 0.0 109.932 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . 69.47 -83.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.365 -0.834 . . . . 0.0 110.015 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -38.72 -95.54 0.01 OUTLIER Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.465 HG12 ' H ' ' A' ' 66' ' ' HIS . 1.3 t -129.77 -148.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.084 -1.245 . . . . 0.0 109.238 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 60' ' ' PHE . 33.6 p80 -122.21 144.03 49.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.153 -0.967 . . . . 0.0 109.73 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.486 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 25.9 m-85 -100.81 -161.94 0.9 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.362 -0.836 . . . . 0.0 109.233 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.703 HG22 ' H ' ' A' ' 69' ' ' THR . 1.4 p -104.32 -171.22 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.052 -1.03 . . . . 0.0 109.287 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.717 HG21 ' HB ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -148.56 64.71 1.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.11 -0.994 . . . . 0.0 109.549 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 70' ' ' LEU . 0.8 OUTLIER -91.84 18.33 7.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.92 . . . . 0.0 109.211 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -161.87 55.9 0.25 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.454 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.588 ' CB ' HG22 ' A' ' 69' ' ' THR . . . -123.46 66.35 1.01 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.735 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.85 -42.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.938 . . . . 0.0 109.635 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 2.2 m-20 -49.65 -86.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.597 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.512 ' NH1' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -145.22 -59.85 0.35 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.897 . . . . 0.0 109.388 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 78' ' ' TYR . 74.2 m -89.6 -165.41 1.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.416 ' CG1' ' O ' ' A' ' 76' ' ' SER . 13.9 mt -154.61 105.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.009 -1.057 . . . . 0.0 109.704 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 78' ' ' TYR . 0.6 OUTLIER -113.52 97.08 6.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 0.0 109.06 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 86' ' ' VAL . . . -60.31 141.38 47.88 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.529 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -151.05 124.62 9.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -1.101 . . . . 0.0 109.417 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.67 132.72 1.51 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.141 -0.974 . . . . 0.0 109.676 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.5 -136.07 47.41 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.18 -10.15 24.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -1.114 . . . . 0.0 109.704 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.48 -173.91 2.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 109.463 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.03 171.06 28.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 79' ' ' GLY . 3.4 p -123.99 153.8 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -1.184 . . . . 0.0 109.55 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.717 HG21 HG21 ' A' ' 113' ' ' VAL . 30.2 mm -127.31 94.67 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.033 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 1.4 p -108.97 129.7 55.45 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.143 -0.973 . . . . 0.0 109.985 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.836 ' HB ' HD23 ' A' ' 96' ' ' LEU . 2.4 t -142.23 143.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -103.1 120.52 40.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.119 -0.988 . . . . 0.0 109.907 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.534 ' HB ' ' CB ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -96.34 -59.13 1.9 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.412 -0.805 . . . . 0.0 108.969 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.599 ' HB3' ' CD2' ' A' ' 125' ' ' PHE . 0.2 OUTLIER 171.86 -32.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.41 -0.806 . . . . 0.0 109.769 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.54 ' C ' HD12 ' A' ' 24' ' ' LEU . 2.3 mmmt -135.85 2.51 2.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.045 -1.034 . . . . 0.0 110.13 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.735 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -156.1 146.31 21.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.021 -1.05 . . . . 0.0 109.692 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.595 HD11 ' HA ' ' A' ' 24' ' ' LEU . 15.2 mt -105.9 139.68 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 0.0 109.298 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.836 HD23 ' HB ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -92.46 154.55 18.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.032 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.779 ' O ' HG12 ' A' ' 97' ' ' VAL . 39.9 t -150.4 68.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.264 -0.897 . . . . 0.0 109.665 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.87 106.91 1.79 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.682 HG22 HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -109.88 127.81 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.958 -1.319 . . . . 0.0 109.538 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 1.043 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -142.54 144.15 32.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.396 -0.815 . . . . 0.0 109.428 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.496 ' O ' ' CB ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -150.4 114.48 5.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.067 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.1 OUTLIER 163.45 -61.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.456 -0.777 . . . . 0.0 109.393 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -174.93 33.14 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.397 -0.814 . . . . 0.0 109.906 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.043 HD12 ' HB2' ' A' ' 100' ' ' TYR . 48.6 mt -84.27 83.6 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -0.959 . . . . 0.0 108.981 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -54.11 149.69 17.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 109.954 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.77 156.45 61.6 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.309 2.006 . . . . 0.0 110.183 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.55 -2.71 46.06 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.65 -39.67 2.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -1.193 . . . . 0.0 109.505 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.544 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -83.93 -27.69 28.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.287 -0.883 . . . . 0.0 109.446 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.464 ' O ' ' OE1' ' A' ' 114' ' ' GLU . . . -83.07 -21.18 33.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.136 -0.977 . . . . 0.0 109.28 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -78.83 -29.26 44.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.537 HG11 HD11 ' A' ' 10' ' ' LEU . 11.5 t -83.08 -39.13 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.301 -0.875 . . . . 0.0 109.39 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.717 HG21 HG21 ' A' ' 87' ' ' ILE . 38.4 t -68.92 -16.25 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.053 -1.029 . . . . 0.0 109.435 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.464 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -81.32 -56.36 4.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.61 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 118' ' ' ASP . 5.4 ttmt -79.0 -52.78 7.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.748 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.691 HD21 ' CD2' ' A' ' 5' ' ' TYR . 1.6 tp -51.87 -47.09 64.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -0.959 . . . . 0.0 109.522 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.75 ' O ' HD13 ' A' ' 121' ' ' ILE . . . -67.93 -35.69 78.86 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.074 -1.016 . . . . 0.0 109.05 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 115' ' ' LYS . 24.1 t0 -47.56 -25.84 1.26 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.134 -0.979 . . . . 0.0 109.266 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -81.32 -51.1 8.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.277 -0.89 . . . . 0.0 109.261 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' ' 125' ' ' PHE . 3.8 mt -71.25 -3.1 18.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.399 -0.813 . . . . 0.0 110.072 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.75 HD13 ' O ' ' A' ' 117' ' ' ALA . 1.2 mp -75.99 -28.41 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.065 -1.022 . . . . 0.0 108.554 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -123.74 29.24 5.23 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.35 57.55 0.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -1.113 . . . . 0.0 109.687 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.507 ' C ' ' CD1' ' A' ' 125' ' ' PHE . . . 104.71 17.72 14.22 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.599 ' CD2' ' HB3' ' A' ' 92' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.743 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.513 ' N ' HD22 ' A' ' 120' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.344 0.592 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.769 ' CB ' HD11 ' A' ' 21' ' ' ILE . 1.1 m-90 -105.66 23.96 13.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.421 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.55 -80.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.076 -1.015 . . . . 0.0 109.787 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.66 ' O ' HG22 ' A' ' 8' ' ' THR . 8.8 t -59.57 -39.21 83.33 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.765 ' CE1' HD12 ' A' ' 10' ' ' LEU . 4.9 t80 -40.14 -36.51 0.51 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.033 0.92 . . . . 0.0 109.172 177.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.109 HG13 HG21 ' A' ' 11' ' ' VAL . 39.7 t -99.37 -29.51 3.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 121.046 -1.034 . . . . 0.0 111.325 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.48 ' C ' HG22 ' A' ' 8' ' ' THR . 77.9 m-20 -91.75 52.25 1.99 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.702 -1.249 . . . . 0.0 112.826 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER 179.61 -94.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.21 -1.556 . . . . 0.0 111.322 178.182 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.7 t-20 -101.89 -66.33 0.93 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.197 -0.94 . . . . 0.0 111.124 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.765 HD12 ' CE1' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -33.88 -31.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.867 -0.521 . . . . 0.0 111.6 -178.411 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.109 HG21 HG13 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -95.39 -56.66 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.751 -1.218 . . . . 0.0 109.745 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.746 ' C ' HG22 ' A' ' 13' ' ' THR . . . -38.79 -37.38 0.57 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.831 -1.707 . . . . 0.0 108.831 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.746 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 159.05 39.64 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.95 -0.735 . . . . 0.0 109.196 178.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.706 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -81.29 16.55 16.92 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 107.776 -2.13 . . . . 0.0 107.776 177.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.716 ' HB1' ' HA ' ' A' ' 109' ' ' ALA . . . 154.99 -27.09 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.419 HG21 ' HB2' ' A' ' 19' ' ' ALA . 5.2 m -140.4 137.29 36.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.041 HG23 HD11 ' A' ' 104' ' ' ILE . 34.5 p -79.38 6.44 10.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.922 -1.111 . . . . 0.0 109.436 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.483 ' OE1' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -167.39 161.95 14.38 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.624 ' HA ' HG23 ' A' ' 99' ' ' VAL . . . -174.01 171.59 3.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.956 -1.09 . . . . 0.0 110.079 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -161.98 157.07 23.13 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.286 -0.884 . . . . 0.0 109.774 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.769 HD11 ' CB ' ' A' ' 2' ' ' TRP . 10.9 mt -115.45 94.63 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.805 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -85.27 128.55 34.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.666 -0.646 . . . . 0.0 109.284 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.6 ' HA2' ' CZ3' ' A' ' 29' ' ' TRP . . . -48.19 167.0 0.16 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.657 HD23 ' CG1' ' A' ' 95' ' ' ILE . 16.2 mt -77.12 -11.96 59.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.349 -1.089 . . . . 0.0 109.276 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 27' ' ' ASN . 5.3 t70 -120.08 57.79 0.93 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.703 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 52.3 69.72 1.1 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 25' ' ' ASP . 8.4 m120 -147.31 -149.89 0.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.282 -1.128 . . . . 0.0 109.519 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -155.26 158.85 39.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.358 -0.839 . . . . 0.0 109.182 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.6 ' CZ3' ' HA2' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -145.33 -41.04 0.23 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -0.986 . . . . 0.0 109.905 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.501 ' HB3' HD12 ' A' ' 21' ' ' ILE . . . -165.1 118.58 1.24 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.999 -1.063 . . . . 0.0 110.15 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 9.3 t -131.86 164.36 26.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.651 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.707 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 3.4 m -147.79 147.55 29.97 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.338 -0.851 . . . . 0.0 109.475 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 81.4 172.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 33' ' ' ALA . . . -60.64 -132.58 0.01 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.651 ' CE1' HG11 ' A' ' 99' ' ' VAL . 91.0 t80 58.81 93.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.031 -1.276 . . . . 0.0 109.203 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.2 124.42 50.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 109.648 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 65.5 t -97.92 106.0 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.833 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -71.22 162.01 75.04 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.285 -0.884 . . . . 0.0 109.529 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.833 ' HD2' HG22 ' A' ' 38' ' ' THR . 2.4 Cg_endo -61.58 108.81 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.18 1.92 . . . . 0.0 110.004 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 39' ' ' PRO . . . 176.24 -71.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.217 -0.927 . . . . 0.0 109.496 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.47 -21.71 65.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.667 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.17 -31.62 61.34 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.468 ' O ' ' OG ' ' A' ' 47' ' ' SER . 4.6 tt0 -74.97 -23.04 58.23 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.388 -1.066 . . . . 0.0 109.374 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.667 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 3.5 m -88.42 -32.72 18.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.233 -0.917 . . . . 0.0 109.301 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.91 -47.81 83.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -0.916 . . . . 0.0 109.352 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 25' ' ' ASP . . . -61.49 -46.55 89.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 0.0 109.218 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -82.82 -0.21 46.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.364 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 44' ' ' THR . . . -82.78 -22.66 34.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 109.716 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -74.76 -0.88 19.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.049 -1.032 . . . . 0.0 109.591 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -88.21 -59.84 2.13 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.188 -0.945 . . . . 0.0 109.953 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 53' ' ' ASP . 0.5 OUTLIER -126.47 6.35 6.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.025 -1.047 . . . . 0.0 110.175 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 51' ' ' ASN . . . 32.25 35.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.234 0.54 . . . . 0.0 110.445 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.618 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 2.7 t0 -73.9 -49.91 5.74 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.896 . . . . 0.0 110.888 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 6.0 Cg_exo -59.98 -9.59 10.33 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.058 1.838 . . . . 0.0 111.317 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.775 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -106.92 -49.46 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.892 -1.13 . . . . 0.0 109.775 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.506 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 3.6 ptm180 -53.87 -19.33 4.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.051 -1.031 . . . . 0.0 110.084 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 56' ' ' ARG . . . -120.6 137.94 54.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.093 -1.005 . . . . 0.0 109.925 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 59' ' ' GLY . 0.6 OUTLIER 49.74 27.24 2.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.405 -0.81 . . . . 0.0 109.653 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 58' ' ' SER . . . 43.39 -136.64 4.44 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 60' ' ' PHE . 2.6 p90 -147.33 143.79 28.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.183 -1.186 . . . . 0.0 109.343 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -101.85 126.86 48.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.266 -0.897 . . . . 0.0 109.765 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -94.51 -160.17 0.76 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.53 -0.731 . . . . 0.0 109.475 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.14 95.3 8.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.4 -23.73 14.49 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -125.53 153.0 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -1.14 . . . . 0.0 108.888 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -149.91 153.58 36.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 109.526 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -141.91 -171.92 3.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.335 -0.853 . . . . 0.0 109.276 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 t -116.89 154.13 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.945 . . . . 0.0 109.602 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.88 124.94 45.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.484 -0.76 . . . . 0.0 109.54 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.03 -35.92 1.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.592 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.434 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -119.33 70.76 0.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.463 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.78 28.6 6.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.423 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -99.69 0.07 41.15 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.248 -0.908 . . . . 0.0 109.606 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -105.22 -95.74 0.34 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.975 . . . . 0.0 109.926 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.526 ' NH1' ' HG3' ' A' ' 75' ' ' ARG . 1.0 OUTLIER -142.47 -36.51 0.4 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.028 . . . . 0.0 110.058 -179.493 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 0.6 OUTLIER -89.52 149.87 22.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 109.553 -179.559 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 76' ' ' SER . 4.3 mp -144.53 70.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 0.0 110.335 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.756 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -90.01 93.62 9.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.814 -1.179 . . . . 0.0 108.46 178.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.422 ' O ' HG12 ' A' ' 86' ' ' VAL . . . -79.21 128.44 8.56 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.56 146.38 26.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -1.233 . . . . 0.0 109.61 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.88 148.83 0.55 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.559 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.47 -106.85 2.76 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.2 m -135.95 7.92 3.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -1.121 . . . . 0.0 109.511 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -130.82 178.12 6.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 0.0 109.159 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -169.28 177.45 42.93 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.325 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 86' ' ' VAL . 9.3 p -153.27 123.63 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.976 . . . . 0.0 108.74 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.821 HG21 HG11 ' A' ' 113' ' ' VAL . 10.6 mt -95.53 99.82 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.177 -0.952 . . . . 0.0 109.793 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 8.6 p -105.95 108.48 20.02 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.566 HG22 ' CE2' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -129.01 173.95 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.927 . . . . 0.0 110.054 -179.174 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.439 ' H ' HG12 ' A' ' 89' ' ' VAL . 29.7 mtmt -101.39 142.81 32.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.392 -0.817 . . . . 0.0 108.941 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 1.088 ' CG2' HD21 ' A' ' 96' ' ' LEU . 66.5 p -149.12 -137.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.105 -0.997 . . . . 0.0 109.828 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.465 ' HA ' ' OXT' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -67.52 84.04 0.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.948 -1.095 . . . . 0.0 111.178 -178.777 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.561 ' HA ' HD11 ' A' ' 24' ' ' LEU . 3.0 mttm 51.04 34.01 10.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -0.855 . . . . 0.0 109.778 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.04 167.35 30.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.051 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.657 ' CG1' HD23 ' A' ' 24' ' ' LEU . 34.5 mt -121.89 123.15 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.239 -0.913 . . . . 0.0 109.135 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.088 HD21 ' CG2' ' A' ' 91' ' ' THR . 0.0 OUTLIER -75.62 165.12 25.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.08 -1.013 . . . . 0.0 108.928 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.785 HG12 HG22 ' A' ' 99' ' ' VAL . 54.0 t -150.91 74.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.389 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -63.78 98.73 0.26 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.785 HG22 HG12 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -97.28 127.64 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -1.15 . . . . 0.0 109.018 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.549 ' HB2' ' CG1' ' A' ' 104' ' ' ILE . 1.5 p90 -146.82 171.19 15.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 109.878 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -113.7 -149.85 0.45 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.394 -0.816 . . . . 0.0 110.023 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -42.5 89.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.47 -0.768 . . . . 0.0 110.221 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.8 -25.05 1.13 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.041 HD11 HG23 ' A' ' 17' ' ' THR . 10.6 mm -103.51 105.72 18.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.053 -1.029 . . . . 0.0 109.698 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.57 142.66 49.99 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.26 -0.9 . . . . 0.0 109.137 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -60.7 149.37 87.91 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.119 1.88 . . . . 0.0 110.503 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.86 -35.46 4.92 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.6 m -83.49 -29.6 27.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -1.182 . . . . 0.0 109.613 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.716 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -89.79 -13.98 35.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.809 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.0 -20.63 23.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.142 -0.974 . . . . 0.0 109.559 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -80.72 -32.67 35.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 0.0 109.695 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 88.8 t -90.05 -35.96 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 110.172 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.821 HG11 HG21 ' A' ' 87' ' ' ILE . 49.1 t -74.35 -17.6 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.148 -0.97 . . . . 0.0 109.768 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -86.97 -42.4 13.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -0.973 . . . . 0.0 109.972 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.06 -40.48 62.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.126 -0.984 . . . . 0.0 109.74 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.729 HD22 ' CE2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -60.16 -47.31 86.47 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.215 -0.928 . . . . 0.0 109.564 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.891 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -63.92 -25.91 68.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.644 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -69.2 -25.63 64.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.714 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -76.91 -40.32 47.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.22 -0.925 . . . . 0.0 110.074 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.571 ' O ' HD12 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -82.86 -21.03 34.47 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.163 -0.96 . . . . 0.0 110.06 -179.449 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.891 HD12 ' O ' ' A' ' 117' ' ' ALA . 8.1 mt -77.62 -22.64 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 109.331 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.13 -24.48 3.41 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.29 -68.88 0.69 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.405 -1.056 . . . . 0.0 109.673 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 125' ' ' PHE . . . 158.33 110.53 0.29 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.493 ' HB3' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.084 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.693 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.535 ' HB2' ' CD1' ' A' ' 120' ' ' LEU . 3.3 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.869 ' CZ2' HD13 ' A' ' 96' ' ' LEU . 1.3 m-90 -82.87 7.46 15.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.174 -0.954 . . . . 0.0 109.371 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -89.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 109.189 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.429 HG23 ' N ' ' A' ' 5' ' ' TYR . 14.4 t -60.72 -36.82 79.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 108.899 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.76 ' CE2' HD11 ' A' ' 116' ' ' LEU . 10.1 m-30 -52.91 -30.89 36.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.455 -0.778 . . . . 0.0 109.41 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.535 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -69.87 -47.87 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.103 -0.998 . . . . 0.0 108.468 179.449 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.8 45.28 1.24 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.936 -1.103 . . . . 0.0 109.929 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.628 HG22 ' N ' ' A' ' 9' ' ' ASN . 54.3 m -156.96 -100.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.83 -1.169 . . . . 0.0 110.704 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.628 ' N ' HG22 ' A' ' 8' ' ' THR . 3.8 m120 -100.86 -59.54 1.68 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.112 -0.992 . . . . 0.0 110.64 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.529 ' C ' ' O ' ' A' ' 9' ' ' ASN . 0.5 OUTLIER -29.56 -48.51 0.08 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.304 0.573 . . . . 0.0 110.516 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.991 HG23 ' HB3' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -100.27 -23.37 4.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.342 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 13' ' ' THR . . . -83.32 57.57 5.06 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.123 -2.391 . . . . 0.0 107.123 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 43.25 51.03 5.83 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.987 0.898 . . . . 0.0 110.281 -178.774 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.704 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -100.59 21.76 42.65 Favored Glycine 0 C--N 1.292 -1.871 0 N-CA-C 105.438 -3.065 . . . . 0.0 105.438 176.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 1.118 ' CB ' HG11 ' A' ' 112' ' ' VAL . . . 152.08 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.722 ' HA ' HD13 ' A' ' 104' ' ' ILE . 2.7 m -138.78 147.14 25.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.703 HG23 HD11 ' A' ' 104' ' ' ILE . 2.4 p -79.76 10.27 4.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.876 -1.14 . . . . 0.0 109.165 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.523 ' CG ' ' C ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -170.71 174.07 5.1 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.381 -0.824 . . . . 0.0 109.409 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.991 ' HB3' HG23 ' A' ' 11' ' ' VAL . . . -177.36 163.69 2.04 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.497 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -160.59 122.1 3.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.832 -1.168 . . . . 0.0 110.758 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.676 HD11 ' CD1' ' A' ' 2' ' ' TRP . 3.1 mm -89.2 104.62 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.777 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.4 OUTLIER -83.29 13.47 4.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.39 -0.819 . . . . 0.0 109.934 -178.788 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 94' ' ' SER . . . 67.67 157.82 0.9 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.723 HD21 ' HB3' ' A' ' 90' ' ' LYS . 14.5 mt -79.94 -58.21 3.28 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.32 -1.106 . . . . 0.0 109.017 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.4 22.18 3.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.484 -0.76 . . . . 0.0 109.009 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -109.84 -110.35 3.29 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -149.5 -145.9 0.18 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -1.141 . . . . 0.0 109.351 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 m -71.43 125.5 27.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.088 -1.008 . . . . 0.0 109.525 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -106.19 -40.92 5.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.06 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.15 155.75 23.36 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.429 ' C ' ' OG ' ' A' ' 32' ' ' SER . 0.7 OUTLIER -160.78 172.13 17.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.954 -1.091 . . . . 0.0 110.113 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.706 ' CB ' HG11 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -176.11 109.97 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.314 -0.866 . . . . 0.0 109.516 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 55.35 41.95 30.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 109.394 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -125.65 138.15 10.7 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -49.61 178.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -1.183 . . . . 0.0 109.417 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.01 107.42 19.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.328 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.692 ' O ' HG22 ' A' ' 38' ' ' THR . 3.9 t -104.9 163.72 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 109.899 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.748 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.6 OUTLIER 94.65 15.45 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.748 ' CD ' ' N ' ' A' ' 38' ' ' THR . 1.8 Cg_endo -64.67 -20.07 65.06 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 CA-C-N 119.783 0.958 . . . . 0.0 109.611 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 39' ' ' PRO . . . 171.74 -66.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.424 -0.797 . . . . 0.0 109.235 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.454 ' O ' ' HB ' ' A' ' 44' ' ' THR . 3.1 mp0 -56.15 -24.82 43.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.91 . . . . 0.0 109.363 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.86 -45.99 55.24 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -57.52 -35.19 69.94 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.236 -1.155 . . . . 0.0 109.103 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 41' ' ' GLN . 63.4 m -57.3 -35.57 69.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.027 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.28 -48.82 75.84 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.17 -23.27 67.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.403 -0.811 . . . . 0.0 109.141 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.0 -20.19 30.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.6 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.34 -24.11 59.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.441 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.583 ' CE2' ' HG2' ' A' ' 90' ' ' LYS . 5.3 m-30 -51.39 -21.63 2.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.217 -0.927 . . . . 0.0 109.314 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -82.68 -37.3 25.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.285 -0.885 . . . . 0.0 109.756 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.92 142.79 33.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.706 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.33 24.49 13.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 109.017 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.631 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 23.3 m-20 -67.22 -46.07 50.84 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.488 -0.757 . . . . 0.0 110.932 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.9 Cg_exo -56.54 -70.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 121.487 1.458 . . . . 0.0 110.61 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.641 ' HB ' HG21 ' A' ' 69' ' ' THR . 0.1 OUTLIER -42.07 -27.68 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.186 -0.946 . . . . 0.0 109.497 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -72.05 -75.31 0.14 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.696 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -104.94 93.84 4.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 0.0 109.527 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 3.8 t 162.82 -78.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.228 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.79 -164.82 33.84 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -124.05 111.98 16.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.472 -1.016 . . . . 0.0 108.796 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -81.2 142.98 32.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 0.0 110.283 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.44 ' HA ' HD23 ' A' ' 62' ' ' LEU . 9.8 mt -149.26 -166.46 2.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.189 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.652 ' HB2' ' HA ' ' A' ' 37' ' ' VAL . . . -71.83 90.77 1.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 0.0 110.157 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.11 24.67 68.93 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -138.96 177.15 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.094 -1.239 . . . . 0.0 108.855 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 3.9 p-80 -159.43 114.43 2.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.162 -0.961 . . . . 0.0 109.744 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.588 ' CE1' ' HG3' ' A' ' 81' ' ' LYS . 11.0 m-30 -100.99 -164.02 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -0.895 . . . . 0.0 109.454 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 t -131.43 164.02 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 108.982 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.641 HG21 ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -123.17 117.45 25.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.156 -0.965 . . . . 0.0 109.835 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.62 24.73 4.05 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.576 ' NH1' ' HG3' ' A' ' 71' ' ' ARG . 0.0 OUTLIER 178.55 57.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.334 -0.854 . . . . 0.0 109.146 -179.655 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.479 ' O ' ' C ' ' A' ' 73' ' ' ASP . . . -90.81 20.69 4.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.192 -0.942 . . . . 0.0 109.263 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER 32.48 -107.09 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.102 -0.374 . . . . 0.0 110.743 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -120.88 -52.42 2.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.754 -1.217 . . . . 0.0 110.479 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.421 ' HA ' ' NE ' ' A' ' 75' ' ' ARG . 6.6 tpm_? -130.45 -9.12 4.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.011 -1.056 . . . . 0.0 110.827 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.63 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -88.77 146.98 24.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.937 -1.102 . . . . 0.0 108.795 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.495 ' HB ' ' OG1' ' A' ' 88' ' ' THR . 0.2 OUTLIER -135.76 79.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.69 -1.256 . . . . 0.0 111.004 -179.276 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.856 ' HD2' HG23 ' A' ' 87' ' ' ILE . 1.2 m-85 -90.12 76.67 6.89 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.1 178.2 7.99 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.521 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 15.6 mtpp -135.39 146.29 48.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.663 -0.904 . . . . 0.0 109.085 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.588 ' HG3' ' CE1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -114.92 25.67 10.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.998 -1.064 . . . . 0.0 109.396 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.68 -94.9 1.94 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.6 m -78.55 -25.13 45.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.226 -1.161 . . . . 0.0 109.183 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 100' ' ' TYR . . . -111.87 -165.44 0.99 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.279 -0.888 . . . . 0.0 109.25 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 80' ' ' LYS . . . -167.98 143.69 8.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 86' ' ' VAL . 10.0 p -106.44 133.6 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -1.164 . . . . 0.0 110.034 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.856 HG23 ' HD2' ' A' ' 78' ' ' TYR . 36.0 mm -106.83 83.2 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.495 ' OG1' ' HB ' ' A' ' 77' ' ' ILE . 15.5 p -95.72 117.77 31.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.004 -1.06 . . . . 0.0 110.63 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.557 HG21 ' CE2' ' A' ' 78' ' ' TYR . 11.7 t -150.36 166.52 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.723 ' HB3' HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -104.4 159.49 15.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.921 -1.112 . . . . 0.0 109.445 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.489 HG21 ' HZ3' ' A' ' 2' ' ' TRP . 0.1 OUTLIER -144.36 -70.17 0.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.611 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 1.2 t -159.87 98.7 1.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.117 -0.989 . . . . 0.0 109.889 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.472 ' CA ' HD12 ' A' ' 24' ' ' LEU . 25.1 mttm 62.54 34.59 15.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.987 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.48 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 0.3 OUTLIER 177.49 145.13 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.008 -1.057 . . . . 0.0 109.813 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.567 ' CG1' HD23 ' A' ' 24' ' ' LEU . 90.1 mt -105.96 114.68 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.88 . . . . 0.0 109.161 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.869 HD13 ' CZ2' ' A' ' 2' ' ' TRP . 0.7 OUTLIER -73.77 139.06 44.94 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.332 -0.855 . . . . 0.0 109.735 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.619 ' O ' HG22 ' A' ' 99' ' ' VAL . 45.8 t -129.89 59.75 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.352 -0.843 . . . . 0.0 109.326 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.485 ' O ' HG12 ' A' ' 87' ' ' ILE . . . -51.66 111.93 1.63 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.619 HG22 ' O ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -110.99 134.63 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.126 -1.22 . . . . 0.0 109.187 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.718 ' HB3' HG12 ' A' ' 16' ' ' VAL . 20.0 p90 -132.27 -178.35 4.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.443 -0.785 . . . . 0.0 109.307 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -118.31 -145.9 0.39 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.598 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 103' ' ' LYS . 7.6 tp10 -80.91 -38.81 27.31 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.145 -0.972 . . . . 0.0 109.665 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 102' ' ' GLU . 0.4 OUTLIER -43.79 -68.26 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.909 . . . . 0.0 109.506 -179.721 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.722 HD13 ' HA ' ' A' ' 16' ' ' VAL . 7.1 mt -65.99 137.7 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.202 -0.936 . . . . 0.0 109.286 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.416 ' HB2' ' OG1' ' A' ' 108' ' ' THR . 0.9 OUTLIER -79.77 152.63 75.06 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.775 -179.747 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.62 -17.72 60.46 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.4 2.067 . . . . 0.0 110.515 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.8 -13.03 51.77 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 105' ' ' GLN . 0.2 OUTLIER -85.65 -42.65 14.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -1.122 . . . . 0.0 109.429 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.86 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -78.07 -22.1 49.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.338 -0.851 . . . . 0.0 109.536 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.03 -21.02 31.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 109.566 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -80.91 -39.09 26.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 109.488 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 1.118 HG11 ' CB ' ' A' ' 15' ' ' ALA . 4.1 p -74.62 -27.83 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.684 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 109' ' ' ALA . 74.7 t -72.94 -35.04 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.409 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 118' ' ' ASP . 48.2 mt-10 -61.58 -41.9 98.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.462 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 118' ' ' ASP . 3.2 ttpm? -74.49 -38.03 63.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.494 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.76 HD11 ' CE2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -53.04 -53.3 52.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.338 -0.851 . . . . 0.0 109.715 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.609 ' HB1' ' CD1' ' A' ' 121' ' ' ILE . . . -75.35 -29.8 60.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 0.0 109.695 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 0.4 OUTLIER -54.02 -25.17 19.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -0.955 . . . . 0.0 109.666 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -85.57 -48.33 9.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.669 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.535 ' CD1' ' HB2' ' A' ' 1' ' ' SER . 4.5 mt -75.32 -2.61 29.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.881 . . . . 0.0 110.274 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.609 ' CD1' ' HB1' ' A' ' 117' ' ' ALA . 0.4 OUTLIER -84.2 -44.7 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.053 -1.029 . . . . 0.0 109.518 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -82.05 9.6 56.41 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -120.75 -87.9 0.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -1.192 . . . . 0.0 109.785 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.17 -90.82 0.92 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.567 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 3.8 m-85 . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.255 -1.144 . . . . 0.0 109.362 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.562 ' O ' ' CD2' ' A' ' 2' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 1.006 ' CH2' HD13 ' A' ' 96' ' ' LEU . 15.5 m95 -146.96 173.35 12.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.295 -0.878 . . . . 0.0 109.4 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.404 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -64.54 -87.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.13 -0.981 . . . . 0.0 111.088 -178.459 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.473 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -60.84 -45.54 94.07 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.025 -1.047 . . . . 0.0 110.465 -178.649 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.813 ' CE2' HD22 ' A' ' 116' ' ' LEU . 2.8 m-30 -50.72 -21.65 1.72 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.87 -1.144 . . . . 0.0 109.466 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.827 HG22 HG21 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -78.0 -41.24 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 108.692 179.445 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.473 ' OD1' ' O ' ' A' ' 4' ' ' THR . 2.1 p-10 -91.28 18.83 6.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.119 -0.988 . . . . 0.0 110.825 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.42 ' OG1' ' HA ' ' A' ' 5' ' ' TYR . 21.1 p -127.59 -106.58 0.31 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.917 -1.114 . . . . 0.0 110.371 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.4 t-20 -102.02 -68.75 0.81 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.025 -1.047 . . . . 0.0 110.512 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.505 ' C ' ' O ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -24.52 -41.8 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.482 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.833 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 1.1 t -83.91 -65.59 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.728 -1.233 . . . . 0.0 110.057 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.751 ' C ' HG22 ' A' ' 13' ' ' THR . . . -36.84 -40.06 0.46 Allowed Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.751 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 158.45 40.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.891 -0.77 . . . . 0.0 109.366 178.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.703 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -86.06 21.3 16.56 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 154.87 -32.72 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.805 HG12 ' HB3' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -136.63 133.66 48.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.457 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.969 HG23 ' HG3' ' A' ' 18' ' ' GLN . 9.0 t -78.83 6.1 9.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.944 -1.097 . . . . 0.0 108.991 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.969 ' HG3' HG23 ' A' ' 17' ' ' THR . 17.3 mt-30 -158.91 153.08 23.74 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.833 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . -170.33 152.38 4.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -0.949 . . . . 0.0 109.193 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.572 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . . . -150.55 130.84 13.67 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.633 HD11 ' N ' ' A' ' 2' ' ' TRP . 4.6 mm -82.85 92.32 2.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.877 HD13 ' CG2' ' A' ' 97' ' ' VAL . 10.9 mp -74.71 106.7 6.39 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.46 -0.775 . . . . 0.0 109.915 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -45.93 174.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.644 HD11 ' C ' ' A' ' 93' ' ' LYS . 0.7 OUTLIER -72.82 -3.16 23.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.331 -1.099 . . . . 0.0 109.859 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.93 8.3 7.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.147 -0.971 . . . . 0.0 109.214 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.32 32.06 58.5 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 28' ' ' THR . 40.4 t-20 -94.97 29.96 2.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.165 -1.197 . . . . 0.0 109.36 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 27' ' ' ASN . 70.3 m 32.31 96.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.559 0.695 . . . . 0.0 110.859 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -79.54 -48.57 13.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.473 -0.767 . . . . 0.0 110.048 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.454 ' O ' HG12 ' A' ' 21' ' ' ILE . . . -158.64 103.06 1.72 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.115 -0.99 . . . . 0.0 109.969 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 14.0 t -114.53 166.58 11.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.037 -1.039 . . . . 0.0 110.278 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.717 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -149.63 143.32 25.45 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.558 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 77.5 171.41 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 0.0 109.16 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -52.17 141.74 24.84 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.683 ' CE2' HG21 ' A' ' 99' ' ' VAL . 0.3 OUTLIER 177.81 117.01 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -1.077 . . . . 0.0 109.134 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.68 125.14 53.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.975 . . . . 0.0 110.015 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.432 HG13 ' OE1' ' A' ' 41' ' ' GLN . 60.7 t -147.84 133.39 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.717 HG23 ' CD ' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -158.15 -62.81 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.001 -1.062 . . . . 0.0 110.598 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.717 ' CD ' HG23 ' A' ' 38' ' ' THR . 8.1 Cg_exo -50.89 133.08 39.24 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 120.87 1.047 . . . . 0.0 109.819 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 39' ' ' PRO . . . -30.39 81.76 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 111.593 0.219 . . . . 0.0 111.593 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.604 ' N ' ' O ' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -90.86 -30.71 16.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.269 -1.519 . . . . 0.0 109.31 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.5 -18.91 78.71 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -80.57 -62.44 1.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.152 -1.205 . . . . 0.0 109.371 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.8 m -60.1 -26.99 66.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 109.152 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.88 -46.43 24.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.0 109.312 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.65 -11.09 22.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 109.649 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.48 -28.15 14.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.63 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.437 ' HB1' HD12 ' A' ' 55' ' ' ILE . . . -66.62 -23.35 66.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.966 . . . . 0.0 109.643 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -70.05 -7.7 43.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.225 -0.922 . . . . 0.0 110.032 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -81.1 -70.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 109.721 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -96.58 175.87 6.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.181 -0.949 . . . . 0.0 109.561 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 56' ' ' ARG . . . -123.82 -2.98 8.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.723 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.613 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 43.5 t0 -80.24 -44.81 1.42 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.158 -0.964 . . . . 0.0 110.721 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.6 Cg_endo -65.37 -13.58 40.52 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.553 1.502 . . . . 0.0 110.575 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.798 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -102.55 -54.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.06 -1.025 . . . . 0.0 109.516 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.502 ' HG2' ' NH1' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -50.58 -22.7 2.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.41 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.573 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -114.93 117.82 31.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.653 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 1.9 m 83.83 -52.92 0.14 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.77 -0.581 . . . . 0.0 109.826 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.8 -145.71 21.02 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.91 ' CE2' HD11 ' A' ' 62' ' ' LEU . 6.1 p90 -146.94 -173.17 4.16 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.256 -1.144 . . . . 0.0 109.143 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 1.5 m-20 -139.49 165.19 27.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.153 -0.967 . . . . 0.0 110.028 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.91 HD11 ' CE2' ' A' ' 60' ' ' PHE . 2.4 mp -136.96 88.25 2.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.42 -0.8 . . . . 0.0 109.268 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . 82.3 -43.17 0.14 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.603 -0.686 . . . . 0.0 109.985 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.06 35.67 0.05 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.644 ' CG1' ' CE1' ' A' ' 67' ' ' TYR . 72.8 t -126.21 111.74 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -1.133 . . . . 0.0 109.447 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.72 86.47 6.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.171 -0.956 . . . . 0.0 110.606 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.644 ' CE1' ' CG1' ' A' ' 65' ' ' VAL . 10.2 m-30 -98.47 162.67 13.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.098 -1.001 . . . . 0.0 109.28 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.617 HG22 ' H ' ' A' ' 69' ' ' THR . 7.3 p -107.41 173.24 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.185 -0.947 . . . . 0.0 109.569 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.617 ' H ' HG22 ' A' ' 68' ' ' VAL . 46.6 m -127.39 109.34 11.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.48 3.14 14.83 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 109.6 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -135.21 89.07 2.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -0.94 . . . . 0.0 109.332 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.42 111.32 4.83 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -157.93 -45.55 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -0.9 . . . . 0.0 109.317 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -79.52 -94.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.412 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.444 ' NH1' ' CG ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -150.23 21.6 0.85 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 109.795 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.978 ' OG ' HG22 ' A' ' 89' ' ' VAL . 29.7 t -132.57 169.66 16.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.074 -1.016 . . . . 0.0 109.501 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.458 ' O ' HG22 ' A' ' 77' ' ' ILE . 23.5 mt -149.5 95.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.865 . . . . 0.0 109.441 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.485 ' HD2' HG23 ' A' ' 87' ' ' ILE . 3.4 m-85 -89.51 85.09 6.43 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -51.05 158.14 2.29 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.46 -173.83 3.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.612 -0.934 . . . . 0.0 108.83 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.45 -30.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.117 -0.989 . . . . 0.0 110.108 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 83' ' ' SER . . . 132.7 92.85 0.53 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 82' ' ' GLY . 0.8 OUTLIER 74.24 4.8 4.59 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.265 -1.138 . . . . 0.0 108.357 -178.3 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.48 148.62 29.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.495 -0.753 . . . . 0.0 109.086 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -168.62 174.44 43.3 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.6 p -132.76 138.09 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -1.159 . . . . 0.0 109.348 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.485 HG23 ' HD2' ' A' ' 78' ' ' TYR . 16.7 mm -98.93 81.21 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 110.021 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 7.6 p -96.8 107.89 20.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.123 -0.986 . . . . 0.0 109.007 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.978 HG22 ' OG ' ' A' ' 76' ' ' SER . 59.4 t -127.9 139.97 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 109.794 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.29 127.01 42.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.884 . . . . 0.0 109.219 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.761 HG22 HG12 ' A' ' 121' ' ' ILE . 3.0 p -100.85 -82.61 0.46 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.31 -0.869 . . . . 0.0 109.927 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.405 ' C ' ' HG2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -151.46 -42.34 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.945 . . . . 0.0 109.612 -179.689 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.644 ' C ' HD11 ' A' ' 24' ' ' LEU . 42.6 mmtt -139.64 40.42 2.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.605 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.595 ' N ' HD21 ' A' ' 24' ' ' LEU . 0.1 OUTLIER 173.25 161.35 0.14 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.912 . . . . 0.0 109.271 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 19.1 mt -133.56 146.72 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.082 -1.011 . . . . 0.0 109.743 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.006 HD13 ' CH2' ' A' ' 2' ' ' TRP . 0.3 OUTLIER -106.24 158.73 16.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.862 . . . . 0.0 108.807 179.396 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.877 ' CG2' HD13 ' A' ' 22' ' ' LEU . 57.4 t -145.44 71.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.946 . . . . 0.0 110.225 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -56.46 144.52 36.9 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.514 -1.835 . . . . 0.0 108.514 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.683 HG21 ' CE2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -144.75 113.33 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.72 -1.459 . . . . 0.0 109.711 -179.502 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.805 ' HB3' HG12 ' A' ' 16' ' ' VAL . 14.3 p90 -135.43 141.34 45.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.345 -0.847 . . . . 0.0 109.415 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -152.05 117.04 5.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.495 -0.753 . . . . 0.0 109.831 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.2 OUTLIER 160.73 -59.22 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.516 -0.74 . . . . 0.0 109.378 179.637 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 174.97 48.06 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.566 -0.709 . . . . 0.0 109.417 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.6 mt -105.91 129.74 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.368 -0.833 . . . . 0.0 108.843 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -66.08 137.43 95.79 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.725 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -65.96 -25.88 51.75 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.175 1.917 . . . . 0.0 110.403 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.09 0.52 88.57 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.5 m -92.66 -42.82 9.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.142 -1.21 . . . . 0.0 109.383 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 112' ' ' VAL . . . -90.09 -19.94 23.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.285 -0.885 . . . . 0.0 109.466 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.12 -24.38 58.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.722 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -81.89 -33.56 30.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.169 -0.957 . . . . 0.0 109.675 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.896 HG22 HD12 ' A' ' 116' ' ' LEU . 9.0 p -78.09 -18.71 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.115 -0.991 . . . . 0.0 109.508 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.774 HG13 ' HZ2' ' A' ' 2' ' ' TRP . 38.1 t -90.92 -23.18 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.928 . . . . 0.0 109.887 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -75.79 -38.69 57.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.139 -0.976 . . . . 0.0 109.911 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.69 -58.94 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.944 . . . . 0.0 109.764 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.896 HD12 HG22 ' A' ' 112' ' ' VAL . 15.1 mt -51.9 -24.17 5.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 109.511 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.905 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -73.64 -39.64 64.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 109.853 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -63.91 -16.72 62.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.013 . . . . 0.0 109.995 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -81.63 -56.46 4.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.041 -1.037 . . . . 0.0 109.755 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.472 ' HA ' HD23 ' A' ' 120' ' ' LEU . 6.1 mt -62.16 -50.15 72.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 109.663 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.905 HD12 ' O ' ' A' ' 117' ' ' ALA . 7.5 mt -59.93 -36.65 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.657 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.12 -14.98 81.74 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -127.09 -68.09 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.254 . . . . 0.0 110.15 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 120' ' ' LEU . . . -85.48 -106.68 0.69 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.348 -1.09 . . . . 0.0 109.166 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.433 ' HA ' HG21 ' A' ' 21' ' ' ILE . 10.8 p . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.666 ' HH2' HD22 ' A' ' 96' ' ' LEU . 29.9 p90 -92.59 97.13 10.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.125 -0.984 . . . . 0.0 109.905 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 8.1 tt0 -81.3 -24.07 37.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 109.218 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.497 ' O ' HG22 ' A' ' 8' ' ' THR . 85.2 m -65.96 -64.89 0.76 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.375 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.84 ' HB3' HD23 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -50.7 -41.59 56.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -0.95 . . . . 0.0 108.895 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.655 ' HA ' HG23 ' A' ' 11' ' ' VAL . 1.2 t -49.44 -48.8 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.56 -0.713 . . . . 0.0 109.894 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.725 ' C ' HG22 ' A' ' 8' ' ' THR . 0.8 OUTLIER -87.52 55.49 3.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.851 -178.598 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.725 HG22 ' C ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER 170.53 -86.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.739 -1.225 . . . . 0.0 111.334 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.56 ' H ' HG23 ' A' ' 8' ' ' THR . 3.1 m-20 -88.45 -74.55 0.46 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.247 -0.908 . . . . 0.0 111.481 -178.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.84 HD23 ' HB3' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -27.54 -46.9 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.917 0.389 . . . . 0.0 111.467 -178.412 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.024 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 49.5 t -101.6 -28.65 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.861 -1.149 . . . . 0.0 110.669 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.615 ' C ' HG22 ' A' ' 13' ' ' THR . . . -45.17 -28.83 2.12 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 106.311 -2.716 . . . . 0.0 106.311 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.717 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.6 OUTLIER -176.28 -39.68 0.01 OUTLIER 'General case' 0 C--O 1.193 -1.9 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.575 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.722 ' O ' ' HB3' ' A' ' 15' ' ' ALA . . . 10.43 44.22 0.0 OUTLIER Glycine 0 N--CA 1.509 3.557 0 C-N-CA 123.671 0.653 . . . . 0.0 112.838 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.903 ' O ' HG21 ' A' ' 104' ' ' ILE . . . 87.58 -34.47 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.941 HG12 ' HB3' ' A' ' 100' ' ' TYR . 35.8 m -120.51 139.08 48.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.771 HG23 ' HG2' ' A' ' 18' ' ' GLN . 9.9 t -79.96 13.3 2.28 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.833 -1.167 . . . . 0.0 109.395 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.771 ' HG2' HG23 ' A' ' 17' ' ' THR . 13.1 mm-40 -158.74 169.21 24.9 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 1.024 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . 173.59 140.95 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.494 -1.379 . . . . 0.0 110.822 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.516 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -136.1 142.34 44.28 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.548 HG13 HG21 ' A' ' 6' ' ' VAL . 2.7 mt -102.32 112.06 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.919 -1.113 . . . . 0.0 108.92 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.054 HD22 ' CG2' ' A' ' 97' ' ' VAL . 2.8 mp -98.46 160.37 14.33 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.527 -0.733 . . . . 0.0 109.089 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.92 -178.93 19.18 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.541 HD11 ' C ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -105.08 -48.46 3.72 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.295 -1.12 . . . . 0.0 109.139 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -136.76 40.11 2.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 109.306 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.06 25.22 2.23 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 1.2 m-20 61.43 -146.4 0.43 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.169 -1.194 . . . . 0.0 109.306 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.95 147.5 25.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.12 -0.987 . . . . 0.0 109.738 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -119.2 -26.49 5.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.379 -0.825 . . . . 0.0 109.145 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -178.44 159.22 1.17 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.391 -0.818 . . . . 0.0 109.372 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 1.1 t -160.22 171.54 19.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.314 -0.866 . . . . 0.0 109.503 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.647 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -178.54 82.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.333 -0.854 . . . . 0.0 109.165 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.04 -69.71 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.856 . . . . 0.0 109.566 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 167.85 -37.78 0.22 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.533 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 14.8 p90 -97.12 160.22 14.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.12 . . . . 0.0 109.482 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.03 -168.91 1.36 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.366 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.717 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 16.4 t -142.85 97.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.343 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.43 HG23 ' H ' ' A' ' 38' ' ' THR . 9.7 p -62.34 143.99 95.36 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.41 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 2.5 Cg_endo -61.59 114.92 2.46 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.193 1.929 . . . . 0.0 110.358 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 39' ' ' PRO . . . 174.77 -77.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.335 -0.853 . . . . 0.0 109.402 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.407 ' NE2' ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -67.59 -11.69 58.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.527 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.33 -43.72 95.49 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.3 -33.9 73.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -1.124 . . . . 0.0 108.936 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.2 m -50.05 -45.76 52.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.295 -0.878 . . . . 0.0 108.799 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.551 ' CD2' HG21 ' A' ' 95' ' ' ILE . 1.3 mp -54.95 -42.16 71.97 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.13 -38.22 73.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.407 -0.808 . . . . 0.0 108.869 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.93 -26.87 63.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.509 -0.745 . . . . 0.0 109.084 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.604 ' HB1' HD11 ' A' ' 55' ' ' ILE . . . -64.61 -20.2 66.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.371 -0.83 . . . . 0.0 109.334 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.603 ' CE1' ' CE ' ' A' ' 90' ' ' LYS . 22.2 m-85 -59.21 -14.54 11.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 109.365 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -79.58 -68.07 0.7 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 109.677 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -148.37 17.99 1.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.13 -0.981 . . . . 0.0 109.872 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 51' ' ' ASN . . . 36.08 32.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.278 0.561 . . . . 0.0 109.977 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.615 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 39.1 t70 -70.61 -43.98 16.52 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 111.004 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 5.3 Cg_exo -61.55 -10.96 18.02 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.381 1.387 . . . . 0.0 110.796 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.604 HD11 ' HB1' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -106.71 -31.25 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.053 -1.029 . . . . 0.0 109.573 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.437 ' CG ' ' HA ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -90.16 20.1 4.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 109.501 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.81 4.57 11.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.55 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 172.5 -55.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.518 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.67 -172.85 33.13 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 67' ' ' TYR . 33.4 p90 -132.46 170.44 15.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -1.164 . . . . 0.0 109.407 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.407 ' HB3' ' NE2' ' A' ' 41' ' ' GLN . 0.2 OUTLIER -122.29 136.93 54.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.567 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.53 ' CD2' HG13 ' A' ' 37' ' ' VAL . 0.6 OUTLIER -103.48 -161.51 0.84 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.248 -0.907 . . . . 0.0 108.93 179.753 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 37' ' ' VAL . . . -46.33 -40.5 11.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.106 -0.996 . . . . 0.0 109.263 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.74 33.63 0.16 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.17 138.02 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -1.108 . . . . 0.0 109.66 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -96.09 142.24 28.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 109.389 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 60' ' ' PHE . 17.3 m-85 -141.76 162.6 35.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.212 -0.93 . . . . 0.0 109.44 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.9 t -121.49 149.2 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.299 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.659 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -138.67 103.54 4.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.466 -179.781 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.745 ' H ' HD23 ' A' ' 70' ' ' LEU . 2.3 pt? -103.08 8.11 38.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.147 -0.97 . . . . 0.0 109.607 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 51.47 0.99 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.305 -0.872 . . . . 0.0 109.022 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.659 ' HB2' ' CG2' ' A' ' 69' ' ' THR . . . -94.88 130.2 41.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.852 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.46 -172.34 4.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.388 -0.82 . . . . 0.0 109.03 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.16 40.04 0.89 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.047 -1.033 . . . . 0.0 109.679 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.552 ' HG2' ' NH1' ' A' ' 75' ' ' ARG . 2.3 tpt180 -145.28 -72.29 0.25 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 108.957 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -113.54 154.1 27.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.352 -0.842 . . . . 0.0 108.738 179.369 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.704 HG22 ' O ' ' A' ' 77' ' ' ILE . 47.1 mt -156.96 58.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.935 -1.103 . . . . 0.0 110.376 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.559 ' CE2' ' CG2' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -94.36 102.59 14.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.087 . . . . 0.0 108.858 179.167 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.491 ' H ' HG13 ' A' ' 86' ' ' VAL . . . -75.05 175.48 50.64 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.45 133.52 16.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -1.094 . . . . 0.0 109.256 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 0.6 OUTLIER -127.51 70.06 1.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 109.762 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 83' ' ' SER . . . 50.85 -118.13 6.08 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 82' ' ' GLY . 3.8 t -44.59 -84.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -1.212 . . . . 0.0 109.525 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . . . -90.04 156.15 18.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.132 -0.98 . . . . 0.0 109.581 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.462 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -147.92 179.31 24.9 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.567 HG22 HG23 ' A' ' 88' ' ' THR . 7.9 p -112.14 159.25 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.062 -1.258 . . . . 0.0 109.974 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.739 HG21 HG21 ' A' ' 113' ' ' VAL . 14.4 mm -141.83 96.43 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.672 HG22 ' HA ' ' A' ' 97' ' ' VAL . 18.8 p -124.19 153.67 41.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.746 -1.222 . . . . 0.0 110.834 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.909 ' HB ' HD21 ' A' ' 96' ' ' LEU . 57.4 t -150.21 135.66 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.835 ' HD3' HG23 ' A' ' 95' ' ' ILE . 10.9 mmtm -91.54 150.38 21.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.897 . . . . 0.0 109.65 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.5 p -142.55 -168.18 2.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 108.959 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 m -47.58 -25.63 1.2 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.248 -0.907 . . . . 0.0 109.109 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.541 ' C ' HD11 ' A' ' 24' ' ' LEU . 5.1 mttt 178.4 67.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -0.824 . . . . 0.0 109.345 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.465 ' HB2' ' CD2' ' A' ' 125' ' ' PHE . 0.6 OUTLIER -173.97 145.9 1.15 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.507 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.835 HG23 ' HD3' ' A' ' 90' ' ' LYS . 3.8 mt -136.14 85.22 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.158 -0.964 . . . . 0.0 109.23 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.909 HD21 ' HB ' ' A' ' 89' ' ' VAL . 0.3 OUTLIER -61.12 165.27 4.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.478 -0.764 . . . . 0.0 109.119 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 1.054 ' CG2' HD22 ' A' ' 22' ' ' LEU . 58.7 t -143.38 47.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.192 -0.942 . . . . 0.0 110.143 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -41.05 130.7 3.39 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.752 HG23 ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -126.22 118.59 51.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.786 -1.42 . . . . 0.0 108.652 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.941 ' HB3' HG12 ' A' ' 16' ' ' VAL . 38.1 p90 -106.51 -179.1 3.84 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.084 -1.01 . . . . 0.0 109.829 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 84' ' ' ALA . 6.4 t-20 -135.06 -155.1 0.62 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 110.029 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -36.96 80.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.484 -0.76 . . . . 0.0 110.053 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.66 -49.99 55.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.95 . . . . 0.0 109.885 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.903 HG21 ' O ' ' A' ' 15' ' ' ALA . 4.3 mp -99.87 150.38 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.131 -0.981 . . . . 0.0 109.754 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -117.42 155.46 50.1 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.393 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.04 -166.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.234 1.956 . . . . 0.0 110.252 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 53.97 21.86 18.31 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.6 m -156.6 -41.15 0.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -1.105 . . . . 0.0 109.072 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.617 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -85.39 -12.88 51.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.358 -0.839 . . . . 0.0 109.133 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.43 -39.01 23.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.414 -0.804 . . . . 0.0 109.45 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -65.1 -40.01 93.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.748 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.483 HG11 ' HB2' ' A' ' 15' ' ' ALA . 5.3 p -69.88 -25.22 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.187 -0.946 . . . . 0.0 109.508 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.739 HG21 HG21 ' A' ' 87' ' ' ILE . 73.1 t -82.57 -25.06 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.204 -0.935 . . . . 0.0 109.474 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -70.55 -35.93 73.38 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.166 -0.959 . . . . 0.0 109.406 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 116' ' ' LEU . 2.5 ptpt -81.52 -39.38 24.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 109.647 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.504 ' N ' ' HG3' ' A' ' 115' ' ' LYS . 59.7 tp -50.83 -33.8 25.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 109.433 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 1.024 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -79.97 -34.5 38.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.325 -0.859 . . . . 0.0 109.592 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -62.76 -12.17 22.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.028 . . . . 0.0 109.577 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 30.7 t80 -90.31 -54.27 4.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 109.896 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.7 ' C ' HD12 ' A' ' 120' ' ' LEU . 0.8 OUTLIER -63.94 -34.47 78.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.0 110.098 -179.642 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.024 HD12 ' O ' ' A' ' 117' ' ' ALA . 5.7 mt -63.2 -13.65 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 121' ' ' ILE . . . -46.06 -27.73 2.66 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -103.26 -65.89 0.97 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.422 -1.046 . . . . 0.0 109.205 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.11 109.17 2.73 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.465 ' CD2' ' HB2' ' A' ' 94' ' ' SER . 22.5 m-85 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.171 -1.194 . . . . 0.0 109.524 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.863 ' N ' ' HB1' ' A' ' 19' ' ' ALA . 1.4 m . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.76 ' CD1' HD23 ' A' ' 10' ' ' LEU . 41.8 m95 -154.5 -167.43 2.62 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.144 -0.973 . . . . 0.0 109.723 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -89.98 -86.01 0.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 110.319 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.74 -16.87 2.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.242 -0.911 . . . . 0.0 110.203 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 2.1 m-30 -88.91 -33.92 17.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.026 -1.046 . . . . 0.0 109.747 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.642 HG22 HG21 ' A' ' 11' ' ' VAL . 1.2 t -56.0 -43.25 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.183 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.63 46.49 1.34 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.387 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 9' ' ' ASN . 67.7 m -158.52 -101.58 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.703 -1.248 . . . . 0.0 110.609 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.604 ' N ' HG22 ' A' ' 8' ' ' THR . 2.2 t-20 -102.1 -72.2 0.69 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.111 -0.993 . . . . 0.0 111.346 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.76 HD23 ' CD1' ' A' ' 2' ' ' TRP . 2.2 mp -25.67 -39.17 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.642 HG21 HG22 ' A' ' 6' ' ' VAL . 1.7 t -82.11 -66.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.559 -1.338 . . . . 0.0 110.341 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.758 ' C ' HG22 ' A' ' 13' ' ' THR . . . -40.24 -33.83 0.55 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.758 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 156.37 39.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.624 0.726 . . . . 0.0 109.357 179.181 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.709 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -83.31 14.28 40.82 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 107.412 -2.275 . . . . 0.0 107.412 177.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 156.93 -25.04 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.605 HG12 ' HB3' ' A' ' 100' ' ' TYR . 17.1 m -138.08 152.67 26.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.425 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -81.85 14.86 2.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.978 -1.076 . . . . 0.0 109.127 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER 173.28 -178.37 0.08 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.863 ' HB1' ' N ' ' A' ' 1' ' ' SER . . . 178.95 160.52 0.66 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.828 -1.17 . . . . 0.0 109.88 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -155.59 127.41 7.46 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.236 -0.915 . . . . 0.0 110.239 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.72 HD11 ' C ' ' A' ' 2' ' ' TRP . 2.2 mm -87.73 78.67 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.004 HD13 HG21 ' A' ' 97' ' ' VAL . 8.8 mp -52.66 164.22 0.38 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.513 -0.742 . . . . 0.0 109.631 -178.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.618 ' O ' HD12 ' A' ' 95' ' ' ILE . . . -106.22 159.49 15.04 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.778 HD11 ' C ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -110.76 -28.13 8.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -1.087 . . . . 0.0 109.275 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.69 6.38 12.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.828 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -136.56 -86.68 0.2 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.467 ' O ' ' OG1' ' A' ' 28' ' ' THR . 6.7 p30 -170.23 -46.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.356 -1.085 . . . . 0.0 109.281 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 27' ' ' ASN . 34.1 m -170.68 127.86 0.77 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 109.567 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.527 ' CZ2' ' O ' ' A' ' 93' ' ' LYS . 26.1 m0 -84.05 -58.11 2.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.383 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.97 169.78 16.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.347 -0.845 . . . . 0.0 109.304 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -160.48 174.47 14.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 109.978 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.525 ' OG ' HG13 ' A' ' 6' ' ' VAL . 3.1 m -154.28 99.49 2.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.337 -0.852 . . . . 0.0 109.374 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 32' ' ' SER . . . 42.64 -152.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.416 -0.803 . . . . 0.0 109.524 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.458 ' N ' ' HG2' ' A' ' 18' ' ' GLN . . . 90.52 -145.74 18.15 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.563 ' CE2' HG11 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -103.43 169.26 8.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -1.139 . . . . 0.0 109.471 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.22 116.73 29.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.321 -0.862 . . . . 0.0 109.244 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.1 t -79.4 122.23 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.157 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.9 m -75.67 132.88 74.26 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.92 . . . . 0.0 109.48 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.736 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 3.4 Cg_exo -59.13 171.36 2.31 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.941 1.761 . . . . 0.0 109.778 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 39' ' ' PRO . . . 83.56 -46.3 0.12 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.672 -0.643 . . . . 0.0 109.379 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.92 -30.46 68.93 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.146 -0.971 . . . . 0.0 109.02 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.79 -32.79 48.38 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -67.03 -37.7 84.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.376 -1.073 . . . . 0.0 108.874 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.8 m -63.78 -29.86 71.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 108.807 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.529 ' HG ' ' CZ ' ' A' ' 49' ' ' PHE . 11.8 tp -70.89 -39.03 73.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.349 -0.844 . . . . 0.0 109.172 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.09 -46.91 79.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.325 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -24.58 66.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.372 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.85 92.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.268 -0.895 . . . . 0.0 109.15 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.529 ' CZ ' ' HG ' ' A' ' 45' ' ' LEU . 2.9 m-30 -68.94 85.66 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.369 -0.832 . . . . 0.0 109.213 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.53 -64.03 0.22 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.64 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 53' ' ' ASP . 9.8 t30 -136.66 19.17 3.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.36 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 51' ' ' ASN . . . 41.97 26.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.55 -0.719 . . . . 0.0 109.954 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.566 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -80.88 -53.58 0.8 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.068 -1.02 . . . . 0.0 110.403 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 3.4 Cg_exo -62.34 -22.47 74.15 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.067 1.845 . . . . 0.0 110.893 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -94.61 -51.76 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.862 -1.149 . . . . 0.0 109.238 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -45.09 -27.0 0.52 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.963 . . . . 0.0 108.748 179.577 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . -115.68 -165.59 1.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.474 -0.766 . . . . 0.0 109.055 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 57' ' ' ALA . 75.0 m 44.37 -95.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.193 -0.942 . . . . 0.0 109.536 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 57' ' ' ALA . . . 164.43 175.0 34.82 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.454 ' HB3' ' HB2' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -80.32 155.54 27.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.393 -1.063 . . . . 0.0 109.38 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -154.07 101.92 2.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.048 -1.032 . . . . 0.0 110.061 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -98.73 -163.01 1.0 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 109.274 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.508 ' O ' HG23 ' A' ' 65' ' ' VAL . . . -61.56 94.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.976 . . . . 0.0 109.798 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.77 51.99 55.23 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.61 ' CG1' ' CE1' ' A' ' 67' ' ' TYR . 3.2 t -150.01 136.23 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.244 -1.151 . . . . 0.0 109.413 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -110.24 91.89 3.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 109.744 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.61 ' CE1' ' CG1' ' A' ' 65' ' ' VAL . 6.0 m-30 -100.68 -168.38 1.57 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.16 -0.963 . . . . 0.0 109.083 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 80' ' ' LYS . 4.4 p -131.06 176.59 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.992 -1.068 . . . . 0.0 109.522 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.852 HG22 ' HB2' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -136.69 69.42 1.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 109.535 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 70' ' ' LEU . 15.1 tp -89.66 2.21 55.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.125 -0.984 . . . . 0.0 109.216 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.468 ' NH1' ' HG3' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -144.93 69.67 1.26 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.36 -0.838 . . . . 0.0 108.85 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.852 ' HB2' HG22 ' A' ' 69' ' ' THR . . . -118.69 91.72 3.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.898 . . . . 0.0 110.125 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -98.49 -162.81 0.98 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.336 -0.852 . . . . 0.0 108.857 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -101.44 41.36 1.21 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.074 -1.016 . . . . 0.0 109.373 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.462 ' NH1' ' CG ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -150.42 -53.64 0.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.816 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.602 ' HA ' HG12 ' A' ' 89' ' ' VAL . 27.0 m -131.85 136.67 47.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 0.0 109.986 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 77' ' ' ILE . 11.1 mt -99.92 72.93 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.576 ' OH ' HD11 ' A' ' 87' ' ' ILE . 2.5 t80 -89.6 82.2 6.39 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.422 -0.799 . . . . 0.0 109.193 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.409 ' O ' ' HG2' ' A' ' 80' ' ' LYS . . . -89.08 176.0 43.54 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.751 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -150.61 -170.74 3.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.335 -1.097 . . . . 0.0 109.697 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -164.65 25.09 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.428 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.1 -78.57 1.7 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 102' ' ' GLU . 1.9 m -81.92 -38.89 24.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -1.157 . . . . 0.0 109.863 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -126.6 164.56 20.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.987 . . . . 0.0 109.538 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -159.08 162.48 32.71 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.482 HG22 HG23 ' A' ' 88' ' ' THR . 14.9 p -123.79 151.45 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.367 -1.078 . . . . 0.0 109.61 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.576 HD11 ' OH ' ' A' ' 78' ' ' TYR . 54.9 mt -124.8 88.84 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.366 -0.834 . . . . 0.0 108.86 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 41.6 p -105.76 129.33 53.98 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.048 -1.033 . . . . 0.0 109.992 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 76' ' ' SER . 6.1 m -145.23 150.94 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.572 -0.705 . . . . 0.0 109.554 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -97.52 122.67 40.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.202 -0.936 . . . . 0.0 109.653 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -58.15 2.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 109.143 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -175.24 -36.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.807 . . . . 0.0 109.184 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.778 ' C ' HD11 ' A' ' 24' ' ' LEU . 10.3 mttm -145.67 28.51 1.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.842 . . . . 0.0 109.497 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.739 ' N ' HD21 ' A' ' 24' ' ' LEU . 58.3 m -161.3 168.89 23.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.894 . . . . 0.0 109.468 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.618 HD12 ' O ' ' A' ' 23' ' ' GLY . 83.5 mt -125.43 123.86 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.113 -0.992 . . . . 0.0 109.371 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.74 HD11 ' CE3' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -81.54 155.47 25.72 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.462 -0.774 . . . . 0.0 109.903 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 1.004 HG21 HD13 ' A' ' 22' ' ' LEU . 48.2 t -151.43 54.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.665 -0.647 . . . . 0.0 109.695 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -55.53 113.88 4.26 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.563 HG11 ' CE2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -111.3 122.95 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.058 -1.26 . . . . 0.0 109.425 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.605 ' HB3' HG12 ' A' ' 16' ' ' VAL . 2.8 p90 -131.72 178.12 7.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 109.66 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -121.69 -167.41 1.52 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.69 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -68.07 -17.76 64.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.702 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.12 -10.98 25.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.946 . . . . 0.0 109.446 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.585 HD13 ' O ' ' A' ' 15' ' ' ALA . 28.2 mt -125.63 158.59 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.15 -0.969 . . . . 0.0 109.777 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.533 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 7.3 mt-30 -139.61 160.08 62.77 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.442 -0.786 . . . . 0.0 109.009 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 105' ' ' GLN . 5.9 Cg_exo -56.27 165.0 4.61 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.928 1.752 . . . . 0.0 110.129 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.21 -28.01 17.33 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.7 m -115.55 -48.63 2.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.448 -1.031 . . . . 0.0 109.235 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.621 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -87.36 -19.28 28.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.882 . . . . 0.0 109.279 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.446 ' HA ' ' CE2' ' A' ' 78' ' ' TYR . . . -85.55 -52.07 6.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.304 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -60.69 -36.19 78.16 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.432 -0.792 . . . . 0.0 109.79 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 13.4 p -65.27 -37.14 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.191 -0.943 . . . . 0.0 109.378 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 87' ' ' ILE . 93.9 t -73.62 -16.02 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.212 -0.93 . . . . 0.0 109.701 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.9 -44.79 38.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.004 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.499 ' HG3' ' N ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -84.62 -46.86 11.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.108 -0.995 . . . . 0.0 110.069 -179.49 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.605 HD22 HD21 ' A' ' 10' ' ' LEU . 2.6 mp -54.27 -32.65 56.75 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.138 -0.976 . . . . 0.0 109.813 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.728 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -72.93 -43.11 62.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -0.946 . . . . 0.0 109.755 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -57.8 -20.99 39.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.85 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -90.08 -56.18 3.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.08 -1.013 . . . . 0.0 109.982 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -73.44 -0.6 15.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.157 -0.964 . . . . 0.0 109.838 -179.604 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.728 HD12 ' O ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER -64.24 -39.08 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.984 -1.072 . . . . 0.0 108.797 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -121.73 45.51 1.21 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -143.11 -73.57 0.28 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.082 -1.246 . . . . 0.0 110.018 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.483 ' H ' HD23 ' A' ' 120' ' ' LEU . . . -123.18 -18.46 3.11 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.517 ' CE2' ' HG3' ' A' ' 93' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.202 -1.175 . . . . 0.0 109.374 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.3 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.259 0.552 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.985 ' CZ2' HD11 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -92.52 -21.45 20.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.973 . . . . 0.0 109.245 179.82 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.49 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 2.5 tt0 -63.56 -51.34 65.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.313 -0.867 . . . . 0.0 109.753 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.403 HG22 ' H ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -54.12 -40.45 67.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 109.233 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.89 ' HB3' HD12 ' A' ' 10' ' ' LEU . 22.1 m-30 -61.9 -33.69 74.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.095 -1.003 . . . . 0.0 108.417 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.719 HG21 HG13 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -62.15 -56.89 14.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.643 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.494 ' N ' HG12 ' A' ' 6' ' ' VAL . 58.9 m-20 -91.64 50.47 1.72 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.05 -1.032 . . . . 0.0 110.314 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 9' ' ' ASN . 65.7 m -156.19 -100.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.77 -1.206 . . . . 0.0 110.78 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.622 ' N ' HG22 ' A' ' 8' ' ' THR . 0.8 OUTLIER -101.53 -56.48 2.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.084 -1.01 . . . . 0.0 111.075 -178.354 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.993 HD11 HD13 ' A' ' 116' ' ' LEU . 6.6 mt -38.16 -30.22 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.142 -0.974 . . . . 0.0 111.158 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.032 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 47.5 t -101.25 -52.27 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.764 -1.21 . . . . 0.0 110.065 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.764 ' C ' HG22 ' A' ' 13' ' ' THR . . . -40.14 -42.29 2.32 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.764 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 161.18 43.68 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.789 -0.83 . . . . 0.0 109.322 178.437 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.717 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -85.69 15.01 49.46 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 177.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.718 ' HB2' HG11 ' A' ' 112' ' ' VAL . . . 155.68 -27.83 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.638 HG12 ' CD1' ' A' ' 100' ' ' TYR . 5.6 m -139.4 155.34 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.652 HG22 ' HA ' ' A' ' 100' ' ' TYR . 14.7 t -87.18 21.66 2.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.896 -1.128 . . . . 0.0 108.877 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.921 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -178.45 -176.81 0.52 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 1.032 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . 175.33 154.65 0.16 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.273 -0.892 . . . . 0.0 109.127 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.507 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -148.27 136.83 21.52 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.244 -0.91 . . . . 0.0 109.68 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.719 HG13 HG21 ' A' ' 6' ' ' VAL . 1.6 mt -106.61 101.68 12.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.811 HD11 HG21 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -84.95 22.83 1.31 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.389 -0.819 . . . . 0.0 110.269 -178.089 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.502 ' O ' HD12 ' A' ' 95' ' ' ILE . . . 47.43 -164.42 0.18 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.738 HD11 ' C ' ' A' ' 93' ' ' LYS . 1.1 mt -98.34 -74.33 0.59 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.388 -1.066 . . . . 0.0 109.114 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -135.15 22.04 3.47 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.307 -0.87 . . . . 0.0 108.832 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.7 67.97 0.25 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.5 t30 48.7 -150.25 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -1.108 . . . . 0.0 109.737 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 60.8 m -94.12 139.26 31.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.812 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -96.67 -65.31 0.97 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.441 ' C ' HG23 ' A' ' 31' ' ' THR . . . -137.53 160.11 40.07 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.441 HG23 ' C ' ' A' ' 30' ' ' ALA . 77.4 p -155.13 137.35 14.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.041 -1.037 . . . . 0.0 110.119 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 1.008 ' CB ' HG21 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -108.81 115.78 30.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.516 -0.74 . . . . 0.0 109.068 179.578 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 82.38 166.69 0.13 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 35' ' ' PHE . . . -48.41 -96.9 0.01 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.957 ' CE1' HG11 ' A' ' 99' ' ' VAL . 4.9 t80 74.35 84.99 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.315 -1.109 . . . . 0.0 109.901 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.09 105.69 17.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 109.356 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 37' ' ' VAL . 59.7 t -108.05 56.3 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.655 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.562 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 57.58 156.43 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.269 -0.894 . . . . 0.0 109.851 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.562 ' HD2' HG22 ' A' ' 38' ' ' THR . 2.7 Cg_endo -62.17 -36.52 68.78 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.294 1.996 . . . . 0.0 110.197 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' A' ' 43' ' ' GLN . . . -83.82 60.69 5.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.838 . . . . 0.0 109.442 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.539 ' CG ' ' HB ' ' A' ' 37' ' ' VAL . 2.2 mt-30 -66.44 -47.83 71.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.681 -1.262 . . . . 0.0 110.111 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -76.64 -29.04 58.32 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.784 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.618 ' HB2' ' HB1' ' A' ' 40' ' ' ALA . 3.4 mt-30 -81.48 -62.86 1.53 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.97 -1.312 . . . . 0.0 109.84 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.3 m -45.84 -50.76 13.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.84 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -66.45 -30.99 71.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.154 -0.966 . . . . 0.0 109.749 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -71.03 -18.59 62.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.4 t -74.66 -52.61 11.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -0.872 . . . . 0.0 109.659 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.51 -21.72 52.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.194 -0.941 . . . . 0.0 109.543 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.583 ' CE2' ' CG ' ' A' ' 90' ' ' LYS . 4.2 m-30 -65.88 -37.08 85.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.432 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -88.28 -74.69 0.45 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 109.587 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -71.9 119.25 15.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.172 -0.955 . . . . 0.0 109.521 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.412 ' C ' HG12 ' A' ' 55' ' ' ILE . . . -104.19 17.52 23.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.113 -0.992 . . . . 0.0 109.056 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.589 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -76.61 -50.14 2.66 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.456 -0.777 . . . . 0.0 110.372 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 4.2 Cg_exo -62.82 -8.17 12.94 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.976 1.784 . . . . 0.0 110.933 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.788 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -104.96 -44.05 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.041 -1.037 . . . . 0.0 109.497 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.534 ' CD ' ' HA ' ' A' ' 53' ' ' ASP . 8.3 ptm180 -61.98 -22.15 65.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 109.948 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.427 ' C ' ' OG ' ' A' ' 58' ' ' SER . . . -107.73 108.11 19.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 109.907 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.427 ' OG ' ' C ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER 72.25 -79.52 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.432 -0.792 . . . . 0.0 109.882 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.88 -138.97 5.76 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.618 ' HE1' HD12 ' A' ' 62' ' ' LEU . 20.5 p90 -155.39 172.5 18.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -1.11 . . . . 0.0 109.573 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.12 160.29 14.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 109.092 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.619 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 3.4 mt -159.57 98.45 1.38 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.924 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . 74.99 -78.22 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.646 -0.659 . . . . 0.0 110.041 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -159.08 23.28 0.31 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 66' ' ' HIS . 66.5 t -137.48 157.36 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -1.145 . . . . 0.0 109.207 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.487 ' CE1' ' HD2' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -100.25 152.66 20.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.153 -0.967 . . . . 0.0 109.472 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.561 ' CE2' ' HB2' ' A' ' 62' ' ' LEU . 92.2 m-85 -137.61 149.44 46.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 109.525 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 69' ' ' THR . 0.9 OUTLIER -93.54 -156.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 109.241 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.552 ' H ' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -161.88 75.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.94 . . . . 0.0 109.5 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.11 12.15 31.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.907 . . . . 0.0 109.44 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -156.92 64.14 0.51 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.709 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 69' ' ' THR . . . -106.21 90.32 3.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 109.062 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.88 -108.05 0.35 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.107 -0.996 . . . . 0.0 109.791 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -121.6 -34.12 3.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.778 -1.201 . . . . 0.0 110.648 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.53 ' HG2' ' NH1' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -134.74 31.7 3.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.887 -1.133 . . . . 0.0 110.878 -178.703 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.55 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 1.2 m -150.57 116.24 5.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.984 -1.073 . . . . 0.0 109.476 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 77' ' ' ILE . 3.6 mp -144.79 50.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 0.0 109.557 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.653 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -91.01 91.5 8.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.092 -1.005 . . . . 0.0 108.612 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.33 170.65 53.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.511 ' HG2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -151.04 147.36 27.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.54 -0.976 . . . . 0.0 109.11 179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.511 ' N ' ' HG2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -124.7 -170.84 2.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.989 -1.069 . . . . 0.0 109.682 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.29 5.41 77.26 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -154.82 -67.98 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -1.098 . . . . 0.0 108.887 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 81' ' ' LYS . . . -91.7 164.42 13.73 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.506 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -156.71 150.23 21.35 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.538 -1.315 . . . . 0.0 109.908 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.8 p -122.32 147.37 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.329 -1.101 . . . . 0.0 109.448 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.653 HG23 ' HD2' ' A' ' 78' ' ' TYR . 11.9 mt -120.75 94.02 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 39.2 p -113.29 133.56 55.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.981 -1.074 . . . . 0.0 110.716 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.594 HG13 ' HB2' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -151.33 152.66 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.042 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.583 ' CG ' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -97.95 117.69 32.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.901 -179.428 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.854 HG21 ' HZ3' ' A' ' 2' ' ' TRP . 0.8 OUTLIER -96.38 -69.17 0.77 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 108.764 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 91' ' ' THR . 1.9 m 157.7 -24.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.738 ' C ' HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -110.99 -12.33 14.23 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.444 -0.785 . . . . 0.0 109.256 179.713 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.484 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -172.5 168.73 5.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.81 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.502 HD12 ' O ' ' A' ' 23' ' ' GLY . 34.1 mt -105.78 134.64 46.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.398 -0.814 . . . . 0.0 108.973 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.985 HD11 ' CZ2' ' A' ' 2' ' ' TRP . 1.6 mt -88.96 148.26 23.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 110.249 -179.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.811 HG21 HD11 ' A' ' 22' ' ' LEU . 75.4 t -151.33 58.55 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.458 -0.776 . . . . 0.0 109.632 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -55.57 112.58 3.15 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.957 HG11 ' CE1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.81 125.52 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.992 -1.299 . . . . 0.0 109.119 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.735 ' HB2' HD12 ' A' ' 104' ' ' ILE . 3.8 p90 -138.82 -178.3 5.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.941 . . . . 0.0 110.14 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -105.19 -147.3 0.39 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.443 -0.785 . . . . 0.0 109.675 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 83' ' ' SER . 46.8 tt0 -102.91 -29.95 11.12 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.166 -0.959 . . . . 0.0 109.948 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -16.06 23.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 110.193 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.735 HD12 ' HB2' ' A' ' 100' ' ' TYR . 16.7 mt -85.68 141.3 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.058 -1.026 . . . . 0.0 109.395 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.51 110.0 2.17 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.394 -0.816 . . . . 0.0 109.631 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 104' ' ' ILE . 1.2 Cg_endo -65.69 145.84 82.42 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.092 1.862 . . . . 0.0 110.27 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.33 -43.81 3.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.8 m -74.63 -30.9 61.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -1.184 . . . . 0.0 109.483 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.808 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -63.54 -45.02 92.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.874 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.09 -32.52 67.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.146 -0.971 . . . . 0.0 109.846 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 7.4 t-20 -67.73 -32.54 73.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 0.0 109.724 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.718 HG11 ' HB2' ' A' ' 15' ' ' ALA . 1.3 t -79.86 -28.0 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.146 -0.971 . . . . 0.0 109.421 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 109' ' ' ALA . 18.2 t -82.83 -17.92 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.952 . . . . 0.0 109.694 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.471 ' CD ' ' CZ ' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -78.16 -37.17 46.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.158 -0.964 . . . . 0.0 109.765 -179.697 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 111' ' ' ASN . 1.5 mmmt -71.73 -46.3 59.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.122 -0.986 . . . . 0.0 109.864 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.993 HD13 HD11 ' A' ' 10' ' ' LEU . 3.2 tt -54.06 -34.22 59.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.931 -1.106 . . . . 0.0 109.162 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 1.0 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -62.55 -37.8 87.55 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.077 -1.014 . . . . 0.0 108.887 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -21.77 61.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.904 . . . . 0.0 109.6 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.603 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 0.0 OUTLIER -73.71 -40.73 63.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 109.879 -179.492 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.687 HD12 ' CE3' ' A' ' 2' ' ' TRP . 5.0 mt -81.04 -36.26 30.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.117 -0.989 . . . . 0.0 110.566 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.0 HD12 ' O ' ' A' ' 117' ' ' ALA . 1.5 mp -64.1 -21.58 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.103 -0.998 . . . . 0.0 109.596 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.538 ' O ' ' CG ' ' A' ' 123' ' ' GLN . . . -97.5 22.48 40.58 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 122' ' ' GLY . 45.7 mt-30 -162.41 -83.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -1.169 . . . . 0.0 109.809 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 125' ' ' PHE . . . -96.1 57.76 1.48 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.543 ' HB3' ' HB3' ' A' ' 92' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.411 -1.052 . . . . 0.0 109.977 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.587 ' O ' ' CE2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.825 ' CE2' HD22 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -99.81 -36.97 9.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -0.907 . . . . 0.0 109.501 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -72.36 -28.68 63.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.051 -1.031 . . . . 0.0 109.986 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -38.99 86.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.07 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.587 ' CE2' ' O ' ' A' ' 1' ' ' SER . 14.6 m-85 -74.81 -23.94 58.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.138 -0.976 . . . . 0.0 109.862 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.911 HG21 HG13 ' A' ' 21' ' ' ILE . 2.0 t -72.47 -23.16 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.18 -0.95 . . . . 0.0 110.062 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -46.77 -91.21 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.023 -1.048 . . . . 0.0 110.359 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.69 -2.23 3.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 110.131 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 14' ' ' GLY . 6.5 m-20 -86.26 -87.06 0.14 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.085 -1.01 . . . . 0.0 109.262 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 2.0 mm? -54.59 -27.5 39.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.996 -1.065 . . . . 0.0 109.669 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.088 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 4.2 t -90.55 -63.8 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.178 -0.952 . . . . 0.0 109.694 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.754 ' C ' HG22 ' A' ' 13' ' ' THR . . . -39.78 -38.91 1.21 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.754 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 157.02 53.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.977 -0.72 . . . . 0.0 109.839 178.689 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.676 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -96.1 21.76 43.38 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 106.339 -2.704 . . . . 0.0 106.339 177.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 144.43 -28.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.901 HG13 ' HB3' ' A' ' 100' ' ' TYR . 4.3 t -131.72 140.5 48.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.517 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 0.2 OUTLIER -77.78 2.34 17.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.733 -1.229 . . . . 0.0 108.476 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.58 ' HB3' ' HB2' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -158.67 -173.68 4.4 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.359 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 1.088 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . 170.78 142.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.007 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -140.4 104.14 4.71 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.058 -1.026 . . . . 0.0 110.305 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.911 HG13 HG21 ' A' ' 6' ' ' VAL . 14.4 mt -79.61 106.01 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.612 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.4 OUTLIER -93.5 116.93 29.46 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.492 -0.755 . . . . 0.0 109.463 -178.317 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -49.72 -178.26 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.796 HD21 ' N ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -103.55 -68.94 0.82 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -1.141 . . . . 0.0 109.545 -179.75 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -113.66 11.83 18.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.269 -0.894 . . . . 0.0 109.543 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.71 -83.51 1.65 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -175.92 -65.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.417 -1.049 . . . . 0.0 109.401 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.6 m -158.62 156.54 30.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.94 . . . . 0.0 109.715 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -114.85 -69.97 0.83 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.354 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.444 ' O ' HG11 ' A' ' 6' ' ' VAL . . . -160.8 117.93 2.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.344 -0.848 . . . . 0.0 109.076 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 1.6 p -128.81 168.68 15.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.92 . . . . 0.0 109.81 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.4 ' HB2' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -171.71 98.32 0.18 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 109.238 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.58 ' HB2' ' HB3' ' A' ' 18' ' ' GLN . . . -166.7 -67.24 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.169 -0.957 . . . . 0.0 109.464 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 139.21 39.61 0.1 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.557 ' CG ' ' O ' ' A' ' 35' ' ' PHE . 1.4 p90 -155.64 117.95 4.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -1.175 . . . . 0.0 109.409 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.91 130.54 41.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.536 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -90.65 161.67 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.373 -0.829 . . . . 0.0 109.353 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -74.11 148.05 86.26 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.293 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.78 -31.91 78.14 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.125 1.883 . . . . 0.0 110.357 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.31 13.38 3.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.196 -0.94 . . . . 0.0 110.285 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 38' ' ' THR . 1.3 mm-40 -90.65 -32.43 16.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.907 -1.121 . . . . 0.0 109.485 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.86 -46.31 94.78 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -21.01 64.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.406 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 46.1 m -68.28 -34.69 76.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -41.84 75.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.367 -0.833 . . . . 0.0 109.445 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.52 -45.86 91.03 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.921 . . . . 0.0 109.021 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -81.55 -5.86 58.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.352 -0.842 . . . . 0.0 109.114 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.648 ' O ' HD11 ' A' ' 55' ' ' ILE . . . -69.09 -37.92 78.69 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.231 -0.918 . . . . 0.0 109.217 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 6.3 m-30 -74.96 81.89 2.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.52 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 2.1 t-20 -130.37 58.2 1.68 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 108.735 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 50' ' ' ASN . 5.2 t-20 84.77 17.84 0.15 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.578 0.704 . . . . 0.0 109.129 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 44.18 23.62 0.07 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.467 -0.771 . . . . 0.0 110.17 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.549 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -91.93 -53.65 0.27 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.067 -1.02 . . . . 0.0 110.638 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 2.4 Cg_endo -65.4 -7.71 16.76 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.994 1.796 . . . . 0.0 110.965 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.648 HD11 ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -109.08 -17.19 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.96 -1.088 . . . . 0.0 109.638 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.489 ' HG2' ' NH1' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -80.3 -46.8 15.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.449 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -107.32 63.47 0.63 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.505 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 4.7 t 167.68 -30.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.43 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.24 -153.3 31.69 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.448 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 6.3 p90 -151.84 -169.27 3.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -1.165 . . . . 0.0 109.169 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.77 146.75 28.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.092 -1.005 . . . . 0.0 110.556 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.5 -166.98 1.44 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.89 -22.08 46.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 109.383 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.72 -111.17 0.14 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 66' ' ' HIS . 1.2 t -125.76 -153.67 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -1.195 . . . . 0.0 109.293 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 47.1 p-80 -88.29 114.14 24.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.167 -0.958 . . . . 0.0 109.416 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.46 ' HA ' ' HB2' ' A' ' 81' ' ' LYS . 12.0 m-30 -95.13 162.95 13.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.586 HG12 ' N ' ' A' ' 69' ' ' THR . 26.1 t -111.3 169.13 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.897 . . . . 0.0 109.451 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.586 ' N ' HG12 ' A' ' 68' ' ' VAL . 91.6 m -122.33 130.94 53.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.909 . . . . 0.0 109.616 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.72 19.54 5.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.126 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -177.16 85.18 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.373 -0.829 . . . . 0.0 109.171 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.71 36.95 1.63 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 0.0 109.64 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.44 -25.86 13.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.28 -0.887 . . . . 0.0 109.446 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.489 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -90.62 -106.65 0.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -139.64 24.24 2.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.793 -1.192 . . . . 0.0 109.564 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -135.47 156.17 49.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -0.905 . . . . 0.0 109.338 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 77' ' ' ILE . 10.8 mt -149.27 68.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.174 -0.954 . . . . 0.0 109.429 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.651 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -94.17 95.26 8.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.904 . . . . 0.0 108.764 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -113.23 173.32 15.01 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 0.7 OUTLIER -151.23 -170.65 3.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -1.153 . . . . 0.0 109.334 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.507 ' HE2' ' NE2' ' A' ' 66' ' ' HIS . 0.3 OUTLIER 175.62 111.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.189 -0.944 . . . . 0.0 109.58 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.54 -135.0 11.91 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 102' ' ' GLU . 2.4 p -100.24 -4.62 29.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -1.192 . . . . 0.0 109.694 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . . . -113.35 166.95 10.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.368 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.566 ' HA3' ' CE1' ' A' ' 100' ' ' TYR . . . -150.22 157.18 27.09 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.689 ' CG2' HG13 ' A' ' 97' ' ' VAL . 11.9 p -135.53 136.64 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -1.18 . . . . 0.0 110.039 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.651 HG23 ' HD2' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -110.26 95.58 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.552 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 6.7 p -106.72 115.75 30.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 109.889 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.724 ' CG2' HD21 ' A' ' 96' ' ' LEU . 3.1 m -135.02 134.16 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 109.536 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.517 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -97.35 146.1 25.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.346 -0.846 . . . . 0.0 109.121 179.785 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.489 ' HB ' HG12 ' A' ' 121' ' ' ILE . 23.4 p -146.17 -145.31 0.17 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 109.913 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 91' ' ' THR . 0.1 OUTLIER -41.41 -74.58 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.295 -0.878 . . . . 0.0 110.548 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.769 ' O ' HD11 ' A' ' 24' ' ' LEU . 1.2 mtpt -149.72 52.85 0.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.993 . . . . 0.0 109.89 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.796 ' N ' HD21 ' A' ' 24' ' ' LEU . 21.2 t -169.86 151.25 4.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.925 . . . . 0.0 109.523 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.461 HD11 ' HD3' ' A' ' 90' ' ' LYS . 12.4 mt -129.32 128.53 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.179 -0.951 . . . . 0.0 109.256 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.825 HD22 ' CE2' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -98.96 154.39 18.11 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.327 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.689 HG13 ' CG2' ' A' ' 86' ' ' VAL . 59.0 t -137.36 64.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.129 -0.982 . . . . 0.0 109.578 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -50.05 118.28 5.66 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.663 ' O ' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -112.31 114.2 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.159 -1.2 . . . . 0.0 109.291 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.901 ' HB3' HG13 ' A' ' 16' ' ' VAL . 19.2 p90 -123.98 -168.78 1.84 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.248 -0.907 . . . . 0.0 109.672 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' ALA . 6.9 m120 -132.82 -168.52 2.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 83' ' ' SER . 16.1 pt-20 -66.28 -9.32 31.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.278 -0.889 . . . . 0.0 109.906 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -73.89 -17.54 61.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.917 . . . . 0.0 109.599 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 16' ' ' VAL . 9.5 mt -117.59 103.66 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.935 . . . . 0.0 109.504 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.475 ' HG2' ' HD2' ' A' ' 106' ' ' PRO . 1.7 tt0 -64.29 142.05 98.25 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.266 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.475 ' HD2' ' HG2' ' A' ' 105' ' ' GLN . 2.8 Cg_endo -61.55 152.58 72.45 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.04 1.827 . . . . 0.0 110.079 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.32 -23.05 23.67 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.1 m -98.08 -53.28 3.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -1.123 . . . . 0.0 109.569 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.761 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -73.77 -32.19 63.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.928 . . . . 0.0 109.465 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.44 -27.85 64.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 0.0 109.587 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.463 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -78.2 -49.28 14.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.715 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 7.5 p -59.26 -21.59 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -0.969 . . . . 0.0 109.523 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 109' ' ' ALA . 91.1 t -78.91 -33.32 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.785 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.463 ' OE2' ' HA ' ' A' ' 111' ' ' ASN . 26.3 mt-10 -59.57 -61.12 2.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.931 . . . . 0.0 109.439 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.29 -38.26 88.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.633 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 4.1 mt -57.97 -24.44 58.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.869 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -80.41 -29.74 37.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.289 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.35 -38.7 74.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.072 . . . . 0.0 109.4 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -75.43 -47.43 27.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 109.554 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.5 OUTLIER -60.92 -57.52 12.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 109.417 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.869 HD12 ' O ' ' A' ' 117' ' ' ALA . 15.7 mt -61.24 -13.81 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.467 -0.771 . . . . 0.0 109.941 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.74 -9.76 40.9 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -119.42 -56.27 2.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -1.185 . . . . 0.0 109.459 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 114.64 112.4 2.94 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.286 -1.126 . . . . 0.0 109.271 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . 1.015 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.943 ' CZ3' HD22 ' A' ' 96' ' ' LEU . 47.7 m95 -159.25 -149.24 0.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.559 -0.713 . . . . 0.0 109.219 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.84 -86.07 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.816 -1.178 . . . . 0.0 109.342 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -63.77 -37.94 89.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.032 -1.042 . . . . 0.0 108.984 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.604 ' CE2' ' HG ' ' A' ' 116' ' ' LEU . 18.7 m-30 -56.34 -39.26 72.56 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.381 -0.825 . . . . 0.0 109.769 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.549 HG21 ' HB1' ' A' ' 30' ' ' ALA . 1.2 t -54.44 -45.56 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.828 -1.17 . . . . 0.0 108.075 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.407 ' N ' HG12 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -91.62 41.12 1.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 110.919 -179.338 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.505 HG22 ' N ' ' A' ' 9' ' ' ASN . 88.8 m -146.06 -106.01 0.1 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.527 -1.358 . . . . 0.0 109.879 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.9 t-20 -102.1 -70.75 0.74 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.043 -1.036 . . . . 0.0 110.08 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.008 HD23 ' OG ' ' A' ' 1' ' ' SER . 0.2 OUTLIER -20.53 -45.34 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.929 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.775 HG23 ' HB3' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -77.39 -68.09 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.851 -1.156 . . . . 0.0 110.125 -179.291 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.769 ' C ' HG22 ' A' ' 13' ' ' THR . . . -38.99 -36.46 0.5 Allowed Glycine 0 N--CA 1.498 2.785 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.769 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 156.61 39.61 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.989 -0.712 . . . . 0.0 109.154 179.011 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.685 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -84.47 17.78 27.77 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 177.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 158.44 -32.04 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.749 HG12 ' HB3' ' A' ' 100' ' ' TYR . 31.2 m -138.88 150.55 23.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.565 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.6 OUTLIER -78.97 6.32 9.57 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.113 -0.992 . . . . 0.0 108.872 179.112 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.589 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 27.4 mt-30 -168.42 160.87 11.54 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 1.015 ' HB1' ' HA ' ' A' ' 1' ' ' SER . . . -163.95 112.4 1.18 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.913 -1.117 . . . . 0.0 112.148 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.531 ' O ' HD13 ' A' ' 21' ' ' ILE . . . -98.32 144.53 27.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.263 -1.523 . . . . 0.0 109.957 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.855 HD11 ' C ' ' A' ' 1' ' ' SER . 45.5 mm -124.07 111.55 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.417 -0.802 . . . . 0.0 109.136 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.874 HD11 HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -116.24 123.42 47.68 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.044 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.71 -158.62 14.79 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.74 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.572 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -106.63 -60.83 1.61 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.349 -1.089 . . . . 0.0 109.977 -179.504 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.83 6.87 14.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.976 -1.078 . . . . 0.0 108.725 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 28' ' ' THR . . . -143.04 88.4 0.18 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.02 -2.032 . . . . 0.0 108.02 179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' A' ' 26' ' ' GLY . 2.1 t30 -30.68 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.067 -0.666 . . . . 0.0 110.838 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 26' ' ' GLY . 12.3 m -166.56 104.23 0.61 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.05 -1.031 . . . . 0.0 109.845 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.51 ' NE1' ' HA3' ' A' ' 26' ' ' GLY . 19.6 m0 -79.4 -27.93 41.83 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.576 ' HB3' ' CG1' ' A' ' 21' ' ' ILE . . . -147.54 163.59 36.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t -143.98 155.84 44.18 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.11 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 96.6 p -64.63 -9.96 23.21 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.649 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 63.8 66.77 0.65 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.16 -87.47 0.07 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -94.24 148.34 22.3 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.218 -1.166 . . . . 0.0 109.212 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.12 148.57 38.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.599 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -103.29 132.8 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.278 -0.888 . . . . 0.0 109.625 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.1 p -72.04 149.24 92.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.92 . . . . 0.0 109.398 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.722 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 6.1 Cg_exo -60.15 177.62 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.184 1.923 . . . . 0.0 110.202 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 39' ' ' PRO . . . 83.37 -42.23 0.1 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.608 -0.682 . . . . 0.0 109.633 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -68.24 -31.81 71.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.058 -1.026 . . . . 0.0 109.569 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.09 -35.93 60.46 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -69.3 -33.96 73.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -1.173 . . . . 0.0 109.531 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.2 m -59.14 -31.73 69.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.412 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 mt -68.7 -40.58 79.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 109.398 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.62 -42.01 99.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.383 -0.823 . . . . 0.0 109.454 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.4 t -74.85 -9.98 59.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 109.562 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.38 -16.65 36.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.923 . . . . 0.0 109.729 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -81.89 -15.93 52.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.248 -0.907 . . . . 0.0 109.688 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -117.3 4.51 12.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.271 -0.893 . . . . 0.0 109.239 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -166.44 107.72 0.69 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -0.865 . . . . 0.0 109.468 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 56' ' ' ARG . . . -95.11 47.74 1.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.379 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.577 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -82.59 -49.62 0.8 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 110.721 -179.534 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 4.8 Cg_exo -63.57 -71.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.974 1.783 . . . . 0.0 111.393 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.769 HG22 ' O ' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -45.52 -54.13 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.13 -0.981 . . . . 0.0 110.053 -178.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 5.0 mtp180 -50.83 -53.24 33.85 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.161 -0.962 . . . . 0.0 109.489 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.81 -87.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.54 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.2 -82.96 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.179 -0.95 . . . . 0.0 109.426 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.769 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -179.97 -99.96 0.13 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.477 ' CB ' ' HB2' ' A' ' 67' ' ' TYR . 1.3 m-85 -131.19 133.53 45.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.358 -1.083 . . . . 0.0 109.273 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -129.25 125.61 37.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.194 -0.942 . . . . 0.0 109.483 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.93 -149.78 0.41 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.329 -0.857 . . . . 0.0 109.302 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.25 -75.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.415 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.57 37.14 1.91 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.85 158.52 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -1.145 . . . . 0.0 109.773 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -131.03 143.21 50.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.448 -0.783 . . . . 0.0 109.51 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.477 ' HB2' ' CB ' ' A' ' 60' ' ' PHE . 33.8 m-85 -134.56 -169.51 2.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.326 -0.859 . . . . 0.0 109.34 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.41 136.96 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.964 . . . . 0.0 109.426 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.642 HG21 ' HB ' ' A' ' 55' ' ' ILE . 1.7 m -93.87 103.03 15.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.943 . . . . 0.0 109.266 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 70' ' ' LEU . 4.0 tp -124.0 38.11 4.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.963 . . . . 0.0 109.715 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER 172.53 50.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 179.634 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.451 ' HA ' HG12 ' A' ' 77' ' ' ILE . . . -113.78 23.38 13.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.866 . . . . 0.0 109.125 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -124.97 -24.02 4.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 109.672 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -75.57 -93.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.119 -0.988 . . . . 0.0 109.253 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.61 -46.9 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 109.254 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.584 ' CB ' ' CZ ' ' A' ' 78' ' ' TYR . 67.7 m -89.39 -164.2 1.11 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.912 . . . . 0.0 108.779 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.714 HG22 ' O ' ' A' ' 77' ' ' ILE . 45.3 mt -157.73 63.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.983 -1.073 . . . . 0.0 110.212 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.861 ' CD1' HG23 ' A' ' 87' ' ' ILE . 1.9 m-85 -90.81 145.22 24.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.996 -1.065 . . . . 0.0 108.432 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -140.61 -171.21 12.38 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.484 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -149.59 -176.66 5.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.584 -0.95 . . . . 0.0 108.944 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER 178.55 34.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.973 . . . . 0.0 109.617 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.431 ' C ' ' OG ' ' A' ' 83' ' ' SER . . . 62.33 95.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 101' ' ' ASN . 0.6 OUTLIER 70.55 6.79 5.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.287 -1.125 . . . . 0.0 109.783 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 81' ' ' LYS . . . -150.35 129.88 13.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.661 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.561 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -150.35 174.8 29.64 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.867 HG22 ' CG2' ' A' ' 88' ' ' THR . 7.4 p -148.14 114.26 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -1.177 . . . . 0.0 110.133 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.861 HG23 ' CD1' ' A' ' 78' ' ' TYR . 7.2 mt -90.72 79.34 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.115 -0.991 . . . . 0.0 109.212 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.867 ' CG2' HG22 ' A' ' 86' ' ' VAL . 1.2 p -105.56 141.78 36.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.198 -0.939 . . . . 0.0 110.116 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 1.026 HG22 HD21 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -150.49 -178.11 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.493 ' N ' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.41 80.3 1.38 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.886 -1.134 . . . . 0.0 110.466 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 1.034 HG22 HD11 ' A' ' 121' ' ' ILE . 19.3 p -98.56 148.65 23.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.935 . . . . 0.0 108.666 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 0.3 OUTLIER 50.85 20.27 0.75 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.341 -0.85 . . . . 0.0 109.754 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 92' ' ' SER . 0.5 OUTLIER 81.95 -18.71 0.46 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.342 -0.849 . . . . 0.0 110.192 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.556 ' HA ' ' CD2' ' A' ' 24' ' ' LEU . 1.4 p -82.28 178.94 7.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.213 -0.93 . . . . 0.0 109.21 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 4.8 mt -130.86 101.65 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.134 -0.979 . . . . 0.0 110.117 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.026 HD21 HG22 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -71.74 157.78 37.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.299 -0.876 . . . . 0.0 108.743 179.602 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.874 HG21 HD11 ' A' ' 22' ' ' LEU . 10.4 t -132.3 68.27 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.952 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -48.26 129.46 19.03 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 107.399 -2.28 . . . . 0.0 107.399 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -132.12 106.0 10.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.715 -1.462 . . . . 0.0 108.73 -178.786 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.868 ' HB2' HD12 ' A' ' 104' ' ' ILE . 22.5 p90 -122.77 164.56 18.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.371 -0.83 . . . . 0.0 109.905 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 102' ' ' GLU . 1.1 m120 -150.68 -164.11 1.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.443 -0.786 . . . . 0.0 109.312 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 101' ' ' ASN . 0.8 OUTLIER 61.49 19.21 10.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.626 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.8 mttt 60.28 62.74 1.52 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.118 -0.989 . . . . 0.0 109.377 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.868 HD12 ' HB2' ' A' ' 100' ' ' TYR . 6.2 mt -73.68 123.05 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.285 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -44.66 104.86 0.41 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.447 -0.783 . . . . 0.0 109.983 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 104' ' ' ILE . 3.6 Cg_exo -62.08 172.82 3.66 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.053 1.835 . . . . 0.0 110.173 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 111' ' ' ASN . . . 87.9 -19.88 31.56 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.846 ' O ' HG23 ' A' ' 112' ' ' VAL . 17.1 m -106.24 -45.56 4.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -1.18 . . . . 0.0 109.273 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.529 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -73.64 -43.31 59.85 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.186 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.71 -30.79 70.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.147 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 107' ' ' GLY . 0.7 OUTLIER -70.09 -40.98 74.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.346 -0.846 . . . . 0.0 109.467 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 108' ' ' THR . 21.6 t -67.2 -26.11 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.124 -0.985 . . . . 0.0 109.33 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.774 HG13 ' HZ2' ' A' ' 2' ' ' TRP . 38.1 t -76.73 -27.63 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.367 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.38 -43.12 82.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.442 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.2 -54.29 11.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 109.062 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.604 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 5.0 mp -51.55 -22.31 3.14 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.268 -0.895 . . . . 0.0 109.084 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.655 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -71.25 -43.73 66.69 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.441 -0.787 . . . . 0.0 109.248 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.44 -14.58 29.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.741 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.485 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 1.7 t80 -78.55 -60.76 2.24 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -0.935 . . . . 0.0 109.512 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.58 -50.08 68.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.909 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.034 HD11 HG22 ' A' ' 91' ' ' THR . 19.6 mt -51.08 -34.21 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.087 -1.008 . . . . 0.0 109.513 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -45.16 -65.3 1.9 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -46.88 -60.42 2.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -1.12 . . . . 0.0 109.642 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.4 74.09 1.19 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 92' ' ' SER . 64.1 m-85 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.256 -1.144 . . . . 0.0 109.482 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 2' ' ' TRP . 2.4 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.856 ' NE1' HD23 ' A' ' 10' ' ' LEU . 3.3 m-90 43.25 30.61 0.31 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.376 -0.827 . . . . 0.0 109.501 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -74.71 0.18 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.957 -1.09 . . . . 0.0 109.248 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 m -69.61 -8.81 50.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.127 -0.983 . . . . 0.0 109.051 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.626 ' HB3' HD13 ' A' ' 10' ' ' LEU . 14.2 m-30 -88.55 -34.43 17.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.356 -0.84 . . . . 0.0 109.098 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.667 ' HA ' HG23 ' A' ' 11' ' ' VAL . 1.0 OUTLIER -60.99 -33.79 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.311 -0.868 . . . . 0.0 108.746 179.565 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -48.83 -89.58 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.484 -0.76 . . . . 0.0 110.504 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 p -133.64 13.36 4.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.068 -1.02 . . . . 0.0 110.556 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 14' ' ' GLY . 16.9 m-20 -96.59 -82.72 0.39 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.965 -1.084 . . . . 0.0 109.123 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.856 HD23 ' NE1' ' A' ' 2' ' ' TRP . 7.9 mp -65.73 -24.18 66.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.927 -1.108 . . . . 0.0 109.322 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.928 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 3.6 t -85.18 -57.7 4.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.748 ' C ' HG22 ' A' ' 13' ' ' THR . . . -47.65 -35.97 12.1 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.748 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER 154.93 49.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 122.032 -0.687 . . . . 0.0 110.628 178.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.72 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -94.87 21.08 45.65 Favored Glycine 0 C--N 1.292 -1.898 0 N-CA-C 106.471 -2.652 . . . . 0.0 106.471 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.758 ' O ' HG21 ' A' ' 104' ' ' ILE . . . 153.21 -30.96 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 5.6 m -139.34 153.11 23.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.476 ' O ' ' OE1' ' A' ' 18' ' ' GLN . 63.2 p -80.36 12.24 3.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.898 -1.126 . . . . 0.0 109.114 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.525 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -171.86 176.57 3.56 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.928 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . -175.05 159.67 2.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.789 -1.194 . . . . 0.0 109.777 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.801 ' HB1' HG22 ' A' ' 31' ' ' THR . . . -153.17 122.56 6.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.15 -0.969 . . . . 0.0 110.0 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.554 ' CD1' ' HB2' ' A' ' 2' ' ' TRP . 5.0 mm -81.58 98.47 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.039 HD22 HG21 ' A' ' 97' ' ' VAL . 5.4 mp -75.99 -79.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.606 -0.684 . . . . 0.0 110.302 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.482 ' HA3' ' CZ3' ' A' ' 29' ' ' TRP . . . 141.04 148.95 5.18 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.532 ' HB3' ' CG1' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -107.51 -16.82 14.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.08 -1.247 . . . . 0.0 109.863 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.11 31.98 0.84 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.064 -1.022 . . . . 0.0 109.843 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.69 -110.94 0.69 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.75 -63.29 0.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.409 -1.053 . . . . 0.0 109.153 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.571 ' O ' ' CE3' ' A' ' 29' ' ' TRP . 0.2 OUTLIER -134.95 -178.06 4.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.91 . . . . 0.0 109.525 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.571 ' CE3' ' O ' ' A' ' 28' ' ' THR . 0.6 OUTLIER -157.3 -54.38 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.871 . . . . 0.0 109.143 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.518 ' O ' HG12 ' A' ' 21' ' ' ILE . . . -173.76 79.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.801 HG22 ' HB1' ' A' ' 20' ' ' ALA . 17.9 p -79.57 166.52 21.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -0.973 . . . . 0.0 110.481 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.501 ' HB2' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -171.17 54.92 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.436 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . . . -124.24 -166.4 1.5 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.365 -0.835 . . . . 0.0 109.631 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.31 -25.01 14.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.412 ' HE2' HG11 ' A' ' 99' ' ' VAL . 4.0 p90 -82.81 -175.44 5.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -1.233 . . . . 0.0 109.453 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.817 ' O ' ' HB2' ' A' ' 63' ' ' ALA . . . -141.8 95.87 2.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 109.636 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 t -84.41 66.6 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 109.377 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.704 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 1.2 t -93.04 -26.87 0.28 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.325 -0.86 . . . . 0.0 112.627 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 38' ' ' THR . 6.3 Cg_exo -59.72 -166.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.739 0 C-N-CA 120.774 0.983 . . . . 0.0 110.37 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.22 47.3 1.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.456 ' HA ' ' OE1' ' A' ' 41' ' ' GLN . 14.0 mm-40 -81.27 -16.6 52.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.069 -1.02 . . . . 0.0 109.124 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.0 -41.54 92.47 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -27.9 65.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -1.209 . . . . 0.0 109.662 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.3 m -63.32 -22.52 66.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.137 -0.977 . . . . 0.0 109.508 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.93 -43.2 16.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 110.289 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . . . -72.38 -54.93 7.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.044 -1.035 . . . . 0.0 109.913 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 m -55.05 -29.39 57.36 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.229 -0.92 . . . . 0.0 109.291 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.9 90.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.336 -0.853 . . . . 0.0 109.641 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 46' ' ' ALA . 17.3 m-30 -53.4 -21.27 5.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.27 -0.894 . . . . 0.0 109.853 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -80.55 -58.57 3.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.011 . . . . 0.0 109.535 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -126.91 133.35 50.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 109.514 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.447 ' C ' HG12 ' A' ' 55' ' ' ILE . . . -112.1 29.17 8.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 109.45 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.618 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 5.0 t70 -81.77 -45.63 1.06 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 110.62 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.3 Cg_endo -66.32 -6.33 14.66 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 121.524 1.483 . . . . 0.0 110.368 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.814 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -103.32 -31.98 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 0.0 109.709 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 69' ' ' THR . 4.3 ptp180 -71.38 -26.75 62.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.013 -1.054 . . . . 0.0 109.515 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.8 -63.16 1.45 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 109.808 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.04 -32.94 5.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 109.459 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 55' ' ' ILE . . . 111.75 -151.03 18.02 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.52 ' HZ ' HG11 ' A' ' 86' ' ' VAL . 21.3 p90 -123.12 166.49 15.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -1.096 . . . . 0.0 109.42 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.674 ' O ' HD23 ' A' ' 62' ' ' LEU . 1.2 p30 -127.32 151.65 48.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 109.922 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 61' ' ' ASP . 25.7 mt -123.62 -141.33 0.31 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.327 -0.858 . . . . 0.0 109.464 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.817 ' HB2' ' O ' ' A' ' 36' ' ' ALA . . . -28.11 -70.81 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.9 -0.5 . . . . 0.0 111.115 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.76 21.6 0.39 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.57 163.77 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.155 -1.203 . . . . 0.0 109.476 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -102.57 155.91 17.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 109.35 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.452 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 64.6 m-85 -141.81 150.32 41.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.258 -0.901 . . . . 0.0 109.324 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 69' ' ' THR . 49.9 t -97.55 161.2 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.747 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.507 ' N ' HG12 ' A' ' 68' ' ' VAL . 19.8 m -146.22 91.76 2.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 109.18 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.84 ' O ' HD23 ' A' ' 70' ' ' LEU . 1.7 tt -109.36 25.92 11.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.226 -0.921 . . . . 0.0 109.599 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.466 ' CG ' ' O ' ' A' ' 70' ' ' LEU . 7.2 mtm180 -158.87 61.17 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.885 . . . . 0.0 109.42 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 73' ' ' ASP . . . -129.91 119.98 24.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.437 -0.79 . . . . 0.0 109.407 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 72' ' ' ALA . 0.7 OUTLIER 169.38 -61.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 109.498 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.526 ' HB3' ' HD2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -56.34 -83.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.167 -0.958 . . . . 0.0 109.328 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.526 ' HD2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -148.67 -34.48 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.028 -1.045 . . . . 0.0 110.264 179.754 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 72.3 m -97.28 162.8 13.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.906 -1.122 . . . . 0.0 109.827 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 76' ' ' SER . 3.4 mp -146.77 83.58 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 109.824 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.862 ' CD2' HG23 ' A' ' 87' ' ' ILE . 1.1 m-85 -92.65 96.14 10.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.007 -1.058 . . . . 0.0 108.718 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.99 174.65 8.62 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.41 85.27 1.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.338 -1.095 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -59.91 178.05 0.2 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.2 -0.937 . . . . 0.0 109.496 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -51.65 -45.0 54.79 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.63 -19.99 3.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -1.172 . . . . 0.0 110.406 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -99.02 167.42 10.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.898 -1.126 . . . . 0.0 109.86 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.51 153.73 23.19 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.573 HG23 HG13 ' A' ' 97' ' ' VAL . 3.9 p -136.34 132.23 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.134 -1.215 . . . . 0.0 109.846 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.862 HG23 ' CD2' ' A' ' 78' ' ' TYR . 67.6 mt -107.5 112.63 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.328 -0.858 . . . . 0.0 109.229 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.422 ' OG1' ' HB ' ' A' ' 77' ' ' ILE . 1.4 p -120.35 117.69 28.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.622 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 1.042 HG22 HD21 ' A' ' 96' ' ' LEU . 18.1 m -144.59 146.66 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 109.532 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -77.22 151.57 35.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.252 -0.905 . . . . 0.0 109.326 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.542 ' O ' ' CB ' ' A' ' 125' ' ' PHE . 25.1 p -147.34 -111.41 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 109.785 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.72 86.41 5.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.772 -1.205 . . . . 0.0 109.88 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.448 ' O ' ' CZ2' ' A' ' 29' ' ' TRP . 0.6 OUTLIER 51.18 21.72 1.15 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.331 -0.855 . . . . 0.0 109.464 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.451 ' O ' ' OG1' ' A' ' 91' ' ' THR . 4.9 t -157.32 147.61 20.95 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.374 -0.829 . . . . 0.0 109.377 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 89' ' ' VAL . 11.0 mt -109.1 154.2 10.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.395 -0.816 . . . . 0.0 109.071 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.042 HD21 HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.59 150.81 34.46 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.028 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 1.039 HG21 HD22 ' A' ' 22' ' ' LEU . 54.9 t -129.68 77.31 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.291 -0.881 . . . . 0.0 110.159 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.03 143.77 45.44 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.457 HG22 HG12 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -143.15 118.33 4.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.691 -1.476 . . . . 0.0 109.853 -179.078 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.582 ' CE1' ' O ' ' A' ' 104' ' ' ILE . 35.1 p90 -131.89 166.0 22.62 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 103' ' ' LYS . 46.7 t30 -150.31 133.33 16.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.871 -1.143 . . . . 0.0 110.864 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 101' ' ' ASN . 0.0 OUTLIER 38.39 29.74 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.634 179.289 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 101' ' ' ASN . 5.6 mmtp -136.19 -51.31 0.71 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.246 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.775 ' O ' HG22 ' A' ' 104' ' ' ILE . 1.7 mp -112.35 75.68 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.127 -0.983 . . . . 0.0 109.841 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.458 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 9.6 mt-30 -54.8 158.1 4.83 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.077 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 105' ' ' GLN . 2.9 Cg_endo -60.03 143.52 99.56 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.088 1.859 . . . . 0.0 110.403 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.16 -22.49 6.7 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.6 m -114.93 -52.87 2.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.125 -1.221 . . . . 0.0 109.499 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.513 ' HB2' HG21 ' A' ' 104' ' ' ILE . . . -72.37 -29.46 63.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 109.527 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -71.43 -21.82 61.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.572 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -90.08 -50.72 5.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.195 -0.94 . . . . 0.0 109.674 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 109' ' ' ALA . 7.1 p -61.05 -38.18 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 109.683 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.778 HG11 HG21 ' A' ' 87' ' ' ILE . 44.8 t -72.72 -31.14 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.133 -0.98 . . . . 0.0 109.601 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 110' ' ' ALA . 6.6 tt0 -65.91 -42.33 90.31 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.171 -0.956 . . . . 0.0 109.824 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -75.87 -36.52 59.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -0.968 . . . . 0.0 109.875 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.554 HD23 ' CH2' ' A' ' 2' ' ' TRP . 17.1 tp -60.0 -62.52 1.81 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.091 -1.006 . . . . 0.0 108.797 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 1.072 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -60.36 -21.53 62.23 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.27 -0.894 . . . . 0.0 109.284 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.465 ' HB2' ' HA ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -58.07 -52.0 67.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.281 -0.887 . . . . 0.0 109.539 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -59.27 -29.38 67.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.201 -0.937 . . . . 0.0 108.982 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.413 HD13 ' HB ' ' A' ' 91' ' ' THR . 4.3 mt -80.0 -22.9 41.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 110.025 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.072 HD12 ' O ' ' A' ' 117' ' ' ALA . 1.3 mp -87.45 -16.08 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.096 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.15 -27.62 15.65 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -81.78 -71.71 0.47 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.363 -1.081 . . . . 0.0 109.367 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 144.9 94.0 0.17 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.542 ' CB ' ' O ' ' A' ' 91' ' ' THR . 22.6 m-85 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.131 -1.217 . . . . 0.0 109.362 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 1.073 ' CZ3' HD22 ' A' ' 96' ' ' LEU . 1.7 m-90 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.49 -67.31 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.072 -1.018 . . . . 0.0 109.568 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -65.81 -30.85 71.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.532 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.967 ' CB ' HD12 ' A' ' 10' ' ' LEU . 6.6 m-30 -81.73 -3.08 52.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.12 -0.987 . . . . 0.0 109.456 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.719 ' HA ' HG23 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -83.19 -41.05 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.983 -1.073 . . . . 0.0 108.794 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -90.46 48.29 1.53 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.378 -0.827 . . . . 0.0 111.117 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.504 HG23 ' H ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -165.85 -96.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.708 -1.245 . . . . 0.0 110.792 179.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -101.46 -68.97 0.8 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.982 -1.073 . . . . 0.0 110.925 -178.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.967 HD12 ' CB ' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -23.05 -43.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.026 HG22 ' HB3' ' A' ' 19' ' ' ALA . 48.9 t -91.94 -55.5 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.725 -1.235 . . . . 0.0 110.815 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.736 ' C ' HG22 ' A' ' 13' ' ' THR . . . -40.03 -47.78 3.39 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.736 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 163.62 41.28 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.709 -0.877 . . . . 0.0 108.792 178.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.706 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -87.19 22.2 16.57 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 153.97 -34.1 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.914 HG12 ' HB3' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -134.46 137.94 50.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.72 HG23 ' CD1' ' A' ' 104' ' ' ILE . 69.2 p -78.21 2.39 18.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.955 -1.091 . . . . 0.0 108.869 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.509 ' CG ' ' C ' ' A' ' 17' ' ' THR . 6.4 mt-30 -161.83 151.11 15.99 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 1.026 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -163.47 147.97 10.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.967 -1.083 . . . . 0.0 109.973 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -141.81 152.03 43.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.429 -0.795 . . . . 0.0 108.974 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.842 HG22 ' HE3' ' A' ' 29' ' ' TRP . 7.0 mt -120.88 103.22 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.949 . . . . 0.0 109.669 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.723 HD23 ' C ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -136.55 164.23 28.67 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.588 ' HA3' ' CD1' ' A' ' 95' ' ' ILE . . . 132.64 172.79 13.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.887 HD13 ' O ' ' A' ' 93' ' ' LYS . 1.4 mp 60.78 121.0 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.148 0 O-C-N 121.159 -1.2 . . . . 0.0 108.377 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -78.03 39.3 0.3 Allowed 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.806 -0.559 . . . . 0.0 111.448 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -105.98 -32.62 3.74 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER 162.79 -172.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.621 -0.929 . . . . 0.0 109.167 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.655 HG22 ' H ' ' A' ' 29' ' ' TRP . 1.3 m -98.56 -174.49 2.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.091 -1.006 . . . . 0.0 108.536 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.842 ' HE3' HG22 ' A' ' 21' ' ' ILE . 3.8 m-90 -142.8 -54.67 0.41 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.013 -1.055 . . . . 0.0 109.993 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.0 134.87 0.2 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.536 -1.266 . . . . 0.0 110.464 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 1.4 t -135.1 157.41 46.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.573 -0.705 . . . . 0.0 109.113 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.473 ' CB ' HG11 ' A' ' 11' ' ' VAL . 13.9 m -159.88 100.59 1.43 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.608 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.532 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . . . -169.81 -164.4 0.43 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 109.161 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -118.13 35.34 4.07 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.532 ' CE1' ' HB3' ' A' ' 33' ' ' ALA . 10.7 p90 -141.59 124.3 16.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 109.48 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.0 116.03 28.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.438 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.707 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 3.5 t -81.78 143.77 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.778 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.535 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 11.2 p -51.05 160.61 0.82 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 0.0 109.444 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 3.9 Cg_exo -59.54 -18.84 49.15 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.128 1.885 . . . . 0.0 110.425 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.17 50.14 1.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.0 109.536 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.535 ' CG ' ' O ' ' A' ' 38' ' ' THR . 36.5 mt-30 -78.36 -55.15 5.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.103 -0.998 . . . . 0.0 109.805 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.94 -17.39 78.49 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -89.66 -18.21 26.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -1.191 . . . . 0.0 109.478 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 53.4 m -89.68 -26.01 20.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.883 . . . . 0.0 109.576 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.9 mt -81.65 -46.53 14.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.81 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.42 87.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.129 -0.982 . . . . 0.0 109.459 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 m -77.56 -39.3 46.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.93 . . . . 0.0 109.421 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 44' ' ' THR . . . -56.75 -29.86 63.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.322 -0.861 . . . . 0.0 109.25 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -87.31 64.55 8.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 109.446 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.1 -69.51 0.77 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 109.227 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.428 ' O ' ' CG ' ' A' ' 51' ' ' ASN . 19.1 t-20 -138.98 33.35 2.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.0 109.069 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 56' ' ' ARG . . . 49.06 22.42 0.6 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.573 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.586 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -88.51 -57.41 0.28 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.636 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.586 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 1.1 Cg_endo -65.62 -41.35 15.08 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.886 1.724 . . . . 0.0 111.005 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.556 ' HB ' HG21 ' A' ' 69' ' ' THR . 0.2 OUTLIER -75.56 -37.2 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.168 -0.957 . . . . 0.0 109.797 -179.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -69.01 -66.94 0.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.0 109.899 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.546 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -77.03 126.03 30.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.107 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 3.5 t 82.52 -42.72 0.13 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.741 -0.599 . . . . 0.0 110.17 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 55' ' ' ILE . . . 95.48 -171.59 29.43 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.418 ' HE1' HD11 ' A' ' 62' ' ' LEU . 46.1 p90 -126.08 164.02 21.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -1.193 . . . . 0.0 109.55 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.465 ' HA ' ' HB3' ' A' ' 66' ' ' HIS . 54.0 m-20 -128.55 162.51 27.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.881 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.418 HD11 ' HE1' ' A' ' 60' ' ' PHE . 61.4 mt -137.0 -147.2 0.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.137 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.707 ' HB2' ' HA ' ' A' ' 37' ' ' VAL . . . -53.78 -54.51 37.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.103 -0.998 . . . . 0.0 109.633 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.75 20.23 0.69 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.465 HG12 ' CE1' ' A' ' 67' ' ' TYR . 71.9 t -135.88 149.0 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -1.188 . . . . 0.0 109.36 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 13.6 p-80 -153.55 160.18 42.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.1 -1.0 . . . . 0.0 109.837 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.465 ' CE1' HG12 ' A' ' 65' ' ' VAL . 52.1 m-85 -139.83 178.47 7.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.355 -0.84 . . . . 0.0 109.481 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.485 ' O ' ' HB ' ' A' ' 69' ' ' THR . 6.0 p -92.03 -29.3 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.212 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.556 HG21 ' HB ' ' A' ' 55' ' ' ILE . 98.8 m 63.85 109.08 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.554 -0.716 . . . . 0.0 109.484 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.6 mt -89.91 -67.65 0.83 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.871 . . . . 0.0 109.503 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.37 137.2 50.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.839 . . . . 0.0 109.298 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 73' ' ' ASP . . . -159.07 91.6 1.04 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 109.527 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 46.7 t0 178.08 -31.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 109.624 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.462 ' O ' ' CD ' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -66.25 -93.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.145 -0.972 . . . . 0.0 109.401 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.462 ' CD ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -138.56 -53.86 0.61 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.07 -1.019 . . . . 0.0 109.725 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.71 ' C ' HD12 ' A' ' 77' ' ' ILE . 20.3 m -90.03 162.76 15.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.0 109.419 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.71 HD12 ' C ' ' A' ' 76' ' ' SER . 4.1 mp -152.9 84.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.177 -0.952 . . . . 0.0 110.246 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.791 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -98.99 98.86 9.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.974 -1.079 . . . . 0.0 108.207 178.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.55 166.56 43.68 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.672 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.17 165.56 32.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.97 . . . . 0.0 108.921 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.54 ' HD3' ' HB3' ' A' ' 84' ' ' ALA . 10.3 ptmt -130.48 -9.26 4.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.954 -1.091 . . . . 0.0 110.403 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.28 -23.36 9.83 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.94 -60.41 1.29 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -1.122 . . . . 0.0 108.945 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.54 ' HB3' ' HD3' ' A' ' 81' ' ' LYS . . . -99.82 -169.73 1.79 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 108.86 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.532 ' O ' ' CE1' ' A' ' 100' ' ' TYR . . . -166.94 152.79 21.94 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.75 ' O ' HG13 ' A' ' 86' ' ' VAL . 14.5 p -135.29 104.07 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -1.097 . . . . 0.0 108.971 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.791 HG23 ' HD2' ' A' ' 78' ' ' TYR . 2.0 mt -79.56 107.6 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 109.7 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.667 HG22 HG22 ' A' ' 97' ' ' VAL . 46.8 p -111.71 98.89 7.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.305 -0.872 . . . . 0.0 109.346 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.867 HG23 HD21 ' A' ' 96' ' ' LEU . 11.4 m -125.75 161.83 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.369 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.66 153.79 17.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 109.659 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.682 HG21 ' HZ3' ' A' ' 2' ' ' TRP . 0.6 OUTLIER -147.09 -92.51 0.09 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.289 -0.882 . . . . 0.0 109.209 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.9 p -98.46 66.1 1.69 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 109.102 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.887 ' O ' HD13 ' A' ' 24' ' ' LEU . 6.9 mtmt 64.74 27.74 13.03 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.32 -0.862 . . . . 0.0 108.994 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.636 ' HA ' ' CH2' ' A' ' 29' ' ' TRP . 77.7 p -146.73 148.61 32.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.9 . . . . 0.0 109.947 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.588 ' CD1' ' HA3' ' A' ' 23' ' ' GLY . 1.1 mt -105.93 94.61 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 109.531 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.073 HD22 ' CZ3' ' A' ' 2' ' ' TRP . 0.3 OUTLIER -56.15 155.12 6.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.966 -1.084 . . . . 0.0 108.6 179.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.667 HG22 HG22 ' A' ' 88' ' ' THR . 73.2 t -135.08 84.61 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.134 -0.979 . . . . 0.0 109.887 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.447 ' CA ' HG11 ' A' ' 16' ' ' VAL . . . -65.71 92.47 0.16 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.539 HG22 HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -91.72 108.48 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.343 -1.092 . . . . 0.0 108.404 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.914 ' HB3' HG12 ' A' ' 16' ' ' VAL . 5.5 p90 -131.31 172.42 12.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.059 -1.026 . . . . 0.0 110.322 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.473 ' OD1' ' HB2' ' A' ' 103' ' ' LYS . 9.0 p30 -102.81 -166.51 1.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.608 -0.682 . . . . 0.0 109.619 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -69.57 -20.44 63.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.892 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 9.9 mttm -52.95 -41.02 64.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.006 . . . . 0.0 109.468 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.72 ' CD1' HG23 ' A' ' 17' ' ' THR . 1.4 mp -91.61 137.59 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.137 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.19 149.34 65.82 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.544 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.86 -8.03 14.73 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.324 2.016 . . . . 0.0 110.628 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -102.95 -39.54 2.66 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -28.18 69.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.113 -1.228 . . . . 0.0 109.893 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.42 -34.9 18.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.116 -0.99 . . . . 0.0 109.677 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.21 -20.43 62.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.738 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.37 -42.28 25.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 109.704 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.44 -37.26 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.771 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.716 HG11 HG21 ' A' ' 87' ' ' ILE . 85.4 t -74.12 -14.02 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.551 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.25 -34.28 22.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.941 . . . . 0.0 109.603 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 118' ' ' ASP . 3.8 mttm -77.74 -51.62 10.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.151 -0.968 . . . . 0.0 109.473 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.46 HD21 ' CD2' ' A' ' 5' ' ' TYR . 1.1 mp -51.41 -48.1 62.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 108.818 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.837 ' HB1' HD11 ' A' ' 121' ' ' ILE . . . -62.34 -47.95 81.96 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.123 -0.986 . . . . 0.0 108.413 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.538 ' CA ' HG12 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -38.52 -29.64 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.405 0.621 . . . . 0.0 109.685 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 117' ' ' ALA . 14.9 m-30 -74.28 -49.59 22.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.305 -0.872 . . . . 0.0 109.317 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.474 HD23 ' CE1' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -80.81 -3.17 50.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.864 . . . . 0.0 111.841 -178.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.837 HD11 ' HB1' ' A' ' 117' ' ' ALA . 2.1 mm -77.22 -38.47 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.256 -1.527 . . . . 0.0 108.994 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 121' ' ' ILE . . . -41.32 -38.56 2.0 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -84.57 -59.59 2.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -1.102 . . . . 0.0 109.145 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.38 106.32 1.62 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.607 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 1.8 m-85 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.128 -1.219 . . . . 0.0 109.397 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.85 ' CD1' HD13 ' A' ' 10' ' ' LEU . 6.4 m95 . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -32.57 -82.21 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.798 -0.564 . . . . 0.0 111.536 -178.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.462 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.6 OUTLIER -64.01 -34.61 78.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.065 -1.022 . . . . 0.0 110.87 -178.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.834 ' CE2' HD12 ' A' ' 116' ' ' LEU . 1.1 m-30 -76.62 3.23 11.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.75 -1.219 . . . . 0.0 109.801 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.928 HG22 HG21 ' A' ' 11' ' ' VAL . 1.1 t -92.82 -46.45 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 8' ' ' THR . 0.9 OUTLIER -91.37 53.57 2.33 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.285 -0.884 . . . . 0.0 110.257 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -171.11 -92.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.738 -1.226 . . . . 0.0 111.687 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 11' ' ' VAL . 3.6 m120 -101.21 -88.34 0.37 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.065 -1.022 . . . . 0.0 112.181 -177.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.85 HD13 ' CD1' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -21.13 -44.26 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -177.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.928 HG21 HG22 ' A' ' 6' ' ' VAL . 41.0 t -94.37 -41.84 12.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.696 -1.252 . . . . 0.0 110.337 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.763 ' C ' HG22 ' A' ' 13' ' ' THR . . . -45.53 -41.04 8.92 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.763 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 157.83 37.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.681 0.753 . . . . 0.0 109.425 178.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.699 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -85.19 19.84 20.18 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 158.92 -25.63 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 13' ' ' THR . 10.8 m -141.11 134.01 30.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.539 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 17.5 p -80.08 10.2 4.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 109.367 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.539 ' CG ' ' O ' ' A' ' 17' ' ' THR . 88.2 mt-30 -162.45 166.31 25.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.432 -0.792 . . . . 0.0 108.931 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.76 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . 179.54 166.48 1.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 110.088 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -165.03 126.18 2.02 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.488 -0.758 . . . . 0.0 109.324 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.634 HD11 ' CA ' ' A' ' 2' ' ' TRP . 2.8 mt -91.01 108.27 19.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.229 -0.919 . . . . 0.0 108.591 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.755 HD11 HG21 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -94.51 101.21 13.1 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.276 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -42.83 169.33 0.01 OUTLIER Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.733 HD21 ' N ' ' A' ' 94' ' ' SER . 1.4 pp -119.9 -17.66 8.42 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.415 -1.05 . . . . 0.0 109.428 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.726 ' N ' HD12 ' A' ' 24' ' ' LEU . 1.9 m-20 -124.97 -4.69 7.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.394 -0.816 . . . . 0.0 109.437 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.28 -90.85 1.42 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -171.69 -45.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.346 -1.091 . . . . 0.0 109.722 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.7 m -166.16 129.88 2.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.859 . . . . 0.0 109.242 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.549 ' CD2' ' OG ' ' A' ' 94' ' ' SER . 14.8 m0 -96.75 -45.45 6.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.6 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.4 171.4 19.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 109.453 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -160.88 174.77 13.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.597 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.829 ' HB2' HG11 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -161.44 135.16 6.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.902 . . . . 0.0 109.581 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 87.12 -16.64 0.38 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . 127.41 -90.25 0.35 Allowed Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.09 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.699 ' CE2' HG21 ' A' ' 99' ' ' VAL . 0.3 OUTLIER 61.49 126.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -1.097 . . . . 0.0 109.105 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' A' ' 63' ' ' ALA . . . -136.7 95.34 3.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 109.849 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.49 ' HB ' ' HG2' ' A' ' 41' ' ' GLN . 3.4 t -105.26 92.34 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.26 -0.9 . . . . 0.0 108.953 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.62 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -93.28 -38.84 0.33 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.513 -0.742 . . . . 0.0 112.684 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 38' ' ' THR . 6.5 Cg_exo -54.91 -73.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.403 1.402 . . . . 0.0 111.806 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.537 ' HB1' ' HB3' ' A' ' 43' ' ' GLN . . . -154.0 81.17 1.14 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.826 -1.171 . . . . 0.0 110.111 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.49 ' HG2' ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -75.53 -63.31 1.32 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.264 -1.522 . . . . 0.0 108.659 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -91.79 -7.85 64.19 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.537 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -80.4 -43.27 21.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -1.103 . . . . 0.0 109.457 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 40' ' ' ALA . 17.3 m -76.31 -51.23 12.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 109.56 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.0 mt -58.35 -27.74 64.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.509 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -67.45 -42.83 82.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.802 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.9 t -91.42 -3.12 56.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.614 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.91 -14.27 37.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.632 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.45 ' CE2' ' HG3' ' A' ' 90' ' ' LYS . 18.1 m-30 -87.18 3.18 47.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 109.877 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.58 -41.4 15.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.051 -1.031 . . . . 0.0 109.251 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.48 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -151.46 146.13 25.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -0.872 . . . . 0.0 109.313 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 56' ' ' ARG . . . -89.6 28.97 1.2 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.886 . . . . 0.0 109.901 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.614 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -85.44 -44.66 0.64 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.029 -1.044 . . . . 0.0 110.587 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.2 Cg_endo -68.45 -74.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 121.617 1.545 . . . . 0.0 110.522 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.438 HD12 ' CB ' ' A' ' 72' ' ' ALA . 0.8 OUTLIER -41.87 -46.04 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.39 -0.818 . . . . 0.0 109.982 -179.449 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 3.1 ttt180 -45.47 -55.04 6.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 109.653 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 58' ' ' SER . . . -86.18 -91.83 0.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.836 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 57' ' ' ALA . 2.9 t -43.41 -76.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.195 -0.94 . . . . 0.0 109.758 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 55' ' ' ILE . . . 121.61 -133.71 9.61 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.964 ' CD2' HD21 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -144.24 153.58 42.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.077 -1.249 . . . . 0.0 109.541 179.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.634 ' C ' HD22 ' A' ' 62' ' ' LEU . 1.8 m-20 -95.21 128.67 42.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 110.094 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.964 HD21 ' CD2' ' A' ' 60' ' ' PHE . 4.0 mm? -107.59 57.35 0.63 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.499 ' CB ' ' O ' ' A' ' 36' ' ' ALA . . . 50.71 26.79 2.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.476 -0.765 . . . . 0.0 109.42 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.39 -97.01 0.12 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.771 -1.204 . . . . 0.0 110.242 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.594 HG12 ' N ' ' A' ' 66' ' ' HIS . 25.9 t -112.76 170.46 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.183 -1.186 . . . . 0.0 110.012 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.594 ' N ' HG12 ' A' ' 65' ' ' VAL . 74.0 m80 -85.29 132.7 34.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.736 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.586 ' CE1' ' HA ' ' A' ' 81' ' ' LYS . 25.3 m-85 -107.84 168.89 8.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.039 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.549 HG12 ' H ' ' A' ' 69' ' ' THR . 1.9 t -109.59 174.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.111 -0.993 . . . . 0.0 110.027 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.617 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -115.8 135.44 54.01 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.433 -0.792 . . . . 0.0 109.323 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.517 HD23 ' NE ' ' A' ' 71' ' ' ARG . 11.5 tp -89.94 -55.9 3.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.156 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.544 ' NH1' ' HG2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -137.23 75.77 1.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 109.048 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.658 ' HA ' HG23 ' A' ' 77' ' ' ILE . . . -101.83 81.68 2.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.89 . . . . 0.0 109.549 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 24.9 t70 178.02 -41.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.62 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.43 -81.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 109.806 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.69 -48.81 0.26 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.166 -0.959 . . . . 0.0 109.618 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.647 ' CB ' ' CZ ' ' A' ' 78' ' ' TYR . 0.7 OUTLIER -90.6 -170.51 2.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -0.941 . . . . 0.0 109.726 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.658 HG23 ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -163.13 63.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.1 -1.0 . . . . 0.0 110.05 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.844 ' HB3' HD13 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -92.14 115.3 27.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.905 -1.122 . . . . 0.0 109.04 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.401 ' C ' ' CG1' ' A' ' 86' ' ' VAL . . . -96.69 -158.33 31.45 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.25 158.79 34.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -1.191 . . . . 0.0 109.614 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 2.1 mtpt -123.92 -178.55 4.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.245 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.18 106.09 1.32 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 55.66 20.47 3.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.153 -1.204 . . . . 0.0 108.9 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.647 ' HB1' ' O ' ' A' ' 100' ' ' TYR . . . -136.18 -164.15 1.51 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 109.309 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 100' ' ' TYR . . . -147.57 131.05 3.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.607 HG22 HG23 ' A' ' 88' ' ' THR . 2.5 p -104.51 131.49 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.215 -1.168 . . . . 0.0 109.43 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.844 HD13 ' HB3' ' A' ' 78' ' ' TYR . 47.3 mm -115.14 101.68 12.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.263 -0.898 . . . . 0.0 109.208 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.971 HG22 HG13 ' A' ' 97' ' ' VAL . 7.8 p -117.46 146.16 43.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.071 -1.018 . . . . 0.0 109.603 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.551 ' HB ' HD21 ' A' ' 96' ' ' LEU . 2.1 t -146.95 141.89 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.768 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.45 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -91.3 124.2 35.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.426 -0.796 . . . . 0.0 108.946 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.682 HG21 HD11 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -103.25 -60.19 1.59 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.128 -0.982 . . . . 0.0 109.73 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -168.47 -66.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 0.0 109.437 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.727 ' HA ' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -120.65 15.85 11.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.182 -0.949 . . . . 0.0 109.473 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.733 ' N ' HD21 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -154.36 154.44 33.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.169 -0.957 . . . . 0.0 110.014 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.523 ' CD1' ' HB3' ' A' ' 24' ' ' LEU . 54.6 mt -125.61 138.37 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.916 HD13 ' N ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -112.29 166.43 11.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.975 -1.078 . . . . 0.0 109.956 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.971 HG13 HG22 ' A' ' 88' ' ' THR . 3.2 t -146.9 77.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -0.917 . . . . 0.0 111.21 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.37 107.09 1.66 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 107.28 -2.328 . . . . 0.0 107.28 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.699 HG21 ' CE2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -115.47 142.55 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.884 -1.363 . . . . 0.0 110.414 -178.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.647 ' O ' ' HB1' ' A' ' 84' ' ' ALA . 16.4 p90 -129.13 171.14 12.7 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.48 ' O ' ' CG ' ' A' ' 102' ' ' GLU . 5.9 p30 -150.2 115.2 5.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.676 -1.265 . . . . 0.0 111.183 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.48 ' CG ' ' O ' ' A' ' 101' ' ' ASN . 22.1 pt-20 39.06 31.4 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.518 0.675 . . . . 0.0 109.374 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.817 ' C ' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -133.18 -25.68 1.75 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.693 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.817 HD12 ' C ' ' A' ' 103' ' ' LYS . 1.8 mp -137.79 149.57 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.847 -1.158 . . . . 0.0 110.028 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 5.4 pm0 -99.72 145.0 29.39 Favored Pre-proline 0 C--N 1.307 -1.246 0 O-C-N 121.48 -0.762 . . . . 0.0 109.202 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 105' ' ' GLN . 1.1 Cg_endo -66.35 177.11 3.43 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.088 1.859 . . . . 0.0 110.103 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.35 -0.16 75.97 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 65.1 m -127.06 -45.24 1.57 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.113 -1.227 . . . . 0.0 109.582 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.795 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -80.1 -40.76 26.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 109.569 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.416 ' HB2' HD12 ' A' ' 87' ' ' ILE . . . -56.72 -17.02 7.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.329 -0.857 . . . . 0.0 109.757 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -78.09 -45.71 22.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.717 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 109' ' ' ALA . 11.1 p -71.54 -22.76 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.949 . . . . 0.0 109.857 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.817 HG21 HG21 ' A' ' 87' ' ' ILE . 6.0 t -71.26 -33.54 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.056 -1.027 . . . . 0.0 109.598 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.417 ' OE1' ' O ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -80.13 -17.04 53.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.138 -0.976 . . . . 0.0 109.894 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.556 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -86.11 -59.2 2.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.965 . . . . 0.0 109.692 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.834 HD12 ' CE2' ' A' ' 5' ' ' TYR . 2.1 mm? -48.43 -35.85 13.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.095 -1.003 . . . . 0.0 109.308 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.763 ' HB2' ' CH2' ' A' ' 2' ' ' TRP . . . -68.8 -39.13 80.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.966 . . . . 0.0 109.478 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.62 -33.92 48.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 109.561 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.556 ' CD1' ' O ' ' A' ' 115' ' ' LYS . 32.8 m-85 -74.76 -58.6 3.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.083 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.736 ' C ' HD12 ' A' ' 120' ' ' LEU . 4.5 pp -72.27 2.35 6.17 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.445 -0.785 . . . . 0.0 110.417 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.473 ' CG1' HG22 ' A' ' 91' ' ' THR . 5.1 mt -88.96 -23.73 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 108.862 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.08 -30.18 53.79 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -92.77 -75.4 0.49 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.377 -1.073 . . . . 0.0 109.461 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 125' ' ' PHE . . . 132.35 36.77 0.29 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.523 ' CE2' HD13 ' A' ' 120' ' ' LEU . 16.0 m-85 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.375 -1.074 . . . . 0.0 109.518 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.888 ' CD1' HD13 ' A' ' 10' ' ' LEU . 7.6 m95 . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -67.13 -80.75 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.13 -0.981 . . . . 0.0 111.366 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.475 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 0.8 OUTLIER -54.6 -22.93 14.83 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.097 -1.002 . . . . 0.0 111.094 -178.373 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.626 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 1.9 m-30 -87.58 -25.08 23.79 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.65 -1.281 . . . . 0.0 109.869 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.61 HG13 ' OG ' ' A' ' 32' ' ' SER . 0.9 OUTLIER -63.87 -26.69 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 108.923 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 1.034 ' OD2' HG22 ' A' ' 8' ' ' THR . 1.0 OUTLIER -52.85 -52.58 56.67 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.449 -0.782 . . . . 0.0 111.966 -177.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 1.034 HG22 ' OD2' ' A' ' 7' ' ' ASP . 5.0 t -163.38 -27.72 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.531 -1.356 . . . . 0.0 111.116 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 14' ' ' GLY . 1.7 m-80 -64.82 -88.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.656 -1.277 . . . . 0.0 109.764 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.888 HD13 ' CD1' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -59.94 -23.65 63.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.202 -0.936 . . . . 0.0 110.295 -179.379 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.599 HG23 ' HA ' ' A' ' 6' ' ' VAL . 1.5 t -89.21 -60.32 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.868 -1.145 . . . . 0.0 108.999 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.741 ' C ' HG22 ' A' ' 13' ' ' THR . . . -43.67 -36.89 3.62 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.741 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER 158.49 46.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.948 -0.736 . . . . 0.0 110.105 178.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.701 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -92.41 23.19 28.85 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 106.294 -2.723 . . . . 0.0 106.294 177.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 1.057 ' O ' HG21 ' A' ' 104' ' ' ILE . . . 154.0 -28.98 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.887 ' HA ' HD13 ' A' ' 104' ' ' ILE . 17.6 m -148.59 139.42 17.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.664 HG23 ' HG3' ' A' ' 18' ' ' GLN . 8.1 t -79.32 6.3 10.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.979 -1.076 . . . . 0.0 109.11 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.664 ' HG3' HG23 ' A' ' 17' ' ' THR . 45.9 mt-30 -160.6 155.63 24.41 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -168.81 175.9 5.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.019 -1.051 . . . . 0.0 110.286 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -165.2 114.09 1.04 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.55 -0.719 . . . . 0.0 109.181 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.751 HD11 ' C ' ' A' ' 2' ' ' TRP . 24.8 mt -79.65 80.74 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 120.999 -1.063 . . . . 0.0 108.851 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -60.33 -150.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.465 -0.772 . . . . 0.0 108.936 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.61 134.63 4.01 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.573 HD23 HG13 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -80.57 4.71 17.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -1.153 . . . . 0.0 109.561 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.12 -13.8 12.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.567 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . 96.26 81.63 1.58 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.551 ' O ' ' C ' ' A' ' 28' ' ' THR . 1.0 OUTLIER 167.8 55.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -1.146 . . . . 0.0 109.442 -179.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.551 ' C ' ' O ' ' A' ' 27' ' ' ASN . 21.2 m -20.55 130.36 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.37 0.605 . . . . 0.0 111.325 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.536 ' CE3' ' OG ' ' A' ' 94' ' ' SER . 22.2 m0 -88.68 -45.34 9.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.447 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.01 164.53 18.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.939 . . . . 0.0 109.853 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 3.2 t -157.92 177.47 11.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.413 -0.805 . . . . 0.0 108.879 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.61 ' OG ' HG13 ' A' ' 6' ' ' VAL . 15.3 m -167.13 117.26 0.87 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.112 -0.992 . . . . 0.0 110.375 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 32' ' ' SER . . . 34.32 90.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.164 0.507 . . . . 0.0 110.53 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.33 -84.32 0.05 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.668 ' CE2' HG22 ' A' ' 37' ' ' VAL . 3.3 p90 -172.74 159.58 4.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -1.067 . . . . 0.0 109.352 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.77 116.2 28.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.291 -0.881 . . . . 0.0 108.757 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.668 HG22 ' CE2' ' A' ' 35' ' ' PHE . 91.6 t -79.62 108.37 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.147 -0.971 . . . . 0.0 109.582 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.522 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 9.1 m -48.22 139.35 10.26 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.341 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.722 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 1.8 Cg_endo -63.92 167.7 13.47 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.13 1.887 . . . . 0.0 110.376 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 39' ' ' PRO . . . 82.36 -41.45 0.12 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.649 -0.657 . . . . 0.0 110.293 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -69.29 -31.22 69.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.044 -1.035 . . . . 0.0 109.745 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.31 -38.71 50.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -63.41 -35.7 81.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.175 -1.191 . . . . 0.0 109.923 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.0 m -56.53 -37.28 70.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -0.918 . . . . 0.0 109.791 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.88 -39.5 93.64 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.216 -0.927 . . . . 0.0 109.806 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.4 -26.01 63.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 109.975 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.4 t -88.22 -18.12 29.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.131 -0.98 . . . . 0.0 109.778 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' ASN . . . -73.18 -30.63 63.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.965 . . . . 0.0 109.571 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -54.9 -47.23 74.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 109.926 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 51' ' ' ASN . 13.7 p30 -79.7 -46.8 16.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.001 -1.062 . . . . 0.0 109.444 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 3.2 t30 -107.58 111.83 24.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 108.855 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.511 ' HA ' HG12 ' A' ' 55' ' ' ILE . . . -108.72 30.67 6.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 109.865 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.562 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -72.19 -55.39 5.01 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.124 -0.985 . . . . 0.0 109.739 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.1 Cg_endo -62.47 -11.58 23.73 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.021 1.814 . . . . 0.0 110.344 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.786 HD13 ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -109.7 -17.61 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.156 -0.965 . . . . 0.0 109.185 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 7.2 ttt180 -89.48 -18.43 26.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.172 -0.955 . . . . 0.0 109.551 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.91 43.47 1.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.424 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.35 61.78 2.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.396 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -137.25 60.31 0.61 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.711 ' HD1' HG22 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -109.21 93.35 4.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -1.172 . . . . 0.0 108.904 179.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -135.43 127.11 29.05 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.384 -0.822 . . . . 0.0 109.722 -179.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 64' ' ' GLY . 1.4 mm? -95.84 -166.38 1.43 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.397 -0.815 . . . . 0.0 109.248 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.97 91.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.185 -0.947 . . . . 0.0 109.067 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 62' ' ' LEU . . . 61.4 52.02 54.17 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 61' ' ' ASP . 2.9 t -141.04 119.44 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.292 -1.122 . . . . 0.0 109.571 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.43 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 34.9 m170 -79.69 124.89 28.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.338 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.526 ' CB ' ' O ' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -149.99 166.43 29.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.11 -0.994 . . . . 0.0 109.934 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.507 ' O ' ' CB ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -115.84 -176.93 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.81 . . . . 0.0 109.016 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.524 ' CB ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -133.64 109.73 9.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.096 -1.002 . . . . 0.0 109.606 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mp -101.72 -25.26 13.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.342 -0.849 . . . . 0.0 109.166 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.511 ' O ' HG23 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -149.38 117.22 6.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.415 -0.803 . . . . 0.0 109.193 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.515 ' HA ' HG12 ' A' ' 77' ' ' ILE . . . -160.5 74.84 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.087 -1.008 . . . . 0.0 109.847 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 30.0 t70 179.26 -36.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.46 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.441 ' OD2' ' NH2' ' A' ' 71' ' ' ARG . 3.2 m-20 -74.84 -84.63 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.216 -0.927 . . . . 0.0 110.045 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.595 ' CB ' ' CZ ' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -137.18 -62.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.994 -1.066 . . . . 0.0 110.288 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.639 ' CB ' ' CZ ' ' A' ' 78' ' ' TYR . 0.7 OUTLIER -90.08 163.79 14.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.384 -0.823 . . . . 0.0 110.495 -178.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.515 HG12 ' HA ' ' A' ' 72' ' ' ALA . 3.0 mt -143.41 70.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.607 -0.683 . . . . 0.0 109.329 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.787 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -88.98 103.8 16.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.713 -1.242 . . . . 0.0 108.928 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.47 169.3 33.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -148.77 147.89 29.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -1.102 . . . . 0.0 109.328 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.16 -30.39 1.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.877 . . . . 0.0 109.845 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 123.35 -66.98 0.5 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.507 ' CB ' ' OE2' ' A' ' 102' ' ' GLU . 1.1 p -87.23 -18.8 29.45 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.372 -1.075 . . . . 0.0 108.444 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.31 166.34 27.41 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -160.69 163.95 34.37 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.759 ' O ' HG13 ' A' ' 86' ' ' VAL . 9.8 p -129.91 104.8 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -1.113 . . . . 0.0 109.471 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.787 HG23 ' HD2' ' A' ' 78' ' ' TYR . 4.1 mt -80.48 94.42 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.087 -1.008 . . . . 0.0 109.013 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 2.7 p -101.86 106.01 16.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 110.16 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.421 HG22 ' CE2' ' A' ' 78' ' ' TYR . 25.5 t -116.89 149.31 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 108.895 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.509 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 29.4 mtpt -86.1 151.99 23.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 110.048 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.81 ' CG2' HD21 ' A' ' 96' ' ' LEU . 2.3 p -145.57 -159.74 1.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.85 . . . . 0.0 109.075 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.402 ' C ' ' HD3' ' A' ' 93' ' ' LYS . 16.2 t -69.07 85.34 0.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.446 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER 62.17 14.79 6.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.206 -0.934 . . . . 0.0 109.427 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.536 ' OG ' ' CE3' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -128.64 151.61 49.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.485 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.573 HG13 HD23 ' A' ' 24' ' ' LEU . 48.8 mt -127.52 123.42 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.952 . . . . 0.0 109.417 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.861 HD13 ' N ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -85.38 130.7 34.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 108.889 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.817 HG12 HG22 ' A' ' 99' ' ' VAL . 42.4 t -121.87 68.21 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.498 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.423 ' C ' HG11 ' A' ' 16' ' ' VAL . . . -62.0 99.65 0.24 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.817 HG22 HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -101.21 126.76 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -1.223 . . . . 0.0 108.983 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.608 ' CD1' HG12 ' A' ' 16' ' ' VAL . 3.7 p90 -141.82 -176.49 4.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 109.733 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 83' ' ' SER . 0.5 OUTLIER -138.1 -116.24 0.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.093 -1.005 . . . . 0.0 110.22 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.507 ' OE2' ' CB ' ' A' ' 83' ' ' SER . 9.9 mm-40 -85.29 -50.64 7.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.843 -1.161 . . . . 0.0 110.276 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -39.16 -27.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 110.574 -179.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.057 HG21 ' O ' ' A' ' 15' ' ' ALA . 12.4 mt -127.86 147.69 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.919 -1.113 . . . . 0.0 110.203 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -127.52 152.71 76.99 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.416 -0.803 . . . . 0.0 108.868 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.43 173.2 1.57 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.992 1.795 . . . . 0.0 110.272 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.74 -51.26 1.2 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 m -94.08 -33.71 13.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.373 -1.075 . . . . 0.0 108.929 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.76 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . . . -80.94 -35.05 32.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.575 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.61 -13.4 59.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.53 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.26 -42.63 12.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.764 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.3 p -70.57 -28.09 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 109.629 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.835 HG13 ' HZ2' ' A' ' 2' ' ' TRP . 73.6 t -83.94 -20.53 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.501 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.48 -37.55 63.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.885 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.534 ' HG3' ' N ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -77.03 -42.79 37.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.684 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.534 ' N ' ' HG3' ' A' ' 115' ' ' LYS . 25.7 mt -52.23 -57.18 10.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.047 -1.033 . . . . 0.0 109.458 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.556 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -64.56 -29.83 70.86 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.131 -0.981 . . . . 0.0 109.095 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -53.78 -21.98 8.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.129 -0.982 . . . . 0.0 109.176 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -90.64 -30.86 16.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.409 -0.807 . . . . 0.0 109.832 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.672 HD22 ' HB ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -73.04 -38.78 66.4 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.063 -1.023 . . . . 0.0 109.77 -179.505 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.556 HD12 ' O ' ' A' ' 117' ' ' ALA . 2.9 mp -64.86 -14.88 17.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.395 -0.816 . . . . 0.0 109.276 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -45.71 -35.4 5.81 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.33 -70.23 0.82 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -1.035 . . . . 0.0 108.974 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -117.39 -77.97 0.64 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.386 -1.067 . . . . 0.0 109.688 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.88 ' HZ2' HD22 ' A' ' 96' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 120.764 0.316 . . . . 0.0 110.394 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -67.49 -59.01 3.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.581 -1.324 . . . . 0.0 108.965 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.42 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.7 OUTLIER -71.82 -31.18 66.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.308 -0.87 . . . . 0.0 108.719 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.923 ' CD2' HD13 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -56.21 -17.12 6.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.451 -0.781 . . . . 0.0 108.925 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.702 HG23 HD11 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -94.39 -48.96 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.245 -0.91 . . . . 0.0 109.955 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.424 ' N ' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -89.83 45.95 1.32 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.785 -1.197 . . . . 0.0 110.677 -178.492 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 4' ' ' THR . 22.5 p -148.63 -104.94 0.08 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.855 -1.153 . . . . 0.0 110.003 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.483 ' O ' ' C ' ' A' ' 10' ' ' LEU . 2.3 t-20 -102.72 -69.14 0.8 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.032 -1.042 . . . . 0.0 111.156 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.923 HD13 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -27.77 -45.44 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.234 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.692 HG21 HG22 ' A' ' 6' ' ' VAL . 85.2 t -101.24 -25.43 3.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.477 -1.389 . . . . 0.0 110.976 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 11' ' ' VAL . . . -45.58 -27.78 2.19 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 106.544 -2.622 . . . . 0.0 106.544 177.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.711 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -175.22 -44.88 0.01 OUTLIER 'General case' 0 C--O 1.196 -1.718 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.716 ' O ' ' HB3' ' A' ' 15' ' ' ALA . . . 14.12 40.45 0.0 OUTLIER Glycine 0 N--CA 1.508 3.435 0 C-N-CA 123.567 0.603 . . . . 0.0 112.79 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 14' ' ' GLY . . . 86.7 -32.12 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.438 -1.036 . . . . 0.0 108.377 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.624 HG13 ' HB1' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -101.39 132.5 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.179 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.9 OUTLIER -86.25 21.04 2.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.958 -1.089 . . . . 0.0 109.261 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -176.99 176.1 1.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.633 ' CB ' HG22 ' A' ' 11' ' ' VAL . . . 174.35 166.33 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.004 -1.06 . . . . 0.0 110.1 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.469 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -163.66 136.09 5.15 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.702 HD11 HG23 ' A' ' 6' ' ' VAL . 1.2 mm -94.33 66.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.036 -1.04 . . . . 0.0 108.453 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.713 ' HG ' HG21 ' A' ' 97' ' ' VAL . 17.5 mt -60.83 109.54 1.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 108.938 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 94' ' ' SER . . . -60.35 159.47 24.87 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.681 ' CB ' HD11 ' A' ' 95' ' ' ILE . 1.0 OUTLIER -108.77 -6.9 15.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -1.022 . . . . 0.0 109.4 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -143.7 34.89 1.27 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.355 -0.841 . . . . 0.0 109.312 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.41 29.84 0.09 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 64.63 -144.58 0.26 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.214 -1.168 . . . . 0.0 109.503 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.3 m -77.66 147.95 35.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.153 -0.967 . . . . 0.0 110.019 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.483 ' CE3' ' HB3' ' A' ' 94' ' ' SER . 7.8 m0 -114.12 -47.45 2.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.336 -0.852 . . . . 0.0 108.786 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.35 167.27 30.54 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 10.1 t -160.3 159.79 31.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.957 -1.089 . . . . 0.0 110.055 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.632 ' HB2' HG13 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -150.99 92.99 1.88 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.591 -0.693 . . . . 0.0 109.155 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 32' ' ' SER . . . 170.78 -54.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.531 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.4 19.48 3.48 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.653 ' CZ ' HG21 ' A' ' 99' ' ' VAL . 10.4 p90 -125.54 134.76 51.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -1.174 . . . . 0.0 109.523 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.59 130.64 55.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.914 . . . . 0.0 109.305 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.1 t -79.62 131.7 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 109.598 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 m -48.29 125.58 11.89 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 108.994 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.82 -39.42 81.79 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.765 1.643 . . . . 0.0 109.976 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.79 -46.96 86.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.258 -0.901 . . . . 0.0 109.182 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -62.72 -21.18 65.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.273 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.79 -29.33 67.2 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -67.48 -44.62 78.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -1.155 . . . . 0.0 109.428 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.4 m -56.72 -25.71 55.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.285 -0.884 . . . . 0.0 109.372 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.528 HD13 HD11 ' A' ' 62' ' ' LEU . 9.9 tp -73.81 -41.68 62.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.26 -50.2 66.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.228 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.78 -16.45 64.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.18 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.89 -28.24 64.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.339 -0.851 . . . . 0.0 109.458 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -88.26 21.53 2.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.361 -0.837 . . . . 0.0 109.533 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -108.69 -44.47 4.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.356 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.89 ' O ' HD11 ' A' ' 55' ' ' ILE . 2.5 m-20 -122.87 141.46 51.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 109.477 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.455 ' HA ' HG13 ' A' ' 55' ' ' ILE . . . -105.82 -3.72 21.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.909 . . . . 0.0 109.611 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.562 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -77.25 -55.37 1.36 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.101 -1.0 . . . . 0.0 110.258 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 2.3 Cg_endo -62.37 -10.33 18.4 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.056 1.837 . . . . 0.0 111.225 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.89 HD11 ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -104.85 -23.72 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.946 -1.096 . . . . 0.0 109.62 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -81.98 -12.18 58.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.085 -1.01 . . . . 0.0 109.356 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.96 -75.85 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.6 t -85.73 -39.32 17.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.385 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 55' ' ' ILE . . . 85.69 -161.73 35.36 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.655 ' CE1' ' CG ' ' A' ' 67' ' ' TYR . 4.6 p90 -145.98 -168.99 3.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -1.11 . . . . 0.0 109.035 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 61' ' ' ASP . 26.7 p30 -160.04 157.53 28.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.012 -1.055 . . . . 0.0 110.483 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.528 HD11 HD13 ' A' ' 45' ' ' LEU . 96.5 mt -124.64 -160.04 0.92 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.73 97.75 10.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.973 -1.079 . . . . 0.0 109.733 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.19 -79.47 0.23 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.513 HG21 ' CB ' ' A' ' 84' ' ' ALA . 54.1 t -124.8 160.97 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -1.153 . . . . 0.0 109.322 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.5 ' N ' HG12 ' A' ' 65' ' ' VAL . 18.7 m170 -75.9 -171.45 1.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.127 -0.983 . . . . 0.0 109.317 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.86 ' OH ' HG13 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -137.39 119.78 15.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 109.831 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.409 HG21 ' HG3' ' A' ' 81' ' ' LYS . 82.7 t -89.71 -24.6 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -0.843 . . . . 0.0 108.735 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.895 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 92.6 m 57.52 101.38 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.599 -0.688 . . . . 0.0 110.151 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.38 -23.67 13.16 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -142.85 72.1 1.36 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.895 ' HB2' ' CG2' ' A' ' 69' ' ' THR . . . -85.4 52.25 2.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 0.0 109.828 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.66 -145.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.241 -0.912 . . . . 0.0 108.835 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.44 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 0.4 OUTLIER -119.66 34.65 5.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.155 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 7.5 mmt180 -136.7 -44.38 0.59 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 110.236 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.669 ' HA ' HG22 ' A' ' 89' ' ' VAL . 14.9 m -145.64 164.88 30.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.929 -1.107 . . . . 0.0 110.31 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.698 ' O ' HG22 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -162.24 97.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.774 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -115.31 129.81 56.72 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.593 ' HA3' ' CE1' ' A' ' 67' ' ' TYR . . . -101.6 155.7 18.89 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.518 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.528 ' HD2' ' CG ' ' A' ' 106' ' ' PRO . 2.0 pttp -151.0 141.24 22.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -1.089 . . . . 0.0 109.347 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.503 ' CG ' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER 165.13 143.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.933 -1.104 . . . . 0.0 110.565 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.401 ' C ' ' N ' ' A' ' 84' ' ' ALA . . . 63.94 48.94 71.23 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 47.03 21.9 0.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.05 -1.265 . . . . 0.0 109.549 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.513 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -151.3 147.28 26.76 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.318 -0.864 . . . . 0.0 108.759 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.555 ' CA ' ' CE2' ' A' ' 100' ' ' TYR . . . -169.68 -171.43 35.26 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.86 HG13 ' OH ' ' A' ' 67' ' ' TYR . 7.3 p -141.62 156.69 20.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.399 -1.059 . . . . 0.0 109.842 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.774 HG23 ' HD2' ' A' ' 78' ' ' TYR . 75.3 mt -121.37 93.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 11.4 p -107.91 133.24 52.54 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.197 -0.939 . . . . 0.0 110.643 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 1.091 ' HB ' HD21 ' A' ' 96' ' ' LEU . 2.1 t -150.76 156.86 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.234 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -79.99 143.89 33.74 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.459 -0.776 . . . . 0.0 109.192 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.601 HG21 ' CE2' ' A' ' 2' ' ' TRP . 67.9 p -146.88 -135.82 0.08 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.209 -0.932 . . . . 0.0 109.29 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -75.78 80.43 2.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.969 -1.082 . . . . 0.0 109.955 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 92' ' ' SER . 13.4 mttm 60.68 13.33 4.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.761 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.547 ' HB2' HG22 ' A' ' 21' ' ' ILE . 3.3 p -138.04 165.35 26.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.064 -1.022 . . . . 0.0 109.966 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.681 HD11 ' CB ' ' A' ' 24' ' ' LEU . 1.7 mt -128.82 112.99 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.418 -0.801 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.091 HD21 ' HB ' ' A' ' 89' ' ' VAL . 1.1 pt? -60.21 164.18 4.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.171 -0.956 . . . . 0.0 108.808 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.725 ' O ' HG12 ' A' ' 97' ' ' VAL . 71.8 t -150.84 57.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.533 -0.73 . . . . 0.0 109.518 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -49.06 114.89 2.35 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.653 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -107.28 143.68 17.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.053 -1.263 . . . . 0.0 109.768 -179.107 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.576 ' N ' ' CD1' ' A' ' 100' ' ' TYR . 0.1 OUTLIER -142.98 153.32 42.9 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -151.24 6.38 0.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.822 -1.174 . . . . 0.0 111.692 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 103' ' ' LYS . 3.0 mm-40 -100.77 -78.22 0.52 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.586 -1.321 . . . . 0.0 109.817 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 8.4 mmtp -155.11 30.03 0.4 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.428 -0.795 . . . . 0.0 109.255 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.728 HD13 ' N ' ' A' ' 104' ' ' ILE . 2.2 mm -62.58 149.35 9.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.263 -0.898 . . . . 0.0 109.644 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -106.54 141.52 22.99 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 109.388 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.528 ' CG ' ' HD2' ' A' ' 80' ' ' LYS . 2.1 Cg_endo -62.33 -26.45 77.08 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.078 1.852 . . . . 0.0 110.4 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.45 37.14 3.51 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.9 m -143.03 -46.25 0.3 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -1.132 . . . . 0.0 109.394 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.624 ' HB1' HG13 ' A' ' 16' ' ' VAL . . . -86.77 -25.47 24.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.414 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.95 -22.23 39.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 109.281 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.86 -39.99 63.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.435 -0.79 . . . . 0.0 109.562 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.4 p -76.34 -23.44 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.532 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 109' ' ' ALA . 70.0 t -85.63 -18.79 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.867 . . . . 0.0 109.581 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.98 -31.45 39.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.331 -0.856 . . . . 0.0 109.586 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -83.7 -55.13 4.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.855 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.454 HD22 HD11 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -58.65 -31.02 67.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.912 . . . . 0.0 109.501 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.945 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -73.51 -26.82 61.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.204 -0.935 . . . . 0.0 109.471 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -66.57 -26.65 67.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.131 -0.98 . . . . 0.0 109.675 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 8.8 t80 -82.23 -52.37 7.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.88 . . . . 0.0 109.608 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.501 HD23 ' HA ' ' A' ' 117' ' ' ALA . 0.5 OUTLIER -63.94 -25.26 68.06 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.22 -0.925 . . . . 0.0 109.943 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.945 HD12 ' O ' ' A' ' 117' ' ' ALA . 2.8 mt -90.63 -18.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.94 . . . . 0.0 109.193 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.28 -16.67 28.37 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -91.26 -60.77 1.81 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -1.148 . . . . 0.0 109.334 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 125' ' ' PHE . . . 158.38 104.39 0.2 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.988 0 O-C-N 121.19 -1.182 . . . . 0.0 108.905 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 1.019 ' N ' HD11 ' A' ' 21' ' ' ILE . 8.1 m95 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -81.88 -90.57 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.924 -1.11 . . . . 0.0 111.08 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.56 -34.61 7.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.101 -0.999 . . . . 0.0 110.332 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.619 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 1.9 m-30 -71.07 -38.17 72.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.049 -1.032 . . . . 0.0 109.601 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.836 ' HA ' HG23 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -51.72 -24.15 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 6' ' ' VAL . 20.5 t0 -40.37 -89.91 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.532 -0.73 . . . . 0.0 111.253 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.2 t -144.05 -23.46 0.56 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.063 -1.023 . . . . 0.0 111.427 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.584 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.4 m120 -75.42 -55.7 5.43 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.674 -1.266 . . . . 0.0 109.504 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 0.6 OUTLIER -76.91 -25.36 52.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.848 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.836 HG23 ' HA ' ' A' ' 6' ' ' VAL . 1.8 t -92.36 -55.12 6.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.183 -0.948 . . . . 0.0 108.712 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.742 ' C ' HG22 ' A' ' 13' ' ' THR . . . -43.69 -39.17 4.57 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 107.952 -2.059 . . . . 0.0 107.952 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.742 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 159.94 47.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.827 -0.808 . . . . 0.0 110.068 178.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.707 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -90.57 20.77 36.2 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 106.918 -2.473 . . . . 0.0 106.918 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.707 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 156.43 -32.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 27.5 m -141.93 147.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.647 ' N ' HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -80.67 12.58 3.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.944 -1.097 . . . . 0.0 109.209 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.712 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -175.42 -178.32 1.12 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 18' ' ' GLN . . . 161.56 148.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 109.31 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.521 ' HB2' ' OG1' ' A' ' 31' ' ' THR . . . -137.82 160.23 39.84 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.166 -0.959 . . . . 0.0 109.482 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 1.019 HD11 ' N ' ' A' ' 2' ' ' TRP . 30.8 mt -131.81 95.9 2.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.832 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -89.86 128.08 36.12 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.442 0.639 . . . . 0.0 109.459 -178.029 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.19 167.54 49.12 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.981 ' N ' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -71.25 -8.34 52.94 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.52 -0.988 . . . . 0.0 109.515 -179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -78.83 -27.21 44.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.555 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.29 -3.03 34.91 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -93.5 -155.51 0.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -1.175 . . . . 0.0 109.145 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.22 129.71 56.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.886 -1.134 . . . . 0.0 110.138 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.577 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 3.1 m0 -101.16 -34.04 9.85 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.316 -0.865 . . . . 0.0 108.907 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 29' ' ' TRP . . . 170.33 92.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.433 -0.792 . . . . 0.0 109.063 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.521 ' OG1' ' HB2' ' A' ' 20' ' ' ALA . 14.1 t -109.31 172.08 7.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 110.105 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.791 ' OG ' HG13 ' A' ' 6' ' ' VAL . 16.1 m -156.41 86.77 1.02 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.481 -0.762 . . . . 0.0 109.366 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.543 ' HB3' ' CE2' ' A' ' 35' ' ' PHE . . . -169.39 -55.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.306 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.94 -43.99 1.29 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.543 ' CE2' ' HB3' ' A' ' 33' ' ' ALA . 11.1 p90 -48.08 162.52 0.08 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -1.091 . . . . 0.0 109.591 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.63 121.82 38.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.213 -0.93 . . . . 0.0 109.484 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.408 HG13 HD22 ' A' ' 62' ' ' LEU . 75.6 t -89.94 123.25 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.887 . . . . 0.0 109.427 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.68 127.2 91.17 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.16 -0.962 . . . . 0.0 109.307 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.737 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 1.9 Cg_endo -62.2 169.41 7.84 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.036 1.824 . . . . 0.0 110.526 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.737 ' HB3' ' O ' ' A' ' 39' ' ' PRO . . . 83.03 -24.41 0.17 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.721 -0.612 . . . . 0.0 110.345 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.471 ' HB3' HD21 ' A' ' 62' ' ' LEU . 0.8 OUTLIER -81.45 -10.55 59.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.986 -1.072 . . . . 0.0 109.55 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -56.74 -34.5 64.89 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -70.35 -39.36 74.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -1.167 . . . . 0.0 109.656 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.9 m -51.22 -34.17 31.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.541 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.6 tp -67.35 -48.38 67.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.467 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.17 -7.52 30.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 0.0 109.62 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.61 -29.45 16.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.087 -1.008 . . . . 0.0 109.735 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.89 -24.84 58.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.137 -0.977 . . . . 0.0 109.819 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.479 ' CE1' ' O ' ' A' ' 75' ' ' ARG . 9.1 m-85 -57.11 -29.59 63.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 109.566 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -113.27 -16.72 12.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.101 -0.999 . . . . 0.0 109.465 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -117.46 112.27 20.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 109.21 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.646 ' HA ' HD11 ' A' ' 55' ' ' ILE . . . -100.26 -8.77 23.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.608 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.573 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -64.79 -52.6 49.5 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 109.902 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.1 Cg_endo -64.33 -4.84 8.66 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.197 1.931 . . . . 0.0 111.205 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.646 HD11 ' HA ' ' A' ' 52' ' ' ALA . 1.9 pp -128.39 0.74 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.932 -1.105 . . . . 0.0 109.684 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -98.27 -34.77 10.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.113 -0.992 . . . . 0.0 109.45 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.46 -23.09 65.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -0.821 . . . . 0.0 109.695 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.9 t -170.47 -38.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.126 -0.984 . . . . 0.0 109.688 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 54' ' ' PRO . . . 132.53 -123.11 3.45 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.667 ' CE1' HD12 ' A' ' 62' ' ' LEU . 34.3 p90 -160.28 170.98 19.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.108 -1.231 . . . . 0.0 109.699 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.33 140.22 43.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.705 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 3.0 mt -147.99 115.69 6.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.885 . . . . 0.0 109.61 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.705 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . 76.62 13.04 2.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 109.753 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.65 29.23 24.58 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.657 HG12 ' H ' ' A' ' 66' ' ' HIS . 1.5 t -130.69 -169.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -1.138 . . . . 0.0 109.2 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.657 ' H ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -134.75 126.08 28.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.122 -0.986 . . . . 0.0 110.195 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -112.88 152.46 29.25 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.61 163.8 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.725 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.1 m -103.85 135.25 45.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.308 -0.87 . . . . 0.0 109.496 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.565 HD13 ' CD ' ' A' ' 80' ' ' LYS . 2.1 tp -113.91 -50.33 2.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.704 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.31 51.63 1.37 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 109.689 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.645 ' HB3' HD13 ' A' ' 55' ' ' ILE . . . -79.28 87.73 4.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.223 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.75 -55.93 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.86 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -81.86 -103.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.064 -1.022 . . . . 0.0 109.716 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.479 ' O ' ' CE1' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -134.59 0.54 3.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.903 -1.123 . . . . 0.0 109.975 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 43.7 m -106.22 142.5 35.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.058 -1.026 . . . . 0.0 109.613 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 77' ' ' ILE . 36.3 mt -139.78 88.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.45 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 76' ' ' SER . 1.7 m-85 -90.25 65.98 6.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.051 -1.03 . . . . 0.0 109.575 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -44.85 153.04 0.55 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.565 ' CD ' HD13 ' A' ' 70' ' ' LEU . 11.6 ptpt -151.49 94.53 2.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.022 -1.281 . . . . 0.0 109.844 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -160.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 0.0 109.263 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -46.06 -73.75 0.27 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.468 ' OG ' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -112.2 -24.2 9.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -1.158 . . . . 0.0 109.483 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.31 -174.02 4.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.152 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.555 ' N ' ' CE1' ' A' ' 100' ' ' TYR . . . 177.18 152.23 9.75 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.092 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 86' ' ' VAL . 9.5 p -117.86 124.27 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -1.042 . . . . 0.0 108.709 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.693 HG21 HG21 ' A' ' 113' ' ' VAL . 67.4 mt -100.62 89.81 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.983 -1.073 . . . . 0.0 110.21 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 11.3 p -101.89 135.24 43.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.131 -0.981 . . . . 0.0 109.64 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.419 ' HB ' HD12 ' A' ' 96' ' ' LEU . 47.2 t -149.16 155.9 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.211 -0.93 . . . . 0.0 109.486 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.405 ' N ' HG12 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -101.82 131.96 47.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.109 -0.994 . . . . 0.0 109.481 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.2 p -107.76 -97.72 0.37 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.252 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.9 p -129.58 -31.92 1.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.017 -1.052 . . . . 0.0 109.484 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.27 51.61 0.53 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.919 . . . . 0.0 109.341 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.605 ' CA ' HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -178.9 159.06 1.0 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.529 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.558 HG13 HD12 ' A' ' 24' ' ' LEU . 25.0 mt -120.38 112.14 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.12 -0.987 . . . . 0.0 109.304 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.863 HD13 ' CH2' ' A' ' 2' ' ' TRP . 8.3 mt -67.54 153.15 44.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.335 -0.853 . . . . 0.0 109.618 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.768 HG21 ' HG ' ' A' ' 22' ' ' LEU . 60.5 t -150.58 53.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.844 . . . . 0.0 109.776 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -45.16 137.44 6.31 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 97' ' ' VAL . 2.4 t -139.48 117.72 11.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.044 -1.268 . . . . 0.0 108.649 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.555 ' CE1' ' N ' ' A' ' 85' ' ' GLY . 7.2 p90 -138.31 164.04 30.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.014 -1.054 . . . . 0.0 109.756 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -110.64 -145.54 0.4 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 0.0 109.881 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.468 ' HG2' ' OG ' ' A' ' 83' ' ' SER . 10.4 mt-10 -76.05 -7.48 54.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.968 . . . . 0.0 110.104 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -16.44 61.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.074 -1.016 . . . . 0.0 109.758 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.647 HD13 ' N ' ' A' ' 17' ' ' THR . 1.2 mp -136.99 141.05 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.246 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -101.98 150.34 37.34 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 109.559 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.458 ' HB2' ' HE2' ' A' ' 80' ' ' LYS . 1.9 Cg_endo -62.32 161.82 25.82 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.27 1.98 . . . . 0.0 110.444 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.6 -55.91 4.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.1 m -67.94 -31.58 71.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -1.081 . . . . 0.0 109.689 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.615 ' O ' HG12 ' A' ' 112' ' ' VAL . . . -84.24 -36.92 22.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 109.504 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.96 -29.79 71.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.297 -0.877 . . . . 0.0 109.498 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -61.28 -36.37 79.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.982 . . . . 0.0 109.524 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.804 HG22 HD13 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -77.76 -31.62 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.135 -0.978 . . . . 0.0 109.432 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.693 HG21 HG21 ' A' ' 87' ' ' ILE . 53.5 t -63.61 -23.65 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.086 -1.008 . . . . 0.0 109.451 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -77.85 -43.73 29.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.342 -0.849 . . . . 0.0 109.715 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -80.81 -63.73 1.34 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 109.23 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.804 HD13 HG22 ' A' ' 112' ' ' VAL . 0.2 OUTLIER -42.23 -28.42 0.19 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.495 -0.753 . . . . 0.0 109.661 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 113' ' ' VAL . . . -73.72 -47.98 35.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.715 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -49.13 -21.39 0.74 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.07 -1.019 . . . . 0.0 110.008 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -85.47 -41.33 15.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.318 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 1.1 mt -78.21 -56.08 4.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.097 -1.002 . . . . 0.0 110.361 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.453 ' C ' ' O ' ' A' ' 120' ' ' LEU . 17.8 mt -39.77 -33.44 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.316 -0.865 . . . . 0.0 109.821 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.58 -51.43 36.43 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -59.65 -71.1 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -1.133 . . . . 0.0 109.475 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 130.27 112.15 1.51 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 120' ' ' LEU . 82.7 m-85 . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.211 -1.17 . . . . 0.0 109.535 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.603 ' CE3' ' HG ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 4' ' ' THR . 35.2 tt0 -77.8 -81.14 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.055 -1.028 . . . . 0.0 108.746 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.652 ' O ' HG22 ' A' ' 8' ' ' THR . 1.2 t -48.47 -30.23 4.93 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.619 ' CD2' ' CD2' ' A' ' 10' ' ' LEU . 3.2 m-30 -48.19 -54.67 12.65 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.841 ' HA ' HG23 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -50.53 -37.77 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -0.799 . . . . 0.0 109.644 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.684 ' C ' HG22 ' A' ' 8' ' ' THR . 1.0 OUTLIER -90.85 51.53 1.99 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.071 -1.018 . . . . 0.0 111.951 -178.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.684 HG22 ' C ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER 173.28 -87.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.482 -1.386 . . . . 0.0 111.486 178.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 11' ' ' VAL . 4.2 m-20 -90.04 -83.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 111.34 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.619 ' CD2' ' CD2' ' A' ' 5' ' ' TYR . 3.8 mm? -21.12 -44.8 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.889 HG13 ' HA ' ' A' ' 18' ' ' GLN . 38.5 t -88.02 -59.22 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.659 -1.276 . . . . 0.0 110.279 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.77 ' C ' HG22 ' A' ' 13' ' ' THR . . . -37.8 -41.07 0.84 Allowed Glycine 0 N--CA 1.498 2.805 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.77 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 155.95 39.88 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.607 0.718 . . . . 0.0 109.378 178.177 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.678 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -83.75 19.32 16.17 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 156.2 -28.08 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 13' ' ' THR . 2.2 m -151.41 152.08 11.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.542 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -79.66 8.12 7.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.798 -1.189 . . . . 0.0 109.292 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.889 ' HA ' HG13 ' A' ' 11' ' ' VAL . 31.5 mt-30 -162.64 176.6 10.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.623 ' HA ' HG23 ' A' ' 99' ' ' VAL . . . -177.78 155.49 1.02 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.863 -1.148 . . . . 0.0 110.234 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.506 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -148.91 114.63 5.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 0.0 109.576 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.62 ' C ' HD23 ' A' ' 22' ' ' LEU . 7.9 mm -81.28 114.86 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.84 -1.162 . . . . 0.0 108.693 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.881 HD11 HG21 ' A' ' 97' ' ' VAL . 0.6 OUTLIER -108.51 88.37 2.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -0.915 . . . . 0.0 108.994 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.609 ' HA3' ' CD2' ' A' ' 29' ' ' TRP . . . -50.11 -177.51 0.02 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.794 HD11 ' CA ' ' A' ' 93' ' ' LYS . 13.0 mt -84.03 -50.93 7.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.384 -1.068 . . . . 0.0 109.408 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.86 13.25 33.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.017 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 28' ' ' THR . . . -130.75 80.31 0.35 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.472 ' C ' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -35.44 -31.04 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.905 -0.762 . . . . 0.0 110.441 -179.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -139.04 99.19 3.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.939 -1.1 . . . . 0.0 110.171 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.609 ' CD2' ' HA3' ' A' ' 23' ' ' GLY . 6.5 m0 -95.85 -24.61 16.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 108.996 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -171.79 145.01 1.87 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.42 HG22 ' HB1' ' A' ' 20' ' ' ALA . 18.5 p -149.82 162.03 41.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.123 -0.986 . . . . 0.0 109.848 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.838 ' OG ' HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -166.08 84.6 0.31 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.445 -0.785 . . . . 0.0 109.205 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.4 -67.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 109.295 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 138.6 -23.34 2.96 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.5 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -62.23 178.71 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.063 -1.257 . . . . 0.0 109.782 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 63' ' ' ALA . . . -107.89 125.84 51.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.024 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.777 HG13 ' CD ' ' A' ' 41' ' ' GLN . 8.3 t -144.89 103.52 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.768 HG23 ' HD3' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -173.66 -59.12 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.176 -0.953 . . . . 0.0 110.175 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.768 ' HD3' HG23 ' A' ' 38' ' ' THR . 1.9 Cg_endo -59.4 118.33 5.2 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.708 1.605 . . . . 0.0 110.774 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.507 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . . . 54.95 35.17 23.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.291 -0.881 . . . . 0.0 109.973 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.777 ' CD ' HG13 ' A' ' 37' ' ' VAL . 2.4 mm-40 -90.39 -53.88 4.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.801 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.59 -42.84 16.65 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.507 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 4.0 pp0? -59.7 -26.94 66.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -1.18 . . . . 0.0 109.679 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.0 m -67.47 -53.66 26.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 109.341 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.556 ' O ' ' CD2' ' A' ' 49' ' ' PHE . 8.5 mp -63.53 -29.71 70.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 109.681 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.16 92.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.952 . . . . 0.0 109.533 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.2 t -86.33 -17.23 35.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.495 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.65 51.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.425 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 45' ' ' LEU . 35.4 m-85 -79.01 -10.38 59.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.175 -0.953 . . . . 0.0 109.642 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -89.38 -0.44 57.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.96 . . . . 0.0 109.578 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.471 ' HB2' ' CD ' ' A' ' 54' ' ' PRO . 1.8 p30 175.28 118.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.069 -1.019 . . . . 0.0 109.839 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 72' ' ' ALA . . . -94.97 -13.35 25.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -0.813 . . . . 0.0 109.259 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.61 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -63.08 -50.17 77.46 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 110.204 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.4 Cg_endo -63.83 -13.63 38.25 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.02 1.814 . . . . 0.0 110.967 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.799 HD11 ' CB ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -91.68 -14.79 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.861 -1.149 . . . . 0.0 109.532 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.603 ' CB ' ' CZ ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -81.29 -48.39 12.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.867 . . . . 0.0 109.477 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 58' ' ' SER . . . -77.01 -86.68 0.05 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.242 -0.911 . . . . 0.0 109.43 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 57' ' ' ALA . 20.2 m -44.36 -57.44 3.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.334 -0.854 . . . . 0.0 109.156 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.89 175.04 18.93 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.495 ' CE1' ' OG1' ' A' ' 69' ' ' THR . 10.7 p90 -124.59 124.44 42.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.436 -1.038 . . . . 0.0 108.984 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.87 161.47 15.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -0.964 . . . . 0.0 110.137 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.61 -142.78 0.24 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 36' ' ' ALA . . . -74.02 -0.59 16.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.24 -0.913 . . . . 0.0 109.557 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.41 -102.09 2.76 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.593 HG12 ' CD2' ' A' ' 66' ' ' HIS . 0.9 OUTLIER -136.22 -147.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.23 -1.159 . . . . 0.0 109.538 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.593 ' CD2' HG12 ' A' ' 65' ' ' VAL . 2.5 m-70 -82.43 133.79 35.22 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.151 -0.968 . . . . 0.0 109.505 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' A' ' 60' ' ' PHE . 3.0 m-30 -112.76 147.64 36.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 109.495 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -93.25 143.12 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.136 -0.978 . . . . 0.0 109.321 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.633 HG21 ' CD1' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -108.41 119.17 38.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.627 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 70' ' ' LEU . 1.4 pp -111.66 21.3 16.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.583 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.423 ' CG ' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER 177.21 102.29 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.134 -0.979 . . . . 0.0 109.523 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.799 ' CB ' HD11 ' A' ' 55' ' ' ILE . . . -153.7 54.6 0.73 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.108 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.24 -16.82 4.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.136 -0.978 . . . . 0.0 110.142 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -110.84 -104.73 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.0 109.752 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -143.41 27.61 1.54 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.955 -1.09 . . . . 0.0 109.253 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.615 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -143.12 129.24 19.73 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.469 ' O ' ' OG1' ' A' ' 88' ' ' THR . 2.4 mp -133.37 99.4 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.922 -1.111 . . . . 0.0 111.025 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.656 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -109.52 96.47 6.3 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.128 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.66 168.98 42.37 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.455 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.451 ' HG3' ' HA3' ' A' ' 85' ' ' GLY . 19.8 tttt -150.52 154.69 38.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.525 -0.985 . . . . 0.0 109.109 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 -13.42 9.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.012 -1.055 . . . . 0.0 109.737 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.37 -76.91 0.23 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.4 p -94.61 -40.9 9.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -1.219 . . . . 0.0 109.384 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.34 145.27 26.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 0.0 109.359 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.578 ' O ' ' CE1' ' A' ' 100' ' ' TYR . . . -138.65 143.46 14.23 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.986 HG23 HG13 ' A' ' 97' ' ' VAL . 2.4 p -110.23 136.05 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -1.099 . . . . 0.0 109.56 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 87' ' ' ILE . 3.2 mt -109.92 91.63 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -0.766 . . . . 0.0 109.011 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 5.0 p -89.33 112.67 23.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.061 -1.024 . . . . 0.0 109.69 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.48 136.88 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.265 -0.897 . . . . 0.0 108.837 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.29 150.62 23.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.067 -1.021 . . . . 0.0 110.032 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.9 p -132.95 -144.63 0.24 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.398 -0.814 . . . . 0.0 109.048 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.543 ' HB3' ' CA ' ' A' ' 124' ' ' GLY . 47.0 t -87.01 -29.86 21.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.039 -1.038 . . . . 0.0 109.447 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.794 ' CA ' HD11 ' A' ' 24' ' ' LEU . 17.2 mttt -159.58 55.91 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 0.0 109.796 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.63 ' CB ' ' CG ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -177.73 151.25 0.7 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.869 -1.144 . . . . 0.0 110.213 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.7 ' C ' HD13 ' A' ' 96' ' ' LEU . 14.7 mt -125.08 126.16 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.805 HD22 ' N ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -108.24 161.61 14.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.992 -178.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.986 HG13 HG23 ' A' ' 86' ' ' VAL . 25.6 t -139.49 125.86 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.61 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.474 ' HA3' ' HB ' ' A' ' 87' ' ' ILE . . . -103.79 101.22 1.98 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 107.875 -2.09 . . . . 0.0 107.875 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.623 HG23 ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -99.23 128.93 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -1.123 . . . . 0.0 109.048 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.633 ' N ' ' CD1' ' A' ' 100' ' ' TYR . 1.3 p90 -144.48 -170.82 3.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.64 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 101' ' ' ASN . 0.0 OUTLIER -120.19 -159.14 0.77 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.895 . . . . 0.0 109.047 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -76.32 -16.33 59.79 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.3 -0.875 . . . . 0.0 109.567 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -37.9 83.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.387 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.553 HG13 ' HB2' ' A' ' 100' ' ' TYR . 14.8 mm -79.62 150.79 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.294 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -93.76 138.18 22.9 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.144 -0.973 . . . . 0.0 109.188 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.96 -23.95 53.67 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.1 1.867 . . . . 0.0 110.828 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.06 -47.04 4.27 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.879 -1.153 . . . . 0.0 110.512 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 112' ' ' VAL . 15.7 m -66.5 -47.44 73.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.004 -1.292 . . . . 0.0 109.89 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.45 -12.13 28.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 0.0 110.023 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.62 -26.44 19.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 0.0 109.942 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -83.7 -42.44 16.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.089 -1.007 . . . . 0.0 109.591 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 108' ' ' THR . 2.5 t -67.31 -36.8 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.346 -0.846 . . . . 0.0 110.064 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.679 HG11 HG21 ' A' ' 87' ' ' ILE . 88.6 t -76.41 -26.81 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.196 -0.94 . . . . 0.0 109.585 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -60.67 -50.88 71.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.847 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 116' ' ' LEU . 13.9 ptmm? -66.66 -35.08 79.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 109.64 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.539 ' HA ' HD22 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -44.26 -42.26 6.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 0.0 109.034 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.497 ' C ' HD12 ' A' ' 121' ' ' ILE . . . -75.58 -37.36 59.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -0.889 . . . . 0.0 109.029 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 115' ' ' LYS . 2.6 m-20 -47.57 -25.65 1.2 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 109.189 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -83.63 -45.97 12.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.811 . . . . 0.0 109.323 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.572 ' HB3' ' CE1' ' A' ' 125' ' ' PHE . 0.5 OUTLIER -87.92 11.03 16.82 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.242 -0.911 . . . . 0.0 109.842 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.497 HD12 ' C ' ' A' ' 117' ' ' ALA . 0.9 OUTLIER -90.41 -22.43 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 109.191 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -71.82 -45.83 41.19 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -84.14 -28.88 27.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -1.176 . . . . 0.0 109.425 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.543 ' CA ' ' HB3' ' A' ' 92' ' ' SER . . . 81.19 48.83 5.82 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.63 ' CG ' ' CB ' ' A' ' 94' ' ' SER . 12.6 m-85 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.405 -1.056 . . . . 0.0 109.876 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.734 ' CH2' HD13 ' A' ' 96' ' ' LEU . 2.8 m95 . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.412 0.625 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.439 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 1.9 mm-40 -72.96 -109.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.873 -1.142 . . . . 0.0 110.567 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.994 ' O ' HG22 ' A' ' 8' ' ' THR . 5.0 t -48.79 -45.47 40.15 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.725 -1.234 . . . . 0.0 109.022 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.003 ' CD2' HD21 ' A' ' 116' ' ' LEU . 14.9 m-30 -41.71 -46.3 3.74 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.549 0.69 . . . . 0.0 109.409 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.659 ' HA ' HG23 ' A' ' 11' ' ' VAL . 1.4 t -52.87 -53.66 20.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.462 -0.774 . . . . 0.0 110.007 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.75 50.76 1.74 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.055 -1.028 . . . . 0.0 112.193 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.994 HG22 ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -160.12 -101.33 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.43 -1.419 . . . . 0.0 110.416 178.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -102.15 -69.72 0.78 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.965 -1.085 . . . . 0.0 110.988 -178.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.731 HD13 ' HB3' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -22.94 -40.86 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.659 HG23 ' HA ' ' A' ' 6' ' ' VAL . 4.9 t -80.98 -70.11 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.509 -1.37 . . . . 0.0 110.377 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.741 ' C ' HG22 ' A' ' 13' ' ' THR . . . -38.18 -31.94 0.12 Allowed Glycine 0 N--CA 1.497 2.756 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.741 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER 152.14 42.58 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.701 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -84.78 22.6 8.91 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 154.62 -31.1 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.626 HG12 ' HB3' ' A' ' 100' ' ' TYR . 25.6 m -152.6 147.1 14.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.525 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -78.8 5.76 10.6 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.014 -1.053 . . . . 0.0 108.619 179.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 17' ' ' THR . 23.3 mt-30 -163.34 160.71 23.99 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.493 ' HA ' HG23 ' A' ' 99' ' ' VAL . . . -173.33 -179.83 2.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.068 -1.02 . . . . 0.0 109.027 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 19' ' ' ALA . . . 176.57 115.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.92 . . . . 0.0 110.36 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.675 HD11 ' CD2' ' A' ' 2' ' ' TRP . 1.5 mp -80.71 100.29 4.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.732 HD11 HG21 ' A' ' 97' ' ' VAL . 3.0 mt -86.93 111.74 21.11 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.542 -0.724 . . . . 0.0 109.863 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.12 -166.37 0.33 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.974 HD11 ' O ' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -116.22 16.19 15.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.381 -1.07 . . . . 0.0 109.481 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -96.35 -29.2 14.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.79 -25.63 3.07 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.7 p30 -100.15 -163.0 0.99 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -1.106 . . . . 0.0 109.449 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.3 m -129.18 136.57 50.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.109 -0.994 . . . . 0.0 109.608 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -79.93 -45.96 17.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.938 . . . . 0.0 108.93 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.29 136.78 38.32 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.06 167.73 21.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.979 -1.076 . . . . 0.0 109.888 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.22 57.2 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 18' ' ' GLN . . . -120.71 -145.51 0.36 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.302 -0.874 . . . . 0.0 109.609 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.94 8.07 5.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.428 ' CZ ' HG11 ' A' ' 99' ' ' VAL . 20.6 p90 -134.26 177.36 7.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -1.167 . . . . 0.0 109.479 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.5 120.79 33.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 109.424 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 t -87.66 151.9 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 109.523 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -105.16 158.48 32.01 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.669 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.14 -30.89 75.46 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.15 1.9 . . . . 0.0 110.41 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.98 78.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.172 -0.955 . . . . 0.0 110.101 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -81.11 -9.93 59.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 109.992 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.27 -34.74 50.47 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -79.45 -41.59 27.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.15 -1.206 . . . . 0.0 109.694 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.1 m -53.96 -42.5 68.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.877 . . . . 0.0 109.397 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.418 HD23 ' CZ ' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -63.16 -40.32 97.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.0 109.496 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.581 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . . . -59.86 -41.76 92.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.191 -0.943 . . . . 0.0 109.314 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.3 p -73.89 -20.67 60.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.335 -0.853 . . . . 0.0 109.121 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 51' ' ' ASN . . . -67.86 -22.54 65.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.407 -0.808 . . . . 0.0 109.477 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.599 ' CE2' ' HG3' ' A' ' 90' ' ' LYS . 51.8 m-85 -70.79 -23.12 62.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.469 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -91.74 -32.81 15.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 0.0 109.446 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.413 ' O ' ' O ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -120.25 147.87 44.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.642 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.615 ' HA ' HD11 ' A' ' 55' ' ' ILE . . . -119.44 8.96 11.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 109.499 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.589 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -78.39 -49.49 1.79 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.279 -0.888 . . . . 0.0 110.337 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.6 Cg_endo -66.02 -9.97 25.31 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.953 1.768 . . . . 0.0 111.115 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -109.05 -13.32 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.955 -1.091 . . . . 0.0 109.886 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.506 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 15.0 ptm180 -97.99 -13.36 21.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 109.464 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -124.99 117.98 25.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.611 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 59' ' ' GLY . 1.5 p 69.11 10.28 7.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.281 -0.887 . . . . 0.0 109.42 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 68' ' ' VAL . . . 44.18 -123.09 4.76 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.402 ' CD2' HG22 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -157.85 -174.72 4.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -1.111 . . . . 0.0 109.539 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -119.13 125.41 49.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.359 -0.838 . . . . 0.0 109.17 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.699 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -120.66 104.27 9.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.888 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . 77.78 -81.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.35 -0.844 . . . . 0.0 109.831 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.63 16.85 0.48 Allowed Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.653 -1.261 . . . . 0.0 110.139 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 66' ' ' HIS . 7.3 t -123.43 164.86 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.055 -1.262 . . . . 0.0 109.245 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.437 ' N ' HG12 ' A' ' 65' ' ' VAL . 5.2 m170 -111.0 123.11 49.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.139 -0.976 . . . . 0.0 109.816 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -120.08 165.89 14.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 108.813 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 69' ' ' THR . 0.9 OUTLIER -124.96 -162.19 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.067 -1.021 . . . . 0.0 109.464 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.794 HG21 ' HB2' ' A' ' 72' ' ' ALA . 57.2 m -155.83 131.31 9.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.925 . . . . 0.0 109.778 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.54 HD22 ' O ' ' A' ' 69' ' ' THR . 2.9 mm? -119.82 19.89 12.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.9 . . . . 0.0 109.238 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.48 ' H ' HG22 ' A' ' 69' ' ' THR . 29.9 ttm180 178.9 78.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.319 -0.863 . . . . 0.0 109.387 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.794 ' HB2' HG21 ' A' ' 69' ' ' THR . . . -106.99 77.4 1.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.751 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -75.45 176.72 7.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 109.187 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.15 -2.43 55.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 109.545 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.486 ' NH1' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -98.16 -66.07 0.92 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 0.0 109.101 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.54 ' HA ' HG23 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -127.25 176.46 7.39 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.306 -0.871 . . . . 0.0 109.402 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.521 ' CG1' ' O ' ' A' ' 76' ' ' SER . 29.8 mt -159.49 134.26 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 109.583 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.68 ' CD1' HG23 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -142.5 81.8 1.75 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.043 179.457 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.52 170.38 42.64 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.49 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -150.82 158.71 44.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -1.103 . . . . 0.0 109.606 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.551 ' HG3' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER 176.22 105.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 109.448 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.544 ' N ' ' HE3' ' A' ' 81' ' ' LYS . . . 85.82 33.51 15.48 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 82' ' ' GLY . 1.7 p 71.36 4.69 5.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -1.108 . . . . 0.0 109.39 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 100' ' ' TYR . . . -122.47 118.28 27.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.241 -0.912 . . . . 0.0 109.14 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 80' ' ' LYS . . . -126.45 149.76 17.58 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.861 HG23 HG13 ' A' ' 97' ' ' VAL . 13.4 p -105.18 123.79 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.405 -1.056 . . . . 0.0 109.379 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.785 HG22 ' O ' ' A' ' 87' ' ' ILE . 1.3 mt -87.7 79.67 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.303 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 7.4 p -92.24 126.55 37.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -0.864 . . . . 0.0 109.723 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.642 HG13 HD12 ' A' ' 96' ' ' LEU . 2.1 p -145.68 130.49 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.278 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.599 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -82.48 131.31 35.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.904 . . . . 0.0 109.598 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.451 ' CG2' HD11 ' A' ' 96' ' ' LEU . 1.9 p -102.75 -95.97 0.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.845 . . . . 0.0 109.401 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.44 ' C ' ' HG2' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -125.81 -43.0 1.87 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.023 -1.048 . . . . 0.0 109.409 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.974 ' O ' HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -146.46 50.37 1.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.915 . . . . 0.0 109.609 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.569 ' N ' HD21 ' A' ' 24' ' ' LEU . 1.2 p 170.73 166.19 0.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.101 -0.999 . . . . 0.0 109.671 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.7 mt -118.91 142.88 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.171 -0.956 . . . . 0.0 109.379 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.734 HD13 ' CH2' ' A' ' 2' ' ' TRP . 0.5 OUTLIER -108.4 147.8 31.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.934 . . . . 0.0 108.731 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.861 HG13 HG23 ' A' ' 86' ' ' VAL . 70.3 t -133.04 131.02 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.895 -1.128 . . . . 0.0 110.653 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.447 ' HA3' ' HB ' ' A' ' 87' ' ' ILE . . . -118.97 91.96 0.52 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -94.97 110.01 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.136 -1.214 . . . . 0.0 109.586 -178.476 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.626 ' HB3' HG12 ' A' ' 16' ' ' VAL . 30.7 p90 -119.87 158.27 26.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.424 -0.797 . . . . 0.0 109.79 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.492 ' O ' HG13 ' A' ' 104' ' ' ILE . 7.1 m-20 -131.29 174.46 10.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.278 -0.889 . . . . 0.0 109.56 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 16.0 mm-40 70.68 26.34 3.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.695 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.45 78.6 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.963 . . . . 0.0 109.42 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.623 ' O ' HG22 ' A' ' 104' ' ' ILE . 5.1 mt -98.04 54.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.146 -0.971 . . . . 0.0 109.879 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER 41.94 97.09 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.476 -0.765 . . . . 0.0 110.238 179.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.41 -13.94 18.66 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.952 1.768 . . . . 0.0 110.297 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -100.78 -30.04 6.28 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 105' ' ' GLN . 31.4 m -73.21 -31.99 64.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.12 -1.223 . . . . 0.0 109.437 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -88.23 -15.04 36.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.32 -0.863 . . . . 0.0 109.527 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.98 -31.27 25.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.628 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.473 ' O ' ' HB3' ' A' ' 114' ' ' GLU . 2.8 m120 -73.55 -39.08 65.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.13 -0.981 . . . . 0.0 109.523 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.564 HG11 ' HB1' ' A' ' 15' ' ' ALA . 6.1 p -61.93 -37.78 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 0.0 109.185 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 109' ' ' ALA . 21.9 t -68.62 -20.68 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.327 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 111' ' ' ASN . 6.5 tt0 -63.79 -61.84 2.04 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.151 -0.968 . . . . 0.0 109.09 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -39.1 89.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.129 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 1.003 HD21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -57.27 -27.02 61.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.381 -0.824 . . . . 0.0 109.448 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.518 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -75.56 -44.2 44.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 0.0 109.49 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -53.26 -19.08 2.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.91 . . . . 0.0 109.472 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -82.58 -58.58 2.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 109.787 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.618 HD22 ' OXT' ' A' ' 125' ' ' PHE . 2.6 mt -61.3 -56.56 19.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.952 . . . . 0.0 110.115 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 117' ' ' ALA . 6.1 mt -41.2 -29.84 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.272 -0.892 . . . . 0.0 109.802 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 123' ' ' GLN . . . -105.61 49.35 0.9 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 122' ' ' GLY . 2.2 mt-30 -173.68 -69.65 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.398 -1.06 . . . . 0.0 109.61 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.452 ' O ' ' OXT' ' A' ' 125' ' ' PHE . . . -133.88 56.13 0.73 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.618 ' OXT' HD22 ' A' ' 120' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.397 -1.061 . . . . 0.0 109.588 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.995 ' C ' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 121.461 0.648 . . . . 0.0 109.988 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.632 ' N ' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -83.63 -76.47 0.29 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.083 -1.011 . . . . 0.0 110.583 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.527 HG23 ' CD1' ' A' ' 5' ' ' TYR . 2.1 t -39.56 -28.81 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.208 -0.933 . . . . 0.0 109.737 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.597 ' HB2' ' HB2' ' A' ' 2' ' ' TRP . 18.1 m-30 -86.36 -43.45 12.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 0.0 108.916 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.809 HG13 ' HB2' ' A' ' 32' ' ' SER . 0.9 OUTLIER -46.77 -27.87 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.472 0.653 . . . . 0.0 109.852 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.56 -84.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 111.869 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.91 2.58 3.68 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.681 -1.262 . . . . 0.0 110.801 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.535 ' O ' ' N ' ' A' ' 14' ' ' GLY . 6.0 m-20 -92.87 -90.99 0.18 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.969 -1.082 . . . . 0.0 109.621 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -52.97 -30.2 33.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.155 -0.966 . . . . 0.0 110.081 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.828 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 21.2 t -88.64 -59.01 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.054 -1.029 . . . . 0.0 109.554 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.744 ' C ' HG22 ' A' ' 13' ' ' THR . . . -42.38 -30.73 0.87 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 107.944 -2.063 . . . . 0.0 107.944 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.744 HG22 ' C ' ' A' ' 12' ' ' GLY . 1.0 OUTLIER 147.66 51.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.12 0.486 . . . . 0.0 109.885 178.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.699 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -90.03 19.22 43.57 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 107.071 -2.411 . . . . 0.0 107.071 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 144.93 -25.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 34.8 m -139.11 149.94 23.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.52 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 5.5 p -87.29 20.75 2.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.976 -1.077 . . . . 0.0 108.662 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.543 ' HB3' ' CB ' ' A' ' 33' ' ' ALA . 4.7 mp0 -171.21 172.59 5.25 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.578 -0.701 . . . . 0.0 109.256 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.828 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . -175.73 135.11 0.3 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.073 -1.017 . . . . 0.0 109.602 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.526 ' O ' HD22 ' A' ' 22' ' ' LEU . . . -133.08 121.06 22.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.072 -1.018 . . . . 0.0 110.079 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.995 HD11 ' C ' ' A' ' 2' ' ' TRP . 8.0 mt -86.16 96.72 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 108.624 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.801 HD23 ' CG2' ' A' ' 97' ' ' VAL . 3.0 mm? -79.15 -179.92 6.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.373 -0.829 . . . . 0.0 109.18 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 94' ' ' SER . . . -133.35 106.36 0.63 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.576 HD23 ' C ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -51.82 -38.2 54.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -1.178 . . . . 0.0 109.465 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -138.85 35.61 2.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.482 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.38 -102.32 1.1 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.424 ' O ' ' HB ' ' A' ' 28' ' ' THR . 0.2 OUTLIER 174.57 52.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -1.12 . . . . 0.0 109.401 -179.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.509 ' O ' HG22 ' A' ' 28' ' ' THR . 1.4 m 59.18 98.93 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.981 -1.074 . . . . 0.0 109.139 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.525 ' CE2' ' OG ' ' A' ' 94' ' ' SER . 38.2 m0 -84.07 -29.27 26.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.88 . . . . 0.0 109.639 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.24 157.99 33.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 109.396 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.457 ' O ' ' OG ' ' A' ' 32' ' ' SER . 0.1 OUTLIER -160.09 152.13 20.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.576 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.809 ' HB2' HG13 ' A' ' 6' ' ' VAL . 73.7 m -169.72 58.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.845 . . . . 0.0 109.402 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 18' ' ' GLN . . . -120.27 -66.38 1.07 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.199 -0.938 . . . . 0.0 109.778 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.6 -37.95 1.88 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.794 -1.723 . . . . 0.0 108.794 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.506 ' CZ ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -59.0 177.47 0.15 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.386 -1.067 . . . . 0.0 109.415 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.49 140.47 29.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 110.439 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.506 ' CG2' ' CZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -149.28 135.64 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.342 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.408 ' OG1' ' HB1' ' A' ' 63' ' ' ALA . 43.6 p -132.66 117.0 15.09 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.168 -0.957 . . . . 0.0 109.617 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.706 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 6.2 Cg_exo -58.07 117.11 3.76 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.952 1.768 . . . . 0.0 110.384 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 39' ' ' PRO . . . 162.91 -63.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 109.005 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 63' ' ' ALA . 9.5 mm-40 -68.08 -12.36 60.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.147 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.88 -24.55 42.13 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -68.69 -52.37 31.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -1.12 . . . . 0.0 109.324 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.9 m -57.86 -25.8 61.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.358 -0.838 . . . . 0.0 109.243 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.511 ' HG ' ' CE1' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -65.13 -43.8 90.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.279 -0.888 . . . . 0.0 109.493 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.71 -30.84 70.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 109.893 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 p -66.11 -30.87 71.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.278 -0.889 . . . . 0.0 110.086 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.07 -10.97 59.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.126 -0.984 . . . . 0.0 109.904 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.708 ' CD2' HD13 ' A' ' 77' ' ' ILE . 4.4 m-85 -90.41 17.61 7.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.928 . . . . 0.0 109.583 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -98.75 5.52 47.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 0.0 109.35 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.539 ' O ' HD11 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -176.47 162.66 2.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.317 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 56' ' ' ARG . . . -101.26 -2.02 32.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.562 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 1.4 m-20 -75.7 -54.65 2.19 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 110.129 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 3.5 Cg_exo -61.57 -11.31 19.62 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.007 1.805 . . . . 0.0 110.686 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.539 HD11 ' O ' ' A' ' 51' ' ' ASN . 0.7 OUTLIER -118.62 -11.08 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.993 . . . . 0.0 109.658 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.511 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -97.89 44.59 1.04 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 0.0 109.264 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -169.85 -58.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.126 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.9 p -94.73 -25.8 16.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.334 -0.854 . . . . 0.0 109.298 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.64 -152.58 20.61 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -142.66 -174.66 4.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -1.073 . . . . 0.0 109.342 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.46 136.37 17.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.144 -0.972 . . . . 0.0 109.812 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.6 mp -82.23 -138.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 108.944 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 41' ' ' GLN . . . -84.5 41.72 0.86 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.942 -1.099 . . . . 0.0 110.328 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.94 0.59 5.57 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.66 140.6 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.175 -1.191 . . . . 0.0 109.748 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.471 ' N ' ' CD2' ' A' ' 66' ' ' HIS . 3.6 m170 -106.14 108.9 20.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 109.565 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.12 166.4 12.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.177 -0.952 . . . . 0.0 109.257 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.603 HG22 ' N ' ' A' ' 69' ' ' THR . 12.0 p -118.57 170.1 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.197 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.624 HG21 ' HB2' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -144.88 154.78 42.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 109.432 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 tp -124.36 -67.09 0.94 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.291 -0.88 . . . . 0.0 109.442 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.409 ' O ' ' O ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -107.11 51.63 0.74 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.565 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.624 ' HB2' HG21 ' A' ' 69' ' ' THR . . . -54.54 -172.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -145.34 -150.82 0.34 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.545 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -111.61 -52.21 2.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.97 . . . . 0.0 109.527 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.417 HH11 ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -96.79 2.7 52.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 109.785 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.689 ' C ' HD12 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -142.19 140.58 32.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.872 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.708 HD13 ' CD2' ' A' ' 49' ' ' PHE . 2.2 mp -158.38 104.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 109.247 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.765 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -108.15 120.64 42.93 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.273 -0.892 . . . . 0.0 108.659 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.92 157.79 49.09 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.484 ' HE3' ' HG3' ' A' ' 106' ' ' PRO . 1.2 mmmp? -151.12 118.64 6.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -1.085 . . . . 0.0 109.471 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.16 141.8 16.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.994 . . . . 0.0 109.429 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 55.16 -126.22 38.23 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.34 18.1 17.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.139 -1.212 . . . . 0.0 109.661 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.09 128.96 33.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.746 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -132.73 164.59 24.02 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 78' ' ' TYR . 1.8 m -127.77 149.48 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.022 -1.281 . . . . 0.0 110.165 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.765 HG23 ' HD2' ' A' ' 78' ' ' TYR . 6.5 mt -116.5 83.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.7 OUTLIER -89.26 142.2 27.86 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.239 -0.913 . . . . 0.0 110.303 -178.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.726 ' HB ' HD12 ' A' ' 96' ' ' LEU . 85.4 t -150.13 154.24 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -109.22 121.82 45.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.005 -1.06 . . . . 0.0 109.802 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.788 HG22 HG13 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -92.26 -55.11 3.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.291 -0.881 . . . . 0.0 109.535 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 91' ' ' THR . 9.3 t 171.51 -31.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.067 -1.021 . . . . 0.0 109.95 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.4 mttm -128.75 -28.53 2.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.015 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.576 ' C ' HD23 ' A' ' 24' ' ' LEU . 39.8 m -135.34 152.45 51.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.044 -1.035 . . . . 0.0 109.847 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.508 HG13 ' N ' ' A' ' 24' ' ' LEU . 14.4 mt -94.08 142.33 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.346 -0.846 . . . . 0.0 109.32 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.82 HD22 ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -107.0 148.52 28.58 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.801 ' CG2' HD23 ' A' ' 22' ' ' LEU . 39.8 t -140.25 131.89 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.995 -1.066 . . . . 0.0 110.215 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.474 ' HA3' ' HB ' ' A' ' 87' ' ' ILE . . . -104.86 102.91 2.13 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 107.444 -2.262 . . . . 0.0 107.444 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -96.73 123.42 49.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.248 -1.148 . . . . 0.0 109.238 -178.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.537 ' HB2' HD12 ' A' ' 104' ' ' ILE . 3.4 p90 -132.52 164.2 27.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.298 -0.876 . . . . 0.0 109.491 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -149.22 -170.41 3.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.506 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 60.81 22.14 12.2 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.175 -0.953 . . . . 0.0 109.371 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.43 82.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.589 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' ' 100' ' ' TYR . 4.0 mt -97.27 147.66 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.155 -0.966 . . . . 0.0 109.283 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -50.88 109.38 1.32 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.307 -0.871 . . . . 0.0 109.546 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.484 ' HG3' ' HE3' ' A' ' 80' ' ' LYS . 2.4 Cg_endo -62.13 -35.26 76.35 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.921 1.748 . . . . 0.0 110.167 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.2 47.18 3.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 112' ' ' VAL . 16.6 m -148.36 -39.2 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 109.414 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.486 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -88.12 -18.94 27.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.604 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.53 -46.98 24.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -63.75 -42.04 97.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.429 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 108' ' ' THR . 89.3 t -62.74 -26.4 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.239 -0.913 . . . . 0.0 109.565 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.543 HG21 HG21 ' A' ' 87' ' ' ILE . 47.6 t -87.55 -22.86 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.366 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -63.89 -42.41 97.49 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.229 -0.919 . . . . 0.0 109.307 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -78.32 -51.24 10.41 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.363 -0.836 . . . . 0.0 109.226 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.593 HD21 ' CE2' ' A' ' 5' ' ' TYR . 4.1 tp -49.67 -33.09 14.74 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.154 -0.966 . . . . 0.0 109.109 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.744 ' C ' HD12 ' A' ' 121' ' ' ILE . . . -62.24 -47.91 82.31 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.248 -0.907 . . . . 0.0 108.584 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -15.79 47.69 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.492 -0.755 . . . . 0.0 109.088 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -83.65 -47.58 11.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.431 -0.793 . . . . 0.0 108.988 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.959 HD23 ' HA3' ' A' ' 124' ' ' GLY . 0.4 OUTLIER -80.92 -7.67 59.56 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.357 -0.839 . . . . 0.0 109.591 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.788 HG13 HG22 ' A' ' 91' ' ' THR . 26.6 mt -90.13 -20.94 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.31 -0.869 . . . . 0.0 109.347 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 123' ' ' GLN . . . -112.92 -0.31 25.65 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 122' ' ' GLY . 1.8 mt-30 -140.7 -47.27 0.41 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -1.147 . . . . 0.0 109.472 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.959 ' HA3' HD23 ' A' ' 120' ' ' LEU . . . -74.88 -102.31 0.1 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.191 -1.182 . . . . 0.0 109.261 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.952 ' CZ2' HD22 ' A' ' 96' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.83 -79.72 0.33 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.734 -1.229 . . . . 0.0 108.219 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -17.59 61.85 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.691 ' CD2' HD12 ' A' ' 10' ' ' LEU . 9.9 m-30 -75.35 -39.34 59.41 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.929 HG23 ' HB2' ' A' ' 2' ' ' TRP . 1.2 t -54.2 -48.42 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.586 -0.696 . . . . 0.0 110.027 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.627 ' O ' HG23 ' A' ' 8' ' ' THR . 5.5 t0 -90.91 52.37 2.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 112.513 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER 176.78 -87.49 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.26 -1.525 . . . . 0.0 112.783 178.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 11' ' ' VAL . 14.0 m120 -83.43 -92.06 0.07 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.105 -0.997 . . . . 0.0 112.494 -176.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.691 HD12 ' CD2' ' A' ' 5' ' ' TYR . 3.0 mt -23.79 -41.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.978 HG22 ' HB3' ' A' ' 19' ' ' ALA . 72.2 t -89.61 -57.42 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.576 -1.327 . . . . 0.0 110.523 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.756 ' C ' HG22 ' A' ' 13' ' ' THR . . . -40.65 -47.56 3.89 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 108.741 -1.743 . . . . 0.0 108.741 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.756 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER 166.72 38.63 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.708 -0.878 . . . . 0.0 108.932 178.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.694 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -82.67 15.35 31.36 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.886 ' HB2' HG11 ' A' ' 112' ' ' VAL . . . 157.99 -27.58 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.626 HG12 ' HB3' ' A' ' 100' ' ' TYR . 23.5 m -143.4 154.34 16.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.2 OUTLIER -83.95 17.41 2.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.974 -1.079 . . . . 0.0 109.533 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.572 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -176.99 177.47 1.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.978 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . 179.19 158.04 0.58 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.84 -1.162 . . . . 0.0 110.265 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.513 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -153.94 117.71 4.7 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.674 HD11 ' CG ' ' A' ' 2' ' ' TRP . 6.9 mm -82.63 113.39 21.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.221 -0.924 . . . . 0.0 109.19 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.119 HD22 ' CG2' ' A' ' 97' ' ' VAL . 0.4 OUTLIER -96.32 117.14 30.21 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.537 -0.727 . . . . 0.0 109.566 -178.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -50.7 179.98 0.03 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.551 HD23 ' H ' ' A' ' 24' ' ' LEU . 1.2 pt? -121.37 -8.98 9.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -1.192 . . . . 0.0 109.659 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -111.58 26.96 10.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.932 . . . . 0.0 109.537 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.08 70.44 1.31 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -171.62 -164.99 0.35 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -1.158 . . . . 0.0 109.331 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.05 111.09 7.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.168 -0.957 . . . . 0.0 109.58 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 36.5 m0 -83.91 -33.63 24.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.428 ' HB3' ' CG1' ' A' ' 21' ' ' ILE . . . -164.9 158.98 17.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.285 -0.884 . . . . 0.0 109.399 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.3 t -152.31 141.55 21.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.159 -0.963 . . . . 0.0 109.812 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.777 ' CB ' HG21 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -130.13 119.97 23.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.396 -0.815 . . . . 0.0 108.998 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 81.73 159.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.589 -0.694 . . . . 0.0 109.375 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 33' ' ' ALA . . . -43.45 -93.25 0.01 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.414 ' CE1' HG21 ' A' ' 99' ' ' VAL . 0.9 OUTLIER 68.75 94.73 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -1.139 . . . . 0.0 109.533 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.564 ' O ' ' HB2' ' A' ' 63' ' ' ALA . . . -102.52 100.3 10.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.385 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.466 ' HB ' ' HG2' ' A' ' 41' ' ' GLN . 1.8 t -109.28 166.24 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.876 . . . . 0.0 109.529 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.479 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -50.22 153.55 2.42 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.372 -0.83 . . . . 0.0 109.545 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.456 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 5.3 Cg_exo -58.97 -16.07 30.55 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.159 1.906 . . . . 0.0 110.436 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 43' ' ' GLN . . . -122.52 56.89 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.222 -0.924 . . . . 0.0 109.48 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 38' ' ' THR . 3.9 mp0 -51.67 -37.05 48.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.026 -1.046 . . . . 0.0 109.265 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.31 -39.58 70.73 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.539 ' HB2' ' HB1' ' A' ' 40' ' ' ALA . 1.3 tm0? -63.15 -37.41 87.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -1.194 . . . . 0.0 110.033 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.1 m -62.46 -51.66 66.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.186 -0.946 . . . . 0.0 109.668 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.899 HD22 HG21 ' A' ' 95' ' ' ILE . 2.1 mp -65.73 -23.32 66.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 109.75 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.582 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . . . -62.92 -37.15 85.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.94 . . . . 0.0 109.674 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.8 m -76.98 -28.39 55.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.539 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.61 -14.22 62.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.548 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CD2' ' HA ' ' A' ' 46' ' ' ALA . 23.2 m-85 -76.51 -39.54 52.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.94 . . . . 0.0 109.398 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -87.48 -66.73 0.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.129 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -117.3 140.73 49.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 0.0 109.117 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.469 ' O ' HG12 ' A' ' 55' ' ' ILE . . . -135.64 33.57 2.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -0.958 . . . . 0.0 109.767 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.638 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -68.22 -45.28 39.22 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.377 -0.827 . . . . 0.0 110.652 179.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 6.3 Cg_exo -59.44 -18.71 47.74 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.524 1.483 . . . . 0.0 110.595 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.127 HD11 ' CB ' ' A' ' 72' ' ' ALA . 1.1 pt -105.7 -19.03 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 109.163 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.438 HH11 ' CG ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -76.79 -37.48 55.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.364 -0.835 . . . . 0.0 109.655 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 56' ' ' ARG . . . -43.87 -71.56 0.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 0.0 109.74 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.464 ' O ' HG23 ' A' ' 68' ' ' VAL . 1.9 t -118.83 -47.12 2.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.636 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 68' ' ' VAL . . . 166.01 -163.42 36.77 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.42 ' HE2' HG23 ' A' ' 69' ' ' THR . 0.3 OUTLIER -112.94 161.16 17.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -1.146 . . . . 0.0 109.475 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.42 104.79 12.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 109.708 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.88 112.67 25.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.865 . . . . 0.0 109.514 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 36' ' ' ALA . . . 49.71 -143.38 0.54 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.567 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.87 46.89 3.75 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.539 HG11 ' CE2' ' A' ' 67' ' ' TYR . 3.4 t -142.34 138.93 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -1.179 . . . . 0.0 108.963 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.407 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 75.9 t60 -121.46 118.91 30.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 0.0 109.77 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.539 ' CE2' HG11 ' A' ' 65' ' ' VAL . 15.9 m-85 -131.73 177.62 7.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 109.241 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.614 HG22 ' N ' ' A' ' 69' ' ' THR . 7.7 p -104.42 166.16 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.268 -0.895 . . . . 0.0 109.846 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.614 ' N ' HG22 ' A' ' 68' ' ' VAL . 1.4 m -95.49 176.76 6.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.933 . . . . 0.0 109.173 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.556 ' H ' HG22 ' A' ' 69' ' ' THR . 0.2 OUTLIER -141.33 -48.42 0.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.141 -0.974 . . . . 0.0 110.234 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 76' ' ' SER . 13.8 ttm180 -142.8 61.38 1.42 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.947 -1.096 . . . . 0.0 110.153 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 1.127 ' CB ' HD11 ' A' ' 55' ' ' ILE . . . -85.34 81.66 8.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.123 -0.985 . . . . 0.0 109.393 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -154.88 -38.56 0.09 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.284 -0.885 . . . . 0.0 109.477 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.93 -100.18 0.35 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.761 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.452 ' CG ' ' NH1' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -129.11 -16.23 4.07 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.882 -1.136 . . . . 0.0 110.106 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.627 ' C ' HD12 ' A' ' 77' ' ' ILE . 6.1 m -89.37 131.82 35.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.827 -1.17 . . . . 0.0 109.415 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.697 ' O ' HG22 ' A' ' 77' ' ' ILE . 4.7 mp -149.21 60.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 110.116 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.847 ' HB3' HD13 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -90.51 161.31 15.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.036 -1.04 . . . . 0.0 108.333 179.008 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.82 158.25 14.45 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.444 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 19.3 mtmt -145.34 132.64 20.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -1.09 . . . . 0.0 109.375 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.9 OUTLIER 171.63 128.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 109.508 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 83' ' ' SER . . . 56.96 54.78 34.23 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 82' ' ' GLY . 0.6 OUTLIER 43.79 26.77 0.14 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -1.151 . . . . 0.0 109.61 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.497 ' HA ' ' CE2' ' A' ' 100' ' ' TYR . . . -145.34 153.36 41.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.205 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 179.5 -166.79 36.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.406 ' O ' HD13 ' A' ' 87' ' ' ILE . 2.5 m -122.38 179.91 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -1.149 . . . . 0.0 109.649 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.847 HD13 ' HB3' ' A' ' 78' ' ' TYR . 36.4 mm -142.85 68.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.104 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.798 HG22 HG13 ' A' ' 97' ' ' VAL . 1.2 p -99.93 116.86 32.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 110.028 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.36 150.99 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.428 -0.795 . . . . 0.0 108.963 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.5 ' HG3' HG12 ' A' ' 95' ' ' ILE . 1.8 mtpt -98.35 149.97 22.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.147 -0.97 . . . . 0.0 109.778 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.6 p -123.42 -138.75 0.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.808 . . . . 0.0 108.871 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.503 ' HB2' ' HA ' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -66.64 -17.01 64.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.858 -1.151 . . . . 0.0 109.302 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.583 ' HB2' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER 167.49 66.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 p 176.86 156.58 0.28 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.347 -0.845 . . . . 0.0 109.126 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.899 HG21 HD22 ' A' ' 45' ' ' LEU . 14.7 mt -129.39 100.67 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.037 -1.039 . . . . 0.0 109.831 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.952 HD22 ' CZ2' ' A' ' 2' ' ' TRP . 2.9 pp -78.42 137.85 38.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 108.954 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 1.119 ' CG2' HD22 ' A' ' 22' ' ' LEU . 11.9 t -117.4 81.28 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.139 -0.976 . . . . 0.0 110.183 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.49 ' CA ' ' HB ' ' A' ' 87' ' ' ILE . . . -74.47 110.5 3.1 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.476 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -111.62 127.74 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -1.228 . . . . 0.0 109.44 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.626 ' HB3' HG12 ' A' ' 16' ' ' VAL . 22.4 p90 -130.97 173.01 11.41 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 109.941 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -122.48 -141.49 0.32 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.597 -0.689 . . . . 0.0 109.372 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.438 ' HG3' ' N ' ' A' ' 103' ' ' LYS . 4.3 pt-20 -79.15 -19.15 51.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.111 -0.993 . . . . 0.0 109.422 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.484 ' CD ' HG21 ' A' ' 17' ' ' THR . 65.7 mttt -58.17 -25.28 61.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.387 -0.82 . . . . 0.0 109.833 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 16' ' ' VAL . 4.7 mt -127.41 143.47 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.014 -1.054 . . . . 0.0 109.541 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.443 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -102.48 158.26 32.1 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 109.33 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 105' ' ' GLN . 2.1 Cg_endo -61.78 153.87 64.77 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.165 1.91 . . . . 0.0 110.195 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.7 -61.57 0.32 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.5 m -75.68 -22.44 56.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -1.125 . . . . 0.0 109.714 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.599 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -75.68 -38.11 59.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.628 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.96 -38.36 32.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 109.683 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.48 ' O ' ' HB3' ' A' ' 114' ' ' GLU . 2.6 t30 -63.74 -41.16 98.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.134 -0.979 . . . . 0.0 109.641 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.886 HG11 ' HB2' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -65.41 -42.95 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.357 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.826 HG21 HG21 ' A' ' 87' ' ' ILE . 51.8 t -67.93 -15.53 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.896 . . . . 0.0 109.64 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 111' ' ' ASN . 5.3 tp10 -67.79 -63.63 1.02 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.239 -0.913 . . . . 0.0 109.625 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -27.1 66.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.178 -0.951 . . . . 0.0 109.753 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.609 HD11 ' HE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -61.34 -47.11 87.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.112 -0.993 . . . . 0.0 110.122 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.538 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -78.21 -33.21 50.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 109.937 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -57.25 -17.74 13.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 109.854 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.44 -57.4 2.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 110.065 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -70.66 -1.96 12.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.135 -0.978 . . . . 0.0 110.689 -178.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.538 HD12 ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -70.03 -36.65 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.965 -1.084 . . . . 0.0 108.97 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.406 ' O ' ' HG2' ' A' ' 123' ' ' GLN . . . -108.72 42.56 1.92 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 122' ' ' GLY . 53.9 mm-40 -147.01 -84.1 0.11 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -1.166 . . . . 0.0 109.864 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.457 ' O ' ' OXT' ' A' ' 125' ' ' PHE . . . -136.7 63.98 0.57 Allowed Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.253 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.583 ' CD1' ' HB2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.241 -1.153 . . . . 0.0 109.625 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.634 ' CH2' ' HB2' ' A' ' 117' ' ' ALA . 3.4 m95 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.43 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 3.0 mp0 -39.09 -92.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.405 -0.809 . . . . 0.0 111.408 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.794 ' O ' HG22 ' A' ' 8' ' ' THR . 91.5 m -57.42 -49.14 77.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.347 -0.846 . . . . 0.0 110.961 -178.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.691 ' CD2' HD21 ' A' ' 116' ' ' LEU . 15.3 m-30 -50.92 -18.42 0.76 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.156 -0.965 . . . . 0.0 110.23 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.517 ' HA ' HG23 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -79.61 -46.85 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.945 -1.097 . . . . 0.0 109.361 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.48 51.42 1.88 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 0.0 111.982 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.794 HG22 ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -166.23 -100.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.36 -1.462 . . . . 0.0 110.892 179.002 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.515 ' H ' HG23 ' A' ' 8' ' ' THR . 1.0 OUTLIER -102.25 -59.35 1.72 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.051 -1.03 . . . . 0.0 110.824 -178.632 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.564 ' CB ' ' HB3' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -33.49 -33.26 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.622 -0.674 . . . . 0.0 110.99 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.842 HG22 ' HB3' ' A' ' 19' ' ' ALA . 2.8 t -99.53 -48.21 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.032 -1.042 . . . . 0.0 109.689 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.768 ' C ' HG22 ' A' ' 13' ' ' THR . . . -40.81 -45.13 3.6 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.768 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 159.66 39.72 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.88 -0.777 . . . . 0.0 109.601 178.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.703 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -84.23 20.04 15.28 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 154.1 -33.55 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.576 ' HA ' HD13 ' A' ' 104' ' ' ILE . 11.9 m -136.44 134.56 49.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.777 HG23 ' HG3' ' A' ' 18' ' ' GLN . 9.2 t -78.4 2.61 18.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.85 -1.156 . . . . 0.0 109.387 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.777 ' HG3' HG23 ' A' ' 17' ' ' THR . 71.7 mt-30 -162.6 155.34 19.43 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.842 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -158.9 152.51 23.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.117 -0.989 . . . . 0.0 109.72 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.5 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -138.6 142.11 39.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.947 . . . . 0.0 109.455 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.597 HD11 ' N ' ' A' ' 2' ' ' TRP . 0.7 OUTLIER -109.32 79.96 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.144 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -62.44 -153.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 108.649 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.425 ' C ' HG13 ' A' ' 95' ' ' ILE . . . -143.1 140.49 9.75 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.565 -1.302 . . . . 0.0 109.986 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 94' ' ' SER . 9.1 mt -68.68 -44.19 74.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -1.137 . . . . 0.0 109.263 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -129.27 2.45 5.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.584 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.35 -102.53 2.15 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -176.91 -46.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -1.122 . . . . 0.0 109.576 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.8 m -167.17 116.81 0.85 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.887 . . . . 0.0 109.666 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.413 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 19.0 m0 -96.78 -34.46 11.31 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.271 -0.893 . . . . 0.0 109.366 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.98 170.72 6.16 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -161.39 -179.27 7.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.059 -1.026 . . . . 0.0 109.945 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.647 ' OG ' HG21 ' A' ' 11' ' ' VAL . 51.9 p 177.74 67.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.531 -0.731 . . . . 0.0 109.23 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.455 ' CB ' ' CE1' ' A' ' 35' ' ' PHE . . . -142.08 -39.39 0.37 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.482 -0.761 . . . . 0.0 109.169 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.3 -52.94 0.95 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.455 ' CE1' ' CB ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -61.22 162.2 7.86 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -1.094 . . . . 0.0 109.385 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.08 148.54 29.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 109.379 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 38' ' ' THR . 61.4 t -102.17 158.69 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.193 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.468 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 6.0 t -43.14 147.19 0.72 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.437 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.468 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 6.1 Cg_exo -58.77 -14.07 20.57 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.153 1.902 . . . . 0.0 110.311 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.949 ' HB1' ' HB3' ' A' ' 43' ' ' GLN . . . -107.8 59.3 0.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.917 . . . . 0.0 109.409 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -65.56 -52.68 50.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.93 -1.107 . . . . 0.0 109.765 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.88 -12.71 84.33 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.949 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 1.5 tt0 -89.98 -20.97 22.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -1.149 . . . . 0.0 109.475 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.1 m -90.1 -29.72 18.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.498 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.518 ' O ' ' CD2' ' A' ' 49' ' ' PHE . 4.2 mm? -87.7 -40.55 14.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.726 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.37 -25.26 60.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 109.995 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.3 t -88.59 -19.6 26.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.124 -0.985 . . . . 0.0 109.779 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.18 -14.25 47.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.103 -0.998 . . . . 0.0 109.689 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.518 ' CD2' ' O ' ' A' ' 45' ' ' LEU . 19.6 m-85 -74.32 -33.0 63.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.658 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -94.11 -20.78 19.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.939 . . . . 0.0 109.303 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -131.55 120.85 23.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 0.0 109.342 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.545 ' HA ' HD11 ' A' ' 55' ' ' ILE . . . -119.84 28.71 7.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 109.554 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.569 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -76.57 -51.42 2.43 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.333 -0.855 . . . . 0.0 110.458 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 1.7 Cg_endo -64.61 -4.81 9.0 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.113 1.875 . . . . 0.0 111.357 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.717 ' HB ' HG21 ' A' ' 69' ' ' THR . 0.0 OUTLIER -112.53 7.62 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.748 -1.22 . . . . 0.0 110.101 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -100.07 -20.38 16.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.891 -1.13 . . . . 0.0 109.604 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.87 -60.9 1.2 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.22 -0.925 . . . . 0.0 109.537 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -78.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.374 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.41 -165.02 28.34 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.486 ' HB2' ' HB2' ' A' ' 67' ' ' TYR . 7.0 m-85 -81.28 170.82 15.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -1.126 . . . . 0.0 109.684 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.509 ' C ' HD12 ' A' ' 62' ' ' LEU . 1.3 m-20 -141.33 101.04 3.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.495 -0.753 . . . . 0.0 108.973 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.569 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 5.9 mp -127.1 61.17 1.36 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.203 -0.936 . . . . 0.0 109.932 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . 69.47 -83.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.365 -0.834 . . . . 0.0 110.015 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -38.72 -95.54 0.01 OUTLIER Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.465 HG12 ' H ' ' A' ' 66' ' ' HIS . 1.3 t -129.77 -148.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.084 -1.245 . . . . 0.0 109.238 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 60' ' ' PHE . 31.6 p-80 -122.21 144.03 49.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.153 -0.967 . . . . 0.0 109.73 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.486 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 25.9 m-85 -100.81 -161.94 0.9 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.362 -0.836 . . . . 0.0 109.233 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.703 HG22 ' H ' ' A' ' 69' ' ' THR . 1.4 p -104.32 -171.22 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.052 -1.03 . . . . 0.0 109.287 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.717 HG21 ' HB ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -148.56 64.71 1.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.11 -0.994 . . . . 0.0 109.549 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 70' ' ' LEU . 0.8 OUTLIER -91.84 18.33 7.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.92 . . . . 0.0 109.211 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -161.87 55.9 0.25 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.454 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.588 ' CB ' HG22 ' A' ' 69' ' ' THR . . . -123.46 66.35 1.01 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.735 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.85 -42.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.938 . . . . 0.0 109.635 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 2.2 m-20 -49.65 -86.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.597 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.512 ' NH1' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -145.22 -59.85 0.35 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.897 . . . . 0.0 109.388 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 78' ' ' TYR . 74.2 m -89.6 -165.41 1.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.416 ' CG1' ' O ' ' A' ' 76' ' ' SER . 13.9 mt -154.61 105.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.009 -1.057 . . . . 0.0 109.704 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 78' ' ' TYR . 0.6 OUTLIER -113.52 97.08 6.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 0.0 109.06 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 86' ' ' VAL . . . -60.31 141.38 47.88 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.529 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -151.05 124.62 9.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -1.101 . . . . 0.0 109.417 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.67 132.72 1.51 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.141 -0.974 . . . . 0.0 109.676 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.5 -136.07 47.41 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.18 -10.15 24.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -1.114 . . . . 0.0 109.704 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.48 -173.91 2.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 109.463 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.03 171.06 28.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 79' ' ' GLY . 3.4 p -123.99 153.8 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -1.184 . . . . 0.0 109.55 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.717 HG21 HG21 ' A' ' 113' ' ' VAL . 30.2 mm -127.31 94.67 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.033 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 1.4 p -108.97 129.7 55.45 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.143 -0.973 . . . . 0.0 109.985 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.836 ' HB ' HD23 ' A' ' 96' ' ' LEU . 2.4 t -142.23 143.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -103.1 120.52 40.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.119 -0.988 . . . . 0.0 109.907 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.534 ' HB ' ' CB ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -96.34 -59.13 1.9 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.412 -0.805 . . . . 0.0 108.969 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.599 ' HB3' ' CD2' ' A' ' 125' ' ' PHE . 0.2 OUTLIER 171.86 -32.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.41 -0.806 . . . . 0.0 109.769 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.54 ' C ' HD12 ' A' ' 24' ' ' LEU . 2.3 mmmt -135.85 2.51 2.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.045 -1.034 . . . . 0.0 110.13 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.735 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -156.1 146.31 21.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.021 -1.05 . . . . 0.0 109.692 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.595 HD11 ' HA ' ' A' ' 24' ' ' LEU . 15.2 mt -105.9 139.68 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 0.0 109.298 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.836 HD23 ' HB ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -92.46 154.55 18.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.032 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.779 ' O ' HG12 ' A' ' 97' ' ' VAL . 39.9 t -150.4 68.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.264 -0.897 . . . . 0.0 109.665 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.87 106.91 1.79 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.682 HG22 HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -109.88 127.81 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.958 -1.319 . . . . 0.0 109.538 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 1.043 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -142.54 144.15 32.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.396 -0.815 . . . . 0.0 109.428 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.496 ' O ' ' CB ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -150.4 114.48 5.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.067 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.1 OUTLIER 163.45 -61.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.456 -0.777 . . . . 0.0 109.393 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -174.93 33.14 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.397 -0.814 . . . . 0.0 109.906 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.043 HD12 ' HB2' ' A' ' 100' ' ' TYR . 48.6 mt -84.27 83.6 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -0.959 . . . . 0.0 108.981 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -54.11 149.69 17.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 109.954 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.77 156.45 61.6 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.309 2.006 . . . . 0.0 110.183 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.55 -2.71 46.06 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.65 -39.67 2.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -1.193 . . . . 0.0 109.505 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.544 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -83.93 -27.69 28.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.287 -0.883 . . . . 0.0 109.446 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.464 ' O ' ' OE1' ' A' ' 114' ' ' GLU . . . -83.07 -21.18 33.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.136 -0.977 . . . . 0.0 109.28 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -78.83 -29.26 44.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.537 HG11 HD11 ' A' ' 10' ' ' LEU . 11.5 t -83.08 -39.13 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.301 -0.875 . . . . 0.0 109.39 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.717 HG21 HG21 ' A' ' 87' ' ' ILE . 38.4 t -68.92 -16.25 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.053 -1.029 . . . . 0.0 109.435 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.464 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -81.32 -56.36 4.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.61 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 118' ' ' ASP . 5.4 ttmt -79.0 -52.78 7.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.748 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.691 HD21 ' CD2' ' A' ' 5' ' ' TYR . 1.6 tp -51.87 -47.09 64.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -0.959 . . . . 0.0 109.522 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.75 ' O ' HD13 ' A' ' 121' ' ' ILE . . . -67.93 -35.69 78.86 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.074 -1.016 . . . . 0.0 109.05 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 115' ' ' LYS . 24.1 t0 -47.56 -25.84 1.26 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.134 -0.979 . . . . 0.0 109.266 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -81.32 -51.1 8.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.277 -0.89 . . . . 0.0 109.261 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' ' 125' ' ' PHE . 3.8 mt -71.25 -3.1 18.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.399 -0.813 . . . . 0.0 110.072 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.75 HD13 ' O ' ' A' ' 117' ' ' ALA . 1.2 mp -75.99 -28.41 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.065 -1.022 . . . . 0.0 108.554 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -123.74 29.24 5.23 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.35 57.55 0.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -1.113 . . . . 0.0 109.687 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.507 ' C ' ' CD1' ' A' ' 125' ' ' PHE . . . 104.71 17.72 14.22 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.599 ' CD2' ' HB3' ' A' ' 92' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.743 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.769 ' CB ' HD11 ' A' ' 21' ' ' ILE . 1.1 m-90 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.55 -80.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.076 -1.015 . . . . 0.0 109.787 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.66 ' O ' HG22 ' A' ' 8' ' ' THR . 8.8 t -59.57 -39.21 83.33 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.765 ' CE1' HD12 ' A' ' 10' ' ' LEU . 4.9 t80 -40.14 -36.51 0.51 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.033 0.92 . . . . 0.0 109.172 177.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.109 HG13 HG21 ' A' ' 11' ' ' VAL . 39.7 t -99.37 -29.51 3.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 121.046 -1.034 . . . . 0.0 111.325 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.48 ' C ' HG22 ' A' ' 8' ' ' THR . 77.9 m-20 -91.75 52.25 1.99 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.702 -1.249 . . . . 0.0 112.826 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER 179.61 -94.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.21 -1.556 . . . . 0.0 111.322 178.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.7 t-20 -101.89 -66.33 0.93 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.197 -0.94 . . . . 0.0 111.124 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.765 HD12 ' CE1' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -33.88 -31.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.867 -0.521 . . . . 0.0 111.6 -178.411 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.109 HG21 HG13 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -95.39 -56.66 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.751 -1.218 . . . . 0.0 109.745 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.746 ' C ' HG22 ' A' ' 13' ' ' THR . . . -38.79 -37.38 0.57 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.831 -1.707 . . . . 0.0 108.831 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.746 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 159.05 39.64 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.95 -0.735 . . . . 0.0 109.196 178.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.706 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -81.29 16.55 16.92 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 107.776 -2.13 . . . . 0.0 107.776 177.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.716 ' HB1' ' HA ' ' A' ' 109' ' ' ALA . . . 154.99 -27.09 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.419 HG21 ' HB2' ' A' ' 19' ' ' ALA . 5.2 m -140.4 137.29 36.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.041 HG23 HD11 ' A' ' 104' ' ' ILE . 34.5 p -79.38 6.44 10.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.922 -1.111 . . . . 0.0 109.436 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.483 ' OE1' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -167.39 161.95 14.38 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.624 ' HA ' HG23 ' A' ' 99' ' ' VAL . . . -174.01 171.59 3.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.956 -1.09 . . . . 0.0 110.079 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -161.98 157.07 23.13 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.286 -0.884 . . . . 0.0 109.774 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.769 HD11 ' CB ' ' A' ' 2' ' ' TRP . 10.9 mt -115.45 94.63 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.805 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -85.27 128.55 34.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.666 -0.646 . . . . 0.0 109.284 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.6 ' HA2' ' CZ3' ' A' ' 29' ' ' TRP . . . -48.19 167.0 0.16 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.657 HD23 ' CG1' ' A' ' 95' ' ' ILE . 16.2 mt -77.12 -11.96 59.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.349 -1.089 . . . . 0.0 109.276 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 27' ' ' ASN . 5.3 t70 -120.08 57.79 0.93 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.703 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 52.3 69.72 1.1 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 25' ' ' ASP . 8.4 m120 -147.31 -149.89 0.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.282 -1.128 . . . . 0.0 109.519 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -155.26 158.85 39.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.358 -0.839 . . . . 0.0 109.182 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.6 ' CZ3' ' HA2' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -145.33 -41.04 0.23 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -0.986 . . . . 0.0 109.905 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.501 ' HB3' HD12 ' A' ' 21' ' ' ILE . . . -165.1 118.58 1.24 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.999 -1.063 . . . . 0.0 110.15 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 9.3 t -131.86 164.36 26.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.651 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.707 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 3.4 m -147.79 147.55 29.97 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.338 -0.851 . . . . 0.0 109.475 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 81.4 172.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 33' ' ' ALA . . . -60.64 -132.58 0.01 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.651 ' CE1' HG11 ' A' ' 99' ' ' VAL . 91.0 t80 58.81 93.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.031 -1.276 . . . . 0.0 109.203 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.2 124.42 50.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 109.648 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 65.5 t -97.92 106.0 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.833 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -71.22 162.01 75.04 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.285 -0.884 . . . . 0.0 109.529 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.833 ' HD2' HG22 ' A' ' 38' ' ' THR . 2.4 Cg_endo -61.58 108.81 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.18 1.92 . . . . 0.0 110.004 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 39' ' ' PRO . . . 176.24 -71.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.217 -0.927 . . . . 0.0 109.496 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.47 -21.71 65.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.667 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.17 -31.62 61.34 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.468 ' O ' ' OG ' ' A' ' 47' ' ' SER . 4.6 tt0 -74.97 -23.04 58.23 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.388 -1.066 . . . . 0.0 109.374 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.667 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 3.5 m -88.42 -32.72 18.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.233 -0.917 . . . . 0.0 109.301 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.91 -47.81 83.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -0.916 . . . . 0.0 109.352 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 25' ' ' ASP . . . -61.49 -46.55 89.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 0.0 109.218 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -82.82 -0.21 46.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.364 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 44' ' ' THR . . . -82.78 -22.66 34.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 109.716 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -74.76 -0.88 19.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.049 -1.032 . . . . 0.0 109.591 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -88.21 -59.84 2.13 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.188 -0.945 . . . . 0.0 109.953 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 53' ' ' ASP . 2.9 t-20 -126.47 6.35 6.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.025 -1.047 . . . . 0.0 110.175 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 51' ' ' ASN . . . 32.25 35.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.234 0.54 . . . . 0.0 110.445 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.618 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 2.7 t0 -73.9 -49.91 5.74 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.896 . . . . 0.0 110.888 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 6.0 Cg_exo -59.98 -9.59 10.33 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.058 1.838 . . . . 0.0 111.317 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.775 HD13 ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -106.92 -49.46 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.892 -1.13 . . . . 0.0 109.775 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.506 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 3.6 ptm180 -53.87 -19.33 4.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.051 -1.031 . . . . 0.0 110.084 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 56' ' ' ARG . . . -120.6 137.94 54.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.093 -1.005 . . . . 0.0 109.925 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 59' ' ' GLY . 0.6 OUTLIER 49.74 27.24 2.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.405 -0.81 . . . . 0.0 109.653 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 58' ' ' SER . . . 43.39 -136.64 4.44 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.537 ' N ' ' CD1' ' A' ' 60' ' ' PHE . 2.6 p90 -147.33 143.79 28.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.183 -1.186 . . . . 0.0 109.343 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -101.85 126.86 48.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.266 -0.897 . . . . 0.0 109.765 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -94.51 -160.17 0.76 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.53 -0.731 . . . . 0.0 109.475 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.14 95.3 8.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.4 -23.73 14.49 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -125.53 153.0 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -1.14 . . . . 0.0 108.888 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -149.91 153.58 36.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 109.526 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -141.91 -171.92 3.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.335 -0.853 . . . . 0.0 109.276 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 t -116.89 154.13 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.945 . . . . 0.0 109.602 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.88 124.94 45.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.484 -0.76 . . . . 0.0 109.54 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.03 -35.92 1.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.592 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.434 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -119.33 70.76 0.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.463 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.78 28.6 6.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.423 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -99.69 0.07 41.15 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.248 -0.908 . . . . 0.0 109.606 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -105.22 -95.74 0.34 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.975 . . . . 0.0 109.926 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.526 ' NH1' ' HG3' ' A' ' 75' ' ' ARG . 1.0 OUTLIER -142.47 -36.51 0.4 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.028 . . . . 0.0 110.058 -179.493 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 0.6 OUTLIER -89.52 149.87 22.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 109.553 -179.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 76' ' ' SER . 4.3 mp -144.53 70.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 0.0 110.335 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.756 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -90.01 93.62 9.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.814 -1.179 . . . . 0.0 108.46 178.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.422 ' O ' HG12 ' A' ' 86' ' ' VAL . . . -79.21 128.44 8.56 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.56 146.38 26.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -1.233 . . . . 0.0 109.61 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.88 148.83 0.55 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.559 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.47 -106.85 2.76 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.2 m -135.95 7.92 3.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -1.121 . . . . 0.0 109.511 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -130.82 178.12 6.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 0.0 109.159 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -169.28 177.45 42.93 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.325 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 86' ' ' VAL . 9.3 p -153.27 123.63 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.976 . . . . 0.0 108.74 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.821 HG21 HG11 ' A' ' 113' ' ' VAL . 10.6 mt -95.53 99.82 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.177 -0.952 . . . . 0.0 109.793 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 8.6 p -105.95 108.48 20.02 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.566 HG22 ' CE2' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -129.01 173.95 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.927 . . . . 0.0 110.054 -179.174 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.439 ' H ' HG12 ' A' ' 89' ' ' VAL . 29.7 mtmt -101.39 142.81 32.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.392 -0.817 . . . . 0.0 108.941 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 1.088 ' CG2' HD21 ' A' ' 96' ' ' LEU . 66.5 p -149.12 -137.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.105 -0.997 . . . . 0.0 109.828 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.465 ' HA ' ' OXT' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -67.52 84.04 0.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.948 -1.095 . . . . 0.0 111.178 -178.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.561 ' HA ' HD11 ' A' ' 24' ' ' LEU . 3.0 mttm 51.04 34.01 10.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -0.855 . . . . 0.0 109.778 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.04 167.35 30.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.051 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.657 ' CG1' HD23 ' A' ' 24' ' ' LEU . 34.5 mt -121.89 123.15 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.239 -0.913 . . . . 0.0 109.135 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.088 HD21 ' CG2' ' A' ' 91' ' ' THR . 0.0 OUTLIER -75.62 165.12 25.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.08 -1.013 . . . . 0.0 108.928 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.785 HG12 HG22 ' A' ' 99' ' ' VAL . 54.0 t -150.91 74.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.389 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -63.78 98.73 0.26 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.785 HG22 HG12 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -97.28 127.64 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -1.15 . . . . 0.0 109.018 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.549 ' HB2' ' CG1' ' A' ' 104' ' ' ILE . 1.5 p90 -146.82 171.19 15.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 109.878 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -113.7 -149.85 0.45 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.394 -0.816 . . . . 0.0 110.023 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -42.5 89.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.47 -0.768 . . . . 0.0 110.221 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.8 -25.05 1.13 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.041 HD11 HG23 ' A' ' 17' ' ' THR . 10.6 mm -103.51 105.72 18.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.053 -1.029 . . . . 0.0 109.698 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.57 142.66 49.99 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.26 -0.9 . . . . 0.0 109.137 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -60.7 149.37 87.91 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.119 1.88 . . . . 0.0 110.503 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.86 -35.46 4.92 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.6 m -83.49 -29.6 27.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -1.182 . . . . 0.0 109.613 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.716 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -89.79 -13.98 35.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.809 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.0 -20.63 23.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.142 -0.974 . . . . 0.0 109.559 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -80.72 -32.67 35.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 0.0 109.695 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 88.8 t -90.05 -35.96 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 110.172 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.821 HG11 HG21 ' A' ' 87' ' ' ILE . 49.1 t -74.35 -17.6 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.148 -0.97 . . . . 0.0 109.768 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -86.97 -42.4 13.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -0.973 . . . . 0.0 109.972 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.06 -40.48 62.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.126 -0.984 . . . . 0.0 109.74 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.729 HD22 ' CE2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -60.16 -47.31 86.47 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.215 -0.928 . . . . 0.0 109.564 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.891 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -63.92 -25.91 68.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.644 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -69.2 -25.63 64.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.714 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -76.91 -40.32 47.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.22 -0.925 . . . . 0.0 110.074 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 120' ' ' LEU . 0.3 OUTLIER -82.86 -21.03 34.47 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.163 -0.96 . . . . 0.0 110.06 -179.449 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.891 HD12 ' O ' ' A' ' 117' ' ' ALA . 8.1 mt -77.62 -22.64 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 109.331 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.13 -24.48 3.41 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.29 -68.88 0.69 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.405 -1.056 . . . . 0.0 109.673 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 125' ' ' PHE . . . 158.33 110.53 0.29 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.493 ' HB3' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.084 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.693 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.869 ' CZ2' HD13 ' A' ' 96' ' ' LEU . 1.3 m-90 . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -89.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 109.189 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.429 HG23 ' N ' ' A' ' 5' ' ' TYR . 14.4 t -60.72 -36.82 79.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 108.899 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.76 ' CE2' HD11 ' A' ' 116' ' ' LEU . 10.1 m-30 -52.91 -30.89 36.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.455 -0.778 . . . . 0.0 109.41 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.535 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -69.87 -47.87 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.103 -0.998 . . . . 0.0 108.468 179.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.8 45.28 1.24 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.936 -1.103 . . . . 0.0 109.929 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.628 HG22 ' N ' ' A' ' 9' ' ' ASN . 54.3 m -156.96 -100.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.83 -1.169 . . . . 0.0 110.704 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.628 ' N ' HG22 ' A' ' 8' ' ' THR . 3.8 m120 -100.86 -59.54 1.68 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.112 -0.992 . . . . 0.0 110.64 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.529 ' C ' ' O ' ' A' ' 9' ' ' ASN . 0.5 OUTLIER -29.56 -48.51 0.08 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.304 0.573 . . . . 0.0 110.516 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.991 HG23 ' HB3' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -100.27 -23.37 4.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.342 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 13' ' ' THR . . . -83.32 57.57 5.06 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.123 -2.391 . . . . 0.0 107.123 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 43.25 51.03 5.83 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.987 0.898 . . . . 0.0 110.281 -178.774 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.704 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -100.59 21.76 42.65 Favored Glycine 0 C--N 1.292 -1.871 0 N-CA-C 105.438 -3.065 . . . . 0.0 105.438 176.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 1.118 ' CB ' HG11 ' A' ' 112' ' ' VAL . . . 152.08 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.722 ' HA ' HD13 ' A' ' 104' ' ' ILE . 2.7 m -138.78 147.14 25.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.703 HG23 HD11 ' A' ' 104' ' ' ILE . 2.4 p -79.76 10.27 4.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.876 -1.14 . . . . 0.0 109.165 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.523 ' CG ' ' C ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -170.71 174.07 5.1 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.381 -0.824 . . . . 0.0 109.409 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.991 ' HB3' HG23 ' A' ' 11' ' ' VAL . . . -177.36 163.69 2.04 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.497 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -160.59 122.1 3.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.832 -1.168 . . . . 0.0 110.758 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.676 HD11 ' CD1' ' A' ' 2' ' ' TRP . 3.1 mm -89.2 104.62 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.777 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.4 OUTLIER -83.29 13.47 4.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.39 -0.819 . . . . 0.0 109.934 -178.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 94' ' ' SER . . . 67.67 157.82 0.9 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.723 HD21 ' HB3' ' A' ' 90' ' ' LYS . 14.5 mt -79.94 -58.21 3.28 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.32 -1.106 . . . . 0.0 109.017 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.4 22.18 3.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.484 -0.76 . . . . 0.0 109.009 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.485 ' O ' ' ND2' ' A' ' 27' ' ' ASN . . . -109.84 -110.35 3.29 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 15.6 m120 -149.5 -145.9 0.18 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -1.141 . . . . 0.0 109.351 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 m -71.43 125.5 27.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.088 -1.008 . . . . 0.0 109.525 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -106.19 -40.92 5.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.06 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.15 155.75 23.36 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.429 ' C ' ' OG ' ' A' ' 32' ' ' SER . 0.7 OUTLIER -160.78 172.13 17.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.954 -1.091 . . . . 0.0 110.113 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.706 ' CB ' HG11 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -176.11 109.97 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.314 -0.866 . . . . 0.0 109.516 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 55.35 41.95 30.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 109.394 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -125.65 138.15 10.7 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.56 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -49.61 178.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -1.183 . . . . 0.0 109.417 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.01 107.42 19.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.328 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.692 ' O ' HG22 ' A' ' 38' ' ' THR . 3.9 t -104.9 163.72 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 109.899 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.748 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.6 OUTLIER 94.65 15.45 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.748 ' CD ' ' N ' ' A' ' 38' ' ' THR . 1.8 Cg_endo -64.67 -20.07 65.06 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 CA-C-N 119.783 0.958 . . . . 0.0 109.611 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 39' ' ' PRO . . . 171.74 -66.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.424 -0.797 . . . . 0.0 109.235 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.454 ' O ' ' HB ' ' A' ' 44' ' ' THR . 3.1 mp0 -56.15 -24.82 43.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.91 . . . . 0.0 109.363 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.86 -45.99 55.24 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -57.52 -35.19 69.94 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.236 -1.155 . . . . 0.0 109.103 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 41' ' ' GLN . 63.4 m -57.3 -35.57 69.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.027 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.28 -48.82 75.84 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.17 -23.27 67.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.403 -0.811 . . . . 0.0 109.141 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.0 -20.19 30.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.6 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.34 -24.11 59.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.441 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.583 ' CE2' ' HG2' ' A' ' 90' ' ' LYS . 5.3 m-30 -51.39 -21.63 2.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.217 -0.927 . . . . 0.0 109.314 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -82.68 -37.3 25.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.285 -0.885 . . . . 0.0 109.756 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.92 142.79 33.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.706 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.33 24.49 13.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 109.017 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.631 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 23.3 m-20 -67.22 -46.07 50.84 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.488 -0.757 . . . . 0.0 110.932 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.9 Cg_exo -56.54 -70.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 121.487 1.458 . . . . 0.0 110.61 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.641 ' HB ' HG21 ' A' ' 69' ' ' THR . 0.1 OUTLIER -42.07 -27.68 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.186 -0.946 . . . . 0.0 109.497 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -72.05 -75.31 0.14 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.696 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -104.94 93.84 4.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 0.0 109.527 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 3.8 t 162.82 -78.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.228 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.79 -164.82 33.84 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -124.05 111.98 16.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.472 -1.016 . . . . 0.0 108.796 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -81.2 142.98 32.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 0.0 110.283 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.44 ' HA ' HD23 ' A' ' 62' ' ' LEU . 9.8 mt -149.26 -166.46 2.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.189 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.652 ' HB2' ' HA ' ' A' ' 37' ' ' VAL . . . -71.83 90.77 1.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 0.0 110.157 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.11 24.67 68.93 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -138.96 177.15 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.094 -1.239 . . . . 0.0 108.855 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -159.43 114.43 2.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.162 -0.961 . . . . 0.0 109.744 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.588 ' CE1' ' HG3' ' A' ' 81' ' ' LYS . 11.0 m-30 -100.99 -164.02 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -0.895 . . . . 0.0 109.454 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 t -131.43 164.02 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 108.982 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.641 HG21 ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -123.17 117.45 25.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.156 -0.965 . . . . 0.0 109.835 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.62 24.73 4.05 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.576 ' HG3' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER 178.55 57.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.334 -0.854 . . . . 0.0 109.146 -179.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.479 ' O ' ' C ' ' A' ' 73' ' ' ASP . . . -90.81 20.69 4.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.192 -0.942 . . . . 0.0 109.263 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER 32.48 -107.09 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.102 -0.374 . . . . 0.0 110.743 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -120.88 -52.42 2.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.754 -1.217 . . . . 0.0 110.479 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.421 ' NE ' ' HA ' ' A' ' 75' ' ' ARG . 6.6 tpm_? -130.45 -9.12 4.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.011 -1.056 . . . . 0.0 110.827 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.63 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -88.77 146.98 24.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.937 -1.102 . . . . 0.0 108.795 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.495 ' HB ' ' OG1' ' A' ' 88' ' ' THR . 0.2 OUTLIER -135.76 79.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.69 -1.256 . . . . 0.0 111.004 -179.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.856 ' HD2' HG23 ' A' ' 87' ' ' ILE . 1.2 m-85 -90.12 76.67 6.89 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.1 178.2 7.99 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.521 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 15.6 mtpp -135.39 146.29 48.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.663 -0.904 . . . . 0.0 109.085 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.588 ' HG3' ' CE1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -114.92 25.67 10.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.998 -1.064 . . . . 0.0 109.396 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.68 -94.9 1.94 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.6 m -78.55 -25.13 45.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.226 -1.161 . . . . 0.0 109.183 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 100' ' ' TYR . . . -111.87 -165.44 0.99 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.279 -0.888 . . . . 0.0 109.25 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 80' ' ' LYS . . . -167.98 143.69 8.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 86' ' ' VAL . 10.0 p -106.44 133.6 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -1.164 . . . . 0.0 110.034 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.856 HG23 ' HD2' ' A' ' 78' ' ' TYR . 36.0 mm -106.83 83.2 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.495 ' OG1' ' HB ' ' A' ' 77' ' ' ILE . 15.5 p -95.72 117.77 31.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.004 -1.06 . . . . 0.0 110.63 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.557 HG21 ' CE2' ' A' ' 78' ' ' TYR . 11.7 t -150.36 166.52 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.723 ' HB3' HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -104.4 159.49 15.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.921 -1.112 . . . . 0.0 109.445 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.489 HG21 ' HZ3' ' A' ' 2' ' ' TRP . 0.1 OUTLIER -144.36 -70.17 0.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.611 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 1.2 t -159.87 98.7 1.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.117 -0.989 . . . . 0.0 109.889 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.472 ' CA ' HD12 ' A' ' 24' ' ' LEU . 25.1 mttm 62.54 34.59 15.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.987 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.48 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 0.3 OUTLIER 177.49 145.13 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.008 -1.057 . . . . 0.0 109.813 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.567 ' CG1' HD23 ' A' ' 24' ' ' LEU . 90.1 mt -105.96 114.68 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.88 . . . . 0.0 109.161 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.869 HD13 ' CZ2' ' A' ' 2' ' ' TRP . 0.7 OUTLIER -73.77 139.06 44.94 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.332 -0.855 . . . . 0.0 109.735 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.619 ' O ' HG22 ' A' ' 99' ' ' VAL . 45.8 t -129.89 59.75 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.352 -0.843 . . . . 0.0 109.326 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.485 ' O ' HG12 ' A' ' 87' ' ' ILE . . . -51.66 111.93 1.63 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.619 HG22 ' O ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -110.99 134.63 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.126 -1.22 . . . . 0.0 109.187 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.718 ' HB3' HG12 ' A' ' 16' ' ' VAL . 20.0 p90 -132.27 -178.35 4.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.443 -0.785 . . . . 0.0 109.307 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -118.31 -145.9 0.39 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.598 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 103' ' ' LYS . 7.6 tp10 -80.91 -38.81 27.31 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.145 -0.972 . . . . 0.0 109.665 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 102' ' ' GLU . 0.4 OUTLIER -43.79 -68.26 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.909 . . . . 0.0 109.506 -179.721 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.722 HD13 ' HA ' ' A' ' 16' ' ' VAL . 7.1 mt -65.99 137.7 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.202 -0.936 . . . . 0.0 109.286 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.416 ' HB2' ' OG1' ' A' ' 108' ' ' THR . 0.9 OUTLIER -79.77 152.63 75.06 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.775 -179.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.62 -17.72 60.46 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.4 2.067 . . . . 0.0 110.515 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.8 -13.03 51.77 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 105' ' ' GLN . 0.2 OUTLIER -85.65 -42.65 14.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -1.122 . . . . 0.0 109.429 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.86 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -78.07 -22.1 49.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.338 -0.851 . . . . 0.0 109.536 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.03 -21.02 31.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 109.566 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -80.91 -39.09 26.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 109.488 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 1.118 HG11 ' CB ' ' A' ' 15' ' ' ALA . 4.1 p -74.62 -27.83 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.684 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 109' ' ' ALA . 74.7 t -72.94 -35.04 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.409 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 118' ' ' ASP . 48.2 mt-10 -61.58 -41.9 98.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.462 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 118' ' ' ASP . 3.2 ttpm? -74.49 -38.03 63.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.494 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.76 HD11 ' CE2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -53.04 -53.3 52.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.338 -0.851 . . . . 0.0 109.715 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.609 ' HB1' ' CD1' ' A' ' 121' ' ' ILE . . . -75.35 -29.8 60.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 0.0 109.695 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 0.4 OUTLIER -54.02 -25.17 19.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -0.955 . . . . 0.0 109.666 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -85.57 -48.33 9.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.669 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 125' ' ' PHE . 4.5 mt -75.32 -2.61 29.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.881 . . . . 0.0 110.274 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.609 ' CD1' ' HB1' ' A' ' 117' ' ' ALA . 0.4 OUTLIER -84.2 -44.7 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.053 -1.029 . . . . 0.0 109.518 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -82.05 9.6 56.41 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -120.75 -87.9 0.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -1.192 . . . . 0.0 109.785 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.17 -90.82 0.92 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.567 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 3.8 m-85 . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.255 -1.144 . . . . 0.0 109.362 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 1.006 ' CH2' HD13 ' A' ' 96' ' ' LEU . 15.5 m95 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.404 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -64.54 -87.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.13 -0.981 . . . . 0.0 111.088 -178.459 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.473 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -60.84 -45.54 94.07 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.025 -1.047 . . . . 0.0 110.465 -178.649 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.813 ' CE2' HD22 ' A' ' 116' ' ' LEU . 2.8 m-30 -50.72 -21.65 1.72 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.87 -1.144 . . . . 0.0 109.466 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.827 HG22 HG21 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -78.0 -41.24 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 108.692 179.445 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.473 ' OD1' ' O ' ' A' ' 4' ' ' THR . 2.1 p-10 -91.28 18.83 6.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.119 -0.988 . . . . 0.0 110.825 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.42 ' OG1' ' HA ' ' A' ' 5' ' ' TYR . 21.1 p -127.59 -106.58 0.31 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.917 -1.114 . . . . 0.0 110.371 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.4 t-20 -102.02 -68.75 0.81 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.025 -1.047 . . . . 0.0 110.512 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.505 ' C ' ' O ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -24.52 -41.8 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.833 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 1.1 t -83.91 -65.59 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.728 -1.233 . . . . 0.0 110.057 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.751 ' C ' HG22 ' A' ' 13' ' ' THR . . . -36.84 -40.06 0.46 Allowed Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.751 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 158.45 40.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.891 -0.77 . . . . 0.0 109.366 178.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.703 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -86.06 21.3 16.56 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 154.87 -32.72 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.805 HG12 ' HB3' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -136.63 133.66 48.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.457 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.969 HG23 ' HG3' ' A' ' 18' ' ' GLN . 9.0 t -78.83 6.1 9.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.944 -1.097 . . . . 0.0 108.991 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.969 ' HG3' HG23 ' A' ' 17' ' ' THR . 17.3 mt-30 -158.91 153.08 23.74 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.833 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . -170.33 152.38 4.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -0.949 . . . . 0.0 109.193 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.572 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . . . -150.55 130.84 13.67 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.633 HD11 ' N ' ' A' ' 2' ' ' TRP . 4.6 mm -82.85 92.32 2.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.877 HD13 ' CG2' ' A' ' 97' ' ' VAL . 10.9 mp -74.71 106.7 6.39 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.46 -0.775 . . . . 0.0 109.915 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -45.93 174.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.644 HD11 ' C ' ' A' ' 93' ' ' LYS . 0.7 OUTLIER -72.82 -3.16 23.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.331 -1.099 . . . . 0.0 109.859 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.93 8.3 7.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.147 -0.971 . . . . 0.0 109.214 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.32 32.06 58.5 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 28' ' ' THR . 40.4 t-20 -94.97 29.96 2.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.165 -1.197 . . . . 0.0 109.36 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 27' ' ' ASN . 70.3 m 32.31 96.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.559 0.695 . . . . 0.0 110.859 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -79.54 -48.57 13.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.473 -0.767 . . . . 0.0 110.048 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.454 ' O ' HG12 ' A' ' 21' ' ' ILE . . . -158.64 103.06 1.72 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.115 -0.99 . . . . 0.0 109.969 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 14.0 t -114.53 166.58 11.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.037 -1.039 . . . . 0.0 110.278 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.717 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -149.63 143.32 25.45 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 77.5 171.41 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 0.0 109.16 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -52.17 141.74 24.84 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.683 ' CE2' HG21 ' A' ' 99' ' ' VAL . 0.3 OUTLIER 177.81 117.01 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -1.077 . . . . 0.0 109.134 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.68 125.14 53.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.975 . . . . 0.0 110.015 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.582 HG13 ' NE2' ' A' ' 41' ' ' GLN . 60.7 t -147.84 133.39 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.717 HG23 ' CD ' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -158.15 -62.81 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.001 -1.062 . . . . 0.0 110.598 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.717 ' CD ' HG23 ' A' ' 38' ' ' THR . 8.1 Cg_exo -50.89 133.08 39.24 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 120.87 1.047 . . . . 0.0 109.819 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 39' ' ' PRO . . . -30.39 81.76 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 111.593 0.219 . . . . 0.0 111.593 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.604 ' N ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -90.86 -30.71 16.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.269 -1.519 . . . . 0.0 109.31 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.5 -18.91 78.71 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -80.57 -62.44 1.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.152 -1.205 . . . . 0.0 109.371 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.8 m -60.1 -26.99 66.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 109.152 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.88 -46.43 24.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.0 109.312 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.65 -11.09 22.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 109.649 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.48 -28.15 14.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.63 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.437 ' HB1' HD12 ' A' ' 55' ' ' ILE . . . -66.62 -23.35 66.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.966 . . . . 0.0 109.643 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -70.05 -7.7 43.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.225 -0.922 . . . . 0.0 110.032 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.1 -70.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 109.721 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -96.58 175.87 6.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.181 -0.949 . . . . 0.0 109.561 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 56' ' ' ARG . . . -123.82 -2.98 8.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.723 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.613 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 43.5 t0 -80.24 -44.81 1.42 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.158 -0.964 . . . . 0.0 110.721 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.6 Cg_endo -65.37 -13.58 40.52 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.553 1.502 . . . . 0.0 110.575 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.798 HD13 ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -102.55 -54.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.06 -1.025 . . . . 0.0 109.516 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.502 ' NH1' ' HG2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -50.58 -22.7 2.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.41 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.573 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -114.93 117.82 31.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.653 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 1.9 m 83.83 -52.92 0.14 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.77 -0.581 . . . . 0.0 109.826 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.8 -145.71 21.02 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.91 ' CE2' HD11 ' A' ' 62' ' ' LEU . 6.1 p90 -146.94 -173.17 4.16 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.256 -1.144 . . . . 0.0 109.143 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 1.5 m-20 -139.49 165.19 27.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.153 -0.967 . . . . 0.0 110.028 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.91 HD11 ' CE2' ' A' ' 60' ' ' PHE . 2.4 mp -136.96 88.25 2.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.42 -0.8 . . . . 0.0 109.268 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . 82.3 -43.17 0.14 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.603 -0.686 . . . . 0.0 109.985 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.06 35.67 0.05 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.644 ' CG1' ' CE1' ' A' ' 67' ' ' TYR . 72.8 t -126.21 111.74 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -1.133 . . . . 0.0 109.447 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.72 86.47 6.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.171 -0.956 . . . . 0.0 110.606 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.644 ' CE1' ' CG1' ' A' ' 65' ' ' VAL . 10.2 m-30 -98.47 162.67 13.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.098 -1.001 . . . . 0.0 109.28 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.617 HG22 ' H ' ' A' ' 69' ' ' THR . 7.3 p -107.41 173.24 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.185 -0.947 . . . . 0.0 109.569 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.617 ' H ' HG22 ' A' ' 68' ' ' VAL . 46.6 m -127.39 109.34 11.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.48 3.14 14.83 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 109.6 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -135.21 89.07 2.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -0.94 . . . . 0.0 109.332 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.42 111.32 4.83 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -157.93 -45.55 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -0.9 . . . . 0.0 109.317 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -79.52 -94.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.412 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.444 ' NH1' ' CG ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -150.23 21.6 0.85 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 109.795 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.978 ' OG ' HG22 ' A' ' 89' ' ' VAL . 29.7 t -132.57 169.66 16.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.074 -1.016 . . . . 0.0 109.501 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.458 ' O ' HG22 ' A' ' 77' ' ' ILE . 23.5 mt -149.5 95.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.865 . . . . 0.0 109.441 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.485 ' HD2' HG23 ' A' ' 87' ' ' ILE . 3.4 m-85 -89.51 85.09 6.43 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -51.05 158.14 2.29 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.46 -173.83 3.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.612 -0.934 . . . . 0.0 108.83 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.45 -30.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.117 -0.989 . . . . 0.0 110.108 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 83' ' ' SER . . . 132.7 92.85 0.53 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 82' ' ' GLY . 0.8 OUTLIER 74.24 4.8 4.59 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.265 -1.138 . . . . 0.0 108.357 -178.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.48 148.62 29.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.495 -0.753 . . . . 0.0 109.086 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -168.62 174.44 43.3 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.6 p -132.76 138.09 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -1.159 . . . . 0.0 109.348 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.485 HG23 ' HD2' ' A' ' 78' ' ' TYR . 16.7 mm -98.93 81.21 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 110.021 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 7.6 p -96.8 107.89 20.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.123 -0.986 . . . . 0.0 109.007 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.978 HG22 ' OG ' ' A' ' 76' ' ' SER . 59.4 t -127.9 139.97 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 109.794 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.29 127.01 42.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.884 . . . . 0.0 109.219 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.761 HG22 HG12 ' A' ' 121' ' ' ILE . 3.0 p -100.85 -82.61 0.46 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.31 -0.869 . . . . 0.0 109.927 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.405 ' C ' ' HG2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -151.46 -42.34 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.945 . . . . 0.0 109.612 -179.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.644 ' C ' HD11 ' A' ' 24' ' ' LEU . 42.6 mmtt -139.64 40.42 2.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.605 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.595 ' N ' HD21 ' A' ' 24' ' ' LEU . 0.1 OUTLIER 173.25 161.35 0.14 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.912 . . . . 0.0 109.271 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 19.1 mt -133.56 146.72 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.082 -1.011 . . . . 0.0 109.743 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.006 HD13 ' CH2' ' A' ' 2' ' ' TRP . 0.3 OUTLIER -106.24 158.73 16.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.862 . . . . 0.0 108.807 179.396 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.877 ' CG2' HD13 ' A' ' 22' ' ' LEU . 57.4 t -145.44 71.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.946 . . . . 0.0 110.225 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -56.46 144.52 36.9 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.514 -1.835 . . . . 0.0 108.514 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.683 HG21 ' CE2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -144.75 113.33 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.72 -1.459 . . . . 0.0 109.711 -179.502 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.805 ' HB3' HG12 ' A' ' 16' ' ' VAL . 14.3 p90 -135.43 141.34 45.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.345 -0.847 . . . . 0.0 109.415 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -152.05 117.04 5.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.495 -0.753 . . . . 0.0 109.831 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.2 OUTLIER 160.73 -59.22 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.516 -0.74 . . . . 0.0 109.378 179.637 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 174.97 48.06 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.566 -0.709 . . . . 0.0 109.417 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.6 mt -105.91 129.74 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.368 -0.833 . . . . 0.0 108.843 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -66.08 137.43 95.79 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.725 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -65.96 -25.88 51.75 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.175 1.917 . . . . 0.0 110.403 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.09 0.52 88.57 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.5 m -92.66 -42.82 9.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.142 -1.21 . . . . 0.0 109.383 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 112' ' ' VAL . . . -90.09 -19.94 23.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.285 -0.885 . . . . 0.0 109.466 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.12 -24.38 58.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.722 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -81.89 -33.56 30.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.169 -0.957 . . . . 0.0 109.675 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.896 HG22 HD12 ' A' ' 116' ' ' LEU . 9.0 p -78.09 -18.71 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.115 -0.991 . . . . 0.0 109.508 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.774 HG13 ' HZ2' ' A' ' 2' ' ' TRP . 38.1 t -90.92 -23.18 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.928 . . . . 0.0 109.887 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -75.79 -38.69 57.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.139 -0.976 . . . . 0.0 109.911 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.69 -58.94 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.944 . . . . 0.0 109.764 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.896 HD12 HG22 ' A' ' 112' ' ' VAL . 15.1 mt -51.9 -24.17 5.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 109.511 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.905 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -73.64 -39.64 64.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 109.853 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -63.91 -16.72 62.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.013 . . . . 0.0 109.995 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -81.63 -56.46 4.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.041 -1.037 . . . . 0.0 109.755 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.472 ' HA ' HD23 ' A' ' 120' ' ' LEU . 6.1 mt -62.16 -50.15 72.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 109.663 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.905 HD12 ' O ' ' A' ' 117' ' ' ALA . 7.5 mt -59.93 -36.65 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.657 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.12 -14.98 81.74 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -127.09 -68.09 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.254 . . . . 0.0 110.15 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 120' ' ' LEU . . . -85.48 -106.68 0.69 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.348 -1.09 . . . . 0.0 109.166 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.666 ' HH2' HD22 ' A' ' 96' ' ' LEU . 29.9 p90 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.588 0.708 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 8.1 tt0 -81.3 -24.07 37.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 109.218 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.497 ' O ' HG22 ' A' ' 8' ' ' THR . 85.2 m -65.96 -64.89 0.76 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.375 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.84 ' HB3' HD23 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -50.7 -41.59 56.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -0.95 . . . . 0.0 108.895 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.655 ' HA ' HG23 ' A' ' 11' ' ' VAL . 1.2 t -49.44 -48.8 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.56 -0.713 . . . . 0.0 109.894 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.725 ' C ' HG22 ' A' ' 8' ' ' THR . 0.8 OUTLIER -87.52 55.49 3.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.851 -178.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.725 HG22 ' C ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER 170.53 -86.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.739 -1.225 . . . . 0.0 111.334 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.56 ' H ' HG23 ' A' ' 8' ' ' THR . 3.1 m-20 -88.45 -74.55 0.46 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.247 -0.908 . . . . 0.0 111.481 -178.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.84 HD23 ' HB3' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -27.54 -46.9 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.917 0.389 . . . . 0.0 111.467 -178.412 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.024 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 49.5 t -101.6 -28.65 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.861 -1.149 . . . . 0.0 110.669 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.615 ' C ' HG22 ' A' ' 13' ' ' THR . . . -45.17 -28.83 2.12 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 106.311 -2.716 . . . . 0.0 106.311 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.717 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.6 OUTLIER -176.28 -39.68 0.01 OUTLIER 'General case' 0 C--O 1.193 -1.9 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.722 ' O ' ' HB3' ' A' ' 15' ' ' ALA . . . 10.43 44.22 0.0 OUTLIER Glycine 0 N--CA 1.509 3.557 0 C-N-CA 123.671 0.653 . . . . 0.0 112.838 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.903 ' O ' HG21 ' A' ' 104' ' ' ILE . . . 87.58 -34.47 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.941 HG12 ' HB3' ' A' ' 100' ' ' TYR . 35.8 m -120.51 139.08 48.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.771 HG23 ' HG2' ' A' ' 18' ' ' GLN . 9.9 t -79.96 13.3 2.28 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.833 -1.167 . . . . 0.0 109.395 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.771 ' HG2' HG23 ' A' ' 17' ' ' THR . 13.1 mm-40 -158.74 169.21 24.9 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 1.024 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . 173.59 140.95 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.494 -1.379 . . . . 0.0 110.822 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.516 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -136.1 142.34 44.28 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.548 HG13 HG21 ' A' ' 6' ' ' VAL . 2.7 mt -102.32 112.06 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.919 -1.113 . . . . 0.0 108.92 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.054 HD22 ' CG2' ' A' ' 97' ' ' VAL . 2.8 mp -98.46 160.37 14.33 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.527 -0.733 . . . . 0.0 109.089 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.92 -178.93 19.18 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.541 HD11 ' C ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -105.08 -48.46 3.72 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.295 -1.12 . . . . 0.0 109.139 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -136.76 40.11 2.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 109.306 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.06 25.22 2.23 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 1.2 m-20 61.43 -146.4 0.43 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.169 -1.194 . . . . 0.0 109.306 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.95 147.5 25.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.12 -0.987 . . . . 0.0 109.738 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -119.2 -26.49 5.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.379 -0.825 . . . . 0.0 109.145 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -178.44 159.22 1.17 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.391 -0.818 . . . . 0.0 109.372 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 1.1 t -160.22 171.54 19.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.314 -0.866 . . . . 0.0 109.503 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.647 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -178.54 82.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.333 -0.854 . . . . 0.0 109.165 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.04 -69.71 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.856 . . . . 0.0 109.566 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 167.85 -37.78 0.22 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.533 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 14.8 p90 -97.12 160.22 14.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.12 . . . . 0.0 109.482 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.03 -168.91 1.36 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.366 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.717 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 16.4 t -142.85 97.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.343 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.43 HG23 ' H ' ' A' ' 38' ' ' THR . 9.7 p -62.34 143.99 95.36 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.41 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 2.5 Cg_endo -61.59 114.92 2.46 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.193 1.929 . . . . 0.0 110.358 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 39' ' ' PRO . . . 174.77 -77.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.335 -0.853 . . . . 0.0 109.402 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.407 ' NE2' ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -67.59 -11.69 58.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.527 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.33 -43.72 95.49 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.3 -33.9 73.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -1.124 . . . . 0.0 108.936 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.2 m -50.05 -45.76 52.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.295 -0.878 . . . . 0.0 108.799 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.551 ' CD2' HG21 ' A' ' 95' ' ' ILE . 1.3 mp -54.95 -42.16 71.97 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.13 -38.22 73.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.407 -0.808 . . . . 0.0 108.869 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.93 -26.87 63.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.509 -0.745 . . . . 0.0 109.084 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.604 ' HB1' HD11 ' A' ' 55' ' ' ILE . . . -64.61 -20.2 66.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.371 -0.83 . . . . 0.0 109.334 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.603 ' CE1' ' CE ' ' A' ' 90' ' ' LYS . 22.2 m-85 -59.21 -14.54 11.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 109.365 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -79.58 -68.07 0.7 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 109.677 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -148.37 17.99 1.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.13 -0.981 . . . . 0.0 109.872 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 51' ' ' ASN . . . 36.08 32.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.278 0.561 . . . . 0.0 109.977 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.615 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 39.1 t70 -70.61 -43.98 16.52 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 111.004 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 5.3 Cg_exo -61.55 -10.96 18.02 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.381 1.387 . . . . 0.0 110.796 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.604 HD11 ' HB1' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -106.71 -31.25 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.053 -1.029 . . . . 0.0 109.573 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.437 ' CG ' ' HA ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -90.16 20.1 4.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 109.501 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.81 4.57 11.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.55 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 172.5 -55.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.518 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.67 -172.85 33.13 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 67' ' ' TYR . 33.4 p90 -132.46 170.44 15.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -1.164 . . . . 0.0 109.407 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.407 ' HB3' ' NE2' ' A' ' 41' ' ' GLN . 0.2 OUTLIER -122.29 136.93 54.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.567 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.53 ' CD2' HG13 ' A' ' 37' ' ' VAL . 0.6 OUTLIER -103.48 -161.51 0.84 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.248 -0.907 . . . . 0.0 108.93 179.753 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 37' ' ' VAL . . . -46.33 -40.5 11.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.106 -0.996 . . . . 0.0 109.263 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.74 33.63 0.16 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.17 138.02 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -1.108 . . . . 0.0 109.66 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.453 ' N ' ' CD2' ' A' ' 66' ' ' HIS . 7.6 m-70 -96.09 142.24 28.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 109.389 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 60' ' ' PHE . 17.3 m-85 -141.76 162.6 35.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.212 -0.93 . . . . 0.0 109.44 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.9 t -121.49 149.2 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.299 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.659 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -138.67 103.54 4.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.466 -179.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.745 HD23 ' H ' ' A' ' 70' ' ' LEU . 2.3 pt? -103.08 8.11 38.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.147 -0.97 . . . . 0.0 109.607 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 51.47 0.99 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.305 -0.872 . . . . 0.0 109.022 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.659 ' HB2' ' CG2' ' A' ' 69' ' ' THR . . . -94.88 130.2 41.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.852 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.46 -172.34 4.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.388 -0.82 . . . . 0.0 109.03 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.16 40.04 0.89 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.047 -1.033 . . . . 0.0 109.679 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.552 ' NH1' ' HG2' ' A' ' 75' ' ' ARG . 2.3 tpt180 -145.28 -72.29 0.25 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 108.957 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -113.54 154.1 27.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.352 -0.842 . . . . 0.0 108.738 179.369 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.704 ' O ' HG22 ' A' ' 77' ' ' ILE . 47.1 mt -156.96 58.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.935 -1.103 . . . . 0.0 110.376 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.559 ' CE2' ' CG2' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -94.36 102.59 14.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.087 . . . . 0.0 108.858 179.167 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.491 ' H ' HG13 ' A' ' 86' ' ' VAL . . . -75.05 175.48 50.64 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.45 133.52 16.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -1.094 . . . . 0.0 109.256 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 0.6 OUTLIER -127.51 70.06 1.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 109.762 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 83' ' ' SER . . . 50.85 -118.13 6.08 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 82' ' ' GLY . 3.8 t -44.59 -84.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -1.212 . . . . 0.0 109.525 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . . . -90.04 156.15 18.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.132 -0.98 . . . . 0.0 109.581 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.462 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -147.92 179.31 24.9 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.567 HG22 HG23 ' A' ' 88' ' ' THR . 7.9 p -112.14 159.25 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.062 -1.258 . . . . 0.0 109.974 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.739 HG21 HG21 ' A' ' 113' ' ' VAL . 14.4 mm -141.83 96.43 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.672 HG22 ' HA ' ' A' ' 97' ' ' VAL . 18.8 p -124.19 153.67 41.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.746 -1.222 . . . . 0.0 110.834 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.909 ' HB ' HD21 ' A' ' 96' ' ' LEU . 57.4 t -150.21 135.66 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.835 ' HD3' HG23 ' A' ' 95' ' ' ILE . 10.9 mmtm -91.54 150.38 21.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.897 . . . . 0.0 109.65 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.5 p -142.55 -168.18 2.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 108.959 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 m -47.58 -25.63 1.2 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.248 -0.907 . . . . 0.0 109.109 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.541 ' C ' HD11 ' A' ' 24' ' ' LEU . 5.1 mttt 178.4 67.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -0.824 . . . . 0.0 109.345 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.465 ' HB2' ' CD2' ' A' ' 125' ' ' PHE . 0.6 OUTLIER -173.97 145.9 1.15 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.507 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.835 HG23 ' HD3' ' A' ' 90' ' ' LYS . 3.8 mt -136.14 85.22 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.158 -0.964 . . . . 0.0 109.23 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.909 HD21 ' HB ' ' A' ' 89' ' ' VAL . 0.3 OUTLIER -61.12 165.27 4.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.478 -0.764 . . . . 0.0 109.119 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 1.054 ' CG2' HD22 ' A' ' 22' ' ' LEU . 58.7 t -143.38 47.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.192 -0.942 . . . . 0.0 110.143 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -41.05 130.7 3.39 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.752 HG23 ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -126.22 118.59 51.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.786 -1.42 . . . . 0.0 108.652 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.941 ' HB3' HG12 ' A' ' 16' ' ' VAL . 38.1 p90 -106.51 -179.1 3.84 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.084 -1.01 . . . . 0.0 109.829 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 84' ' ' ALA . 6.4 t-20 -135.06 -155.1 0.62 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 110.029 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -36.96 80.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.484 -0.76 . . . . 0.0 110.053 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.66 -49.99 55.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.95 . . . . 0.0 109.885 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.903 HG21 ' O ' ' A' ' 15' ' ' ALA . 4.3 mp -99.87 150.38 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.131 -0.981 . . . . 0.0 109.754 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -117.42 155.46 50.1 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.393 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.04 -166.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.234 1.956 . . . . 0.0 110.252 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 53.97 21.86 18.31 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.6 m -156.6 -41.15 0.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -1.105 . . . . 0.0 109.072 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.617 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -85.39 -12.88 51.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.358 -0.839 . . . . 0.0 109.133 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.43 -39.01 23.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.414 -0.804 . . . . 0.0 109.45 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -65.1 -40.01 93.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.748 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.483 HG11 ' HB2' ' A' ' 15' ' ' ALA . 5.3 p -69.88 -25.22 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.187 -0.946 . . . . 0.0 109.508 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.739 HG21 HG21 ' A' ' 87' ' ' ILE . 73.1 t -82.57 -25.06 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.204 -0.935 . . . . 0.0 109.474 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -70.55 -35.93 73.38 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.166 -0.959 . . . . 0.0 109.406 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 116' ' ' LEU . 2.5 ptpt -81.52 -39.38 24.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 109.647 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.504 ' N ' ' HG3' ' A' ' 115' ' ' LYS . 59.7 tp -50.83 -33.8 25.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 109.433 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 1.024 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -79.97 -34.5 38.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.325 -0.859 . . . . 0.0 109.592 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -62.76 -12.17 22.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.028 . . . . 0.0 109.577 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 30.7 t80 -90.31 -54.27 4.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 109.896 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.7 ' C ' HD12 ' A' ' 120' ' ' LEU . 0.8 OUTLIER -63.94 -34.47 78.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.0 110.098 -179.642 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.024 HD12 ' O ' ' A' ' 117' ' ' ALA . 5.7 mt -63.2 -13.65 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 121' ' ' ILE . . . -46.06 -27.73 2.66 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -103.26 -65.89 0.97 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.422 -1.046 . . . . 0.0 109.205 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.11 109.17 2.73 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.465 ' CD2' ' HB2' ' A' ' 94' ' ' SER . 22.5 m-85 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.171 -1.194 . . . . 0.0 109.524 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.76 ' CD1' HD23 ' A' ' 10' ' ' LEU . 41.8 m95 . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 121.097 0.475 . . . . 0.0 109.723 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -89.98 -86.01 0.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 110.319 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.74 -16.87 2.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.242 -0.911 . . . . 0.0 110.203 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 2.1 m-30 -88.91 -33.92 17.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.026 -1.046 . . . . 0.0 109.747 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.642 HG22 HG21 ' A' ' 11' ' ' VAL . 1.2 t -56.0 -43.25 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.183 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.63 46.49 1.34 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.387 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 9' ' ' ASN . 67.7 m -158.52 -101.58 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.703 -1.248 . . . . 0.0 110.609 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.604 ' N ' HG22 ' A' ' 8' ' ' THR . 2.2 t-20 -102.1 -72.2 0.69 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.111 -0.993 . . . . 0.0 111.346 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.76 HD23 ' CD1' ' A' ' 2' ' ' TRP . 2.2 mp -25.67 -39.17 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.642 HG21 HG22 ' A' ' 6' ' ' VAL . 1.7 t -82.11 -66.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.559 -1.338 . . . . 0.0 110.341 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.758 ' C ' HG22 ' A' ' 13' ' ' THR . . . -40.24 -33.83 0.55 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.758 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 156.37 39.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.624 0.726 . . . . 0.0 109.357 179.181 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.709 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -83.31 14.28 40.82 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 107.412 -2.275 . . . . 0.0 107.412 177.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 156.93 -25.04 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.605 HG12 ' HB3' ' A' ' 100' ' ' TYR . 17.1 m -138.08 152.67 26.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.425 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -81.85 14.86 2.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.978 -1.076 . . . . 0.0 109.127 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER 173.28 -178.37 0.08 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.533 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . 178.95 160.52 0.66 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.828 -1.17 . . . . 0.0 109.88 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -155.59 127.41 7.46 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.236 -0.915 . . . . 0.0 110.239 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.72 HD11 ' C ' ' A' ' 2' ' ' TRP . 2.2 mm -87.73 78.67 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.004 HD13 HG21 ' A' ' 97' ' ' VAL . 8.8 mp -52.66 164.22 0.38 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.513 -0.742 . . . . 0.0 109.631 -178.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.618 ' O ' HD12 ' A' ' 95' ' ' ILE . . . -106.22 159.49 15.04 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.778 HD11 ' C ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -110.76 -28.13 8.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -1.087 . . . . 0.0 109.275 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.69 6.38 12.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.828 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -136.56 -86.68 0.2 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.467 ' O ' ' OG1' ' A' ' 28' ' ' THR . 6.7 p30 -170.23 -46.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.356 -1.085 . . . . 0.0 109.281 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 27' ' ' ASN . 34.1 m -170.68 127.86 0.77 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 109.567 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.527 ' CZ2' ' O ' ' A' ' 93' ' ' LYS . 26.1 m0 -84.05 -58.11 2.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.383 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.97 169.78 16.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.347 -0.845 . . . . 0.0 109.304 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -160.48 174.47 14.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 109.978 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.525 ' OG ' HG13 ' A' ' 6' ' ' VAL . 3.1 m -154.28 99.49 2.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.337 -0.852 . . . . 0.0 109.374 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 32' ' ' SER . . . 42.64 -152.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.416 -0.803 . . . . 0.0 109.524 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.458 ' N ' ' HG2' ' A' ' 18' ' ' GLN . . . 90.52 -145.74 18.15 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.563 ' CE2' HG11 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -103.43 169.26 8.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -1.139 . . . . 0.0 109.471 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.22 116.73 29.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.321 -0.862 . . . . 0.0 109.244 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.1 t -79.4 122.23 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.157 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.9 m -75.67 132.88 74.26 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.92 . . . . 0.0 109.48 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.736 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 3.4 Cg_exo -59.13 171.36 2.31 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.941 1.761 . . . . 0.0 109.778 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 39' ' ' PRO . . . 83.56 -46.3 0.12 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.672 -0.643 . . . . 0.0 109.379 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.92 -30.46 68.93 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.146 -0.971 . . . . 0.0 109.02 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.79 -32.79 48.38 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -67.03 -37.7 84.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.376 -1.073 . . . . 0.0 108.874 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.8 m -63.78 -29.86 71.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 108.807 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.529 ' HG ' ' CZ ' ' A' ' 49' ' ' PHE . 11.8 tp -70.89 -39.03 73.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.349 -0.844 . . . . 0.0 109.172 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.09 -46.91 79.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.325 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -24.58 66.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.372 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.85 92.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.268 -0.895 . . . . 0.0 109.15 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.529 ' CZ ' ' HG ' ' A' ' 45' ' ' LEU . 2.9 m-30 -68.94 85.66 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.369 -0.832 . . . . 0.0 109.213 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.53 -64.03 0.22 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.64 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 53' ' ' ASP . 3.7 t-20 -136.66 19.17 3.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.36 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 51' ' ' ASN . . . 41.97 26.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.55 -0.719 . . . . 0.0 109.954 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.566 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -80.88 -53.58 0.8 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.068 -1.02 . . . . 0.0 110.403 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 3.4 Cg_exo -62.34 -22.47 74.15 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.067 1.845 . . . . 0.0 110.893 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -94.61 -51.76 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.862 -1.149 . . . . 0.0 109.238 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -45.09 -27.0 0.52 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.963 . . . . 0.0 108.748 179.577 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . -115.68 -165.59 1.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.474 -0.766 . . . . 0.0 109.055 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 57' ' ' ALA . 75.0 m 44.37 -95.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.193 -0.942 . . . . 0.0 109.536 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 57' ' ' ALA . . . 164.43 175.0 34.82 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.454 ' HB3' ' HB2' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -80.32 155.54 27.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.393 -1.063 . . . . 0.0 109.38 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -154.07 101.92 2.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.048 -1.032 . . . . 0.0 110.061 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -98.73 -163.01 1.0 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 109.274 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.508 ' O ' HG23 ' A' ' 65' ' ' VAL . . . -61.56 94.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.976 . . . . 0.0 109.798 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.77 51.99 55.23 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.61 ' CG1' ' CE1' ' A' ' 67' ' ' TYR . 3.2 t -150.01 136.23 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.244 -1.151 . . . . 0.0 109.413 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -110.24 91.89 3.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 109.744 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.61 ' CE1' ' CG1' ' A' ' 65' ' ' VAL . 6.0 m-30 -100.68 -168.38 1.57 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.16 -0.963 . . . . 0.0 109.083 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 80' ' ' LYS . 4.4 p -131.06 176.59 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.992 -1.068 . . . . 0.0 109.522 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.852 HG22 ' HB2' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -136.69 69.42 1.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 109.535 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 70' ' ' LEU . 15.1 tp -89.66 2.21 55.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.125 -0.984 . . . . 0.0 109.216 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.468 ' HG3' ' NH1' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -144.93 69.67 1.26 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.36 -0.838 . . . . 0.0 108.85 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.852 ' HB2' HG22 ' A' ' 69' ' ' THR . . . -118.69 91.72 3.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.898 . . . . 0.0 110.125 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -98.49 -162.81 0.98 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.336 -0.852 . . . . 0.0 108.857 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -101.44 41.36 1.21 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.074 -1.016 . . . . 0.0 109.373 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.462 ' CG ' ' NH1' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -150.42 -53.64 0.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.816 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.602 ' HA ' HG12 ' A' ' 89' ' ' VAL . 27.0 m -131.85 136.67 47.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 0.0 109.986 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 77' ' ' ILE . 11.1 mt -99.92 72.93 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.576 ' OH ' HD11 ' A' ' 87' ' ' ILE . 2.5 t80 -89.6 82.2 6.39 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.422 -0.799 . . . . 0.0 109.193 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.409 ' O ' ' HG2' ' A' ' 80' ' ' LYS . . . -89.08 176.0 43.54 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.751 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -150.61 -170.74 3.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.335 -1.097 . . . . 0.0 109.697 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.408 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -164.65 25.09 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.428 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.1 -78.57 1.7 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 102' ' ' GLU . 1.9 m -81.92 -38.89 24.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -1.157 . . . . 0.0 109.863 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -126.6 164.56 20.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.987 . . . . 0.0 109.538 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -159.08 162.48 32.71 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.482 HG22 HG23 ' A' ' 88' ' ' THR . 14.9 p -123.79 151.45 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.367 -1.078 . . . . 0.0 109.61 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.576 HD11 ' OH ' ' A' ' 78' ' ' TYR . 54.9 mt -124.8 88.84 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.366 -0.834 . . . . 0.0 108.86 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 41.6 p -105.76 129.33 53.98 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.048 -1.033 . . . . 0.0 109.992 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 76' ' ' SER . 6.1 m -145.23 150.94 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.572 -0.705 . . . . 0.0 109.554 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -97.52 122.67 40.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.202 -0.936 . . . . 0.0 109.653 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -58.15 2.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 109.143 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -175.24 -36.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.807 . . . . 0.0 109.184 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.778 ' C ' HD11 ' A' ' 24' ' ' LEU . 10.3 mttm -145.67 28.51 1.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.842 . . . . 0.0 109.497 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.739 ' N ' HD21 ' A' ' 24' ' ' LEU . 58.3 m -161.3 168.89 23.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.894 . . . . 0.0 109.468 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.618 HD12 ' O ' ' A' ' 23' ' ' GLY . 83.5 mt -125.43 123.86 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.113 -0.992 . . . . 0.0 109.371 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.74 HD11 ' CE3' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -81.54 155.47 25.72 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.462 -0.774 . . . . 0.0 109.903 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 1.004 HG21 HD13 ' A' ' 22' ' ' LEU . 48.2 t -151.43 54.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.665 -0.647 . . . . 0.0 109.695 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -55.53 113.88 4.26 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.563 HG11 ' CE2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -111.3 122.95 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.058 -1.26 . . . . 0.0 109.425 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.605 ' HB3' HG12 ' A' ' 16' ' ' VAL . 2.8 p90 -131.72 178.12 7.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 109.66 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -121.69 -167.41 1.52 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.69 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -68.07 -17.76 64.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.702 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.12 -10.98 25.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.946 . . . . 0.0 109.446 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.585 HD13 ' O ' ' A' ' 15' ' ' ALA . 28.2 mt -125.63 158.59 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.15 -0.969 . . . . 0.0 109.777 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.533 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 7.3 mt-30 -139.61 160.08 62.77 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.442 -0.786 . . . . 0.0 109.009 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 105' ' ' GLN . 5.9 Cg_exo -56.27 165.0 4.61 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.928 1.752 . . . . 0.0 110.129 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.21 -28.01 17.33 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.7 m -115.55 -48.63 2.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.448 -1.031 . . . . 0.0 109.235 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.621 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -87.36 -19.28 28.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.882 . . . . 0.0 109.279 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.446 ' HA ' ' CE2' ' A' ' 78' ' ' TYR . . . -85.55 -52.07 6.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.304 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -60.69 -36.19 78.16 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.432 -0.792 . . . . 0.0 109.79 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 13.4 p -65.27 -37.14 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.191 -0.943 . . . . 0.0 109.378 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 87' ' ' ILE . 93.9 t -73.62 -16.02 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.212 -0.93 . . . . 0.0 109.701 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.9 -44.79 38.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.004 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.499 ' HG3' ' N ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -84.62 -46.86 11.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.108 -0.995 . . . . 0.0 110.069 -179.49 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.605 HD22 HD21 ' A' ' 10' ' ' LEU . 2.6 mp -54.27 -32.65 56.75 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.138 -0.976 . . . . 0.0 109.813 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.728 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -72.93 -43.11 62.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -0.946 . . . . 0.0 109.755 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -57.8 -20.99 39.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.85 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -90.08 -56.18 3.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.08 -1.013 . . . . 0.0 109.982 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -73.44 -0.6 15.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.157 -0.964 . . . . 0.0 109.838 -179.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.728 HD12 ' O ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER -64.24 -39.08 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.984 -1.072 . . . . 0.0 108.797 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -121.73 45.51 1.21 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -143.11 -73.57 0.28 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.082 -1.246 . . . . 0.0 110.018 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.483 ' H ' HD23 ' A' ' 120' ' ' LEU . . . -123.18 -18.46 3.11 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.517 ' CE2' ' HG3' ' A' ' 93' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.202 -1.175 . . . . 0.0 109.374 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.985 ' CZ2' HD11 ' A' ' 96' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.49 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 2.5 tt0 -63.56 -51.34 65.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.313 -0.867 . . . . 0.0 109.753 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.403 HG22 ' H ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -54.12 -40.45 67.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 109.233 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.89 ' HB3' HD12 ' A' ' 10' ' ' LEU . 22.1 m-30 -61.9 -33.69 74.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.095 -1.003 . . . . 0.0 108.417 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.719 HG21 HG13 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -62.15 -56.89 14.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.643 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.494 ' N ' HG12 ' A' ' 6' ' ' VAL . 58.9 m-20 -91.64 50.47 1.72 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.05 -1.032 . . . . 0.0 110.314 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 9' ' ' ASN . 65.7 m -156.19 -100.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.77 -1.206 . . . . 0.0 110.78 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.622 ' N ' HG22 ' A' ' 8' ' ' THR . 0.8 OUTLIER -101.53 -56.48 2.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.084 -1.01 . . . . 0.0 111.075 -178.354 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.993 HD11 HD13 ' A' ' 116' ' ' LEU . 6.6 mt -38.16 -30.22 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.142 -0.974 . . . . 0.0 111.158 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.032 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 47.5 t -101.25 -52.27 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.764 -1.21 . . . . 0.0 110.065 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.764 ' C ' HG22 ' A' ' 13' ' ' THR . . . -40.14 -42.29 2.32 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.764 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 161.18 43.68 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.789 -0.83 . . . . 0.0 109.322 178.437 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.717 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -85.69 15.01 49.46 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 177.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.718 ' HB2' HG11 ' A' ' 112' ' ' VAL . . . 155.68 -27.83 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.638 HG12 ' CD1' ' A' ' 100' ' ' TYR . 5.6 m -139.4 155.34 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.652 HG22 ' HA ' ' A' ' 100' ' ' TYR . 14.7 t -87.18 21.66 2.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.896 -1.128 . . . . 0.0 108.877 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.921 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -178.45 -176.81 0.52 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 1.032 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . 175.33 154.65 0.16 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.273 -0.892 . . . . 0.0 109.127 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.507 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -148.27 136.83 21.52 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.244 -0.91 . . . . 0.0 109.68 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.719 HG13 HG21 ' A' ' 6' ' ' VAL . 1.6 mt -106.61 101.68 12.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.811 HD11 HG21 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -84.95 22.83 1.31 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.389 -0.819 . . . . 0.0 110.269 -178.089 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.502 ' O ' HD12 ' A' ' 95' ' ' ILE . . . 47.43 -164.42 0.18 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.738 HD11 ' C ' ' A' ' 93' ' ' LYS . 1.1 mt -98.34 -74.33 0.59 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.388 -1.066 . . . . 0.0 109.114 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -135.15 22.04 3.47 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.307 -0.87 . . . . 0.0 108.832 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.7 67.97 0.25 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.5 t30 48.7 -150.25 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -1.108 . . . . 0.0 109.737 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 60.8 m -94.12 139.26 31.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.812 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -96.67 -65.31 0.97 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.441 ' C ' HG23 ' A' ' 31' ' ' THR . . . -137.53 160.11 40.07 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.441 HG23 ' C ' ' A' ' 30' ' ' ALA . 77.4 p -155.13 137.35 14.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.041 -1.037 . . . . 0.0 110.119 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 1.008 ' CB ' HG21 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -108.81 115.78 30.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.516 -0.74 . . . . 0.0 109.068 179.578 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 82.38 166.69 0.13 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 35' ' ' PHE . . . -48.41 -96.9 0.01 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.957 ' CE1' HG11 ' A' ' 99' ' ' VAL . 4.9 t80 74.35 84.99 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.315 -1.109 . . . . 0.0 109.901 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.09 105.69 17.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 109.356 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.592 ' O ' HG12 ' A' ' 37' ' ' VAL . 59.7 t -108.05 56.3 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.655 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.562 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 57.58 156.43 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.269 -0.894 . . . . 0.0 109.851 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.562 ' HD2' HG22 ' A' ' 38' ' ' THR . 2.7 Cg_endo -62.17 -36.52 68.78 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.294 1.996 . . . . 0.0 110.197 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' A' ' 43' ' ' GLN . . . -83.82 60.69 5.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.838 . . . . 0.0 109.442 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.539 ' CG ' ' HB ' ' A' ' 37' ' ' VAL . 2.2 mt-30 -66.44 -47.83 71.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.681 -1.262 . . . . 0.0 110.111 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -76.64 -29.04 58.32 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.784 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.618 ' HB2' ' HB1' ' A' ' 40' ' ' ALA . 3.4 mt-30 -81.48 -62.86 1.53 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.97 -1.312 . . . . 0.0 109.84 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.3 m -45.84 -50.76 13.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.84 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -66.45 -30.99 71.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.154 -0.966 . . . . 0.0 109.749 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -71.03 -18.59 62.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.4 t -74.66 -52.61 11.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -0.872 . . . . 0.0 109.659 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.51 -21.72 52.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.194 -0.941 . . . . 0.0 109.543 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.583 ' CE2' ' CG ' ' A' ' 90' ' ' LYS . 4.2 m-30 -65.88 -37.08 85.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.432 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -88.28 -74.69 0.45 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 109.587 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -71.9 119.25 15.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.172 -0.955 . . . . 0.0 109.521 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.412 ' C ' HG12 ' A' ' 55' ' ' ILE . . . -104.19 17.52 23.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.113 -0.992 . . . . 0.0 109.056 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.589 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -76.61 -50.14 2.66 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.456 -0.777 . . . . 0.0 110.372 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 4.2 Cg_exo -62.82 -8.17 12.94 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.976 1.784 . . . . 0.0 110.933 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.788 HD13 ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -104.96 -44.05 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.041 -1.037 . . . . 0.0 109.497 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.534 ' CD ' ' HA ' ' A' ' 53' ' ' ASP . 8.3 ptm180 -61.98 -22.15 65.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 109.948 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.427 ' C ' ' OG ' ' A' ' 58' ' ' SER . . . -107.73 108.11 19.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 109.907 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.427 ' OG ' ' C ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER 72.25 -79.52 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.432 -0.792 . . . . 0.0 109.882 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.88 -138.97 5.76 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.618 ' HE1' HD12 ' A' ' 62' ' ' LEU . 20.5 p90 -155.39 172.5 18.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -1.11 . . . . 0.0 109.573 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.12 160.29 14.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 109.092 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.619 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 3.4 mt -159.57 98.45 1.38 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.924 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . 74.99 -78.22 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.646 -0.659 . . . . 0.0 110.041 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -159.08 23.28 0.31 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 66' ' ' HIS . 66.5 t -137.48 157.36 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -1.145 . . . . 0.0 109.207 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.487 ' CE1' ' HD2' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -100.25 152.66 20.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.153 -0.967 . . . . 0.0 109.472 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.561 ' CE2' ' HB2' ' A' ' 62' ' ' LEU . 92.2 m-85 -137.61 149.44 46.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 109.525 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 69' ' ' THR . 0.9 OUTLIER -93.54 -156.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 109.241 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.552 ' H ' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -161.88 75.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.94 . . . . 0.0 109.5 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.11 12.15 31.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.907 . . . . 0.0 109.44 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -156.92 64.14 0.51 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.709 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 69' ' ' THR . . . -106.21 90.32 3.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 109.062 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.88 -108.05 0.35 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.107 -0.996 . . . . 0.0 109.791 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -121.6 -34.12 3.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.778 -1.201 . . . . 0.0 110.648 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.53 ' NH1' ' HG2' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -134.74 31.7 3.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.887 -1.133 . . . . 0.0 110.878 -178.703 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.55 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 1.2 m -150.57 116.24 5.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.984 -1.073 . . . . 0.0 109.476 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.602 ' O ' HG22 ' A' ' 77' ' ' ILE . 3.6 mp -144.79 50.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 0.0 109.557 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.653 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -91.01 91.5 8.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.092 -1.005 . . . . 0.0 108.612 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.33 170.65 53.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.511 ' HG2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -151.04 147.36 27.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.54 -0.976 . . . . 0.0 109.11 179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.511 ' N ' ' HG2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -124.7 -170.84 2.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.989 -1.069 . . . . 0.0 109.682 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.29 5.41 77.26 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -154.82 -67.98 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -1.098 . . . . 0.0 108.887 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 81' ' ' LYS . . . -91.7 164.42 13.73 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.506 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -156.71 150.23 21.35 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.538 -1.315 . . . . 0.0 109.908 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.8 p -122.32 147.37 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.329 -1.101 . . . . 0.0 109.448 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.653 HG23 ' HD2' ' A' ' 78' ' ' TYR . 11.9 mt -120.75 94.02 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 39.2 p -113.29 133.56 55.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.981 -1.074 . . . . 0.0 110.716 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.594 HG13 ' HB2' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -151.33 152.66 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.042 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.583 ' CG ' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -97.95 117.69 32.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.901 -179.428 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.854 HG21 ' HZ3' ' A' ' 2' ' ' TRP . 0.8 OUTLIER -96.38 -69.17 0.77 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 108.764 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 91' ' ' THR . 1.9 m 157.7 -24.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.738 ' C ' HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -110.99 -12.33 14.23 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.444 -0.785 . . . . 0.0 109.256 179.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.484 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -172.5 168.73 5.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.81 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.502 HD12 ' O ' ' A' ' 23' ' ' GLY . 34.1 mt -105.78 134.64 46.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.398 -0.814 . . . . 0.0 108.973 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.985 HD11 ' CZ2' ' A' ' 2' ' ' TRP . 1.6 mt -88.96 148.26 23.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 110.249 -179.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.811 HG21 HD11 ' A' ' 22' ' ' LEU . 75.4 t -151.33 58.55 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.458 -0.776 . . . . 0.0 109.632 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -55.57 112.58 3.15 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.957 HG11 ' CE1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.81 125.52 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.992 -1.299 . . . . 0.0 109.119 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.735 ' HB2' HD12 ' A' ' 104' ' ' ILE . 3.8 p90 -138.82 -178.3 5.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.941 . . . . 0.0 110.14 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.19 -147.3 0.39 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.443 -0.785 . . . . 0.0 109.675 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 83' ' ' SER . 46.8 tt0 -102.91 -29.95 11.12 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.166 -0.959 . . . . 0.0 109.948 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -16.06 23.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 110.193 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.735 HD12 ' HB2' ' A' ' 100' ' ' TYR . 16.7 mt -85.68 141.3 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.058 -1.026 . . . . 0.0 109.395 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.51 110.0 2.17 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.394 -0.816 . . . . 0.0 109.631 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 104' ' ' ILE . 1.2 Cg_endo -65.69 145.84 82.42 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.092 1.862 . . . . 0.0 110.27 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.33 -43.81 3.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.8 m -74.63 -30.9 61.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -1.184 . . . . 0.0 109.483 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.808 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -63.54 -45.02 92.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.874 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.09 -32.52 67.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.146 -0.971 . . . . 0.0 109.846 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 7.4 t-20 -67.73 -32.54 73.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 0.0 109.724 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.718 HG11 ' HB2' ' A' ' 15' ' ' ALA . 1.3 t -79.86 -28.0 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.146 -0.971 . . . . 0.0 109.421 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 109' ' ' ALA . 18.2 t -82.83 -17.92 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.952 . . . . 0.0 109.694 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.471 ' CD ' ' CZ ' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -78.16 -37.17 46.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.158 -0.964 . . . . 0.0 109.765 -179.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 111' ' ' ASN . 1.5 mmmt -71.73 -46.3 59.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.122 -0.986 . . . . 0.0 109.864 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.993 HD13 HD11 ' A' ' 10' ' ' LEU . 3.2 tt -54.06 -34.22 59.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.931 -1.106 . . . . 0.0 109.162 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 1.0 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -62.55 -37.8 87.55 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.077 -1.014 . . . . 0.0 108.887 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -21.77 61.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.904 . . . . 0.0 109.6 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.603 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 0.0 OUTLIER -73.71 -40.73 63.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 109.879 -179.492 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.687 HD12 ' CE3' ' A' ' 2' ' ' TRP . 5.0 mt -81.04 -36.26 30.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.117 -0.989 . . . . 0.0 110.566 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.0 HD12 ' O ' ' A' ' 117' ' ' ALA . 1.5 mp -64.1 -21.58 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.103 -0.998 . . . . 0.0 109.596 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.538 ' O ' ' CG ' ' A' ' 123' ' ' GLN . . . -97.5 22.48 40.58 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 122' ' ' GLY . 45.7 mt-30 -162.41 -83.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -1.169 . . . . 0.0 109.809 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 125' ' ' PHE . . . -96.1 57.76 1.48 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.543 ' HB3' ' HB3' ' A' ' 92' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.411 -1.052 . . . . 0.0 109.977 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.825 ' CE2' HD22 ' A' ' 96' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.363 0.601 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -72.36 -28.68 63.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.051 -1.031 . . . . 0.0 109.986 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -38.99 86.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.07 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.542 ' HB3' ' HB2' ' A' ' 10' ' ' LEU . 14.6 m-85 -74.81 -23.94 58.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.138 -0.976 . . . . 0.0 109.862 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.911 HG21 HG13 ' A' ' 21' ' ' ILE . 2.0 t -72.47 -23.16 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.18 -0.95 . . . . 0.0 110.062 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -46.77 -91.21 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.023 -1.048 . . . . 0.0 110.359 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.69 -2.23 3.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 110.131 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -86.26 -87.06 0.14 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.085 -1.01 . . . . 0.0 109.262 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 2.0 mm? -54.59 -27.5 39.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.996 -1.065 . . . . 0.0 109.669 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.088 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 4.2 t -90.55 -63.8 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.178 -0.952 . . . . 0.0 109.694 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.754 ' C ' HG22 ' A' ' 13' ' ' THR . . . -39.78 -38.91 1.21 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.754 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 157.02 53.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.977 -0.72 . . . . 0.0 109.839 178.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.676 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -96.1 21.76 43.38 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 106.339 -2.704 . . . . 0.0 106.339 177.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 144.43 -28.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.901 HG13 ' HB3' ' A' ' 100' ' ' TYR . 4.3 t -131.72 140.5 48.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.517 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 0.2 OUTLIER -77.78 2.34 17.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.733 -1.229 . . . . 0.0 108.476 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.58 ' HB3' ' HB2' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -158.67 -173.68 4.4 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.359 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 1.088 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . 170.78 142.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.007 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -140.4 104.14 4.71 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.058 -1.026 . . . . 0.0 110.305 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.911 HG13 HG21 ' A' ' 6' ' ' VAL . 14.4 mt -79.61 106.01 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.612 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.4 OUTLIER -93.5 116.93 29.46 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.492 -0.755 . . . . 0.0 109.463 -178.317 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -49.72 -178.26 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.796 HD21 ' N ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -103.55 -68.94 0.82 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -1.141 . . . . 0.0 109.545 -179.75 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -113.66 11.83 18.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.269 -0.894 . . . . 0.0 109.543 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.71 -83.51 1.65 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -175.92 -65.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.417 -1.049 . . . . 0.0 109.401 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.6 m -158.62 156.54 30.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.94 . . . . 0.0 109.715 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -114.85 -69.97 0.83 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.354 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.444 ' O ' HG11 ' A' ' 6' ' ' VAL . . . -160.8 117.93 2.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.344 -0.848 . . . . 0.0 109.076 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 1.6 p -128.81 168.68 15.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.92 . . . . 0.0 109.81 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.4 ' HB2' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -171.71 98.32 0.18 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 109.238 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.58 ' HB2' ' HB3' ' A' ' 18' ' ' GLN . . . -166.7 -67.24 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.169 -0.957 . . . . 0.0 109.464 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 139.21 39.61 0.1 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.557 ' CG ' ' O ' ' A' ' 35' ' ' PHE . 1.4 p90 -155.64 117.95 4.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -1.175 . . . . 0.0 109.409 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.91 130.54 41.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.536 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -90.65 161.67 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.373 -0.829 . . . . 0.0 109.353 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -74.11 148.05 86.26 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.293 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.78 -31.91 78.14 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.125 1.883 . . . . 0.0 110.357 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.31 13.38 3.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.196 -0.94 . . . . 0.0 110.285 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 38' ' ' THR . 1.3 mm-40 -90.65 -32.43 16.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.907 -1.121 . . . . 0.0 109.485 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.86 -46.31 94.78 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -21.01 64.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.406 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 46.1 m -68.28 -34.69 76.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -41.84 75.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.367 -0.833 . . . . 0.0 109.445 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.52 -45.86 91.03 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.921 . . . . 0.0 109.021 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -81.55 -5.86 58.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.352 -0.842 . . . . 0.0 109.114 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.648 ' O ' HD11 ' A' ' 55' ' ' ILE . . . -69.09 -37.92 78.69 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.231 -0.918 . . . . 0.0 109.217 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 6.3 m-30 -74.96 81.89 2.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.52 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 2.1 t-20 -130.37 58.2 1.68 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 108.735 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 50' ' ' ASN . 5.2 t-20 84.77 17.84 0.15 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.578 0.704 . . . . 0.0 109.129 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 44.18 23.62 0.07 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.467 -0.771 . . . . 0.0 110.17 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.549 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -91.93 -53.65 0.27 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.067 -1.02 . . . . 0.0 110.638 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 2.4 Cg_endo -65.4 -7.71 16.76 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.994 1.796 . . . . 0.0 110.965 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.648 HD11 ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -109.08 -17.19 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.96 -1.088 . . . . 0.0 109.638 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.489 ' NH1' ' HG2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -80.3 -46.8 15.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.449 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -107.32 63.47 0.63 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.505 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 4.7 t 167.68 -30.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.43 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.24 -153.3 31.69 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.448 ' C ' ' CD1' ' A' ' 60' ' ' PHE . 6.3 p90 -151.84 -169.27 3.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -1.165 . . . . 0.0 109.169 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.77 146.75 28.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.092 -1.005 . . . . 0.0 110.556 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.5 -166.98 1.44 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.89 -22.08 46.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 109.383 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.72 -111.17 0.14 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 66' ' ' HIS . 1.2 t -125.76 -153.67 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -1.195 . . . . 0.0 109.293 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 47.1 p-80 -88.29 114.14 24.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.167 -0.958 . . . . 0.0 109.416 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.46 ' HA ' ' HB2' ' A' ' 81' ' ' LYS . 12.0 m-30 -95.13 162.95 13.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.586 HG12 ' N ' ' A' ' 69' ' ' THR . 26.1 t -111.3 169.13 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.897 . . . . 0.0 109.451 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.586 ' N ' HG12 ' A' ' 68' ' ' VAL . 91.6 m -122.33 130.94 53.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.909 . . . . 0.0 109.616 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.72 19.54 5.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.126 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -177.16 85.18 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.373 -0.829 . . . . 0.0 109.171 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.71 36.95 1.63 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 0.0 109.64 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.44 -25.86 13.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.28 -0.887 . . . . 0.0 109.446 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.489 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -90.62 -106.65 0.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -139.64 24.24 2.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.793 -1.192 . . . . 0.0 109.564 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -135.47 156.17 49.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -0.905 . . . . 0.0 109.338 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.617 ' O ' HG22 ' A' ' 77' ' ' ILE . 10.8 mt -149.27 68.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.174 -0.954 . . . . 0.0 109.429 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.651 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -94.17 95.26 8.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.904 . . . . 0.0 108.764 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -113.23 173.32 15.01 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 0.7 OUTLIER -151.23 -170.65 3.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -1.153 . . . . 0.0 109.334 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.507 ' HE2' ' NE2' ' A' ' 66' ' ' HIS . 0.3 OUTLIER 175.62 111.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.189 -0.944 . . . . 0.0 109.58 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.54 -135.0 11.91 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 102' ' ' GLU . 2.4 p -100.24 -4.62 29.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -1.192 . . . . 0.0 109.694 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . . . -113.35 166.95 10.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.368 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.566 ' HA3' ' CE1' ' A' ' 100' ' ' TYR . . . -150.22 157.18 27.09 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.689 ' CG2' HG13 ' A' ' 97' ' ' VAL . 11.9 p -135.53 136.64 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -1.18 . . . . 0.0 110.039 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.651 HG23 ' HD2' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -110.26 95.58 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 6.7 p -106.72 115.75 30.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 109.889 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.724 ' CG2' HD21 ' A' ' 96' ' ' LEU . 3.1 m -135.02 134.16 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 109.536 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.517 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -97.35 146.1 25.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.346 -0.846 . . . . 0.0 109.121 179.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.489 ' HB ' HG12 ' A' ' 121' ' ' ILE . 23.4 p -146.17 -145.31 0.17 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 109.913 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 91' ' ' THR . 0.1 OUTLIER -41.41 -74.58 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.295 -0.878 . . . . 0.0 110.548 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.769 ' O ' HD11 ' A' ' 24' ' ' LEU . 1.2 mtpt -149.72 52.85 0.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.993 . . . . 0.0 109.89 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.796 ' N ' HD21 ' A' ' 24' ' ' LEU . 21.2 t -169.86 151.25 4.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.925 . . . . 0.0 109.523 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.461 HD11 ' HD3' ' A' ' 90' ' ' LYS . 12.4 mt -129.32 128.53 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.179 -0.951 . . . . 0.0 109.256 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.825 HD22 ' CE2' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -98.96 154.39 18.11 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.327 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.689 HG13 ' CG2' ' A' ' 86' ' ' VAL . 59.0 t -137.36 64.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.129 -0.982 . . . . 0.0 109.578 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -50.05 118.28 5.66 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.663 ' O ' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -112.31 114.2 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.159 -1.2 . . . . 0.0 109.291 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.901 ' HB3' HG13 ' A' ' 16' ' ' VAL . 19.2 p90 -123.98 -168.78 1.84 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.248 -0.907 . . . . 0.0 109.672 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' ALA . 6.9 m120 -132.82 -168.52 2.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 83' ' ' SER . 16.1 pt-20 -66.28 -9.32 31.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.278 -0.889 . . . . 0.0 109.906 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -73.89 -17.54 61.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.917 . . . . 0.0 109.599 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 16' ' ' VAL . 9.5 mt -117.59 103.66 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.935 . . . . 0.0 109.504 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.475 ' HG2' ' HD2' ' A' ' 106' ' ' PRO . 1.7 tt0 -64.29 142.05 98.25 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.266 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.475 ' HD2' ' HG2' ' A' ' 105' ' ' GLN . 2.8 Cg_endo -61.55 152.58 72.45 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.04 1.827 . . . . 0.0 110.079 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.32 -23.05 23.67 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.1 m -98.08 -53.28 3.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -1.123 . . . . 0.0 109.569 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.761 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -73.77 -32.19 63.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.928 . . . . 0.0 109.465 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.44 -27.85 64.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 0.0 109.587 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.463 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -78.2 -49.28 14.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.715 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 7.5 p -59.26 -21.59 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -0.969 . . . . 0.0 109.523 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 109' ' ' ALA . 91.1 t -78.91 -33.32 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.785 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.463 ' OE2' ' HA ' ' A' ' 111' ' ' ASN . 26.3 mt-10 -59.57 -61.12 2.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.931 . . . . 0.0 109.439 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.29 -38.26 88.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.633 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 4.1 mt -57.97 -24.44 58.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.869 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -80.41 -29.74 37.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.289 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.35 -38.7 74.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.072 . . . . 0.0 109.4 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -75.43 -47.43 27.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 109.554 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.5 OUTLIER -60.92 -57.52 12.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 109.417 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.869 HD12 ' O ' ' A' ' 117' ' ' ALA . 15.7 mt -61.24 -13.81 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.467 -0.771 . . . . 0.0 109.941 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.74 -9.76 40.9 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -119.42 -56.27 2.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -1.185 . . . . 0.0 109.459 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 114.64 112.4 2.94 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.286 -1.126 . . . . 0.0 109.271 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.943 ' CZ3' HD22 ' A' ' 96' ' ' LEU . 47.7 m95 . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.84 -86.07 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.816 -1.178 . . . . 0.0 109.342 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -63.77 -37.94 89.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.032 -1.042 . . . . 0.0 108.984 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.604 ' CE2' ' HG ' ' A' ' 116' ' ' LEU . 18.7 m-30 -56.34 -39.26 72.56 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.381 -0.825 . . . . 0.0 109.769 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.549 HG21 ' HB1' ' A' ' 30' ' ' ALA . 1.2 t -54.44 -45.56 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.828 -1.17 . . . . 0.0 108.075 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.407 ' N ' HG12 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -91.62 41.12 1.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 110.919 -179.338 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.505 HG22 ' N ' ' A' ' 9' ' ' ASN . 88.8 m -146.06 -106.01 0.1 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.527 -1.358 . . . . 0.0 109.879 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.9 t-20 -102.1 -70.75 0.74 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.043 -1.036 . . . . 0.0 110.08 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.696 HD22 ' CD1' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -20.53 -45.34 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.775 HG23 ' HB3' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -77.39 -68.09 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.851 -1.156 . . . . 0.0 110.125 -179.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.769 ' C ' HG22 ' A' ' 13' ' ' THR . . . -38.99 -36.46 0.5 Allowed Glycine 0 N--CA 1.498 2.785 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.769 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 156.61 39.61 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.989 -0.712 . . . . 0.0 109.154 179.011 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.685 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -84.47 17.78 27.77 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 177.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 158.44 -32.04 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.749 HG12 ' HB3' ' A' ' 100' ' ' TYR . 31.2 m -138.88 150.55 23.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.565 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.6 OUTLIER -78.97 6.32 9.57 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.113 -0.992 . . . . 0.0 108.872 179.112 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.589 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 27.4 mt-30 -168.42 160.87 11.54 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.775 ' HB3' HG23 ' A' ' 11' ' ' VAL . . . -163.95 112.4 1.18 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.913 -1.117 . . . . 0.0 112.148 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.531 ' O ' HD13 ' A' ' 21' ' ' ILE . . . -98.32 144.53 27.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.263 -1.523 . . . . 0.0 109.957 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.787 ' C ' HD23 ' A' ' 22' ' ' LEU . 45.5 mm -124.07 111.55 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.417 -0.802 . . . . 0.0 109.136 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.874 HD11 HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -116.24 123.42 47.68 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.044 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.71 -158.62 14.79 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.74 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.572 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -106.63 -60.83 1.61 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.349 -1.089 . . . . 0.0 109.977 -179.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.83 6.87 14.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.976 -1.078 . . . . 0.0 108.725 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 28' ' ' THR . . . -143.04 88.4 0.18 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.02 -2.032 . . . . 0.0 108.02 179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' A' ' 26' ' ' GLY . 2.1 t30 -30.68 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.067 -0.666 . . . . 0.0 110.838 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 26' ' ' GLY . 12.3 m -166.56 104.23 0.61 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.05 -1.031 . . . . 0.0 109.845 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.51 ' NE1' ' HA3' ' A' ' 26' ' ' GLY . 19.6 m0 -79.4 -27.93 41.83 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.576 ' HB3' ' CG1' ' A' ' 21' ' ' ILE . . . -147.54 163.59 36.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t -143.98 155.84 44.18 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.11 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 96.6 p -64.63 -9.96 23.21 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.649 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 63.8 66.77 0.65 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.16 -87.47 0.07 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -94.24 148.34 22.3 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.218 -1.166 . . . . 0.0 109.212 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.12 148.57 38.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.599 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -103.29 132.8 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.278 -0.888 . . . . 0.0 109.625 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.1 p -72.04 149.24 92.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.92 . . . . 0.0 109.398 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.722 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 6.1 Cg_exo -60.15 177.62 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.184 1.923 . . . . 0.0 110.202 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 39' ' ' PRO . . . 83.37 -42.23 0.1 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.608 -0.682 . . . . 0.0 109.633 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -68.24 -31.81 71.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.058 -1.026 . . . . 0.0 109.569 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.09 -35.93 60.46 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.3 -33.96 73.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -1.173 . . . . 0.0 109.531 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.2 m -59.14 -31.73 69.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.412 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 mt -68.7 -40.58 79.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 109.398 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.62 -42.01 99.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.383 -0.823 . . . . 0.0 109.454 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.4 t -74.85 -9.98 59.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 109.562 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.38 -16.65 36.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.923 . . . . 0.0 109.729 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -81.89 -15.93 52.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.248 -0.907 . . . . 0.0 109.688 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -117.3 4.51 12.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.271 -0.893 . . . . 0.0 109.239 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -166.44 107.72 0.69 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -0.865 . . . . 0.0 109.468 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 56' ' ' ARG . . . -95.11 47.74 1.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.379 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.577 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -82.59 -49.62 0.8 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 110.721 -179.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 4.8 Cg_exo -63.57 -71.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.974 1.783 . . . . 0.0 111.393 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.769 HG22 ' O ' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -45.52 -54.13 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.13 -0.981 . . . . 0.0 110.053 -178.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 5.0 mtp180 -50.83 -53.24 33.85 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.161 -0.962 . . . . 0.0 109.489 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.81 -87.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.54 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.2 -82.96 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.179 -0.95 . . . . 0.0 109.426 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.769 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -179.97 -99.96 0.13 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.477 ' CB ' ' HB2' ' A' ' 67' ' ' TYR . 1.3 m-85 -131.19 133.53 45.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.358 -1.083 . . . . 0.0 109.273 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -129.25 125.61 37.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.194 -0.942 . . . . 0.0 109.483 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.93 -149.78 0.41 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.329 -0.857 . . . . 0.0 109.302 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.25 -75.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.415 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.57 37.14 1.91 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.85 158.52 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -1.145 . . . . 0.0 109.773 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -131.03 143.21 50.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.448 -0.783 . . . . 0.0 109.51 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.477 ' HB2' ' CB ' ' A' ' 60' ' ' PHE . 33.8 m-85 -134.56 -169.51 2.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.326 -0.859 . . . . 0.0 109.34 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.41 136.96 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.964 . . . . 0.0 109.426 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.642 HG21 ' HB ' ' A' ' 55' ' ' ILE . 1.7 m -93.87 103.03 15.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.943 . . . . 0.0 109.266 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 70' ' ' LEU . 4.0 tp -124.0 38.11 4.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.963 . . . . 0.0 109.715 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER 172.53 50.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 179.634 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.451 ' HA ' HG12 ' A' ' 77' ' ' ILE . . . -113.78 23.38 13.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.866 . . . . 0.0 109.125 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -124.97 -24.02 4.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 109.672 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -75.57 -93.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.119 -0.988 . . . . 0.0 109.253 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.61 -46.9 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 109.254 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 67.7 m -89.39 -164.2 1.11 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.912 . . . . 0.0 108.779 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.714 ' O ' HG22 ' A' ' 77' ' ' ILE . 45.3 mt -157.73 63.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.983 -1.073 . . . . 0.0 110.212 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.861 ' CD1' HG23 ' A' ' 87' ' ' ILE . 1.9 m-85 -90.81 145.22 24.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.996 -1.065 . . . . 0.0 108.432 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -140.61 -171.21 12.38 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.484 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -149.59 -176.66 5.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.584 -0.95 . . . . 0.0 108.944 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER 178.55 34.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.973 . . . . 0.0 109.617 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.431 ' C ' ' OG ' ' A' ' 83' ' ' SER . . . 62.33 95.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 101' ' ' ASN . 0.6 OUTLIER 70.55 6.79 5.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.287 -1.125 . . . . 0.0 109.783 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 81' ' ' LYS . . . -150.35 129.88 13.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.661 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.561 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -150.35 174.8 29.64 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.867 HG22 ' CG2' ' A' ' 88' ' ' THR . 7.4 p -148.14 114.26 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -1.177 . . . . 0.0 110.133 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.861 HG23 ' CD1' ' A' ' 78' ' ' TYR . 7.2 mt -90.72 79.34 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.115 -0.991 . . . . 0.0 109.212 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.867 ' CG2' HG22 ' A' ' 86' ' ' VAL . 1.2 p -105.56 141.78 36.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.198 -0.939 . . . . 0.0 110.116 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 1.026 HG22 HD21 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -150.49 -178.11 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.493 ' N ' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.41 80.3 1.38 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.886 -1.134 . . . . 0.0 110.466 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 1.034 HG22 HD11 ' A' ' 121' ' ' ILE . 19.3 p -98.56 148.65 23.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.935 . . . . 0.0 108.666 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 0.3 OUTLIER 50.85 20.27 0.75 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.341 -0.85 . . . . 0.0 109.754 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 92' ' ' SER . 0.5 OUTLIER 81.95 -18.71 0.46 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.342 -0.849 . . . . 0.0 110.192 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.556 ' HA ' ' CD2' ' A' ' 24' ' ' LEU . 1.4 p -82.28 178.94 7.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.213 -0.93 . . . . 0.0 109.21 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 4.8 mt -130.86 101.65 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.134 -0.979 . . . . 0.0 110.117 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.026 HD21 HG22 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -71.74 157.78 37.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.299 -0.876 . . . . 0.0 108.743 179.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.874 HG21 HD11 ' A' ' 22' ' ' LEU . 10.4 t -132.3 68.27 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.952 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -48.26 129.46 19.03 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 107.399 -2.28 . . . . 0.0 107.399 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -132.12 106.0 10.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.715 -1.462 . . . . 0.0 108.73 -178.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.868 ' HB2' HD12 ' A' ' 104' ' ' ILE . 22.5 p90 -122.77 164.56 18.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.371 -0.83 . . . . 0.0 109.905 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 102' ' ' GLU . 1.1 m120 -150.68 -164.11 1.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.443 -0.786 . . . . 0.0 109.312 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 101' ' ' ASN . 0.8 OUTLIER 61.49 19.21 10.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.626 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.8 mttt 60.28 62.74 1.52 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.118 -0.989 . . . . 0.0 109.377 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.868 HD12 ' HB2' ' A' ' 100' ' ' TYR . 6.2 mt -73.68 123.05 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.285 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -44.66 104.86 0.41 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.447 -0.783 . . . . 0.0 109.983 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 104' ' ' ILE . 3.6 Cg_exo -62.08 172.82 3.66 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.053 1.835 . . . . 0.0 110.173 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 111' ' ' ASN . . . 87.9 -19.88 31.56 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.846 ' O ' HG23 ' A' ' 112' ' ' VAL . 17.1 m -106.24 -45.56 4.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -1.18 . . . . 0.0 109.273 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.529 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -73.64 -43.31 59.85 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.186 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.71 -30.79 70.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.147 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 107' ' ' GLY . 0.7 OUTLIER -70.09 -40.98 74.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.346 -0.846 . . . . 0.0 109.467 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 108' ' ' THR . 21.6 t -67.2 -26.11 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.124 -0.985 . . . . 0.0 109.33 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.774 HG13 ' HZ2' ' A' ' 2' ' ' TRP . 38.1 t -76.73 -27.63 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.367 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.38 -43.12 82.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.442 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.2 -54.29 11.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 109.062 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.604 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 5.0 mp -51.55 -22.31 3.14 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.268 -0.895 . . . . 0.0 109.084 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.655 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -71.25 -43.73 66.69 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.441 -0.787 . . . . 0.0 109.248 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.44 -14.58 29.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.741 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.485 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 1.7 t80 -78.55 -60.76 2.24 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -0.935 . . . . 0.0 109.512 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.58 -50.08 68.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.909 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.034 HD11 HG22 ' A' ' 91' ' ' THR . 19.6 mt -51.08 -34.21 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.087 -1.008 . . . . 0.0 109.513 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -45.16 -65.3 1.9 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -46.88 -60.42 2.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -1.12 . . . . 0.0 109.642 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.4 74.09 1.19 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 92' ' ' SER . 64.1 m-85 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.256 -1.144 . . . . 0.0 109.482 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.856 ' NE1' HD23 ' A' ' 10' ' ' LEU . 3.3 m-90 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -74.71 0.18 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.957 -1.09 . . . . 0.0 109.248 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 m -69.61 -8.81 50.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.127 -0.983 . . . . 0.0 109.051 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.626 ' HB3' HD13 ' A' ' 10' ' ' LEU . 14.2 m-30 -88.55 -34.43 17.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.356 -0.84 . . . . 0.0 109.098 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.667 ' HA ' HG23 ' A' ' 11' ' ' VAL . 1.0 OUTLIER -60.99 -33.79 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.311 -0.868 . . . . 0.0 108.746 179.565 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -48.83 -89.58 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.484 -0.76 . . . . 0.0 110.504 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 p -133.64 13.36 4.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.068 -1.02 . . . . 0.0 110.556 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 14' ' ' GLY . 16.9 m-20 -96.59 -82.72 0.39 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.965 -1.084 . . . . 0.0 109.123 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.856 HD23 ' NE1' ' A' ' 2' ' ' TRP . 7.9 mp -65.73 -24.18 66.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.927 -1.108 . . . . 0.0 109.322 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.928 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 3.6 t -85.18 -57.7 4.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.748 ' C ' HG22 ' A' ' 13' ' ' THR . . . -47.65 -35.97 12.1 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.748 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER 154.93 49.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 122.032 -0.687 . . . . 0.0 110.628 178.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.72 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -94.87 21.08 45.65 Favored Glycine 0 C--N 1.292 -1.898 0 N-CA-C 106.471 -2.652 . . . . 0.0 106.471 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.758 ' O ' HG21 ' A' ' 104' ' ' ILE . . . 153.21 -30.96 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 5.6 m -139.34 153.11 23.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.476 ' O ' ' OE1' ' A' ' 18' ' ' GLN . 63.2 p -80.36 12.24 3.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.898 -1.126 . . . . 0.0 109.114 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.525 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -171.86 176.57 3.56 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.928 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . -175.05 159.67 2.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.789 -1.194 . . . . 0.0 109.777 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.801 ' HB1' HG22 ' A' ' 31' ' ' THR . . . -153.17 122.56 6.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.15 -0.969 . . . . 0.0 110.0 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.554 ' CD1' ' HB2' ' A' ' 2' ' ' TRP . 5.0 mm -81.58 98.47 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.039 HD22 HG21 ' A' ' 97' ' ' VAL . 5.4 mp -75.99 -79.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.606 -0.684 . . . . 0.0 110.302 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.482 ' HA3' ' CZ3' ' A' ' 29' ' ' TRP . . . 141.04 148.95 5.18 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.532 ' HB3' ' CG1' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -107.51 -16.82 14.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.08 -1.247 . . . . 0.0 109.863 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.11 31.98 0.84 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.064 -1.022 . . . . 0.0 109.843 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.69 -110.94 0.69 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.75 -63.29 0.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.409 -1.053 . . . . 0.0 109.153 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.571 ' O ' ' CE3' ' A' ' 29' ' ' TRP . 0.2 OUTLIER -134.95 -178.06 4.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.91 . . . . 0.0 109.525 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.571 ' CE3' ' O ' ' A' ' 28' ' ' THR . 0.6 OUTLIER -157.3 -54.38 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.871 . . . . 0.0 109.143 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.518 ' O ' HG12 ' A' ' 21' ' ' ILE . . . -173.76 79.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.801 HG22 ' HB1' ' A' ' 20' ' ' ALA . 17.9 p -79.57 166.52 21.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -0.973 . . . . 0.0 110.481 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.501 ' HB2' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -171.17 54.92 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.436 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . . . -124.24 -166.4 1.5 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.365 -0.835 . . . . 0.0 109.631 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.31 -25.01 14.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.412 ' HE2' HG11 ' A' ' 99' ' ' VAL . 4.0 p90 -82.81 -175.44 5.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -1.233 . . . . 0.0 109.453 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.817 ' O ' ' HB2' ' A' ' 63' ' ' ALA . . . -141.8 95.87 2.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 109.636 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 t -84.41 66.6 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 109.377 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.704 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 1.2 t -93.04 -26.87 0.28 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.325 -0.86 . . . . 0.0 112.627 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 38' ' ' THR . 6.3 Cg_exo -59.72 -166.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.739 0 C-N-CA 120.774 0.983 . . . . 0.0 110.37 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.22 47.3 1.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.456 ' OE1' ' HA ' ' A' ' 41' ' ' GLN . 14.0 mm-40 -81.27 -16.6 52.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.069 -1.02 . . . . 0.0 109.124 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.0 -41.54 92.47 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -27.9 65.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -1.209 . . . . 0.0 109.662 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.3 m -63.32 -22.52 66.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.137 -0.977 . . . . 0.0 109.508 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.93 -43.2 16.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 110.289 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . . . -72.38 -54.93 7.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.044 -1.035 . . . . 0.0 109.913 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 m -55.05 -29.39 57.36 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.229 -0.92 . . . . 0.0 109.291 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.9 90.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.336 -0.853 . . . . 0.0 109.641 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 46' ' ' ALA . 17.3 m-30 -53.4 -21.27 5.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.27 -0.894 . . . . 0.0 109.853 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -80.55 -58.57 3.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.011 . . . . 0.0 109.535 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -126.91 133.35 50.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 109.514 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.447 ' C ' HG12 ' A' ' 55' ' ' ILE . . . -112.1 29.17 8.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 109.45 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.618 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 5.0 t70 -81.77 -45.63 1.06 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 110.62 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.3 Cg_endo -66.32 -6.33 14.66 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 121.524 1.483 . . . . 0.0 110.368 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.814 HD13 ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -103.32 -31.98 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 0.0 109.709 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 69' ' ' THR . 4.3 ptp180 -71.38 -26.75 62.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.013 -1.054 . . . . 0.0 109.515 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.8 -63.16 1.45 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 109.808 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.04 -32.94 5.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 109.459 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 55' ' ' ILE . . . 111.75 -151.03 18.02 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.52 ' HZ ' HG11 ' A' ' 86' ' ' VAL . 21.3 p90 -123.12 166.49 15.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -1.096 . . . . 0.0 109.42 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.674 ' O ' HD23 ' A' ' 62' ' ' LEU . 1.2 p30 -127.32 151.65 48.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 109.922 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 61' ' ' ASP . 25.7 mt -123.62 -141.33 0.31 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.327 -0.858 . . . . 0.0 109.464 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.817 ' HB2' ' O ' ' A' ' 36' ' ' ALA . . . -28.11 -70.81 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.9 -0.5 . . . . 0.0 111.115 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.76 21.6 0.39 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.57 163.77 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.155 -1.203 . . . . 0.0 109.476 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -102.57 155.91 17.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 109.35 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.452 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 64.6 m-85 -141.81 150.32 41.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.258 -0.901 . . . . 0.0 109.324 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 69' ' ' THR . 49.9 t -97.55 161.2 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.747 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.507 ' N ' HG12 ' A' ' 68' ' ' VAL . 19.8 m -146.22 91.76 2.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 109.18 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.84 HD23 ' O ' ' A' ' 70' ' ' LEU . 1.7 tt -109.36 25.92 11.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.226 -0.921 . . . . 0.0 109.599 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.466 ' CG ' ' O ' ' A' ' 70' ' ' LEU . 7.2 mtm180 -158.87 61.17 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.885 . . . . 0.0 109.42 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 73' ' ' ASP . . . -129.91 119.98 24.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.437 -0.79 . . . . 0.0 109.407 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 72' ' ' ALA . 0.7 OUTLIER 169.38 -61.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 109.498 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.526 ' HB3' ' HD2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -56.34 -83.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.167 -0.958 . . . . 0.0 109.328 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.526 ' HD2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -148.67 -34.48 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.028 -1.045 . . . . 0.0 110.264 179.754 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 72.3 m -97.28 162.8 13.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.906 -1.122 . . . . 0.0 109.827 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 76' ' ' SER . 3.4 mp -146.77 83.58 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 109.824 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.862 ' CD2' HG23 ' A' ' 87' ' ' ILE . 1.1 m-85 -92.65 96.14 10.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.007 -1.058 . . . . 0.0 108.718 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.99 174.65 8.62 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.41 85.27 1.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.338 -1.095 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -59.91 178.05 0.2 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.2 -0.937 . . . . 0.0 109.496 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -51.65 -45.0 54.79 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.63 -19.99 3.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -1.172 . . . . 0.0 110.406 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -99.02 167.42 10.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.898 -1.126 . . . . 0.0 109.86 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.51 153.73 23.19 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.573 HG23 HG13 ' A' ' 97' ' ' VAL . 3.9 p -136.34 132.23 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.134 -1.215 . . . . 0.0 109.846 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.862 HG23 ' CD2' ' A' ' 78' ' ' TYR . 67.6 mt -107.5 112.63 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.328 -0.858 . . . . 0.0 109.229 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.422 ' OG1' ' HB ' ' A' ' 77' ' ' ILE . 1.4 p -120.35 117.69 28.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.622 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 1.042 HG22 HD21 ' A' ' 96' ' ' LEU . 18.1 m -144.59 146.66 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 109.532 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -77.22 151.57 35.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.252 -0.905 . . . . 0.0 109.326 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.542 ' O ' ' CB ' ' A' ' 125' ' ' PHE . 25.1 p -147.34 -111.41 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 109.785 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.72 86.41 5.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.772 -1.205 . . . . 0.0 109.88 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.448 ' O ' ' CZ2' ' A' ' 29' ' ' TRP . 0.6 OUTLIER 51.18 21.72 1.15 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.331 -0.855 . . . . 0.0 109.464 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.451 ' O ' ' OG1' ' A' ' 91' ' ' THR . 4.9 t -157.32 147.61 20.95 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.374 -0.829 . . . . 0.0 109.377 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 89' ' ' VAL . 11.0 mt -109.1 154.2 10.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.395 -0.816 . . . . 0.0 109.071 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.042 HD21 HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.59 150.81 34.46 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.028 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 1.039 HG21 HD22 ' A' ' 22' ' ' LEU . 54.9 t -129.68 77.31 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.291 -0.881 . . . . 0.0 110.159 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.03 143.77 45.44 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.457 HG22 HG12 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -143.15 118.33 4.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.691 -1.476 . . . . 0.0 109.853 -179.078 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.582 ' CE1' ' O ' ' A' ' 104' ' ' ILE . 35.1 p90 -131.89 166.0 22.62 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 103' ' ' LYS . 46.7 t30 -150.31 133.33 16.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.871 -1.143 . . . . 0.0 110.864 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 101' ' ' ASN . 0.0 OUTLIER 38.39 29.74 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.634 179.289 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 101' ' ' ASN . 5.6 mmtp -136.19 -51.31 0.71 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.246 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.775 ' O ' HG22 ' A' ' 104' ' ' ILE . 1.7 mp -112.35 75.68 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.127 -0.983 . . . . 0.0 109.841 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.458 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 9.6 mt-30 -54.8 158.1 4.83 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.077 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 105' ' ' GLN . 2.9 Cg_endo -60.03 143.52 99.56 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.088 1.859 . . . . 0.0 110.403 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.16 -22.49 6.7 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.6 m -114.93 -52.87 2.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.125 -1.221 . . . . 0.0 109.499 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.513 ' HB2' HG21 ' A' ' 104' ' ' ILE . . . -72.37 -29.46 63.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 109.527 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -71.43 -21.82 61.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.572 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -90.08 -50.72 5.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.195 -0.94 . . . . 0.0 109.674 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 109' ' ' ALA . 7.1 p -61.05 -38.18 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 109.683 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.778 HG11 HG21 ' A' ' 87' ' ' ILE . 44.8 t -72.72 -31.14 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.133 -0.98 . . . . 0.0 109.601 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 110' ' ' ALA . 6.6 tt0 -65.91 -42.33 90.31 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.171 -0.956 . . . . 0.0 109.824 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -75.87 -36.52 59.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -0.968 . . . . 0.0 109.875 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.554 HD23 ' CH2' ' A' ' 2' ' ' TRP . 17.1 tp -60.0 -62.52 1.81 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.091 -1.006 . . . . 0.0 108.797 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 1.072 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -60.36 -21.53 62.23 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.27 -0.894 . . . . 0.0 109.284 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.465 ' HB2' ' HA ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -58.07 -52.0 67.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.281 -0.887 . . . . 0.0 109.539 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -59.27 -29.38 67.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.201 -0.937 . . . . 0.0 108.982 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.413 HD13 ' HB ' ' A' ' 91' ' ' THR . 4.3 mt -80.0 -22.9 41.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 110.025 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.072 HD12 ' O ' ' A' ' 117' ' ' ALA . 1.3 mp -87.45 -16.08 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.096 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.15 -27.62 15.65 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -81.78 -71.71 0.47 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.363 -1.081 . . . . 0.0 109.367 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 144.9 94.0 0.17 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.542 ' CB ' ' O ' ' A' ' 91' ' ' THR . 22.6 m-85 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.131 -1.217 . . . . 0.0 109.362 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.54 ' HB2' ' CD1' ' A' ' 120' ' ' LEU . 11.5 t . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.273 0.559 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 1.073 ' CZ3' HD22 ' A' ' 96' ' ' LEU . 1.7 m-90 -75.02 -1.5 23.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 0.0 109.383 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.49 -67.31 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.072 -1.018 . . . . 0.0 109.568 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -65.81 -30.85 71.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.532 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.967 ' CB ' HD12 ' A' ' 10' ' ' LEU . 6.6 m-30 -81.73 -3.08 52.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.12 -0.987 . . . . 0.0 109.456 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.719 ' HA ' HG23 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -83.19 -41.05 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.983 -1.073 . . . . 0.0 108.794 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -90.46 48.29 1.53 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.378 -0.827 . . . . 0.0 111.117 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.504 HG23 ' H ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -165.85 -96.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.708 -1.245 . . . . 0.0 110.792 179.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -101.46 -68.97 0.8 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.982 -1.073 . . . . 0.0 110.925 -178.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.967 HD12 ' CB ' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -23.05 -43.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.026 HG22 ' HB3' ' A' ' 19' ' ' ALA . 48.9 t -91.94 -55.5 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.725 -1.235 . . . . 0.0 110.815 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.736 ' C ' HG22 ' A' ' 13' ' ' THR . . . -40.03 -47.78 3.39 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.736 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 163.62 41.28 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.709 -0.877 . . . . 0.0 108.792 178.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.706 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -87.19 22.2 16.57 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 153.97 -34.1 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.914 HG12 ' HB3' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -134.46 137.94 50.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.72 HG23 ' CD1' ' A' ' 104' ' ' ILE . 69.2 p -78.21 2.39 18.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.955 -1.091 . . . . 0.0 108.869 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.509 ' CG ' ' C ' ' A' ' 17' ' ' THR . 6.4 mt-30 -161.83 151.11 15.99 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 1.026 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -163.47 147.97 10.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.967 -1.083 . . . . 0.0 109.973 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -141.81 152.03 43.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.429 -0.795 . . . . 0.0 108.974 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.842 HG22 ' HE3' ' A' ' 29' ' ' TRP . 7.0 mt -120.88 103.22 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.949 . . . . 0.0 109.669 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.723 HD23 ' C ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -136.55 164.23 28.67 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.588 ' HA3' ' CD1' ' A' ' 95' ' ' ILE . . . 132.64 172.79 13.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.887 HD13 ' O ' ' A' ' 93' ' ' LYS . 1.4 mp 60.78 121.0 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.148 0 O-C-N 121.159 -1.2 . . . . 0.0 108.377 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -78.03 39.3 0.3 Allowed 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.806 -0.559 . . . . 0.0 111.448 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -105.98 -32.62 3.74 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER 162.79 -172.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.621 -0.929 . . . . 0.0 109.167 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.655 HG22 ' H ' ' A' ' 29' ' ' TRP . 1.3 m -98.56 -174.49 2.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.091 -1.006 . . . . 0.0 108.536 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.842 ' HE3' HG22 ' A' ' 21' ' ' ILE . 3.8 m-90 -142.8 -54.67 0.41 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.013 -1.055 . . . . 0.0 109.993 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.0 134.87 0.2 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.536 -1.266 . . . . 0.0 110.464 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 1.4 t -135.1 157.41 46.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.573 -0.705 . . . . 0.0 109.113 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.473 ' CB ' HG11 ' A' ' 11' ' ' VAL . 13.9 m -159.88 100.59 1.43 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.608 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.532 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . . . -169.81 -164.4 0.43 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 109.161 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -118.13 35.34 4.07 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.532 ' CE1' ' HB3' ' A' ' 33' ' ' ALA . 10.7 p90 -141.59 124.3 16.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 109.48 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.0 116.03 28.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.438 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.707 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 3.5 t -81.78 143.77 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.778 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.535 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 11.2 p -51.05 160.61 0.82 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 0.0 109.444 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 3.9 Cg_exo -59.54 -18.84 49.15 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.128 1.885 . . . . 0.0 110.425 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.17 50.14 1.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.0 109.536 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.535 ' CG ' ' O ' ' A' ' 38' ' ' THR . 36.5 mt-30 -78.36 -55.15 5.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.103 -0.998 . . . . 0.0 109.805 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.94 -17.39 78.49 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -89.66 -18.21 26.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -1.191 . . . . 0.0 109.478 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 53.4 m -89.68 -26.01 20.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.883 . . . . 0.0 109.576 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.9 mt -81.65 -46.53 14.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.81 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.42 87.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.129 -0.982 . . . . 0.0 109.459 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 m -77.56 -39.3 46.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.93 . . . . 0.0 109.421 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 44' ' ' THR . . . -56.75 -29.86 63.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.322 -0.861 . . . . 0.0 109.25 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -87.31 64.55 8.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 109.446 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.1 -69.51 0.77 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 109.227 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.428 ' O ' ' CG ' ' A' ' 51' ' ' ASN . 19.1 t-20 -138.98 33.35 2.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.0 109.069 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 56' ' ' ARG . . . 49.06 22.42 0.6 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.573 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.586 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -88.51 -57.41 0.28 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.636 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.586 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 1.1 Cg_endo -65.62 -41.35 15.08 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.886 1.724 . . . . 0.0 111.005 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.556 ' HB ' HG21 ' A' ' 69' ' ' THR . 0.2 OUTLIER -75.56 -37.2 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.168 -0.957 . . . . 0.0 109.797 -179.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -69.01 -66.94 0.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.0 109.899 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.546 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -77.03 126.03 30.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.107 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 3.5 t 82.52 -42.72 0.13 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.741 -0.599 . . . . 0.0 110.17 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 55' ' ' ILE . . . 95.48 -171.59 29.43 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.418 ' HE1' HD11 ' A' ' 62' ' ' LEU . 46.1 p90 -126.08 164.02 21.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -1.193 . . . . 0.0 109.55 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.465 ' HA ' ' HB3' ' A' ' 66' ' ' HIS . 54.0 m-20 -128.55 162.51 27.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.881 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.418 HD11 ' HE1' ' A' ' 60' ' ' PHE . 61.4 mt -137.0 -147.2 0.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.137 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.707 ' HB2' ' HA ' ' A' ' 37' ' ' VAL . . . -53.78 -54.51 37.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.103 -0.998 . . . . 0.0 109.633 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.75 20.23 0.69 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.465 HG12 ' CE1' ' A' ' 67' ' ' TYR . 71.9 t -135.88 149.0 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -1.188 . . . . 0.0 109.36 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 13.6 p-80 -153.55 160.18 42.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.1 -1.0 . . . . 0.0 109.837 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.465 ' CE1' HG12 ' A' ' 65' ' ' VAL . 52.1 m-85 -139.83 178.47 7.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.355 -0.84 . . . . 0.0 109.481 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.485 ' O ' ' HB ' ' A' ' 69' ' ' THR . 6.0 p -92.03 -29.3 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.212 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.556 HG21 ' HB ' ' A' ' 55' ' ' ILE . 98.8 m 63.85 109.08 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.554 -0.716 . . . . 0.0 109.484 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.6 mt -89.91 -67.65 0.83 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.871 . . . . 0.0 109.503 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.37 137.2 50.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.839 . . . . 0.0 109.298 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 73' ' ' ASP . . . -159.07 91.6 1.04 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 109.527 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 46.7 t0 178.08 -31.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 109.624 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.462 ' O ' ' CD ' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -66.25 -93.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.145 -0.972 . . . . 0.0 109.401 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.462 ' CD ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -138.56 -53.86 0.61 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.07 -1.019 . . . . 0.0 109.725 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.71 ' C ' HD12 ' A' ' 77' ' ' ILE . 20.3 m -90.03 162.76 15.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.0 109.419 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.71 HD12 ' C ' ' A' ' 76' ' ' SER . 4.1 mp -152.9 84.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.177 -0.952 . . . . 0.0 110.246 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.791 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -98.99 98.86 9.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.974 -1.079 . . . . 0.0 108.207 178.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.55 166.56 43.68 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.672 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.17 165.56 32.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.97 . . . . 0.0 108.921 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.54 ' HD3' ' HB3' ' A' ' 84' ' ' ALA . 10.3 ptmt -130.48 -9.26 4.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.954 -1.091 . . . . 0.0 110.403 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.28 -23.36 9.83 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.94 -60.41 1.29 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -1.122 . . . . 0.0 108.945 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.54 ' HB3' ' HD3' ' A' ' 81' ' ' LYS . . . -99.82 -169.73 1.79 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 108.86 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.532 ' O ' ' CE1' ' A' ' 100' ' ' TYR . . . -166.94 152.79 21.94 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.75 ' O ' HG13 ' A' ' 86' ' ' VAL . 14.5 p -135.29 104.07 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -1.097 . . . . 0.0 108.971 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.791 HG23 ' HD2' ' A' ' 78' ' ' TYR . 2.0 mt -79.56 107.6 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 109.7 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.667 HG22 HG22 ' A' ' 97' ' ' VAL . 46.8 p -111.71 98.89 7.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.305 -0.872 . . . . 0.0 109.346 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.867 HG23 HD21 ' A' ' 96' ' ' LEU . 11.4 m -125.75 161.83 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.369 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.66 153.79 17.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 109.659 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.682 HG21 ' HZ3' ' A' ' 2' ' ' TRP . 0.6 OUTLIER -147.09 -92.51 0.09 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.289 -0.882 . . . . 0.0 109.209 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.9 p -98.46 66.1 1.69 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 109.102 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.887 ' O ' HD13 ' A' ' 24' ' ' LEU . 6.9 mtmt 64.74 27.74 13.03 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.32 -0.862 . . . . 0.0 108.994 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.636 ' HA ' ' CH2' ' A' ' 29' ' ' TRP . 77.7 p -146.73 148.61 32.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.9 . . . . 0.0 109.947 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.588 ' CD1' ' HA3' ' A' ' 23' ' ' GLY . 1.1 mt -105.93 94.61 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 109.531 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.073 HD22 ' CZ3' ' A' ' 2' ' ' TRP . 0.3 OUTLIER -56.15 155.12 6.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.966 -1.084 . . . . 0.0 108.6 179.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.667 HG22 HG22 ' A' ' 88' ' ' THR . 73.2 t -135.08 84.61 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.134 -0.979 . . . . 0.0 109.887 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.447 ' CA ' HG11 ' A' ' 16' ' ' VAL . . . -65.71 92.47 0.16 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.539 HG22 HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -91.72 108.48 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.343 -1.092 . . . . 0.0 108.404 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.914 ' HB3' HG12 ' A' ' 16' ' ' VAL . 5.5 p90 -131.31 172.42 12.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.059 -1.026 . . . . 0.0 110.322 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.473 ' OD1' ' HB2' ' A' ' 103' ' ' LYS . 9.0 p30 -102.81 -166.51 1.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.608 -0.682 . . . . 0.0 109.619 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -69.57 -20.44 63.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.892 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 9.9 mttm -52.95 -41.02 64.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.006 . . . . 0.0 109.468 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.72 ' CD1' HG23 ' A' ' 17' ' ' THR . 1.4 mp -91.61 137.59 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.137 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.19 149.34 65.82 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.544 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.86 -8.03 14.73 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.324 2.016 . . . . 0.0 110.628 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -102.95 -39.54 2.66 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -28.18 69.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.113 -1.228 . . . . 0.0 109.893 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.42 -34.9 18.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.116 -0.99 . . . . 0.0 109.677 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.21 -20.43 62.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.738 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.37 -42.28 25.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 109.704 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.44 -37.26 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.771 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.716 HG11 HG21 ' A' ' 87' ' ' ILE . 85.4 t -74.12 -14.02 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.551 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.25 -34.28 22.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.941 . . . . 0.0 109.603 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 118' ' ' ASP . 3.8 mttm -77.74 -51.62 10.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.151 -0.968 . . . . 0.0 109.473 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.46 HD21 ' CD2' ' A' ' 5' ' ' TYR . 1.1 mp -51.41 -48.1 62.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 108.818 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.837 ' HB1' HD11 ' A' ' 121' ' ' ILE . . . -62.34 -47.95 81.96 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.123 -0.986 . . . . 0.0 108.413 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.538 ' CA ' HG12 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -38.52 -29.64 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.405 0.621 . . . . 0.0 109.685 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 117' ' ' ALA . 14.9 m-30 -74.28 -49.59 22.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.305 -0.872 . . . . 0.0 109.317 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 1' ' ' SER . 0.7 OUTLIER -80.81 -3.17 50.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.864 . . . . 0.0 111.841 -178.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.837 HD11 ' HB1' ' A' ' 117' ' ' ALA . 2.1 mm -77.22 -38.47 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.256 -1.527 . . . . 0.0 108.994 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 121' ' ' ILE . . . -41.32 -38.56 2.0 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -84.57 -59.59 2.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -1.102 . . . . 0.0 109.145 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.38 106.32 1.62 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.607 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 1.8 m-85 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.128 -1.219 . . . . 0.0 109.397 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.609 ' O ' ' CD2' ' A' ' 2' ' ' TRP . 31.5 m . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.85 ' CD1' HD13 ' A' ' 10' ' ' LEU . 6.4 m95 -152.66 140.24 19.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.171 -0.956 . . . . 0.0 109.025 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -32.57 -82.21 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.798 -0.564 . . . . 0.0 111.536 -178.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.462 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.6 OUTLIER -64.01 -34.61 78.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.065 -1.022 . . . . 0.0 110.87 -178.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.834 ' CE2' HD12 ' A' ' 116' ' ' LEU . 1.1 m-30 -76.62 3.23 11.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.75 -1.219 . . . . 0.0 109.801 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.928 HG22 HG21 ' A' ' 11' ' ' VAL . 1.1 t -92.82 -46.45 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 8' ' ' THR . 0.9 OUTLIER -91.37 53.57 2.33 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.285 -0.884 . . . . 0.0 110.257 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -171.11 -92.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.738 -1.226 . . . . 0.0 111.687 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 11' ' ' VAL . 3.6 m120 -101.21 -88.34 0.37 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.065 -1.022 . . . . 0.0 112.181 -177.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.85 HD13 ' CD1' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -21.13 -44.26 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -177.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.928 HG21 HG22 ' A' ' 6' ' ' VAL . 41.0 t -94.37 -41.84 12.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.696 -1.252 . . . . 0.0 110.337 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.763 ' C ' HG22 ' A' ' 13' ' ' THR . . . -45.53 -41.04 8.92 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.763 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 157.83 37.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.681 0.753 . . . . 0.0 109.425 178.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.699 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -85.19 19.84 20.18 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 158.92 -25.63 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 13' ' ' THR . 10.8 m -141.11 134.01 30.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.539 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 17.5 p -80.08 10.2 4.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 109.367 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.539 ' CG ' ' O ' ' A' ' 17' ' ' THR . 88.2 mt-30 -162.45 166.31 25.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.432 -0.792 . . . . 0.0 108.931 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.76 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . 179.54 166.48 1.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 110.088 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -165.03 126.18 2.02 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.488 -0.758 . . . . 0.0 109.324 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.634 HD11 ' CA ' ' A' ' 2' ' ' TRP . 2.8 mt -91.01 108.27 19.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.229 -0.919 . . . . 0.0 108.591 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.755 HD11 HG21 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -94.51 101.21 13.1 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.276 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -42.83 169.33 0.01 OUTLIER Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.733 HD21 ' N ' ' A' ' 94' ' ' SER . 1.4 pp -119.9 -17.66 8.42 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.415 -1.05 . . . . 0.0 109.428 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.726 ' N ' HD12 ' A' ' 24' ' ' LEU . 1.9 m-20 -124.97 -4.69 7.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.394 -0.816 . . . . 0.0 109.437 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.28 -90.85 1.42 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -171.69 -45.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.346 -1.091 . . . . 0.0 109.722 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.7 m -166.16 129.88 2.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.859 . . . . 0.0 109.242 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.549 ' CD2' ' OG ' ' A' ' 94' ' ' SER . 14.8 m0 -96.75 -45.45 6.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.6 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.4 171.4 19.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 109.453 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -160.88 174.77 13.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.597 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.829 ' HB2' HG11 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -161.44 135.16 6.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.902 . . . . 0.0 109.581 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 87.12 -16.64 0.38 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . 127.41 -90.25 0.35 Allowed Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.09 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.699 ' CE2' HG21 ' A' ' 99' ' ' VAL . 0.3 OUTLIER 61.49 126.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -1.097 . . . . 0.0 109.105 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' A' ' 63' ' ' ALA . . . -136.7 95.34 3.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 109.849 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.49 ' HB ' ' HG2' ' A' ' 41' ' ' GLN . 3.4 t -105.26 92.34 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.26 -0.9 . . . . 0.0 108.953 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.62 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -93.28 -38.84 0.33 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.513 -0.742 . . . . 0.0 112.684 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 38' ' ' THR . 6.5 Cg_exo -54.91 -73.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.403 1.402 . . . . 0.0 111.806 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.537 ' HB1' ' HB3' ' A' ' 43' ' ' GLN . . . -154.0 81.17 1.14 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.826 -1.171 . . . . 0.0 110.111 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.49 ' HG2' ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -75.53 -63.31 1.32 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.264 -1.522 . . . . 0.0 108.659 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -91.79 -7.85 64.19 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.537 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -80.4 -43.27 21.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -1.103 . . . . 0.0 109.457 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 40' ' ' ALA . 17.3 m -76.31 -51.23 12.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 109.56 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.0 mt -58.35 -27.74 64.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.509 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -67.45 -42.83 82.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.802 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.9 t -91.42 -3.12 56.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.614 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.91 -14.27 37.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.632 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.45 ' CE2' ' HG3' ' A' ' 90' ' ' LYS . 18.1 m-30 -87.18 3.18 47.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 109.877 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.58 -41.4 15.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.051 -1.031 . . . . 0.0 109.251 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.48 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -151.46 146.13 25.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -0.872 . . . . 0.0 109.313 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 56' ' ' ARG . . . -89.6 28.97 1.2 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.886 . . . . 0.0 109.901 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.614 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -85.44 -44.66 0.64 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.029 -1.044 . . . . 0.0 110.587 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.2 Cg_endo -68.45 -74.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 121.617 1.545 . . . . 0.0 110.522 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.438 HD12 ' CB ' ' A' ' 72' ' ' ALA . 0.8 OUTLIER -41.87 -46.04 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.39 -0.818 . . . . 0.0 109.982 -179.449 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 3.1 ttt180 -45.47 -55.04 6.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 109.653 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 58' ' ' SER . . . -86.18 -91.83 0.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.836 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 57' ' ' ALA . 2.9 t -43.41 -76.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.195 -0.94 . . . . 0.0 109.758 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 55' ' ' ILE . . . 121.61 -133.71 9.61 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.964 ' CD2' HD21 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -144.24 153.58 42.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.077 -1.249 . . . . 0.0 109.541 179.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.634 ' C ' HD22 ' A' ' 62' ' ' LEU . 1.8 m-20 -95.21 128.67 42.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 110.094 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.964 HD21 ' CD2' ' A' ' 60' ' ' PHE . 4.0 mm? -107.59 57.35 0.63 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.499 ' CB ' ' O ' ' A' ' 36' ' ' ALA . . . 50.71 26.79 2.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.476 -0.765 . . . . 0.0 109.42 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.39 -97.01 0.12 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.771 -1.204 . . . . 0.0 110.242 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.594 HG12 ' N ' ' A' ' 66' ' ' HIS . 25.9 t -112.76 170.46 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.183 -1.186 . . . . 0.0 110.012 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.594 ' N ' HG12 ' A' ' 65' ' ' VAL . 74.0 m80 -85.29 132.7 34.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.736 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.586 ' CE1' ' HA ' ' A' ' 81' ' ' LYS . 25.3 m-85 -107.84 168.89 8.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.039 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.549 HG12 ' H ' ' A' ' 69' ' ' THR . 1.9 t -109.59 174.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.111 -0.993 . . . . 0.0 110.027 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.617 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -115.8 135.44 54.01 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.433 -0.792 . . . . 0.0 109.323 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.517 HD23 ' NE ' ' A' ' 71' ' ' ARG . 11.5 tp -89.94 -55.9 3.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.156 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.544 ' NH1' ' HG2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -137.23 75.77 1.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 109.048 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.658 ' HA ' HG23 ' A' ' 77' ' ' ILE . . . -101.83 81.68 2.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.89 . . . . 0.0 109.549 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 24.9 t70 178.02 -41.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.62 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.43 -81.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 109.806 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.69 -48.81 0.26 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.166 -0.959 . . . . 0.0 109.618 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.647 ' CB ' ' CZ ' ' A' ' 78' ' ' TYR . 0.7 OUTLIER -90.6 -170.51 2.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -0.941 . . . . 0.0 109.726 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.658 HG23 ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -163.13 63.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.1 -1.0 . . . . 0.0 110.05 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.844 ' HB3' HD13 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -92.14 115.3 27.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.905 -1.122 . . . . 0.0 109.04 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.401 ' C ' ' CG1' ' A' ' 86' ' ' VAL . . . -96.69 -158.33 31.45 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.25 158.79 34.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -1.191 . . . . 0.0 109.614 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 2.1 mtpt -123.92 -178.55 4.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.245 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.18 106.09 1.32 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 55.66 20.47 3.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.153 -1.204 . . . . 0.0 108.9 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.647 ' HB1' ' O ' ' A' ' 100' ' ' TYR . . . -136.18 -164.15 1.51 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 109.309 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 100' ' ' TYR . . . -147.57 131.05 3.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.607 HG22 HG23 ' A' ' 88' ' ' THR . 2.5 p -104.51 131.49 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.215 -1.168 . . . . 0.0 109.43 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.844 HD13 ' HB3' ' A' ' 78' ' ' TYR . 47.3 mm -115.14 101.68 12.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.263 -0.898 . . . . 0.0 109.208 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.971 HG22 HG13 ' A' ' 97' ' ' VAL . 7.8 p -117.46 146.16 43.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.071 -1.018 . . . . 0.0 109.603 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.551 ' HB ' HD21 ' A' ' 96' ' ' LEU . 2.1 t -146.95 141.89 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.768 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.45 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -91.3 124.2 35.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.426 -0.796 . . . . 0.0 108.946 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.682 HG21 HD11 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -103.25 -60.19 1.59 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.128 -0.982 . . . . 0.0 109.73 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -168.47 -66.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 0.0 109.437 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.727 ' HA ' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -120.65 15.85 11.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.182 -0.949 . . . . 0.0 109.473 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.733 ' N ' HD21 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -154.36 154.44 33.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.169 -0.957 . . . . 0.0 110.014 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.523 ' CD1' ' HB3' ' A' ' 24' ' ' LEU . 54.6 mt -125.61 138.37 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.916 HD13 ' N ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -112.29 166.43 11.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.975 -1.078 . . . . 0.0 109.956 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.971 HG13 HG22 ' A' ' 88' ' ' THR . 3.2 t -146.9 77.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -0.917 . . . . 0.0 111.21 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.37 107.09 1.66 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 107.28 -2.328 . . . . 0.0 107.28 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.699 HG21 ' CE2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -115.47 142.55 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.884 -1.363 . . . . 0.0 110.414 -178.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.647 ' O ' ' HB1' ' A' ' 84' ' ' ALA . 16.4 p90 -129.13 171.14 12.7 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.48 ' O ' ' CG ' ' A' ' 102' ' ' GLU . 5.9 p30 -150.2 115.2 5.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.676 -1.265 . . . . 0.0 111.183 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.48 ' CG ' ' O ' ' A' ' 101' ' ' ASN . 22.1 pt-20 39.06 31.4 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.518 0.675 . . . . 0.0 109.374 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.817 ' C ' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -133.18 -25.68 1.75 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.693 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.817 HD12 ' C ' ' A' ' 103' ' ' LYS . 1.8 mp -137.79 149.57 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.847 -1.158 . . . . 0.0 110.028 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 5.4 pm0 -99.72 145.0 29.39 Favored Pre-proline 0 C--N 1.307 -1.246 0 O-C-N 121.48 -0.762 . . . . 0.0 109.202 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 105' ' ' GLN . 1.1 Cg_endo -66.35 177.11 3.43 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.088 1.859 . . . . 0.0 110.103 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.35 -0.16 75.97 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 65.1 m -127.06 -45.24 1.57 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.113 -1.227 . . . . 0.0 109.582 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.795 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -80.1 -40.76 26.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 109.569 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.416 ' HB2' HD12 ' A' ' 87' ' ' ILE . . . -56.72 -17.02 7.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.329 -0.857 . . . . 0.0 109.757 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -78.09 -45.71 22.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.717 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 109' ' ' ALA . 11.1 p -71.54 -22.76 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.949 . . . . 0.0 109.857 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.817 HG21 HG21 ' A' ' 87' ' ' ILE . 6.0 t -71.26 -33.54 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.056 -1.027 . . . . 0.0 109.598 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.417 ' O ' ' OE1' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -80.13 -17.04 53.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.138 -0.976 . . . . 0.0 109.894 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.556 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -86.11 -59.2 2.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.965 . . . . 0.0 109.692 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.834 HD12 ' CE2' ' A' ' 5' ' ' TYR . 2.1 mm? -48.43 -35.85 13.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.095 -1.003 . . . . 0.0 109.308 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.763 ' HB2' ' CH2' ' A' ' 2' ' ' TRP . . . -68.8 -39.13 80.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.966 . . . . 0.0 109.478 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.62 -33.92 48.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 109.561 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.556 ' CD1' ' O ' ' A' ' 115' ' ' LYS . 32.8 m-85 -74.76 -58.6 3.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.083 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.736 ' C ' HD12 ' A' ' 120' ' ' LEU . 4.5 pp -72.27 2.35 6.17 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.445 -0.785 . . . . 0.0 110.417 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.473 ' CG1' HG22 ' A' ' 91' ' ' THR . 5.1 mt -88.96 -23.73 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 108.862 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.08 -30.18 53.79 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -92.77 -75.4 0.49 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.377 -1.073 . . . . 0.0 109.461 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 125' ' ' PHE . . . 132.35 36.77 0.29 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.523 ' CE2' HD13 ' A' ' 120' ' ' LEU . 16.0 m-85 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.375 -1.074 . . . . 0.0 109.518 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.593 ' C ' HG23 ' A' ' 6' ' ' VAL . 82.1 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.888 ' CD1' HD13 ' A' ' 10' ' ' LEU . 7.6 m95 61.69 154.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.924 . . . . 0.0 108.998 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -67.13 -80.75 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.13 -0.981 . . . . 0.0 111.366 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.475 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 0.8 OUTLIER -54.6 -22.93 14.83 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.097 -1.002 . . . . 0.0 111.094 -178.373 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.626 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 1.9 m-30 -87.58 -25.08 23.79 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.65 -1.281 . . . . 0.0 109.869 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.61 HG13 ' OG ' ' A' ' 32' ' ' SER . 0.9 OUTLIER -63.87 -26.69 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 108.923 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 1.034 ' OD2' HG22 ' A' ' 8' ' ' THR . 1.0 OUTLIER -52.85 -52.58 56.67 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.449 -0.782 . . . . 0.0 111.966 -177.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 1.034 HG22 ' OD2' ' A' ' 7' ' ' ASP . 5.0 t -163.38 -27.72 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.531 -1.356 . . . . 0.0 111.116 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 14' ' ' GLY . 1.7 m-80 -64.82 -88.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.656 -1.277 . . . . 0.0 109.764 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.888 HD13 ' CD1' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -59.94 -23.65 63.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.202 -0.936 . . . . 0.0 110.295 -179.379 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.599 HG23 ' HA ' ' A' ' 6' ' ' VAL . 1.5 t -89.21 -60.32 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.868 -1.145 . . . . 0.0 108.999 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.741 ' C ' HG22 ' A' ' 13' ' ' THR . . . -43.67 -36.89 3.62 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.741 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER 158.49 46.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.948 -0.736 . . . . 0.0 110.105 178.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.701 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -92.41 23.19 28.85 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 106.294 -2.723 . . . . 0.0 106.294 177.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 1.057 ' O ' HG21 ' A' ' 104' ' ' ILE . . . 154.0 -28.98 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.887 ' HA ' HD13 ' A' ' 104' ' ' ILE . 17.6 m -148.59 139.42 17.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.664 HG23 ' HG3' ' A' ' 18' ' ' GLN . 8.1 t -79.32 6.3 10.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.979 -1.076 . . . . 0.0 109.11 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.664 ' HG3' HG23 ' A' ' 17' ' ' THR . 45.9 mt-30 -160.6 155.63 24.41 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -168.81 175.9 5.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.019 -1.051 . . . . 0.0 110.286 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -165.2 114.09 1.04 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.55 -0.719 . . . . 0.0 109.181 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.751 HD11 ' C ' ' A' ' 2' ' ' TRP . 24.8 mt -79.65 80.74 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 120.999 -1.063 . . . . 0.0 108.851 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -60.33 -150.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.465 -0.772 . . . . 0.0 108.936 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.61 134.63 4.01 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.573 HD23 HG13 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -80.57 4.71 17.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -1.153 . . . . 0.0 109.561 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.12 -13.8 12.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.567 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . 96.26 81.63 1.58 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.551 ' O ' ' C ' ' A' ' 28' ' ' THR . 1.0 OUTLIER 167.8 55.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -1.146 . . . . 0.0 109.442 -179.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.551 ' C ' ' O ' ' A' ' 27' ' ' ASN . 21.2 m -20.55 130.36 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.37 0.605 . . . . 0.0 111.325 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.536 ' CE3' ' OG ' ' A' ' 94' ' ' SER . 22.2 m0 -88.68 -45.34 9.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.447 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.01 164.53 18.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.939 . . . . 0.0 109.853 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 3.2 t -157.92 177.47 11.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.413 -0.805 . . . . 0.0 108.879 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.61 ' OG ' HG13 ' A' ' 6' ' ' VAL . 15.3 m -167.13 117.26 0.87 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.112 -0.992 . . . . 0.0 110.375 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 32' ' ' SER . . . 34.32 90.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.164 0.507 . . . . 0.0 110.53 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.33 -84.32 0.05 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.668 ' CE2' HG22 ' A' ' 37' ' ' VAL . 3.3 p90 -172.74 159.58 4.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -1.067 . . . . 0.0 109.352 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.77 116.2 28.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.291 -0.881 . . . . 0.0 108.757 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.668 HG22 ' CE2' ' A' ' 35' ' ' PHE . 91.6 t -79.62 108.37 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.147 -0.971 . . . . 0.0 109.582 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.522 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 9.1 m -48.22 139.35 10.26 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.341 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.722 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 1.8 Cg_endo -63.92 167.7 13.47 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.13 1.887 . . . . 0.0 110.376 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 39' ' ' PRO . . . 82.36 -41.45 0.12 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.649 -0.657 . . . . 0.0 110.293 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -69.29 -31.22 69.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.044 -1.035 . . . . 0.0 109.745 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.31 -38.71 50.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -63.41 -35.7 81.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.175 -1.191 . . . . 0.0 109.923 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.0 m -56.53 -37.28 70.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -0.918 . . . . 0.0 109.791 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.88 -39.5 93.64 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.216 -0.927 . . . . 0.0 109.806 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.4 -26.01 63.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 109.975 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.4 t -88.22 -18.12 29.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.131 -0.98 . . . . 0.0 109.778 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' ASN . . . -73.18 -30.63 63.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.965 . . . . 0.0 109.571 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -54.9 -47.23 74.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 109.926 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 51' ' ' ASN . 13.7 p30 -79.7 -46.8 16.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.001 -1.062 . . . . 0.0 109.444 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 3.2 t30 -107.58 111.83 24.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 108.855 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.511 ' HA ' HG12 ' A' ' 55' ' ' ILE . . . -108.72 30.67 6.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 109.865 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.562 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -72.19 -55.39 5.01 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.124 -0.985 . . . . 0.0 109.739 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.1 Cg_endo -62.47 -11.58 23.73 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.021 1.814 . . . . 0.0 110.344 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.786 HD13 ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -109.7 -17.61 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.156 -0.965 . . . . 0.0 109.185 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 7.2 ttt180 -89.48 -18.43 26.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.172 -0.955 . . . . 0.0 109.551 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.91 43.47 1.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.424 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.35 61.78 2.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.396 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -137.25 60.31 0.61 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.711 ' HD1' HG22 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -109.21 93.35 4.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -1.172 . . . . 0.0 108.904 179.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -135.43 127.11 29.05 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.384 -0.822 . . . . 0.0 109.722 -179.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 64' ' ' GLY . 1.4 mm? -95.84 -166.38 1.43 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.397 -0.815 . . . . 0.0 109.248 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.97 91.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.185 -0.947 . . . . 0.0 109.067 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 62' ' ' LEU . . . 61.4 52.02 54.17 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 61' ' ' ASP . 2.9 t -141.04 119.44 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.292 -1.122 . . . . 0.0 109.571 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.43 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 34.9 m170 -79.69 124.89 28.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.338 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.526 ' CB ' ' O ' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -149.99 166.43 29.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.11 -0.994 . . . . 0.0 109.934 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.507 ' O ' ' CB ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -115.84 -176.93 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.81 . . . . 0.0 109.016 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.524 ' CB ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -133.64 109.73 9.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.096 -1.002 . . . . 0.0 109.606 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mp -101.72 -25.26 13.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.342 -0.849 . . . . 0.0 109.166 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.511 ' O ' HG23 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -149.38 117.22 6.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.415 -0.803 . . . . 0.0 109.193 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.515 ' HA ' HG12 ' A' ' 77' ' ' ILE . . . -160.5 74.84 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.087 -1.008 . . . . 0.0 109.847 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 30.0 t70 179.26 -36.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.46 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.441 ' OD2' ' NH2' ' A' ' 71' ' ' ARG . 3.2 m-20 -74.84 -84.63 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.216 -0.927 . . . . 0.0 110.045 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.595 ' CB ' ' CZ ' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -137.18 -62.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.994 -1.066 . . . . 0.0 110.288 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.639 ' CB ' ' CZ ' ' A' ' 78' ' ' TYR . 0.7 OUTLIER -90.08 163.79 14.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.384 -0.823 . . . . 0.0 110.495 -178.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.515 HG12 ' HA ' ' A' ' 72' ' ' ALA . 3.0 mt -143.41 70.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.607 -0.683 . . . . 0.0 109.329 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.787 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -88.98 103.8 16.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.713 -1.242 . . . . 0.0 108.928 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.47 169.3 33.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -148.77 147.89 29.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -1.102 . . . . 0.0 109.328 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.16 -30.39 1.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.877 . . . . 0.0 109.845 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 123.35 -66.98 0.5 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.507 ' CB ' ' OE2' ' A' ' 102' ' ' GLU . 1.1 p -87.23 -18.8 29.45 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.372 -1.075 . . . . 0.0 108.444 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.31 166.34 27.41 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -160.69 163.95 34.37 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.759 ' O ' HG13 ' A' ' 86' ' ' VAL . 9.8 p -129.91 104.8 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -1.113 . . . . 0.0 109.471 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.787 HG23 ' HD2' ' A' ' 78' ' ' TYR . 4.1 mt -80.48 94.42 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.087 -1.008 . . . . 0.0 109.013 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 2.7 p -101.86 106.01 16.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 110.16 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.421 HG22 ' CE2' ' A' ' 78' ' ' TYR . 25.5 t -116.89 149.31 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 108.895 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.509 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 29.4 mtpt -86.1 151.99 23.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 110.048 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.81 ' CG2' HD21 ' A' ' 96' ' ' LEU . 2.3 p -145.57 -159.74 1.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.85 . . . . 0.0 109.075 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.402 ' C ' ' HD3' ' A' ' 93' ' ' LYS . 16.2 t -69.07 85.34 0.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.446 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER 62.17 14.79 6.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.206 -0.934 . . . . 0.0 109.427 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.536 ' OG ' ' CE3' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -128.64 151.61 49.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.485 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.573 HG13 HD23 ' A' ' 24' ' ' LEU . 48.8 mt -127.52 123.42 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.952 . . . . 0.0 109.417 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.861 HD13 ' N ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -85.38 130.7 34.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 108.889 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.817 HG12 HG22 ' A' ' 99' ' ' VAL . 42.4 t -121.87 68.21 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.498 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.423 ' C ' HG11 ' A' ' 16' ' ' VAL . . . -62.0 99.65 0.24 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.817 HG22 HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -101.21 126.76 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -1.223 . . . . 0.0 108.983 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.608 ' CD1' HG12 ' A' ' 16' ' ' VAL . 3.7 p90 -141.82 -176.49 4.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 109.733 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 83' ' ' SER . 0.5 OUTLIER -138.1 -116.24 0.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.093 -1.005 . . . . 0.0 110.22 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.507 ' OE2' ' CB ' ' A' ' 83' ' ' SER . 9.9 mm-40 -85.29 -50.64 7.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.843 -1.161 . . . . 0.0 110.276 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -39.16 -27.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 110.574 -179.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.057 HG21 ' O ' ' A' ' 15' ' ' ALA . 12.4 mt -127.86 147.69 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.919 -1.113 . . . . 0.0 110.203 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -127.52 152.71 76.99 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.416 -0.803 . . . . 0.0 108.868 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.43 173.2 1.57 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.992 1.795 . . . . 0.0 110.272 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.74 -51.26 1.2 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 m -94.08 -33.71 13.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.373 -1.075 . . . . 0.0 108.929 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.76 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . . . -80.94 -35.05 32.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.575 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.61 -13.4 59.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.53 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.26 -42.63 12.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.764 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.3 p -70.57 -28.09 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 109.629 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.835 HG13 ' HZ2' ' A' ' 2' ' ' TRP . 73.6 t -83.94 -20.53 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.501 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.48 -37.55 63.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.885 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.534 ' HG3' ' N ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -77.03 -42.79 37.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.684 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.534 ' N ' ' HG3' ' A' ' 115' ' ' LYS . 25.7 mt -52.23 -57.18 10.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.047 -1.033 . . . . 0.0 109.458 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.556 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -64.56 -29.83 70.86 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.131 -0.981 . . . . 0.0 109.095 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -53.78 -21.98 8.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.129 -0.982 . . . . 0.0 109.176 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -90.64 -30.86 16.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.409 -0.807 . . . . 0.0 109.832 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.672 HD22 ' HB ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -73.04 -38.78 66.4 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.063 -1.023 . . . . 0.0 109.77 -179.505 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.556 HD12 ' O ' ' A' ' 117' ' ' ALA . 2.9 mp -64.86 -14.88 17.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.395 -0.816 . . . . 0.0 109.276 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -45.71 -35.4 5.81 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.33 -70.23 0.82 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -1.035 . . . . 0.0 108.974 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -117.39 -77.97 0.64 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.386 -1.067 . . . . 0.0 109.688 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.596 ' O ' ' HB2' ' A' ' 2' ' ' TRP . 84.3 p . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.88 ' HZ2' HD22 ' A' ' 96' ' ' LEU . 0.1 OUTLIER 79.28 -46.28 0.37 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 120.764 0.316 . . . . 0.0 110.394 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -67.49 -59.01 3.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.581 -1.324 . . . . 0.0 108.965 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.42 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.7 OUTLIER -71.82 -31.18 66.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.308 -0.87 . . . . 0.0 108.719 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.923 ' CD2' HD13 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -56.21 -17.12 6.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.451 -0.781 . . . . 0.0 108.925 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.702 HG23 HD11 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -94.39 -48.96 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.245 -0.91 . . . . 0.0 109.955 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.424 ' N ' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -89.83 45.95 1.32 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.785 -1.197 . . . . 0.0 110.677 -178.492 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 4' ' ' THR . 22.5 p -148.63 -104.94 0.08 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.855 -1.153 . . . . 0.0 110.003 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.483 ' O ' ' C ' ' A' ' 10' ' ' LEU . 2.3 t-20 -102.72 -69.14 0.8 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.032 -1.042 . . . . 0.0 111.156 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.923 HD13 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -27.77 -45.44 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.234 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.692 HG21 HG22 ' A' ' 6' ' ' VAL . 85.2 t -101.24 -25.43 3.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.477 -1.389 . . . . 0.0 110.976 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 11' ' ' VAL . . . -45.58 -27.78 2.19 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 106.544 -2.622 . . . . 0.0 106.544 177.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.711 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -175.22 -44.88 0.01 OUTLIER 'General case' 0 C--O 1.196 -1.718 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.716 ' O ' ' HB3' ' A' ' 15' ' ' ALA . . . 14.12 40.45 0.0 OUTLIER Glycine 0 N--CA 1.508 3.435 0 C-N-CA 123.567 0.603 . . . . 0.0 112.79 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 14' ' ' GLY . . . 86.7 -32.12 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.438 -1.036 . . . . 0.0 108.377 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.624 HG13 ' HB1' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -101.39 132.5 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.179 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.9 OUTLIER -86.25 21.04 2.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.958 -1.089 . . . . 0.0 109.261 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -176.99 176.1 1.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.633 ' CB ' HG22 ' A' ' 11' ' ' VAL . . . 174.35 166.33 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.004 -1.06 . . . . 0.0 110.1 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.469 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -163.66 136.09 5.15 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.702 HD11 HG23 ' A' ' 6' ' ' VAL . 1.2 mm -94.33 66.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.036 -1.04 . . . . 0.0 108.453 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.713 ' HG ' HG21 ' A' ' 97' ' ' VAL . 17.5 mt -60.83 109.54 1.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 108.938 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 94' ' ' SER . . . -60.35 159.47 24.87 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.681 ' CB ' HD11 ' A' ' 95' ' ' ILE . 1.0 OUTLIER -108.77 -6.9 15.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -1.022 . . . . 0.0 109.4 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -143.7 34.89 1.27 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.355 -0.841 . . . . 0.0 109.312 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.41 29.84 0.09 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 64.63 -144.58 0.26 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.214 -1.168 . . . . 0.0 109.503 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.3 m -77.66 147.95 35.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.153 -0.967 . . . . 0.0 110.019 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.483 ' CE3' ' HB3' ' A' ' 94' ' ' SER . 7.8 m0 -114.12 -47.45 2.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.336 -0.852 . . . . 0.0 108.786 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.35 167.27 30.54 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 10.1 t -160.3 159.79 31.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.957 -1.089 . . . . 0.0 110.055 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.632 ' HB2' HG13 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -150.99 92.99 1.88 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.591 -0.693 . . . . 0.0 109.155 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 32' ' ' SER . . . 170.78 -54.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.531 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.4 19.48 3.48 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.653 ' CZ ' HG21 ' A' ' 99' ' ' VAL . 10.4 p90 -125.54 134.76 51.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -1.174 . . . . 0.0 109.523 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.59 130.64 55.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.914 . . . . 0.0 109.305 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.1 t -79.62 131.7 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 109.598 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 m -48.29 125.58 11.89 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 108.994 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.82 -39.42 81.79 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.765 1.643 . . . . 0.0 109.976 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.79 -46.96 86.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.258 -0.901 . . . . 0.0 109.182 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -62.72 -21.18 65.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.273 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.79 -29.33 67.2 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -67.48 -44.62 78.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -1.155 . . . . 0.0 109.428 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.4 m -56.72 -25.71 55.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.285 -0.884 . . . . 0.0 109.372 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.528 HD13 HD11 ' A' ' 62' ' ' LEU . 9.9 tp -73.81 -41.68 62.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.26 -50.2 66.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.228 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.78 -16.45 64.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.18 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.89 -28.24 64.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.339 -0.851 . . . . 0.0 109.458 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -88.26 21.53 2.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.361 -0.837 . . . . 0.0 109.533 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -108.69 -44.47 4.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.356 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.89 ' O ' HD11 ' A' ' 55' ' ' ILE . 2.5 m-20 -122.87 141.46 51.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 109.477 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.455 ' HA ' HG13 ' A' ' 55' ' ' ILE . . . -105.82 -3.72 21.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.909 . . . . 0.0 109.611 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.562 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -77.25 -55.37 1.36 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.101 -1.0 . . . . 0.0 110.258 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 2.3 Cg_endo -62.37 -10.33 18.4 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.056 1.837 . . . . 0.0 111.225 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.89 HD11 ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -104.85 -23.72 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.946 -1.096 . . . . 0.0 109.62 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -81.98 -12.18 58.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.085 -1.01 . . . . 0.0 109.356 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.96 -75.85 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.6 t -85.73 -39.32 17.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.385 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 55' ' ' ILE . . . 85.69 -161.73 35.36 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.655 ' CE1' ' CG ' ' A' ' 67' ' ' TYR . 4.6 p90 -145.98 -168.99 3.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -1.11 . . . . 0.0 109.035 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 61' ' ' ASP . 26.7 p30 -160.04 157.53 28.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.012 -1.055 . . . . 0.0 110.483 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.528 HD11 HD13 ' A' ' 45' ' ' LEU . 96.5 mt -124.64 -160.04 0.92 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.73 97.75 10.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.973 -1.079 . . . . 0.0 109.733 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.19 -79.47 0.23 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.513 HG21 ' CB ' ' A' ' 84' ' ' ALA . 54.1 t -124.8 160.97 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -1.153 . . . . 0.0 109.322 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.5 ' N ' HG12 ' A' ' 65' ' ' VAL . 18.7 m170 -75.9 -171.45 1.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.127 -0.983 . . . . 0.0 109.317 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.86 ' OH ' HG13 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -137.39 119.78 15.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 109.831 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.409 HG21 ' HG3' ' A' ' 81' ' ' LYS . 82.7 t -89.71 -24.6 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -0.843 . . . . 0.0 108.735 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.895 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 92.6 m 57.52 101.38 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.599 -0.688 . . . . 0.0 110.151 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.38 -23.67 13.16 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -142.85 72.1 1.36 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.895 ' HB2' ' CG2' ' A' ' 69' ' ' THR . . . -85.4 52.25 2.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 0.0 109.828 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.66 -145.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.241 -0.912 . . . . 0.0 108.835 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.44 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 0.4 OUTLIER -119.66 34.65 5.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.155 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 7.5 mmt180 -136.7 -44.38 0.59 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 110.236 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.669 ' HA ' HG22 ' A' ' 89' ' ' VAL . 14.9 m -145.64 164.88 30.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.929 -1.107 . . . . 0.0 110.31 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.698 ' O ' HG22 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -162.24 97.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.774 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -115.31 129.81 56.72 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.593 ' HA3' ' CE1' ' A' ' 67' ' ' TYR . . . -101.6 155.7 18.89 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.518 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.528 ' HD2' ' CG ' ' A' ' 106' ' ' PRO . 2.0 pttp -151.0 141.24 22.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -1.089 . . . . 0.0 109.347 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.503 ' CG ' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER 165.13 143.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.933 -1.104 . . . . 0.0 110.565 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.401 ' C ' ' N ' ' A' ' 84' ' ' ALA . . . 63.94 48.94 71.23 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 47.03 21.9 0.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.05 -1.265 . . . . 0.0 109.549 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.513 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -151.3 147.28 26.76 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.318 -0.864 . . . . 0.0 108.759 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.555 ' CA ' ' CE2' ' A' ' 100' ' ' TYR . . . -169.68 -171.43 35.26 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.86 HG13 ' OH ' ' A' ' 67' ' ' TYR . 7.3 p -141.62 156.69 20.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.399 -1.059 . . . . 0.0 109.842 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.774 HG23 ' HD2' ' A' ' 78' ' ' TYR . 75.3 mt -121.37 93.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 11.4 p -107.91 133.24 52.54 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.197 -0.939 . . . . 0.0 110.643 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 1.091 ' HB ' HD21 ' A' ' 96' ' ' LEU . 2.1 t -150.76 156.86 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.234 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -79.99 143.89 33.74 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.459 -0.776 . . . . 0.0 109.192 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.601 HG21 ' CE2' ' A' ' 2' ' ' TRP . 67.9 p -146.88 -135.82 0.08 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.209 -0.932 . . . . 0.0 109.29 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -75.78 80.43 2.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.969 -1.082 . . . . 0.0 109.955 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 92' ' ' SER . 13.4 mttm 60.68 13.33 4.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.761 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.547 ' HB2' HG22 ' A' ' 21' ' ' ILE . 3.3 p -138.04 165.35 26.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.064 -1.022 . . . . 0.0 109.966 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.681 HD11 ' CB ' ' A' ' 24' ' ' LEU . 1.7 mt -128.82 112.99 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.418 -0.801 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.091 HD21 ' HB ' ' A' ' 89' ' ' VAL . 1.1 pt? -60.21 164.18 4.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.171 -0.956 . . . . 0.0 108.808 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.725 ' O ' HG12 ' A' ' 97' ' ' VAL . 71.8 t -150.84 57.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.533 -0.73 . . . . 0.0 109.518 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -49.06 114.89 2.35 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.653 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -107.28 143.68 17.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.053 -1.263 . . . . 0.0 109.768 -179.107 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.576 ' N ' ' CD1' ' A' ' 100' ' ' TYR . 0.1 OUTLIER -142.98 153.32 42.9 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -151.24 6.38 0.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.822 -1.174 . . . . 0.0 111.692 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 103' ' ' LYS . 3.0 mm-40 -100.77 -78.22 0.52 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.586 -1.321 . . . . 0.0 109.817 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 8.4 mmtp -155.11 30.03 0.4 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.428 -0.795 . . . . 0.0 109.255 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.728 HD13 ' N ' ' A' ' 104' ' ' ILE . 2.2 mm -62.58 149.35 9.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.263 -0.898 . . . . 0.0 109.644 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -106.54 141.52 22.99 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 109.388 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.528 ' CG ' ' HD2' ' A' ' 80' ' ' LYS . 2.1 Cg_endo -62.33 -26.45 77.08 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.078 1.852 . . . . 0.0 110.4 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.45 37.14 3.51 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.9 m -143.03 -46.25 0.3 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -1.132 . . . . 0.0 109.394 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.624 ' HB1' HG13 ' A' ' 16' ' ' VAL . . . -86.77 -25.47 24.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.414 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.95 -22.23 39.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 109.281 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.86 -39.99 63.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.435 -0.79 . . . . 0.0 109.562 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.4 p -76.34 -23.44 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.532 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 109' ' ' ALA . 70.0 t -85.63 -18.79 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.867 . . . . 0.0 109.581 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.98 -31.45 39.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.331 -0.856 . . . . 0.0 109.586 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -83.7 -55.13 4.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.855 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.454 HD22 HD11 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -58.65 -31.02 67.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.912 . . . . 0.0 109.501 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.945 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -73.51 -26.82 61.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.204 -0.935 . . . . 0.0 109.471 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -66.57 -26.65 67.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.131 -0.98 . . . . 0.0 109.675 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 8.8 t80 -82.23 -52.37 7.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.88 . . . . 0.0 109.608 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.501 HD23 ' HA ' ' A' ' 117' ' ' ALA . 0.5 OUTLIER -63.94 -25.26 68.06 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.22 -0.925 . . . . 0.0 109.943 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.945 HD12 ' O ' ' A' ' 117' ' ' ALA . 2.8 mt -90.63 -18.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.94 . . . . 0.0 109.193 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.28 -16.67 28.37 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -91.26 -60.77 1.81 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -1.148 . . . . 0.0 109.334 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 125' ' ' PHE . . . 158.38 104.39 0.2 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.988 0 O-C-N 121.19 -1.182 . . . . 0.0 108.905 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.546 ' C ' ' CG ' ' A' ' 2' ' ' TRP . 1.2 p . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 1.019 ' N ' HD11 ' A' ' 21' ' ' ILE . 8.1 m95 74.28 173.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.365 -0.834 . . . . 0.0 109.335 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -81.88 -90.57 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.924 -1.11 . . . . 0.0 111.08 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.56 -34.61 7.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.101 -0.999 . . . . 0.0 110.332 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.619 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 1.9 m-30 -71.07 -38.17 72.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.049 -1.032 . . . . 0.0 109.601 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.836 ' HA ' HG23 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -51.72 -24.15 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 6' ' ' VAL . 20.5 t0 -40.37 -89.91 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.532 -0.73 . . . . 0.0 111.253 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.2 t -144.05 -23.46 0.56 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.063 -1.023 . . . . 0.0 111.427 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.584 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.4 m120 -75.42 -55.7 5.43 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.674 -1.266 . . . . 0.0 109.504 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 0.6 OUTLIER -76.91 -25.36 52.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.848 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.836 HG23 ' HA ' ' A' ' 6' ' ' VAL . 1.8 t -92.36 -55.12 6.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.183 -0.948 . . . . 0.0 108.712 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.742 ' C ' HG22 ' A' ' 13' ' ' THR . . . -43.69 -39.17 4.57 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 107.952 -2.059 . . . . 0.0 107.952 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.742 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 159.94 47.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.827 -0.808 . . . . 0.0 110.068 178.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.707 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -90.57 20.77 36.2 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 106.918 -2.473 . . . . 0.0 106.918 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.707 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 156.43 -32.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 27.5 m -141.93 147.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.647 ' N ' HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -80.67 12.58 3.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.944 -1.097 . . . . 0.0 109.209 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.712 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -175.42 -178.32 1.12 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 18' ' ' GLN . . . 161.56 148.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 109.31 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.521 ' HB2' ' OG1' ' A' ' 31' ' ' THR . . . -137.82 160.23 39.84 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.166 -0.959 . . . . 0.0 109.482 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 1.019 HD11 ' N ' ' A' ' 2' ' ' TRP . 30.8 mt -131.81 95.9 2.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.832 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -89.86 128.08 36.12 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.442 0.639 . . . . 0.0 109.459 -178.029 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.19 167.54 49.12 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.981 ' N ' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -71.25 -8.34 52.94 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.52 -0.988 . . . . 0.0 109.515 -179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -78.83 -27.21 44.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.555 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.29 -3.03 34.91 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -93.5 -155.51 0.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -1.175 . . . . 0.0 109.145 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.22 129.71 56.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.886 -1.134 . . . . 0.0 110.138 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.577 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 3.1 m0 -101.16 -34.04 9.85 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.316 -0.865 . . . . 0.0 108.907 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 29' ' ' TRP . . . 170.33 92.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.433 -0.792 . . . . 0.0 109.063 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.521 ' OG1' ' HB2' ' A' ' 20' ' ' ALA . 14.1 t -109.31 172.08 7.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 110.105 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.791 ' OG ' HG13 ' A' ' 6' ' ' VAL . 16.1 m -156.41 86.77 1.02 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.481 -0.762 . . . . 0.0 109.366 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.543 ' HB3' ' CE2' ' A' ' 35' ' ' PHE . . . -169.39 -55.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.306 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.94 -43.99 1.29 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.543 ' CE2' ' HB3' ' A' ' 33' ' ' ALA . 11.1 p90 -48.08 162.52 0.08 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -1.091 . . . . 0.0 109.591 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.63 121.82 38.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.213 -0.93 . . . . 0.0 109.484 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.408 HG13 HD22 ' A' ' 62' ' ' LEU . 75.6 t -89.94 123.25 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.887 . . . . 0.0 109.427 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.68 127.2 91.17 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.16 -0.962 . . . . 0.0 109.307 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.737 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 1.9 Cg_endo -62.2 169.41 7.84 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.036 1.824 . . . . 0.0 110.526 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.737 ' HB3' ' O ' ' A' ' 39' ' ' PRO . . . 83.03 -24.41 0.17 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.721 -0.612 . . . . 0.0 110.345 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.471 ' HB3' HD21 ' A' ' 62' ' ' LEU . 0.8 OUTLIER -81.45 -10.55 59.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.986 -1.072 . . . . 0.0 109.55 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -56.74 -34.5 64.89 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -70.35 -39.36 74.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -1.167 . . . . 0.0 109.656 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.9 m -51.22 -34.17 31.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.541 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.6 tp -67.35 -48.38 67.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.467 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.17 -7.52 30.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 0.0 109.62 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.61 -29.45 16.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.087 -1.008 . . . . 0.0 109.735 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.89 -24.84 58.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.137 -0.977 . . . . 0.0 109.819 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.479 ' CE1' ' O ' ' A' ' 75' ' ' ARG . 9.1 m-85 -57.11 -29.59 63.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 109.566 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -113.27 -16.72 12.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.101 -0.999 . . . . 0.0 109.465 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -117.46 112.27 20.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 109.21 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.646 ' HA ' HD11 ' A' ' 55' ' ' ILE . . . -100.26 -8.77 23.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.608 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.573 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -64.79 -52.6 49.5 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 109.902 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.1 Cg_endo -64.33 -4.84 8.66 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.197 1.931 . . . . 0.0 111.205 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.646 HD11 ' HA ' ' A' ' 52' ' ' ALA . 1.9 pp -128.39 0.74 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.932 -1.105 . . . . 0.0 109.684 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -98.27 -34.77 10.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.113 -0.992 . . . . 0.0 109.45 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.46 -23.09 65.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -0.821 . . . . 0.0 109.695 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.9 t -170.47 -38.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.126 -0.984 . . . . 0.0 109.688 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 54' ' ' PRO . . . 132.53 -123.11 3.45 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.667 ' CE1' HD12 ' A' ' 62' ' ' LEU . 34.3 p90 -160.28 170.98 19.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.108 -1.231 . . . . 0.0 109.699 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.33 140.22 43.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.705 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 3.0 mt -147.99 115.69 6.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.885 . . . . 0.0 109.61 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.705 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . 76.62 13.04 2.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 109.753 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.65 29.23 24.58 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.657 HG12 ' H ' ' A' ' 66' ' ' HIS . 1.5 t -130.69 -169.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -1.138 . . . . 0.0 109.2 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.657 ' H ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -134.75 126.08 28.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.122 -0.986 . . . . 0.0 110.195 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -112.88 152.46 29.25 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.61 163.8 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.725 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.1 m -103.85 135.25 45.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.308 -0.87 . . . . 0.0 109.496 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.565 HD13 ' CD ' ' A' ' 80' ' ' LYS . 2.1 tp -113.91 -50.33 2.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.704 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.31 51.63 1.37 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 109.689 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.645 ' HB3' HD13 ' A' ' 55' ' ' ILE . . . -79.28 87.73 4.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.223 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.75 -55.93 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.86 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -81.86 -103.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.064 -1.022 . . . . 0.0 109.716 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.479 ' O ' ' CE1' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -134.59 0.54 3.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.903 -1.123 . . . . 0.0 109.975 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 43.7 m -106.22 142.5 35.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.058 -1.026 . . . . 0.0 109.613 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 77' ' ' ILE . 36.3 mt -139.78 88.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.45 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 76' ' ' SER . 1.7 m-85 -90.25 65.98 6.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.051 -1.03 . . . . 0.0 109.575 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -44.85 153.04 0.55 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.565 ' CD ' HD13 ' A' ' 70' ' ' LEU . 11.6 ptpt -151.49 94.53 2.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.022 -1.281 . . . . 0.0 109.844 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -160.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 0.0 109.263 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -46.06 -73.75 0.27 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.468 ' OG ' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -112.2 -24.2 9.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -1.158 . . . . 0.0 109.483 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.31 -174.02 4.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.152 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.555 ' N ' ' CE1' ' A' ' 100' ' ' TYR . . . 177.18 152.23 9.75 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.092 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 86' ' ' VAL . 9.5 p -117.86 124.27 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -1.042 . . . . 0.0 108.709 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.693 HG21 HG21 ' A' ' 113' ' ' VAL . 67.4 mt -100.62 89.81 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.983 -1.073 . . . . 0.0 110.21 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 11.3 p -101.89 135.24 43.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.131 -0.981 . . . . 0.0 109.64 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.419 ' HB ' HD12 ' A' ' 96' ' ' LEU . 47.2 t -149.16 155.9 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.211 -0.93 . . . . 0.0 109.486 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.405 ' N ' HG12 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -101.82 131.96 47.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.109 -0.994 . . . . 0.0 109.481 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.2 p -107.76 -97.72 0.37 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.252 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.9 p -129.58 -31.92 1.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.017 -1.052 . . . . 0.0 109.484 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.27 51.61 0.53 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.919 . . . . 0.0 109.341 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.605 ' CA ' HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -178.9 159.06 1.0 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.529 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.558 HG13 HD12 ' A' ' 24' ' ' LEU . 25.0 mt -120.38 112.14 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.12 -0.987 . . . . 0.0 109.304 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.863 HD13 ' CH2' ' A' ' 2' ' ' TRP . 8.3 mt -67.54 153.15 44.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.335 -0.853 . . . . 0.0 109.618 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.768 HG21 ' HG ' ' A' ' 22' ' ' LEU . 60.5 t -150.58 53.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.844 . . . . 0.0 109.776 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -45.16 137.44 6.31 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 97' ' ' VAL . 2.4 t -139.48 117.72 11.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.044 -1.268 . . . . 0.0 108.649 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.555 ' CE1' ' N ' ' A' ' 85' ' ' GLY . 7.2 p90 -138.31 164.04 30.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.014 -1.054 . . . . 0.0 109.756 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -110.64 -145.54 0.4 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 0.0 109.881 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.468 ' HG2' ' OG ' ' A' ' 83' ' ' SER . 10.4 mt-10 -76.05 -7.48 54.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.968 . . . . 0.0 110.104 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -16.44 61.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.074 -1.016 . . . . 0.0 109.758 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.647 HD13 ' N ' ' A' ' 17' ' ' THR . 1.2 mp -136.99 141.05 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.246 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -101.98 150.34 37.34 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 109.559 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.458 ' HB2' ' HE2' ' A' ' 80' ' ' LYS . 1.9 Cg_endo -62.32 161.82 25.82 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.27 1.98 . . . . 0.0 110.444 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.6 -55.91 4.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.1 m -67.94 -31.58 71.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -1.081 . . . . 0.0 109.689 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.615 ' O ' HG12 ' A' ' 112' ' ' VAL . . . -84.24 -36.92 22.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 109.504 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.96 -29.79 71.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.297 -0.877 . . . . 0.0 109.498 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -61.28 -36.37 79.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.982 . . . . 0.0 109.524 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.804 HG22 HD13 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -77.76 -31.62 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.135 -0.978 . . . . 0.0 109.432 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.693 HG21 HG21 ' A' ' 87' ' ' ILE . 53.5 t -63.61 -23.65 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.086 -1.008 . . . . 0.0 109.451 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -77.85 -43.73 29.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.342 -0.849 . . . . 0.0 109.715 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -80.81 -63.73 1.34 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 109.23 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.804 HD13 HG22 ' A' ' 112' ' ' VAL . 0.2 OUTLIER -42.23 -28.42 0.19 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.495 -0.753 . . . . 0.0 109.661 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 113' ' ' VAL . . . -73.72 -47.98 35.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.715 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -49.13 -21.39 0.74 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.07 -1.019 . . . . 0.0 110.008 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -85.47 -41.33 15.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.318 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 1.1 mt -78.21 -56.08 4.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.097 -1.002 . . . . 0.0 110.361 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.453 ' C ' ' O ' ' A' ' 120' ' ' LEU . 17.8 mt -39.77 -33.44 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.316 -0.865 . . . . 0.0 109.821 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.58 -51.43 36.43 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -59.65 -71.1 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -1.133 . . . . 0.0 109.475 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 130.27 112.15 1.51 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 120' ' ' LEU . 82.7 m-85 . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.211 -1.17 . . . . 0.0 109.535 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.759 ' HA ' HD11 ' A' ' 120' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.603 ' CE3' ' HG ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER 78.28 -6.62 1.92 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.329 -0.857 . . . . 0.0 109.435 -179.524 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 4' ' ' THR . 35.2 tt0 -77.8 -81.14 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.055 -1.028 . . . . 0.0 108.746 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.652 ' O ' HG22 ' A' ' 8' ' ' THR . 1.2 t -48.47 -30.23 4.93 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.619 ' CD2' ' CD2' ' A' ' 10' ' ' LEU . 3.2 m-30 -48.19 -54.67 12.65 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.841 ' HA ' HG23 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -50.53 -37.77 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -0.799 . . . . 0.0 109.644 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.684 ' C ' HG22 ' A' ' 8' ' ' THR . 1.0 OUTLIER -90.85 51.53 1.99 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.071 -1.018 . . . . 0.0 111.951 -178.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.684 HG22 ' C ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER 173.28 -87.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.482 -1.386 . . . . 0.0 111.486 178.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 11' ' ' VAL . 4.2 m-20 -90.04 -83.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 111.34 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.619 ' CD2' ' CD2' ' A' ' 5' ' ' TYR . 3.8 mm? -21.12 -44.8 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.889 HG13 ' HA ' ' A' ' 18' ' ' GLN . 38.5 t -88.02 -59.22 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.659 -1.276 . . . . 0.0 110.279 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.77 ' C ' HG22 ' A' ' 13' ' ' THR . . . -37.8 -41.07 0.84 Allowed Glycine 0 N--CA 1.498 2.805 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.77 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 155.95 39.88 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.607 0.718 . . . . 0.0 109.378 178.177 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.678 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -83.75 19.32 16.17 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 156.2 -28.08 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 13' ' ' THR . 2.2 m -151.41 152.08 11.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.542 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -79.66 8.12 7.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.798 -1.189 . . . . 0.0 109.292 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.889 ' HA ' HG13 ' A' ' 11' ' ' VAL . 31.5 mt-30 -162.64 176.6 10.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.623 ' HA ' HG23 ' A' ' 99' ' ' VAL . . . -177.78 155.49 1.02 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.863 -1.148 . . . . 0.0 110.234 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.506 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -148.91 114.63 5.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 0.0 109.576 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.62 ' C ' HD23 ' A' ' 22' ' ' LEU . 7.9 mm -81.28 114.86 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.84 -1.162 . . . . 0.0 108.693 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.881 HD11 HG21 ' A' ' 97' ' ' VAL . 0.6 OUTLIER -108.51 88.37 2.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -0.915 . . . . 0.0 108.994 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.609 ' HA3' ' CD2' ' A' ' 29' ' ' TRP . . . -50.11 -177.51 0.02 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.794 HD11 ' CA ' ' A' ' 93' ' ' LYS . 13.0 mt -84.03 -50.93 7.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.384 -1.068 . . . . 0.0 109.408 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.86 13.25 33.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.017 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 28' ' ' THR . . . -130.75 80.31 0.35 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.472 ' C ' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -35.44 -31.04 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.905 -0.762 . . . . 0.0 110.441 -179.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -139.04 99.19 3.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.939 -1.1 . . . . 0.0 110.171 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.609 ' CD2' ' HA3' ' A' ' 23' ' ' GLY . 6.5 m0 -95.85 -24.61 16.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 108.996 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -171.79 145.01 1.87 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.42 HG22 ' HB1' ' A' ' 20' ' ' ALA . 18.5 p -149.82 162.03 41.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.123 -0.986 . . . . 0.0 109.848 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.838 ' OG ' HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -166.08 84.6 0.31 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.445 -0.785 . . . . 0.0 109.205 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.4 -67.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 109.295 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 138.6 -23.34 2.96 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.5 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -62.23 178.71 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.063 -1.257 . . . . 0.0 109.782 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 63' ' ' ALA . . . -107.89 125.84 51.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.024 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.777 HG13 ' CD ' ' A' ' 41' ' ' GLN . 8.3 t -144.89 103.52 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.768 HG23 ' HD3' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -173.66 -59.12 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.176 -0.953 . . . . 0.0 110.175 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.768 ' HD3' HG23 ' A' ' 38' ' ' THR . 1.9 Cg_endo -59.4 118.33 5.2 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.708 1.605 . . . . 0.0 110.774 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.507 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . . . 54.95 35.17 23.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.291 -0.881 . . . . 0.0 109.973 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.777 ' CD ' HG13 ' A' ' 37' ' ' VAL . 2.4 mm-40 -90.39 -53.88 4.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.801 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.59 -42.84 16.65 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.507 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 4.0 pp0? -59.7 -26.94 66.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -1.18 . . . . 0.0 109.679 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.0 m -67.47 -53.66 26.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 109.341 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.556 ' O ' ' CD2' ' A' ' 49' ' ' PHE . 8.5 mp -63.53 -29.71 70.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 109.681 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.16 92.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.952 . . . . 0.0 109.533 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.2 t -86.33 -17.23 35.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.495 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.65 51.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.425 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 45' ' ' LEU . 35.4 m-85 -79.01 -10.38 59.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.175 -0.953 . . . . 0.0 109.642 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -89.38 -0.44 57.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.96 . . . . 0.0 109.578 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.471 ' HB2' ' CD ' ' A' ' 54' ' ' PRO . 1.8 p30 175.28 118.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.069 -1.019 . . . . 0.0 109.839 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 72' ' ' ALA . . . -94.97 -13.35 25.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -0.813 . . . . 0.0 109.259 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.61 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -63.08 -50.17 77.46 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 110.204 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.4 Cg_endo -63.83 -13.63 38.25 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.02 1.814 . . . . 0.0 110.967 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.799 HD11 ' CB ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -91.68 -14.79 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.861 -1.149 . . . . 0.0 109.532 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.603 ' CB ' ' CZ ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -81.29 -48.39 12.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.867 . . . . 0.0 109.477 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 58' ' ' SER . . . -77.01 -86.68 0.05 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.242 -0.911 . . . . 0.0 109.43 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 57' ' ' ALA . 20.2 m -44.36 -57.44 3.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.334 -0.854 . . . . 0.0 109.156 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.89 175.04 18.93 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.495 ' CE1' ' OG1' ' A' ' 69' ' ' THR . 10.7 p90 -124.59 124.44 42.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.436 -1.038 . . . . 0.0 108.984 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.87 161.47 15.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -0.964 . . . . 0.0 110.137 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.61 -142.78 0.24 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 36' ' ' ALA . . . -74.02 -0.59 16.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.24 -0.913 . . . . 0.0 109.557 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.41 -102.09 2.76 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.593 HG12 ' CD2' ' A' ' 66' ' ' HIS . 0.9 OUTLIER -136.22 -147.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.23 -1.159 . . . . 0.0 109.538 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.593 ' CD2' HG12 ' A' ' 65' ' ' VAL . 2.5 m-70 -82.43 133.79 35.22 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.151 -0.968 . . . . 0.0 109.505 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' A' ' 60' ' ' PHE . 3.0 m-30 -112.76 147.64 36.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 109.495 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -93.25 143.12 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.136 -0.978 . . . . 0.0 109.321 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.633 HG21 ' CD1' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -108.41 119.17 38.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.627 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 70' ' ' LEU . 1.4 pp -111.66 21.3 16.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.583 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.423 ' CG ' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER 177.21 102.29 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.134 -0.979 . . . . 0.0 109.523 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.799 ' CB ' HD11 ' A' ' 55' ' ' ILE . . . -153.7 54.6 0.73 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.108 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.24 -16.82 4.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.136 -0.978 . . . . 0.0 110.142 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -110.84 -104.73 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.0 109.752 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -143.41 27.61 1.54 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.955 -1.09 . . . . 0.0 109.253 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.615 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -143.12 129.24 19.73 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.469 ' O ' ' OG1' ' A' ' 88' ' ' THR . 2.4 mp -133.37 99.4 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.922 -1.111 . . . . 0.0 111.025 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.656 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -109.52 96.47 6.3 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.128 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.66 168.98 42.37 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.455 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.451 ' HG3' ' HA3' ' A' ' 85' ' ' GLY . 19.8 tttt -150.52 154.69 38.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.525 -0.985 . . . . 0.0 109.109 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 -13.42 9.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.012 -1.055 . . . . 0.0 109.737 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.37 -76.91 0.23 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.4 p -94.61 -40.9 9.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -1.219 . . . . 0.0 109.384 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.34 145.27 26.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 0.0 109.359 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.578 ' O ' ' CE1' ' A' ' 100' ' ' TYR . . . -138.65 143.46 14.23 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.986 HG23 HG13 ' A' ' 97' ' ' VAL . 2.4 p -110.23 136.05 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -1.099 . . . . 0.0 109.56 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 87' ' ' ILE . 3.2 mt -109.92 91.63 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -0.766 . . . . 0.0 109.011 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 5.0 p -89.33 112.67 23.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.061 -1.024 . . . . 0.0 109.69 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.48 136.88 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.265 -0.897 . . . . 0.0 108.837 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.29 150.62 23.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.067 -1.021 . . . . 0.0 110.032 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.9 p -132.95 -144.63 0.24 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.398 -0.814 . . . . 0.0 109.048 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.543 ' HB3' ' CA ' ' A' ' 124' ' ' GLY . 47.0 t -87.01 -29.86 21.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.039 -1.038 . . . . 0.0 109.447 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.794 ' CA ' HD11 ' A' ' 24' ' ' LEU . 17.2 mttt -159.58 55.91 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 0.0 109.796 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.63 ' CB ' ' CG ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -177.73 151.25 0.7 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.869 -1.144 . . . . 0.0 110.213 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.7 ' C ' HD13 ' A' ' 96' ' ' LEU . 14.7 mt -125.08 126.16 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.805 HD22 ' N ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -108.24 161.61 14.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.992 -178.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.986 HG13 HG23 ' A' ' 86' ' ' VAL . 25.6 t -139.49 125.86 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.61 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.474 ' HA3' ' HB ' ' A' ' 87' ' ' ILE . . . -103.79 101.22 1.98 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 107.875 -2.09 . . . . 0.0 107.875 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.623 HG23 ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -99.23 128.93 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -1.123 . . . . 0.0 109.048 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.633 ' N ' ' CD1' ' A' ' 100' ' ' TYR . 1.3 p90 -144.48 -170.82 3.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.64 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 101' ' ' ASN . 0.0 OUTLIER -120.19 -159.14 0.77 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.895 . . . . 0.0 109.047 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -76.32 -16.33 59.79 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.3 -0.875 . . . . 0.0 109.567 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -37.9 83.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.387 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.553 HG13 ' HB2' ' A' ' 100' ' ' TYR . 14.8 mm -79.62 150.79 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.294 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -93.76 138.18 22.9 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.144 -0.973 . . . . 0.0 109.188 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.96 -23.95 53.67 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.1 1.867 . . . . 0.0 110.828 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.06 -47.04 4.27 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.879 -1.153 . . . . 0.0 110.512 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 112' ' ' VAL . 15.7 m -66.5 -47.44 73.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.004 -1.292 . . . . 0.0 109.89 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.45 -12.13 28.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 0.0 110.023 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.62 -26.44 19.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 0.0 109.942 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -83.7 -42.44 16.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.089 -1.007 . . . . 0.0 109.591 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 108' ' ' THR . 2.5 t -67.31 -36.8 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.346 -0.846 . . . . 0.0 110.064 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.679 HG11 HG21 ' A' ' 87' ' ' ILE . 88.6 t -76.41 -26.81 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.196 -0.94 . . . . 0.0 109.585 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -60.67 -50.88 71.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.847 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 116' ' ' LEU . 13.9 ptmm? -66.66 -35.08 79.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 109.64 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.539 ' HA ' HD22 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -44.26 -42.26 6.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 0.0 109.034 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.497 ' C ' HD12 ' A' ' 121' ' ' ILE . . . -75.58 -37.36 59.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -0.889 . . . . 0.0 109.029 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 115' ' ' LYS . 2.6 m-20 -47.57 -25.65 1.2 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 109.189 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -83.63 -45.97 12.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.811 . . . . 0.0 109.323 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.759 HD11 ' HA ' ' A' ' 1' ' ' SER . 0.5 OUTLIER -87.92 11.03 16.82 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.242 -0.911 . . . . 0.0 109.842 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.497 HD12 ' C ' ' A' ' 117' ' ' ALA . 0.9 OUTLIER -90.41 -22.43 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 109.191 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -71.82 -45.83 41.19 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -84.14 -28.88 27.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -1.176 . . . . 0.0 109.425 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.543 ' CA ' ' HB3' ' A' ' 92' ' ' SER . . . 81.19 48.83 5.82 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.63 ' CG ' ' CB ' ' A' ' 94' ' ' SER . 12.6 m-85 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.405 -1.056 . . . . 0.0 109.876 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.937 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 121.011 0.434 . . . . 0.0 110.282 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.734 ' CH2' HD13 ' A' ' 96' ' ' LEU . 2.8 m95 -88.53 -160.29 0.63 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.986 -1.071 . . . . 0.0 110.242 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.439 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 1.9 mm-40 -72.96 -109.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.873 -1.142 . . . . 0.0 110.567 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.994 ' O ' HG22 ' A' ' 8' ' ' THR . 5.0 t -48.79 -45.47 40.15 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.725 -1.234 . . . . 0.0 109.022 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.003 ' CD2' HD21 ' A' ' 116' ' ' LEU . 14.9 m-30 -41.71 -46.3 3.74 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.549 0.69 . . . . 0.0 109.409 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.669 HG23 ' HB2' ' A' ' 1' ' ' SER . 1.4 t -52.87 -53.66 20.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.462 -0.774 . . . . 0.0 110.007 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.75 50.76 1.74 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.055 -1.028 . . . . 0.0 112.193 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.994 HG22 ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -160.12 -101.33 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.43 -1.419 . . . . 0.0 110.416 178.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -102.15 -69.72 0.78 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.965 -1.085 . . . . 0.0 110.988 -178.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.731 HD13 ' HB3' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -22.94 -40.86 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.659 HG23 ' HA ' ' A' ' 6' ' ' VAL . 4.9 t -80.98 -70.11 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.509 -1.37 . . . . 0.0 110.377 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.741 ' C ' HG22 ' A' ' 13' ' ' THR . . . -38.18 -31.94 0.12 Allowed Glycine 0 N--CA 1.497 2.756 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.741 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER 152.14 42.58 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.701 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -84.78 22.6 8.91 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 154.62 -31.1 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.626 HG12 ' HB3' ' A' ' 100' ' ' TYR . 25.6 m -152.6 147.1 14.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.525 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -78.8 5.76 10.6 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.014 -1.053 . . . . 0.0 108.619 179.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 17' ' ' THR . 23.3 mt-30 -163.34 160.71 23.99 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.815 ' HB3' ' CB ' ' A' ' 1' ' ' SER . . . -173.33 -179.83 2.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.068 -1.02 . . . . 0.0 109.027 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.651 ' HA ' ' H1 ' ' A' ' 1' ' ' SER . . . 176.57 115.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.92 . . . . 0.0 110.36 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.937 HD13 ' C ' ' A' ' 1' ' ' SER . 1.5 mp -80.71 100.29 4.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.732 HD11 HG21 ' A' ' 97' ' ' VAL . 3.0 mt -86.93 111.74 21.11 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.542 -0.724 . . . . 0.0 109.863 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.12 -166.37 0.33 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.974 HD11 ' O ' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -116.22 16.19 15.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.381 -1.07 . . . . 0.0 109.481 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -96.35 -29.2 14.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.79 -25.63 3.07 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.7 p30 -100.15 -163.0 0.99 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -1.106 . . . . 0.0 109.449 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.3 m -129.18 136.57 50.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.109 -0.994 . . . . 0.0 109.608 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -79.93 -45.96 17.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.938 . . . . 0.0 108.93 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 1' ' ' SER . . . -137.29 136.78 38.32 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.06 167.73 21.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.979 -1.076 . . . . 0.0 109.888 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.22 57.2 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 18' ' ' GLN . . . -120.71 -145.51 0.36 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.302 -0.874 . . . . 0.0 109.609 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.94 8.07 5.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.428 ' CZ ' HG11 ' A' ' 99' ' ' VAL . 20.6 p90 -134.26 177.36 7.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -1.167 . . . . 0.0 109.479 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.5 120.79 33.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 109.424 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 t -87.66 151.9 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 109.523 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -105.16 158.48 32.01 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.669 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.14 -30.89 75.46 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.15 1.9 . . . . 0.0 110.41 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.98 78.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.172 -0.955 . . . . 0.0 110.101 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -81.11 -9.93 59.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 109.992 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.27 -34.74 50.47 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -79.45 -41.59 27.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.15 -1.206 . . . . 0.0 109.694 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.1 m -53.96 -42.5 68.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.877 . . . . 0.0 109.397 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.418 HD23 ' CZ ' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -63.16 -40.32 97.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.0 109.496 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.581 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . . . -59.86 -41.76 92.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.191 -0.943 . . . . 0.0 109.314 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.3 p -73.89 -20.67 60.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.335 -0.853 . . . . 0.0 109.121 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 51' ' ' ASN . . . -67.86 -22.54 65.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.407 -0.808 . . . . 0.0 109.477 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.599 ' CE2' ' HG3' ' A' ' 90' ' ' LYS . 51.8 m-85 -70.79 -23.12 62.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.469 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -91.74 -32.81 15.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 0.0 109.446 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.413 ' O ' ' O ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -120.25 147.87 44.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.642 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.615 ' HA ' HD11 ' A' ' 55' ' ' ILE . . . -119.44 8.96 11.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 109.499 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.589 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -78.39 -49.49 1.79 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.279 -0.888 . . . . 0.0 110.337 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.6 Cg_endo -66.02 -9.97 25.31 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.953 1.768 . . . . 0.0 111.115 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -109.05 -13.32 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.955 -1.091 . . . . 0.0 109.886 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.506 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 15.0 ptm180 -97.99 -13.36 21.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 109.464 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -124.99 117.98 25.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.611 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 59' ' ' GLY . 1.5 p 69.11 10.28 7.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.281 -0.887 . . . . 0.0 109.42 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 68' ' ' VAL . . . 44.18 -123.09 4.76 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.402 ' CD2' HG22 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -157.85 -174.72 4.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -1.111 . . . . 0.0 109.539 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -119.13 125.41 49.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.359 -0.838 . . . . 0.0 109.17 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.699 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -120.66 104.27 9.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.888 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . 77.78 -81.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.35 -0.844 . . . . 0.0 109.831 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.63 16.85 0.48 Allowed Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.653 -1.261 . . . . 0.0 110.139 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 66' ' ' HIS . 7.3 t -123.43 164.86 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.055 -1.262 . . . . 0.0 109.245 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.437 ' N ' HG12 ' A' ' 65' ' ' VAL . 5.2 m170 -111.0 123.11 49.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.139 -0.976 . . . . 0.0 109.816 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -120.08 165.89 14.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 108.813 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 69' ' ' THR . 0.9 OUTLIER -124.96 -162.19 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.067 -1.021 . . . . 0.0 109.464 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.794 HG21 ' HB2' ' A' ' 72' ' ' ALA . 57.2 m -155.83 131.31 9.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.925 . . . . 0.0 109.778 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.54 HD22 ' O ' ' A' ' 69' ' ' THR . 2.9 mm? -119.82 19.89 12.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.9 . . . . 0.0 109.238 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.48 ' H ' HG22 ' A' ' 69' ' ' THR . 29.9 ttm180 178.9 78.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.319 -0.863 . . . . 0.0 109.387 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.794 ' HB2' HG21 ' A' ' 69' ' ' THR . . . -106.99 77.4 1.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.751 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -75.45 176.72 7.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 109.187 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.15 -2.43 55.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 109.545 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.486 ' NH1' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -98.16 -66.07 0.92 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 0.0 109.101 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.54 ' HA ' HG23 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -127.25 176.46 7.39 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.306 -0.871 . . . . 0.0 109.402 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.521 ' CG1' ' O ' ' A' ' 76' ' ' SER . 29.8 mt -159.49 134.26 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 109.583 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.68 ' CD1' HG23 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -142.5 81.8 1.75 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.043 179.457 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.52 170.38 42.64 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.49 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -150.82 158.71 44.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -1.103 . . . . 0.0 109.606 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.551 ' HG3' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER 176.22 105.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 109.448 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.544 ' N ' ' HE3' ' A' ' 81' ' ' LYS . . . 85.82 33.51 15.48 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 82' ' ' GLY . 1.7 p 71.36 4.69 5.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -1.108 . . . . 0.0 109.39 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 100' ' ' TYR . . . -122.47 118.28 27.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.241 -0.912 . . . . 0.0 109.14 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 80' ' ' LYS . . . -126.45 149.76 17.58 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.861 HG23 HG13 ' A' ' 97' ' ' VAL . 13.4 p -105.18 123.79 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.405 -1.056 . . . . 0.0 109.379 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.785 HG22 ' O ' ' A' ' 87' ' ' ILE . 1.3 mt -87.7 79.67 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.303 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 7.4 p -92.24 126.55 37.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -0.864 . . . . 0.0 109.723 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.642 HG13 HD12 ' A' ' 96' ' ' LEU . 2.1 p -145.68 130.49 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.278 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.599 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -82.48 131.31 35.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.904 . . . . 0.0 109.598 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.451 ' CG2' HD11 ' A' ' 96' ' ' LEU . 1.9 p -102.75 -95.97 0.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.845 . . . . 0.0 109.401 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.44 ' C ' ' HG2' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -125.81 -43.0 1.87 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.023 -1.048 . . . . 0.0 109.409 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.974 ' O ' HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -146.46 50.37 1.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.915 . . . . 0.0 109.609 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.569 ' N ' HD21 ' A' ' 24' ' ' LEU . 1.2 p 170.73 166.19 0.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.101 -0.999 . . . . 0.0 109.671 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.7 mt -118.91 142.88 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.171 -0.956 . . . . 0.0 109.379 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.734 HD13 ' CH2' ' A' ' 2' ' ' TRP . 0.5 OUTLIER -108.4 147.8 31.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.934 . . . . 0.0 108.731 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.861 HG13 HG23 ' A' ' 86' ' ' VAL . 70.3 t -133.04 131.02 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.895 -1.128 . . . . 0.0 110.653 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.447 ' HA3' ' HB ' ' A' ' 87' ' ' ILE . . . -118.97 91.96 0.52 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -94.97 110.01 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.136 -1.214 . . . . 0.0 109.586 -178.476 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.626 ' HB3' HG12 ' A' ' 16' ' ' VAL . 30.7 p90 -119.87 158.27 26.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.424 -0.797 . . . . 0.0 109.79 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.492 ' O ' HG13 ' A' ' 104' ' ' ILE . 7.1 m-20 -131.29 174.46 10.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.278 -0.889 . . . . 0.0 109.56 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 16.0 mm-40 70.68 26.34 3.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.695 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.45 78.6 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.963 . . . . 0.0 109.42 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.623 HG22 ' O ' ' A' ' 104' ' ' ILE . 5.1 mt -98.04 54.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.146 -0.971 . . . . 0.0 109.879 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER 41.94 97.09 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.476 -0.765 . . . . 0.0 110.238 179.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.41 -13.94 18.66 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.952 1.768 . . . . 0.0 110.297 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -100.78 -30.04 6.28 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 105' ' ' GLN . 31.4 m -73.21 -31.99 64.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.12 -1.223 . . . . 0.0 109.437 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -88.23 -15.04 36.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.32 -0.863 . . . . 0.0 109.527 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.98 -31.27 25.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.628 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.473 ' O ' ' HB3' ' A' ' 114' ' ' GLU . 2.8 m120 -73.55 -39.08 65.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.13 -0.981 . . . . 0.0 109.523 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.564 HG11 ' HB1' ' A' ' 15' ' ' ALA . 6.1 p -61.93 -37.78 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 0.0 109.185 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 109' ' ' ALA . 21.9 t -68.62 -20.68 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.327 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 111' ' ' ASN . 6.5 tt0 -63.79 -61.84 2.04 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.151 -0.968 . . . . 0.0 109.09 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -39.1 89.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.129 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.003 HD21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -57.27 -27.02 61.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.381 -0.824 . . . . 0.0 109.448 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.518 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -75.56 -44.2 44.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 0.0 109.49 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -53.26 -19.08 2.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.91 . . . . 0.0 109.472 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -82.58 -58.58 2.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 109.787 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.618 HD22 ' OXT' ' A' ' 125' ' ' PHE . 2.6 mt -61.3 -56.56 19.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.952 . . . . 0.0 110.115 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 117' ' ' ALA . 6.1 mt -41.2 -29.84 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.272 -0.892 . . . . 0.0 109.802 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 123' ' ' GLN . . . -105.61 49.35 0.9 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 122' ' ' GLY . 2.2 mt-30 -173.68 -69.65 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.398 -1.06 . . . . 0.0 109.61 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.452 ' O ' ' OXT' ' A' ' 125' ' ' PHE . . . -133.88 56.13 0.73 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.618 ' OXT' HD22 ' A' ' 120' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.397 -1.061 . . . . 0.0 109.588 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.566 ' C ' ' CG ' ' A' ' 2' ' ' TRP . 1.5 t . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.995 ' C ' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER 57.67 146.13 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.17 -0.956 . . . . 0.0 109.988 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.632 ' N ' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -83.63 -76.47 0.29 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.083 -1.011 . . . . 0.0 110.583 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.527 HG23 ' CD1' ' A' ' 5' ' ' TYR . 2.1 t -39.56 -28.81 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.208 -0.933 . . . . 0.0 109.737 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.597 ' HB2' ' HB2' ' A' ' 2' ' ' TRP . 18.1 m-30 -86.36 -43.45 12.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 0.0 108.916 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.809 HG13 ' HB2' ' A' ' 32' ' ' SER . 0.9 OUTLIER -46.77 -27.87 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.472 0.653 . . . . 0.0 109.852 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.56 -84.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 111.869 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.91 2.58 3.68 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.681 -1.262 . . . . 0.0 110.801 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.535 ' O ' ' N ' ' A' ' 14' ' ' GLY . 6.0 m-20 -92.87 -90.99 0.18 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.969 -1.082 . . . . 0.0 109.621 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -52.97 -30.2 33.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.155 -0.966 . . . . 0.0 110.081 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.828 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 21.2 t -88.64 -59.01 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.054 -1.029 . . . . 0.0 109.554 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.744 ' C ' HG22 ' A' ' 13' ' ' THR . . . -42.38 -30.73 0.87 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 107.944 -2.063 . . . . 0.0 107.944 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.744 HG22 ' C ' ' A' ' 12' ' ' GLY . 1.0 OUTLIER 147.66 51.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.12 0.486 . . . . 0.0 109.885 178.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.699 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -90.03 19.22 43.57 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 107.071 -2.411 . . . . 0.0 107.071 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 144.93 -25.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 34.8 m -139.11 149.94 23.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.52 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 5.5 p -87.29 20.75 2.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.976 -1.077 . . . . 0.0 108.662 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.543 ' HB3' ' CB ' ' A' ' 33' ' ' ALA . 4.7 mp0 -171.21 172.59 5.25 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.578 -0.701 . . . . 0.0 109.256 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.828 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . -175.73 135.11 0.3 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.073 -1.017 . . . . 0.0 109.602 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.526 ' O ' HD22 ' A' ' 22' ' ' LEU . . . -133.08 121.06 22.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.072 -1.018 . . . . 0.0 110.079 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.995 HD11 ' C ' ' A' ' 2' ' ' TRP . 8.0 mt -86.16 96.72 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 108.624 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.801 HD23 ' CG2' ' A' ' 97' ' ' VAL . 3.0 mm? -79.15 -179.92 6.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.373 -0.829 . . . . 0.0 109.18 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 94' ' ' SER . . . -133.35 106.36 0.63 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.576 HD23 ' C ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -51.82 -38.2 54.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -1.178 . . . . 0.0 109.465 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -138.85 35.61 2.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.482 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.38 -102.32 1.1 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.424 ' O ' ' HB ' ' A' ' 28' ' ' THR . 0.2 OUTLIER 174.57 52.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -1.12 . . . . 0.0 109.401 -179.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.509 ' O ' HG22 ' A' ' 28' ' ' THR . 1.4 m 59.18 98.93 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.981 -1.074 . . . . 0.0 109.139 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.525 ' CE2' ' OG ' ' A' ' 94' ' ' SER . 38.2 m0 -84.07 -29.27 26.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.88 . . . . 0.0 109.639 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.24 157.99 33.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 109.396 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.457 ' O ' ' OG ' ' A' ' 32' ' ' SER . 0.1 OUTLIER -160.09 152.13 20.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.576 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.809 ' HB2' HG13 ' A' ' 6' ' ' VAL . 73.7 m -169.72 58.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.845 . . . . 0.0 109.402 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 18' ' ' GLN . . . -120.27 -66.38 1.07 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.199 -0.938 . . . . 0.0 109.778 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.6 -37.95 1.88 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.794 -1.723 . . . . 0.0 108.794 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.506 ' CZ ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -59.0 177.47 0.15 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.386 -1.067 . . . . 0.0 109.415 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.49 140.47 29.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 110.439 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.506 ' CG2' ' CZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -149.28 135.64 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.342 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.408 ' OG1' ' HB1' ' A' ' 63' ' ' ALA . 43.6 p -132.66 117.0 15.09 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.168 -0.957 . . . . 0.0 109.617 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.706 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 6.2 Cg_exo -58.07 117.11 3.76 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.952 1.768 . . . . 0.0 110.384 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 39' ' ' PRO . . . 162.91 -63.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 109.005 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 63' ' ' ALA . 9.5 mm-40 -68.08 -12.36 60.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.147 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.88 -24.55 42.13 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -68.69 -52.37 31.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -1.12 . . . . 0.0 109.324 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.9 m -57.86 -25.8 61.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.358 -0.838 . . . . 0.0 109.243 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.511 ' HG ' ' CE1' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -65.13 -43.8 90.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.279 -0.888 . . . . 0.0 109.493 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.71 -30.84 70.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 109.893 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 p -66.11 -30.87 71.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.278 -0.889 . . . . 0.0 110.086 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.07 -10.97 59.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.126 -0.984 . . . . 0.0 109.904 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.708 ' CD2' HD13 ' A' ' 77' ' ' ILE . 4.4 m-85 -90.41 17.61 7.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.928 . . . . 0.0 109.583 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -98.75 5.52 47.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 0.0 109.35 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.539 ' O ' HD11 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -176.47 162.66 2.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.317 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 56' ' ' ARG . . . -101.26 -2.02 32.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.562 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 1.4 m-20 -75.7 -54.65 2.19 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 110.129 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 3.5 Cg_exo -61.57 -11.31 19.62 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.007 1.805 . . . . 0.0 110.686 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.539 HD11 ' O ' ' A' ' 51' ' ' ASN . 0.7 OUTLIER -118.62 -11.08 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.993 . . . . 0.0 109.658 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.511 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -97.89 44.59 1.04 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 0.0 109.264 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -169.85 -58.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.126 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.9 p -94.73 -25.8 16.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.334 -0.854 . . . . 0.0 109.298 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.64 -152.58 20.61 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -142.66 -174.66 4.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -1.073 . . . . 0.0 109.342 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.46 136.37 17.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.144 -0.972 . . . . 0.0 109.812 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.6 mp -82.23 -138.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 108.944 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 41' ' ' GLN . . . -84.5 41.72 0.86 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.942 -1.099 . . . . 0.0 110.328 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.94 0.59 5.57 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.66 140.6 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.175 -1.191 . . . . 0.0 109.748 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.471 ' N ' ' CD2' ' A' ' 66' ' ' HIS . 3.6 m170 -106.14 108.9 20.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 109.565 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.12 166.4 12.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.177 -0.952 . . . . 0.0 109.257 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.603 HG22 ' N ' ' A' ' 69' ' ' THR . 12.0 p -118.57 170.1 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.197 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.624 HG21 ' HB2' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -144.88 154.78 42.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 109.432 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 tp -124.36 -67.09 0.94 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.291 -0.88 . . . . 0.0 109.442 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.409 ' O ' ' O ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -107.11 51.63 0.74 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.565 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.624 ' HB2' HG21 ' A' ' 69' ' ' THR . . . -54.54 -172.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -145.34 -150.82 0.34 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.545 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -111.61 -52.21 2.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.97 . . . . 0.0 109.527 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.417 HH11 ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -96.79 2.7 52.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 109.785 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.689 ' C ' HD12 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -142.19 140.58 32.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.872 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.708 HD13 ' CD2' ' A' ' 49' ' ' PHE . 2.2 mp -158.38 104.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 109.247 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.765 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -108.15 120.64 42.93 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.273 -0.892 . . . . 0.0 108.659 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.92 157.79 49.09 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.484 ' HE3' ' HG3' ' A' ' 106' ' ' PRO . 1.2 mmmp? -151.12 118.64 6.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -1.085 . . . . 0.0 109.471 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.16 141.8 16.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.994 . . . . 0.0 109.429 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 55.16 -126.22 38.23 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.34 18.1 17.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.139 -1.212 . . . . 0.0 109.661 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.09 128.96 33.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.746 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -132.73 164.59 24.02 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 78' ' ' TYR . 1.8 m -127.77 149.48 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.022 -1.281 . . . . 0.0 110.165 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.765 HG23 ' HD2' ' A' ' 78' ' ' TYR . 6.5 mt -116.5 83.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.7 OUTLIER -89.26 142.2 27.86 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.239 -0.913 . . . . 0.0 110.303 -178.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.726 ' HB ' HD12 ' A' ' 96' ' ' LEU . 85.4 t -150.13 154.24 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -109.22 121.82 45.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.005 -1.06 . . . . 0.0 109.802 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.788 HG22 HG13 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -92.26 -55.11 3.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.291 -0.881 . . . . 0.0 109.535 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 91' ' ' THR . 9.3 t 171.51 -31.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.067 -1.021 . . . . 0.0 109.95 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.4 mttm -128.75 -28.53 2.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.015 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.576 ' C ' HD23 ' A' ' 24' ' ' LEU . 39.8 m -135.34 152.45 51.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.044 -1.035 . . . . 0.0 109.847 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.508 HG13 ' N ' ' A' ' 24' ' ' LEU . 14.4 mt -94.08 142.33 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.346 -0.846 . . . . 0.0 109.32 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.82 HD22 ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -107.0 148.52 28.58 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.801 ' CG2' HD23 ' A' ' 22' ' ' LEU . 39.8 t -140.25 131.89 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.995 -1.066 . . . . 0.0 110.215 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.474 ' HA3' ' HB ' ' A' ' 87' ' ' ILE . . . -104.86 102.91 2.13 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 107.444 -2.262 . . . . 0.0 107.444 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -96.73 123.42 49.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.248 -1.148 . . . . 0.0 109.238 -178.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.537 ' HB2' HD12 ' A' ' 104' ' ' ILE . 3.4 p90 -132.52 164.2 27.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.298 -0.876 . . . . 0.0 109.491 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -149.22 -170.41 3.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.506 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 60.81 22.14 12.2 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.175 -0.953 . . . . 0.0 109.371 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.43 82.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.589 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' ' 100' ' ' TYR . 4.0 mt -97.27 147.66 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.155 -0.966 . . . . 0.0 109.283 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -50.88 109.38 1.32 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.307 -0.871 . . . . 0.0 109.546 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.484 ' HG3' ' HE3' ' A' ' 80' ' ' LYS . 2.4 Cg_endo -62.13 -35.26 76.35 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.921 1.748 . . . . 0.0 110.167 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.2 47.18 3.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 112' ' ' VAL . 16.6 m -148.36 -39.2 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 109.414 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.486 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -88.12 -18.94 27.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.604 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.53 -46.98 24.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -63.75 -42.04 97.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.429 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 108' ' ' THR . 89.3 t -62.74 -26.4 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.239 -0.913 . . . . 0.0 109.565 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.543 HG21 HG21 ' A' ' 87' ' ' ILE . 47.6 t -87.55 -22.86 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.366 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -63.89 -42.41 97.49 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.229 -0.919 . . . . 0.0 109.307 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -78.32 -51.24 10.41 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.363 -0.836 . . . . 0.0 109.226 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.593 HD21 ' CE2' ' A' ' 5' ' ' TYR . 4.1 tp -49.67 -33.09 14.74 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.154 -0.966 . . . . 0.0 109.109 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.744 ' C ' HD12 ' A' ' 121' ' ' ILE . . . -62.24 -47.91 82.31 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.248 -0.907 . . . . 0.0 108.584 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -15.79 47.69 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.492 -0.755 . . . . 0.0 109.088 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -83.65 -47.58 11.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.431 -0.793 . . . . 0.0 108.988 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.959 HD23 ' HA3' ' A' ' 124' ' ' GLY . 0.4 OUTLIER -80.92 -7.67 59.56 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.357 -0.839 . . . . 0.0 109.591 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.788 HG13 HG22 ' A' ' 91' ' ' THR . 26.6 mt -90.13 -20.94 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.31 -0.869 . . . . 0.0 109.347 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 123' ' ' GLN . . . -112.92 -0.31 25.65 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 122' ' ' GLY . 1.8 mt-30 -140.7 -47.27 0.41 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -1.147 . . . . 0.0 109.472 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.959 ' HA3' HD23 ' A' ' 120' ' ' LEU . . . -74.88 -102.31 0.1 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.191 -1.182 . . . . 0.0 109.261 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.569 ' HB3' HG21 ' A' ' 21' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.952 ' CZ2' HD22 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -67.2 94.52 0.36 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.11 -0.994 . . . . 0.0 109.675 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.83 -79.72 0.33 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.734 -1.229 . . . . 0.0 108.219 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -17.59 61.85 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.691 ' CD2' HD12 ' A' ' 10' ' ' LEU . 9.9 m-30 -75.35 -39.34 59.41 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.929 HG23 ' HB2' ' A' ' 2' ' ' TRP . 1.2 t -54.2 -48.42 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.586 -0.696 . . . . 0.0 110.027 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.627 ' O ' HG23 ' A' ' 8' ' ' THR . 5.5 t0 -90.91 52.37 2.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 112.513 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER 176.78 -87.49 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.26 -1.525 . . . . 0.0 112.783 178.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 11' ' ' VAL . 14.0 m120 -83.43 -92.06 0.07 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.105 -0.997 . . . . 0.0 112.494 -176.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.691 HD12 ' CD2' ' A' ' 5' ' ' TYR . 3.0 mt -23.79 -41.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.978 HG22 ' HB3' ' A' ' 19' ' ' ALA . 72.2 t -89.61 -57.42 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.576 -1.327 . . . . 0.0 110.523 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.756 ' C ' HG22 ' A' ' 13' ' ' THR . . . -40.65 -47.56 3.89 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 108.741 -1.743 . . . . 0.0 108.741 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.756 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER 166.72 38.63 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.708 -0.878 . . . . 0.0 108.932 178.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.694 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -82.67 15.35 31.36 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.886 ' HB2' HG11 ' A' ' 112' ' ' VAL . . . 157.99 -27.58 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.626 HG12 ' HB3' ' A' ' 100' ' ' TYR . 23.5 m -143.4 154.34 16.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.2 OUTLIER -83.95 17.41 2.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.974 -1.079 . . . . 0.0 109.533 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.572 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -176.99 177.47 1.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.978 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . 179.19 158.04 0.58 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.84 -1.162 . . . . 0.0 110.265 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.513 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -153.94 117.71 4.7 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.674 HD11 ' CG ' ' A' ' 2' ' ' TRP . 6.9 mm -82.63 113.39 21.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.221 -0.924 . . . . 0.0 109.19 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.119 HD22 ' CG2' ' A' ' 97' ' ' VAL . 0.4 OUTLIER -96.32 117.14 30.21 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.537 -0.727 . . . . 0.0 109.566 -178.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -50.7 179.98 0.03 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.551 HD23 ' H ' ' A' ' 24' ' ' LEU . 1.2 pt? -121.37 -8.98 9.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -1.192 . . . . 0.0 109.659 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -111.58 26.96 10.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.932 . . . . 0.0 109.537 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.08 70.44 1.31 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -171.62 -164.99 0.35 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -1.158 . . . . 0.0 109.331 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.05 111.09 7.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.168 -0.957 . . . . 0.0 109.58 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 36.5 m0 -83.91 -33.63 24.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.428 ' HB3' ' CG1' ' A' ' 21' ' ' ILE . . . -164.9 158.98 17.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.285 -0.884 . . . . 0.0 109.399 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.3 t -152.31 141.55 21.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.159 -0.963 . . . . 0.0 109.812 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.777 ' CB ' HG21 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -130.13 119.97 23.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.396 -0.815 . . . . 0.0 108.998 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 81.73 159.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.589 -0.694 . . . . 0.0 109.375 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 33' ' ' ALA . . . -43.45 -93.25 0.01 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.414 ' CE1' HG21 ' A' ' 99' ' ' VAL . 0.9 OUTLIER 68.75 94.73 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -1.139 . . . . 0.0 109.533 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.564 ' O ' ' HB2' ' A' ' 63' ' ' ALA . . . -102.52 100.3 10.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.385 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.466 ' HB ' ' HG2' ' A' ' 41' ' ' GLN . 1.8 t -109.28 166.24 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.876 . . . . 0.0 109.529 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.479 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -50.22 153.55 2.42 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.372 -0.83 . . . . 0.0 109.545 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.456 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 5.3 Cg_exo -58.97 -16.07 30.55 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.159 1.906 . . . . 0.0 110.436 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 43' ' ' GLN . . . -122.52 56.89 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.222 -0.924 . . . . 0.0 109.48 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 38' ' ' THR . 3.9 mp0 -51.67 -37.05 48.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.026 -1.046 . . . . 0.0 109.265 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.31 -39.58 70.73 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.539 ' HB2' ' HB1' ' A' ' 40' ' ' ALA . 1.3 tm0? -63.15 -37.41 87.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -1.194 . . . . 0.0 110.033 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.1 m -62.46 -51.66 66.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.186 -0.946 . . . . 0.0 109.668 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.899 HD22 HG21 ' A' ' 95' ' ' ILE . 2.1 mp -65.73 -23.32 66.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 109.75 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.582 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . . . -62.92 -37.15 85.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.94 . . . . 0.0 109.674 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.8 m -76.98 -28.39 55.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.539 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.61 -14.22 62.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.548 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CD2' ' HA ' ' A' ' 46' ' ' ALA . 23.2 m-85 -76.51 -39.54 52.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.94 . . . . 0.0 109.398 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -87.48 -66.73 0.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.129 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -117.3 140.73 49.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 0.0 109.117 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.469 ' O ' HG12 ' A' ' 55' ' ' ILE . . . -135.64 33.57 2.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -0.958 . . . . 0.0 109.767 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.638 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -68.22 -45.28 39.22 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.377 -0.827 . . . . 0.0 110.652 179.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 6.3 Cg_exo -59.44 -18.71 47.74 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.524 1.483 . . . . 0.0 110.595 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.127 HD11 ' CB ' ' A' ' 72' ' ' ALA . 1.1 pt -105.7 -19.03 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 109.163 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.438 HH11 ' CG ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -76.79 -37.48 55.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.364 -0.835 . . . . 0.0 109.655 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 56' ' ' ARG . . . -43.87 -71.56 0.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 0.0 109.74 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.464 ' O ' HG23 ' A' ' 68' ' ' VAL . 1.9 t -118.83 -47.12 2.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.636 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 68' ' ' VAL . . . 166.01 -163.42 36.77 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.42 ' HE2' HG23 ' A' ' 69' ' ' THR . 0.3 OUTLIER -112.94 161.16 17.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -1.146 . . . . 0.0 109.475 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.42 104.79 12.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 109.708 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.88 112.67 25.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.865 . . . . 0.0 109.514 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 36' ' ' ALA . . . 49.71 -143.38 0.54 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.567 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.87 46.89 3.75 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.539 HG11 ' CE2' ' A' ' 67' ' ' TYR . 3.4 t -142.34 138.93 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -1.179 . . . . 0.0 108.963 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.407 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 75.9 t60 -121.46 118.91 30.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 0.0 109.77 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.539 ' CE2' HG11 ' A' ' 65' ' ' VAL . 15.9 m-85 -131.73 177.62 7.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 109.241 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.614 HG22 ' N ' ' A' ' 69' ' ' THR . 7.7 p -104.42 166.16 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.268 -0.895 . . . . 0.0 109.846 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.614 ' N ' HG22 ' A' ' 68' ' ' VAL . 1.4 m -95.49 176.76 6.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.933 . . . . 0.0 109.173 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.556 ' H ' HG22 ' A' ' 69' ' ' THR . 0.2 OUTLIER -141.33 -48.42 0.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.141 -0.974 . . . . 0.0 110.234 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 76' ' ' SER . 13.8 ttm180 -142.8 61.38 1.42 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.947 -1.096 . . . . 0.0 110.153 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 1.127 ' CB ' HD11 ' A' ' 55' ' ' ILE . . . -85.34 81.66 8.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.123 -0.985 . . . . 0.0 109.393 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -154.88 -38.56 0.09 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.284 -0.885 . . . . 0.0 109.477 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.93 -100.18 0.35 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.761 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.452 ' CG ' ' NH1' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -129.11 -16.23 4.07 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.882 -1.136 . . . . 0.0 110.106 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.627 ' C ' HD12 ' A' ' 77' ' ' ILE . 6.1 m -89.37 131.82 35.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.827 -1.17 . . . . 0.0 109.415 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.697 ' O ' HG22 ' A' ' 77' ' ' ILE . 4.7 mp -149.21 60.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 110.116 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.847 ' HB3' HD13 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -90.51 161.31 15.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.036 -1.04 . . . . 0.0 108.333 179.008 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.82 158.25 14.45 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.444 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 19.3 mtmt -145.34 132.64 20.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -1.09 . . . . 0.0 109.375 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.9 OUTLIER 171.63 128.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 109.508 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 83' ' ' SER . . . 56.96 54.78 34.23 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 82' ' ' GLY . 0.6 OUTLIER 43.79 26.77 0.14 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -1.151 . . . . 0.0 109.61 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.497 ' HA ' ' CE2' ' A' ' 100' ' ' TYR . . . -145.34 153.36 41.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.205 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 179.5 -166.79 36.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.406 ' O ' HD13 ' A' ' 87' ' ' ILE . 2.5 m -122.38 179.91 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -1.149 . . . . 0.0 109.649 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.847 HD13 ' HB3' ' A' ' 78' ' ' TYR . 36.4 mm -142.85 68.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.104 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.798 HG22 HG13 ' A' ' 97' ' ' VAL . 1.2 p -99.93 116.86 32.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 110.028 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.36 150.99 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.428 -0.795 . . . . 0.0 108.963 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.5 ' HG3' HG12 ' A' ' 95' ' ' ILE . 1.8 mtpt -98.35 149.97 22.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.147 -0.97 . . . . 0.0 109.778 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.6 p -123.42 -138.75 0.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.808 . . . . 0.0 108.871 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.503 ' HB2' ' HA ' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -66.64 -17.01 64.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.858 -1.151 . . . . 0.0 109.302 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.583 ' HB2' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER 167.49 66.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 p 176.86 156.58 0.28 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.347 -0.845 . . . . 0.0 109.126 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.899 HG21 HD22 ' A' ' 45' ' ' LEU . 14.7 mt -129.39 100.67 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.037 -1.039 . . . . 0.0 109.831 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.952 HD22 ' CZ2' ' A' ' 2' ' ' TRP . 2.9 pp -78.42 137.85 38.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 108.954 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 1.119 ' CG2' HD22 ' A' ' 22' ' ' LEU . 11.9 t -117.4 81.28 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.139 -0.976 . . . . 0.0 110.183 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.49 ' CA ' ' HB ' ' A' ' 87' ' ' ILE . . . -74.47 110.5 3.1 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.476 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -111.62 127.74 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -1.228 . . . . 0.0 109.44 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.626 ' HB3' HG12 ' A' ' 16' ' ' VAL . 22.4 p90 -130.97 173.01 11.41 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 109.941 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -122.48 -141.49 0.32 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.597 -0.689 . . . . 0.0 109.372 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.438 ' HG3' ' N ' ' A' ' 103' ' ' LYS . 4.3 pt-20 -79.15 -19.15 51.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.111 -0.993 . . . . 0.0 109.422 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.484 ' CD ' HG21 ' A' ' 17' ' ' THR . 65.7 mttt -58.17 -25.28 61.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.387 -0.82 . . . . 0.0 109.833 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 16' ' ' VAL . 4.7 mt -127.41 143.47 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.014 -1.054 . . . . 0.0 109.541 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.443 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -102.48 158.26 32.1 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 109.33 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 105' ' ' GLN . 2.1 Cg_endo -61.78 153.87 64.77 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.165 1.91 . . . . 0.0 110.195 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.7 -61.57 0.32 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.5 m -75.68 -22.44 56.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -1.125 . . . . 0.0 109.714 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.599 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -75.68 -38.11 59.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.628 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.96 -38.36 32.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 109.683 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.48 ' O ' ' HB3' ' A' ' 114' ' ' GLU . 2.6 t30 -63.74 -41.16 98.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.134 -0.979 . . . . 0.0 109.641 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.886 HG11 ' HB2' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -65.41 -42.95 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.357 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.826 HG21 HG21 ' A' ' 87' ' ' ILE . 51.8 t -67.93 -15.53 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.896 . . . . 0.0 109.64 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 111' ' ' ASN . 5.3 tp10 -67.79 -63.63 1.02 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.239 -0.913 . . . . 0.0 109.625 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -27.1 66.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.178 -0.951 . . . . 0.0 109.753 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.609 HD11 ' HE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -61.34 -47.11 87.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.112 -0.993 . . . . 0.0 110.122 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.538 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -78.21 -33.21 50.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 109.937 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -57.25 -17.74 13.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 109.854 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.44 -57.4 2.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 110.065 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -70.66 -1.96 12.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.135 -0.978 . . . . 0.0 110.689 -178.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.538 HD12 ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -70.03 -36.65 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.965 -1.084 . . . . 0.0 108.97 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.406 ' O ' ' HG2' ' A' ' 123' ' ' GLN . . . -108.72 42.56 1.92 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 122' ' ' GLY . 53.9 mm-40 -147.01 -84.1 0.11 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -1.166 . . . . 0.0 109.864 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.457 ' O ' ' OXT' ' A' ' 125' ' ' PHE . . . -136.7 63.98 0.57 Allowed Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.253 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.583 ' CD1' ' HB2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.241 -1.153 . . . . 0.0 109.625 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.5 ' O ' HD12 ' A' ' 96' ' ' LEU . 37.4 m . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.634 ' CH2' ' HB2' ' A' ' 117' ' ' ALA . 3.4 m95 -147.73 155.77 42.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.403 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.43 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 3.0 mp0 -39.09 -92.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.405 -0.809 . . . . 0.0 111.408 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.794 ' O ' HG22 ' A' ' 8' ' ' THR . 91.5 m -57.42 -49.14 77.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.347 -0.846 . . . . 0.0 110.961 -178.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.691 ' CD2' HD21 ' A' ' 116' ' ' LEU . 15.3 m-30 -50.92 -18.42 0.76 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.156 -0.965 . . . . 0.0 110.23 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.517 ' HA ' HG23 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -79.61 -46.85 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.945 -1.097 . . . . 0.0 109.361 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.48 51.42 1.88 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 0.0 111.982 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.794 HG22 ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -166.23 -100.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.36 -1.462 . . . . 0.0 110.892 179.002 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.515 ' H ' HG23 ' A' ' 8' ' ' THR . 1.0 OUTLIER -102.25 -59.35 1.72 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.051 -1.03 . . . . 0.0 110.824 -178.632 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.564 ' CB ' ' HB3' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -33.49 -33.26 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.622 -0.674 . . . . 0.0 110.99 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.842 HG22 ' HB3' ' A' ' 19' ' ' ALA . 2.8 t -99.53 -48.21 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.032 -1.042 . . . . 0.0 109.689 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.768 ' C ' HG22 ' A' ' 13' ' ' THR . . . -40.81 -45.13 3.6 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.768 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 159.66 39.72 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.88 -0.777 . . . . 0.0 109.601 178.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.703 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -84.23 20.04 15.28 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 154.1 -33.55 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.576 ' HA ' HD13 ' A' ' 104' ' ' ILE . 11.9 m -136.44 134.56 49.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.777 HG23 ' HG3' ' A' ' 18' ' ' GLN . 9.2 t -78.4 2.61 18.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.85 -1.156 . . . . 0.0 109.387 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.777 ' HG3' HG23 ' A' ' 17' ' ' THR . 71.7 mt-30 -162.6 155.34 19.43 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.842 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -158.9 152.51 23.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.117 -0.989 . . . . 0.0 109.72 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.5 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -138.6 142.11 39.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.947 . . . . 0.0 109.455 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.597 HD11 ' N ' ' A' ' 2' ' ' TRP . 0.7 OUTLIER -109.32 79.96 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.144 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -62.44 -153.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 108.649 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.425 ' C ' HG13 ' A' ' 95' ' ' ILE . . . -143.1 140.49 9.75 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.565 -1.302 . . . . 0.0 109.986 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 94' ' ' SER . 9.1 mt -68.68 -44.19 74.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -1.137 . . . . 0.0 109.263 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -129.27 2.45 5.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.584 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.35 -102.53 2.15 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -176.91 -46.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -1.122 . . . . 0.0 109.576 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.8 m -167.17 116.81 0.85 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.887 . . . . 0.0 109.666 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.413 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 19.0 m0 -96.78 -34.46 11.31 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.271 -0.893 . . . . 0.0 109.366 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.98 170.72 6.16 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -161.39 -179.27 7.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.059 -1.026 . . . . 0.0 109.945 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.647 ' OG ' HG21 ' A' ' 11' ' ' VAL . 51.9 p 177.74 67.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.531 -0.731 . . . . 0.0 109.23 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.455 ' CB ' ' CE1' ' A' ' 35' ' ' PHE . . . -142.08 -39.39 0.37 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.482 -0.761 . . . . 0.0 109.169 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.3 -52.94 0.95 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.455 ' CE1' ' CB ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -61.22 162.2 7.86 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -1.094 . . . . 0.0 109.385 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.08 148.54 29.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 109.379 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 38' ' ' THR . 61.4 t -102.17 158.69 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.193 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.468 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 6.0 t -43.14 147.19 0.72 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.437 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.468 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 6.1 Cg_exo -58.77 -14.07 20.57 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.153 1.902 . . . . 0.0 110.311 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.949 ' HB1' ' HB3' ' A' ' 43' ' ' GLN . . . -107.8 59.3 0.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.917 . . . . 0.0 109.409 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -65.56 -52.68 50.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.93 -1.107 . . . . 0.0 109.765 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.88 -12.71 84.33 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.949 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 1.5 tt0 -89.98 -20.97 22.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -1.149 . . . . 0.0 109.475 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.1 m -90.1 -29.72 18.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.498 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.518 ' O ' ' CD2' ' A' ' 49' ' ' PHE . 4.2 mm? -87.7 -40.55 14.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.726 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.37 -25.26 60.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 109.995 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.3 t -88.59 -19.6 26.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.124 -0.985 . . . . 0.0 109.779 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.18 -14.25 47.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.103 -0.998 . . . . 0.0 109.689 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.518 ' CD2' ' O ' ' A' ' 45' ' ' LEU . 19.6 m-85 -74.32 -33.0 63.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.658 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -94.11 -20.78 19.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.939 . . . . 0.0 109.303 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -131.55 120.85 23.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 0.0 109.342 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.545 ' HA ' HD11 ' A' ' 55' ' ' ILE . . . -119.84 28.71 7.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 109.554 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.569 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -76.57 -51.42 2.43 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.333 -0.855 . . . . 0.0 110.458 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 1.7 Cg_endo -64.61 -4.81 9.0 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.113 1.875 . . . . 0.0 111.357 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.717 ' HB ' HG21 ' A' ' 69' ' ' THR . 0.0 OUTLIER -112.53 7.62 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.748 -1.22 . . . . 0.0 110.101 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -100.07 -20.38 16.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.891 -1.13 . . . . 0.0 109.604 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.87 -60.9 1.2 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.22 -0.925 . . . . 0.0 109.537 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -78.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.374 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.41 -165.02 28.34 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.486 ' HB2' ' HB2' ' A' ' 67' ' ' TYR . 7.0 m-85 -81.28 170.82 15.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -1.126 . . . . 0.0 109.684 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.509 ' C ' HD12 ' A' ' 62' ' ' LEU . 1.3 m-20 -141.33 101.04 3.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.495 -0.753 . . . . 0.0 108.973 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.569 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 5.9 mp -127.1 61.17 1.36 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.203 -0.936 . . . . 0.0 109.932 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . 69.47 -83.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.365 -0.834 . . . . 0.0 110.015 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -38.72 -95.54 0.01 OUTLIER Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.465 HG12 ' H ' ' A' ' 66' ' ' HIS . 1.3 t -129.77 -148.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.084 -1.245 . . . . 0.0 109.238 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 60' ' ' PHE . 31.6 p-80 -122.21 144.03 49.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.153 -0.967 . . . . 0.0 109.73 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.486 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 25.9 m-85 -100.81 -161.94 0.9 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.362 -0.836 . . . . 0.0 109.233 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.703 HG22 ' H ' ' A' ' 69' ' ' THR . 1.4 p -104.32 -171.22 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.052 -1.03 . . . . 0.0 109.287 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.717 HG21 ' HB ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -148.56 64.71 1.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.11 -0.994 . . . . 0.0 109.549 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 70' ' ' LEU . 0.8 OUTLIER -91.84 18.33 7.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.92 . . . . 0.0 109.211 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -161.87 55.9 0.25 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.454 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.588 ' CB ' HG22 ' A' ' 69' ' ' THR . . . -123.46 66.35 1.01 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.735 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.85 -42.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.938 . . . . 0.0 109.635 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 2.2 m-20 -49.65 -86.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.597 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.512 ' NH1' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -145.22 -59.85 0.35 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.897 . . . . 0.0 109.388 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 78' ' ' TYR . 74.2 m -89.6 -165.41 1.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.416 ' CG1' ' O ' ' A' ' 76' ' ' SER . 13.9 mt -154.61 105.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.009 -1.057 . . . . 0.0 109.704 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 78' ' ' TYR . 0.6 OUTLIER -113.52 97.08 6.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 0.0 109.06 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 86' ' ' VAL . . . -60.31 141.38 47.88 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.529 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -151.05 124.62 9.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -1.101 . . . . 0.0 109.417 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.67 132.72 1.51 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.141 -0.974 . . . . 0.0 109.676 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.5 -136.07 47.41 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.18 -10.15 24.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -1.114 . . . . 0.0 109.704 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.48 -173.91 2.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 109.463 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.03 171.06 28.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 79' ' ' GLY . 3.4 p -123.99 153.8 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -1.184 . . . . 0.0 109.55 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.717 HG21 HG21 ' A' ' 113' ' ' VAL . 30.2 mm -127.31 94.67 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.033 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 1.4 p -108.97 129.7 55.45 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.143 -0.973 . . . . 0.0 109.985 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.836 ' HB ' HD23 ' A' ' 96' ' ' LEU . 2.4 t -142.23 143.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -103.1 120.52 40.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.119 -0.988 . . . . 0.0 109.907 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.534 ' HB ' ' CB ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -96.34 -59.13 1.9 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.412 -0.805 . . . . 0.0 108.969 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.599 ' HB3' ' CD2' ' A' ' 125' ' ' PHE . 0.2 OUTLIER 171.86 -32.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.41 -0.806 . . . . 0.0 109.769 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.54 ' C ' HD12 ' A' ' 24' ' ' LEU . 2.3 mmmt -135.85 2.51 2.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.045 -1.034 . . . . 0.0 110.13 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.735 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -156.1 146.31 21.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.021 -1.05 . . . . 0.0 109.692 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.595 HD11 ' HA ' ' A' ' 24' ' ' LEU . 15.2 mt -105.9 139.68 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 0.0 109.298 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.836 HD23 ' HB ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -92.46 154.55 18.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.032 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.779 ' O ' HG12 ' A' ' 97' ' ' VAL . 39.9 t -150.4 68.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.264 -0.897 . . . . 0.0 109.665 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.87 106.91 1.79 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.682 HG22 HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -109.88 127.81 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.958 -1.319 . . . . 0.0 109.538 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 1.043 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -142.54 144.15 32.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.396 -0.815 . . . . 0.0 109.428 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.496 ' O ' ' CB ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -150.4 114.48 5.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.067 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.1 OUTLIER 163.45 -61.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.456 -0.777 . . . . 0.0 109.393 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -174.93 33.14 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.397 -0.814 . . . . 0.0 109.906 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.043 HD12 ' HB2' ' A' ' 100' ' ' TYR . 48.6 mt -84.27 83.6 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -0.959 . . . . 0.0 108.981 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -54.11 149.69 17.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 109.954 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.77 156.45 61.6 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.309 2.006 . . . . 0.0 110.183 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.55 -2.71 46.06 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.65 -39.67 2.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -1.193 . . . . 0.0 109.505 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.544 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -83.93 -27.69 28.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.287 -0.883 . . . . 0.0 109.446 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.464 ' O ' ' OE1' ' A' ' 114' ' ' GLU . . . -83.07 -21.18 33.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.136 -0.977 . . . . 0.0 109.28 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -78.83 -29.26 44.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.537 HG11 HD11 ' A' ' 10' ' ' LEU . 11.5 t -83.08 -39.13 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.301 -0.875 . . . . 0.0 109.39 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.717 HG21 HG21 ' A' ' 87' ' ' ILE . 38.4 t -68.92 -16.25 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.053 -1.029 . . . . 0.0 109.435 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.464 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -81.32 -56.36 4.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.61 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 118' ' ' ASP . 5.4 ttmt -79.0 -52.78 7.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.748 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.691 HD21 ' CD2' ' A' ' 5' ' ' TYR . 1.6 tp -51.87 -47.09 64.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -0.959 . . . . 0.0 109.522 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.75 ' O ' HD13 ' A' ' 121' ' ' ILE . . . -67.93 -35.69 78.86 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.074 -1.016 . . . . 0.0 109.05 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 115' ' ' LYS . 24.1 t0 -47.56 -25.84 1.26 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.134 -0.979 . . . . 0.0 109.266 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -81.32 -51.1 8.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.277 -0.89 . . . . 0.0 109.261 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' ' 125' ' ' PHE . 3.8 mt -71.25 -3.1 18.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.399 -0.813 . . . . 0.0 110.072 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.75 HD13 ' O ' ' A' ' 117' ' ' ALA . 1.2 mp -75.99 -28.41 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.065 -1.022 . . . . 0.0 108.554 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -123.74 29.24 5.23 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.35 57.55 0.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -1.113 . . . . 0.0 109.687 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.507 ' C ' ' CD1' ' A' ' 125' ' ' PHE . . . 104.71 17.72 14.22 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.599 ' CD2' ' HB3' ' A' ' 92' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.743 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.513 ' N ' HD22 ' A' ' 120' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.344 0.592 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.769 ' CB ' HD11 ' A' ' 21' ' ' ILE . 1.1 m-90 -105.66 23.96 13.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.421 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.55 -80.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.076 -1.015 . . . . 0.0 109.787 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.66 ' O ' HG22 ' A' ' 8' ' ' THR . 8.8 t -59.57 -39.21 83.33 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.765 ' CE1' HD12 ' A' ' 10' ' ' LEU . 4.9 t80 -40.14 -36.51 0.51 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.033 0.92 . . . . 0.0 109.172 177.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.109 HG13 HG21 ' A' ' 11' ' ' VAL . 39.7 t -99.37 -29.51 3.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 121.046 -1.034 . . . . 0.0 111.325 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.48 ' C ' HG22 ' A' ' 8' ' ' THR . 77.9 m-20 -91.75 52.25 1.99 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.702 -1.249 . . . . 0.0 112.826 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER 179.61 -94.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.21 -1.556 . . . . 0.0 111.322 178.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.7 t-20 -101.89 -66.33 0.93 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.197 -0.94 . . . . 0.0 111.124 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.765 HD12 ' CE1' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -33.88 -31.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.867 -0.521 . . . . 0.0 111.6 -178.411 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.109 HG21 HG13 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -95.39 -56.66 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.751 -1.218 . . . . 0.0 109.745 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.746 ' C ' HG22 ' A' ' 13' ' ' THR . . . -38.79 -37.38 0.57 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.831 -1.707 . . . . 0.0 108.831 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.746 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 159.05 39.64 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.95 -0.735 . . . . 0.0 109.196 178.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.706 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -81.29 16.55 16.92 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 107.776 -2.13 . . . . 0.0 107.776 177.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.716 ' HB1' ' HA ' ' A' ' 109' ' ' ALA . . . 154.99 -27.09 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.419 HG21 ' HB2' ' A' ' 19' ' ' ALA . 5.2 m -140.4 137.29 36.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.041 HG23 HD11 ' A' ' 104' ' ' ILE . 34.5 p -79.38 6.44 10.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.922 -1.111 . . . . 0.0 109.436 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.483 ' OE1' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -167.39 161.95 14.38 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.624 ' HA ' HG23 ' A' ' 99' ' ' VAL . . . -174.01 171.59 3.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.956 -1.09 . . . . 0.0 110.079 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -161.98 157.07 23.13 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.286 -0.884 . . . . 0.0 109.774 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.769 HD11 ' CB ' ' A' ' 2' ' ' TRP . 10.9 mt -115.45 94.63 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.805 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -85.27 128.55 34.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.666 -0.646 . . . . 0.0 109.284 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.6 ' HA2' ' CZ3' ' A' ' 29' ' ' TRP . . . -48.19 167.0 0.16 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.657 HD23 ' CG1' ' A' ' 95' ' ' ILE . 16.2 mt -77.12 -11.96 59.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.349 -1.089 . . . . 0.0 109.276 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 27' ' ' ASN . 5.3 t70 -120.08 57.79 0.93 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.703 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 52.3 69.72 1.1 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 25' ' ' ASP . 8.4 m120 -147.31 -149.89 0.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.282 -1.128 . . . . 0.0 109.519 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -155.26 158.85 39.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.358 -0.839 . . . . 0.0 109.182 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.6 ' CZ3' ' HA2' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -145.33 -41.04 0.23 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -0.986 . . . . 0.0 109.905 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.501 ' HB3' HD12 ' A' ' 21' ' ' ILE . . . -165.1 118.58 1.24 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.999 -1.063 . . . . 0.0 110.15 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 9.3 t -131.86 164.36 26.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.651 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.707 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 3.4 m -147.79 147.55 29.97 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.338 -0.851 . . . . 0.0 109.475 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 81.4 172.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 33' ' ' ALA . . . -60.64 -132.58 0.01 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.651 ' CE1' HG11 ' A' ' 99' ' ' VAL . 91.0 t80 58.81 93.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.031 -1.276 . . . . 0.0 109.203 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.2 124.42 50.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 109.648 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 65.5 t -97.92 106.0 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.833 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -71.22 162.01 75.04 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.285 -0.884 . . . . 0.0 109.529 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.833 ' HD2' HG22 ' A' ' 38' ' ' THR . 2.4 Cg_endo -61.58 108.81 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.18 1.92 . . . . 0.0 110.004 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 39' ' ' PRO . . . 176.24 -71.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.217 -0.927 . . . . 0.0 109.496 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.47 -21.71 65.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.667 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.17 -31.62 61.34 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.468 ' O ' ' OG ' ' A' ' 47' ' ' SER . 4.6 tt0 -74.97 -23.04 58.23 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.388 -1.066 . . . . 0.0 109.374 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.667 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 3.5 m -88.42 -32.72 18.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.233 -0.917 . . . . 0.0 109.301 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.91 -47.81 83.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -0.916 . . . . 0.0 109.352 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 25' ' ' ASP . . . -61.49 -46.55 89.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 0.0 109.218 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -82.82 -0.21 46.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.364 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 44' ' ' THR . . . -82.78 -22.66 34.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 109.716 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -74.76 -0.88 19.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.049 -1.032 . . . . 0.0 109.591 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -88.21 -59.84 2.13 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.188 -0.945 . . . . 0.0 109.953 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 53' ' ' ASP . 2.9 t-20 -126.47 6.35 6.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.025 -1.047 . . . . 0.0 110.175 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 51' ' ' ASN . . . 32.25 35.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.234 0.54 . . . . 0.0 110.445 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.618 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 2.7 t0 -73.9 -49.91 5.74 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.896 . . . . 0.0 110.888 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 6.0 Cg_exo -59.98 -9.59 10.33 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.058 1.838 . . . . 0.0 111.317 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.775 HD13 ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -106.92 -49.46 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.892 -1.13 . . . . 0.0 109.775 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.506 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 3.6 ptm180 -53.87 -19.33 4.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.051 -1.031 . . . . 0.0 110.084 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 56' ' ' ARG . . . -120.6 137.94 54.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.093 -1.005 . . . . 0.0 109.925 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 59' ' ' GLY . 0.6 OUTLIER 49.74 27.24 2.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.405 -0.81 . . . . 0.0 109.653 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 58' ' ' SER . . . 43.39 -136.64 4.44 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.537 ' N ' ' CD1' ' A' ' 60' ' ' PHE . 2.6 p90 -147.33 143.79 28.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.183 -1.186 . . . . 0.0 109.343 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -101.85 126.86 48.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.266 -0.897 . . . . 0.0 109.765 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -94.51 -160.17 0.76 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.53 -0.731 . . . . 0.0 109.475 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.14 95.3 8.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.4 -23.73 14.49 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -125.53 153.0 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -1.14 . . . . 0.0 108.888 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -149.91 153.58 36.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 109.526 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -141.91 -171.92 3.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.335 -0.853 . . . . 0.0 109.276 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 t -116.89 154.13 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.945 . . . . 0.0 109.602 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.88 124.94 45.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.484 -0.76 . . . . 0.0 109.54 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.03 -35.92 1.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.592 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.434 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -119.33 70.76 0.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.463 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.78 28.6 6.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.423 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -99.69 0.07 41.15 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.248 -0.908 . . . . 0.0 109.606 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -105.22 -95.74 0.34 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.975 . . . . 0.0 109.926 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.526 ' NH1' ' HG3' ' A' ' 75' ' ' ARG . 1.0 OUTLIER -142.47 -36.51 0.4 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.028 . . . . 0.0 110.058 -179.493 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 0.6 OUTLIER -89.52 149.87 22.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 109.553 -179.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 76' ' ' SER . 4.3 mp -144.53 70.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 0.0 110.335 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.756 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -90.01 93.62 9.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.814 -1.179 . . . . 0.0 108.46 178.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.422 ' O ' HG12 ' A' ' 86' ' ' VAL . . . -79.21 128.44 8.56 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.56 146.38 26.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -1.233 . . . . 0.0 109.61 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.88 148.83 0.55 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.559 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.47 -106.85 2.76 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.2 m -135.95 7.92 3.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -1.121 . . . . 0.0 109.511 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -130.82 178.12 6.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 0.0 109.159 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -169.28 177.45 42.93 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.325 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 86' ' ' VAL . 9.3 p -153.27 123.63 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.976 . . . . 0.0 108.74 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.821 HG21 HG11 ' A' ' 113' ' ' VAL . 10.6 mt -95.53 99.82 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.177 -0.952 . . . . 0.0 109.793 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 8.6 p -105.95 108.48 20.02 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.566 HG22 ' CE2' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -129.01 173.95 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.927 . . . . 0.0 110.054 -179.174 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.439 ' H ' HG12 ' A' ' 89' ' ' VAL . 29.7 mtmt -101.39 142.81 32.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.392 -0.817 . . . . 0.0 108.941 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 1.088 ' CG2' HD21 ' A' ' 96' ' ' LEU . 66.5 p -149.12 -137.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.105 -0.997 . . . . 0.0 109.828 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.465 ' HA ' ' OXT' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -67.52 84.04 0.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.948 -1.095 . . . . 0.0 111.178 -178.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.561 ' HA ' HD11 ' A' ' 24' ' ' LEU . 3.0 mttm 51.04 34.01 10.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -0.855 . . . . 0.0 109.778 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.04 167.35 30.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.051 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.657 ' CG1' HD23 ' A' ' 24' ' ' LEU . 34.5 mt -121.89 123.15 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.239 -0.913 . . . . 0.0 109.135 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.088 HD21 ' CG2' ' A' ' 91' ' ' THR . 0.0 OUTLIER -75.62 165.12 25.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.08 -1.013 . . . . 0.0 108.928 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.785 HG12 HG22 ' A' ' 99' ' ' VAL . 54.0 t -150.91 74.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.389 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -63.78 98.73 0.26 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.785 HG22 HG12 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -97.28 127.64 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -1.15 . . . . 0.0 109.018 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.549 ' HB2' ' CG1' ' A' ' 104' ' ' ILE . 1.5 p90 -146.82 171.19 15.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 109.878 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -113.7 -149.85 0.45 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.394 -0.816 . . . . 0.0 110.023 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -42.5 89.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.47 -0.768 . . . . 0.0 110.221 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.8 -25.05 1.13 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.041 HD11 HG23 ' A' ' 17' ' ' THR . 10.6 mm -103.51 105.72 18.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.053 -1.029 . . . . 0.0 109.698 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.57 142.66 49.99 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.26 -0.9 . . . . 0.0 109.137 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -60.7 149.37 87.91 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.119 1.88 . . . . 0.0 110.503 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.86 -35.46 4.92 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.6 m -83.49 -29.6 27.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -1.182 . . . . 0.0 109.613 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.716 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -89.79 -13.98 35.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.809 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.0 -20.63 23.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.142 -0.974 . . . . 0.0 109.559 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -80.72 -32.67 35.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 0.0 109.695 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 88.8 t -90.05 -35.96 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 110.172 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.821 HG11 HG21 ' A' ' 87' ' ' ILE . 49.1 t -74.35 -17.6 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.148 -0.97 . . . . 0.0 109.768 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -86.97 -42.4 13.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -0.973 . . . . 0.0 109.972 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.06 -40.48 62.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.126 -0.984 . . . . 0.0 109.74 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.729 HD22 ' CE2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -60.16 -47.31 86.47 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.215 -0.928 . . . . 0.0 109.564 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.891 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -63.92 -25.91 68.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.644 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -69.2 -25.63 64.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.714 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -76.91 -40.32 47.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.22 -0.925 . . . . 0.0 110.074 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 120' ' ' LEU . 0.3 OUTLIER -82.86 -21.03 34.47 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.163 -0.96 . . . . 0.0 110.06 -179.449 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.891 HD12 ' O ' ' A' ' 117' ' ' ALA . 8.1 mt -77.62 -22.64 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 109.331 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.13 -24.48 3.41 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.29 -68.88 0.69 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.405 -1.056 . . . . 0.0 109.673 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 125' ' ' PHE . . . 158.33 110.53 0.29 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.493 ' HB3' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.084 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.693 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.535 ' HB2' ' CD1' ' A' ' 120' ' ' LEU . 3.3 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.869 ' CZ2' HD13 ' A' ' 96' ' ' LEU . 1.3 m-90 -82.87 7.46 15.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.174 -0.954 . . . . 0.0 109.371 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -89.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 109.189 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.429 HG23 ' N ' ' A' ' 5' ' ' TYR . 14.4 t -60.72 -36.82 79.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 108.899 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.76 ' CE2' HD11 ' A' ' 116' ' ' LEU . 10.1 m-30 -52.91 -30.89 36.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.455 -0.778 . . . . 0.0 109.41 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.535 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -69.87 -47.87 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.103 -0.998 . . . . 0.0 108.468 179.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.8 45.28 1.24 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.936 -1.103 . . . . 0.0 109.929 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.628 HG22 ' N ' ' A' ' 9' ' ' ASN . 54.3 m -156.96 -100.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.83 -1.169 . . . . 0.0 110.704 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.628 ' N ' HG22 ' A' ' 8' ' ' THR . 3.8 m120 -100.86 -59.54 1.68 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.112 -0.992 . . . . 0.0 110.64 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.529 ' C ' ' O ' ' A' ' 9' ' ' ASN . 0.5 OUTLIER -29.56 -48.51 0.08 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.304 0.573 . . . . 0.0 110.516 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.991 HG23 ' HB3' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -100.27 -23.37 4.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.342 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 13' ' ' THR . . . -83.32 57.57 5.06 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.123 -2.391 . . . . 0.0 107.123 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 43.25 51.03 5.83 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.987 0.898 . . . . 0.0 110.281 -178.774 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.704 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -100.59 21.76 42.65 Favored Glycine 0 C--N 1.292 -1.871 0 N-CA-C 105.438 -3.065 . . . . 0.0 105.438 176.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 1.118 ' CB ' HG11 ' A' ' 112' ' ' VAL . . . 152.08 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.722 ' HA ' HD13 ' A' ' 104' ' ' ILE . 2.7 m -138.78 147.14 25.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.703 HG23 HD11 ' A' ' 104' ' ' ILE . 2.4 p -79.76 10.27 4.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.876 -1.14 . . . . 0.0 109.165 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.523 ' CG ' ' C ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -170.71 174.07 5.1 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.381 -0.824 . . . . 0.0 109.409 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.991 ' HB3' HG23 ' A' ' 11' ' ' VAL . . . -177.36 163.69 2.04 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.497 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -160.59 122.1 3.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.832 -1.168 . . . . 0.0 110.758 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.676 HD11 ' CD1' ' A' ' 2' ' ' TRP . 3.1 mm -89.2 104.62 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.777 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.4 OUTLIER -83.29 13.47 4.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.39 -0.819 . . . . 0.0 109.934 -178.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 94' ' ' SER . . . 67.67 157.82 0.9 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.723 HD21 ' HB3' ' A' ' 90' ' ' LYS . 14.5 mt -79.94 -58.21 3.28 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.32 -1.106 . . . . 0.0 109.017 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.4 22.18 3.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.484 -0.76 . . . . 0.0 109.009 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.485 ' O ' ' ND2' ' A' ' 27' ' ' ASN . . . -109.84 -110.35 3.29 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 15.6 m120 -149.5 -145.9 0.18 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -1.141 . . . . 0.0 109.351 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 m -71.43 125.5 27.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.088 -1.008 . . . . 0.0 109.525 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -106.19 -40.92 5.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.06 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.15 155.75 23.36 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.429 ' C ' ' OG ' ' A' ' 32' ' ' SER . 0.7 OUTLIER -160.78 172.13 17.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.954 -1.091 . . . . 0.0 110.113 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.706 ' CB ' HG11 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -176.11 109.97 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.314 -0.866 . . . . 0.0 109.516 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 55.35 41.95 30.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 109.394 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -125.65 138.15 10.7 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.56 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -49.61 178.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -1.183 . . . . 0.0 109.417 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.01 107.42 19.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.328 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.692 ' O ' HG22 ' A' ' 38' ' ' THR . 3.9 t -104.9 163.72 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 109.899 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.748 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.6 OUTLIER 94.65 15.45 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.748 ' CD ' ' N ' ' A' ' 38' ' ' THR . 1.8 Cg_endo -64.67 -20.07 65.06 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 CA-C-N 119.783 0.958 . . . . 0.0 109.611 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 39' ' ' PRO . . . 171.74 -66.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.424 -0.797 . . . . 0.0 109.235 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.454 ' O ' ' HB ' ' A' ' 44' ' ' THR . 3.1 mp0 -56.15 -24.82 43.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.91 . . . . 0.0 109.363 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.86 -45.99 55.24 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -57.52 -35.19 69.94 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.236 -1.155 . . . . 0.0 109.103 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 41' ' ' GLN . 63.4 m -57.3 -35.57 69.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.027 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.28 -48.82 75.84 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.17 -23.27 67.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.403 -0.811 . . . . 0.0 109.141 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.0 -20.19 30.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.6 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.34 -24.11 59.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.441 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.583 ' CE2' ' HG2' ' A' ' 90' ' ' LYS . 5.3 m-30 -51.39 -21.63 2.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.217 -0.927 . . . . 0.0 109.314 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -82.68 -37.3 25.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.285 -0.885 . . . . 0.0 109.756 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.92 142.79 33.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.706 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.33 24.49 13.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 109.017 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.631 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 23.3 m-20 -67.22 -46.07 50.84 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.488 -0.757 . . . . 0.0 110.932 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 2.9 Cg_exo -56.54 -70.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 121.487 1.458 . . . . 0.0 110.61 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.641 ' HB ' HG21 ' A' ' 69' ' ' THR . 0.1 OUTLIER -42.07 -27.68 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.186 -0.946 . . . . 0.0 109.497 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -72.05 -75.31 0.14 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.696 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -104.94 93.84 4.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 0.0 109.527 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 3.8 t 162.82 -78.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.228 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.79 -164.82 33.84 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -124.05 111.98 16.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.472 -1.016 . . . . 0.0 108.796 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -81.2 142.98 32.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 0.0 110.283 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.44 ' HA ' HD23 ' A' ' 62' ' ' LEU . 9.8 mt -149.26 -166.46 2.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.189 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.652 ' HB2' ' HA ' ' A' ' 37' ' ' VAL . . . -71.83 90.77 1.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 0.0 110.157 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.11 24.67 68.93 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -138.96 177.15 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.094 -1.239 . . . . 0.0 108.855 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -159.43 114.43 2.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.162 -0.961 . . . . 0.0 109.744 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.588 ' CE1' ' HG3' ' A' ' 81' ' ' LYS . 11.0 m-30 -100.99 -164.02 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -0.895 . . . . 0.0 109.454 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 t -131.43 164.02 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 108.982 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.641 HG21 ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -123.17 117.45 25.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.156 -0.965 . . . . 0.0 109.835 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.62 24.73 4.05 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.576 ' HG3' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER 178.55 57.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.334 -0.854 . . . . 0.0 109.146 -179.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.479 ' O ' ' C ' ' A' ' 73' ' ' ASP . . . -90.81 20.69 4.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.192 -0.942 . . . . 0.0 109.263 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER 32.48 -107.09 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.102 -0.374 . . . . 0.0 110.743 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -120.88 -52.42 2.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.754 -1.217 . . . . 0.0 110.479 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.421 ' NE ' ' HA ' ' A' ' 75' ' ' ARG . 6.6 tpm_? -130.45 -9.12 4.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.011 -1.056 . . . . 0.0 110.827 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.63 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -88.77 146.98 24.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.937 -1.102 . . . . 0.0 108.795 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.495 ' HB ' ' OG1' ' A' ' 88' ' ' THR . 0.2 OUTLIER -135.76 79.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.69 -1.256 . . . . 0.0 111.004 -179.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.856 ' HD2' HG23 ' A' ' 87' ' ' ILE . 1.2 m-85 -90.12 76.67 6.89 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.1 178.2 7.99 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.521 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 15.6 mtpp -135.39 146.29 48.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.663 -0.904 . . . . 0.0 109.085 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.588 ' HG3' ' CE1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -114.92 25.67 10.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.998 -1.064 . . . . 0.0 109.396 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.68 -94.9 1.94 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.6 m -78.55 -25.13 45.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.226 -1.161 . . . . 0.0 109.183 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 100' ' ' TYR . . . -111.87 -165.44 0.99 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.279 -0.888 . . . . 0.0 109.25 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 80' ' ' LYS . . . -167.98 143.69 8.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 86' ' ' VAL . 10.0 p -106.44 133.6 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -1.164 . . . . 0.0 110.034 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.856 HG23 ' HD2' ' A' ' 78' ' ' TYR . 36.0 mm -106.83 83.2 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.495 ' OG1' ' HB ' ' A' ' 77' ' ' ILE . 15.5 p -95.72 117.77 31.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.004 -1.06 . . . . 0.0 110.63 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.557 HG21 ' CE2' ' A' ' 78' ' ' TYR . 11.7 t -150.36 166.52 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.723 ' HB3' HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -104.4 159.49 15.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.921 -1.112 . . . . 0.0 109.445 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.489 HG21 ' HZ3' ' A' ' 2' ' ' TRP . 0.1 OUTLIER -144.36 -70.17 0.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.611 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 1.2 t -159.87 98.7 1.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.117 -0.989 . . . . 0.0 109.889 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.472 ' CA ' HD12 ' A' ' 24' ' ' LEU . 25.1 mttm 62.54 34.59 15.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.987 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.48 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 0.3 OUTLIER 177.49 145.13 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.008 -1.057 . . . . 0.0 109.813 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.567 ' CG1' HD23 ' A' ' 24' ' ' LEU . 90.1 mt -105.96 114.68 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.88 . . . . 0.0 109.161 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.869 HD13 ' CZ2' ' A' ' 2' ' ' TRP . 0.7 OUTLIER -73.77 139.06 44.94 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.332 -0.855 . . . . 0.0 109.735 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.619 ' O ' HG22 ' A' ' 99' ' ' VAL . 45.8 t -129.89 59.75 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.352 -0.843 . . . . 0.0 109.326 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.485 ' O ' HG12 ' A' ' 87' ' ' ILE . . . -51.66 111.93 1.63 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.619 HG22 ' O ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -110.99 134.63 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.126 -1.22 . . . . 0.0 109.187 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.718 ' HB3' HG12 ' A' ' 16' ' ' VAL . 20.0 p90 -132.27 -178.35 4.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.443 -0.785 . . . . 0.0 109.307 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -118.31 -145.9 0.39 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.598 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 103' ' ' LYS . 7.6 tp10 -80.91 -38.81 27.31 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.145 -0.972 . . . . 0.0 109.665 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 102' ' ' GLU . 0.4 OUTLIER -43.79 -68.26 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.909 . . . . 0.0 109.506 -179.721 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.722 HD13 ' HA ' ' A' ' 16' ' ' VAL . 7.1 mt -65.99 137.7 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.202 -0.936 . . . . 0.0 109.286 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.416 ' HB2' ' OG1' ' A' ' 108' ' ' THR . 0.9 OUTLIER -79.77 152.63 75.06 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.775 -179.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.62 -17.72 60.46 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.4 2.067 . . . . 0.0 110.515 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.8 -13.03 51.77 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 105' ' ' GLN . 0.2 OUTLIER -85.65 -42.65 14.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -1.122 . . . . 0.0 109.429 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.86 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -78.07 -22.1 49.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.338 -0.851 . . . . 0.0 109.536 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.03 -21.02 31.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 109.566 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -80.91 -39.09 26.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 109.488 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 1.118 HG11 ' CB ' ' A' ' 15' ' ' ALA . 4.1 p -74.62 -27.83 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.684 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 109' ' ' ALA . 74.7 t -72.94 -35.04 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.409 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 118' ' ' ASP . 48.2 mt-10 -61.58 -41.9 98.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.462 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 118' ' ' ASP . 3.2 ttpm? -74.49 -38.03 63.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.494 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.76 HD11 ' CE2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -53.04 -53.3 52.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.338 -0.851 . . . . 0.0 109.715 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.609 ' HB1' ' CD1' ' A' ' 121' ' ' ILE . . . -75.35 -29.8 60.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 0.0 109.695 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 0.4 OUTLIER -54.02 -25.17 19.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -0.955 . . . . 0.0 109.666 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -85.57 -48.33 9.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.669 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.535 ' CD1' ' HB2' ' A' ' 1' ' ' SER . 4.5 mt -75.32 -2.61 29.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.881 . . . . 0.0 110.274 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.609 ' CD1' ' HB1' ' A' ' 117' ' ' ALA . 0.4 OUTLIER -84.2 -44.7 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.053 -1.029 . . . . 0.0 109.518 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -82.05 9.6 56.41 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -120.75 -87.9 0.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -1.192 . . . . 0.0 109.785 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.17 -90.82 0.92 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.567 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 3.8 m-85 . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.255 -1.144 . . . . 0.0 109.362 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.562 ' O ' ' CD2' ' A' ' 2' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 1.006 ' CH2' HD13 ' A' ' 96' ' ' LEU . 15.5 m95 -146.96 173.35 12.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.295 -0.878 . . . . 0.0 109.4 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.404 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -64.54 -87.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.13 -0.981 . . . . 0.0 111.088 -178.459 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.473 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -60.84 -45.54 94.07 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.025 -1.047 . . . . 0.0 110.465 -178.649 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.813 ' CE2' HD22 ' A' ' 116' ' ' LEU . 2.8 m-30 -50.72 -21.65 1.72 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.87 -1.144 . . . . 0.0 109.466 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.827 HG22 HG21 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -78.0 -41.24 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 108.692 179.445 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.473 ' OD1' ' O ' ' A' ' 4' ' ' THR . 2.1 p-10 -91.28 18.83 6.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.119 -0.988 . . . . 0.0 110.825 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.42 ' OG1' ' HA ' ' A' ' 5' ' ' TYR . 21.1 p -127.59 -106.58 0.31 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.917 -1.114 . . . . 0.0 110.371 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.4 t-20 -102.02 -68.75 0.81 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.025 -1.047 . . . . 0.0 110.512 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.505 ' C ' ' O ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -24.52 -41.8 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.833 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 1.1 t -83.91 -65.59 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.728 -1.233 . . . . 0.0 110.057 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.751 ' C ' HG22 ' A' ' 13' ' ' THR . . . -36.84 -40.06 0.46 Allowed Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.751 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 158.45 40.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.891 -0.77 . . . . 0.0 109.366 178.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.703 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -86.06 21.3 16.56 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 154.87 -32.72 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.805 HG12 ' HB3' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -136.63 133.66 48.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.457 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.969 HG23 ' HG3' ' A' ' 18' ' ' GLN . 9.0 t -78.83 6.1 9.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.944 -1.097 . . . . 0.0 108.991 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.969 ' HG3' HG23 ' A' ' 17' ' ' THR . 17.3 mt-30 -158.91 153.08 23.74 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.833 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . -170.33 152.38 4.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -0.949 . . . . 0.0 109.193 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.572 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . . . -150.55 130.84 13.67 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.633 HD11 ' N ' ' A' ' 2' ' ' TRP . 4.6 mm -82.85 92.32 2.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.877 HD13 ' CG2' ' A' ' 97' ' ' VAL . 10.9 mp -74.71 106.7 6.39 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.46 -0.775 . . . . 0.0 109.915 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -45.93 174.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.644 HD11 ' C ' ' A' ' 93' ' ' LYS . 0.7 OUTLIER -72.82 -3.16 23.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.331 -1.099 . . . . 0.0 109.859 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.93 8.3 7.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.147 -0.971 . . . . 0.0 109.214 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.32 32.06 58.5 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 28' ' ' THR . 40.4 t-20 -94.97 29.96 2.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.165 -1.197 . . . . 0.0 109.36 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 27' ' ' ASN . 70.3 m 32.31 96.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.559 0.695 . . . . 0.0 110.859 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -79.54 -48.57 13.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.473 -0.767 . . . . 0.0 110.048 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.454 ' O ' HG12 ' A' ' 21' ' ' ILE . . . -158.64 103.06 1.72 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.115 -0.99 . . . . 0.0 109.969 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 14.0 t -114.53 166.58 11.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.037 -1.039 . . . . 0.0 110.278 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.717 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -149.63 143.32 25.45 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 77.5 171.41 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 0.0 109.16 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -52.17 141.74 24.84 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.683 ' CE2' HG21 ' A' ' 99' ' ' VAL . 0.3 OUTLIER 177.81 117.01 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -1.077 . . . . 0.0 109.134 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.68 125.14 53.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.975 . . . . 0.0 110.015 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.582 HG13 ' NE2' ' A' ' 41' ' ' GLN . 60.7 t -147.84 133.39 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.717 HG23 ' CD ' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -158.15 -62.81 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.001 -1.062 . . . . 0.0 110.598 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.717 ' CD ' HG23 ' A' ' 38' ' ' THR . 8.1 Cg_exo -50.89 133.08 39.24 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 120.87 1.047 . . . . 0.0 109.819 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 39' ' ' PRO . . . -30.39 81.76 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 111.593 0.219 . . . . 0.0 111.593 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.604 ' N ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -90.86 -30.71 16.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.269 -1.519 . . . . 0.0 109.31 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.5 -18.91 78.71 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -80.57 -62.44 1.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.152 -1.205 . . . . 0.0 109.371 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.8 m -60.1 -26.99 66.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 109.152 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.88 -46.43 24.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.0 109.312 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.65 -11.09 22.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 109.649 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.48 -28.15 14.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.63 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.437 ' HB1' HD12 ' A' ' 55' ' ' ILE . . . -66.62 -23.35 66.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.966 . . . . 0.0 109.643 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -70.05 -7.7 43.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.225 -0.922 . . . . 0.0 110.032 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.1 -70.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 109.721 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -96.58 175.87 6.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.181 -0.949 . . . . 0.0 109.561 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 56' ' ' ARG . . . -123.82 -2.98 8.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.723 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.613 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 43.5 t0 -80.24 -44.81 1.42 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.158 -0.964 . . . . 0.0 110.721 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.6 Cg_endo -65.37 -13.58 40.52 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.553 1.502 . . . . 0.0 110.575 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.798 HD13 ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -102.55 -54.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.06 -1.025 . . . . 0.0 109.516 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.502 ' NH1' ' HG2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -50.58 -22.7 2.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.41 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.573 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -114.93 117.82 31.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.653 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 1.9 m 83.83 -52.92 0.14 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.77 -0.581 . . . . 0.0 109.826 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.8 -145.71 21.02 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.91 ' CE2' HD11 ' A' ' 62' ' ' LEU . 6.1 p90 -146.94 -173.17 4.16 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.256 -1.144 . . . . 0.0 109.143 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 1.5 m-20 -139.49 165.19 27.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.153 -0.967 . . . . 0.0 110.028 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.91 HD11 ' CE2' ' A' ' 60' ' ' PHE . 2.4 mp -136.96 88.25 2.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.42 -0.8 . . . . 0.0 109.268 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . 82.3 -43.17 0.14 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.603 -0.686 . . . . 0.0 109.985 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.06 35.67 0.05 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.644 ' CG1' ' CE1' ' A' ' 67' ' ' TYR . 72.8 t -126.21 111.74 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -1.133 . . . . 0.0 109.447 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.72 86.47 6.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.171 -0.956 . . . . 0.0 110.606 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.644 ' CE1' ' CG1' ' A' ' 65' ' ' VAL . 10.2 m-30 -98.47 162.67 13.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.098 -1.001 . . . . 0.0 109.28 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.617 HG22 ' H ' ' A' ' 69' ' ' THR . 7.3 p -107.41 173.24 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.185 -0.947 . . . . 0.0 109.569 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.617 ' H ' HG22 ' A' ' 68' ' ' VAL . 46.6 m -127.39 109.34 11.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.48 3.14 14.83 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 109.6 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -135.21 89.07 2.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -0.94 . . . . 0.0 109.332 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.42 111.32 4.83 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -157.93 -45.55 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -0.9 . . . . 0.0 109.317 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -79.52 -94.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.412 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.444 ' NH1' ' CG ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -150.23 21.6 0.85 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 109.795 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.978 ' OG ' HG22 ' A' ' 89' ' ' VAL . 29.7 t -132.57 169.66 16.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.074 -1.016 . . . . 0.0 109.501 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.458 ' O ' HG22 ' A' ' 77' ' ' ILE . 23.5 mt -149.5 95.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.865 . . . . 0.0 109.441 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.485 ' HD2' HG23 ' A' ' 87' ' ' ILE . 3.4 m-85 -89.51 85.09 6.43 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -51.05 158.14 2.29 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.46 -173.83 3.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.612 -0.934 . . . . 0.0 108.83 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.45 -30.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.117 -0.989 . . . . 0.0 110.108 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 83' ' ' SER . . . 132.7 92.85 0.53 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 82' ' ' GLY . 0.8 OUTLIER 74.24 4.8 4.59 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.265 -1.138 . . . . 0.0 108.357 -178.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.48 148.62 29.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.495 -0.753 . . . . 0.0 109.086 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -168.62 174.44 43.3 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.6 p -132.76 138.09 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -1.159 . . . . 0.0 109.348 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.485 HG23 ' HD2' ' A' ' 78' ' ' TYR . 16.7 mm -98.93 81.21 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 110.021 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 7.6 p -96.8 107.89 20.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.123 -0.986 . . . . 0.0 109.007 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.978 HG22 ' OG ' ' A' ' 76' ' ' SER . 59.4 t -127.9 139.97 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 109.794 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.29 127.01 42.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.884 . . . . 0.0 109.219 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.761 HG22 HG12 ' A' ' 121' ' ' ILE . 3.0 p -100.85 -82.61 0.46 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.31 -0.869 . . . . 0.0 109.927 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.405 ' C ' ' HG2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -151.46 -42.34 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.945 . . . . 0.0 109.612 -179.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.644 ' C ' HD11 ' A' ' 24' ' ' LEU . 42.6 mmtt -139.64 40.42 2.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.605 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.595 ' N ' HD21 ' A' ' 24' ' ' LEU . 0.1 OUTLIER 173.25 161.35 0.14 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.912 . . . . 0.0 109.271 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 19.1 mt -133.56 146.72 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.082 -1.011 . . . . 0.0 109.743 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.006 HD13 ' CH2' ' A' ' 2' ' ' TRP . 0.3 OUTLIER -106.24 158.73 16.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.862 . . . . 0.0 108.807 179.396 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.877 ' CG2' HD13 ' A' ' 22' ' ' LEU . 57.4 t -145.44 71.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.946 . . . . 0.0 110.225 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -56.46 144.52 36.9 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.514 -1.835 . . . . 0.0 108.514 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.683 HG21 ' CE2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -144.75 113.33 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.72 -1.459 . . . . 0.0 109.711 -179.502 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.805 ' HB3' HG12 ' A' ' 16' ' ' VAL . 14.3 p90 -135.43 141.34 45.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.345 -0.847 . . . . 0.0 109.415 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -152.05 117.04 5.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.495 -0.753 . . . . 0.0 109.831 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 0.2 OUTLIER 160.73 -59.22 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.516 -0.74 . . . . 0.0 109.378 179.637 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 174.97 48.06 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.566 -0.709 . . . . 0.0 109.417 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.6 mt -105.91 129.74 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.368 -0.833 . . . . 0.0 108.843 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -66.08 137.43 95.79 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.725 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -65.96 -25.88 51.75 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.175 1.917 . . . . 0.0 110.403 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.09 0.52 88.57 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.5 m -92.66 -42.82 9.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.142 -1.21 . . . . 0.0 109.383 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 112' ' ' VAL . . . -90.09 -19.94 23.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.285 -0.885 . . . . 0.0 109.466 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.12 -24.38 58.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.722 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -81.89 -33.56 30.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.169 -0.957 . . . . 0.0 109.675 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.896 HG22 HD12 ' A' ' 116' ' ' LEU . 9.0 p -78.09 -18.71 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.115 -0.991 . . . . 0.0 109.508 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.774 HG13 ' HZ2' ' A' ' 2' ' ' TRP . 38.1 t -90.92 -23.18 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.928 . . . . 0.0 109.887 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -75.79 -38.69 57.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.139 -0.976 . . . . 0.0 109.911 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.69 -58.94 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.944 . . . . 0.0 109.764 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.896 HD12 HG22 ' A' ' 112' ' ' VAL . 15.1 mt -51.9 -24.17 5.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 109.511 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.905 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -73.64 -39.64 64.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 109.853 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -63.91 -16.72 62.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.013 . . . . 0.0 109.995 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -81.63 -56.46 4.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.041 -1.037 . . . . 0.0 109.755 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.472 ' HA ' HD23 ' A' ' 120' ' ' LEU . 6.1 mt -62.16 -50.15 72.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 109.663 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.905 HD12 ' O ' ' A' ' 117' ' ' ALA . 7.5 mt -59.93 -36.65 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.657 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.12 -14.98 81.74 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -127.09 -68.09 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.254 . . . . 0.0 110.15 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 120' ' ' LEU . . . -85.48 -106.68 0.69 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.348 -1.09 . . . . 0.0 109.166 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.433 ' HA ' HG21 ' A' ' 21' ' ' ILE . 10.8 p . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.666 ' HH2' HD22 ' A' ' 96' ' ' LEU . 29.9 p90 -92.59 97.13 10.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.125 -0.984 . . . . 0.0 109.905 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 8.1 tt0 -81.3 -24.07 37.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 109.218 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.497 ' O ' HG22 ' A' ' 8' ' ' THR . 85.2 m -65.96 -64.89 0.76 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.375 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.84 ' HB3' HD23 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -50.7 -41.59 56.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -0.95 . . . . 0.0 108.895 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.655 ' HA ' HG23 ' A' ' 11' ' ' VAL . 1.2 t -49.44 -48.8 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.56 -0.713 . . . . 0.0 109.894 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.725 ' C ' HG22 ' A' ' 8' ' ' THR . 0.8 OUTLIER -87.52 55.49 3.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.851 -178.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.725 HG22 ' C ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER 170.53 -86.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.739 -1.225 . . . . 0.0 111.334 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.56 ' H ' HG23 ' A' ' 8' ' ' THR . 3.1 m-20 -88.45 -74.55 0.46 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.247 -0.908 . . . . 0.0 111.481 -178.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.84 HD23 ' HB3' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -27.54 -46.9 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.917 0.389 . . . . 0.0 111.467 -178.412 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.024 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 49.5 t -101.6 -28.65 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.861 -1.149 . . . . 0.0 110.669 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.615 ' C ' HG22 ' A' ' 13' ' ' THR . . . -45.17 -28.83 2.12 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 106.311 -2.716 . . . . 0.0 106.311 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.717 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.6 OUTLIER -176.28 -39.68 0.01 OUTLIER 'General case' 0 C--O 1.193 -1.9 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.722 ' O ' ' HB3' ' A' ' 15' ' ' ALA . . . 10.43 44.22 0.0 OUTLIER Glycine 0 N--CA 1.509 3.557 0 C-N-CA 123.671 0.653 . . . . 0.0 112.838 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.903 ' O ' HG21 ' A' ' 104' ' ' ILE . . . 87.58 -34.47 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.941 HG12 ' HB3' ' A' ' 100' ' ' TYR . 35.8 m -120.51 139.08 48.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.771 HG23 ' HG2' ' A' ' 18' ' ' GLN . 9.9 t -79.96 13.3 2.28 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.833 -1.167 . . . . 0.0 109.395 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.771 ' HG2' HG23 ' A' ' 17' ' ' THR . 13.1 mm-40 -158.74 169.21 24.9 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 1.024 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . 173.59 140.95 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.494 -1.379 . . . . 0.0 110.822 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.516 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -136.1 142.34 44.28 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.548 HG13 HG21 ' A' ' 6' ' ' VAL . 2.7 mt -102.32 112.06 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.919 -1.113 . . . . 0.0 108.92 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.054 HD22 ' CG2' ' A' ' 97' ' ' VAL . 2.8 mp -98.46 160.37 14.33 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.527 -0.733 . . . . 0.0 109.089 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.92 -178.93 19.18 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.541 HD11 ' C ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -105.08 -48.46 3.72 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.295 -1.12 . . . . 0.0 109.139 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -136.76 40.11 2.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 109.306 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.06 25.22 2.23 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 1.2 m-20 61.43 -146.4 0.43 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.169 -1.194 . . . . 0.0 109.306 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.95 147.5 25.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.12 -0.987 . . . . 0.0 109.738 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -119.2 -26.49 5.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.379 -0.825 . . . . 0.0 109.145 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -178.44 159.22 1.17 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.391 -0.818 . . . . 0.0 109.372 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 1.1 t -160.22 171.54 19.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.314 -0.866 . . . . 0.0 109.503 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.647 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -178.54 82.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.333 -0.854 . . . . 0.0 109.165 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.04 -69.71 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.856 . . . . 0.0 109.566 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 167.85 -37.78 0.22 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.533 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 14.8 p90 -97.12 160.22 14.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.12 . . . . 0.0 109.482 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.03 -168.91 1.36 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.366 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.717 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 16.4 t -142.85 97.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.343 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.43 HG23 ' H ' ' A' ' 38' ' ' THR . 9.7 p -62.34 143.99 95.36 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.41 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 2.5 Cg_endo -61.59 114.92 2.46 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.193 1.929 . . . . 0.0 110.358 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 39' ' ' PRO . . . 174.77 -77.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.335 -0.853 . . . . 0.0 109.402 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.407 ' NE2' ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -67.59 -11.69 58.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.527 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.33 -43.72 95.49 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.3 -33.9 73.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -1.124 . . . . 0.0 108.936 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.2 m -50.05 -45.76 52.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.295 -0.878 . . . . 0.0 108.799 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.551 ' CD2' HG21 ' A' ' 95' ' ' ILE . 1.3 mp -54.95 -42.16 71.97 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.13 -38.22 73.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.407 -0.808 . . . . 0.0 108.869 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.93 -26.87 63.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.509 -0.745 . . . . 0.0 109.084 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.604 ' HB1' HD11 ' A' ' 55' ' ' ILE . . . -64.61 -20.2 66.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.371 -0.83 . . . . 0.0 109.334 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.603 ' CE1' ' CE ' ' A' ' 90' ' ' LYS . 22.2 m-85 -59.21 -14.54 11.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 109.365 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -79.58 -68.07 0.7 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 109.677 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -148.37 17.99 1.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.13 -0.981 . . . . 0.0 109.872 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 51' ' ' ASN . . . 36.08 32.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.278 0.561 . . . . 0.0 109.977 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.615 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 39.1 t70 -70.61 -43.98 16.52 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 111.004 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 5.3 Cg_exo -61.55 -10.96 18.02 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.381 1.387 . . . . 0.0 110.796 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.604 HD11 ' HB1' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -106.71 -31.25 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.053 -1.029 . . . . 0.0 109.573 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.437 ' CG ' ' HA ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -90.16 20.1 4.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 109.501 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.81 4.57 11.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.55 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 172.5 -55.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.518 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.67 -172.85 33.13 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 67' ' ' TYR . 33.4 p90 -132.46 170.44 15.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -1.164 . . . . 0.0 109.407 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.407 ' HB3' ' NE2' ' A' ' 41' ' ' GLN . 0.2 OUTLIER -122.29 136.93 54.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.567 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.53 ' CD2' HG13 ' A' ' 37' ' ' VAL . 0.6 OUTLIER -103.48 -161.51 0.84 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.248 -0.907 . . . . 0.0 108.93 179.753 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 37' ' ' VAL . . . -46.33 -40.5 11.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.106 -0.996 . . . . 0.0 109.263 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.74 33.63 0.16 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.17 138.02 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -1.108 . . . . 0.0 109.66 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.453 ' N ' ' CD2' ' A' ' 66' ' ' HIS . 7.6 m-70 -96.09 142.24 28.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 109.389 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 60' ' ' PHE . 17.3 m-85 -141.76 162.6 35.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.212 -0.93 . . . . 0.0 109.44 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.9 t -121.49 149.2 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.299 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.659 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -138.67 103.54 4.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.466 -179.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.745 HD23 ' H ' ' A' ' 70' ' ' LEU . 2.3 pt? -103.08 8.11 38.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.147 -0.97 . . . . 0.0 109.607 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 51.47 0.99 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.305 -0.872 . . . . 0.0 109.022 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.659 ' HB2' ' CG2' ' A' ' 69' ' ' THR . . . -94.88 130.2 41.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.852 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.46 -172.34 4.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.388 -0.82 . . . . 0.0 109.03 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.16 40.04 0.89 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.047 -1.033 . . . . 0.0 109.679 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.552 ' NH1' ' HG2' ' A' ' 75' ' ' ARG . 2.3 tpt180 -145.28 -72.29 0.25 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 108.957 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -113.54 154.1 27.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.352 -0.842 . . . . 0.0 108.738 179.369 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.704 ' O ' HG22 ' A' ' 77' ' ' ILE . 47.1 mt -156.96 58.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.935 -1.103 . . . . 0.0 110.376 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.559 ' CE2' ' CG2' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -94.36 102.59 14.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.087 . . . . 0.0 108.858 179.167 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.491 ' H ' HG13 ' A' ' 86' ' ' VAL . . . -75.05 175.48 50.64 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.45 133.52 16.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -1.094 . . . . 0.0 109.256 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 0.6 OUTLIER -127.51 70.06 1.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 109.762 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 83' ' ' SER . . . 50.85 -118.13 6.08 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 82' ' ' GLY . 3.8 t -44.59 -84.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -1.212 . . . . 0.0 109.525 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . . . -90.04 156.15 18.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.132 -0.98 . . . . 0.0 109.581 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.462 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -147.92 179.31 24.9 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.567 HG22 HG23 ' A' ' 88' ' ' THR . 7.9 p -112.14 159.25 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.062 -1.258 . . . . 0.0 109.974 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.739 HG21 HG21 ' A' ' 113' ' ' VAL . 14.4 mm -141.83 96.43 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.672 HG22 ' HA ' ' A' ' 97' ' ' VAL . 18.8 p -124.19 153.67 41.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.746 -1.222 . . . . 0.0 110.834 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.909 ' HB ' HD21 ' A' ' 96' ' ' LEU . 57.4 t -150.21 135.66 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.835 ' HD3' HG23 ' A' ' 95' ' ' ILE . 10.9 mmtm -91.54 150.38 21.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.897 . . . . 0.0 109.65 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.5 p -142.55 -168.18 2.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 108.959 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 m -47.58 -25.63 1.2 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.248 -0.907 . . . . 0.0 109.109 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.541 ' C ' HD11 ' A' ' 24' ' ' LEU . 5.1 mttt 178.4 67.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -0.824 . . . . 0.0 109.345 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.465 ' HB2' ' CD2' ' A' ' 125' ' ' PHE . 0.6 OUTLIER -173.97 145.9 1.15 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.507 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.835 HG23 ' HD3' ' A' ' 90' ' ' LYS . 3.8 mt -136.14 85.22 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.158 -0.964 . . . . 0.0 109.23 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.909 HD21 ' HB ' ' A' ' 89' ' ' VAL . 0.3 OUTLIER -61.12 165.27 4.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.478 -0.764 . . . . 0.0 109.119 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 1.054 ' CG2' HD22 ' A' ' 22' ' ' LEU . 58.7 t -143.38 47.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.192 -0.942 . . . . 0.0 110.143 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -41.05 130.7 3.39 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.752 HG23 ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -126.22 118.59 51.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.786 -1.42 . . . . 0.0 108.652 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.941 ' HB3' HG12 ' A' ' 16' ' ' VAL . 38.1 p90 -106.51 -179.1 3.84 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.084 -1.01 . . . . 0.0 109.829 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 84' ' ' ALA . 6.4 t-20 -135.06 -155.1 0.62 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 110.029 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -36.96 80.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.484 -0.76 . . . . 0.0 110.053 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.66 -49.99 55.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.95 . . . . 0.0 109.885 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.903 HG21 ' O ' ' A' ' 15' ' ' ALA . 4.3 mp -99.87 150.38 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.131 -0.981 . . . . 0.0 109.754 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -117.42 155.46 50.1 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.393 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.04 -166.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.234 1.956 . . . . 0.0 110.252 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 53.97 21.86 18.31 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.6 m -156.6 -41.15 0.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -1.105 . . . . 0.0 109.072 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.617 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -85.39 -12.88 51.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.358 -0.839 . . . . 0.0 109.133 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.43 -39.01 23.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.414 -0.804 . . . . 0.0 109.45 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -65.1 -40.01 93.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.748 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.483 HG11 ' HB2' ' A' ' 15' ' ' ALA . 5.3 p -69.88 -25.22 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.187 -0.946 . . . . 0.0 109.508 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.739 HG21 HG21 ' A' ' 87' ' ' ILE . 73.1 t -82.57 -25.06 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.204 -0.935 . . . . 0.0 109.474 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -70.55 -35.93 73.38 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.166 -0.959 . . . . 0.0 109.406 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 116' ' ' LEU . 2.5 ptpt -81.52 -39.38 24.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 109.647 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.504 ' N ' ' HG3' ' A' ' 115' ' ' LYS . 59.7 tp -50.83 -33.8 25.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 109.433 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 1.024 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -79.97 -34.5 38.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.325 -0.859 . . . . 0.0 109.592 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -62.76 -12.17 22.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.028 . . . . 0.0 109.577 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 30.7 t80 -90.31 -54.27 4.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 109.896 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.7 ' C ' HD12 ' A' ' 120' ' ' LEU . 0.8 OUTLIER -63.94 -34.47 78.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.0 110.098 -179.642 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.024 HD12 ' O ' ' A' ' 117' ' ' ALA . 5.7 mt -63.2 -13.65 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 121' ' ' ILE . . . -46.06 -27.73 2.66 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -103.26 -65.89 0.97 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.422 -1.046 . . . . 0.0 109.205 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.11 109.17 2.73 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.465 ' CD2' ' HB2' ' A' ' 94' ' ' SER . 22.5 m-85 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.171 -1.194 . . . . 0.0 109.524 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.863 ' N ' ' HB1' ' A' ' 19' ' ' ALA . 1.4 m . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.76 ' CD1' HD23 ' A' ' 10' ' ' LEU . 41.8 m95 -154.5 -167.43 2.62 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.144 -0.973 . . . . 0.0 109.723 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -89.98 -86.01 0.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 110.319 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.74 -16.87 2.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.242 -0.911 . . . . 0.0 110.203 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 2.1 m-30 -88.91 -33.92 17.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.026 -1.046 . . . . 0.0 109.747 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.642 HG22 HG21 ' A' ' 11' ' ' VAL . 1.2 t -56.0 -43.25 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.183 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.63 46.49 1.34 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.387 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 9' ' ' ASN . 67.7 m -158.52 -101.58 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.703 -1.248 . . . . 0.0 110.609 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.604 ' N ' HG22 ' A' ' 8' ' ' THR . 2.2 t-20 -102.1 -72.2 0.69 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.111 -0.993 . . . . 0.0 111.346 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.76 HD23 ' CD1' ' A' ' 2' ' ' TRP . 2.2 mp -25.67 -39.17 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.642 HG21 HG22 ' A' ' 6' ' ' VAL . 1.7 t -82.11 -66.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.559 -1.338 . . . . 0.0 110.341 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.758 ' C ' HG22 ' A' ' 13' ' ' THR . . . -40.24 -33.83 0.55 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.758 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 156.37 39.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.624 0.726 . . . . 0.0 109.357 179.181 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.709 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -83.31 14.28 40.82 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 107.412 -2.275 . . . . 0.0 107.412 177.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 156.93 -25.04 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.605 HG12 ' HB3' ' A' ' 100' ' ' TYR . 17.1 m -138.08 152.67 26.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.425 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -81.85 14.86 2.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.978 -1.076 . . . . 0.0 109.127 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER 173.28 -178.37 0.08 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.863 ' HB1' ' N ' ' A' ' 1' ' ' SER . . . 178.95 160.52 0.66 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.828 -1.17 . . . . 0.0 109.88 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -155.59 127.41 7.46 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.236 -0.915 . . . . 0.0 110.239 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.72 HD11 ' C ' ' A' ' 2' ' ' TRP . 2.2 mm -87.73 78.67 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.004 HD13 HG21 ' A' ' 97' ' ' VAL . 8.8 mp -52.66 164.22 0.38 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.513 -0.742 . . . . 0.0 109.631 -178.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.618 ' O ' HD12 ' A' ' 95' ' ' ILE . . . -106.22 159.49 15.04 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.778 HD11 ' C ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -110.76 -28.13 8.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -1.087 . . . . 0.0 109.275 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.69 6.38 12.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.828 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -136.56 -86.68 0.2 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.467 ' O ' ' OG1' ' A' ' 28' ' ' THR . 6.7 p30 -170.23 -46.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.356 -1.085 . . . . 0.0 109.281 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 27' ' ' ASN . 34.1 m -170.68 127.86 0.77 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 109.567 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.527 ' CZ2' ' O ' ' A' ' 93' ' ' LYS . 26.1 m0 -84.05 -58.11 2.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.383 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.97 169.78 16.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.347 -0.845 . . . . 0.0 109.304 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -160.48 174.47 14.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 109.978 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.525 ' OG ' HG13 ' A' ' 6' ' ' VAL . 3.1 m -154.28 99.49 2.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.337 -0.852 . . . . 0.0 109.374 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 32' ' ' SER . . . 42.64 -152.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.416 -0.803 . . . . 0.0 109.524 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.458 ' N ' ' HG2' ' A' ' 18' ' ' GLN . . . 90.52 -145.74 18.15 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.563 ' CE2' HG11 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -103.43 169.26 8.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -1.139 . . . . 0.0 109.471 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.22 116.73 29.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.321 -0.862 . . . . 0.0 109.244 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.1 t -79.4 122.23 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.157 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.9 m -75.67 132.88 74.26 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.92 . . . . 0.0 109.48 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.736 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 3.4 Cg_exo -59.13 171.36 2.31 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.941 1.761 . . . . 0.0 109.778 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 39' ' ' PRO . . . 83.56 -46.3 0.12 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.672 -0.643 . . . . 0.0 109.379 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.92 -30.46 68.93 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.146 -0.971 . . . . 0.0 109.02 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.79 -32.79 48.38 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -67.03 -37.7 84.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.376 -1.073 . . . . 0.0 108.874 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.8 m -63.78 -29.86 71.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 108.807 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.529 ' HG ' ' CZ ' ' A' ' 49' ' ' PHE . 11.8 tp -70.89 -39.03 73.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.349 -0.844 . . . . 0.0 109.172 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.09 -46.91 79.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.325 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -24.58 66.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.372 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.85 92.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.268 -0.895 . . . . 0.0 109.15 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.529 ' CZ ' ' HG ' ' A' ' 45' ' ' LEU . 2.9 m-30 -68.94 85.66 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.369 -0.832 . . . . 0.0 109.213 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.53 -64.03 0.22 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.64 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 53' ' ' ASP . 3.7 t-20 -136.66 19.17 3.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.36 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 51' ' ' ASN . . . 41.97 26.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.55 -0.719 . . . . 0.0 109.954 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.566 ' N ' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -80.88 -53.58 0.8 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.068 -1.02 . . . . 0.0 110.403 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 53' ' ' ASP . 3.4 Cg_exo -62.34 -22.47 74.15 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.067 1.845 . . . . 0.0 110.893 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -94.61 -51.76 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.862 -1.149 . . . . 0.0 109.238 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -45.09 -27.0 0.52 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.963 . . . . 0.0 108.748 179.577 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . -115.68 -165.59 1.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.474 -0.766 . . . . 0.0 109.055 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 57' ' ' ALA . 75.0 m 44.37 -95.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.193 -0.942 . . . . 0.0 109.536 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 57' ' ' ALA . . . 164.43 175.0 34.82 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.454 ' HB3' ' HB2' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -80.32 155.54 27.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.393 -1.063 . . . . 0.0 109.38 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -154.07 101.92 2.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.048 -1.032 . . . . 0.0 110.061 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -98.73 -163.01 1.0 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 109.274 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.508 ' O ' HG23 ' A' ' 65' ' ' VAL . . . -61.56 94.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.976 . . . . 0.0 109.798 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.77 51.99 55.23 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.61 ' CG1' ' CE1' ' A' ' 67' ' ' TYR . 3.2 t -150.01 136.23 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.244 -1.151 . . . . 0.0 109.413 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -110.24 91.89 3.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 109.744 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.61 ' CE1' ' CG1' ' A' ' 65' ' ' VAL . 6.0 m-30 -100.68 -168.38 1.57 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.16 -0.963 . . . . 0.0 109.083 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 80' ' ' LYS . 4.4 p -131.06 176.59 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.992 -1.068 . . . . 0.0 109.522 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.852 HG22 ' HB2' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -136.69 69.42 1.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 109.535 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 70' ' ' LEU . 15.1 tp -89.66 2.21 55.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.125 -0.984 . . . . 0.0 109.216 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.468 ' HG3' ' NH1' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -144.93 69.67 1.26 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.36 -0.838 . . . . 0.0 108.85 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.852 ' HB2' HG22 ' A' ' 69' ' ' THR . . . -118.69 91.72 3.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.898 . . . . 0.0 110.125 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -98.49 -162.81 0.98 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.336 -0.852 . . . . 0.0 108.857 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -101.44 41.36 1.21 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.074 -1.016 . . . . 0.0 109.373 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.462 ' CG ' ' NH1' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -150.42 -53.64 0.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.816 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.602 ' HA ' HG12 ' A' ' 89' ' ' VAL . 27.0 m -131.85 136.67 47.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 0.0 109.986 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 77' ' ' ILE . 11.1 mt -99.92 72.93 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.576 ' OH ' HD11 ' A' ' 87' ' ' ILE . 2.5 t80 -89.6 82.2 6.39 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.422 -0.799 . . . . 0.0 109.193 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.409 ' O ' ' HG2' ' A' ' 80' ' ' LYS . . . -89.08 176.0 43.54 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.751 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -150.61 -170.74 3.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.335 -1.097 . . . . 0.0 109.697 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.408 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -164.65 25.09 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.428 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.1 -78.57 1.7 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 102' ' ' GLU . 1.9 m -81.92 -38.89 24.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -1.157 . . . . 0.0 109.863 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -126.6 164.56 20.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.987 . . . . 0.0 109.538 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -159.08 162.48 32.71 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.482 HG22 HG23 ' A' ' 88' ' ' THR . 14.9 p -123.79 151.45 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.367 -1.078 . . . . 0.0 109.61 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.576 HD11 ' OH ' ' A' ' 78' ' ' TYR . 54.9 mt -124.8 88.84 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.366 -0.834 . . . . 0.0 108.86 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 41.6 p -105.76 129.33 53.98 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.048 -1.033 . . . . 0.0 109.992 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 76' ' ' SER . 6.1 m -145.23 150.94 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.572 -0.705 . . . . 0.0 109.554 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -97.52 122.67 40.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.202 -0.936 . . . . 0.0 109.653 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -58.15 2.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 109.143 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -175.24 -36.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.807 . . . . 0.0 109.184 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.778 ' C ' HD11 ' A' ' 24' ' ' LEU . 10.3 mttm -145.67 28.51 1.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.842 . . . . 0.0 109.497 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.739 ' N ' HD21 ' A' ' 24' ' ' LEU . 58.3 m -161.3 168.89 23.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.894 . . . . 0.0 109.468 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.618 HD12 ' O ' ' A' ' 23' ' ' GLY . 83.5 mt -125.43 123.86 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.113 -0.992 . . . . 0.0 109.371 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.74 HD11 ' CE3' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -81.54 155.47 25.72 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.462 -0.774 . . . . 0.0 109.903 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 1.004 HG21 HD13 ' A' ' 22' ' ' LEU . 48.2 t -151.43 54.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.665 -0.647 . . . . 0.0 109.695 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -55.53 113.88 4.26 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.563 HG11 ' CE2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -111.3 122.95 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.058 -1.26 . . . . 0.0 109.425 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.605 ' HB3' HG12 ' A' ' 16' ' ' VAL . 2.8 p90 -131.72 178.12 7.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 109.66 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -121.69 -167.41 1.52 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.69 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -68.07 -17.76 64.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.702 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.12 -10.98 25.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.946 . . . . 0.0 109.446 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.585 HD13 ' O ' ' A' ' 15' ' ' ALA . 28.2 mt -125.63 158.59 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.15 -0.969 . . . . 0.0 109.777 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.533 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 7.3 mt-30 -139.61 160.08 62.77 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.442 -0.786 . . . . 0.0 109.009 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 105' ' ' GLN . 5.9 Cg_exo -56.27 165.0 4.61 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.928 1.752 . . . . 0.0 110.129 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.21 -28.01 17.33 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.7 m -115.55 -48.63 2.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.448 -1.031 . . . . 0.0 109.235 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.621 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -87.36 -19.28 28.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.882 . . . . 0.0 109.279 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.446 ' HA ' ' CE2' ' A' ' 78' ' ' TYR . . . -85.55 -52.07 6.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.304 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -60.69 -36.19 78.16 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.432 -0.792 . . . . 0.0 109.79 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 13.4 p -65.27 -37.14 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.191 -0.943 . . . . 0.0 109.378 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 87' ' ' ILE . 93.9 t -73.62 -16.02 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.212 -0.93 . . . . 0.0 109.701 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.9 -44.79 38.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.004 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.499 ' HG3' ' N ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -84.62 -46.86 11.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.108 -0.995 . . . . 0.0 110.069 -179.49 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.605 HD22 HD21 ' A' ' 10' ' ' LEU . 2.6 mp -54.27 -32.65 56.75 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.138 -0.976 . . . . 0.0 109.813 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.728 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -72.93 -43.11 62.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -0.946 . . . . 0.0 109.755 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -57.8 -20.99 39.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.85 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -90.08 -56.18 3.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.08 -1.013 . . . . 0.0 109.982 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -73.44 -0.6 15.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.157 -0.964 . . . . 0.0 109.838 -179.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.728 HD12 ' O ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER -64.24 -39.08 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.984 -1.072 . . . . 0.0 108.797 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -121.73 45.51 1.21 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -143.11 -73.57 0.28 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.082 -1.246 . . . . 0.0 110.018 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.483 ' H ' HD23 ' A' ' 120' ' ' LEU . . . -123.18 -18.46 3.11 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.517 ' CE2' ' HG3' ' A' ' 93' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.202 -1.175 . . . . 0.0 109.374 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.3 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.259 0.552 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.985 ' CZ2' HD11 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -92.52 -21.45 20.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.973 . . . . 0.0 109.245 179.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.49 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 2.5 tt0 -63.56 -51.34 65.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.313 -0.867 . . . . 0.0 109.753 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.403 HG22 ' H ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -54.12 -40.45 67.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 109.233 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.89 ' HB3' HD12 ' A' ' 10' ' ' LEU . 22.1 m-30 -61.9 -33.69 74.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.095 -1.003 . . . . 0.0 108.417 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.719 HG21 HG13 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -62.15 -56.89 14.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.643 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.494 ' N ' HG12 ' A' ' 6' ' ' VAL . 58.9 m-20 -91.64 50.47 1.72 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.05 -1.032 . . . . 0.0 110.314 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 9' ' ' ASN . 65.7 m -156.19 -100.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.77 -1.206 . . . . 0.0 110.78 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.622 ' N ' HG22 ' A' ' 8' ' ' THR . 0.8 OUTLIER -101.53 -56.48 2.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.084 -1.01 . . . . 0.0 111.075 -178.354 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.993 HD11 HD13 ' A' ' 116' ' ' LEU . 6.6 mt -38.16 -30.22 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.142 -0.974 . . . . 0.0 111.158 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.032 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 47.5 t -101.25 -52.27 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.764 -1.21 . . . . 0.0 110.065 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.764 ' C ' HG22 ' A' ' 13' ' ' THR . . . -40.14 -42.29 2.32 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.764 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 161.18 43.68 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.789 -0.83 . . . . 0.0 109.322 178.437 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.717 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -85.69 15.01 49.46 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 177.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.718 ' HB2' HG11 ' A' ' 112' ' ' VAL . . . 155.68 -27.83 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.638 HG12 ' CD1' ' A' ' 100' ' ' TYR . 5.6 m -139.4 155.34 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.652 HG22 ' HA ' ' A' ' 100' ' ' TYR . 14.7 t -87.18 21.66 2.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.896 -1.128 . . . . 0.0 108.877 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.921 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -178.45 -176.81 0.52 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 1.032 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . 175.33 154.65 0.16 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.273 -0.892 . . . . 0.0 109.127 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.507 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . -148.27 136.83 21.52 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.244 -0.91 . . . . 0.0 109.68 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.719 HG13 HG21 ' A' ' 6' ' ' VAL . 1.6 mt -106.61 101.68 12.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.811 HD11 HG21 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -84.95 22.83 1.31 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.389 -0.819 . . . . 0.0 110.269 -178.089 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.502 ' O ' HD12 ' A' ' 95' ' ' ILE . . . 47.43 -164.42 0.18 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.738 HD11 ' C ' ' A' ' 93' ' ' LYS . 1.1 mt -98.34 -74.33 0.59 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.388 -1.066 . . . . 0.0 109.114 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -135.15 22.04 3.47 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.307 -0.87 . . . . 0.0 108.832 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.7 67.97 0.25 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.5 t30 48.7 -150.25 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -1.108 . . . . 0.0 109.737 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 60.8 m -94.12 139.26 31.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.812 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -96.67 -65.31 0.97 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.441 ' C ' HG23 ' A' ' 31' ' ' THR . . . -137.53 160.11 40.07 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.441 HG23 ' C ' ' A' ' 30' ' ' ALA . 77.4 p -155.13 137.35 14.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.041 -1.037 . . . . 0.0 110.119 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 1.008 ' CB ' HG21 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -108.81 115.78 30.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.516 -0.74 . . . . 0.0 109.068 179.578 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 82.38 166.69 0.13 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 35' ' ' PHE . . . -48.41 -96.9 0.01 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.957 ' CE1' HG11 ' A' ' 99' ' ' VAL . 4.9 t80 74.35 84.99 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.315 -1.109 . . . . 0.0 109.901 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.09 105.69 17.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 109.356 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.592 ' O ' HG12 ' A' ' 37' ' ' VAL . 59.7 t -108.05 56.3 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.655 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.562 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 57.58 156.43 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.269 -0.894 . . . . 0.0 109.851 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.562 ' HD2' HG22 ' A' ' 38' ' ' THR . 2.7 Cg_endo -62.17 -36.52 68.78 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.294 1.996 . . . . 0.0 110.197 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' A' ' 43' ' ' GLN . . . -83.82 60.69 5.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.838 . . . . 0.0 109.442 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.539 ' CG ' ' HB ' ' A' ' 37' ' ' VAL . 2.2 mt-30 -66.44 -47.83 71.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.681 -1.262 . . . . 0.0 110.111 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -76.64 -29.04 58.32 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.784 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.618 ' HB2' ' HB1' ' A' ' 40' ' ' ALA . 3.4 mt-30 -81.48 -62.86 1.53 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.97 -1.312 . . . . 0.0 109.84 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.3 m -45.84 -50.76 13.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.84 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -66.45 -30.99 71.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.154 -0.966 . . . . 0.0 109.749 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -71.03 -18.59 62.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.4 t -74.66 -52.61 11.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -0.872 . . . . 0.0 109.659 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.51 -21.72 52.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.194 -0.941 . . . . 0.0 109.543 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.583 ' CE2' ' CG ' ' A' ' 90' ' ' LYS . 4.2 m-30 -65.88 -37.08 85.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.432 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -88.28 -74.69 0.45 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 109.587 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -71.9 119.25 15.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.172 -0.955 . . . . 0.0 109.521 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.412 ' C ' HG12 ' A' ' 55' ' ' ILE . . . -104.19 17.52 23.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.113 -0.992 . . . . 0.0 109.056 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.589 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -76.61 -50.14 2.66 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.456 -0.777 . . . . 0.0 110.372 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 4.2 Cg_exo -62.82 -8.17 12.94 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.976 1.784 . . . . 0.0 110.933 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.788 HD13 ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -104.96 -44.05 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.041 -1.037 . . . . 0.0 109.497 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.534 ' CD ' ' HA ' ' A' ' 53' ' ' ASP . 8.3 ptm180 -61.98 -22.15 65.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 109.948 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.427 ' C ' ' OG ' ' A' ' 58' ' ' SER . . . -107.73 108.11 19.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 109.907 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.427 ' OG ' ' C ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER 72.25 -79.52 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.432 -0.792 . . . . 0.0 109.882 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.88 -138.97 5.76 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.618 ' HE1' HD12 ' A' ' 62' ' ' LEU . 20.5 p90 -155.39 172.5 18.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -1.11 . . . . 0.0 109.573 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.12 160.29 14.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 109.092 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.619 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 3.4 mt -159.57 98.45 1.38 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.924 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . 74.99 -78.22 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.646 -0.659 . . . . 0.0 110.041 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -159.08 23.28 0.31 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 66' ' ' HIS . 66.5 t -137.48 157.36 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -1.145 . . . . 0.0 109.207 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.487 ' CE1' ' HD2' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -100.25 152.66 20.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.153 -0.967 . . . . 0.0 109.472 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.561 ' CE2' ' HB2' ' A' ' 62' ' ' LEU . 92.2 m-85 -137.61 149.44 46.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 109.525 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 69' ' ' THR . 0.9 OUTLIER -93.54 -156.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 109.241 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.552 ' H ' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -161.88 75.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.94 . . . . 0.0 109.5 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.11 12.15 31.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.907 . . . . 0.0 109.44 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -156.92 64.14 0.51 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.709 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 69' ' ' THR . . . -106.21 90.32 3.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 109.062 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.88 -108.05 0.35 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.107 -0.996 . . . . 0.0 109.791 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -121.6 -34.12 3.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.778 -1.201 . . . . 0.0 110.648 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.53 ' NH1' ' HG2' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -134.74 31.7 3.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.887 -1.133 . . . . 0.0 110.878 -178.703 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.55 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 1.2 m -150.57 116.24 5.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.984 -1.073 . . . . 0.0 109.476 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.602 ' O ' HG22 ' A' ' 77' ' ' ILE . 3.6 mp -144.79 50.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 0.0 109.557 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.653 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -91.01 91.5 8.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.092 -1.005 . . . . 0.0 108.612 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.33 170.65 53.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.511 ' HG2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -151.04 147.36 27.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.54 -0.976 . . . . 0.0 109.11 179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.511 ' N ' ' HG2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -124.7 -170.84 2.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.989 -1.069 . . . . 0.0 109.682 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.29 5.41 77.26 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -154.82 -67.98 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -1.098 . . . . 0.0 108.887 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 81' ' ' LYS . . . -91.7 164.42 13.73 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.506 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -156.71 150.23 21.35 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.538 -1.315 . . . . 0.0 109.908 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.8 p -122.32 147.37 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.329 -1.101 . . . . 0.0 109.448 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.653 HG23 ' HD2' ' A' ' 78' ' ' TYR . 11.9 mt -120.75 94.02 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 39.2 p -113.29 133.56 55.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.981 -1.074 . . . . 0.0 110.716 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.594 HG13 ' HB2' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -151.33 152.66 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.042 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.583 ' CG ' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -97.95 117.69 32.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.901 -179.428 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.854 HG21 ' HZ3' ' A' ' 2' ' ' TRP . 0.8 OUTLIER -96.38 -69.17 0.77 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 108.764 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 91' ' ' THR . 1.9 m 157.7 -24.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.738 ' C ' HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -110.99 -12.33 14.23 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.444 -0.785 . . . . 0.0 109.256 179.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.484 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -172.5 168.73 5.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.81 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.502 HD12 ' O ' ' A' ' 23' ' ' GLY . 34.1 mt -105.78 134.64 46.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.398 -0.814 . . . . 0.0 108.973 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.985 HD11 ' CZ2' ' A' ' 2' ' ' TRP . 1.6 mt -88.96 148.26 23.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 110.249 -179.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.811 HG21 HD11 ' A' ' 22' ' ' LEU . 75.4 t -151.33 58.55 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.458 -0.776 . . . . 0.0 109.632 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -55.57 112.58 3.15 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.957 HG11 ' CE1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.81 125.52 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.992 -1.299 . . . . 0.0 109.119 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.735 ' HB2' HD12 ' A' ' 104' ' ' ILE . 3.8 p90 -138.82 -178.3 5.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.941 . . . . 0.0 110.14 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.19 -147.3 0.39 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.443 -0.785 . . . . 0.0 109.675 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 83' ' ' SER . 46.8 tt0 -102.91 -29.95 11.12 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.166 -0.959 . . . . 0.0 109.948 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -16.06 23.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 110.193 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.735 HD12 ' HB2' ' A' ' 100' ' ' TYR . 16.7 mt -85.68 141.3 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.058 -1.026 . . . . 0.0 109.395 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.51 110.0 2.17 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.394 -0.816 . . . . 0.0 109.631 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 104' ' ' ILE . 1.2 Cg_endo -65.69 145.84 82.42 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.092 1.862 . . . . 0.0 110.27 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.33 -43.81 3.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.8 m -74.63 -30.9 61.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -1.184 . . . . 0.0 109.483 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.808 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -63.54 -45.02 92.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.874 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.09 -32.52 67.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.146 -0.971 . . . . 0.0 109.846 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 7.4 t-20 -67.73 -32.54 73.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 0.0 109.724 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.718 HG11 ' HB2' ' A' ' 15' ' ' ALA . 1.3 t -79.86 -28.0 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.146 -0.971 . . . . 0.0 109.421 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 109' ' ' ALA . 18.2 t -82.83 -17.92 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.952 . . . . 0.0 109.694 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.471 ' CD ' ' CZ ' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -78.16 -37.17 46.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.158 -0.964 . . . . 0.0 109.765 -179.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 111' ' ' ASN . 1.5 mmmt -71.73 -46.3 59.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.122 -0.986 . . . . 0.0 109.864 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.993 HD13 HD11 ' A' ' 10' ' ' LEU . 3.2 tt -54.06 -34.22 59.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.931 -1.106 . . . . 0.0 109.162 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 1.0 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -62.55 -37.8 87.55 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.077 -1.014 . . . . 0.0 108.887 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -21.77 61.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.904 . . . . 0.0 109.6 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.603 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 0.0 OUTLIER -73.71 -40.73 63.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 109.879 -179.492 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.687 HD12 ' CE3' ' A' ' 2' ' ' TRP . 5.0 mt -81.04 -36.26 30.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.117 -0.989 . . . . 0.0 110.566 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.0 HD12 ' O ' ' A' ' 117' ' ' ALA . 1.5 mp -64.1 -21.58 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.103 -0.998 . . . . 0.0 109.596 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.538 ' O ' ' CG ' ' A' ' 123' ' ' GLN . . . -97.5 22.48 40.58 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 122' ' ' GLY . 45.7 mt-30 -162.41 -83.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -1.169 . . . . 0.0 109.809 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 125' ' ' PHE . . . -96.1 57.76 1.48 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.543 ' HB3' ' HB3' ' A' ' 92' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.411 -1.052 . . . . 0.0 109.977 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.587 ' O ' ' CE2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.825 ' CE2' HD22 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -99.81 -36.97 9.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -0.907 . . . . 0.0 109.501 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -72.36 -28.68 63.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.051 -1.031 . . . . 0.0 109.986 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -38.99 86.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.07 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.587 ' CE2' ' O ' ' A' ' 1' ' ' SER . 14.6 m-85 -74.81 -23.94 58.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.138 -0.976 . . . . 0.0 109.862 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.911 HG21 HG13 ' A' ' 21' ' ' ILE . 2.0 t -72.47 -23.16 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.18 -0.95 . . . . 0.0 110.062 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -46.77 -91.21 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.023 -1.048 . . . . 0.0 110.359 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.69 -2.23 3.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 110.131 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -86.26 -87.06 0.14 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.085 -1.01 . . . . 0.0 109.262 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 2.0 mm? -54.59 -27.5 39.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.996 -1.065 . . . . 0.0 109.669 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.088 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 4.2 t -90.55 -63.8 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.178 -0.952 . . . . 0.0 109.694 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.754 ' C ' HG22 ' A' ' 13' ' ' THR . . . -39.78 -38.91 1.21 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.754 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 157.02 53.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.977 -0.72 . . . . 0.0 109.839 178.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.676 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -96.1 21.76 43.38 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 106.339 -2.704 . . . . 0.0 106.339 177.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 144.43 -28.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.901 HG13 ' HB3' ' A' ' 100' ' ' TYR . 4.3 t -131.72 140.5 48.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.517 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 0.2 OUTLIER -77.78 2.34 17.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.733 -1.229 . . . . 0.0 108.476 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.58 ' HB3' ' HB2' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -158.67 -173.68 4.4 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.359 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 1.088 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . 170.78 142.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.007 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 31' ' ' THR . . . -140.4 104.14 4.71 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.058 -1.026 . . . . 0.0 110.305 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.911 HG13 HG21 ' A' ' 6' ' ' VAL . 14.4 mt -79.61 106.01 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.612 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.4 OUTLIER -93.5 116.93 29.46 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.492 -0.755 . . . . 0.0 109.463 -178.317 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 22' ' ' LEU . . . -49.72 -178.26 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.796 HD21 ' N ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -103.55 -68.94 0.82 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -1.141 . . . . 0.0 109.545 -179.75 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -113.66 11.83 18.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.269 -0.894 . . . . 0.0 109.543 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.71 -83.51 1.65 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -175.92 -65.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.417 -1.049 . . . . 0.0 109.401 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.6 m -158.62 156.54 30.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.94 . . . . 0.0 109.715 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -114.85 -69.97 0.83 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.354 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.444 ' O ' HG11 ' A' ' 6' ' ' VAL . . . -160.8 117.93 2.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.344 -0.848 . . . . 0.0 109.076 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . 1.6 p -128.81 168.68 15.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.92 . . . . 0.0 109.81 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.4 ' HB2' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -171.71 98.32 0.18 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 109.238 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.58 ' HB2' ' HB3' ' A' ' 18' ' ' GLN . . . -166.7 -67.24 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.169 -0.957 . . . . 0.0 109.464 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 139.21 39.61 0.1 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.557 ' CG ' ' O ' ' A' ' 35' ' ' PHE . 1.4 p90 -155.64 117.95 4.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -1.175 . . . . 0.0 109.409 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.91 130.54 41.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.536 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -90.65 161.67 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.373 -0.829 . . . . 0.0 109.353 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -74.11 148.05 86.26 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.293 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.78 -31.91 78.14 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.125 1.883 . . . . 0.0 110.357 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.31 13.38 3.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.196 -0.94 . . . . 0.0 110.285 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 38' ' ' THR . 1.3 mm-40 -90.65 -32.43 16.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.907 -1.121 . . . . 0.0 109.485 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.86 -46.31 94.78 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -21.01 64.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.406 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 46.1 m -68.28 -34.69 76.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -41.84 75.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.367 -0.833 . . . . 0.0 109.445 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.52 -45.86 91.03 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.921 . . . . 0.0 109.021 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -81.55 -5.86 58.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.352 -0.842 . . . . 0.0 109.114 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.648 ' O ' HD11 ' A' ' 55' ' ' ILE . . . -69.09 -37.92 78.69 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.231 -0.918 . . . . 0.0 109.217 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 6.3 m-30 -74.96 81.89 2.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.52 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 2.1 t-20 -130.37 58.2 1.68 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 108.735 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 50' ' ' ASN . 5.2 t-20 84.77 17.84 0.15 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.578 0.704 . . . . 0.0 109.129 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 44.18 23.62 0.07 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.467 -0.771 . . . . 0.0 110.17 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.549 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -91.93 -53.65 0.27 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.067 -1.02 . . . . 0.0 110.638 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 2.4 Cg_endo -65.4 -7.71 16.76 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.994 1.796 . . . . 0.0 110.965 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.648 HD11 ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -109.08 -17.19 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.96 -1.088 . . . . 0.0 109.638 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.489 ' NH1' ' HG2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -80.3 -46.8 15.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.449 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -107.32 63.47 0.63 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.505 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 4.7 t 167.68 -30.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.43 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.24 -153.3 31.69 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.448 ' C ' ' CD1' ' A' ' 60' ' ' PHE . 6.3 p90 -151.84 -169.27 3.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -1.165 . . . . 0.0 109.169 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.77 146.75 28.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.092 -1.005 . . . . 0.0 110.556 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.5 -166.98 1.44 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.89 -22.08 46.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 109.383 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.72 -111.17 0.14 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 66' ' ' HIS . 1.2 t -125.76 -153.67 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -1.195 . . . . 0.0 109.293 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 47.1 p-80 -88.29 114.14 24.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.167 -0.958 . . . . 0.0 109.416 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.46 ' HA ' ' HB2' ' A' ' 81' ' ' LYS . 12.0 m-30 -95.13 162.95 13.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.586 HG12 ' N ' ' A' ' 69' ' ' THR . 26.1 t -111.3 169.13 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.897 . . . . 0.0 109.451 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.586 ' N ' HG12 ' A' ' 68' ' ' VAL . 91.6 m -122.33 130.94 53.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.909 . . . . 0.0 109.616 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.72 19.54 5.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.126 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -177.16 85.18 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.373 -0.829 . . . . 0.0 109.171 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.71 36.95 1.63 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 0.0 109.64 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.44 -25.86 13.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.28 -0.887 . . . . 0.0 109.446 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.489 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -90.62 -106.65 0.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -139.64 24.24 2.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.793 -1.192 . . . . 0.0 109.564 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -135.47 156.17 49.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -0.905 . . . . 0.0 109.338 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.617 ' O ' HG22 ' A' ' 77' ' ' ILE . 10.8 mt -149.27 68.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.174 -0.954 . . . . 0.0 109.429 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.651 ' HD2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -94.17 95.26 8.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.904 . . . . 0.0 108.764 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -113.23 173.32 15.01 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 0.7 OUTLIER -151.23 -170.65 3.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -1.153 . . . . 0.0 109.334 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.507 ' HE2' ' NE2' ' A' ' 66' ' ' HIS . 0.3 OUTLIER 175.62 111.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.189 -0.944 . . . . 0.0 109.58 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.54 -135.0 11.91 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 102' ' ' GLU . 2.4 p -100.24 -4.62 29.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -1.192 . . . . 0.0 109.694 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . . . -113.35 166.95 10.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.368 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.566 ' HA3' ' CE1' ' A' ' 100' ' ' TYR . . . -150.22 157.18 27.09 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.689 ' CG2' HG13 ' A' ' 97' ' ' VAL . 11.9 p -135.53 136.64 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -1.18 . . . . 0.0 110.039 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.651 HG23 ' HD2' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -110.26 95.58 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 6.7 p -106.72 115.75 30.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 109.889 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.724 ' CG2' HD21 ' A' ' 96' ' ' LEU . 3.1 m -135.02 134.16 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 109.536 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.517 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -97.35 146.1 25.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.346 -0.846 . . . . 0.0 109.121 179.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.489 ' HB ' HG12 ' A' ' 121' ' ' ILE . 23.4 p -146.17 -145.31 0.17 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 109.913 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 91' ' ' THR . 0.1 OUTLIER -41.41 -74.58 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.295 -0.878 . . . . 0.0 110.548 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.769 ' O ' HD11 ' A' ' 24' ' ' LEU . 1.2 mtpt -149.72 52.85 0.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.993 . . . . 0.0 109.89 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.796 ' N ' HD21 ' A' ' 24' ' ' LEU . 21.2 t -169.86 151.25 4.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.925 . . . . 0.0 109.523 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.461 HD11 ' HD3' ' A' ' 90' ' ' LYS . 12.4 mt -129.32 128.53 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.179 -0.951 . . . . 0.0 109.256 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.825 HD22 ' CE2' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -98.96 154.39 18.11 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.327 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.689 HG13 ' CG2' ' A' ' 86' ' ' VAL . 59.0 t -137.36 64.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.129 -0.982 . . . . 0.0 109.578 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -50.05 118.28 5.66 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.663 ' O ' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -112.31 114.2 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.159 -1.2 . . . . 0.0 109.291 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.901 ' HB3' HG13 ' A' ' 16' ' ' VAL . 19.2 p90 -123.98 -168.78 1.84 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.248 -0.907 . . . . 0.0 109.672 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' ALA . 6.9 m120 -132.82 -168.52 2.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 83' ' ' SER . 16.1 pt-20 -66.28 -9.32 31.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.278 -0.889 . . . . 0.0 109.906 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -73.89 -17.54 61.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.917 . . . . 0.0 109.599 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 16' ' ' VAL . 9.5 mt -117.59 103.66 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.935 . . . . 0.0 109.504 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.475 ' HG2' ' HD2' ' A' ' 106' ' ' PRO . 1.7 tt0 -64.29 142.05 98.25 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.266 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.475 ' HD2' ' HG2' ' A' ' 105' ' ' GLN . 2.8 Cg_endo -61.55 152.58 72.45 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.04 1.827 . . . . 0.0 110.079 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.32 -23.05 23.67 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.1 m -98.08 -53.28 3.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -1.123 . . . . 0.0 109.569 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.761 ' O ' HG23 ' A' ' 113' ' ' VAL . . . -73.77 -32.19 63.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.928 . . . . 0.0 109.465 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.44 -27.85 64.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 0.0 109.587 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.463 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -78.2 -49.28 14.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.715 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 7.5 p -59.26 -21.59 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -0.969 . . . . 0.0 109.523 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 109' ' ' ALA . 91.1 t -78.91 -33.32 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.785 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.463 ' OE2' ' HA ' ' A' ' 111' ' ' ASN . 26.3 mt-10 -59.57 -61.12 2.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.931 . . . . 0.0 109.439 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.29 -38.26 88.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.633 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 4.1 mt -57.97 -24.44 58.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.869 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -80.41 -29.74 37.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.289 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.35 -38.7 74.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.072 . . . . 0.0 109.4 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -75.43 -47.43 27.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 109.554 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.5 OUTLIER -60.92 -57.52 12.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 109.417 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.869 HD12 ' O ' ' A' ' 117' ' ' ALA . 15.7 mt -61.24 -13.81 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.467 -0.771 . . . . 0.0 109.941 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.74 -9.76 40.9 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -119.42 -56.27 2.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -1.185 . . . . 0.0 109.459 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 114.64 112.4 2.94 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.286 -1.126 . . . . 0.0 109.271 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 1.015 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.943 ' CZ3' HD22 ' A' ' 96' ' ' LEU . 47.7 m95 -159.25 -149.24 0.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.559 -0.713 . . . . 0.0 109.219 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.84 -86.07 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.816 -1.178 . . . . 0.0 109.342 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -63.77 -37.94 89.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.032 -1.042 . . . . 0.0 108.984 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.604 ' CE2' ' HG ' ' A' ' 116' ' ' LEU . 18.7 m-30 -56.34 -39.26 72.56 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.381 -0.825 . . . . 0.0 109.769 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.549 HG21 ' HB1' ' A' ' 30' ' ' ALA . 1.2 t -54.44 -45.56 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.828 -1.17 . . . . 0.0 108.075 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.407 ' N ' HG12 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -91.62 41.12 1.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 110.919 -179.338 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.505 HG22 ' N ' ' A' ' 9' ' ' ASN . 88.8 m -146.06 -106.01 0.1 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.527 -1.358 . . . . 0.0 109.879 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.9 t-20 -102.1 -70.75 0.74 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.043 -1.036 . . . . 0.0 110.08 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.008 HD23 ' OG ' ' A' ' 1' ' ' SER . 0.2 OUTLIER -20.53 -45.34 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.775 HG23 ' HB3' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -77.39 -68.09 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.851 -1.156 . . . . 0.0 110.125 -179.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.769 ' C ' HG22 ' A' ' 13' ' ' THR . . . -38.99 -36.46 0.5 Allowed Glycine 0 N--CA 1.498 2.785 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.769 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER 156.61 39.61 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.989 -0.712 . . . . 0.0 109.154 179.011 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.685 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -84.47 17.78 27.77 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 177.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 14' ' ' GLY . . . 158.44 -32.04 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.749 HG12 ' HB3' ' A' ' 100' ' ' TYR . 31.2 m -138.88 150.55 23.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.565 ' O ' ' CG ' ' A' ' 18' ' ' GLN . 0.6 OUTLIER -78.97 6.32 9.57 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.113 -0.992 . . . . 0.0 108.872 179.112 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.589 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 27.4 mt-30 -168.42 160.87 11.54 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 1.015 ' HB1' ' HA ' ' A' ' 1' ' ' SER . . . -163.95 112.4 1.18 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.913 -1.117 . . . . 0.0 112.148 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.531 ' O ' HD13 ' A' ' 21' ' ' ILE . . . -98.32 144.53 27.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.263 -1.523 . . . . 0.0 109.957 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.855 HD11 ' C ' ' A' ' 1' ' ' SER . 45.5 mm -124.07 111.55 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.417 -0.802 . . . . 0.0 109.136 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.874 HD11 HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -116.24 123.42 47.68 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.044 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.71 -158.62 14.79 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.74 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.572 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -106.63 -60.83 1.61 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.349 -1.089 . . . . 0.0 109.977 -179.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.83 6.87 14.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.976 -1.078 . . . . 0.0 108.725 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 28' ' ' THR . . . -143.04 88.4 0.18 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.02 -2.032 . . . . 0.0 108.02 179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' A' ' 26' ' ' GLY . 2.1 t30 -30.68 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.067 -0.666 . . . . 0.0 110.838 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 26' ' ' GLY . 12.3 m -166.56 104.23 0.61 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.05 -1.031 . . . . 0.0 109.845 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.51 ' NE1' ' HA3' ' A' ' 26' ' ' GLY . 19.6 m0 -79.4 -27.93 41.83 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.576 ' HB3' ' CG1' ' A' ' 21' ' ' ILE . . . -147.54 163.59 36.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t -143.98 155.84 44.18 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.11 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 96.6 p -64.63 -9.96 23.21 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.649 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 32' ' ' SER . . . 63.8 66.77 0.65 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.16 -87.47 0.07 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -94.24 148.34 22.3 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.218 -1.166 . . . . 0.0 109.212 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.12 148.57 38.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.599 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -103.29 132.8 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.278 -0.888 . . . . 0.0 109.625 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.1 p -72.04 149.24 92.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.92 . . . . 0.0 109.398 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.722 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 6.1 Cg_exo -60.15 177.62 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.184 1.923 . . . . 0.0 110.202 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 39' ' ' PRO . . . 83.37 -42.23 0.1 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.608 -0.682 . . . . 0.0 109.633 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -68.24 -31.81 71.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.058 -1.026 . . . . 0.0 109.569 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.09 -35.93 60.46 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.3 -33.96 73.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -1.173 . . . . 0.0 109.531 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.2 m -59.14 -31.73 69.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.412 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 mt -68.7 -40.58 79.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 109.398 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.62 -42.01 99.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.383 -0.823 . . . . 0.0 109.454 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.4 t -74.85 -9.98 59.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 109.562 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.38 -16.65 36.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.923 . . . . 0.0 109.729 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -81.89 -15.93 52.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.248 -0.907 . . . . 0.0 109.688 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -117.3 4.51 12.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.271 -0.893 . . . . 0.0 109.239 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -166.44 107.72 0.69 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -0.865 . . . . 0.0 109.468 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 56' ' ' ARG . . . -95.11 47.74 1.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.379 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.577 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -82.59 -49.62 0.8 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 110.721 -179.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 4.8 Cg_exo -63.57 -71.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.974 1.783 . . . . 0.0 111.393 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.769 HG22 ' O ' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -45.52 -54.13 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.13 -0.981 . . . . 0.0 110.053 -178.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 5.0 mtp180 -50.83 -53.24 33.85 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.161 -0.962 . . . . 0.0 109.489 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.81 -87.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.54 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.2 -82.96 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.179 -0.95 . . . . 0.0 109.426 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.769 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -179.97 -99.96 0.13 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.477 ' CB ' ' HB2' ' A' ' 67' ' ' TYR . 1.3 m-85 -131.19 133.53 45.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.358 -1.083 . . . . 0.0 109.273 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -129.25 125.61 37.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.194 -0.942 . . . . 0.0 109.483 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.93 -149.78 0.41 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.329 -0.857 . . . . 0.0 109.302 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.25 -75.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.415 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.57 37.14 1.91 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.85 158.52 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -1.145 . . . . 0.0 109.773 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -131.03 143.21 50.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.448 -0.783 . . . . 0.0 109.51 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.477 ' HB2' ' CB ' ' A' ' 60' ' ' PHE . 33.8 m-85 -134.56 -169.51 2.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.326 -0.859 . . . . 0.0 109.34 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.41 136.96 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.964 . . . . 0.0 109.426 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.642 HG21 ' HB ' ' A' ' 55' ' ' ILE . 1.7 m -93.87 103.03 15.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.943 . . . . 0.0 109.266 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 70' ' ' LEU . 4.0 tp -124.0 38.11 4.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.963 . . . . 0.0 109.715 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER 172.53 50.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 179.634 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.451 ' HA ' HG12 ' A' ' 77' ' ' ILE . . . -113.78 23.38 13.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.866 . . . . 0.0 109.125 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -124.97 -24.02 4.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 109.672 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -75.57 -93.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.119 -0.988 . . . . 0.0 109.253 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.61 -46.9 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 109.254 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 67.7 m -89.39 -164.2 1.11 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.912 . . . . 0.0 108.779 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.714 ' O ' HG22 ' A' ' 77' ' ' ILE . 45.3 mt -157.73 63.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.983 -1.073 . . . . 0.0 110.212 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.861 ' CD1' HG23 ' A' ' 87' ' ' ILE . 1.9 m-85 -90.81 145.22 24.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.996 -1.065 . . . . 0.0 108.432 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -140.61 -171.21 12.38 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.484 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -149.59 -176.66 5.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.584 -0.95 . . . . 0.0 108.944 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER 178.55 34.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.973 . . . . 0.0 109.617 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.431 ' C ' ' OG ' ' A' ' 83' ' ' SER . . . 62.33 95.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 101' ' ' ASN . 0.6 OUTLIER 70.55 6.79 5.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.287 -1.125 . . . . 0.0 109.783 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 81' ' ' LYS . . . -150.35 129.88 13.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.661 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.561 ' HA3' ' CZ ' ' A' ' 100' ' ' TYR . . . -150.35 174.8 29.64 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.867 HG22 ' CG2' ' A' ' 88' ' ' THR . 7.4 p -148.14 114.26 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -1.177 . . . . 0.0 110.133 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.861 HG23 ' CD1' ' A' ' 78' ' ' TYR . 7.2 mt -90.72 79.34 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.115 -0.991 . . . . 0.0 109.212 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.867 ' CG2' HG22 ' A' ' 86' ' ' VAL . 1.2 p -105.56 141.78 36.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.198 -0.939 . . . . 0.0 110.116 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 1.026 HG22 HD21 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -150.49 -178.11 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.493 ' N ' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.41 80.3 1.38 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.886 -1.134 . . . . 0.0 110.466 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 1.034 HG22 HD11 ' A' ' 121' ' ' ILE . 19.3 p -98.56 148.65 23.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.935 . . . . 0.0 108.666 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 0.3 OUTLIER 50.85 20.27 0.75 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.341 -0.85 . . . . 0.0 109.754 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 92' ' ' SER . 0.5 OUTLIER 81.95 -18.71 0.46 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.342 -0.849 . . . . 0.0 110.192 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.556 ' HA ' ' CD2' ' A' ' 24' ' ' LEU . 1.4 p -82.28 178.94 7.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.213 -0.93 . . . . 0.0 109.21 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 4.8 mt -130.86 101.65 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.134 -0.979 . . . . 0.0 110.117 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.026 HD21 HG22 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -71.74 157.78 37.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.299 -0.876 . . . . 0.0 108.743 179.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.874 HG21 HD11 ' A' ' 22' ' ' LEU . 10.4 t -132.3 68.27 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.952 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 86' ' ' VAL . . . -48.26 129.46 19.03 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 107.399 -2.28 . . . . 0.0 107.399 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -132.12 106.0 10.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.715 -1.462 . . . . 0.0 108.73 -178.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.868 ' HB2' HD12 ' A' ' 104' ' ' ILE . 22.5 p90 -122.77 164.56 18.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.371 -0.83 . . . . 0.0 109.905 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 102' ' ' GLU . 1.1 m120 -150.68 -164.11 1.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.443 -0.786 . . . . 0.0 109.312 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 101' ' ' ASN . 0.8 OUTLIER 61.49 19.21 10.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.626 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.8 mttt 60.28 62.74 1.52 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.118 -0.989 . . . . 0.0 109.377 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.868 HD12 ' HB2' ' A' ' 100' ' ' TYR . 6.2 mt -73.68 123.05 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.285 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -44.66 104.86 0.41 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.447 -0.783 . . . . 0.0 109.983 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 104' ' ' ILE . 3.6 Cg_exo -62.08 172.82 3.66 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.053 1.835 . . . . 0.0 110.173 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 111' ' ' ASN . . . 87.9 -19.88 31.56 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.846 ' O ' HG23 ' A' ' 112' ' ' VAL . 17.1 m -106.24 -45.56 4.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -1.18 . . . . 0.0 109.273 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.529 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . . . -73.64 -43.31 59.85 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.186 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.71 -30.79 70.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.147 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 107' ' ' GLY . 0.7 OUTLIER -70.09 -40.98 74.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.346 -0.846 . . . . 0.0 109.467 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 108' ' ' THR . 21.6 t -67.2 -26.11 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.124 -0.985 . . . . 0.0 109.33 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.774 HG13 ' HZ2' ' A' ' 2' ' ' TRP . 38.1 t -76.73 -27.63 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.367 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.38 -43.12 82.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.442 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.2 -54.29 11.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 109.062 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.604 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 5.0 mp -51.55 -22.31 3.14 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.268 -0.895 . . . . 0.0 109.084 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.655 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -71.25 -43.73 66.69 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.441 -0.787 . . . . 0.0 109.248 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.44 -14.58 29.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.741 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.485 ' CD1' ' C ' ' A' ' 119' ' ' TYR . 1.7 t80 -78.55 -60.76 2.24 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -0.935 . . . . 0.0 109.512 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.58 -50.08 68.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.909 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.034 HD11 HG22 ' A' ' 91' ' ' THR . 19.6 mt -51.08 -34.21 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.087 -1.008 . . . . 0.0 109.513 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -45.16 -65.3 1.9 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -46.88 -60.42 2.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -1.12 . . . . 0.0 109.642 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.4 74.09 1.19 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 92' ' ' SER . 64.1 m-85 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.256 -1.144 . . . . 0.0 109.482 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 2' ' ' TRP . 2.4 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.856 ' NE1' HD23 ' A' ' 10' ' ' LEU . 3.3 m-90 43.25 30.61 0.31 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.376 -0.827 . . . . 0.0 109.501 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -74.71 0.18 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.957 -1.09 . . . . 0.0 109.248 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 m -69.61 -8.81 50.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.127 -0.983 . . . . 0.0 109.051 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.626 ' HB3' HD13 ' A' ' 10' ' ' LEU . 14.2 m-30 -88.55 -34.43 17.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.356 -0.84 . . . . 0.0 109.098 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.667 ' HA ' HG23 ' A' ' 11' ' ' VAL . 1.0 OUTLIER -60.99 -33.79 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.311 -0.868 . . . . 0.0 108.746 179.565 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -48.83 -89.58 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.484 -0.76 . . . . 0.0 110.504 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 p -133.64 13.36 4.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.068 -1.02 . . . . 0.0 110.556 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 14' ' ' GLY . 16.9 m-20 -96.59 -82.72 0.39 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.965 -1.084 . . . . 0.0 109.123 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.856 HD23 ' NE1' ' A' ' 2' ' ' TRP . 7.9 mp -65.73 -24.18 66.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.927 -1.108 . . . . 0.0 109.322 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.928 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 3.6 t -85.18 -57.7 4.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.748 ' C ' HG22 ' A' ' 13' ' ' THR . . . -47.65 -35.97 12.1 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.748 HG22 ' C ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER 154.93 49.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 122.032 -0.687 . . . . 0.0 110.628 178.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.72 ' O ' ' HB2' ' A' ' 15' ' ' ALA . . . -94.87 21.08 45.65 Favored Glycine 0 C--N 1.292 -1.898 0 N-CA-C 106.471 -2.652 . . . . 0.0 106.471 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.758 ' O ' HG21 ' A' ' 104' ' ' ILE . . . 153.21 -30.96 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 18' ' ' GLN . 5.6 m -139.34 153.11 23.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.476 ' O ' ' OE1' ' A' ' 18' ' ' GLN . 63.2 p -80.36 12.24 3.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.898 -1.126 . . . . 0.0 109.114 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.525 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -171.86 176.57 3.56 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.928 ' HB3' ' CG2' ' A' ' 11' ' ' VAL . . . -175.05 159.67 2.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.789 -1.194 . . . . 0.0 109.777 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.801 ' HB1' HG22 ' A' ' 31' ' ' THR . . . -153.17 122.56 6.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.15 -0.969 . . . . 0.0 110.0 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.554 ' CD1' ' HB2' ' A' ' 2' ' ' TRP . 5.0 mm -81.58 98.47 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.039 HD22 HG21 ' A' ' 97' ' ' VAL . 5.4 mp -75.99 -79.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.606 -0.684 . . . . 0.0 110.302 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.482 ' HA3' ' CZ3' ' A' ' 29' ' ' TRP . . . 141.04 148.95 5.18 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.532 ' HB3' ' CG1' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -107.51 -16.82 14.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.08 -1.247 . . . . 0.0 109.863 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.11 31.98 0.84 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.064 -1.022 . . . . 0.0 109.843 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.69 -110.94 0.69 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.75 -63.29 0.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.409 -1.053 . . . . 0.0 109.153 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.571 ' O ' ' CE3' ' A' ' 29' ' ' TRP . 0.2 OUTLIER -134.95 -178.06 4.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.91 . . . . 0.0 109.525 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.571 ' CE3' ' O ' ' A' ' 28' ' ' THR . 0.6 OUTLIER -157.3 -54.38 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.871 . . . . 0.0 109.143 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.518 ' O ' HG12 ' A' ' 21' ' ' ILE . . . -173.76 79.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.801 HG22 ' HB1' ' A' ' 20' ' ' ALA . 17.9 p -79.57 166.52 21.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -0.973 . . . . 0.0 110.481 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.501 ' HB2' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -171.17 54.92 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.436 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . . . -124.24 -166.4 1.5 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.365 -0.835 . . . . 0.0 109.631 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.31 -25.01 14.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.412 ' HE2' HG11 ' A' ' 99' ' ' VAL . 4.0 p90 -82.81 -175.44 5.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -1.233 . . . . 0.0 109.453 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.817 ' O ' ' HB2' ' A' ' 63' ' ' ALA . . . -141.8 95.87 2.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 109.636 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 t -84.41 66.6 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 109.377 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.704 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 1.2 t -93.04 -26.87 0.28 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.325 -0.86 . . . . 0.0 112.627 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 38' ' ' THR . 6.3 Cg_exo -59.72 -166.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.739 0 C-N-CA 120.774 0.983 . . . . 0.0 110.37 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.22 47.3 1.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.456 ' OE1' ' HA ' ' A' ' 41' ' ' GLN . 14.0 mm-40 -81.27 -16.6 52.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.069 -1.02 . . . . 0.0 109.124 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.0 -41.54 92.47 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -27.9 65.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -1.209 . . . . 0.0 109.662 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.3 m -63.32 -22.52 66.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.137 -0.977 . . . . 0.0 109.508 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.93 -43.2 16.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 110.289 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . . . -72.38 -54.93 7.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.044 -1.035 . . . . 0.0 109.913 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 m -55.05 -29.39 57.36 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.229 -0.92 . . . . 0.0 109.291 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.9 90.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.336 -0.853 . . . . 0.0 109.641 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 46' ' ' ALA . 17.3 m-30 -53.4 -21.27 5.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.27 -0.894 . . . . 0.0 109.853 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -80.55 -58.57 3.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.011 . . . . 0.0 109.535 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -126.91 133.35 50.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 109.514 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.447 ' C ' HG12 ' A' ' 55' ' ' ILE . . . -112.1 29.17 8.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 109.45 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.618 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 5.0 t70 -81.77 -45.63 1.06 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 110.62 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 1.3 Cg_endo -66.32 -6.33 14.66 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 121.524 1.483 . . . . 0.0 110.368 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.814 HD13 ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -103.32 -31.98 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 0.0 109.709 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 69' ' ' THR . 4.3 ptp180 -71.38 -26.75 62.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.013 -1.054 . . . . 0.0 109.515 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.8 -63.16 1.45 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 109.808 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.04 -32.94 5.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 109.459 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 55' ' ' ILE . . . 111.75 -151.03 18.02 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.52 ' HZ ' HG11 ' A' ' 86' ' ' VAL . 21.3 p90 -123.12 166.49 15.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -1.096 . . . . 0.0 109.42 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.674 ' O ' HD23 ' A' ' 62' ' ' LEU . 1.2 p30 -127.32 151.65 48.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 109.922 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 61' ' ' ASP . 25.7 mt -123.62 -141.33 0.31 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.327 -0.858 . . . . 0.0 109.464 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.817 ' HB2' ' O ' ' A' ' 36' ' ' ALA . . . -28.11 -70.81 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.9 -0.5 . . . . 0.0 111.115 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.76 21.6 0.39 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.57 163.77 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.155 -1.203 . . . . 0.0 109.476 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -102.57 155.91 17.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 109.35 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.452 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 64.6 m-85 -141.81 150.32 41.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.258 -0.901 . . . . 0.0 109.324 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 69' ' ' THR . 49.9 t -97.55 161.2 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.747 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.507 ' N ' HG12 ' A' ' 68' ' ' VAL . 19.8 m -146.22 91.76 2.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 109.18 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.84 HD23 ' O ' ' A' ' 70' ' ' LEU . 1.7 tt -109.36 25.92 11.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.226 -0.921 . . . . 0.0 109.599 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.466 ' CG ' ' O ' ' A' ' 70' ' ' LEU . 7.2 mtm180 -158.87 61.17 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.885 . . . . 0.0 109.42 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 73' ' ' ASP . . . -129.91 119.98 24.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.437 -0.79 . . . . 0.0 109.407 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 72' ' ' ALA . 0.7 OUTLIER 169.38 -61.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 109.498 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.526 ' HB3' ' HD2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -56.34 -83.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.167 -0.958 . . . . 0.0 109.328 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.526 ' HD2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -148.67 -34.48 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.028 -1.045 . . . . 0.0 110.264 179.754 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 72.3 m -97.28 162.8 13.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.906 -1.122 . . . . 0.0 109.827 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 76' ' ' SER . 3.4 mp -146.77 83.58 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 109.824 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.862 ' CD2' HG23 ' A' ' 87' ' ' ILE . 1.1 m-85 -92.65 96.14 10.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.007 -1.058 . . . . 0.0 108.718 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.99 174.65 8.62 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.41 85.27 1.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.338 -1.095 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -59.91 178.05 0.2 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.2 -0.937 . . . . 0.0 109.496 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -51.65 -45.0 54.79 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.63 -19.99 3.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -1.172 . . . . 0.0 110.406 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -99.02 167.42 10.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.898 -1.126 . . . . 0.0 109.86 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.51 153.73 23.19 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.573 HG23 HG13 ' A' ' 97' ' ' VAL . 3.9 p -136.34 132.23 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.134 -1.215 . . . . 0.0 109.846 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.862 HG23 ' CD2' ' A' ' 78' ' ' TYR . 67.6 mt -107.5 112.63 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.328 -0.858 . . . . 0.0 109.229 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.422 ' OG1' ' HB ' ' A' ' 77' ' ' ILE . 1.4 p -120.35 117.69 28.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.622 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 1.042 HG22 HD21 ' A' ' 96' ' ' LEU . 18.1 m -144.59 146.66 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 109.532 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -77.22 151.57 35.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.252 -0.905 . . . . 0.0 109.326 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.542 ' O ' ' CB ' ' A' ' 125' ' ' PHE . 25.1 p -147.34 -111.41 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 109.785 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.72 86.41 5.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.772 -1.205 . . . . 0.0 109.88 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.448 ' O ' ' CZ2' ' A' ' 29' ' ' TRP . 0.6 OUTLIER 51.18 21.72 1.15 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.331 -0.855 . . . . 0.0 109.464 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.451 ' O ' ' OG1' ' A' ' 91' ' ' THR . 4.9 t -157.32 147.61 20.95 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.374 -0.829 . . . . 0.0 109.377 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 89' ' ' VAL . 11.0 mt -109.1 154.2 10.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.395 -0.816 . . . . 0.0 109.071 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.042 HD21 HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.59 150.81 34.46 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.028 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 1.039 HG21 HD22 ' A' ' 22' ' ' LEU . 54.9 t -129.68 77.31 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.291 -0.881 . . . . 0.0 110.159 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.03 143.77 45.44 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.457 HG22 HG12 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -143.15 118.33 4.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.691 -1.476 . . . . 0.0 109.853 -179.078 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.582 ' CE1' ' O ' ' A' ' 104' ' ' ILE . 35.1 p90 -131.89 166.0 22.62 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 103' ' ' LYS . 46.7 t30 -150.31 133.33 16.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.871 -1.143 . . . . 0.0 110.864 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 101' ' ' ASN . 0.0 OUTLIER 38.39 29.74 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.634 179.289 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 101' ' ' ASN . 5.6 mmtp -136.19 -51.31 0.71 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.246 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.775 ' O ' HG22 ' A' ' 104' ' ' ILE . 1.7 mp -112.35 75.68 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.127 -0.983 . . . . 0.0 109.841 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.458 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 9.6 mt-30 -54.8 158.1 4.83 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.077 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 105' ' ' GLN . 2.9 Cg_endo -60.03 143.52 99.56 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.088 1.859 . . . . 0.0 110.403 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.16 -22.49 6.7 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.6 m -114.93 -52.87 2.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.125 -1.221 . . . . 0.0 109.499 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.513 ' HB2' HG21 ' A' ' 104' ' ' ILE . . . -72.37 -29.46 63.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 109.527 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -71.43 -21.82 61.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.572 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -90.08 -50.72 5.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.195 -0.94 . . . . 0.0 109.674 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 109' ' ' ALA . 7.1 p -61.05 -38.18 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 109.683 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.778 HG11 HG21 ' A' ' 87' ' ' ILE . 44.8 t -72.72 -31.14 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.133 -0.98 . . . . 0.0 109.601 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 110' ' ' ALA . 6.6 tt0 -65.91 -42.33 90.31 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.171 -0.956 . . . . 0.0 109.824 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -75.87 -36.52 59.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -0.968 . . . . 0.0 109.875 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.554 HD23 ' CH2' ' A' ' 2' ' ' TRP . 17.1 tp -60.0 -62.52 1.81 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.091 -1.006 . . . . 0.0 108.797 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 1.072 ' O ' HD12 ' A' ' 121' ' ' ILE . . . -60.36 -21.53 62.23 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.27 -0.894 . . . . 0.0 109.284 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.465 ' HB2' ' HA ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -58.07 -52.0 67.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.281 -0.887 . . . . 0.0 109.539 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -59.27 -29.38 67.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.201 -0.937 . . . . 0.0 108.982 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.413 HD13 ' HB ' ' A' ' 91' ' ' THR . 4.3 mt -80.0 -22.9 41.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 110.025 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.072 HD12 ' O ' ' A' ' 117' ' ' ALA . 1.3 mp -87.45 -16.08 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.096 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.15 -27.62 15.65 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -81.78 -71.71 0.47 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.363 -1.081 . . . . 0.0 109.367 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 144.9 94.0 0.17 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.542 ' CB ' ' O ' ' A' ' 91' ' ' THR . 22.6 m-85 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.131 -1.217 . . . . 0.0 109.362 179.691 . . . . . . . . 1 1 . 1 stop_ save_